Methods for diagnosing, treating, and monitoring chronic inflammatory response syndrome

ABSTRACT

The present invention relates generally to the diagnosis, treatment, and monitoring of Chronic Inflammatory Response Syndrome (CIRS), kits for use in the methods, and pharmaceutical compositions for use in the methods of treatment. The invention specifically relates to the diagnosis, treatment and monitoring of CIRS through a comprehensive approach comprising an assessment of a subject for case definition parameters and a proteogenomic analysis. The proteogenomic analysis for the diagnosis, treatment, and monitoring of CIRS is based on identifying proteins and/or genes that are differentially expressed in subjects suffering from CIRS compared to healthy subjects.

RELATED APPLICATION DATA

This application claims priority to Provisional Application No. 61/680,613, filed on Aug. 7, 2012, the disclosure of which is hereby incorporated by reference herein in its entirety.

FIELD OF THE INVENTION

The present invention relates generally to the diagnosis, treatment, and monitoring of Chronic Inflammatory Response Syndrome (CIRS), kits for use in the methods, and pharmaceutical compositions for use in the methods of treatment. The invention specifically relates to the diagnosis, treatment and monitoring of CIRS through a comprehensive approach comprising an assessment of a subject for case definition parameters and a proteogenomic analysis. The proteogenomic analysis for the diagnosis, treatment, and monitoring of CIRS is based on identifying proteins and/or genes that are differentially expressed in subjects suffering from CIRS compared to healthy subjects.

BACKGROUND OF THE INVENTION

CIRS is a form of Systemic Inflammatory Response Syndrome (SIRS) and is characterized by (1) lack of regulation of host inflammatory response as evidenced by deficiency of alpha melanocyte stimulating hormone (MSH) and/or vasoactive intestinal polypeptide (VIP); (2) presence of more than one of Th1 responses (pro-inflammatory); Th2 responses (anti-inflammatory); Th17 responses (tied to transforming growth factor beta-1 (TGF-β1)); coagulation abnormalities, especially abnormalities in von Willebrand's profile; activation of complement split products; activation of elements under regulation of hypoxia inducible factor including vascular endothelial growth factor (VEGF) and erythropoietin; abnormal regulation of ACTH responses to cortisol and ADH responses to osmolality. CIRS may be acquired through different mechanisms, for example, an exposure to toxins or inflammagens that may include, but are not limited to, environmental biotoxins, and chronic illness from Lyme disease present even after treatment with antibiotics. The exposure to environmental sources of biotoxins includes a chronic exposure to the interior environment of water-damaged buildings (WDB), or ingestion of fish contaminated with the toxins of marine dinoflagellates, such as ciguatoxins. Other environmental sources of biotoxins that can lead to CIRS include certain compounds made by dinoflagellates, cyanobacteria, fungi, actinomycetes, bacteria, mycobacteria, etc. When CIRS is acquired because of an exposure to a WDB, it is termed CIRS-WDB (Expert Treating Physicians Consensus, 2010).

According to a report released by the World Health Organization in 2009, in a WDB, people are chronically exposed to different microbes and/or compounds of microbial or other origin that are present in the indoor air of a WDB. These compounds initiate an innate immune inflammatory response in the human host. These microbes and compounds include but are not limited to fungi, bacteria, actinomycetes, and mycobacteria and their toxins; as well as inflammagens from fragments of fungal structures; and beta glucans, mannans, hemolysins, proteinases, spirocyclic drimanes and volatile organic compounds (VOCs). An ongoing exposure to the above microbes and/or compounds can result in a recurrent activation of immune responses, leading to exaggerated immune responses and prolonged production of inflammatory mediators, especially in the absence of regulation of inflammation by neuropeptides MSH or VIP.

Some of the organisms that make biotoxins that can cause CIRS include dinoflagellates (Pfiesteria, Gambierdiscus (ciguatera), Karenia (and other species that produce brevetoxins) cyanobacteria (Microcystis, Cylindrospermopsis, Lyngbya wollei); fungi (Wallemia, Stachybotrys, Chaetomium, Trichoderma, Aspergillus versicolor, Aspergillus versicolor and others); actinomycetes (Streptomyces and others); apicomplexans (Babesia, Sarcocystis, Eimeria), and spirochetes (Borrelia spp burgdorferi and (likely) B. lonestari). Organisms such as commensal multiple-antibiotic resistant coagulase negative staphylococci (MARCoNS), including methicillin resistant Staphylococcus epidermidis, may also contribute to CIRS.

Two examples of inflammagens that may cause CIRS are beta-glucans and mannans made by fungi that activate specific C-type lectin receptors, namely dectin-1 and dectin-2 receptors.

Patients with CIRS are often misdiagnosed as having depression, stress, allergy, fibromyalgia, post traumatic stress disorder, Chronic Fatigue Syndrome or somatization, etc., and are treated with various therapies, some of them being potentially toxic, which have not yet been shown to be effective, and are often costly. One reason that CIRS may be misdiagnosed is because there are no biomarkers that have been identified yet for CIRS or for those commonly-misdiagnosed illnesses, which would allow for a confirmatory diagnosis. Treating CIRS patients for the above conditions does not improve their symptoms of CIRS. With proper detection, diagnosis, and documentation of the objective basis of illness pathophysiology, CIRS may be treated effectively to improve symptoms and decrease the recurrence of uncontrolled inflammatory responses. Therefore, there exists a need for accurate diagnosing of CIRS in order to effectively treat patients with CIRS.

SUMMARY OF THE INVENTION

The present invention relates to the diagnosis, prognosis, prevention and/or treatment of CIRS. In particular, the invention is directed to the differential diagnosis of CIRS in a subject suspected of having CIRS, including differential diagnosis based on a detailed medical history and optional visual contrast sensitivity testing (VCS), and also identifying a panel of proteogenomic markers that are differentially expressed in subjects with CIRS relative to reference levels of expression of these markers either in disease-free healthy subjects or in subjects with CIRS prior to receiving the treatment for CIRS.

The term “a subject suspected of having CIRS” refers to, but is not limited to, individuals who are exposed to CIRS etiological factors such as environmental sources of toxins, including WDB, ciguatoxins, or other toxic components originating from dinoflagellates, cyanobacteria, fungi, actinomycetes, bacteria, mycobacteria, etc., or chronic illness from Lyme disease.

The term “differential diagnosis” as used herein refers to obtaining medical history and objective parameters from a subject, determining whether the subject has been exposed to any potential CIRS etiological factors, optionally performing visual contrast sensitivity (VCS) testing on the subject, and making a determination as to whether the subject is suspected of having CIRS or not having CIRS based on the medical history, laboratory testing, and the results of VCS testing, if performed.

The term “proteogenomic markers” as used herein refers to a combination of one or more genomic markers and/or one or more proteomic markers that are used in order to make a determination of whether a subject is suspected of having CIRS or not having CIRS. The proteogenomic markers may include any one of the markers set forth in Tables 3-4 and Appendices A-D, any combination of markers set forth in Tables 3-4 and Appendices A-D, or all of the markers set forth in Tables 3-4 and Appendices A-D.

The present invention also includes methods for testing trigger mechanisms of CIRS, such as an Environmental Relative Moldiness Index (ERMI) and its derivative, Health Roster of Type Specific formers of Mycotoxins and Inflammagens, second iteration (HERTSMI-2); testing for the presence of fungi in the built environment; testing for Lyme borreliosis; or an assessment of intoxication with ciguatoxins.

The treatment methods of the invention may also include removing the subject from the source of the toxins and/or inflammagens, and/or removing the toxins and/or inflammagens from the subject or the environment surrounding the subject. Such toxins or inflammagens may include, but are not limited to, environmental biotoxins, such as those found in the interior environment of water-damaged buildings (WDB), in fish contaminated with the toxins of marine dinoflagellates (e.g., ciguatoxins), as well as certain compounds produced by dinoflagellates, cyanobacteria, fungi, actinomycetes, bacteria, mycobacteria, etc. The toxins may also be present in the subject as a result of chronic illness from Lyme disease present even after treatment with antibiotics, for example.

In one embodiment, the method of diagnosing Chronic Inflammatory Response Syndrome (CIRS) in a subject suspected of having CIRS, comprises a) obtaining at least the case definition parameters listed in Table 1 for the subject; and b) diagnosing the subject as having CIRS if the subject shows the presence of one or more, two or more, three or more, four or more, five or more, six or more, seven or more eight or more, nine or more, or all ten of the case definition parameters listed in Table 1. Preferably, the presence of at least three of these parameters is detected; more preferably, the presence of at least four parameters is detected; most preferably, the presence of at least five parameters is detected. The step of obtaining case definition parameters may comprise i) obtaining medical history of the subject; ii) optionally performing a visual contrast sensitivity testing on the subject; iii) determining levels of one or more protein markers listed in Tables 3 and 4 in a biological sample obtained from the subject; iv) determining levels of one or more mRNA markers selected from Appendices A, B and/or C in the biological sample; v) determining levels of one or more micro-RNA markers listed in Appendix D in the biological sample.

In one embodiment, the step of obtaining medical history is followed by differential diagnosis to diagnose the subject as suspected of having CIRS or not having CIRS. The differential diagnosis is then confirmed by determining the levels of one or more proteogenomic markers.

In another embodiment, the method of diagnosing CIRS comprises diagnosing CIRS based on the expression levels of one or more protein markers. According to this embodiment, the method of diagnosing chronic inflammatory response syndrome (CIRS) in a subject suspected of having CIRS comprises a) determining levels of one or more protein markers listed in Table 3 in a biological sample obtained from the subject; b) diagnosing the subject as having CIRS if the levels of the one or more protein markers are statistically significantly different from reference levels for the one or more protein markers.

In yet another embodiment, the method of diagnosing CIRS comprises diagnosing CIRS based on the expression levels of one or more mRNA markers. According to this embodiment, the method of diagnosing chronic inflammatory response syndrome (CIRS) in a subject suspected of having CIRS comprises a) determining levels of one or more mRNA markers selected from Appendices A, B and/or C in a biological sample obtained from the subject; b) diagnosing the subject as having CIRS if the levels of the one or more mRNA markers are statistically significantly different from reference levels for the one or more mRNA markers.

In yet another embodiment, the method of diagnosing CIRS comprises diagnosing CIRS based on the expression levels of one or more micro-RNA markers. According to this embodiment, the method of diagnosing chronic inflammatory response syndrome (CIRS) in a subject suspected of having CIRS comprises a) determining levels of one or more micro-RNA markers listed in Appendix D in a biological sample obtained from the subject; b) diagnosing the subject as having CIRS if the levels of the one or more micro-RNA markers are statistically significantly different from reference levels for the one or more micro-RNA markers.

According to the invention, it has been found that subjects with CIRS may also exhibit brain abnormalities. Specifically, it has been found that subjects with CIRS may exhibit structural brain volumes abnormalities including, but not limited to, an increase in forebrain parenchyma, an increase in cortical gray area, an increase in the volume of the hippocampus, a decrease in the volume of caudate, and/or an increase in the volume of pallidum. These structural brain abnormalities have been identified, for example, in subjects suffering from CIRS-WDB. Accordingly, in another embodiment, the method of diagnosing CIRS may further comprise detecting brain abnormalities in a subject suspected of having CIRS using known or as-yet undeveloped methods for detecting brain abnormalities. The methods of monitoring treatment of CIRS may also further comprise detecting brain abnormalities in a subject being treated for CIRS at a first time period prior to treatment, and comparing the abnormalities with brain abnormalities detected at a second time period after treatment has been initiated, and determining whether improvement in brain abnormalities is observed. Methods known in the art for detecting brain abnormalities may include, but are not limited to, CT scans, MRI scans, PET scans, brain volume measurement (i.e., FreeSurfer, Martinos Center for Biomedical Imaging, Charlestown, Mass.), and NeuroQuant® (CorTechs Labs, La Jolla, Calif.).

The present invention also provides methods of treating chronic inflammatory response syndrome (CIRS). In one embodiment, a method of treating CIRS in a subject, comprises: a) obtaining case definition parameters listed in Table 1 for the subject; b) diagnosing the subject as having CIRS if the subject shows the presence of at least five of the case definition parameters listed in Table 1; c) administering cholestyramine to the subject. The methods may also optionally include removing or reducing the amount of any toxins and/or inflammagens that are suspected of causing CIRS in the subject. When cholestyramine is administered to the subject, dosage amounts and schedules are within the ability of the skilled practitioner to determine, and may be, for example, in the range of 1 to 40 grams per day, preferably 8 to 36 grams per day, more preferably 16 to 24 grams per day. The doses may be provided from 1 to 6 times per day, preferably 2 to 4 times per day. The doses are preferably administered orally. Cholestyramine may be administered for any period of time necessary to achieve relief from CIRS. However, it should be noted that the present invention is not limited by the dosage amount, administration route, or length of administration.

In another embodiment, a method of treating CIRS in a subject comprises: a) obtaining case definition parameters listed in Table 1 for the subject; b) diagnosing the subject as having CIRS if the subject shows the presence of at least five of the case definition parameters listed in Table 1; c) administering vasoactive intestinal peptide (VIP) to the subject. The methods may also optionally include removing or reducing the amount of any toxins and/or inflammagens that are suspected of causing CIRS in the subject. When VIP (aviptadil) is administered to the subject, dosage amounts and schedules are within the ability of the skilled practitioner to determine, and may be, for example, in the range of 5 to 200 micrograms, preferably 10 to 100 micrograms, more preferably 25 to 75 micrograms. According to one embodiment, a dose of 50 micrograms is administered. The doses may be provided from 1 to 4 times per day, preferably 1 time per day. The doses may be administered nasally or injected, although nasal instillation is a preferred method of administration. VIP may be administered for any period of time necessary to achieve relief from CIRS. However, it should be noted that the present invention is not limited by the dosage amount, administration route, or length of administration.

In yet another embodiment, a method of treating CIRS in a subject comprises sequential therapeutic intervention shown in FIG. 2. According to this embodiment, a method of treating CIRS in a subject comprises: a) obtaining case definition parameters listed in Table 1 for the subject including performing differential diagnosis; b) diagnosing the subject as having CIRS if the subject shows the presence of at least five of the case definition parameters listed in Table 1; c) administering a therapeutically effective dose of cholestyramine to the subject; d) treating the subject to eliminate MARCoNS infection if the subject has MARCoNS infection; e) correcting or restoring levels of antigliadin, androgens, ADH/osmolality, MMP9, VEGF, C3a, C4a, TGF-β1; and f) administering a therapeutically effective dose of VIP to the subject.

In one embodiment, the method of treating chronic inflammatory response syndrome (CIRS) in a subject comprises a) determining levels of: one or more protein markers listed in Table 3 and/or one or more mRNA markers selected from Appendices A, B and/or C and/or one or more micro-RNA markers listed in Appendix D in a biological sample obtained from the subject; b) diagnosing the subject as having CIRS if the levels of the one or more protein markers and/or the one or more mRNA markers and/or the one or more micro-RNA markers are statistically significantly different from reference levels for corresponding markers; c) administering a therapeutically effective dose of cholestyramine to the subject.

In another embodiment, the method of treating chronic inflammatory response syndrome (CIRS) in a subject comprises a) obtaining case definition parameters listed in Table 1 for the subject, including performing differential diagnosis, at a first time; b) diagnosing the subject as having CIRS if the subject shows the presence of at least five of the case definition parameters listed in Table 1; c) administering a therapeutically effective dose of cholestyramine to the subject; d) treating the subject to eliminate MARCoNS infection if the subject has MARCoNS infection; e) correcting or restoring levels of antigliadin, androgens, ADH/osmolality, MMP9, VEGF, C3a, C4a, TGF-β1; f) administering a therapeutically effective dose of VIP to the subject; g) obtaining case definition parameters listed in Table 1 for the subject at a second time for monitoring the status of CIRS in the subject, wherein the second time is later than the first time; h) diagnosing the subject as showing an improvement of CIRS if, at the second time, the subject shows the presence of fewer health symptoms or the presence of less than five case definition parameters listed in Table 1 or diagnosing the subject as not showing an improvement if the subject shows the presence of at least five of the case definition parameters listed in Table 1; i) repeating steps d) to g), until resolution of CIRS is obtained.

The present invention also provides a method for monitoring CIRS in a subject comprising: a) obtaining case definition parameters listed in Table 1 for the subject at a first time; b) diagnosing the subject as having CIRS if the subject shows the presence of at least five of the case definition parameters listed in Table 1; c) administering a dose of cholestyramine to the subject; d) obtaining case definition parameters listed in Table 1 for the subject at a second time for monitoring the status of CIRS in the subject, wherein the second time is later than the first time; e) diagnosing the subject as showing an improvement of CIRS if the subject shows the presence of less than five case definition parameters listed in Table 1 or diagnosing the subject as not showing an improvement if the subject shows the presence of at least five of the case definition parameters listed in Table 1; f) adjusting the dose of cholestyramine, if required based on the diagnosis in step e); g) administering the adjusted or the same dose of cholestyramine to the subject; h) repeating steps d) to g) until resolution of CIRS is obtained.

In one aspect, the method for diagnosing or monitoring CIRS in a subject according to the invention further comprises a step of detecting, in a biological sample of the subject, a level of regulatory T lymphocytes (Treg cells) as an indirect indicator of the status of tissue-based inflammation in the subject.

In another aspect, the method for diagnosing or monitoring CIRS in a subject according to the invention further comprises determining the presence of unusual staphylococci such as coagulase negative staphylococci, staphylococci which are resistant in Kirby-Bauer susceptibility testing to at least two classes of antibiotics (MARCoNS), and methicillin resistant staphylococci (MRCoNS) in the subject by obtaining an aerobic culture using the API-STAPH or similar technique from deep nasal spaces from the subject. These organisms invariably form biofilm, providing a mechanism to continue to colonize deep nasal spaces without causing overt invasive symptoms such as headache or sinus congestion. In one aspect, the method for diagnosing or monitoring CIRS in a subject according to the invention comprises determining diagnostic parameters that are not altered in CIRS compared to other diseases or disorders the symptoms of which may overlap with CIRS. Such diagnostic parameters include, but are not limited to, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), etc.

The methods of diagnosing, treating, and monitoring CIRS according to the invention may comprise various permutations and combinations of the methods disclosed herein.

According to the invention, it has been found that subjects with CIRS may show a distinct and specific pattern or profile of expression for a set of genes (for example, set X) compared to healthy subjects or subjects with illnesses that have symptoms similar to CIRS. For example, in one aspect of the invention, subjects with CIRS may show a distinct and specific pattern of expression for one or more mRNA markers selected from Appendices A, B and/or C and/or one or more micro RNA markers selected from Appendix D. It has also been found that the expression profile of a set of genes (for example, set Y) may vary between the subjects with CIRS based on the etiology of CIRS. For example, a subject that has acquired CIRS because of an exposure to WDB may show a gene expression pattern different from the gene expression pattern of a subject that has acquired CIRS because of chronic illness from Lyme disease. According to one aspect of the invention, set Y is a subset of set X. Accordingly, the present invention is also directed to predicting the causative agent of CIRS.

In one aspect of the invention, the diagnosis of CIRS is carried out by detecting levels of one or more genes that are differentially expressed between the subjects with CIRS and disease-free healthy subjects. The differential expression of CIRS genes may be measured at the gene level, transcript level and/or polypeptide level. The term “transcript” as used herein encompasses all RNA products produced from the genome, including sense and antisense products, coding RNAs such as messenger RNAs (mRNAs) as well as non-coding RNAs such as Long Intergenic Non-Coding (linc) RNAs as well as regulatory RNAs such as micro-RNAs. Micro-RNAs are a class of small, non-coding RNAs that control gene expression by hybridizing to and triggering either translational repression or, more frequently, degradation of a messenger RNA (mRNA) target. linc RNAs are in general considered as non-protein coding transcripts longer than 200 nucleotides.

The term “differential expression” as used herein means either an over-expression or under-expression of one or more CIRS genes, transcripts or proteins relative to reference levels of expression of corresponding genes, transcripts or proteins. That is, in an embodiment, certain genes, transcripts, and/or proteins are down-regulated while certain other genes, transcripts, and/or proteins are up-regulated compared to reference levels of corresponding genes, transcripts, and/or proteins. In one example, a gene, transcript, and/or protein for vasoactive intestinal peptide (VIP) may be under-expressed while a gene, transcript, and/or protein for anaphylatoxin C4a may be over-expressed. The term CIRS gene, transcript or protein means a gene, transcript or protein that is differentially expressed in CIRS subjects compared to healthy subjects.

In one embodiment, reference levels of expression are the expression levels of genes, transcripts or proteins in a healthy subject. In another embodiment, reference levels of expression are the expression levels of genes, transcripts or proteins in a subject with CIRS prior to the treatment of CIRS. In another embodiment, reference levels of expression are the expression levels of genes, transcripts or proteins in a subject with CIRS at various stages during the course of treatment for CIRS.

The term “statistically significantly different” means the p-value of the differential expression for each selected CIRS gene, transcript or protein is no more than 0.05. In one embodiment, the difference in the expression levels of CIRS genes, transcripts or proteins compared to the reference levels of expression of corresponding genes, transcripts or proteins is at least 1.3-, 2-, 3-, 4-, 5-, 10-, 20-fold or more. In another embodiment, the expression level is indicative of CIRS if it is found in at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, at least 99%, or more in subjects with CIRS and is found in less than 20%, less than 10%, less than 8%, less than 5%, less than 2.5%, or less than 1% of subjects who do not have CIRS.

In yet another embodiment, the differentially expressed CIRS genes, transcripts, and proteins are selected from Tables 3-4 and Appendices A-D. In still another embodiment, the CIRS genes include innate immune response genes such as genes encoding complement factors, neuropeptides, hormones, transcription factors, cytokines, etc.

In one aspect, the differential expression of CIRS genes is diagnosed by measuring the levels of expression of one or more polypeptides, mRNA and/or micro RNA in a biological sample obtained from a subject with CIRS and a biological sample obtained from a healthy individual. The biological sample may be blood, nasal swab, a bodily waste sample or any other body fluid or tissue that can provide a meaningful diagnosis of differentially expressed CIRS genes.

In one aspect, levels of protein markers listed in Table 3, mRNA markers selected from Appendices A, B and/or C, and micro-RNA markers listed in Appendix D in a biological sample may be detected by methods known in the art. In one example, levels of protein markers listed in Table 3 may be determined using antibodies or fragments of antibodies specific for these markers. In another example, levels of protein markers may be detected using methods such as enzyme-linked immunosorbent assays (ELISA), radio-immuno assay (RIA), or western blot analysis. In another example, levels of protein markers may be detected using direct methods such as mass spectrometry. In yet another example, levels of protein markers listed in Table 3 may be determined using commercially available kits such as those available from Laboratory Corporation of America (LabCorp) or Quest Diagnostics, Inc. Although ELISA is one preferred technique for detecting the protein markers used in the invention, alternative techniques such as immunoblotting nuclease protection assays, in situ hybridization, microarrays, immunohistochemistry, are also envisioned, and appropriate apparatus, and reagents for use in carrying out these well-known techniques are envisioned for use in the methods and included as components of the kits.

In an embodiment, levels of mRNA markers selected from Appendices A, B and/or C and levels of micro-RNA markers listed in Appendix D in a biological sample may be determined by extracting total RNA from the biological sample and hybridizing the extracted RNA to labeled nucleic acid probes complementary to mRNA and micro-RNA markers using any state of the art techniques. Techniques for detecting mRNAs and micro-RNAs using labeled nucleic acid probes include microarray analysis, northern blot analysis, and nuclease protection assays. Alternatively, mRNA and micro-RNA markers can be detected using reverse transcription-polymerase chain reaction (RT-PCR) with or without labeled nucleic acid probes. Additionally, newer techniques that do not rely on complementary target-probe hybridization, such as Next Generation Sequencing (NGS), may be used to determine levels of transcripts.

The present invention also provides pharmaceutical compositions useful for treating or preventing CIRS. In one embodiment, the pharmaceutical compositions of the present invention include a pharmaceutically acceptable carrier and at least one polynucleotide encoded by a CIRS gene that is over-expressed or under-expressed in CIRS subjects relative to healthy subjects. The pharmaceutical compositions can also include a variant or an allele of the polynucleotide. In one example, the pharmaceutical compositions are compositions comprising at least one micro-RNA listed in Appendix D.

In another embodiment, the pharmaceutical compositions of the present invention include a pharmaceutically acceptable carrier and at least one active component selected from (i) agents capable of modulating the expression of one or more CIRS genes which are over-expressed or under-expressed in CIRS subjects relative to healthy subjects, (ii) agents capable of binding to, or modulating the biological activity of, the polypeptide(s) encoded by the CIRS gene, (iii) agents capable of modulating Treg cells, or (iv) Treg cells. Exemplary modulations include, but are not limited to, up-regulation, induction, stimulation, inhibition, down-regulation, and suppression.

In one example, the active component is a polynucleotide comprising or encoding an RNA that is capable of inhibiting or decreasing expression of the CIRS gene by RNA interference or an antisense mechanism. In another example, the active component is an agonist or antagonist of a protein encoded by the CIRS gene. In yet another example, the active component is a monoclonal antibody or a fragment thereof. Proteins encoded by CIRS genes can be, for example, innate immune response proteins such as complement factors, neuropeptides, hormones, transcription factors, cytokines, etc. These proteins and genes are potential targets for drug action and development.

In still yet another aspect, the present invention provides methods for screening anti-CIRS agents based on their effects on the expression or function of CIRS genes.

In a further aspect, the present invention provides kits useful for diagnosing CIRS. Each kit can include at least one of the following: (a) one or more polynucleotide probes capable of hybridizing under reduced stringent, stringent, or highly stringent conditions to one or more CIRS genes (or a complement thereof), or (ii) one or more antibodies capable of specifically binding to one or more polypeptides encoded by CIRS genes (e.g., antibodies to the polypeptides). The kits may include a carrier where the polynucleotide probes or antibodies are immobilized and one or more reagents or detection agents for detecting a reaction between the one or more probes or antibodies and target nucleic acids or polypeptides. The kit may also include one or more software and/or instructions to analyze the data generated by using the kit.

In another embodiment, the invention is directed to an antibody or antibodies that specifically bind to proteins or protein fragments that are differentially expressed in subjects with CIRS.

It is further intended that the inventions not be limited only to the specific structure, material or acts that are described in the preferred embodiments, but in addition, include any and all structures, materials or acts that are capable of performing the claimed function, along with any and all known or later-developed equivalent structures, materials or acts capable of performing the claimed function.

BRIEF DESCRIPTION OF THE DRAWINGS

The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 shows that patients with CIRS exhibit defects in visual contrast sensitivity as compared to control healthy individuals.

FIG. 2 shows a sequential therapeutic intervention for treating subjects with CIRS according to one embodiment of the invention.

FIG. 3 shows mean values of various laboratory parameters with significant differences between baseline and controls.

DETAILED DESCRIPTION OF THE INVENTION

The present invention provides methods of diagnosing, treating and monitoring CIRS, as well as test kits for use in the methods. In one aspect, the method of diagnosing CIRS in a subject suspected of having CIRS comprises a) obtaining case definition parameters listed in Table 1 for the subject, comprising: i) obtaining medical history of the subject, ii) performing differential diagnosis; iii) optionally performing visual contrast sensitivity testing on the subject, iv) determining levels of one or more protein markers listed in Table 3 in a biological sample obtained from the subject, v) determining levels of one or more mRNA markers selected from Appendices A, B and/or C in the biological sample, vi) optionally performing brain scanning on the subject, vii) determining levels of one or more micro-RNA markers listed in Appendix D in the biological sample; and b) diagnosing the subject as having CIRS if the subject shows the presence of three or more, preferably four or more, and most preferably five or more of the case definition parameters listed in Table 1.

TABLE 1 Case Definition Parameters Parameters Symptoms score > 8 VCS deficit MSH < 25 pg/mL VIP < 23 pg/mL C4a > 2830 ng/mL TGF-β1 > 2380 pg/mL MMP9 > 332 ng/mL ADH/osmolality dysregulation ACTH/cortisol dysregulation Genomic SVM confidence > 0.9

The case definition parameters listed in Table 1 are explained in more detail below.

Symptoms Score:

Symptoms score is obtained by obtaining a detailed medical history of a subject. Medical history evaluates both subjective patient complaints and causative environmental parameters for potential exposure to biotoxins in the home, school or workplace. Medical history includes a detailed analysis of past medical conditions and current symptoms experienced by the subject. A symptom roster (Table 2) may be used to determine the symptoms experienced by the subject. The symptom roster comprises a list of symptoms grouped by symptom clusters which are discussed in the following references: Shoemaker et al., “Sick Building Syndrome in water-damaged buildings: Generalization of the chronic biotoxin-associated illness paradigm to indoor toxigenic fungi,” Bioaerosols, Fungi, Bacteria, Mycotoxins and Human Health, Johanning, E., editor, 2005, pages 66-77; Shoemaker et al., “A time-series of sick building syndrome; chronic, biotoxin-associated illness from exposure to water-damaged buildings,” Neurotoxicology and Teratology, 2005, 27(1) 29-46; Shoemaker et al., “SBS and exposure to water damaged buildings: time series study, clinical trial and mechanisms,” Neurotoxicology and Teratology, 2006, 28: 573-588; Shoemaker et al., “Innate immunity, MR spectroscopy, HLA DR, TGF beta-1, VIP and capillary hypoperfusion define acute and chronic human illness acquired following exposure to water-damaged buildings,” Healthy Buildings, Syracuse, N.Y., 2009; Shoemaker, “Innate immune responses define pediatric CFS,” International Association for CFS/ME Conference, 2009, Reno, Nev.; Shoemaker, “Exposure to water-damaged buildings causes a readily identifiable chronic inflammatory response syndrome that is successfully treated by a sequential intervention protocol,” 9^(th) International Mycology Congress, Edinburgh, Scotland, 2010; Shoemaker, “Vasoactive Intestinal Polypeptide (VIP): a final step in correction of the inflammatory illness acquired following exposure to water-damaged buildings,” “T regulatory cells in chronic inflammatory response syndrome from water-damaged buildings (CIRS-WDB),” and “HERTSMI-2 Simplifying analysis of safety of WDB,” 6^(th) International Scientific Conference on Bioaerosols, Fungi, Bacteria, Mycotoxins in Indoor and Outdoor Environments and Human Health, Saratoga Springs, N.Y., September 2011. Each of these references is hereby incorporated by reference herein in its entirety.

Each symptom cluster may comprise one or more symptoms. A symptoms score is the number of symptom clusters experienced by the subject. For example, a symptoms score of 5 means the symptoms experienced by the subject belong to 5 symptom clusters. A symptoms score of 8 or more indicates that a subject may be suffering from CIRS.

TABLE 2 Symptom Roster Score Symptom/Cluster Patient Fatigue/1 Weak/2 Ache/2 Cramp/5 Unusual pain/10 Ice pick pain/10 Headache/2 Light sensitivity/2 Red eyes/10 Blurred vision/10 Tearing/12 Sinus/7 Cough/8 Shortness of breath/7 Abdominal pain/11 Diarrhea/11 Joint pain/5 Morning stiffness/5 Memory/3 Focus/concentration/4 Word recall/3 Decreased assimilation/2 Confusion/8 Disorientation/12 Skin sensitivity/6 Mood swings/10 Appetite/9 Sweats/10 Temp regulation/9 Thirst/8 Increased urination/9 Static shocks/13 Numbness/11 Tingling/6 Vertigo/13 Metallic taste/12

2. Visual Contrast Sensitivity (VCS) Testing:

VCS testing measures the neurologic function called contrast that permits an eye to resolve patterns. This test is regarded as the best current test of functional vision. VCS deficiencies due to an exposure to CIRS causative agents such as biotoxins have been shown to correlate with capillary hypoperfusion in the retina and neural rim of the optic nerve head as measured by a dual laser device, Heidelberg Retinal Flowmeter (Hudnell, EPA 2003). Since excessive optical-refraction errors can cause abnormal VCS readings, a visual acuity as measured by Snellen Distance Equivalent Score of better than 20:50 is required for inclusion of this element in the diagnosis of CIRS. Apart from CIRS, VCS deficiencies may occur in certain neurologic conditions such as neurologic conditions developed due to an exposure to mercury, organic solvents, hydrocarbons, or Parkinson's disease (see, e.g., Residential and Recreational Acquisition of Possible Estuarine Associated Syndrome: A New approach to Successful Diagnosis and Therapy, Environmental Health Perspectives, Special CDC Pfiesteria Supplement, 2001; 109S5; 791-796). However, according to the present invention, a combination of symptoms score and VCS can differentially diagnose CIRS subjects from those experiencing non-CIRS illnesses such as the neurologic conditions described above (Table 5). Differences in VCS between subjects exposed to CIRS causative agents and control subjects are shown in FIG. 1.

3. Protein Markers:

The present invention uses a panel of protein markers (Table 3) that are differentially expressed in CIRS subjects compared to healthy individuals. These protein markers are indicative of the physiologic status of inflammatory responses in CIRS subjects. Methods for detecting levels of protein markers listed in Table 3 are known in the art, and include commercially-available enzyme linked immunosorbent assays (ELISAs), radioimmunoassays, and other immunoassay technologies. Additional detection methods may also be employed in order to identify biomarkers, including PCR and related technologies. Various techniques for the detection of the biomarkers may be used in accordance with the invention, such as those described in Ausubel et al., Current Protocols In Molecular Biology, John Wiley & Sons, New York, N.Y., 2002, or Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor, N.Y., 1989. In one embodiment, levels of protein markers listed in Table 3 in a biological sample may be determined using commercially available test kits such as those available from LabCorp or Quest Diagnostics, Inc.

TABLE 3 Protein markers Protein marker C4a VIP MSH TGF-β1 MMP9 ACTH/Cortisol ADH/Osmolality Von Willebrand's profile HLA-DR

The protein markers that may be measured in accordance with the invention can be obtained from any sample of a biological material that is suspected of containing the protein markers as an analyte of interest. Examples of biological materials include, but are not limited to, stool, whole blood, serum, plasma, red blood cells, platelets, interstitial fluid, saliva, ocular lens fluid, cerebral spinal fluid, sweat, urine, ascites fluid, mucous, nasal fluid, sputum, synovial fluid, peritoneal fluid, vaginal fluid, menses, amniotic fluid, semen, etc. Preferably, the test sample is a blood, serum, or urine sample. The test sample may be used directly as obtained or following a pretreatment to modify the sample. For example, pretreatment may include preparing plasma or serum from blood. Methods of pretreatment may also involve filtration, precipitation, dilution, distillation, mixing, concentration, inactivation of interfering components, the addition of reagents, lysing, etc. If such methods of pretreatment are employed with respect to the test sample, such pretreatment methods are such that the analyte of interest remains in the test sample at a concentration proportional to that in an untreated test sample (e.g., a test sample that is not subjected to any such pretreatment method(s)).

3.1. C4a

is a split product of complement component 4. The complement system is an important component of both innate and adaptive immune responses. CIRS patients show a statistically significant difference from normal levels of C4a. Interestingly, CIRS patients, mainly those with CIRS-WDB or CIRS-ciguatera, are not likely to show an increase in the levels of C3a, a product immediately downstream of C4 activation. Complement activation through both the classical pathway and mannose binding lectin system generates increased levels of C4a.

3.2. And 3.3. Vasoactive Intestinal Peptide (VIP) and Alpha Melanocyte stimulating hormone (MSH):

VIP and MSH are neuropeptides critical for the regulation of inflammation. CIRS patients consistently exhibit low levels of VIP and MSH, suggesting lack of regulation of inflammation in the development and persistence of CIRS. These two neuropeptides have been shown to have profound anti-inflammatory effects both in vivo and in vitro and could be used for treating inflammatory diseases.

VIP and/or MSH deficiencies can be acquired either acutely or at an advanced stage of CIRS, as well as through diverse mechanisms such as acute brain injuries (S. Magnoni, et al., Alpha-melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury, J Neurotrauma 20 (2003) 251-60) or persistent viral infection (Y.-R. Tan, et al., Pulmonary peptidergic innervation remodeling and development of airway hyperresponsiveness induced by RSV persistent infection, Peptides 29 (2008) 47-56). It has been shown that VIP agonists effectively protect against Alzheimer-related learning impairment in rats (I. Gozes, et al., Neuropeptides and neuronal survival: neuroprotective strategy for Alzheimer's disease, Annals of the New York Academy of Sciences 814 (1997) 161-6) while deficiency of VIP has been shown to cause cognitive defects in mice (D. Chaudhury, et al., Select cognitive deficits in vasoactive intestinal peptide deficient mice, BMC Neurosci 9 (2008) 63), common symptoms observed in CIRS subjects. One important role of these two neuropeptides is the induction of tolerogenic dendritic cells and generation of T regulatory cells (Tregs), which suppress autoreactive T cells and autoimmune progression (M. Delgado and D. Ganea, Anti-inflammatory neuropeptides: A new class of endogenous immunoregulatory agents, Brain, Behavior, and Immunity 22 (2008) 1146-1151). Even in healthy individuals autoreactive T cells can escape clonal deletion and must be policed in the periphery by Tregs to prevent pathologic autoimmunity (N. A. Danke, et al., Autoreactive T Cells in Healthy Individuals, J Immunol 172 (2004) 5967-5972). Decreased levels of Treg cells due to lower levels of VIP and MSH could be the reason that both pediatric and adult CIRS patients show certain features of autoimmune disease such as markedly elevated levels of anti-gliadin and anti-cardiolipin antibodies compared to healthy individuals.

3.4. And 3.5. Matrix Metalloproteinase 9 (MMP9) and Transforming Growth Factor Beta-1 (TGF-β1):

CIRS patients often show high levels of MMP9 and TGF-β1. These two proteins have been demonstrated to have wide ranging effects on the immune system, including important roles in autoimmune and inflammatory diseases. The timing, duration and target tissues are important aspects for protection or pathological activity of these proteins.

Similar to VIP and MSH, TGF-β1 has been shown to regulate T-cell differentiation pathways and is considered to have an anti-inflammatory action (M. A. Kriegel, et al., Transforming growth factor-beta: recent advances on its role in immune tolerance, Curr Rheumatol Rep 8 (2006) 138-44). However, in the presence of low levels of Treg cells in blood and increased levels of inflammatory cytokines in tissues, TGF-β1 may act in a pro-inflammatory manner. TGF-β1 requires a proteolytic cleavage for its transformation from a latent to a mature complex. Interestingly, MMP9 can drive this transformation. MMP9 expression is also up regulated by TGF-β1 and can influence disease progression by both tissue destruction and cytokine processing (P. Van Lint and C. Libert, Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation, J Leukoc Biol 82 (2007) 1375-1381). Elevated levels of both MMP9 and TGF-β1 have been reported in systemic sclerosis, a generalized disorder of the microvascular characterized by excessive fibrosis (M. Ram, et al., Matrix Metalloproteinase-9 and Autoimmune Diseases, Journal of Clinical Immunology 26 (2006) 299-307). Further, the role of TGF-β1 as a stimulant to pro-fibrotic effects in lung parenchyma, including epithelial to mesenchymal transformation, may support an explanation of restrictive pulmonary function seen in some CIRS cases.

3.6. and 3.7. ACTH/Cortisol and ADH/Osmolality:

Levels of ACTH and cortisol as well as levels of ADH along with osmolality values are important diagnostic parameters in the differential diagnosis of CIRS. Antidiuretic hormone (ADH), also known as vasopressin, is an important hormone in regulating body osmolality or salt balance. All cells in the body rely on maintenance of voltage potential between the intracellular and extracellular compartments, which is maintained by an appropriate concentration of salts in each compartment. Absence of adequate ADH can result in intravascular and systemic dehydration.

Abnormal osmolality values can result in widespread cellular dysfunction. Abnormalities in ADH/osmolality are recorded as “absolute” if ADH is less than 1.3 pg/ml or more than 13.3 pg/ml or if osmolality is more than 295 mOsm/kg or less than 275 mOsm/kg. Abnormalities in ADH/osmolality are recorded as “relative or dysregulated” if simultaneous readings for ADH and osmolality are ADH less than 2.3 pg/ml and osmolality of 292-295 mOsm/kg or ADH more than 4.0 pg/ml and osmolality of 275-278 mOsm/kg. Symptoms associated with dysregulation of ADH include migraine-like headaches, dehydration, frequent urination, excessive thirst and sensitivity to static electrical shocks. Elevated levels of ADH can cause edema and rapid weight gain due to fluid retention.

ACTH/cortisol: Abnormalities in ACTH/cortisol are recorded as “absolute” if morning cortisol levels are more than 18 μg/ml or less than 5 μg/ml; or if morning ACTH levels are more than 45 pg/ml or less than 6 pg/ml. Abnormalities in ACTH/cortisol are recorded as “relative or dysregulated” if simultaneous readings for cortisol and adrenocorticotropic hormone (ACTH), also known as corticotropin, are greater than 16 μg/ml and ACTH greater 20 pg/ml or cortisol less than 12 μg/ml and ACTH less than 10 pg/ml. At an early stage of CIRS, levels of ACTH may remain high; however, at later stages, ACTH levels begin to fall. Simultaneously high levels of cortisol and ACTH could be interpreted to indicate the presence of ACTH secreting tumors. However, in contrast to ACTH secreting tumors, in CIRS, high levels of cortisol and ACTH are usually corrected with treatment.

3.8 von Willebrand's Profile:

von Willebrand's profile consists of measuring the levels of clotting factor Factor VIII as well as von Willebrand's antigen and ristocetin-associated cofactor. More than 66% of CIRS patients show a lack of normal levels of one or more of these components. Combined low levels of ristocetin-associated co-factor and multimers of von Willebrand's factor are called acquired von Willebrand's disease, a rare entity except in CIRS-WDB.

3.9 HLA-DR Typing:

HLA-DR typing is offered by LabCorp as a standard typing assay of 10 alleles using a PCR technique. HLA-DR typing using PCR provides greater specificity in distinguishing individual allele polymorphisms compared to serologic assays for HLA-DR genotypes. CIRS patients show a strong linkage disequilibrium with multiple associations to inflammatory and autoimmune disease. HLA-DR typing by itself may not conclusively indicate the presence or absence of CIRS, but it helps in assessing the susceptibility of a subject to develop CIRS. The role of HLA allele types in determining subjects at risk of chronic illnesses has been investigated, for example, in U.S. Published Application No. 2003/0219400, the contents of which are incorporated herein by reference.

4. Aerobic Culture:

An aerobic culture may be used to detect the presence of biofilm-forming coagulase-negative staphylococci in CIRS patients. API-STAPH nasal culture test can identify slow-growing, commensal biofilm-forming, multiple-antibiotic resistant coagulase-negative staphylococci. These staphylococci differ significantly from non-pathogenic staphylococci and alter levels of MSH, C4a, and TGF-β1. CIRS patients with an ongoing colonization of multiple-antibiotic resistant coagulase-negative staphylococci may not show a significant improvement in their symptoms until the organism is eradicated. If detected, these infections may be treated using medications and treatment regimens known to those skilled in the art.

5. CD4⁺ CD25⁺ Treg Cells:

CD4⁺ CD25⁺ Treg cells in CIRS patients can be measured by flow cytometry. CD4⁺ CD25⁺ Treg cells mature in response to an inflammatory stimulation, and in particular, in response to increasing levels of TGF-β1. Matured CD4⁺ CD25⁺ Treg cells migrate to tissues to suppress inflammation and autoimmunity. However, if there is a pre-existing inflammatory response ongoing in tissues, CD4⁺ CD25⁺ Treg cells may turn into autoreactive T cells. Therefore, the determination of CD4⁺ CD25⁺ Treg cells in blood as well as in tissues may be helpful in assessing the status of inflammation in CIRS patients.

6. Brain Abnormalities:

It has been found that subjects with CIRS may exhibit brain abnormalities. Specifically, it has been found that subjects with CIRS may exhibit structural brain volumes abnormalities including, but not limited to, an increase in forebrain parenchyma, an increase in cortical gray area, an increase in the volume of the hippocampus, a decrease in the volume of caudate, and/or an increase in the volume of pallidum. These structural brain abnormalities have been identified, for example, in subjects suffering from CIRS-WDB. Accordingly, methods for diagnosing, treating, and monitoring CIRS may further include detecting one or more brain abnormalities using presently known or as-yet undeveloped techniques. Methods known in the art for detecting brain abnormalities may include, but are not limited to, CT scans, MRI scans, PET scans, brain volume measurement (i.e., FreeSurfer, Martinos Center for Biomedical Imaging, Charlestown, Mass.), and NeuroQuant® (CorTechs Labs, La Jolla, Calif.).

7. Genomic SVM Confidence>0.9:

The present invention uses gene expression microarrays and micro-RNA profiling to identify changes in expression profiles of genes, mRNAs, and/or micro-RNAs in subjects suspected of having CIRS compared to healthy subjects. The data obtained in whole genome microarray experiments and micro-RNA profiling experiments may be analyzed, for example, by using a Support Vector Machine (SVM) classification algorithm to predict whether a given sample is from a CIRS patient or a healthy individual. If the algorithm indicates that it has greater than 90% confidence (confidence>0.9) in its prediction, then the subject suspected of having CIRS is considered to be positive for this parameter.

7A. mRNA Markers:

In an embodiment, one or more of mRNA markers, listed in Appendices A, B and/or C, are differentially expressed between CIRS patients and healthy controls.

7B. Micro-RNA Markers:

In an embodiment, one or more of micro-RNA markers, provided in Appendix D, is differentially expressed between CIRS patients and healthy controls. Preferably, one or more of the subset of micro-RNA markers provided in Appendix E is differentially expressed in CIRS patients as compared to healthy controls.

In one embodiment, a physician's order sheet, such as the sample shown in Table 4, may be used to obtain case definition parameters described above.

TABLE 4 Sample Physician's Order Sheet. Test Lab to Use Spec Code # DX Codes HLA DR by PCR Lab Corp Yellow, refrig 012542 279.10, 377.34, 279.8 VIP Quest Lav - freeze-Trasylol  10397 279.8, 286.5, 710.0 MSH Lab Corp Lav - freeze-Trasylol 010421 253.2 Leptin Quest SST-freeze  84657N 253.2 ADH Quest SST refrig LAV freeze  31260P 253.5 Osmo Quest SST - refrig   677X 253.5 ACTH LabCorp Lav - freeze 004440 255.41 Cortisol Quest SST refrig  11281X 255.41 DHEAS Quest SST - freeze  21915R M 257.2 F 256.39 Testosterone Quest SST - freeze  29868W M 257.2 F 256.39 Androstenedione Quest SST - freeze  17182X M 607.84 F 256.39 CRP Lab Corp SST - refrig 006627 378.54 ESR Here Lav — TGF-B1 Quest Lav freeze  99895 platelet poor plasma TGF-B1 Lab Corp Lav freeze 905036 platelet poor plasma MMP-9 Quest SST- freeze  41865 340 PAI-1 Lab Corp Blue freeze 146787 437.6 Lipid with Phenotype Lab Corp SST - refrig 033886 272.0 CBC Quest Lav - refrig  6399X 285.0 CMP Quest SST - refrig  10231X 780.79 GGT Quest SST - refrig  23242E 250.00 Nasal Culture API-STAPH Rm temp DLM 478.21 VEGF Quest Lav - freeze  14512X 416.9, 253.2, 710.0 Erythropoietin Quest Red - freeze  22376R 285.9 Anticardiolipins Quest SST - refrig  36333X 710.0 Antigliadin, IgA, IgG Quest SST - refrig  3517N 579.0 B-Type Natriuretic Peptide LabCorp Plastic Tube Lav-Freeze 140889 428.0 C3a RIA Quest Lav - freeze  42003 279.8, 286.5 C4a RIA Quest Lav - freeze  42658 279.8 IgE Quest SST - refrig 002170 493.01 Lyme WB Lab Corp SST freeze 163600 088.81 TSH Quest SST - refrig  30163E 244.8 von Willebrands profile Quest Blue freeze  15540X 279.8, 286.5 710.0 Fe Quest SST-refrig  24984R 280.1 IBC Quest SST-refrig  7573X 720.0 Ferritin Quest SST-refrig   457X HgB A1C Quest Lav-refrig   496X 250.00 PAXgene Research whole blood Two aliquots

In another embodiment, blood drawn from CIRS patients may be used to determine the levels of one or more protein markers, mRNA markers, and/or micro-RNA markers listed in Tables 3-4, Appendices A, B and/or C, and Appendix D, respectively. The testing of protein markers listed in Table 3 is preferably conducted at CLIA-approved facilities and handled according to the facility's standard operating protocol (SOP). In certain aspects of the invention, one of the tubes used for blood draw is a specialized tube, PAXgene™ Blood DNA tube (Qiagen, Venlo, Netherlands), for stabilizing RNA, and is processed according to a Proteogenomics, LLC SOP. Briefly, PAXgene™ tubes are incubated at room temperature for 5 hours and frozen until they are shipped overnight to a processing facility. The tubes may be processed using a Qiagen PAXgene™ RNA blood processing kit, preferably according to an FDA-approved manufacturer's protocol. Extracted RNA may be quantified, for example, using a UV-Visible spectrophotometer, and the quality of the extracted RNA may be analyzed, for example, using Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, Calif.).

The extracted RNA may be subjected to an nCounter digital gene expression detection assay (nanoString Technologies, Seattle, Wash.), for example, in order to concurrently measuring mRNAs and micro-RNAs to determine differential expression of genes in CIRS patients.

Once diagnosed, subjects having CIRS may be treated in accordance with the methods of the invention. Treatment may include removing the subject from the source of the agent (toxins, biotoxins, inflammagens, etc.) responsible for causing CIRS, and/or removing or reducing the agent or its metabolites or byproducts from the subject.

In accordance with the methods of the invention, treating CIRS in a subject who has been diagnosed as having CIRS may include administering cholestyramine and/or VIP to the subject. When cholestyramine is administered to the subject, dosage amounts and schedules are within the ability of the skilled practitioner to determine, and may be, for example, in the range of 1 to 40 grams per day, preferably 8 to 36 grams per day, more preferably 16 to 24 grams per day. The doses may be provided from 1 to 6 times per day, preferably 2 to 4 times per day. The doses of cholestyramine are preferably administered orally. When VIP (aviptadil) is administered to the subject, dosage amounts and schedules are within the ability of the skilled practitioner to determine, and may be, for example, in the range of 5 to 200 micrograms, preferably 10 to 100 micrograms, more preferably 25 to 75 micrograms. According to one embodiment, a dose of 50 micrograms is administered. The doses may be provided from 1 to 4 times per day, preferably 1 time per day. The doses of VIP may be administered nasally or injected, although nasal instillation is a preferred method of administration. Cholestyramine and/or VIP may be administered for any period of time necessary to achieve relief from CIRS. However, it should be noted that the present invention is not limited by the dosage amount, administration route, or length of administration.

The methods of treating CIRS in a subject may further include sequential therapeutic intervention, such as those shown in FIG. 2. According to this embodiment, a method of treating CIRS in a subject includes: administering a therapeutically effective dose of cholestyramine to the subject; treating the subject to eliminate MARCoNS infection if the subject has MARCoNS infection; correcting or restoring levels of antigliadin, androgens, ADH/osmolality, MMP9, VEGF, C3a, C4a, TGF-β1; and administering a therapeutically effective dose of VIP to the subject.

The treatment may be monitored in accordance with further methods of the invention in which testing of one or more of the parameters used to diagnose a subject with CIRS is repeated during the course of treatment, and compared with the results obtained for that parameter prior to treatment. Improvement in the selected parameter or parameters over time may be used as an indication that the treatment is effective.

The present invention is illustrated by the following examples, which are set forth to illustrate certain embodiments of the present invention and are not to be construed as limiting.

EXAMPLES Example 1: Subjects, VCS Testing, Blood Analysis and Statistical Analysis

1A. Subjects: For all subjects, medical history was obtained concerning possible biotoxin exposure from dinoflagellates, fungi, actinomycetes, mycobacteria, endotoxin-producing bacteria, cyanobacteria, apicomplexans and spirochetes, as well as undiagnosed neurologic disease, alcoholism, occupational exposure to solvents, petroleum products, known neurotoxicants and metal fumes. Symptoms roster and VCS testing was used to determine whether or not a cause of illness other than WDB-CIRS or ciguatera could be identified. Differential diagnosis was performed. Subjects were included as patients with CIRS (n>1650) if they were considered to have symptoms that persisted beyond three months, had a non-exclusionary differential diagnosis and had abnormalities in laboratory parameters listed in Table 4. Patients coming to the clinic for well-physicals as well as volunteers were included as controls (n>150) if they had (i) no illness of any kind requiring acute intervention during the office visit; (ii) no history of acute multi-system, multi-symptom illness following exposure to environmentally produced biotoxins as described above; (iii) any untreated chronic illness. Patients meeting inclusion criteria received a physical examination and blood analyses. Pregnant or nursing patients were excluded from study participation. All participants signed a HIPAA waiver permitting use of their clinical data. Internal review board's (IRB) approval for retrospective analysis was obtained from the Copernicus Group IRB, Cary, N.C. Participants were not remunerated for study participation.

1B. VCS testing: Visual contrast sensitivity (VCS) testing measures the eye's ability to resolve patterns and was performed by an experienced physician using a previously published protocol (R. C. Shoemaker, Residential and recreational acquisition of possible estuary-associated syndrome: a new approach to successful diagnosis and treatment, Environmental Health Perspectives 109 Suppl 5 (2001) 791-6). Visual acuity and VCS testing were administered monocularly, with patients wearing any necessary corrective lenses, under a “daylight” illuminator (exceeding 70 foot lamberts) in a clinical unit with normal background lighting. A test card holder was used to position the acuity and VCS test cards at a constant, standardized distance (acuity—36 cm, contrast sensitivity—46 cm).

Visual acuity using Snellen score (e.g. 20/20) was determined for each eye using the acuity test card (MIS Pocket Vision Guide, ©1997 MIS, Inc.). To avoid inaccurate VCS results, a visual acuity of 20:50 or better was required for each eye to be included in analysis. All participants had at least one eye included in analysis. Two-tailed Student t-tests were performed, using the mean score±S.E.M. of each participant's two eyes, to determine if acuity scores differed significantly (p≦0.05) between cohorts.

The contrast sensitivity test card (Functional Acuity Contrast Test, (FACT), Stereo Optical Co., Chicago, Ill.) contained a matrix (5×9) of circles filled with sinusoidal gratings (dark and light bars) with spatial frequencies of 1.5, 3, 6, 12 and 18 cycles/degree of visual arc. The grating bars were oriented either vertically, or tilted 15 degrees to the left or right. Subjects identified the orientation of the grating by saying either: vertical, left, right or blank. The contrast sensitivity score for each row (spatial frequency) was recorded as the contrast of the last circle correctly identified on that row following verification by repeated testing of that circle. The procedure was repeated for each row in descending order. The units of analysis for the VCS test were the mean scores±S.E.M. of the participant's two eyes at each spatial frequency.

It was found that using a combination of symptoms roster, VCS test results, and results of laboratory parameters listed in Table 4, 98.2% patients were accurately diagnosed as having CIRS (Table 5). The statistical significance of the rate of accuracy in case detection is shown in Table 6.

TABLE 5 Predicted Predicted Controls Cases Row Total Observed Controls 37 2 39 Observed Cases 3 243 246 Column Total 40 245 285 Percent Agreement 98.2 Agreement Odds: 280/285 Standard Deviation: 0.78% 95% confidence interval: (96.72%, 96.72%) or (1 to 9 disparities)

TABLE 6 Test of Agreement Test Chi-sq P-value Likelihood 183.01 <.0001 Pearson 244.71 <.0001

1C. Blood tests: Laboratory measurements were performed by CLIA licensed facilities, LabCorp, Quest Diagnostics, National Jewish Center, Cambridge Biomedical, and Diagnostic Laboratory Medicine. Testing included HLA-DR by PCR, alpha melanocyte stimulating hormone (MSH), vasoactive intestinal peptide (VIP), leptin, matrix metalloproteinase 9 (MMP9), split product of complement component 3 (C3a) and component 4 (C4a), transforming growth factor beta-1 (TGF-β1), IgG for gliadin (AGA), and IgM for cardiolipin (ACLA), vascular endothelial growth factor (VEGF), plasminogen activator inhibitor (PAI-1), cortisol, erythrocyte sedimentation rate, C reactive protein (CRP), lipid profile, complete blood count (CBC), comprehensive metabolic panel (CMP), gamma-glutamyl transpeptidase (GGTP), thyroid stimulating hormone (TSH), lipid profile, and von Willebrand's profile.

Patients were classified abnormal for von Willebrand's antigen if the values were less than 50 IU or greater than 150 IU. Dysregulation of simultaneously measured ACTH/cortisol and ADH/osmolality was determined by adding (i) the number of cases with absolute high (ACTH>45 or cortisol>21; ADH>13 or osmolality>300) or low (ACTH<5 or cortisol<4; ADH<1.3 or osmolality<275) values for the two paired tests; to the cases (ii) in which ACTH was below 10 when cortisol was below 7; or ADH was below 2.2 when osmolality was 292-300; to the cases (iii) in which ACTH was >15 when cortisol was >16; and ADH>4.0 when osmolality was 275-278. The results of prior in-house analysis showed that such dysregulation was highly associated with low MSH and was essentially not found in normal-MSH patients.

1D. Statistical analysis of symptoms, results of blood test and VCS testing: To determine the most accurate indicators of illness, we tested 37 symptoms and 22 blood parameters measured in this study for a total of 59 variables not including VCS. Because of the presence of multiple variables, the Bonferroni correction was applied to symptom and blood variables which resulted in a single variable p-value being considered statistically significant if p<0.001 (0.05/59 rounded) in order to have an experiment wise p<0.05. The units of analysis for the VCS test were the mean scores of the participant's two eyes at each spatial frequency. The VCS data were analyzed using multivariate analyses of variance (MANOVA, with the Wilks' lambda statistic) procedures suitable for repeated measures with an α=0.05. The factors in this model were group, spatial frequency, age and their interaction terms. A factor for gender was not included as no gender differences in VCS have been reported. Results further showed that a significant group-by-spatial-frequency interaction were further analyzed in step down, two-tailed Student's t-tests (α=0.05), the equivalent of a univariate ANOVA, to determine which spatial frequencies accounted for the overall effect.

Symptoms:

The prevalence of each symptom in the illness and control groups was compared for statistical significance (p<0.001) using Fisher's exact test.

Blood Testing Parameters:

For each blood parameter, the difference between the two groups was tested for statistical significance (p<0.001) using the two-tailed two-sample Student t-test.

VCS:

The VCS data were analyzed using multivariate analyses of variance procedures suitable for repeated measures. The factors in the model were group, spatial frequency, and their interaction. A significant (p<0.05) overall group by spatial frequency interaction was further analyzed by a two-tailed Student t-test at each spatial frequency to determine which frequencies accounted for the effect.

HLA Haplotype Relative Risk:

Differences in relative risk were assessed using incidence in cases to incidence in an established control population. Results were considered significant if the ratio exceeded 2.0. Such relative risk ratios were observed in the following HLA-DR types: 4-3-53, 7-2/3-53, 11-3-52B, 12-3-52B, 13-6-52ABC, 17-2-52A.

Example 2: RNA Collection, Microarray Testing for mRNA and Micro-RNA Markers, and Statistical Analysis of Microarray Data

2A. RNA collection: Blood samples were collected from willing participants after written consent using PAXgene tubes under manufacturers recommended protocol (Qiagen, Valencia, Calif.). The patient samples were all drawn at the Center for Research on Biotoxin Associated Illness (CRBAI, Pocomoke Md.). Illness status was determined using a combination of medical history, physical findings, VCS testing, pulmonary functions, laboratory findings and response to clinical treatment to avoid possible mis-diagnosis. Reference samples from 80 healthy subjects were drawn at 3 separate locations, CRBAI, Washington D.C. metro area, and Charleston, S.C. All samples were first incubated at room temperature, as recommended by manufacturer, and then frozen at −40 or −80° C. for storage. All blood samples were extracted according to manufacturer's protocol. Total RNA was quantified by UV-Visible spectroscopy and the quality was assessed using Agilent 2100 Bioanalyzer. Only samples with a RIN score of 7.5 or better were used for analysis.

Of the 280 blood samples collected, 200 were chosen for analysis due to quality and quantity of RNA or age and gender to balance the study. Of these 200 samples, 60 samples were considered clinically healthy since their participation was not based on seeking medical attention and their presentation was not that of any illness. RNA from blood was extracted using the PAXGene Blood RNA Kit according to manufacturer (Qiagen, Valencia, Calif.). RNA was then quantified using a NanoDrop N. Dak.-1000 (Wilmington, Del.), qualified on an Agilent 2100 Bioanalyzer (Foster City, Calif.) and stored at −80° C. until needed for gene expression profiling.

2B. Microarray labeling and hybridization: All RNA labeling and microarray hybridizations were performed according to the manufacturer's instructions in the Agilent One-Color Microarray-Based Gene Expression Analysis manual (Agilent Technologies, Santa Clara, Calif.) with one exception. The amount of recommended labeled material for hybridization is 1.65 micrograms, this study used 2.45 micrograms. This amount of material was rigorously tested and found to give highly reproducible results before adopting the experimental protocol described here. Total RNA was amplified and labeled with Cy3 labeled CTP with the Agilent Quick Amp labeling kit (Agilent Technologies, Santa Clara, Calif.). The amplification product was measured for quantity and dye incorporation using the NanoDrop 1000. 2.45 micrograms of amplified, fluorescently labeled RNA was hybridized to an Agilent human whole genome microarray at and incubated at 65° C. in a rotating oven. After 17 hours, the hybridization arrays were washed consecutively in solutions of 6×SSPE with 0.005% N-lauroylsarcosine and 0.06×SSPE with 0.005% N-lauroylsarcosine for 1 min each at room temperature. This was followed by a final 15 sec wash in acetonitrile.

2C. Microarray Data Analysis: Microarrays were imaged on an Agilent microarray scanner, extracted with Agilent Feature Extraction software version A8.5.3, and data analyzed with both Rosetta Resolver 7.0 gene expression analysis system (Rosetta Informatics, Seattle, Wash.) as well as GeneSpring 11.5.1 (Agilent Technologies, Santa Clara, Calif.).

One color gene expression arrays were normalized by removing control and flagged data, applying a trimming function to remove the top and bottom 5% of intensity data, then scaling to the mean intensity. Samples, cases, and controls were segregated by sex. The arrays from each treatment/gender group (Patient and Control and Male and Female) were then combined and feature intensities underwent averaging and ratios were built between patient and control groups. These ratio data were initially filtered using a p<0.05 cutoff and 1.3 fold change to feed into an SVM classification algorithm. This gene set was then used for unsupervised clustering using K-means with both Euclidean and Pearson metrics, and principal component analysis using z-score values.

2D. Micro RNA Data Analysis: Micro RNA populations from the same total RNA samples used for gene expression microarrays were elucidated using the nCounter® Human v1 miRNA Expression Assay Kit, with two probes, mir191 and mir451 removed because of signal saturation. The assays were run according to manufacturer's recommendations and read on the nCounter array reader. Micro RNA data was imported into GeneSpring v12 as single color generic assays. The data were normalized with a 75 percentile shift and using the median of all samples as baseline.

Samples, cases and controls, were segregated and underwent class prediction using a support vector machine classification algorithm. The results obtained using an SVM to stratify patients and controls are shown in Appendix F. As shown in Appendix F, the total successful prediction rate was approximately 90% using an n-fold validation. Subjects were segregated by gender before classification was attempted.

Example 3: Treatment of CIRS Subjects with VIP

3A. Treatment: Human research approval for this study was provided by Copernicus Group IRB, Cary, N.C. After providing informed consent, 20 patients (11 Caucasian females, mean age 51.1; and 9 Caucasian males, mean age 48.2) with clinically-confirmed CIRS-WDB refractory to all prior treatment modalities (steps 1-10 (removal from exposure to correcting C4a), as described in FIG. 2) were enrolled in this trial. Specifically, prior to the treatment with VIP, patients were treated sequentially in 30-day steps by 1) removal from exposure; 2) treatment with cholestyramine for at least one month and ongoing; 3) eradication biofilm-forming coagulase negative staphylococci; 4) discontinuance of consumption of gluten if they had a positive antigliadin antibody titer (three months minimum required); 5) correction of abnormalities in androgens; 6) correction of abnormalities in regulation of salt and water with synthetic desmopressin as shown by simultaneous ADH and osmolality; 7) normalizing MMP9 with pioglitazone 45 mg daily; 8) normalizing VEGF with high dose omega-3 fish oils (4.2 grams daily); 9) correction of C3a with high dose statins; 10) attempting to correct C4a with erythropoietin but only if entry criteria met; 11) attempting to correct TGF beta-1 with losartan 25 mg daily, monitoring blood pressure carefully. Further, certain patients were excluded from the trial for the following reason. Specifically, initial use of low dose VIP by nasal instillation was shown to be safe in human volunteers; its use provided prompt reduction in symptoms and blunted accentuated pulmonary artery responses to exercise. However, benefit of replacement VIP in earlier trials was not observed to be universal. Specifically, the presence of any one of the following three parameters was associated with reduced efficacy: 1) depressed visual contrast sensitivity (VCS); 2) measurement of fungal DNA in settled dust using QPCR that resulted in an Environmental Relative Mold Index (ERMI)>2; and 3) presence of multiply antibiotic resistant biofilm-forming coagulase negative staphylococci (MAR-CoNS) in deep nasal aerobic spaces. Patients with these findings were excluded from the formal replacement trial.

All patients enrolled in the trial were confirmed to be exposed to WDB by observation of illness acquisition solely following water intrusion followed by either (1) visible microbial growth; (2) specification of molds by QPCR DNA testing; or (3) musty smells. All patients met the case criteria established by the GAO (US GAO 2008). Patients were known to the clinic with a 36-month mean duration of prior treatment following exposure to WDB. No patients had been treated with VIP previously.

Entry criteria also included a rise in pulmonary artery systolic pressure (PASP) in exercise as measured by stress echocardiography that exceeded 8 mm Hg as compared to resting PASP. Standard Bruce protocols were employed during stress echocardiography testing. Target heart rate of 85% of maximum was obtained after baseline recording showed no evidence of PASP greater than 30 mm Hg or left ventricular ejection fraction of less than 50%. All patients achieved target heart rate; none developed ischemic changes on EKG or chest pain during stress testing. Each had a repeat measurement of the tricuspid regurgitation jet (TR) immediately after exercise with recordings of TR performed within 30 seconds of cessation of exercise.

For the experimental protocol, subjects self-administered 50 mcg VIP (Aviptadil; Bachem AG, Switzerland) four times a day via nasal aerosol and returned to the clinic to review symptoms and clinical course, and undergo interval physical exam and laboratory exam at scheduled intervals. Clinical data were collected before any treatments, or baseline (BASE); after all other treatments and before VIP (AC2); after 12 months of VIP (12M); and after 18 months of VIP (18M). Data collection included physician recorded symptoms in a medical history (Table 2); levels of VIP, MSH, C4a, TGF beta-1, VEGF, MMP9, estradiol, testosterone, 25-0H vitamin D, lipase, CBC and CMP. Measurement of CD4+CD25+T regulatory (Treg) cells was not available at BASE; Treg testing was performed at AC2 and 18 month time periods. Laboratory testing for all analytes was performed by high complexity CLIA-certified labs including LabCorp and Quest Diagnostics. All data were compared to either established normative values or values from prior testing of healthy control populations (N=850) performed at this clinic. Data were analyzed by two-sample T-tests for each of two study time points and one-sample T-tests that compared the specified data to the corresponding historical control values. A Bonferroni correction to the p-values was done to control the experiment-wise error rate. A p value of <0.001 was chosen as the determinant of significance for the study.

3B. Results: Patients tolerated the drug well and there were no dropouts due to adverse effects over the course of the 18 month study. Use of replacement doses of the regulatory neuropeptide VIP in a nasal spray (i) safely reduced refractory symptoms to control levels; (ii) corrected inflammatory parameters to be not significantly different from controls; (iii) raised levels of VIP and MSH; (iv) returned PASP during exercise to normal; and (v) enhanced quality of life in 20 patients in an open-label trial. Follow-up as long as 18 months after initiation of the study showed durable salutary responses without significant adverse effects. Elevated PASP in stress exercise testing was reduced to <8 mm Hg in all subjects within two months. Symptom reduction to equal those of controls occurred in all treated patients. Laboratory results showed a marked improvement over both baseline values and following all previously employed therapies (Table 7 and FIG. 3) although MSH and VIP continued to be significantly depressed compared to controls. In FIG. 3, values from Table 7 were log transformed and normalized to baseline.

TABLE 7 LAB Control Base AC2 12 mon 18 mon SX 2.9 29.8 17.8 5.5 3.4 VIP 28.9 9.3 14.4 12.3 16.6 MSH 37.2 9.4 16.8 17.3 18.2 C4a 2830 8346 4662 5679 3306 TGF 2380 12579 13015 5359 4040 VEGF 65 61 95.3 73.4 66.2 MMP-9 332 628 358 302 290 Estra-F 29.8 28 26.6 27.8 28.9 Estra-M 23.1 36 30.3 27.7 22.8 Test-F 282 20 18.9 22.6 25.2 Test-M 415 298.8 293.5 546.7 511.5 VIT D 38.4 19.4 24.1 38.3 39.3 Lipase 30.1 24.2 30.8 30.7 27.9 Symptoms and laboratory parameters mean values for patients and controls. Sx = symptoms, Estra-F = estradiol in females, Estra-M = estradiol in males, Test-F = testosterone in females, Test-M = testosterone in males.

Cases were similar at baseline to known cases of CIRS-WDB in large cohorts previously published (Shoemaker et al. “Innate immunity, MR spectroscopy, HLA DR, TGF beta-1, VIP and capillary hypoperfusion define acute and chronic human illness acquired following exposure to water-damaged buildings,” Healthy Buildings, Syracuse, N.Y., 2009; and Shoemaker “Exposure to water-damaged buildings causes a readily identifiable chronic inflammatory response syndrome that is successfully treated by a sequential intervention protocol,” 9^(th) International Mycology Congress, Edinburgh, Scotland, August 2010) with excessive numbers of symptoms in cases compared to controls and multiple laboratory abnormalities (Tables 8 and 9) in cases compared to controls. This cohort may be affected by an innate immune inflammatory process with nearly 23 health symptoms at baseline; marked reduction in VIP and MSH; significant elevation of C4a, MMP9 and TGF beta-1; evidence of increased activity of aromatase with reduction of testosterone and elevated estradiol in males but not females; and reduced Vitamin D3 levels. Lipase levels did not rise in this cohort during the trial.

TABLE 8 2007 2009 Control Case Control Case N Mean N Mean P value N Mean N Mean P value Age 37 51.1 202 46.1 0.027 132 50.3 815 Symptoms 37 2.5 202 22.9 <0.0001 132 2.9 815 22.6 <.001 VIP 132 36.6 815 12.8 <.001 MSH 37 34.7 201 14.1 <0.0001 132 41.2 815 13.1 <.001 Leptin 36 14.5 197 27.9 0.546 132 17.9 815 ADH 34 3.9 192 3.3 0.709 132 3.7 815 Osmo 34 238 200 298 <0.0001 132 288 815 ADH/osmo 132 5 815 69 <.001 ACTH 35 23.2 200 15.8 0.084 132 22 815 Cortisol 36 16.8 201 15.4 0.811 132 21.7 815 >.5 ACTH/cortisol 132 3 815 58 <.001 MMP-9 37 284 201 376 0.04 132 269 815 419 <.001 PAI-1 37 6.63 182 5.72 0.561 132 6.3 815 21 <.001 VEGF 30 67.2 198 64.7 0.888 132 67.9 815 C3A 24 242 185 929 0.24 132 253 815 C4A 22 1852 190 8818 <0.001 132 2303 815 9924 <.001 TGF Beta-1 132 2365 815 4602 <.001 GGTP 132 16 815 <.5 CRP 35 2.6 187 5.12 2.4 132 2.4 815 1.9 0.424 ESR 37 0.08 187 27.9 <0.0001 132 9 815 >.5 IgE 36 49 191 82.5 0.732 132 34 815 >.5 CBC 132 nl 815 5 0.999 CMP 132 nl 815 5 0.999 Lipids 132 nl 815 >.5 VwF 132 2 815 71 <.001 ACLA 132 7 815 23 <.001 AGA 8 815 17 <.001 HLA DR RR >2 6 0 815  4-3-53 1 0  7-2-53 1 0 11-3-52B 1 0 13-6-52A 1 0 14-5-52B 1 0 17-2-52A 1 0

TABLE 9 2010 Control Case N Mean N Mean P value Age 132 50.3 812 47.8 0.0378 Symptoms 132 2.9 812 22.7 <.0001 VIP 132 36.6 812 12.8 <.0001 MSH 132 41.2 799 13.1 <.0001 Leptin 132 17.9 697 19.4 0.816 ADH 132 3.7 692 3.1 0.544 Osmo 132 288 709 302 <.0001 ADH/osmo 132 ACTH 132 22 687 16.8 0.0007 Cortisol 132 21.7 689 13 0.0009 ACTH/cortisol 132 MMP-9 132 269 812 420 <.0001 PAI-1 132 6.3 636 7 0.6605 VEGF 132 67.9 656 62.2 0.4084 C3A 132 253 808 427 <.0001 C4A 132 2303 812 9661 <.0001 TGF Beta-1 132 2365 812 6412 <.0001 GGTP 132 16 788 21 Not signif CRP 132 1.2 812 1.8 Not signif ESR 132 9 792 6 Not signif IgE 132 34 802 39 Not signif CBC 132 nl 812 nl Not signif CMP 132 nl 812 nl Not signif Lipids 132 nl 812 IV* VwF 132 5 704 67 ACLA 132 1 812 24 AGA 2 812 32 HLA DR RR > 2 0 812 6 4-3-53 0 1 7-2-53 0 1 11-3-526 0 1 13-6-52A 0 1 14-5-52B 0 1 17-2-52A 0 1

While significant differences (p<0.01) were identified between controls and baseline lab values in patients for symptoms, MSH, VIP, MMP9, C4a, TGF-β1, 25-OH Vitamin D, and testosterone (in males), by the end of the trial patient values were not statistically different from controls, except for VIP and MSH. Flow cytometry showed a significant increase of CD4+CD25+ Treg cells from a mean of 8.9 to 22.5. No changes in CBC and CMP were noted. One patient had a transient elevated level of lipase without abdominal pain that resolved without cessation of use of VIP. After six months patients titrated use of VIP to these symptoms with verification of benefit obtained by clinical exam and blood testing at three month intervals. Eight patients consistently used VIP at three or four times a day; four patients used VIP once or twice a day. Three patients used VIP before strenuous activity only; five patients stopped using VIP at various points during the trial as they had correction of symptoms and no evidence of relapse without protocol medications. For these patients, only data while using VIP was collected for statistical calculation.

This study confirms the hypotheses that the use of VIP in VIP-deficient patients is both durably safe and effective for up to 18 months. When used by nasal instillation, VIP is well-tolerated, has few side effects and is unlikely to result in an over-dosage. Treatment with VIP restored clinical functioning in a cohort of CIRS-WDB patients with severe illness characterized by profound, refractory abnormalities in innate immune inflammatory responses (see BASE on Table 7). Symptom improvement was remarkable, including correction of chronic fatigue, shortness of breath and asthma-like conditions, executive cognitive deficits, neurologic symptoms and chronic joint pain. The known effects of VIP in the normalization of Treg levels and controlling cytokine responses were also confirmed by this study. Use of VIP corrected abnormal PASP responses during exercise; reduced total number of symptoms to equal controls; and down-regulated inflammatory responses as measured by MMP9, TGF beta-1 and C4a levels, with positive effects occurring over time. The benefit of restoration of androgen levels to equal control levels suggests a down-regulating effect of VIP on the enzyme aromatase. The normalization of Vitamin D3 levels was unexpected, suggesting additional but as yet undefined upstream aspects of VIP as a pluripotent immunoregulatory hormone.

It will, of course, be appreciated that the above description has been given by way of example only and that modifications in detail may be made within the scope of the present invention.

Throughout this application, various patents and publications have been cited. The disclosures of these patents and publications in their entireties are hereby incorporated by reference into this application, in order to more fully describe the state of the art to which this invention pertains.

The invention is capable of considerable modification, alteration, and equivalents in form and function, as will occur to those ordinarily skilled in the pertinent arts having the benefit of this disclosure.

While the present invention has been described for what are presently considered the preferred embodiments, the invention is not so limited. To the contrary, the invention is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the detailed description provided above.

APPENDIX A “[control, “[patient, ProbeName p FC (abs) Regulation male](normalized)” male](normalized)” GeneSymbol Description GenbankAccession A_33_P3270084 0.00612545 1.3278185 down −0.16680224 0.2422558 “CDC2L1S13 PITSLRE protein kinase alpha SV9 isoform {Homo sapiens} (exp = −1; wgp = 0; cg = 0), partial (38%) [THC2524986]” A_33_P3323607 0.093110725 1.3602716 up 0.49521056 0.05131583 CCDC129 coiled-coil domain containing 129 ENST00000409717 [Source: HGNC Symbol; Acc: 27363] [ENST00000409717] A_33_P3223397 0.05119932 1.4744513 up 0.67229843 0.1121203 “DHH_HUMAN (O43323) Desert hedgehog THC2641433 protein precursor (DHH) (HHG-3) [Contains: Desert hedgehog protein N- product; Desert hedgehog protein C- product], partial (19%) [THC2641433]” A_33_P3267118 0.001896308 1.5818226 down −0.18506314 0.47652474 EIF4G3 “eukaryotic translation initiation factor 4 ENST00000374933 gamma, 3 [Source: HGNC Symbol; Acc: 3298] [ENST00000374933]” A_33_P3741678 0.07977711 1.4179299 up 0.55385005 0.050063804 LOC284926 full-length cDNA clone CS0DB004YM09 of CR624447 Neuroblastoma Cot 10-normalized of Homo sapiens (human), [CR624447] A_33_P3353921 0.01310896 1.355142 down −0.3329265 0.105517514 GNLY granulysin [Source: HGNC AK310057 Symbol; Acc: 4414] [ENST00000489214] A_32_P170397 0.002955175 1.3198497 down −0.21135516 0.18901852 HCG1998685 AK057625 [Source: UniProtKB/TrEMBL; Acc: Q8TCB4] [ENST00000309874] A_33_P3245489 0.07131087 1.4297409 up 0.5176838 0.001930128 ADAMTSL5 “Homo sapiens ADAMTS-like 5 NM_213604 (ADAMTSL5), mRNA [NM_213604]” A_33_P3396010 5.68E−04 1.3479198 down −0.06803578 0.36269885 AGER “Homo sapiens advanced glycosylation end NM_001206966 product-specific receptor (AGER), transcript variant 9, mRNA [NM_001206966]” A_24_P419087 0.016834442 1.3516667 down −0.08188986 0.3528496 AVIL “Homo sapiens advillin (AVIL), mRNA NM_006576 [NM_006576]” A_23_P157299 2.52E−04 1.4233145 down −0.3408891 0.16836533 AEBP1 “Homo sapiens AE binding protein 1 NM_001129 (AEBP1), mRNA [NM_001129]” A_23_P138541 0.009355155 1.3682036 down −0.39919707 0.0530859 AKR1C3 “Homo sapiens aldo-keto reductase family 1, NM_003739 member C3 (3-alpha hydroxysteroid dehydrogenase, type II) (AKR1C3), mRNA [NM_003739]” A_33_P3239854 0.0542805 1.3841722 up 0.42232788 −0.046695653 ALKBH5 “Homo sapiens alkB, alkylation repair NM_017758 homolog 5 (E. coli) (ALKBH5), mRNA [NM_017758]” A_33_P3213288 0.079706766 1.3334428 up 0.41348496 −0.001670848 AIF1 “Homo sapiens allograft inflammatory factor NM_004847 1 (AIF1), transcript variant 2, mRNA [NM_004847]” A_33_P3245454 0.062027268 1.3335233 up 0.24097094 −0.17427202 LOC389834 “Homo sapiens ankyrin repeat domain 57 NR_027420 pseudogene (LOC389834), non-coding RNA [NR_027420]” A_32_P148345 0.021261923 1.4266403 up 0.19728537 −0.31533623 ANXA2 “Homo sapiens annexin A2 (ANXA2), NM_001002857 transcript variant 2, mRNA [NM_001002857]” A_23_P55373 0.035340752 1.4090601 up 0.25950173 −0.2352314 ALOX15 “Homo sapiens arachidonate 15- NM_001140 lipoxygenase (ALOX15), mRNA [NM_001140]” A_23_P146325 0.001061829 1.5097016 down −0.23241776 0.36184567 ASAP1-IT1 “Homo sapiens ASAP1 intronic transcript 1 NR_002765 (non-protein coding) (ASAP1-IT1), non- coding RNA [NR_002765]” A_33_P3320782 0.077936664 1.4928937 up 0.81035405 0.23224276 ATXN7 “Homo sapiens ataxin 7 (ATXN7), transcript NM_000333 variant SCA7a, mRNA [NM_000333]” A_23_P98686 8.34E−04 1.3329782 down −0.19140579 0.22324742 ATHL1 “Homo sapiens ATH1, acid trehalase-like 1 NM_025092 (yeast) (ATHL1), mRNA [NM_025092]” A_33_P3372563 0.09315603 1.323163 up 0.6748213 0.27083063 ABCC10 “Homo sapiens ATP-binding cassette, sub- NM_033450 family C (CFTR/MRP), member 10 (ABCC10), transcript variant MRP7A, mRNA [NM_033450]” A_23_P254797 0.086991735 1.5577642 up 0.63674116 −0.002735821 BPIL1 “Homo sapiens bactericidal/permeability- NM_025227 increasing protein-like 1 (BPIL1), mRNA [NM_025227]” A_23_P379034 1.32E−06 1.3577511 down −0.16047189 0.28074712 BAIAP2L2 “Homo sapiens BAI1-associated protein 2- NM_025045 like 2 (BAIAP2L2), mRNA [NM_025045]” A_23_P370682 0.032763295 1.3114529 down −0.21279402 0.17837192 BATF2 “Homo sapiens basic leucine zipper NM_138456 transcription factor, ATF-like 2 (BATF2), mRNA [NM_138456]” A_23_P71946 4.27E−04 1.420993 down −0.34374356 0.16315591 BSPRY “Homo sapiens B-box and SPRY domain NM_017688 containing (BSPRY), mRNA [NM_017688]” A_33_P3373775 0.084006816 1.3487155 up 0.53638214 0.10479598 BCL2L15 “Homo sapiens BCL2-like 15 (BCL2L15), NM_001010922 mRNA [NM_001010922]” A_23_P1833 0.026519855 1.4303471 down −0.52439135 −0.00802621 B3GAT1 “Homo sapiens beta-1,3- NM_054025 glucuronyltransferase 1 (glucuronosyltransferase P) (B3GAT1), transcript variant 2, mRNA [NM_054025]” A_23_P158297 2.52E−05 1.677964 down 7.7513523 8.498064 BTNL3 “Homo sapiens butyrophilin-like 3 NM_197975 (BTNL3), mRNA [NM_197975]” A_23_P501933 0.019021226 1.4456453 up 0.4912875 −0.04042622 CACNG6 “Homo sapiens calcium channel, voltage- NM_145814 dependent, gamma subunit 6 (CACNG6), transcript variant 1, mRNA [NM_145814]” A_33_P3260307 0.08299556 1.3104521 up 0.63487047 0.24480557 CARHSP1 “Homo sapiens calcium regulated heat stable NM_001042476 protein 1, 241 kDa (CARHSP1), transcript variant 2, mRNA [NM_001042476]” A_23_P431933 8.82E−04 1.3190647 down −0.26084927 0.13866611 CAMKK1 “Homo sapiens calcium/calmodulin- NM_032294 dependent protein kinase kinase 1, alpha (CAMKK1), transcript variant 1, mRNA [NM_032294]” A_23_P18017 0.034780383 1.446666 up 0.41961122 −0.1131207 CPA3 “Homo sapiens carboxypeptidase A3 (mast NM_001870 cell) (CPA3), mRNA [NM_001870]” A_23_P380240 0.023509948 1.5988463 down −0.70409876 −0.027067412 CEACAM8 “Homo sapiens carcinoembryonic antigen- NM_001816 related cell adhesion molecule 8 (CEACAM8), mRNA [NM_001816]” A_23_P253791 0.029807681 1.3400142 down −0.43290272 −0.010654482 CAMP “Homo sapiens cathelicidin antimicrobial NM_004345 peptide (CAMP), mRNA [NM_004345]” A_23_P140384 0.002161369 1.6987963 down −0.67417175 0.09034092 CTSG “Homo sapiens cathepsin G (CTSG), mRNA NM_001911 [NM_001911]” A_23_P259863 5.98E−05 2.142295 down −0.712246 0.38691115 CD177 “Homo sapiens CD177 molecule (CD177), NM_020406 mRNA [NM_020406]” A_23_P76364 0.020632394 1.3664228 up 0.36852786 −0.08187599 CD9 “Homo sapiens CD9 molecule (CD9), NM_001769 mRNA [NM_001769]” A_33_P3243652 0.0462046 1.4135683 up 0.5954616 0.09612002 LOC100131831 “Homo sapiens cDNA FLJ26174 fis, clone AK129685 ADG03920. [AK129685]” A_33_P3250253 0.07040643 1.3652743 up 0.5216825 0.0724917 LOC100131150 “Homo sapiens cDNA FLJ38875 fis, clone AK096194 MESAN2013936. [AK096194]” A_33_P3423700 0.001282435 1.3389032 down −0.22081345 0.2002382 LOC100131829 “Homo sapiens cDNA F1142008 fis, clone AK124002 SPLEN2031724. [AK124002]” A_33_P3289476 0.006421264 1.3492424 down −0.16770722 0.26444238 LOC100128697 “Homo sapiens cDNA F1142049 fis, clone AK124043 SPLEN2041720. [AK124043]” A_33_P3294177 0.012347413 1.3150665 down −0.1425866 0.25254914 LOC100131043 “Homo sapiens cDNA FLJ42228 fis, clone AK124222 THYMU2041252. [AK124222]” A_33_P3570228 0.08450483 1.3391069 up 0.59726006 0.17598878 LOC644962 “Homo sapiens cDNA FLJ46065 fis, clone AK127954 TBAES2007862. [AK127954]” A_33_P3367850 0.001904829 2.156447 down −0.006115405 1.1025405 CHRM4 “Homo sapiens cholinergic receptor, NM_000741 muscarinic 4 (CHRM4), mRNA [NM_000741]” A_33_P3370521 0.00145644 2.722483 up 1.2393239 −0.20559905 “Homo sapiens chromosome 1 genomic XM_001721393 contig, GRCh37.p5 Primary Assembly” A_33_P3390673 0.010252777 1.3512726 down −0.22451176 0.20980695 “Homo sapiens chromosome 10 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3363305 0.002453787 2.1227565 up 0.7126395 −0.37329924 “Homo sapiens chromosome 11 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3406255 0.023001177 1.3501295 up 0.07665181 −0.35644597 “Homo sapiens chromosome 12 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3354728 0.042722464 1.3140639 up 0.26061577 −0.13341968 “Homo sapiens chromosome 14 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3399755 0.003660518 1.9749763 up 0.5097168 −0.47211847 “Homo sapiens chromosome 15 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3286929 0.081707925 1.315834 down −0.642461 −0.2464835 “Homo sapiens chromosome 15 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3396275 0.085680954 1.4504157 up 0.59298533 0.056519065 C15orf62 “Homo sapiens chromosome 15 open NM_001130448 reading frame 62 (C15orf62), mRNA [NM_001130448]” A_33_P3280502 0.001151151 1.4021606 down −0.22208095 0.26557073 “Homo sapiens chromosome 16 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3382887 0.001611512 2.5672042 up 0.5943423 −0.7658557 “Homo sapiens chromosome 18 genomic contig, GRCh37.p5 Primary Assembly” A_23_P397120 0.037768755 1.3278565 up −0.19747072 −0.60657007 C19orf77 “Homo sapiens chromosome 19 open NM_001136503 reading frame 77 (C19orf77), mRNA [NM_001136503]” A_33_P3227010 0.06222416 1.4045763 up 0.62080085 0.13066588 “Homo sapiens chromosome 2 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3308553 0.08915168 1.4213793 up 0.6727052 0.16541366 “Homo sapiens chromosome 2 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3251462 0.011439879 1.3474795 up 0.38007137 −0.05019189 C20orf141 “Homo sapiens chromosome 20 open NM_080739 reading frame 141 (C20orf141), mRNA [NM_080739]” A_33_P3251412 0.01645751 1.4453737 down −0.3556638 0.17577872 “Homo sapiens chromosome 22 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3310588 0.07022539 1.3154078 up 0.40690875 0.011398749 “Homo sapiens chromosome 22 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3212799 5.33E−06 1.4400822 down −0.13911884 0.38703233 C22orf34 “Homo sapiens chromosome 22 open NR_026997 reading frame 34 (C22orf34), non-coding RNA [NR_026997]” A_33_3267865 0.006212906 1.5480765 down −0.37141854 0.25905824 “Homo sapiens chromosome 6 genomic contig, GRCh37.p5” A_33_P3274001 0.027731817 1.3519478 up 0.46000475 0.024965255 “Homo sapiens chromosome 6 genomic contig, GRCh37.p5 Primary Assembly” A_24_P3804 7.77E−04 1.3040819 down −0.05207756 0.33095688 C6orf26 “Homo sapiens chromosome 6 open reading NM_001039651 frame 26 (C6orf26), mRNA [NM_001039651]” A_33_P3407049 1.04E−06 1.4317865 down −0.29225388 0.2255625 “Homo sapiens chromosome 7 genomic contig, GRCh37.p5 Primary Assembly” A_23_P25069 0.06541135 1.3128676 up 0.30542582 −0.08729571 “Homo sapiens chromosome 7 genomic XM_003119523 contig, GRCh37.p5 Primary Assembly” A_33_P3295814 0.08207279 1.3790425 up 0.5061583 0.042491328 “Homo sapiens chromosome 7 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3348151 0.09765747 1.4145614 up 0.7725938 0.272239 “Homo sapiens chromosome 9 genomic contig, GRCh37.p5 Primary Assembly” A_33_P3422712 0.013273941 1.8041428 up 0.5600057 −0.2913078 “Homo sapiens chromosome X genomic contig, GRCh37.p5 Primary Assembly” A_33_P3303355 0.06306925 1.3997774 up 0.43767375 −0.04752365 “Homo sapiens chromosome X genomic contig, GRCh37.p5 Primary Assembly” A_32_P101352 6.90E−06 1.3438206 down −0.14233096 0.28400952 CXorf65 “Homo sapiens chromosome X open reading NM_001025265 frame 65 (CXorf65), transcript variant 1, mRNA [NM_001025265]” A_23_P51711 0.032540936 1.336754 up 0.3910381 −0.027695797 CELA2B “Homo sapiens chymotrypsin-like elastase NM_015849 family, member 2B (CELA2B), mRNA [NM_015849]” A_33_P3232945 0.030156614 1.329383 up 0.09898835 −0.31176832 F2RL1 “Homo sapiens coagulation factor II NM_005242 (thrombin) receptor-like 1 (F2RL1), mRNA [NM_005242]” A_33_P3216448 0.08353515 1.4946696 up 0.52763623 −0.05219024 COL11A2 “Homo sapiens collagen, type XI, alpha 2 NM_001163771 (COL11A2), transcript variant 4, mRNA [NM_001163771]” A_24_P418203 0.051317006 1.3029847 up 0.24762823 −0.13419197 CNTNAP3 “Homo sapiens contactin associated protein- NM_033655 like 3 (CNTNAP3), mRNA [NM_033655]” A_33_P3242614 0.001806715 1.3097177 down −0.13025276 0.25900304 LOC606724 “Homo sapiens coronin, actin binding NR_002454 protein, 1A pseudogene (LOC606724), non- coding RNA [NR_002454]” A_23_P215331 0.06954535 1.3630785 up 0.4849613 0.038092636 CRHR2 “Homo sapiens corticotropin releasing NM_001883 hormone receptor 2 (CRHR2), transcript variant 1, mRNA [NM_001883]” A_23_P141505 3.90E−04 1.3431782 up 0.3066318 −0.11901883 CLEC10A “Homo sapiens C-type lectin domain family NM_182906 10, member A (CLEC10A), transcript variant 1, mRNA [NM_182906]” A_23_P206501 0.00173709 1.3321601 down −0.15516487 0.2586026 CLEC18B “Homo sapiens C-type lectin domain family NM_001011880 18, member B (CLEC18B), mRNA [NM_001011880]” A_23_P166306 0.014803309 1.6775806 down −0.51784945 0.22853269 CBS “Homo sapiens cystathionine-beta-synthase NM_000071 (CBS), transcript variant 1, mRNA [NM_000071]” A_23_P44724 0.006138469 1.3435929 down −0.3317573 0.09433877 CSRP2 “Homo sapiens cysteine and glycine-rich NM_001321 protein 2 (CSRP2), mRNA [NM_001321]” A_23_P431330 1.23E−04 1.3079846 down −0.042533595 0.34481198 CRIPAK “Homo sapiens cysteine-rich PAK1 inhibitor NM_175918 (CRIPAK), mRNA [NM_175918]” A_33_P3379341 0.015438097 1.328918 down −0.023474546 0.38677746 LOC391322 “Homo sapiens D-dopachrome tautomerase- NM_001144931 like (LOC391322), mRNA [NM_001144931]” A_23_P31816 0.05428833 1.4323628 down −0.6479673 −0.12957029 DEFA3 “Homo sapiens defensin, alpha 3, neutrophil- NM_005217 specific (DEFA3), mRNA [NM_005217]” A_23_P326080 0.053808365 1.4519137 down −0.6926883 −0.15473257 DEFA4 “Homo sapiens defensin, alpha 4, NM_001925 corticostatin (DEFA4), mRNA [NM_001925]” A_23_P4494 0.008288973 1.4349773 down −0.18896562 0.3320622 DSC2 “Homo sapiens desmocollin 2 (DSC2), NM_024422 transcript variant Dsc2a, mRNA [NM_024422]” A_32_P52785 0.08880611 1.309323 up 0.1742377 −0.2145833 DAAM2 “Homo sapiens dishevelled associated NM_015345 activator of morphogenesis 2 (DAAM2), transcript variant 2, mRNA [NM_015345]” A_23_P131139 0.001917165 1.6789535 up 0.61781263 −0.1297497 DIRC1 “Homo sapiens disrupted in renal carcinoma NM_052952 1 (DIRC1), mRNA [NM_052952]” A_23_P316472 4.37E−05 1.3186158 down −0.20222439 0.19679987 DNHD1 “Homo sapiens dynein heavy chain domain NM_144666 1 (DNHD1), transcript variant 1, mRNA [NM_144666]” A_23_P130961 0.08317351 1.3075476 down −0.4996647 −0.11280126 ELANE “Homo sapiens elastase, neutrophil NM_001972 expressed (ELANE), mRNA [NM_001972]” A_33_P3413701 0.0011926 1.6410688 down −0.7812019 −0.06656598 ERAP1 “Homo sapiens endoplasmic reticulum NM_001040458 aminopeptidase 1 (ERAP1), transcript variant 2, mRNA [NM_001040458]” A_33_P3417626 0.001605189 1.3939557 up 0.265658 −0.21352668 ENHO “Homo sapiens energy homeostasis NM_198573 associated (ENHO), mRNA [NM_198573]” A_33_P3216532 0.002821366 1.8402331 up 0.9307808 0.050892483 EPHB4 “Homo sapiens EPH receptor B4 (EPHB4), NM_004444 mRNA [NM_004444]” A_23_P76488 0.005429512 1.4041661 up 0.58240914 0.09269561 EMP1 “Homo sapiens epithelial membrane protein NM_001423 1 (EMP1), mRNA [NM_001423]” A_33_P3265504 0.09525203 1.440512 up 0.68339294 0.15681118 EIF5AL1 “Homo sapiens eukaryotic translation NM_001099692 initiation factor 5A-like 1 (EIF5AL1), mRNA [NM_001099692]” A_24_P169073 0.046566848 1.3259208 up 0.31766993 −0.089324735 FAM131C “Homo sapiens family with sequence NM_182623 similarity 131, member C (FAM131C), mRNA [NM_182623]” A_33_P3222501 0.029698186 1.3356988 down −0.27530906 0.14228569 FAM157A “Homo sapiens family with sequence NM_001145248 similarity 157, member A (FAM157A), mRNA [NM_001145248]” A_23_P103765 0.036611106 1.4173152 up 0.25399694 −0.24916382 FCER1A “Homo sapiens Fc fragment of IgE, high NM_002001 affinity I, receptor for; alpha polypeptide (FCER1A), mRNA [NM_002001]” A_23_P63390 0.041602947 1.3429631 down −0.08972688 0.33569276 FCGR1B “Homo sapiens Fc fragment of IgG, high NM_001017986 affinity Ib, receptor (CD64) (FCGR1B), transcript variant 1, mRNA [NM_001017986]” A_23_P149368 0.016182061 1.3384151 down −0.3338697 0.08665597 FCRL1 “Homo sapiens Fc receptor-like 1 (FCRL1), NM_052938 transcript variant 1, mRNA [NM_052938]” A_24_P319647 0.002448884 1.4621583 down −0.5400526 0.008046966 FCRL2 “Homo sapiens Fc receptor-like 2 (FCRL2), NM_030764 mRNA [NM_030764]” A_23_P201211 0.072885185 1.3331984 down −0.34657237 0.06831916 FCRL5 “Homo sapiens Fc receptor-like 5 (FCRL5), NM_031281 transcript variant 1, mRNA [NM_031281]” A_24_P226069 0.038782354 1.3155049 down −0.52783656 −0.13221988 FGFBP2 “Homo sapiens fibroblast growth factor NM_031950 binding protein 2 (FGFBP2), mRNA [NM_031950]” A_33_P3414789 0.001758171 1.8266654 up 0.9952169 0.12600459 FSD1 “Homo sapiens fibronectin type III and NM_024333 SPRY domain containing 1 (FSD1), mRNA [NM_024333]” A_23_P414308 0.08055564 1.3528732 up 0.6390451 0.20301853 FLCN “Homo sapiens folliculin (FLCN), transcript NM_144606 variant 2, mRNA [NM_144606]” A_33_P3849275 0.013713419 1.3071018 up 0.03065578 −0.35571575 FHL1 “Homo sapiens four and a half LIM domains NM_001159704 1 (FHL 1), transcript variant 4, mRNA [NM_001159704]” A_23_P74609 0.020694846 1.425474 down −0.41973794 0.09170383 G0S2 “Homo sapiens G0/G1switch 2 (G0S2), NM_015714 mRNA [NM_015714]” A_33_P3550894 0.037090957 1.499201 down −0.8526115 −0.2684176 GATA2 “Homo sapiens GATA binding protein 2 NM_001145661 (GATA2), transcript variant 1, mRNA [NM_001145661]” A_23_P115407 0.010135848 1.3188878 up 0.31084928 −0.08847254 GSTM1 “Homo sapiens glutathione S-transferase mu NM_146421 1 (GSTM1), transcript variant 2, mRNA [NM_146421]” A_23_P12343 0.01809803 1.4180923 up 0.31395653 −0.18999486 GSTM3 “Homo sapiens glutathione S-transferase mu NM_000849 3 (brain) (GSTM3), transcript variant 1, mRNA [NM_000849]” A_24_P50972 0.047969874 1.3672184 down −0.56622344 −0.11497975 GOLGA6L6 “Homo sapiens golgin A6 family-like 6 NM_001145004 (GOLGA6L6), mRNA [NM_001145004]” A_33_P3331687 0.07681634 1.4575082 up 0.5978242 0.054320335 GPSM1 “Homo sapiens G-protein signaling NM_001145638 modulator 1 (GPSM1), transcript variant 1, mRNA [NM_001145638]” A_23_P51487 0.020316713 1.3146726 down −0.26225594 0.13244759 GBP3 “Homo sapiens guanylate binding protein 3 NM_018284 (GBP3), mRNA [NM_018284]” A_23_P74290 8.34E−05 1.36265 down −0.25034246 0.19607258 GBP5 “Homo sapiens guanylate binding protein 5 NM_052942 (GBP5), transcript variant 1, mRNA [NM_052942]” A_33_P3364060 0.041923005 1.3391094 up 0.38413158 −0.03714231 HR “Homo sapiens hairless homolog (mouse) NM_005144 (HR), transcript variant 1, mRNA [NM_005144]” A_23_P2601 0.0556336 1.3637878 up 0.6045371 0.15691787 HSP90B1 “Homo sapiens heat shock protein 90 kDa NM_003299 beta (Grp94), member 1 (HSP90B1), mRNA [NM_003299]” A_33_P3235400 0.09289805 1.4275789 up 0.57690924 0.06333871 HDGF “Homo sapiens hepatoma-derived growth NM_004494 factor (HDGF), transcript variant 1, mRNA [NM_004494]” A_24_P136161 0.005481314 1.3070174 up 0.08381522 −0.30246323 HNRNPCL1 “Homo sapiens heterogeneous nuclear NM_001013631 ribonucleoprotein C-like 1 (HNRNPCL1), mRNA [NM_001013631]” A_23_P117662 0.030373184 1.733141 up 0.53507316 −0.25831598 HDC “Homo sapiens histidine decarboxylase NM_002112 (HDC), mRNA [NM_002112]” A_33_P3257678 0.050762586 1.3800672 down −0.1279434 0.33679512 HIST2H3A “Homo sapiens histone cluster 2, H3a NM_001005464 (HIST2H3A), mRNA [NM_001005464]” A_23_P134684 3.45E−04 1.3789066 down −0.39460433 0.06892046 HMBOX1 “Homo sapiens homeobox containing 1 NM_024567 (HMBOX1), transcript variant 1, mRNA [NM_024567]” A_23_P97990 0.019677851 1.374254 down −0.27780554 0.18084311 HTRA1 “Homo sapiens HtrA serine peptidase 1 NM_002775 (HTRA1), mRNA [NM_002775]” A_24_P363548 0.002504433 1.4040958 down −0.18716349 0.30247787 HIP1 “Homo sapiens huntingtin interacting protein NM_005338 1 (HIP1), mRNA [NM_005338]” A_33_P3308481 5.75E−05 1.4845908 down −0.3298521 0.24021314 HYMAI “Homo sapiens hydatidiform mole NR_002768 associated and imprinted (non-protein coding) (HYMAI), non-coding RNA [NR_002768]” A_32_P211248 7.56E−04 2.5825121 up 1.3989235 0.030148894 LOC100131138 “Homo sapiens hypothetical LOC100131138 NR_036513 (LOC100131138), non-coding RNA [NR_036513]” A_24_P586390 0.014898183 1.3297529 down −0.17911632 0.23204184 LOC100133331 “Homo sapiens hypothetical LOC100133331 NR_028327 (LOC100133331), non-coding RNA [NR_028327]” A_33_P3390042 0.08727153 1.4229659 up 0.5128816 0.003980539 LOC143188 “Homo sapiens hypothetical LOC143188 NR_015409 (LOC143188), non-coding RNA [NR_015409]” A_33_P3327697 0.001619901 1.352933 down −0.30568862 0.1304018 LOC145474 “Homo sapiens hypothetical LOC145474 NR_027046 (LOC145474), non-coding RNA [NR_027046]” A_23_P406227 5.47E−04 1.3153083 up 0.2099269 −0.18547417 MGC23284 “Homo sapiens hypothetical LOC197187 NR_024399 (MGC23284), transcript variant 2, non- coding RNA [NR_024399]” A_23_P405282 0.089760005 1.5368778 up 0.6276134 0.007610971 MGC45922 “Homo sapiens hypothetical LOC284365 NR_038359 (MGC45922), non-coding RNA [NR_038359]” A_33_P3234472 0.005810714 1.4360186 down −0.24649546 0.27557907 LOC284751 “Homo sapiens hypothetical LOC284751 NR_034124 (LOC284751), non-coding RNA [NR_034124]” A_33_P3243502 5.36E−04 1.3541956 down −0.14575173 0.29168436 LOC389634 “Homo sapiens hypothetical LOC389634 NR_024420 (LOC389634), non-coding RNA [NR_024420]” A_24_P366787 0.083696164 1.3104081 up 0.38772547 −0.002290747 FLJ42875 “Homo sapiens hypothetical LOC440556 NR_024371 (FLJ42875), transcript variant 2, non-coding RNA [NR_024371]” A_24_P709377 0.023045259 1.4163723 down −0.32548106 0.17671943 LOC654433 “Homo sapiens hypothetical LOC654433 NR_015377 (LOC654433), non-coding RNA [NR_015377]” A_33_P3226380 0.019924704 1.3318514 down −0.24102229 0.17241085 LOC731275 “Homo sapiens hypothetical LOC731275 NR_029401 (LOC731275), non-coding RNA [NR_029401]” A_33_P3395859 0.006850161 1.3092291 up 0.1764826 −0.21223497 LOC147646 “Homo sapiens hypothetical protein NM_001193623 LOC147646 (LOC147646), mRNA [NM_001193623]” A_33_P3394868 0.048862364 1.5409874 up 0.24851498 −0.37534 LOC388588 “Homo sapiens hypothetical protein NM_001163724 LOC388588 (LOC388588), mRNA [NM_001163724]” A_33_P3714341 0.02940068 1.326508 down −0.15401596 0.25361747 “Homo sapiens IGK mRNA for AB363267 immunoglobulin kappa light chain, partial cds, clone: F010-014L. [AB363267]” A_23_P112026 0.027687857 1.3015393 up 0.19036265 −0.18985619 IDO1 “Homo sapiens indoleamine 2,3- NM_002164 dioxygenase 1 (ID01), mRNA [NM_002164]” A_23_P150609 0.0912217 1.345673 down −0.18211056 0.24621743 IGF2 “Homo sapiens insulin-like growth factor 2 NM_000612 (somatomedin A) (IGF2), transcript variant 1, mRNA [NM_000612]” A_23_P500271 0.024961589 1.3794471 up 0.1452673 −0.31882286 IRF5 “Homo sapiens interferon regulatory factor 5 NM_001098627 (IRF5), transcript variant 3, mRNA [NM_001098627]” A_33_P3221960 0.001459079 1.3767601 down −0.37895703 0.08232018 IL18RAP “Homo sapiens interleukin 18 receptor NM_003853 accessory protein (IL18RAP), mRNA [NM_003853]” A_33_P3328254 0.032091603 1.3400984 up 0.08808277 −0.3342561 IL5RA “Homo sapiens interleukin 5 receptor, alpha NM_175725 (IL5RA), transcript variant 3, mRNA [NM_175725]” A_33_P3253234 3.36E−04 1.3071045 up 0.09673596 −0.28963846 IQSEC2 “Homo sapiens IQ motif and Sec7 domain 2 NR_024449 (IQSEC2), transcript variant 3, non-coding RNA [NR_024449]” A_33_P3221114 0.002548156 1.3464185 down −0.38539615 0.043730713 JAKMIP1 “Homo sapiens janus kinase and microtubule NM_144720 interacting protein 1 (JAKMIP1), transcript variant 2, mRNA [NM_144720]” A_33_P3255290 0.004402624 1.3701937 down −0.51986045 −0.06548052 JAKMIP2 “Homo sapiens janus kinase and microtubule NM_014790 interacting protein 2 (JAKMIP2), mRNA [NM_014790]” A_33_P3379396 0.022671197 1.5983387 up 0.7085939 0.0320207 KRT1 “Homo sapiens keratin 1 (KRT1), mRNA NM_006121 [NM_006121]” A_33_P3299761 0.042684495 1.3185656 down −0.37402976 0.024939574 KRT23 “Homo sapiens keratin 23 (histone NM_015515 deacetylase inducible) (KRT23), mRNA [NM_015515]” A_33_P3293785 0.06718372 1.3514819 up 0.5921231 0.15758102 KRTAP10-3 “Homo sapiens keratin associated protein NM_198696 10-3 (KRTAP10-3), mRNA [NM_198696]” A_24_P142495 0.016049417 1.4313754 up 0.5575752 0.040173087 KRTAP1-3 “Homo sapiens keratin associated protein 1- NM_030966 3 (KRTAP1-3), mRNA [NM_030966]” A_33_P3311267 0.00196464 2.0485787 up 0.5750864 −0.45953703 KRTAP19-2 “Homo sapiens keratin associated protein NM_181608 19-2 (KRTAP19-2), mRNA [NM_181608]” A_33_P3247473 0.055842146 1.555453 up 0.601481 −0.0358537 KRTAP23-1 “Homo sapiens keratin associated protein NM_181624 23-1 (KRTAP23-1), mRNA [NM_181624]” A_24_P61753 0.001950238 1.4875685 up 0.48825037 −0.08470581 KIAA0664 “Homo sapiens KIAA0664 (KIAA0664), NM_015229 mRNA [NM_015229]” A_33_P3265222 0.037706073 1.4690068 down −0.38025752 0.17458357 KIAA1324 “Homo sapiens KIAA1324 (KIAA1324), NM_020775 mRNA [NM_020775]” A_23_P166848 0.012082896 1.7126892 down −0.8880412 −0.111777835 LTF “Homo sapiens lactotransferrin (LTF), NM_002343 transcript variant 1, mRNA [NM_002343]” A_33_P3311285 0.087441646 1.4525914 up 0.51191515 −0.026713826 LMNA “Homo sapiens lamin A/C (LMNA), NM_170707 transcript variant 1, mRNA [NM_170707]” A_33_P3356811 0.002943031 1.6657962 up 0.69400465 −0.04220723 LCE1E “Homo sapiens late cornified envelope 1E NM_178353 (LCE1E), mRNA [NM_178353]” A_23_P120902 0.090559945 1.3033013 down −0.55106217 −0.16889149 LGALS2 “Homo sapiens lectin, galactoside-binding, NM_006498 soluble, 2 (LGALS2), mRNA [NM_006498]” A_33_P3269844 0.08599462 1.4475169 up 0.6968315 0.1632513 LRRC26 “Homo sapiens leucine rich repeat NM_001013653 containing 26 (LRRC26), mRNA [NM_001013653]” A_33_P3420446 0.00271936 2.366392 up 0.7168905 −0.52579856 LRRD1 “Homo sapiens leucine-rich repeats and NM_001161528 death domain containing 1 (LRRD1), mRNA [NM_001161528]” A_23_P209129 0.01875381 1.6142532 down −0.2496036 0.4412632 LAIR2 “Homo sapiens leukocyte-associated NM_002288 immunoglobulin-like receptor 2 (LAIR2), transcript variant 1, mRNA [NM_002288]” A_23_P215461 0.002549152 1.300507 down −0.18881646 0.19025768 LIMK1 “Homo sapiens LIM domain kinase 1 NM_002314 (LIMK1), transcript variant 1, mRNA [NM_002314]” A_33_P3223678 0.083056256 1.3900585 up 0.42437238 −0.05077323 LHX3 “Homo sapiens LIM homeobox 3 (LHX3), NM_014564 transcript variant 2, mRNA [NM_014564]” A_33_P3883985 2.77E−04 1.4781803 down −0.39256123 0.17126101 LMF1 “Homo sapiens lipase maturation factor 1 NR_036442 (LMF1), transcript variant 4, non-coding RNA [NR_036442]” A_23_P169437 0.026562108 1.3425556 down −0.27172977 0.15325205 LCN2 “Homo sapiens lipocalin 2 (LCN2), mRNA NM_005564 [NM_005564]” A_33_P3418194 0.08478003 1.3773015 up 0.4566962 −0.005148216 LYNX1 “Homo sapiens Ly6/neurotoxin 1 (LYNX1), NM_023946 transcript variant 1, mRNA [NM_023946]” A_23_P94186 0.011679071 1.5363395 up 0.18567842 −0.43381873 LYPD2 “Homo sapiens LY6/PLAUR domain NM_205545 containing 2 (LYPD2), mRNA [NM_205545]” A_24_P148907 0.001661408 2.865912 up 1.2227665 −0.29622796 MAB21L2 “Homo sapiens mab-21-like 2 (C. elegans) NM_006439 (MAB21L2), mRNA [NM_006439]” A_33_P3424222 0.017523954 1.3362783 up 0.07366995 −0.34455052 HLA-DQB1 “Homo sapiens major histocompatibility NM_002123 complex, class II, DQ beta 1 (HLA-DQB1), mRNA [NM_002123]” A_23_P116614 3.10E−05 1.4666952 down −0.10582965 0.44673944 ME3 “Homo sapiens malic enzyme 3, NADP(+)- NM_001014811 dependent, mitochondrial (ME3), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_001014811]” A_33_P3255434 0.060425054 1.3492434 up 0.28156415 −0.15058652 MEG3 “Homo sapiens maternally expressed 3 (non- NR_003531 protein coding) (MEG3), transcript variant 3, non-coding RNA [NR_003531]” A_33_P3329444 0.001861639 1.7145877 up 0.9819033 0.20404148 MAMSTR “Homo sapiens MEF2 activating motif and NM_182574 SAP domain containing transcriptional regulator (MAMSTR), transcript variant 2, mRNA [NM_182574]” A_23_P75769 0.001481862 1.3274643 up 0.29444453 −0.11422854 MS4A4A “Homo sapiens membrane-spanning 4- NM_024021 domains, subfamily A, member 4 (MS4A4A), transcript variant 1, mRNA [NM_024021]” A_33_P3375576 0.002459711 1.3197386 up 0.08183793 −0.3184143 MAP7 “Homo sapiens microtubule-associated NM_003980 protein 7 (MAP7), transcript variant 4, mRNA [NM_003980]” A_23_P116235 0.09601189 1.4094809 up 0.6359941 0.14083026 MDK “Homo sapiens midkine (neurite growth- NM_001012334 promoting factor 2) (MDK), transcript variant 1, mRNA [NM_001012334]” A_33_P3713035 0.06089847 1.3921365 up 0.49190181 0.014601317 LOC221814 Homo sapiens mRNA; cDNA AL122087 DKFZp564C0371 (from clone DKFZp564C0371) [AL122087] A_33_P3576797 5.14E−05 1.3676219 down −0.19595735 0.25571203 LOC158863 Homo sapiens mRNA; cDNA AL110203 DKFZp586J1922 (from clone DKFZp586J1922) [AL110203] A_24_P239177 0.07026498 1.3379579 up 0.37570342 −0.044329308 MUC4 “Homo sapiens mucin 4, cell surface NM_018406 associated (MUC4), transcript variant 1, mRNA [NM_018406]” A_23_P153616 0.037463963 1.3608772 up 0.15519878 −0.28933802 MADCAM1 “Homo sapiens mucosal vascular addressin NM_130760 cell adhesion molecule 1 (MADCAM1), transcript variant 1, mRNA [NM_130760]” A_24_P926960 0.007280337 1.3126051 down −0.11324262 0.27919033 MEGF6 “Homo sapiens multiple EGF-like-domains NM_001409 6 (MEGF6), mRNA [NM_001409]” A_23_P258912 0.004170403 2.2495987 up 1.0578427 −0.11182482 MYOM2 “Homo sapiens myomesin (M-protein) 2, NM_003970 165 kDa (MYOM2), mRNA [NM_003970]” A_23_P148737 0.021698399 1.3982097 down −0.10234106 0.38123974 MYBPH “Homo sapiens myosin binding protein H NM_004997 (MYBPH), mRNA [NM_004997]” A_32_P475513 2.20E−04 1.3007798 down −0.16332881 0.21604796 MYO15B “Homo sapiens myosin XVB pseudogene NR_003587 (MYO15B), non-coding RNA [NR_003587]” A_23_P59888 0.022967694 1.4164991 up 0.1757084 −0.3266213 NACAP1 “Homo sapiens nascent-polypeptide- NR_002182 associated complex alpha polypeptide pseudogene 1 (NACAP1), non-coding RNA [NR_002182]” A_33_P3363799 0.001432941 1.3627709 down −0.32955402 0.11698904 NCAM1 “Homo sapiens neural cell adhesion NM_001242607 molecule 1 (NCAM1), transcript variant 5, mRNA [NM_001242607]” A_33_P3293524 5.14E−04 1.7614166 up 0.5752742 −0.24146186 NEURL “Homo sapiens neuralized homolog NM_004210 (Drosophila) (NEURL), mRNA [NM_004210]” A_33_P3417880 0.09242977 1.4802772 up 0.7100061 0.1441387 NKAPL “Homo sapiens NFKB activating protein- NM_001007531 like (NKAPL), mRNA [NM_001007531]” A_32_P29954 0.09568178 1.323937 up 0.31786942 −0.0869652 NCRNA00168 “Homo sapiens non-protein coding RNA 168 NR_033387 (NCRNA00168), non-coding RNA [NR_033387]” A_23_P348257 0.005219493 1.3868356 down −0.49135873 −0.019561974 NUAK1 “Homo sapiens NUAK family, SNF1-like NM_014840 kinase, 1 (NUAK1), mRNA [NM_014840]” A_24_P181254 1.12E−05 2.610549 down −0.9120534 0.47229984 OLFM4 “Homo sapiens olfactomedin 4 (OLFM4), NM_006418 mRNA [NM_006418]” A_23_P123164 0.086086884 1.4242122 up 0.74071884 0.23055477 OR6W1P “Homo sapiens olfactory receptor, family 6, NR_002140 subfamily W, member 1 pseudogene (OR6W1P), non-coding RNA [NR_002140]” A_23_P154849 9.79E−04 1.3476431 up 0.24389891 −0.18653955 OLIG1 “Homo sapiens oligodendrocyte NM_138983 transcription factor 1 (OLIG1), mRNA [NM_138983]” A_33_P3424057 0.036320634 1.4471698 down −0.04955366 0.48368058 PEG3 “Homo sapiens paternally expressed 3 NM_006210 (PEG3), transcript variant 1, mRNA [NM_006210]” A_33_P3358213 0.07315914 1.3551917 down −0.50678235 −0.06828541 PADI6 “Homo sapiens peptidyl arginine deiminase, NM_207421 type VI (PADI6), mRNA [NM_207421]” A_33_P3389649 6.15E−04 1.4486274 down −0.36063802 0.17404853 PDE4D “Homo sapiens phosphodiesterase 4D, NM_001197218 cAMP-specific (PDE4D), transcript variant 4, mRNA [NM_001197218]” A_23_P50508 0.038823243 1.3111038 down −0.10175071 0.28903127 PLA2G4C “Homo sapiens phospholipase A2, group NM_003706 IVC (cytosolic, calcium-independent) (PLA2G4C), transcript variant 1, mRNA [NM_003706]” A_32_P220750 9.14E−04 1.3145334 down −0.19883072 0.19572005 PLGLB1 “Homo sapiens plasminogen-like B1 NM_001032392 (PLGLB1), mRNA [NM_001032392]” A_23_P208293 0.003093129 1.7755167 down −0.106243365 0.7219956 PVRL2 “Homo sapiens poliovirus receptor-related 2 NM_001042724 (herpesvirus entry mediator B) (PVRL2), transcript variant delta, mRNA [NM_001042724]” A_33_P3412233 0.001612926 1.3889495 down −0.14588183 0.32811236 POMZP3 “Homo sapiens POM121 and ZP3 fusion NM_152992 (POMZP3), transcript variant 2, mRNA [NM_152992]” A_33_P3835524 0.08983538 1.3188908 up 0.3992639 −6.13E−05 POU2F2 “Homo sapiens POU class 2 homeobox 2 NM_001207026 (POU2F2), transcript variant 3, mRNA [NM_001207026]” A_33_P3253440 0.04686745 1.3020296 up 0.4306891 0.049926866 PQLC3 “Homo sapiens PQ loop repeat containing 3 NM_152391 (PQLC3), mRNA [NM_152391]” A_23_P135257 0.042998407 1.3288782 up 0.42078122 0.010572314 PRSS3 “Homo sapiens protease, serine, 3 (PRSS3), NM_002771 transcript variant 2, mRNA [NM_002771]” A_24_P412734 0.0017587 2.3188243 up 0.60075295 −0.6126407 PRSS36 “Homo sapiens protease, serine, 36 NM_173502 (PRSS36), mRNA [NM_173502]” A_33_P3284197 0.08594889 1.3667958 up 0.65785617 0.20705844 POMGNT1 “Homo sapiens protein O-linked mannose NM_017739 beta1,2-N-acetylglucosaminyltransferase (POMGNT1), transcript variant 1, mRNA [NM_017739]” A_24_P350649 1.59E−04 1.3157947 down −0.19939834 0.1965361 PDPR “Homo sapiens pyruvate dehydrogenase NM_017990 phosphatase regulatory subunit (PDPR), mRNA [NM_017990]” A_23_P395632 0.092577755 1.3042655 up 0.41154584 0.028308326 R3HDML “Homo sapiens R3H domain containing-like NM_178491 (R3HDML), mRNA [NM_178491]” A_23_P412214 0.012191882 1.4418955 down 0.008509423 0.53647596 RAP1GAP2 “Homo sapiens RAP1 GTPase activating NM_015085 protein 2 (RAP1GAP2), transcript variant 1, mRNA [NM_015085]” A_24_P321525 0.09530078 1.4714687 up 0.7249367 0.1676798 RERG “Homo sapiens RAS-like, estrogen- NM_032918 regulated, growth inhibitor (RERG), transcript variant 1, mRNA [NM_032918]” A_33_P3233906 0.031552453 1.3244379 up 0.13838409 −0.26699603 RAMP1 “Homo sapiens receptor (G protein-coupled) NM_005855 activity modifying protein 1 (RAMP1), mRNA [NM_005855]” A_23_P207842 0.07773515 1.6012361 up 0.8123088 0.13312276 RARA “Homo sapiens retinoic acid receptor, alpha NM_001024809 (RARA), transcript variant 2, mRNA [NM_001024809]” A_24_P218814 7.21E−06 1.3163062 down −0.13313852 0.2633566 RDH5 “Homo sapiens retinol dehydrogenase 5 (11- NM_002905 cis/9-cis) (RDH5), transcript variant 2, mRNA [NM_002905]” A_33_P3234794 0.08135664 1.5102085 up 0.80040497 0.20565729 ARHGAP40 “Homo sapiens Rho GTPase activating NM_001164431 protein 40 (ARHGAP40), mRNA [NM_001164431]” A_33_P3299110 6.68E−04 2.0504975 up 1.2687314 0.23275743 ARHGAP42 “Homo sapiens Rho GTPase activating NM_152432 protein 42 (ARHGAP42), mRNA [NM_152432]” A_23_P253221 4.89E−05 1.3480966 up 0.232708 −0.19821592 ARHGEF4 “Homo sapiens Rho guanine nucleotide NM_032995 exchange factor (GEF) 4 (ARHGEF4), transcript variant 2, mRNA [NM_032995]” A_33_P3389394 0.024702093 1.319288 up −0.025534749 −0.42529428 RPPH1 “Homo sapiens ribonuclease P RNA NR_002312 component H1 (RPPH1), RNase P RNA [NR_002312]” A_23_P151637 0.006104208 1.3874338 up 0.44583097 −0.026587963 RNASE2 “Homo sapiens ribonuclease, RNase A NM_002934 family, 2 (liver, eosinophil-derived neurotoxin) (RNASE2), mRNA [NM_002934]” A_23_P163025 0.022805661 1.34434 up 0.38591552 −0.04098246 RNASE3 “Homo sapiens ribonuclease, RNase A NM_002935 family, 3 (RNASE3), mRNA [NM_002935]” A_23_P143526 0.019984735 1.6951951 down −0.11775185 0.64369947 S100B “Homo sapiens S100 calcium binding NM_006272 protein B (S100B), mRNA [NM_006272]” A_23_P150583 0.09199147 1.4211044 up 0.7121389 0.20512642 SCGB1A1 “Homo sapiens secretoglobin, family 1A, NM_003357 member 1 (uteroglobin) (SCGB1A1), mRNA [NM_003357]” A_24_P917866 0.014710876 1.3474284 up 0.06467435 −0.36553437 SET “Homo sapiens SET nuclear oncogene NM_003011 (SET), transcript variant 2, mRNA [NM_003011]” A_33_P3270636 0.002022835 1.3082175 up 0.41448945 0.026887037 SHISA5 “Homo sapiens shisa homolog 5 (Xenopus NM_016479 laevis) (SHISA5), mRNA [NM_016479]” A_24_P40001 0.011109361 1.4188412 up 0.22393192 −0.28078127 SIGLEC8 “Homo sapiens sialic acid binding Ig-like NM_014442 lectin 8 (SIGLEC8), mRNA [NM_014442]” A_33_P3252333 0.09818985 1.4077512 up −0.3091631 −0.80255544 SNORD3B-1 “Homo sapiens small nucleolar RNA, C/D NR_003271 box 3B-1 (SNORD3B-1), small nucleolar RNA [NR_003271]” A_33_P3227217 0.04919367 1.354897 up 0.25370643 −0.18447681 SNORA81 “Homo sapiens small nucleolar RNA, NR_002989 H/ACA box 81 (SNORA81), small nucleolar RNA [NR_002989]” A_23_P325562 0.00332791 1.4054743 down −0.43519023 0.0558669 SLC1A7 “Homo sapiens solute carrier family 1 NM_006671 (glutamate transporter), member 7 (SLC1A7), mRNA [NM_006671]” A_23_P160159 1.37E−04 1.3007578 down −0.22973682 0.14961547 SLC2A5 “Homo sapiens solute carrier family 2 NM_003039 (facilitated glucose/fructose transporter), member 5 (SLC2A5), transcript variant 1, mRNA [NM_003039]” A_33_P3335920 0.08877471 1.330463 up 0.45973876 0.047810316 SYNE1 “Homo sapiens spectrin repeat containing, NM_182961 nuclear envelope 1 (SYNE1), transcript variant 1, mRNA [NM_182961]” A_33_P3216438 7.26E−04 2.372752 up 1.3489308 0.10236969 SPATA21 “Homo sapiens spermatogenesis associated NM_198546 21 (SPATA21), mRNA [NM_198546]” A_23_P163567 0.01641856 1.3127929 up 0.21629916 −0.17634013 SMPD3 “Homo sapiens sphingomyelin NM_018667 phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (SMPD3), mRNA [NM_018667]” A_33_P3871347 0.053434405 1.3910446 up 0.6208837 0.14471498 SNED1 “Homo sapiens sushi, nidogen and EGF-like NM_001080437 domains 1 (SNED1), mRNA [NM_001080437]” A_23_P362893 0.086125314 1.3498223 up 0.4291114 −0.003657948 TEAD1 “Homo sapiens TEA domain family member NM_021961 1 (SV40 transcriptional enhancer factor) (TEAD1), mRNA [NM_021961]” A_33_P3209386 6.43E−04 1.5380307 up 0.5672639 −0.053820457 TXNDC17 “Homo sapiens thioredoxin domain NM_032731 containing 17 (TXNDC17), mRNA [NM_032731]” A_23_P57118 0.026512504 1.3210843 up 0.28625846 −0.11546404 TGM3 “Homo sapiens transglutaminase 3 (E NM_003245 polypeptide, protein-glutamine-gamma- glutamyltransferase) (TGM3), mRNA [NM_003245]” A_33_P3387696 0.05335964 1.3100442 up 0.04848023 −0.3411352 TMBIM4 “Homo sapiens transmembrane BAX NM_016056 inhibitor motif containing 4 (TMBIM4), mRNA [NM_016056]” A_23_P369899 0.08287382 1.3267201 up −0.22741964 −0.63528365 TMEM158 “Homo sapiens transmembrane protein 158 NM_015444 (gene/pseudogene) (TMEM158), mRNA [NM_015444]” A_33_P3277611 0.003524825 1.6475877 up 0.87635684 0.15600152 TMEM8C “Homo sapiens transmembrane protein 8C NM_001080483 (TMEM8C), mRNA [NM_001080483]” A_32_P396186 2.71E−04 1.3270874 down −0.21896301 0.18930034 TRIM66 “Homo sapiens tripartite motif containing 66 NM_014818 (TRIM66), mRNA [NM_014818]” A_23_P26386 5.48E−04 1.373854 up 0.257141 −0.2010878 TPPP3 “Homo sapiens tubulin polymerization- NM_016140 promoting protein family member 3 (TPPP3), mRNA [NM_016140]” A_23_P19291 0.007322263 2.2345412 down −0.85803705 0.30194163 TUBB2A “Homo sapiens tubulin, beta 2A (TUBB2A), NM_001069 mRNA [NM_001069]” A_23_P254271 0.006233792 1.3433877 up 0.21792516 −0.20795049 TUBB6 “Homo sapiens tubulin, beta 6 (TUBB6), NM_032525 mRNA [NM_032525]” A_24_P813147 0.044909976 1.3454928 down −0.10447685 0.32365793 TUBB8 “Homo sapiens tubulin, beta 8 (TUBB8), NM_177987 transcript variant 1, mRNA [NM_177987]” A_33_P3409518 0.002293216 2.2983027 up 1.0949807 −0.10558822 TUBBP5 “Homo sapiens tubulin, beta pseudogene 5 NR_027156 (TUBBP5), non-coding RNA [NR_027156]” A_23_P52986 0.014557628 1.4165095 up 0.41923535 −0.08310499 VWCE “Homo sapiens von Willebrand factor C and NM_152718 EGF domains (VWCE), mRNA [NM_152718]” A_33_P3222019 0.062055603 1.4264376 up 0.49954265 −0.012873986 WSCD2 “Homo sapiens WSC domain containing 2 NM_014653 (WSCD2), mRNA [NM_014653]” A_23_P131024 0.012060405 1.3444775 down −0.33537063 0.09167503 ZBTB32 “Homo sapiens zinc finger and BTB domain NM_014383 containing 32 (ZBTB32), mRNA [NM_014383]” A_33_P3263538 9.06E−05 1.586441 down −0.104649104 0.56114477 NEAT1 “Human MEN1 region clone epsilon/beta AF001893 mRNA, 3′ fragment. [AF001893]” A_33_P3299329 0.008540989 1.3169246 up −0.020110765 −0.41728345 “Human mRNA for T-cell receptor V beta A25969 gene segment V-beta-7, clone IGRb18. [X58812]” A_33_P3351180 0.043619018 1.4690309 down −0.12071315 0.4341515 immunoglobulin heavy constant alpha 1 XR_114797 [Source: HGNC Symbol; Acc: 5478] [ENST00000390547] A_33_P3370019 0.05750756 1.3361309 down −0.1561117 0.26194954 immunoglobulin heavy constant delta AK093943 [Source: HGNC Symbol; Acc: 5480] [ENST00000390556] A_33_P3424591 0.029236536 1.4456568 down −0.15465923 0.3770659 immunoglobulin heavy constant gamma 1 CR611254 (G1m marker) [Source: HGNC Symbol; Acc: 5525] [ENST00000390549] A_33_P3263319 0.028588455 1.5212795 down −0.34599957 0.25928557 immunoglobulin heavy constant gamma 3 AY172958 (G3m marker) [Source: HGNC Symbol; Acc: 5527] [ENST00000390551] A_23_P361654 0.015799953 1.3459028 down −0.2903985 0.13817567 immunoglobulin kappa variable 1D-16 BC073764 [Source: HGNC Symbol; Acc: 5748] [ENST00000492446] A_24_P173566 0.025859203 1.3649294 down −0.15881252 0.29001373 immunoglobulin lambda variable 3-1 X57818 [Source: HGNC Symbol; Acc: 5896] [ENST00000390319] A_33_P3226085 0.053354543 1.4504704 down −0.117482714 0.41903824 immunoglobulin lambda variable 3-10 AF063703 [Source: HGNC Symbol; Acc: 5897] [ENST00000390315] A_33_P3287610 0.011096977 1.3215991 down −0.113103464 0.2891812 immunoglobulin lambda variable 3-12 DQ098743 [Source: HGNC Symbol; Acc: 5898] [ENST00000390313] A_33_P3424489 0.03241414 1.3218818 down −0.122637704 0.2799555 immunoglobulin lambda variable 3-25 S73129 [Source: HGNC Symbol; Acc: 5908] [ENST00000390305] A_33_P3251205 0.01186517 1.4074701 down −0.2519347 0.2411696 immunoglobulin lambda variable 3-9 AF194657 (gene/pseudogene) [Source: HGNC Symbol; Acc: 5918] [ENST00000390316] A_33_P3398143 0.05249057 1.9251307 up 0.8772388 −0.067717604 ITGB2 “integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) [Source: HGNC Symbol; Acc: 6155] [ENST00000397846]” A_33_P3423721 0.001939164 1.3729306 up 0.2945948 −0.16266395 JPH3 junctophilin 3 [Source: HGNC AB593088 Symbol; Acc: 14203] [ENST00000301008] A_33_P3399208 0.050488997 1.379161 up 0.03240173 −0.43138912 HLA-B*1531 “major histocompatibility complex, class I, AF298582 B [Source: HGNC Symbol; Acc: 4932] [ENST00000466304]” A_33_P3409765 0.043177925 1.3497835 down −0.26763448 0.16509363 MGAM maltase-glucoamylase (alpha-glucosidase) ENST00000312952 [Source: HGNC Symbol; Acc: 7043] [ENST00000312952] A_23_P420942 0.07993442 1.3811071 up 0.5835465 0.11772156 metallothionein 1E [Source: HGNC AF495759 Symbol; Acc: 73971 [ENST00000330439] A_33_P3323699 0.089966744 1.4933032 up 0.6035198 0.025012754 NPPA natriuretic peptide A [Source: HGNC ENST00000376476 Symbol; Acc: 7939] [ENST00000376476] A_33_P3300495 2.46E−05 1.6870832 down −0.45745656 0.2970746 plasminogen-like B1 [Source: HGNC BC022294 Symbol; Acc: 9072] [ENST00000409310] A_33_P3221055 0.014507352 1.33372 down −0.2336753 0.18178049 LOC100128729 “PREDICTED: Homo sapiens hypothetical XR_110743 LOC100128729, transcript variant 1 (LOC100128729), partial miscRNA [XR_110743]” A_33_P3369245 0.07990449 1.3084261 up 0.4190942 0.031261757 LOC100129826 “PREDICTED: Homo sapiens hypothetical XR_114456 LOC100129826 (LOC100129826), miscRNA [XR_114456]” A_33_P3514859 2.30E−04 1.3660825 down −0.2139588 0.23608589 LOC100506342 “PREDICTED: Homo sapiens hypothetical XR_108862 LOC100506342 (LOC100506342), partial miscRNA [XR_108862]” A_33_P3589543 7.69E−04 1.349322 down −0.08960023 0.34263444 “PREDICTED: Homo sapiens hypothetical XR_109057 locus LOC692247 (LOC692247), miscRNA [XR_109057]” A_33_P3789693 0.017359855 1.3408446 down −0.33839023 0.084751904 MGC24103 “PREDICTED: Homo sapiens hypothetical XR_108934 MGC24103 (MGC24103), miscRNA [XR_108934]” A_33_P3214072 0.067344286 1.3672006 up 0.46909365 0.01786866 LOC729175 “PREDICTED: Homo sapiens hypothetical XM_001129558 protein LOC729175 (LOC729175), mRNA [XM_001129558]” A_33_P3402257 0.08375601 1.3421152 up 0.46482745 0.040318932 LOC100508241 “PREDICTED: Homo sapiens membrane- XM_003119499 spanning 4-domains subfamily A member 18-like (LOC100508241), mRNA [XM_003119499]” A_32_P49668 0.009767092 1.4546022 down −0.35131896 0.1893057 LOC100510697 “PREDICTED: Homo sapiens putative XM_003118465 POM121-like protein 1-like (LOC100510697), mRNA [XM_003118465]” A_24_P312325 4.08E−05 1.337715 down −0.27505833 0.14471245 “PREDICTED: Homo sapiens XM_003119008 uncharacterized protein C8orf15-like (LOC100505981), mRNA [XM_003119008]” A_23_P359870 1.74E−04 1.3308623 down −0.2763381 0.13602321 “PREDICTED: Homo sapiens XM_003119009 uncharacterized protein C8orf16-like (LOC100506010), mRNA [XM_003119009]” A_24_P316019 0.002571515 1.3050936 down −0.23434815 0.14980525 Putative golgin subfamily A member 6-like XM_003118656 protein 11 [Source: UniProtKB/Swiss- Prot; Acc: A6NCC3] [ENST00000333156] A_33_P3292130 0.027860254 1.3341794 up −0.014861028 −0.43081373 “Q2JG47_FRASC (Q2JG47) Methyltransferase type 11, partial (6%) [THC2566648]” A_33_P3369716 0.0608446 1.3832763 down −0.5539065 −0.08581712 “Q9VKG5_DROME (Q9VKG5) CG14930- PA (AT28291p), partial (5%) [THC2679405]” A_33_P3254121 0.06008231 1.4974492 up 0.86985826 0.2873513 RNASET2 ribonuclease T2 [Source: HGNC AK001769 Symbol; Acc: 21686] [ENST00000358165] A_24_P24972 0.007481211 1.5367382 up 0.3232862 −0.29658514 ribosomal protein L22 pseudogene 11 CR590757 [Source: HGNC Symbol; Acc: 35603] [ENST00000538228] A_32_P133090 0.0117861 1.3314247 up 0.28210762 −0.13086325 “RST35951 Athersys RAGE Library Homo BG216262 sapiens cDNA, mRNA sequence [BG216262]” A_23_P311201 0.064578146 1.5723459 up 0.6262721 −0.026646452 serine/arginine-rich splicing factor 10 XM_003119082 [Source: HGNC Symbol; Acc: 16713] [ENST00000344989] A_33_P3250750 0.004187005 1.8083831 up −0.119524024 −0.9742244 Synthetic construct Homo sapiens gateway CU677518 clone IMAGE: 100018551 3′ read RAB35 mRNA. [CU677518] A_33_P3233404 0.03517226 1.4829948 down −0.40898976 0.15952376 T cell receptor beta variable 28 AB305916 [Source: HGNC Symbol; Acc: 12209] [ENST00000390400] A_33_P3297545 0.002523841 1.7698867 up 1.0880127 0.26435575 T cell receptor beta variable 6-8 [Source: HGNC Symbol; Acc: 12233] [ENST00000390376] A_33_P3786807 0.005465086 1.3740717 up 0.13381559 −0.32464167 SNAR-E “UI-H-DF1-auh-i-18-0-UI.s1 CA436475 NCI_CGAP_DF1 Homo sapiens cDNA clone UI-H-DF1-auh-i-18-0-UI 3′, mRNA sequence [CA436475]”

APPENDIX B MALES: Technology: Agilent.SingleColor.26652 # Created On: Tue Jan 31 13:34:51 EST 2012 Entrez RefSeq ProbeName Gene Description Gb Accession EnsemblID GeneID Accession TIGRID A_23_P120048 BAZ2B bromodomain adjacent to zinc finger domain, 2B (BAZ2B), NM_013450 ENST00000392783 29994 NM_013450 THC2491976 mRNA [NM_013450] A_23_P250800 ST3GAL6 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6), NM_006100 ENST00000477899 10402 NM_006100 THC2493961 mRNA [NM_006100] A_23_P150583 SCGB1A1 secretoglobin, family 1A, member 1 (uteroglobin) (SCGB1A1), NM_003357 ENST00000278282 7356 NM_003357 THC2472230 mRNA [NM_003357] A_23_P250302 CCR3 chemokine (C-C motif) receptor 3 (CCR3), transcript variant 1, NM_001837 ENST00000357422 1232 NM_001837 THC2516499 mRNA [NM_001837] A_33_P3349637 PCDH1 protocadherin 1 (PCDH1), transcript variant 1, mRNA NM_002587 ENST00000456271 5097 NM_002587 NP099071 [NM_002587] A_23_P131024 ZBTB32 zinc finger and BTB domain containing 32 (ZBTB32), mRNA NM_014383 ENST00000262630 27033 NM_014383 THC2760977 [NM_014383] A_24_P272451 C17orf87 cDNA FLJ32580 fis, clone SPLEN2000270. [AK057142] AK057142 388325 THC2484848 A_33_P3337609 chromosome 2 genomic contig, GRCh37.p5 NP113779 A_32_P396186 TRIM66 tripartite motif containing 66 (TRIM66), mRNA [NM_014818] NM_014818 ENST00000299550 9866 NM_014818 THC2602835 A_23_P87879 CD69 CD69 molecule (CD69), transcript variant 1, mRNA NM_001781 ENST00000228434 969 NM_001781 THC2461298 [NM_001781] A_33_P3287610 immunoglobulin lambda variable 3-12 [Source: HGNC DQ098743 ENST00000390313 NP1087705 Symbol; Acc: 5898] [ENST00000390313] A_23_P109322 PCP4 Purkinje cell protein 4 (PCP4), mRNA [NM_006198] NM_006198 ENST00000468717 5121 NM_006198 THC2617631 A_33_P3388016 CCDC72 coiled-coil domain containing 72 (CCDC72), mRNA NM_015933 ENST00000477624 51372 NM_015933 THC2469917 [NM_015933] A_23_P23850 DAB1 disabled homolog 1 (Drosophila) (DAB1), mRNA [NM_021080] NM_021080 ENST00000371231 1600 NM_021080 THC2533734 A_23_P56736 TUBA3D tubulin, alpha 3d (TUBA3D), mRNA [NM_080386] NM_080386 ENST00000321253 113457 NM_080386 THC2628673 A_33_P3246010 cDNA FLJ35175 fis, clone PLACE6013400. [AK092494] AK092494 THC2636441 A_23_P113572 CD19 CD19 molecule (CD19), transcript variant 2, mRNA NM_001770 ENST00000537306 930 NM_001770 THC2473305 [NM_001770] A_23_P50907 ITGAV integrin, alpha V (vitronectin receptor, alpha polypeptide, NM_002210 ENST00000374907 3685 NM_002210 THC2544883 antigen CD51) (ITGAV), transcript variant 1, mRNA [NM_002210] A_23_P138881 ACTN3 actinin, alpha 3 (ACTN3), mRNA [NM_001104] NM_001104 ENST00000502692 89 NM_001104 THC2472718 A_24_P110242 immunoglobulin heavy variable 3/OR16-8 (non-functional) ENST00000354689 THC2579601 [Source: HGNC Symbol; Acc: 5643] [ENST00000438532] A_33_P3412125 chromosome 19 genomic contig, GRCh37 A_33_P3254121 RNASET2 ribonuclease 12 [Source: HGNC Symbol; Acc: 21686] AK001769 ENST00000358165 8635 THC2479694 [ENST00000358165] A_33_P3247534 LOC389834 ankyrin repeat domain 57 pseudogene (LOC389834), non- NR_027420 389834 NR_027420 THC2524997 coding RNA [NR_027420] A_23_P316472 DNHD1 dynein heavy chain domain 1 (DNHD1), transcript variant 1, NM_144666 ENST00000254579 144132 NM_144666 THC2629994 mRNA [NM_144666] A_33_P3415551 GPAT2 glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2), NM_207328 ENST00000377137 150763 NM_207328 THC2483887 nuclear gene encoding mitochondrial protein, mRNA [NM_207328] A_33_P3253234 IQSEC2 IQ motif and Sec7 domain 2 (IQSEC2), transcript variant 3, non- NR_024449 23096 NR_024449 THC2765959 coding RNA [NR_024449] A_33_P3277883 LOC100129931 hypothetical LOC100129931 (LOC100129931), non-coding RNA NR_033828 100129931 NR_033828 THC2623255 [NR_033828] A_33_P3292844 NEUROG3 neurogenin 3 (NEUROG3), mRNA [NM_020999] NM_020999 ENST00000242462 50674 NM_020999 THC2483225 A_33_P3356811 LCE1E late cornified envelope 1E (LCE1E), mRNA [NM_178353] NM_178353 ENST00000368771 353135 NM_178353 THC2643480 A_33_P3412233 POMZP3 POM121 and ZP3 fusion (POMZP3), transcript variant 2, mRNA NM_152992 ENST00000275569 22932 NM_152992 THC2487398 [NM_152992] A_33_P3223467 VCPIP1 valosin containing protein (p97)/p47 complex interacting NM_025054 ENST00000310421 80124 NM_025054 THC2602555 protein 1 (VCPIP1), mRNA [NM_025054] A_33_P3304696 clone ASPBLL50 immunoglobulin lambda light chain VJ region AF058072 THC2560573 mRNA, partial cds. [AF058072] A_33_P3514487 VSTM1 V-set and transmembrane domain containing 1 (VSTM1), NM_198481 ENST00000376626 284415 NM_198481 NP1474893 mRNA [NM_198481] A_32_P153725 KIAA1033 KIAA1033 (KIAA1033), mRNA [NM_015275] NM_015275 ENST00000550053 23325 NM_015275 THC2601307 A_23_P94009 NAA38 N(alpha)-acetyltransferase 38, NatC auxiliary subunit (NAA38), NM_016200 ENST00000249299 51691 NM_016200 THC2492301 mRNA [NM_016200] A_23_P375419 TTC16 tetratricopeptide repeat domain 16 (TTC16), mRNA NM_144965 ENST00000316259 158248 NM_144965 THC2491012 [NM_144965] A_33_P3327470 Q6I984_HUMAN (Q6I984) Acidic neurotrophin 6 alpha THC2606816 (Fragment), complete [THC2606816] A_23_P156826 C6orf105 chromosome 6 open reading frame 105 (C6orf105), transcript NM_032744 ENST00000514824 84830 NM_032744 THC2473206 variant 2, mRNA [NM_032744] A_33_P3378284 COX6B2 cytochrome c oxidase subunit VIb polypeptide 2 (testis) NM_144613 ENST00000326529 125965 NM_144613 NP1157598 (COX6B2), mRNA [NM_144613] A_24_P28811 C2orf14 chromosome 2 open reading frame 14 (C2orf14), non-coding NR_023391 ENST00000439137 100132708 NR_023391 THC2535623 RNA [NR_023391] A_23_P21425 GPR119 G protein-coupled receptor 119 (GPR119), mRNA NM_178471 ENST00000276218 139760 NM_178471 THC2479570 [NM_178471] A_33_P3317431 chromosome 7 genomic contig, GRCh37 A_33_P3411315 KRTAP3-3 keratin associated protein 3-3 (KRTAP3-3), mRNA NM_033185 ENST00000391586 85293 NM_033185 THC2485385 [NM_033185] A_23_P44724 CSRP2 cysteine and glycine-rich protein 2 (CSRP2), mRNA NM_001321 ENST00000548783 1466 NM_001321 NP1153753 [NM_001321] A_23_P157007 TMEM176B transmembrane protein 176B (TMEM176B), transcript variant NM_014020 ENST00000528038 28959 NM_014020 THC2467726 1, mRNA [NM_014020] A_23_P84910 ZNF157 zinc finger protein 157 (ZNF157), mRNA [NM_003446] NM_003446 ENST00000377073 7712 NM_003446 THC2478782 A_23_P53467 IKBIP IKBKB interacting protein (IKBIP), transcript variant 2, mRNA NM_201612 ENST00000393042 121457 NM_201612 THC2478224 [NM_201612] A_33_P3246995 chromosome 7 genomic contig, GRCh37 A_23_P157117 CREB5 cAMP responsive element binding protein 5 (CREB5), transcript NM_182898 ENST00000409603 9586 NM_182898 NP082957 variant 1, mRNA [NM_182898] A_33_P3281435 immunoglobulin kappa variable 1D-8 [Source: HGNC AF035035 ENST00000471857 THC2548990 Symbol; Acc: 5759] [ENST00000471857] A_33_P3389394 RPPH1 ribonuclease P RNA component H1 (RPPH1), RNase P RNA NR_002312 85495 NR_002312 THC2674967 [NR_002312] A_33_P3345036 POMC proopiomelanocortin (POMC), transcript variant 1, mRNA NM_001035256 ENST00000395826 5443 NM_001035256 THC2481015 [NM_001035256] A_33_P3227686 FLJ43860 FLJ43860 protein (FLJ43860), mRNA [NM_207414] NM_207414 ENST00000521053 389690 NM_207414 THC2480285 A_33_P3281437 immunoglobulin kappa variable 1D-8 [Source: HGNC AF035035 ENST00000471857 NP1465439 Symbol; Acc: 5759] [ENST00000471857] A_33_P3327592 RNF13 ring finger protein 13 (RNF13), transcript variant 1, mRNA NM_007282 ENST00000392894 11342 NM_007282 THC2483942 [NM_007282] A_23_P30956 KIAA0776 KIAA0776 (KIAA0776), mRNA [NM_015323] NM_015323 ENST00000369278 23376 NM_015323 THC2461444 A_33_P3371785 DTNA dystrobrevin, alpha (DTNA), transcript variant 9, mRNA NM_001128175 ENST00000315456 1837 NM_001128175 THC2748155 [NM_001128175] A_33_P3377399 ENST00000520078 A_32_P211248 LOC100131138 hypothetical LOC100131138 (LOC100131138), non-coding RNA NR_036513 100131138 NR_036513 THC2471096 [NR_036513] A_33_P3287105 A_33_P3245841 A_23_P213661 PPIP5K2 diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2), NM_015216 ENST00000451606 23262 NM_015216 THC2462111 mRNA [NM_015216] A_33_P3354539 CHURC1 churchill domain containing 1 (CHURC1), transcript variant 1, NM_145165 ENST00000359118 91612 NM_145165 mRNA [NM_145165] A_24_P15765 RPS7P5 ribosomal protein S7 pseudogene 5 (RPS7P5), non-coding RNA NR_036695 645884 NR_036695 THC2681026 [NR_036695] A_23_P384857 chromosome 6 genomic contig NP274062 A_24_P274615 ARRDC3 arrestin domain containing 3 (ARRDC3), mRNA [NM_020801] NM_020801 ENST00000265138 57561 NM_020801 THC2491990 A_33_P3397150 FLJ22184 hypothetical protein FLJ22184 (FLJ22184), mRNA NM_001190467 ENST00000327607 80164 NM_001190467 THC2477241 [NM_001190467] A_23_P257478 CYP21A2 cytochrome P450, family 21, subfamily A, polypeptide 2 NM_000500 ENST00000547683 1589 NM_000500 THC2469155 (CYP21A2), transcript variant 1, mRNA [NM_000500] A_32_P334325 RIMBP2 RIMS binding protein 2 (RIMBP2), mRNA [NM_015347] NM_015347 ENST00000392375 23504 NM_015347 THC2782045 A_24_P235988 CLEC7A C-type lectin domain family 7, member A (CLEC7A), transcript NM_197947 ENST00000534609 64581 NM_197947 THC2485854 variant 1, mRNA [NM_197947] A_23_P83073 HIATL1 hippocampus abundant transcript-like 1 (HIATL1), mRNA NM_032558 ENST00000375344 84641 NM_032558 THC2465988 [NM_032558] A_23_P110362 LAMTOR3 late endosomal/lysosomal adaptor, MAPK and MTOR activator NM_021970 ENST00000515100 8649 NM_021970 THC2609212 3 (LAMTOR3), transcript variant 1, mRNA [NM_021970] A_23_P2129 TMEM126B transmembrane protein 126B (TMEM126B), transcript variant NM_018480 ENST00000530783 55863 NM_018480 THC2619491 1, mRNA [NM_018480] A_23_P10559 AATK apoptosis-associated tyrosine kinase (AATK), transcript variant NM_001080395 ENST00000374792 9625 NM_001080395 THC2471583 1, mRNA [NM_001080395] A_32_P230868 FAM65A family with sequence similarity 65, member A (FAM65A), NM_024519 ENST00000422602 79567 NM_024519 THC2468574 transcript variant 1, mRNA [NM_024519] A_33_P3300495 plasminogen-like B1 [Source: HGNC Symbol; Acc: 9072] BC022294 ENST00000409310 THC2475376 [ENST00000409310] A_33_P3360814 NFE4 transcription factor NF-E4 (NFE4), mRNA [NM_001085386] NM_001085386 58160 NM_001085386 NP1072324 A_24_P172768 GMFB glia maturation factor, beta (GMFB), mRNA [NM_004124] NM_004124 ENST00000358056 2764 NM_004124 THC2494751 A_23_P140069 FBXL3 F-box and leucine-rich repeat protein 3 (FBXL3), mRNA NM_012158 ENST00000355619 26224 NM_012158 THC2468176 [NM_012158] A_33_P3244347 PC pyruvate carboxylase (PC), nuclear gene encoding NM_001040716 ENST00000393960 5091 NM_001040716 THC2463909 mitochondrial protein, transcript variant 3, mRNA [NM_001040716] A_24_P117147 KIR3DL1 killer cell immunoglobulin-like receptor, three domains, long NM_013289 ENST00000400847 3811 NM_013289 THC2470697 cytoplasmic tail, 1 (KIR3DL1), mRNA [NM_013289] A_24_P281395 C1D nuclear receptor corepressor pseudogene 3 [Source: HGNC XM_003119469 ENST00000412019 XM_003119469 Symbol; Acc: 31661] [ENST00000412019] A_23_P983 PRDX6 peroxiredoxin 6 (PRDX6), mRNA [NM_004905] NM_004905 ENST00000470017 9588 NM_004905 THC2531006 A_23_P422083 TMEM55A transmembrane protein 55A (TMEM55A), mRNA [NM_018710] NM_018710 ENST00000285419 55529 NM_018710 THC2463130 A_23_P429491 C11orf82 chromosome 11 open reading frame 82 (C11orf82), mRNA NM_145018 ENST00000329143 220042 NM_145018 THC2642949 [NM_145018] A_23_P116614 ME3 malic enzyme 3, NADP(+)-dependent, mitochondrial (ME3), NM_001014811 ENST00000393324 10873 NM_001014811 THC2614244 nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_001014811] A_23_P31671 UQCRB ubiquinol-cytochrome c reductase binding protein (UQCRB), NM_006294 ENST00000521948 7381 NM_006294 THC2546410 nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_006294] A_33_P3350643 LMX1B LIM homeobox transcription factor 1, beta (LMX1B), transcript NM_001174146 ENST00000355497 4010 NM_001174146 THC2611342 variant 3, mRNA [NM_001174146] A_33_P3243878 GOLGA6L9 golgin A6 family-like 9 (GOLGA6L9), mRNA [NM_198181] NM_198181 ENST00000306827 440295 NM_198181 THC2475605 A_24_P100517 C9orf140 chromosome 9 open reading frame 140 (C9orf140), mRNA NM_178448 ENST00000409687 89958 NM_178448 THC2461698 [NM_178448] A_33_P3250750 Synthetic construct gateway clone IMAGE: 100018551 3′ read CU677518 RAB35 mRNA. [CU677518] A_33_P3370226 RPL7 ribosomal protein L7 (RPL7), mRNA [NM_000971] NM_000971 ENST00000352983 6129 NM_000971 THC2551101 A_33_P3370019 immunoglobulin heavy constant delta [Source: HGNC AK093943 ENST00000390556 THC2503414 Symbol; Acc: 5480] [ENST00000390556] A_33_P3280950 LOC144571 hypothetical LOC144571 (LOC144571), non-coding RNA NR_026971 144571 NR_026971 THC2505447 [NR_026971] A_32_P207124 CT47A11 cancer/testis antigen family 47, member A11 (CT47A11), mRNA NM_173571 ENST00000371280 255313 NM_173571 THC2477537 [NM_173571] A_33_P3244361 A_33_P3354203 NELL1 NEL-like 1 (chicken) [Source: HGNC Symbol; Acc: 7750] AB085898 ENST00000534263 4745 THC2486544 [ENST00000534263] A_33_P3335920 SYNE1 spectrin repeat containing, nuclear envelope 1 (SYNE1), NM_182961 ENST00000367255 23345 NM_182961 NP1154489 transcript variant 1, mRNA [NM_182961] A_23_P216023 ANGPT1 angiopoietin 1 (ANGPT1), transcript variant 1, mRNA NM_001146 ENST00000395820 284 NM_001146 THC2463915 [NM_001146] A_23_P119593 EPHX3 epoxide hydrolase 3 (EPHX3), transcript variant 1, mRNA NM_024794 ENST00000435261 79852 NM_024794 THC2653397 [NM_024794] A_24_P50554 A_33_P3233981 NASP nuclear autoantigenic sperm protein (histone-binding) (NASP), NM_002482 ENST00000481782 4678 NM_002482 THC2496068 transcript variant 2, mRNA [NM_002482] A_33_P3283906 NIP7 nuclear import 7 homolog (S. cerevisiae) (NIP7), transcript NM_016101 ENST00000254941 51388 NM_016101 THC2482970 variant 1, mRNA [NM_016101] A_23_P114414 LONRF3 LON peptidase N-terminal domain and ring finger 3 (LONRF3), NM_001031855 ENST00000371628 79836 NM_001031855 THC2485491 transcript variant 1, mRNA [NM_001031855] A_33_P3316928 PELI1 pellino homolog 1 (Drosophila) (PELI1), mRNA [NM_020651] NM_020651 ENST00000358912 57162 NM_020651 THC2468725 A_23_P143526 S100B S100 calcium binding protein B (S100B), mRNA [NM_006272] NM_006272 ENST00000291700 6285 NM_006272 THC2605292 A_23_P501080 ZNF92 zinc finger protein 92 (ZNF92), transcript variant 1, mRNA NM_007139 ENST00000450302 168374 NM_007139 THC2470444 [NM_007139] A_23_P101374 CYP251 cytochrome P450, family 2, subfamily S, polypeptide 1 NM_030622 ENST00000310054 29785 NM_030622 THC2546669 (CYP2S1), mRNA [NM_030622] A_24_P66125 STAG2 stromal antigen 2 (STAG2), transcript variant 1, mRNA NM_001042749 ENST00000371160 10735 NM_001042749 THC2787590 [NM_001042749] A_23_P167856 TMEM63B transmembrane protein 63B (TMEM63B), mRNA [NM_018426] NM_018426 ENST00000323267 55362 NM_018426 THC2462238 A_23_P143774 MOV10L1 Mov10l1, Moloney leukemia virus 10-like 1, homolog (mouse) NM_018995 ENST00000545383 54456 NM_018995 THC2473678 (MOV10L1), transcript variant 1, mRNA [NM_018995] A_33_P3364741 MRC2 mannose receptor, C type 2 (MRC2), mRNA [NM_006039] NM_006039 ENST00000303375 9902 NM_006039 THC2608201 A_33_P3613358 cDNA FLJ39824 fis, clone SPLEN2011981. [AK097143] AK097143 THC2489859 A_33_P3499692 LOC645261 PP565 mRNA, complete cds. [AF258587] AF258587 645261 NP1472476 A_33_P3270451 TXNDC5 thioredoxin domain containing 5 (endoplasmic reticulum) NM_030810 ENST00000439343 81567 NM_030810 THC2520615 (TXNDC5), transcript variant 1, mRNA [NM_030810] A_33_P3375451 NYNRIN NYN domain and retroviral integrase containing (NYNRIN), NM_025081 ENST00000206466 57523 NM_025081 THC2483568 mRNA [NM_025081] A_33_P3358957 PAPL iron/zinc purple acid phosphatase-like protein (PAPL), mRNA NM_001004318 ENST00000331256 390928 NM_001004318 THC2482977 [NM_001004318] A_33_P3231888 C5orf15 chromosome 5 open reading frame 15 (C5orf15), mRNA NM_020199 ENST00000451255 56951 NM_020199 THC2469485 [NM_020199] A_23_P122724 VNN2 vanin 2 (VNN2), transcript variant 1, mRNA [NM_004665] NM_004665 ENST00000392389 8875 NM_004665 NP1195731 A_23_P204850 RB1 retinoblastoma 1 (RB1), mRNA [NM_000321] NM_000321 ENST00000267163 5925 NM_000321 THC2601211 A_24_P317450 OSTCL oligosaccharyltransferase complex subunit-like (OSTCL), non- NR_028496 ENST00000522287 202459 NR_028496 THC2486050 coding RNA [NR_028496] A_33_P3227774 AGSK1 golgin subfamily A member 2-like (AGSK1), non-coding RNA NR_026811 ENST00000357253 80154 NR_026811 THC2476453 [NR_026811] A_23_P207058 SOCS3 suppressor of cytokine signaling 3 (SOCS3), mRNA NM_003955 ENST00000330871 9021 NM_003955 THC2461868 [NM_003955] A_24_P228130 CCL3L3 chemokine (C-C motif) ligand 3-like 3 (CCL3L3), mRNA NM_001001437 ENST00000425833 414062 NM_001001437 THC2605779 [NM_001001437] A_24_P922631 C5orf58 chromosome 5 open reading frame 58 (C5orf58), mRNA NM_001102609 ENST00000521850 133874 NM_001102609 THC2771591 [NM_001102609] A_33_P3416762 LYPLA1 lysophospholipase I (LYPLA1), mRNA [NM_006330] NM_006330 ENST00000316963 10434 NM_006330 THC2469064 A_33_P3358740 OSBPL7 oxysterol binding protein-like 7 (OSBPL7), transcript variant 1, NM_145798 ENST00000007414 114881 NM_145798 THC2471195 mRNA [NM_145798] A_23_P26468 RHBDL1 rhomboid, veinlet-like 1 (Drosophila) (RHBDL1), mRNA NM_003961 ENST00000219551 9028 NM_003961 THC2606656 [NM_003961] A_24_P134195 MYADM myeloid-associated differentiation marker (MYADM), transcript NM_001020818 ENST00000415619 91663 NM_001020818 THC2480965 variant 1, mRNA [NM_001020818] A_23_P65768 RSL24D1 ribosomal L24 domain containing 1 (RSL24D1), mRNA NM_016304 ENST00000260443 51187 NM_016304 THC2535982 [NM_016304] A_32_P8813 LOC283663 hypothetical LOC283663 (LOC283663), non-coding RNA NR_024433 283663 NR_024433 THC2513469 [NR_024433] A_33_P3274001 A_23_P103034 CRYBA4 crystallin, beta A4 (CRYBA4), mRNA [NM_001886] NM_001886 ENST00000466315 1413 NM_001886 THC2467739 A_23_P116765 LALBA lactalbumin, alpha- (LALBA), mRNA [NM_002289] NM_002289 ENST00000301046 3906 NM_002289 THC2481150 A_33_P3407105 YTHDF1 YTH domain family, member 1 (YTHDF1), mRNA [NM_017798] NM_017798 ENST00000342761 54915 NM_017798 THC2465870 A_33_P3768930 MYE4344 Myeloma (MYE) cDNA library cDNA, mRNA sequence BF175071 THC2543611 [BF175071] A_24_P272917 USP17 ubiquitin specific peptidase 17 (USP17), mRNA NM_001105662 ENST00000421288 391627 NM_001105662 THC2525229 [NM_001105662] A_33_P3223869 A_33_P3258324 A_23_P134684 HMBOX1 homeobox containing 1 (HMBOX1), transcript variant 1, mRNA NM_024567 ENST00000521516 79618 NM_024567 THC2498923 [NM_024567] A_23_P11843 LRRN2 leucine rich repeat neuronal 2 (LRRN2), transcript variant 2, NM_201630 ENST00000367175 10446 NM_201630 THC2471115 mRNA [NM_201630] A_24_P183864 IMPA1 inositol(myo)-1(or 4)-monophosphatase 1 (IMPA1), transcript NM_005536 ENST00000256108 3612 NM_005536 THC2466293 variant 1, mRNA [NM_005536] A_23_P8763 PTPN12 protein tyrosine phosphatase, non-receptor type 12 (PTPN12), NM_002835 ENST00000248594 5782 NM_002835 THC2466264 transcript variant 1, mRNA [NM_002835] A_23_P217384 AP1S2 adaptor-related protein complex 1, sigma 2 subunit (AP1S2), NM_003916 ENST00000329235 8905 NM_003916 THC2618612 mRNA [NM_003916] A_33_P3227320 MIER3 mesoderm induction early response 1, family member 3 NM_152622 ENST00000452157 166968 NM_152622 THC2634883 (MIER3), mRNA [NM_152622] A_33_P3232038 RBAK- RBAK-LOC389458 readthrough (RBAK-LOC389458), mRNA NM_001204513 ENST00000498308 100533952 NM_001204513 THC2464334 LOC389458 [NM_001204513] A_33_P3259708 CMA1 chymase 1, mast cell (CMA1), mRNA [NM_001836] NM_001836 ENST00000206446 1215 NM_001836 THC2480549 A_33_P3263319 immunoglobulin heavy constant gamma 3 (G3m marker) AY172958 ENST00000390551 NP594088 [Source: HGNC Symbol; Acc: 5527] [ENST00000390551] A_33_P3324495 ZFP41 zinc finger protein 41 homolog (mouse) (ZFP41), mRNA NM_173832 ENST00000330701 286128 NM_173832 THC2498694 [NM_173832] A_33_P3339202 A_23_P500271 IRF5 interferon regulatory factor 5 (IRF5), transcript variant 3, mRNA NM_001098627 ENST00000412326 3663 NM_001098627 THC2489805 [NM_001098627] A_33_P3246950 BX117927 Soares_NFL_T_GBC_S1 cDNA clone BX117927 ENST00000434321 THC2685258 IMAGp998E153901, mRNA sequence [BX117927] A_24_P65722 LILRB4 leukocyte immunoglobulin-like receptor, subfamily B (with TM BC026309 ENST00000391736 11006 THC2464369 and ITIM domains), member 4 [Source: HGNC Symbol; Acc: 6608] [ENST00000391736] A_33_P3424222 HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 (HLA- NM_002123 ENST00000484729 3119 NM_002123 THC2557334 DQB1), mRNA [NM_002123] A_23_P252082 TMEM176A transmembrane protein 176A (TMEM176A), mRNA NM_018487 ENST00000484928 55365 NM_018487 THC2624423 [NM_018487] A_33_P3460043 C8orf56 chromosome 8 open reading frame 56 (C8orf56), non-coding NR_027071 ENST00000436771 157556 NR_027071 THC2481642 RNA [NR_027071] A_33_P3292130 Q2JG47_FRASC (Q2JG47) Methyltransferase type 11, partial THC2566648 (6%) [THC2566648] A_23_P72503 KLHL2 kelch-like 2, Mayven (Drosophila) (KLHL2), transcript variant 1, NM_007246 ENST00000226725 11275 NM_007246 THC2464595 mRNA [NM_007246] A_23_P8640 GPER G protein-coupled estrogen receptor 1 (GPER), transcript NM_001039966 ENST00000508834 2852 NM_001039966 THC2471419 variant 3, mRNA [NM_001039966] A_23_P18325 PDCD10 programmed cell death 10 (PDCD10), transcript variant 1, NM_007217 ENST00000470131 11235 NM_007217 THC2764223 mRNA [NM_007217] A_33_P3372189 , Similar to LOC223018, clone IMAGE: 4732541, mRNA. BC029410 THC2501412 [BC029410] A_33_P3234641 A_23_P259863 CD177 CD177 molecule (CD177), mRNA [NM_020406] NM_020406 ENST00000378009 57126 NM_020406 NP924649 A_23_P145006 SCGB3A2 secretoglobin, family 3A, member 2 (SCGB3A2), mRNA NM_054023 ENST00000507160 117156 NM_054023 THC2472125 [NM_054023] A_33_P3410849 C8orf58 chromosome 8 open reading frame 58 (C8orf58), transcript NM_001013842 ENST00000381191 541565 NM_001013842 THC2609844 variant 1, mRNA [NM_001013842] A_23_P18372 B3GNT5 UDP-GlcNAc: betaGal beta-1,3-N-acetylglucosaminyltransferase NM_032047 ENST00000326505 84002 NM_032047 THC2462855 5 (B3GNT5), mRNA [NM_032047] A_23_P44257 COMMD8 COMM domain containing 8 (COMMD8), mRNA [NM_017845] NM_017845 ENST00000381571 54951 NM_017845 THC2602334 A_23_P55356 VMO1 vitelline membrane outer layer 1 homolog (chicken) (VMO1), NM_182566 ENST00000441199 284013 NM_182566 THC2477391 transcript variant 1, mRNA [NM_182566] A_33_P3352349 KRTAP9-1 keratin associated protein 9-1 (KRTAP9-1), mRNA NM_001190460 ENST00000377723 728318 NM_001190460 [NM_001190460] A_24_P320328 SUB1 SUB1 homolog (S. cerevisiae) (SUB1), mRNA [NM_006713] NM_006713 ENST00000511988 10923 NM_006713 THC2521496 A_32_P159192 immunoglobulin kappa variable 3-7 (non-functional) X85155 ENST00000390247 [Source: HGNC Symbol; Acc: 5821] [ENST00000390247] A_23_P113005 EFNA1 ephrin-A1 (EFNA1), transcript variant 1, mRNA [NM_004428] NM_004428 ENST00000469878 1942 NM_004428 THC2506968 A_24_P297537 MAMSTR MEF2 activating motif and SAP domain containing NM_182574 ENST00000356751 284358 NM_182574 THC2487203 transcriptional regulator (MAMSTR), transcript variant 2, mRNA [NM_182574] A_23_P2431 C3AR1 complement component 3a receptor 1 (C3AR1), mRNA NM_004054 ENST00000307637 719 NM_004054 THC2461342 [NM_004054] A_23_P408955 E2F2 E2F transcription factor 2 (E2F2), mRNA [NM_004091] NM_004091 ENST00000361729 1870 NM_004091 THC2471250 A_33_P3383606 KCP kielin/chordin-like protein (KCP), transcript variant 1, mRNA NM_001135914 ENST00000476647 375616 NM_001135914 THC2609353 [NM_001135914] A_23_P86801 RAPSN receptor-associated protein of the synapse (RAPSN), transcript NM_032645 ENST00000352508 5913 NM_032645 NP091080 variant 2, mRNA [NM_032645] A_24_P363745 LRRC14 leucine rich repeat containing 14 (LRRC14), mRNA NM_014665 ENST00000292524 9684 NM_014665 [NM_014665] A_33_P3374117 anoctamin 7-like 1 [Source: HGNC Symbol; Acc: 32248] BU656309 ENST00000475369 THC2713054 [ENST00000475369] A_24_P626951 immunoglobulin kappa variable 1-16 [Source: HGNC AF078945 ENST00000479981 NP074934 Symbol; Acc: 5732] [ENST00000479981] A_23_P77980 SLC4A1 solute carrier family 4, anion exchanger, member 1 NM_000342 ENST00000262418 6521 NM_000342 THC2474664 (erythrocyte membrane protein band 3, Diego blood group) (SLC4A1), mRNA [NM_000342] A_23_P99693 ZBTB1 zinc finger and BTB domain containing 1 (ZBTB1), transcript NM_014950 ENST00000358738 22890 NM_014950 THC2505601 variant 2, mRNA [NM_014950] A_32_P178966 TMEM170B transmembrane protein 170B (TMEM170B), mRNA NM_001100829 ENST00000379426 100113407 NM_001100829 THC2634604 [NM_001100829] A_33_P3332627 A_33_P3334895 GRIN2A glutamate receptor, ionotropic, N-methyl D-aspartate 2A NM_001134408 ENST00000396575 2903 NM_001134408 THC2475567 (GRIN2A), transcript variant 3, mRNA [NM_001134408] A_23_P20275 PLEKHF2 pleckstrin homology domain containing, family F (with FYVE NM_024613 ENST00000315367 79666 NM_024613 THC2462394 domain) member 2 (PLEKHF2), mRNA [NM_024613] A_23_P111583 CD36 CD36 molecule (thrombospondin receptor) (CD36), transcript NM_001001547 ENST00000419819 948 NM_001001547 NP097737 variant 2, mRNA [NM_001001547] A_33_P3251901 APBB2 amyloid beta (A4) precursor protein-binding, family B, member NM_004307 ENST00000316212 323 NM_004307 THC2536043 2 (APBB2), transcript variant 1, mRNA [NM_004307] A_32_P145153 RPL31 ribosomal protein L31 (RPL31), transcript variant 1, mRNA NM_000993 ENST00000456292 6160 NM_000993 THC2465680 [NM_000993] A_32_P31182 RPL7 ribosomal protein L7 (RPL7), mRNA [NM_000971] NM_000971 ENST00000352983 6129 NM_000971 THC2573169 A_33_P3620488 CATSPERG cation channel, sperm-associated, gamma (CATSPERG), mRNA NM_021185 ENST00000492088 57828 NM_021185 NP1144122 [NM_021185] A_33_P3235891 cDNA FLJ46681 fis, clone TRACH3010382. [AK128523] AK128523 A_23_P211047 BACH1 BTB and CNC homology 1, basic leucine zipper transcription NM_206866 ENST00000399921 571 NM_206866 THC2646890 factor 1 (BACH1), transcript variant 1, mRNA [NM_206866] A_32_P192474 PRRT1 proline-rich transmembrane protein 1 (PRRT1), mRNA NM_030651 ENST00000375152 80863 NM_030651 THC2463883 [NM_030651] A_23_P59798 MKRN1 makorin ring finger protein 1 (MKRN1), transcript variant 1, NM_013446 ENST00000539898 23608 NM_013446 THC2508588 mRNA [NM_013446] A_33_P3229288 ACE angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 NM_000789 ENST00000290863 1636 NM_000789 THC2470503 (ACE), transcript variant 1, mRNA [NM_000789] A_23_P7144 CXCL1 chemokine (C-X-C motif) ligand 1 (melanoma growth NM_001511 ENST00000395761 2919 NM_001511 THC2462921 stimulating activity, alpha) (CXCL1), mRNA [NM_001511] A_23_P152002 BCL2A1 BCL2-related protein Al (BCL2A1), transcript variant 1, mRNA NM_004049 ENST00000267953 597 NM_004049 THC2486797 [NM_004049] A_24_P196592 MMP28 matrix metallopeptidase 28 (MMP28), transcript variant 3, NM_001032278 ENST00000250144 79148 NM_001032278 THC2778644 mRNA [NM_001032278] A_23_P149375 THEM4 thioesterase superfamily member 4 (THEM4), mRNA NM_053055 ENST00000483207 117145 NM_053055 THC2516317 [NM_053055] A_33_P3359012 DUSP8 dual specificity phosphatase 8 (DUSP8), mRNA [NM_004420] NM_004420 ENST00000331588 1850 NM_004420 THC2474457 A_24_P13041 RTKN2 rhotekin 2 (RTKN2), mRNA [NM_145307] NM_145307 ENST00000373789 219790 NM_145307 A_23_P142070 TSPAN16 tetraspanin 16 (TSPAN16), mRNA [NM_012466] NM_012466 ENST00000316737 26526 NM_012466 THC2483075 A_23_P303260 STX7 syntaxin 7 (STX7), mRNA [NM_003569] NM_003569 ENST00000367941 8417 NM_003569 THC2468285 A_33_P3272823 MAG myelin associated glycoprotein (MAG), transcript variant 1, NM_002361 ENST00000262624 4099 NM_002361 THC2517997 mRNA [NM_002361] A_33_P3424612 immunoglobulin kappa variable 3-11 [Source: HGNC Symbol; Acc: 5815] [ENST00000483158] XM_003120829 ENST00000483158 XM_003120829 NP1455229 A_23_P112187 FIBCD1 fibrinogen C domain containing 1 (FIBCD1), transcript variant 1, NM_032843 ENST00000372338 84929 NM_032843 THC2474476 mRNA [NM_032843] A_23_P3602 NUDT7 nudix (nucleoside diphosphate linked moiety X)-type motif 7 NM_001105663 ENST00000268533 283927 NM_001105663 THC2521963 (NUDT7), transcript variant 1, mRNA [NM_001105663] A_33_P3278475 FOXN2 forkhead box N2 (FOXN2), mRNA [NM_002158] NM_002158 ENST00000340553 3344 NM_002158 THC2601791 A_33_P3399755 A_23_P116942 LAG3 lymphocyte-activation gene 3 (LAG3), mRNA [NM_002286] NM_002286 ENST00000203629 3902 NM_002286 THC2475230 A_33_P3408305 CERS3 ceramide synthase 3 (CERS3), mRNA [NM_178842] NM_178842 ENST00000538112 204219 NM_178842 THC2475513 A_33_P3314441 FBXL17 F-box and leucine-rich repeat protein 17 (FBXL17), mRNA NM_001163315 ENST00000542267 64839 NM_001163315 THC2473457 [NM_001163315] A_33_P3419419 PIK3C2B phosphoinositide-3-kinase, class 2, beta polypeptide ENST00000367184 5287 THC2703322 [Source: HGNC Symbol; Acc: 8972] [ENST00000367184] A_23_P202587 KIAA1598 KIAA1598 (KIAA1598), transcript variant 2, mRNA NM_018330 ENST00000469231 57698 NM_018330 THC2491701 [NM_018330] A_23_P212354 CCR2 chemokine (C-C motif) receptor 2 (CCR2), transcript variant A, NM_001123041 ENST00000292301 729230 NM_001123041 THC2475638 mRNA [NM_001123041] A_33_P3228252 DA666023 NCRRM1 cDNA clone NCRRM1000040 5′, mRNA DA666023 sequence [DA666023] A_24_P312325 PREDICTED: uncharacterized protein C8orf15-like XM_003119008 ENST00000500944 XM_003119008 THC2481137 (LOC100505981), mRNA [XM_003119008] A_33_P3407049 A_24_P150874 GNA13 guanine nucleotide binding protein (G protein), alpha 13 NM_006572 ENST00000439174 10672 NM_006572 THC2603923 (GNA13), mRNA [NM_006572] A_23_P59099 OR11A1 olfactory receptor, family 11, subfamily A, member 1 NM_013937 ENST00000377149 26531 NM_013937 THC2487340 (OR11A1), mRNA [NM_013937] A_32_P158746 RPL17 ribosomal protein L17 (RPL17), transcript variant 1, mRNA NM_000985 ENST00000392739 6139 NM_000985 THC2554858 [NM_000985] A_33_P3381943 DMTF1 cyclin D binding myb-like transcription factor 1 (DMTF1), NR_024549 ENST00000394702 9988 NR_024549 THC2504564 transcript variant 4, non-coding RNA [NR_024549] A_33_P3358104 CD300E CD300e molecule (CD300E), mRNA [NM_181449] NM_181449 ENST00000412268 342510 NM_181449 THC2480696 A_33_P3390177 FLJ34208 hypothetical LOC401106 (FLJ34208), non-coding RNA NR_033929 401106 NR_033929 THC2503254 [NR_033929] A_33_P3277611 TMEM8C transmembrane protein 8C (TMEM8C), mRNA NM_001080483 ENST00000339996 389827 NM_001080483 THC2645713 [NM_001080483] A_24_P63347 PF4V1 platelet factor 4 variant 1 (PF4V1), mRNA [NM_002620] NM_002620 5197 NM_002620 THC2488247 A_24_P418418 RPS17 ribosomal protein S17 (RPS17), mRNA [NM_001021] NM_001021 ENST00000330244 6218 NM_001021 THC2513112 A_33_P3285077 COMMD8 COMM domain containing 8 (COMMD8), mRNA [NM_017845] NM_017845 ENST00000381571 54951 NM_017845 THC2632032 A_23_P128470 CLEC12A C-type lectin domain family 12, member A (CLEC12A), NM_138337 ENST00000396507 160364 NM_138337 NP923350 transcript variant 1, mRNA [NM_138337] A_33_P3216438 SPATA21 spermatogenesis associated 21 (SPATA21), mRNA NM_198546 ENST00000335496 374955 NM_198546 THC2485745 [NM_198546] A_24_P218814 RDH5 retinol dehydrogenase 5 (11-cis/9-cis) (RDH5), transcript NM_002905 ENST00000548123 5959 NM_002905 THC2499847 variant 2, mRNA [NM_002905] A_33_P3255290 JAKMIP2 janus kinase and microtubule interacting protein 2 (JAKMIP2), NM_014790 ENST00000333010 9832 NM_014790 THC2471193 mRNA [NM_014790] A_24_P84808 A_23_P252201 EAF2 ELL associated factor 2 (EAF2), mRNA [NM_018456] NM_018456 ENST00000490434 55840 NM_018456 THC2482477 A_24_P254949 PGM5 phosphoglucomutase 5 (PGM5), mRNA [NM_021965] NM_021965 ENST00000377314 5239 NM_021965 THC2767986 A_33_P3260575 CERCAM cerebral endothelial cell adhesion molecule (CERCAM), mRNA NM_016174 ENST00000372842 51148 NM_016174 THC2468263 [NM_016174] A_24_P357847 LOC100510044 immunoglobulin kappa variable 3-15 [Source: HGNC XM_003120829 ENST00000390252 100510044 XM_003120829 NP1170004 Symbol; Acc: 5816] [ENST00000390252] A_33_P3555937 STEAP4 STEAP family member 4 (STEAP4), transcript variant 2, mRNA NM_001205315 ENST00000301959 79689 NM_001205315 THC2475717 [NM_001205315] A_23_P84596 MZB1 marginal zone B and B1 cell-specific protein (MZB1), mRNA NM_016459 ENST00000503351 51237 NM_016459 THC2605618 [NM_016459] A_33_P3215412 C2CD4C C2 calcium-dependent domain containing 4C (C2CD4C), mRNA NM_001136263 ENST00000332235 126567 NM_001136263 THC2615089 [NM_001136263] A_23_P117380 FAM181A family with sequence similarity 181, member A (FAM181A), NM_138344 ENST00000267594 90050 NM_138344 THC2478030 transcript variant 1, mRNA [NM_138344] A_33_P3372004 IGSF6 immunoglobulin superfamily, member 6 (IG5F6), mRNA NM_005849 ENST00000268389 10261 NM_005849 THC2475474 [NM_005849] A_24_P368943 EVX1 even-skipped homeobox 1 (EVX1), mRNA [NM_001989] NM_001989 ENST00000496902 2128 NM_001989 THC2484995 A_33_P3210399 SLC14A1 solute carrier family 14 (urea transporter), member 1 (Kidd NM_001146037 ENST00000402943 6563 NM_001146037 THC2514421 blood group) (SLC14A1), transcript variant 4, mRNA [NM_001146037] A_23_P153390 CLEC4G C-type lectin domain family 4, member G (CLEC4G), mRNA NM_198492 ENST00000328853 339390 NM_198492 THC2479109 [NM_198492] A_33_P3349252 DKFZP547L112 mRNA; cDNA DKFZp547L112 (from clone DKFZp547L112). AL512723 81787 NP304591 [AL512723] A_24_P419028 MOP-1 mRNA for MOP-1, complete cds. [AB014771] AB014771 643616 NP373383 A_23_P134935 DUSP4 dual specificity phosphatase 4 (DUSP4), transcript variant 1, NM_001394 ENST00000240100 1846 NM_001394 THC2466297 mRNA [NM_001394] A_32_P100830 KIF19 kinesin family member 19 (KIF19), mRNA [NM_153209] NM_153209 ENST00000389916 124602 NM_153209 THC2686967 A_33_P3419970 NPB neuropeptide B (NPB), mRNA [NM_148896] NM_148896 ENST00000333383 256933 NM_148896 A_23_P391857 ESRRB estrogen-related receptor beta (ESRRB), mRNA [NM_004452] NM_004452 ENST00000261532 2103 NM_004452 THC2489574 A_32_P82623 AGBL3 ATP/GTP binding protein-like 3 (AGBL3), mRNA [NM_178563] NM_178563 ENST00000359383 340351 NM_178563 THC2636775 A_24_P191417 NAB1 NGFI-A binding protein 1 (EGR1 binding protein 1) (NAB1), NM_005966 ENST00000337386 4664 NM_005966 THC2620109 mRNA [NM_005966] A_23_P71946 BSPRY B-box and SPRY domain containing (BSPRY), mRNA NM_017688 ENST00000374183 54836 NM_017688 THC2464724 [NM_017688] A_33_P3283601 LOC389033 placenta-specific 9 pseudogene (LOC389033), non-coding RNA NR_026740 ENST00000433290 389033 NR_026740 THC2691539 [NR_026740] A_33_P3424591 immunoglobulin heavy constant gamma 1 (G1m marker) CR611254 ENST00000390549 NP232832 [Source: HGNC Symbol; Acc: 5525] [ENST00000390549] A_23_P76488 EMP1 epithelial membrane protein 1 (EMP1), mRNA [NM_001423] NM_001423 ENST00000256951 2012 NM_001423 THC2465394 A_33_P3576797 LOC158863 mRNA; cDNA DKFZp586J1922 (from clone DKFZp586J1922) AL110203 158863 THC2504931 [AL110203] A_23_P167168 IGJ immunoglobulin J polypeptide, linker protein for NM_144646 ENST00000254801 3512 NM_144646 THC2469801 immunoglobulin alpha and mu polypeptides (IGJ), mRNA [NM_144646] A_24_P187970 PADI2 peptidyl arginine deiminase, type II (PADI2), mRNA NM_007365 ENST00000375481 11240 NM_007365 THC2486805 [NM_007365] A_33_P3251205 immunoglobulin lambda variable 3-9 (gene/pseudogene) AF194657 ENST00000390316 NP078180 [Source: HGNC Symbol; Acc: 5918] [ENST00000390316] A_33_P3318444 RNF222 ring finger protein 222 (RNF222), mRNA [NM_001146684] NM_001146684 ENST00000399398 643904 NM_001146684 A_33_P3257568 CNTRL centrosomal protein 110 kDa [Source: HGNC Symbol; Acc: 1858] AK097636 ENST00000373851 11064 THC2721284 [ENST00000373851] A_32_P72940 RPL35 ribosomal protein L35 (RPL35), mRNA [NM_007209] NM_007209 ENST00000348462 11224 NM_007209 THC2590230 A_33_P3212799 C22orf34 chromosome 22 open reading frame 34 (C22orf34), non-coding NR_026997 ENST00000400023 348645 NR_026997 THC2483736 RNA [NR_026997] A_23_P109881 ITIH4 inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive NM_002218 ENST00000538421 3700 NM_002218 NP1161208 glycoprotein) (ITIH4), transcript variant 1, mRNA [NM_002218] A_24_P213783 RPL31 ribosomal protein L31 (RPL31), transcript variant 1, mRNA NM_000993 ENST00000409733 6160 NM_000993 THC2465680 [NM_000993] A_33_P3263938 LCN15 lipocalin 15 (LCN15), mRNA [NM_203347] NM_203347 ENST00000316144 389812 NM_203347 THC2485824 A_23_P136683 HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 (HLA- NM_002123 ENST00000484729 3119 NM_002123 THC2506278 DQB1), mRNA [NM_002123] A_23_P315122 EMX1 empty spiracles homeobox 1 (EMX1), mRNA [NM_004097] NM_004097 ENST00000491023 2016 NM_004097 THC2602195 A_23_P57941 RBM6 RNA binding motif protein 6 (RBM6), transcript variant 1, NM_005777 ENST00000454079 10180 NM_005777 THC2785726 mRNA [NM_005777] A_23_P128663 SACS spastic ataxia of Charlevoix-Saguenay (sacsin) (SACS), mRNA NM_014363 ENST00000382298 26278 NM_014363 NP843920 [NM_014363] A_23_P7325 BST1 bone marrow stromal cell antigen 1 (BST1), mRNA NM_004334 ENST00000265016 683 NM_004334 THC2677068 [NM_004334] A_33_P3283201 cDNA FLJ45443 fis, clone BRSSN2012157. [AK128779] AK128779 THC2482363 A_33_P3327697 LOC145474 hypothetical LOC145474 (LOC145474), non-coding RNA NR_027046 145474 NR_027046 [NR_027046] A_23_P42353 ETV7 ets variant 7 (ETV7), transcript variant 1, mRNA [NM_016135] NM_016135 ENST00000339796 51513 NM_016135 NP190936 A_33_P3351529 A_24_P242036 RRP7B ribosomal RNA processing 7 homolog B (S. cerevisiae) (RRP7B), NR_002184 ENST00000458605 91695 NR_002184 THC2463180 non-coding RNA [NR_002184] A_33_P3422712 A_33_P3806721 JMJD5 jumonji domain containing 5 (JMJD5), transcript variant 1, NM_001145348 ENST00000540888 79831 NM_001145348 THC2632015 mRNA [NM_001145348] A_23_P360240 MYEOV myeloma overexpressed (in a subset of t(11; 14) positive NM_138768 ENST00000535653 26579 NM_138768 THC2470814 multiple myelomas) (MYEOV), mRNA [NM_138768] A_33_P3279708 RNU2-2 RNA, U2 small nuclear 2 (RNU2-2), small nuclear RNA NR_002761 ENST00000538098 26855 NR_002761 THC2591139 [NR_002761] A_33_P3384694 A_23_P359870 PREDICTED: uncharacterized protein C8orf16-like XM_003119009 ENST00000400102 XM_003119009 THC2478877 (LOC100506010), mRNA [XM_003119009] A_23_P33683 2-Mar membrane-associated ring finger (C3HC4) 2 (MARCH2), NM_016496 ENST00000393944 51257 NM_016496 THC2532151 transcript variant 1, mRNA [NM_016496] A_33_P3256334 PRB3 proline-rich protein BstNI subfamily 3 (PRB3), mRNA NM_006249 ENST00000279573 5544 NM_006249 THC2479522 [NM_006249] A_33_P3321205 BEGAIN brain-enriched guanylate kinase-associated homolog (rat) NM_001159531 ENST00000443071 57596 NM_001159531 THC2475256 (BEGAIN), transcript variant 1, mRNA [NM_001159531] A_23_P156842 EEF1E1 eukaryotic translation elongation factor 1 epsilon 1 (EEF1E1), NM_004280 ENST00000429723 9521 NM_004280 THC2708665 transcript variant 1, mRNA [NM_004280] A_33_P3713035 LOC221814 mRNA; cDNA DKFZp564C0371 (from clone DKFZp564C0371) AL122087 221814 THC2606193 [AL122087] A_23_P213832 SPINK7 serine peptidase inhibitor, Kazal type 7 (putative) (SPINK7), NM_032566 ENST00000514646 84651 NM_032566 THC2734765 mRNA [NM_032566] A_32_P2452 TMTC1 transmembrane and tetratricopeptide repeat containing 1 NM_175861 ENST00000256062 83857 NM_175861 THC2470774 (TMTC1), transcript variant 2, mRNA [NM_175861] A_33_P3245818 PQLC1 PQ loop repeat containing 1 [Source: HGNC Symbol; Acc: 26188] AK126188 ENST00000466449 80148 THC2483810 [ENST00000466449] A_24_P398940 CASC4 cancer susceptibility candidate 4 (CASC4), transcript variant 1, NM_138423 ENST00000345795 113201 NM_138423 THC2469136 mRNA [NM_138423] A_32_P110390 TMEM171 transmembrane protein 171 (TMEM171), transcript variant 1, NM_173490 ENST00000287773 134285 NM_173490 THC2480044 mRNA [NM_173490] A_33_P3217719 TLE1 transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) NM_005077 ENST00000376472 7088 NM_005077 THC2594224 (TLE1), mRNA [NM_005077] A_33_P3222664 PREDICTED: hypothetical protein LOC100133214 XM_001718031 XM_001718031 (LOC100133214), mRNA [XM_001718031] A_23_P305198 STAT4 signal transducer and activator of transcription 4 (STAT4), NM_003151 ENST00000450994 6775 NM_003151 THC2501921 mRNA [NM_003151] A_33_P3260053 AIF1L allograft inflammatory factor 1-like (AIF1L), transcript variant 3, NM_001185095 ENST00000372312 83543 NM_001185095 THC2520939 mRNA [NM_001185095] A_23_P417921 DNAJC5G DnaJ (Hsp40) homolog, subfamily C, member 5 gamma NM_173650 ENST00000296097 285126 NM_173650 THC2478898 (DNAJC5G), mRNA [NM_173650] A_33_P3212350 CARD11 cDNA FLJ39820 fis, clone SPLEN2010625. [AK097139] AK097139 84433 THC2480953 A_33_P3347040 LOC100131094 hypothetical LOC100131094 (LOC100131094), mRNA NM_001242901 ENST00000381796 100131094 NM_001242901 THC2483730 [NM_001242901] A_32_P152696 A_24_P319647 FCRL2 Fc receptor-like 2 (FCRL2), mRNA [NM_030764] NM_030764 ENST00000392274 79368 NM_030764 NP458656 A_33_P3881056 PREDICTED: hypothetical protein LOC100507169 XM_003119710 XM_003119710 THC2486918 (LOC100507169), mRNA [XM_003119710] A_33_P3402615 SLC6A9 solute carrier family 6 (neurotransmitter transporter, glycine), NM_201649 ENST00000372310 6536 NM_201649 THC2615837 member 9 (SLC6A9), transcript variant 2, mRNA [NM_201649] A_33_P3289476 LOC100128697 cDNA FLJ42049 fis, clone SPLEN2041720. [AK124043] AK124043 100128697 THC2485306 A_33_P3309849 A_23_P90273 CHST8 carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 NM_022467 ENST00000262622 64377 NM_022467 THC2603946 (CHST8), transcript variant 3, mRNA [NM_022467] A_24_P64407 HMX2 H6 family homeobox 2 (HMX2), mRNA [NM_005519] NM_005519 ENST00000339992 3167 NM_005519 THC2478985 A_23_P100326 NPRL3 nitrogen permease regulator-like 3 (S. cerevisiae) (NPRL3), NM_001039476 ENST00000399953 8131 NM_001039476 THC2589758 transcript variant 2, mRNA [NM_001039476] A_33_P3332018 FGL2 fibrinogen-like 2 (FGL2), mRNA [NM_006682] NM_006682 ENST00000248598 10875 NM_006682 THC2610602 A_33_P3343485 HIP1 huntingtin interacting protein 1 [Source: HGNC AY358103 ENST00000479835 3092 THC2760507 Symbol; Acc: 4913] [ENST00000479835] A_33_P3321432 FAM198B family with sequence similarity 198, member B (FAM198B), NM_016613 ENST00000393807 51313 NM_016613 THC2461168 transcript variant 2, mRNA [NM_016613] A_32_P148345 ANXA2 annexin A2 (ANXA2), transcript variant 2, mRNA NM_001002857 ENST00000504475 302 NM_001002857 NP1174962 [NM_001002857] A_23_P36658 MGST1 microsomal glutathione S-transferase 1 (MGST1), transcript NM_145791 ENST00000539708 4257 NM_145791 THC2625515 variant 1c, mRNA [NM_145791] A_33_P3413701 ERAP1 endoplasmic reticulum aminopeptidase 1 (ERAP1), transcript NM_001040458 ENST00000443439 51752 NM_001040458 THC2533844 variant 2, mRNA [NM_001040458] A_33_P3403773 ZNF569 zinc finger protein 569 (ZNF569), mRNA [NM_152484] NM_152484 ENST00000316950 148266 NM_152484 THC2472283 A_33_P3419806 RPS29 ribosomal protein S29 (RPS29), transcript variant 1, mRNA NM_001032 ENST00000245458 6235 NM_001032 THC2465277 [NM_001032] A_24_P132787 RAB18 RAB18, member RAS oncogene family (RAB18), mRNA NM_021252 ENST00000540268 22931 NM_021252 THC2778145 [NM_021252] A_33_P3299110 ARHGAP42 Rho GTPase activating protein 42 (ARHGAP42), mRNA NM_152432 ENST00000298815 143872 NM_152432 THC2655447 [NM_152432] A_23_P169494 ORM1 orosomucoid 1 (ORM1), mRNA [NM_000607] NM_000607 ENST00000477456 5004 NM_000607 THC2558758 A_23_P150407 CREB3L1 cAMP responsive element binding protein 3-like 1 (CREB3L1), NM_052854 ENST00000530244 90993 NM_052854 THC2501749 mRNA [NM_052854] A_32_P208178 RPS3A ribosomal protein S3A (RPS3A), mRNA [NM_001006] NM_001006 ENST00000512797 6189 NM_001006 THC2568491 A_33_P3234540 A_32_P209624 MKRN7P makorin ring finger protein 7, pseudogene (MKRN7P), non- NR_026640 7686 NR_026640 THC2522223 coding RNA [NR_026640] A_23_P74609 G0S2 G0/G1switch 2 (G0S2), mRNA [NM_015714] NM_015714 ENST00000367029 50486 NM_015714 THC2463882 A_33_P3270084 CDC2L1S13 PITSLRE protein kinase alpha SV9 isoform { } (exp = −1; THC2524986 wgp = 0; cg = 0), partial (38%) [THC2524986] A_33_P3223874 ZMYND17 mRNA; cDNA DKFZp686D03167 (from clone DKFZp686D03167). CR936824 118490 THC2502061 [CR936824] A_23_P160751 FCRL2 Fc receptor-like 2 (FCRL2), mRNA [NM_030764] NM_030764 ENST00000368181 79368 NM_030764 NP1165213 A_23_P19673 SGK1 serum/glucocorticoid regulated kinase 1 (SGK1), transcript NM_005627 ENST00000367857 6446 NM_005627 THC2495241 variant 1, mRNA [NM_005627] A_33_P3251322 MTMR14 cDNA FLJ46453 fis, clone THYMU3019916. [AK128312] AK128312 64419 THC2484657 A_33_P3267118 EIF4G3 eukaryotic translation initiation factor 4 gamma, 3 ENST00000374933 8672 THC2511801 [Source: HGNC Symbol; Acc: 3298] [ENST00000374933] A_33_P3883912 ZCCHC10 zinc finger, CCHC domain containing 10 (ZCCHC10), mRNA NM_017665 ENST00000324170 54819 NM_017665 THC2522779 [NM_017665] A_23_P347198 SP3 Sp3 transcription factor (SP3), transcript variant 1, mRNA NM_003111 ENST00000465379 6670 NM_003111 THC2466406 [NM_003111] A_23_P7066 RPL9 ribosomal protein L9 (RPL9), transcript variant 2, mRNA NM_001024921 ENST00000437992 6133 NM_001024921 THC2541724 [NM_001024921] A_33_P3398862 RHOB ras homolog gene family, member B (RHOB), mRNA NM_004040 ENST00000272233 388 NM_004040 THC2711134 [NM_004040] A_33_P3366073 EBPL emopamil binding protein-like [Source: HGNC BC073152 ENST00000378274 84650 THC2760012 Symbol; Acc: 18061] [ENST00000378274] A_32_P190488 HUMRPL26X ribosomal protein L26 { } (exp = −1; wgp = 0; cg = 0), THC2550570 partial (91%) [THC2550570] A_23_P111092 OR2H1 olfactory receptor, family 2, subfamily H, member 1 (OR2H1), NM_030883 ENST00000461453 26716 NM_030883 THC2734737 mRNA [NM_030883] A_24_P410516 GOLGA6L9 golgin A6 family-like 9 (GOLGA6L9), mRNA [NM_198181] NM_198181 ENST00000306827 440295 NM_198181 THC2574212 A_33_P3214310 FOXP1 forkhead box P1 (FOXP1), transcript variant 2, mRNA NM_001012505 ENST00000318779 27086 NM_001012505 THC2480877 [NM_001012505] A_32_P200237 LOC157740 mRNA for chromosome 8 open reading frame 9 (c8ORF9). AJ291676 157740 THC2480673 [AJ291676] A_33_P3414789 FSD1 fibronectin type III and SPRY domain containing 1 (FSD1), NM_024333 ENST00000221856 79187 NM_024333 THC2693421 mRNA [NM_024333] A_32_P77102 LOC100128420 hypothetical LOC100128420 (LOC100128420), transcript NR_038461 ENST00000454385 100128420 NR_038461 THC2660884 variant 1, non-coding RNA [NR_038461] A_32_P226786 FAM126B family with sequence similarity 126, member B (FAM126B), NM_173822 285172 NM_173822 THC2492001 mRNA [NM_173822] A_33_P3221458 ZNF204P zinc finger protein 204, pseudogene (ZNF204P), non-coding NR_002722 7754 NR_002722 THC2495874 RNA [NR_002722] A_23_P92994 MFF mitochondrial fission factor (MFF), nuclear gene encoding NM_020194 ENST00000409565 56947 NM_020194 NP1211685 mitochondrial protein, mRNA [NM_020194] A_33_P3295415 ZBTB3 zinc finger and BTB domain containing 3 (ZBTB3), mRNA NM_024784 ENST00000394807 79842 NM_024784 THC2477256 [NM_024784] A_33_P3389837 GPN3 GPN-loop GTPase 3 (GPN3), transcript variant 2, mRNA NM_001164372 ENST00000537466 51184 NM_001164372 THC2461939 [NM_001164372] A_33_P3221761 MLL4 myeloid/lymphoid or mixed-lineage leukemia 4 (MLL4), mRNA NM_014727 ENST00000341701 9757 NM_014727 THC2491229 [NM_014727] A_23_P89380 SLC4A1 solute carrier family 4, anion exchanger, member 1 NM_000342 ENST00000399246 6521 NM_000342 THC2474785 (erythrocyte membrane protein band 3, Diego blood group) (SLC4A1), mRNA [NM_000342] A_33_P3422822 GJC2 gap junction protein, gamma 2, 47 kDa (GJC2), mRNA NM_020435 ENST00000366714 57165 NM_020435 [NM_020435] A_23_P107051 TCAP titin-cap (telethonin) (TCAP), mRNA [NM_003673] NM_003673 ENST00000309889 8557 NM_003673 THC2512009 A_23_P34597 CDA cytidine deaminase (CDA), mRNA [NM_001785] NM_001785 ENST00000461985 978 NM_001785 NP1079190 A_33_P3288135 CPLX2 complexin 2 [Source: HGNC Symbol; Acc: 2310] ENST00000506642 10814 [ENST00000506642] A_32_P1712 RNASE2 ribonuclease, RNase A family, 2 (liver, eosinophil-derived NM_002934 ENST00000258817 6036 NM_002934 NP103298 neurotoxin) (RNASE2), mRNA [NM_002934] A_32_P157927 immunoglobulin kappa variable 4-1 [Source: HGNC S62210 ENST00000390243 NP836564 Symbol; Acc: 5834] [ENST00000390243] A_33_P3293524 NEURL neuralized homolog (Drosophila) (NEURL), mRNA [NM_004210] NM_004210 ENST00000369780 9148 NM_004210 THC2463576 A_24_P372625 RNF141 ring finger protein 141 (RNF141), mRNA [NM_016422] NM_016422 ENST00000534281 50862 NM_016422 THC2492115 A_33_P3629678 COL5A1 collagen, type V, alpha 1 (COL5A1), mRNA [NM_000093] NM_000093 ENST00000371817 1289 NM_000093 THC2469461 A_23_P149368 FCRL1 Fc receptor-like 1 (FCRL1), transcript variant 1, mRNA NM_052938 ENST00000495126 115350 NM_052938 THC2478058 [NM_052938] A_33_P3420446 LRRD1 leucine-rich repeats and death domain containing 1 (LRRD1), NM_001161528 ENST00000430130 401387 NM_001161528 mRNA [NM_001161528] A_33_P3248900 FLJ45445 hypothetical LOC399844 (FLJ45445), non-coding RNA NR_028324 ENST00000425496 399844 NR_028324 THC2466370 [NR_028324] A_23_P58390 C4orf32 chromosome 4 open reading frame 32 (C4orf32), mRNA NM_152400 ENST00000309733 132720 NM_152400 THC2471790 [NM_152400] A_33_P3345614 A_23_P208482 CLEC4M C-type lectin domain family 4, member M (CLEC4M), transcript NM_001144904 ENST00000327325 10332 NM_001144904 NP076516 variant 2, mRNA [NM_001144904] A_33_P3294277 CYP4F3 cytochrome P450, family 4, subfamily F, polypeptide 3 NM_000896 ENST00000221307 4051 NM_000896 THC2633164 (CYP4F3), transcript variant 1, mRNA [NM_000896] A_23_P131139 DIRC1 disrupted in renal carcinoma 1 (DIRC1), mRNA [NM_052952] NM_052952 ENST00000308100 116093 NM_052952 THC2479514 A_23_P92035 SETD5 SET domain containing 5 (SETD5), mRNA [NM_001080517] NM_001080517 ENST00000466826 55209 NM_001080517 THC2521629 A_32_P122240 ASCL5 PREDICTED: achaete-scute complex homolog 5 (Drosophila) XM_940966 647219 XM_940966 THC2659820 (ASCL5), mRNA [XM_940966] A_23_P208293 PVRL2 poliovirus receptor-related 2 (herpesvirus entry mediator B) NM_001042724 ENST00000252483 5819 NM_001042724 THC2582406 (PVRL2), transcript variant delta, mRNA [NM_001042724] A_23_P310460 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 NM_153487 ENST00000297153 266727 NM_153487 THC2479103 (MDGA1), mRNA [NM_153487] A_33_P3238433 ALDH3A1 aldehyde dehydrogenase 3 family, member A1 (ALDH3A1), NM_001135168 ENST00000457844 218 NM_001135168 THC2506362 transcript variant 1, mRNA [NM_001135168] A_24_P136161 HNRNPCL1 heterogeneous nuclear ribonucleoprotein C-like 1 (HNRNPCL1), NM_001013631 ENST00000317869 343069 NM_001013631 THC2493506 mRNA [NM_001013631] A_33_P3325349 TSPAN5 tetraspanin 5 (TSPAN5), mRNA [NM_005723] NM_005723 ENST00000305798 10098 NM_005723 THC2462540 A_32_P224666 CAPZA2 capping protein (actin filament) muscle Z-line, alpha 2 NM_006136 ENST00000361183 830 NM_006136 THC2470172 (CAPZA2), mRNA [NM_006136] A_23_P116890 PRB3 proline-rich protein BstNI subfamily 3 (PRB3), mRNA NM_006249 ENST00000538488 5544 NM_006249 THC2479522 [NM_006249] A_23_P89755 RNF138 ring finger protein 138 (RNF138), transcript variant 1, mRNA NM_016271 ENST00000257190 51444 NM_016271 THC2601652 [NM_016271] A_24_P321511 GOLT1B golgi transport 1B (GOLT1B), mRNA [NM_016072] NM_016072 ENST00000229314 51026 NM_016072 THC2466175 A_33_P3325011 A_23_P336554 IL1RAP interleukin 1 receptor accessory protein (IL1RAP), transcript NM_134470 ENST00000422485 3556 NM_134470 THC2473060 variant 2, mRNA [NM_134470] A_24_P142495 KRTAP1-3 keratin associated protein 1-3 (KRTAP1-3), mRNA NM_030966 ENST00000344363 81850 NM_030966 NP367289 [NM_030966] A_23_P209652 INO80D INO80 complex subunit D (INO80D), mRNA [NM_017759] NM_017759 ENST00000233270 54891 NM_017759 THC2699199 A_33_P3321369 LOC145757 PREDICTED: hypothetical LOC145757 (LOC145757), miscRNA XR_109231 145757 XR_109231 THC2646184 [XR_109231] A_23_P120435 WFDC3 WAP four-disulfide core domain 3 (WFDC3), mRNA NM_080614 ENST00000467679 140686 NM_080614 NP819189 [NM_080614] A_23_P129629 MT3 metallothionein 3 (MT3), mRNA [NM_005954] NM_005954 ENST00000200691 4504 NM_005954 THC2602129 A_33_P3283669 ATP1A3 ATPase, Na+/K+ transporting, alpha 3 polypeptide (ATP1A3), NM_152296 ENST00000545399 478 NM_152296 THC2493019 mRNA [NM_152296] A_23_P201747 PADI2 peptidyl arginine deiminase, type II (PADI2), mRNA NM_007365 ENST00000375486 11240 NM_007365 THC2503010 [NM_007365] A_33_P3248072 SIRPB1 signal-regulatory protein beta 1 (SIRPB1), transcript variant 3, NM_001135844 ENST00000279477 10326 NM_001135844 THC2475815 mRNA [NM_001135844] A_23_P157299 AEBP1 AE binding protein 1 (AEBP1), mRNA [NM_001129] NM_001129 ENST00000413907 165 NM_001129 THC2469029 A_32_P170397 HCG1998685 [Source: UniProtKB/TrEMBL; Acc: Q8TCB4] AK057625 ENST00000309874 THC2627263 [ENST00000309874] A_33_P3222069 SPHK1 sphingosine kinase 1 (SPHK1), transcript variant 2, mRNA NM_182965 ENST00000545180 8877 NM_182965 THC2474958 [NM_182965] A_33_P3305763 PREDICTED: uncharacterized protein C8orf6-like XM_003119010 ENST00000531549 XM_003119010 THC2483388 (LOC100506042), mRNA [XM_003119010] A_33_P3368560 AHSA2 AHA1, activator of heat shock 90 kDa protein ATPase homolog 2 BC050395 130872 THC2533385 (yeast), mRNA (cDNA clone IMAGE: 5735095), partial cds. [BC050395] A_33_P3294826 CRABP2 cellular retinoic acid binding protein 2 (CRABP2), transcript NM_001199723 ENST00000368220 1382 NM_001199723 variant 2, mRNA [NM_001199723] A_23_P82047 STXBP5 syntaxin binding protein 5 (tomosyn) (STXBP5), transcript NM_001127715 ENST00000367479 134957 NM_001127715 THC2505040 variant 2, mRNA [NM_001127715] A_33_P3246833 IL1RN interleukin 1 receptor antagonist (IL1RN), transcript variant 4, NM_173843 ENST00000259206 3557 NM_173843 THC2498493 mRNA [NM_173843] A_33_P3338152 HIF3A hypoxia inducible factor 3, alpha subunit [Source: HGNC AB118749 ENST00000457865 64344 THC2485400 Symbol; Acc: 15825] [ENST00000457865] A_33_P3818959 SAMD11 sterile alpha motif domain containing 11 (SAMD11), mRNA NM_152486 ENST00000342066 148398 NM_152486 THC2480231 [NM_152486] A_33_P3224710 TFEC transcription factor EC (TFEC), transcript variant 1, mRNA NM_012252 ENST00000393485 22797 NM_012252 THC2474951 [NM_012252] A_23_P413796 HAUS1 HAUS augmin-like complex, subunit 1 (HAUS1), transcript NM_138443 ENST00000282058 115106 NM_138443 THC2467428 variant 1, mRNA [NM_138443] A_33_P3308481 HYMAI hydatidiform mole associated and imprinted (non-protein NR_002768 57061 NR_002768 THC2645509 coding) (HYMAI), non-coding RNA [NR_002768] clone 1120 immunoglobulin lambda light chain variable region A_33_P3279861 mRNA, partial cds. [AF194718] AF194718 NP079543 A_32_P193322 RICTOR RPTOR independent companion of MTOR, complex 2 (RICTOR), NM_152756 ENST00000357387 253260 NM_152756 THC2491721 mRNA [NM_152756] A_23_P216108 ANK1 ankyrin 1, erythrocytic (ANK1), transcript variant 3, mRNA NM_000037 ENST00000265709 286 NM_000037 NP1475647 [NM_000037] A_23_P75769 MS4A4A membrane-spanning 4-domains, subfamily A, member 4 NM_024021 ENST00000529991 51338 NM_024021 THC2628883 (MS4A4A), transcript variant 1, mRNA [NM_024021] A_24_P90097 ADD3 adducin 3 (gamma) (ADD3), transcript variant 1, mRNA NM_016824 ENST00000277900 120 NM_016824 THC2759750 [NM_016824] A_23_P141549 RPS7 ribosomal protein S7 (RPS7), mRNA [NM_001011] NM_001011 ENST00000406376 6201 NM_001011 THC2557544 A_23_P103532 GPR161 G protein-coupled receptor 161 (GPR161), transcript variant 2, NM_153832 ENST00000493800 23432 NM_153832 THC2628589 mRNA [NM_153832] A_23_P328069 HPS1 Hermansky-Pudlak syndrome 1 (HPS1), transcript variant 1, NM_000195 ENST00000325103 3257 NM_000195 THC2603389 mRNA [NM_000195] A_24_P40001 SIGLEC8 sialic acid binding Ig-like lectin 8 (SIGLEC8), mRNA NM_014442 ENST00000321424 27181 NM_014442 THC2478774 [NM_014442] A_23_P217609 RPL36A ribosomal protein L36a (RPL36A), transcript variant 1, mRNA NM_021029 ENST00000372849 6173 NM_021029 THC2465210 [NM_021029] A_33_P3417626 ENHO energy homeostasis associated (ENHO), mRNA [NM_198573] NM_198573 ENST00000303992 375704 NM_198573 THC2482843 A_33_P3372910 DDX58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (DDX58), mRNA NM_014314 ENST00000379882 23586 NM_014314 NP1162083 [NM_014314] A_33_P3210443 LOC145216 hypothetical LOC145216 (LOC145216), non-coding RNA NR_038436 145216 NR_038436 NP1154465 [NR_038436] A_24_P172993 UBE2O ubiquitin-conjugating enzyme E2O (UBE2O), mRNA NM_022066 ENST00000319380 63893 NM_022066 THC2624034 [NM_022066] A_23_P14734 RPS27L ribosomal protein S27-like (RPS27L), mRNA [NM_015920] NM_015920 ENST00000462430 51065 NM_015920 THC2473897 A_24_P390833 MPPE1 metallophosphoesterase 1 (MPPE1), transcript variant 1, mRNA NM_023075 ENST00000399978 65258 NM_023075 NP1162383 [NM_023075] A_33_P3279124 FAM21C family with sequence similarity 21, member C (FAM21C), NM_001169107 ENST00000434114 253725 NM_001169107 THC2572798 transcript variant 3, mRNA [NM_001169107] A_33_P3233404 T cell receptor beta variable 28 [Source: HGNC AB305916 ENST00000390400 NP285374 Symbol; Acc: 12209] [ENST00000390400] A_23_P67127 TMEM145 transmembrane protein 145 (TMEM145), mRNA [NM_173633] NM_173633 ENST00000301204 284339 NM_173633 THC2483750 A_33_P3415859 NLRC3 NLR family, CARD domain containing 3 [Source: HGNC AK090476 ENST00000324659 197358 THC2563500 Symbol; Acc: 29889] [ENST00000324659] A_33_P3280502 A_33_P3406567 MS4A1 membrane-spanning 4-domains, subfamily A, member 1 NM_152866 ENST00000389939 931 NM_152866 THC2461914 (MS4A1), transcript variant 1, mRNA [NM_152866] A_33_P3408244 SPRNP1 shadow of prion protein homolog (zebrafish) pseudogene 1 NR_033789 ENST00000450958 399833 NR_033789 THC2482646 (SPRNP1), non-coding RNA [NR_033789] A_33_P3224803 NCF1 neutrophil cytosolic factor 1 (NCF1), mRNA [NM_000265] NM_000265 ENST00000438106 653361 NM_000265 THC2505727 A_33_P3408962 FLJ33996 PREDICTED: hypothetical protein FLJ33996 (FLJ33996), XR_110352 283401 XR_110352 THC2475169 miscRNA [XR_110352] A_33_P3327818 AL157466 ENST00000366116 THC2612300 A_33_P3338793 KCNC3 potassium voltage-gated channel, Shaw-related subfamily, NM_004977 ENST00000477616 3748 NM_004977 THC2481537 member 3 (KCNC3), mRNA [NM_004977] A_33_P3395675 immunoglobulin lambda constant 2 (Kern-Oz- marker) EU937523 ENST00000390323 NP093469 [Source: HGNC Symbol; Acc: 5856] [ENST00000390323] A_33_P3878772 JAK2 Janus kinase 2 (JAK2), mRNA [NM_004972] NM_004972 ENST00000381652 3717 NM_004972 THC2472565 A_33_P3629131 CDRT3 DKFZp686P15240_r1 686 (synonym: hlcc3) cDNA clone BX484257 94145 DKFZp686P15240 5′, mRNA sequence [BX484257] A_33_P3250730 ACCN4 amiloride-sensitive cation channel 4, pituitary (ACCN4), NM_018674 ENST00000358078 55515 NM_018674 NP835056 transcript variant 1, mRNA [NM_018674] A_33_P3390773 TRIM66 tripartite motif containing 66 (TRIM66), mRNA [NM_014818] NM_014818 ENST00000299550 9866 NM_014818 THC2604054 A_33_P3293391 LOC642826 hypothetical LOC642826 (LOC642826), non-coding RNA NR_024495 642826 NR_024495 THC2517511 [NR_024495] A_33_P3315268 KRT78 keratin 78 (KRT78), mRNA [NM_173352] NM_173352 ENST00000539860 196374 NM_173352 THC2473566 A_33_P3269723 ZSWIM7 zinc finger, SWIM-type containing 7 (ZSWIM7), transcript NM_001042697 ENST00000399277 125150 NM_001042697 THC2492535 variant 1, mRNA [NM_001042697] A_23_P349083 FCHO2 FCH domain only 2 (FCHO2), transcript variant 1, mRNA NM_138782 ENST00000341845 115548 NM_138782 THC2508618 [NM_138782] A_33_P3256793 KIAA1324 KIAA1324 (KIAA1324), mRNA [NM_020775] NM_020775 ENST00000369938 57535 NM_020775 THC2629991 A_33_P3275835 TOR2A torsin family 2, member A (TOR2A), transcript variant 3, mRNA NM_001134430 ENST00000336067 27433 NM_001134430 THC2485391 [NM_001134430] A_33_P3415744 ANKRD36B ankyrin repeat domain 36B (ANKRD36B), mRNA [NM_025190] NM_025190 ENST00000357042 57730 NM_025190 THC2477306 A_33_P3278649 ENTPD2 ectonucleoside triphosphate diphosphohydrolase 2 (ENTPD2), NM_203468 ENST00000355097 954 NM_203468 THC2487916 transcript variant 1, mRNA [NM_203468] A_33_P3326553 TMEM82 transmembrane protein 82 (TMEM82), mRNA NM_001013641 ENST00000375782 388595 NM_001013641 THC2477712 [NM_001013641] A_33_P3232945 F2RL1 coagulation factor II (thrombin) receptor-like 1 (F2RL1), mRNA NM_005242 ENST00000296677 2150 NM_005242 THC2464357 [NM_005242] A_33_P3789693 MGC24103 PREDICTED: hypothetical MGC24103 (MGC24103), miscRNA XR_108934 158295 XR_108934 NP1159657 [XR_108934] A_24_P148151 TSNAX translin-associated factor X (TSNAX), mRNA [NM_005999] NM_005999 ENST00000475168 7257 NM_005999 THC2467018 A_23_P52986 VWCE von Willebrand factor C and EGF domains (VWCE), mRNA NM_152718 ENST00000335613 220001 NM_152718 THC2474163 [NM_152718] A_23_P301995 LIN9 lin-9 homolog (C. elegans) (LIN9), mRNA [NM_173083] NM_173083 ENST00000366807 286826 NM_173083 THC2484578 A_33_P3883985 LMF1 lipase maturation factor 1 (LMF1), transcript variant 4, non- NR_036442 64788 NR_036442 THC2605210 coding RNA [NR_036442] A_23_P25445 FAM186B family with sequence similarity 186, member B (FAM186B), NM_032130 ENST00000257894 84070 NM_032130 THC2706486 transcript variant 1, mRNA [NM_032130] A_33_P3302070 GB NP1243929 A_33_P3324675 A_33_P3326235 HBM hemoglobin, mu (HBM), mRNA [NM_001003938] NM_001003938 ENST00000472539 3042 NM_001003938 THC2477716 A_23_P134835 CSGALNACT1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 NM_018371 ENST00000311540 55790 NM_018371 THC2486893 (CSGALNACT1), transcript variant 2, mRNA [NM_018371] A_23_P338168 FBXL19 F-box and leucine-rich repeat protein 19 (FBXL19), mRNA NM_001099784 ENST00000338343 54620 NM_001099784 THC2686436 [NM_001099784] A_33_P3358403 DNLZ DNL-type zinc finger (DNLZ), mRNA [NM_001080849] NM_001080849 ENST00000481053 728489 NM_001080849 THC2612845 A_33_P3362068 LOC100129149 full-length cDNA clone CS0DI084YD11 of Placenta Cot 25- CR595361 100129149 THC2688744 normalized of (human). [CR595361] A_32_P20367 RPS7 ribosomal protein S7 (RPS7), mRNA [NM_001011] NM_001011 ENST00000406376 6201 NM_001011 THC2578871 A_24_P510357 immunoglobulin lambda variable 2-14 [Source: HGNC S76132 ENST00000390312 NP1087720 Symbol; Acc: 5888] [ENST00000390312] A_33_P3589543 PREDICTED: hypothetical locus LOC692247 (LOC692247), XR_109057 ENST00000527620 XR_109057 THC2480441 miscRNA [XR_109057] A_33_P3290672 SELT selenoprotein T (SELT), mRNA [NM_016275] NM_016275 51714 NM_016275 THC2731852 A_33_P3313411 ARHGAP33 Rho GTPase activating protein 33 (ARHGAP33), transcript NM_001172630 ENST00000007510 115703 NM_001172630 NP107616 variant 2, mRNA [NM_001172630] A_33_P3248749 RSPH9 radial spoke head 9 homolog (Chlamydomonas) [Source: HGNC AK055407 ENST00000372154 221421 THC2478697 Symbol; Acc: 21057] [ENST00000372154] A_33_P3252146 HMX3 H6 family homeobox 3 (HMX3), mRNA [NM_001105574] NM_001105574 ENST00000357878 340784 NM_001105574 A_23_P500410 ATP6V1G2 ATPase, H+ transporting, lysosomal 13 kDa, V1 subunit G2 NM_130463 ENST00000303892 534 NM_130463 THC2504847 (ATP6V1G2), transcript variant 1, mRNA [NM_130463] A_33_P3363305 A_33_P3335506 FCRL5 Fc receptor-like 5 [Source: HGNC Symbol; Acc: 18508] AF343662 ENST00000368190 83416 THC2478268 [ENST00000368190] A_23_P255663 MANEA man nosidase, endo-alpha (MANEA), mRNA [NM_024641] NM_024641 ENST00000358812 79694 NM_024641 THC2492910 A_33_P3339109 POLR1C polymerase (RNA) I polypeptide C, 30 kDa [Source: HGNC CA416988 ENST00000512472 9533 THC2626465 Symbol; Acc: 20194] [ENST00000512472] A_33_P3358213 PADI6 peptidyl arginine deiminase, type VI (PADI6), mRNA NM_207421 ENST00000434762 353238 NM_207421 THC2488002 [NM_207421] A_33_P3369761 PDP1 pyruvate dehyrogenase phosphatase catalytic subunit 1 (PDP1), NM_001161779 ENST00000396200 54704 NM_001161779 THC2466932 nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_001161779] A_33_P3272352 HCG1988162Uncharacterized protein ENST00000397064 [Source: UniProtKB/TrEMBL; Acc: A8MTT3] [ENST00000397064] A_33_P3364240 PAEP progestagen-associated endometrial protein (PAEP), transcript NM_002571 ENST00000344007 5047 NM_002571 NP1192436 variant 2, mRNA [NM_002571] A_23_P39453 MEX3D mex-3 homolog D (C. elegans) (MEX3D), transcript variant 1, NM_203304 ENST00000402693 399664 NM_203304 THC2473313 mRNA [NM_203304] A_33_P3424861 FAM118A family with sequence similarity 118, member A (FAM118A), NM_001104595 ENST00000216214 55007 NM_001104595 THC2595955 transcript variant 1, mRNA [NM_001104595] A_33_P3408665 A_24_P188800 1-Mar membrane-associated ring finger (C3HC4) 1 (MARCH1), NM_017923 ENST00000339875 55016 NM_017923 THC2483811 transcript variant 2, mRNA [NM_017923] A_23_P303891 LCE1C late cornified envelope 1C (LCE1C), mRNA [NM_178351] NM_178351 ENST00000368768 353133 NM_178351 NP1250118 A_23_P44974 MRPL13 mitochondrial ribosomal protein L13 (MRPL13), nuclear gene NM_014078 ENST00000523316 28998 NM_014078 THC2498425 encoding mitochondrial protein, mRNA [NM_014078] A_33_P3284463 ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 NM_177924 ENST00000417108 427 NM_177924 THC2495793 (ASAH1), transcript variant 1, mRNA [NM_177924] A_33_P3806676 T cell receptor beta variable 28 [Source: HGNC AY751906 ENST00000390400 NP161158 Symbol; Acc: 12209] [ENST00000390400] A_24_P169073 FAM131C family with sequence similarity 131, member C (FAM131C), NM_182623 ENST00000375662 348487 NM_182623 THC2475284 mRNA [NM_182623] A_24_P366165 A_24_P229871 chromosome 17 open reading frame 54 [Source: HGNC BC101214 ENST00000321800 NP1465661 Symbol; Acc: 26863] [ENST00000321800] A_33_P3385656 FNDC9 fibronectin type III domain containing 9 (FNDC9), mRNA NM_001001343 ENST00000312349 408263 NM_001001343 THC2644705 [NM_001001343] A_33_P3352664 SP7 Sp7 transcription factor (SP7), transcript variant 1, mRNA NM_001173467 ENST00000303846 121340 NM_001173467 THC2479201 [NM_001173467] A_33_P3253832 FV367791 A_23_P430670 CHST5 carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 NM_024533 ENST00000336257 23563 NM_024533 NP175264 (CHST5), mRNA [NM_024533] A_23_P379034 BAIAP2L2 BAI1-associated protein 2-like 2 (BAIAP2L2), mRNA NM_025045 ENST00000402500 80115 NM_025045 THC2618191 [NM_025045] A_23_P116235 MDK midkine (neurite growth-promoting factor 2) (MDK), transcript NM_001012334 ENST00000407067 4192 NM_001012334 NP1464770 variant 1, mRNA [NM_001012334] A_33_P3247095 ENST00000447610 A_23_P170857 IL1RAP interleukin 1 receptor accessory protein (IL1RAP), transcript NM_002182 ENST00000447382 3556 NM_002182 THC2628876 variant 1, mRNA [NM_002182] A_33_P3264444 PFDN6 prefoldin subunit 6 [Source: HGNC Symbol; Acc: 4926] CR609151 ENST00000482292 10471 THC2557117 [ENST00000482292] A_23_P26386 TPPP3 tubulin polymerization-promoting protein family member 3 NM_016140 ENST00000290942 51673 NM_016140 NP211869 (TPPP3), mRNA [NM_016140] A_23_P372848 P2RX1 purinergic receptor P2X, ligand-gated ion channel, 1 (P2RX1), NM_002558 ENST00000225538 5023 NM_002558 THC2488665 mRNA [NM_002558] A_33_P3356341 MSL1 male-specific lethal 1 homolog (Drosophila) (MSL1), mRNA NM_001012241 ENST00000398532 339287 NM_001012241 THC2629023 [NM_001012241] A_23_P59888 NACAP1 nascent-polypeptide-associated complex alpha polypeptide NR_002182 ENST00000419462 83955 NR_002182 THC2490918 pseudogene 1 (NACAP1), non-coding RNA [NR_002182] A_23_P92520 ANP32C acidic (leucine-rich) nuclear phosphoprotein 32 family, member NM_012403 23520 NM_012403 NP175117 C (ANP32C), mRNA [NM_012403] A_24_P239076 IGLL1 immunoglobulin lambda-like polypeptide 1 (IGLL1), transcript NM_020070 ENST00000330377 3543 NM_020070 THC2471192 variant 1, mRNA [NM_020070] A_33_P3386297 MSTP159 (MST159) mRNA, complete cds. [AF190162] AF190162 THC2488126 A_24_P82630 SMCHD1 structural maintenance of chromosomes flexible hinge domain NM_015295 ENST00000320876 23347 NM_015295 THC2657862 containing 1 (SMCHD1), mRNA [NM_015295] A_33_P3395314 DB335107 SYNOV4 cDNA clone SYNOV4009599 3′, mRNA DB335107 sequence [DB335107] A_33_P3261024 A_33_P3389649 PDE4D phosphodiesterase 4D, cAMP-specific (PDE4D), transcript NM_001197218 ENST00000502575 5144 NM_001197218 NP285196 variant 4, mRNA [NM_001197218] A_23_P361654 immunoglobulin kappa variable 1D-16 [Source: HGNC BC073764 ENST00000492446 THC2551789 Symbol; Acc: 5748] [ENST00000492446] A_33_P3344574 SFTPA2 surfactant protein A2 (SFTPA2), mRNA [NM_001098668] NM_001098668 ENST00000372325 729238 NM_001098668 A_23_P48495 TCL1B T-cell leukemia/lymphoma 1B (TCL1B), transcript variant 1, NM_004918 ENST00000461160 9623 NM_004918 NP073518 mRNA [NM_004918] A_33_P3417502 WNT3A wingless-type MMTV integration site family, member 3A NM_033131 ENST00000366753 89780 NM_033131 NP1459415 (WNT3A), mRNA [NM_033131] A_33_P3229863 LOC100128714 hypothetical LOC100128714 (LOC100128714), non-coding RNA NR_040082 ENST00000383019 100128714 NR_040082 THC2487359 [NR_040082] A_33_P3322388 SPRR2D small proline-rich protein 2D (SPRR2D), mRNA [NM_006945] NM_006945 ENST00000439437 6703 NM_006945 THC2480904 A_33_P3338071 A_23_P42282 C4B complement component 4B (Chido blood group) (C4B), mRNA NM_001002029 ENST00000463249 721 NM_001002029 THC2501809 [NM_001002029] A_33_P3369128 LOC100132966 cDNA FLJ42565 fis, clone BRACE3007472. [AK124556] AK124556 100132966 THC2585044 A_33_P3304707 immunoglobulin lambda variable 2-8 [Source: HGNC Z46314 ENST00000390317 NP165804 Symbol; Acc: 5895] [ENST00000390317] A_23_P29079 PFKL phosphofructokinase, liver (PFKL), transcript variant 2, mRNA NM_002626 ENST00000495274 5211 NM_002626 NP1150810 [NM_002626] A_23_P151637 RNASE2 ribonuclease, RNase A family, 2 (liver, eosinophil-derived NM_002934 ENST00000304625 6036 NM_002934 THC2473665 neurotoxin) (RNASE2), mRNA [NM_002934] A_23_P412214 RAP1GAP2 RAP1 GTPase activating protein 2 (RAP1GAP2), transcript NM_015085 ENST00000254695 23108 NM_015085 THC2680829 variant 1, mRNA [NM_015085] A_33_P3279620 cDNA FLJ37513 fis, clone BRCAN2000620. [AK094832] AK094832 THC2579088 A_24_P68311 SYNE2 spectrin repeat containing, nuclear envelope 2 (SYNE2), NM_015180 ENST00000356081 23224 NM_015180 NP590721 transcript variant 1, mRNA [NM_015180] A_33_P3550894 GATA2 GATA binding protein 2 (GATA2), transcript variant 1, mRNA NM_001145661 ENST00000430265 2624 NM_001145661 NP099465 [NM_001145661] A_33_P3370364 PRLHR prolactin releasing hormone receptor (PRLHR), mRNA NM_004248 ENST00000369169 2834 NM_004248 THC2605922 [NM_004248] A_24_P412734 PRSS36 protease, serine, 36 (PRSS36), mRNA [NM_173502] NM_173502 ENST00000268281 146547 NM_173502 THC2477817 A_24_P387869 PKN2 protein kinase N2 (PKN2), mRNA [NM_006256] NM_006256 ENST00000370521 5586 NM_006256 THC2648997 A_33_P3215788 ANKRD36 ankyrin repeat domain 36 (ANKRD36), mRNA [NM_001164315] NM_001164315 ENST00000447597 375248 NM_001164315 THC2498566 A_33_P3269844 LRRC26 leucine rich repeat containing 26 (LRRC26), mRNA NM_001013653 ENST00000371542 389816 NM_001013653 THC2675561 [NM_001013653] A_33_P3271395 LOC100129534 small nuclear ribonucleoprotein polypeptide N pseudogene NR_024489 100129534 NR_024489 THC2481166 (LOC100129534), non-coding RNA [NR_024489] A_23_P22433 RP2 retinitis pigmentosa 2 (X-linked recessive) (RP2), mRNA NM_006915 ENST00000218340 6102 NM_006915 THC2526448 [NM_006915] A_23_P140190 KIAA0125 KIAA0125 (KIAA0125), non-coding RNA [NR_026800] NR_026800 ENST00000484511 9834 NR_026800 THC2483256 A_33_P3320782 ATXN7 ataxin 7 (ATXN7), transcript variant SCA7a, mRNA NM_000333 ENST00000398590 6314 NM_000333 THC2471545 [NM_000333] A_33_P3226154 immunoglobulin kappa constant [Source: HGNC AY538254 ENST00000390237 NP1073961 Symbol; Acc: 5716] [ENST00000390237] A_33_P3257486 LOC651536 immunoglobulin lambda variable 5-45 [Source: HGNC XM_001719621 ENST00000390296 651536 XM_001719621 NP084478 Symbol; Acc: 5924] [ENST00000390296] A_32_P186981 RPL17 ribosomal protein L17 (RPL17), transcript variant 1, mRNA NM_000985 ENST00000418495 6139 NM_000985 THC2596675 [NM_000985] A_23_P411723 PLAG1 pleiomorphic adenoma gene 1 (PLAG1), transcript variant 1, NM_002655 ENST00000316981 5324 NM_002655 THC2649104 mRNA [NM_002655] A_33_P3324805 LOC100130345 PREDICTED: cadherin-related family member 3-like XM_001716484 100130345 XM_001716484 (LOC100130345), mRNA [XM_001716484] A_33_P3370521 XM_001721393 ENST00000427872 XM_001721393 THC2698492 A_23_P350059 C1orf152 chromosome 1 open reading frame 152 (C1orf152), non-coding NR_003242 767846 NR_003242 THC2476417 RNA [NR_003242] A_33_P3375934 NAMPT nicotinamide phosphoribosyltransferase (NAMPT), mRNA NM_005746 ENST00000222553 10135 NM_005746 THC2554375 [NM_005746] A_23_P502808 PRIMA1 proline rich membrane anchor 1 (PRIMA1), mRNA NM_178013 ENST00000477603 145270 NM_178013 THC2489283 [NM_178013] A_33_P3364493 A_33_P3281468 STARD9 StAR-related lipid transfer (START) domain containing 9 NM_020759 ENST00000290607 57519 NM_020759 THC2602580 (STARD9), mRNA [NM_020759] A_33_P3403082 NCRNA00176 non-protein coding RNA 176 (NCRNA00176), transcript variant NR_027686 284739 NR_027686 1, non-coding RNA [NR_027686] A_24_P290751 DTX1 deltex homolog 1 (Drosophila) (DTX1), mRNA [NM_004416] NM_004416 ENST00000547974 1840 NM_004416 THC2471651 A_32_P125549 A_33_P3408203 TGFA transforming growth factor, alpha (TGFA), transcript variant 1, NM_003236 ENST00000418333 7039 NM_003236 THC2490361 mRNA [NM_003236] A_33_P3246829 IL1RN interleukin 1 receptor antagonist (IL1RN), transcript variant 4, NM_173843 ENST00000409930 3557 NM_173843 THC2498493 mRNA [NM_173843] A_33_P3229390 A_32_P21384 RPL17 ribosomal protein L17 (RPL17), transcript variant 1, mRNA NM_000985 ENST00000418495 6139 NM_000985 THC2535265 [NM_000985] A_33_P3786807 SNAR-E UI-H-DF1-auh-i-18−0-UI.s1 NCI_CGAP_DF1 cDNA clone UI-H- CA436475 100170220 DF1-auh-i-18−0-UI 3′, mRNA sequence [CA436475] A_33_P3325843 FLJ40039 cDNA FLJ40039 fis, clone SYNOV2000397. [AK097358] AK097358 647662 THC2490969 A_23_P146325 ASAP1-IT1 ASAP1 intronic transcript 1 (non-protein coding) (ASAP1-IT1), NR_002765 29065 NR_002765 THC2490392 non-coding RNA [NR_002765] A_24_P131580 ALPPL2 alkaline phosphatase, placental-like 2 (ALPPL2), mRNA NM_031313 ENST00000295453 251 NM_031313 THC2603490 [NM_031313] A_33_P3335461 putative CHST11/IgH oncoprotein (CHST11/IgH fusion) mRNA, AY533203 THC2490416 complete cds. [AY533203] A_32_P49616 EEF1B2 eukaryotic translation elongation factor 1 beta 2 (EEF1B2), NM_001959 ENST00000392221 1933 NM_001959 THC2570764 transcript variant 1, mRNA [NM_001959] A_23_P30283 FAM174A family with sequence similarity 174, member A (FAM174A), NM_198507 ENST00000312637 345757 NM_198507 THC2464536 mRNA [NM_198507] A_23_P42144 PEX6 peroxisomal biogenesis factor 6 (PEX6), mRNA [NM_000287] NM_000287 ENST00000304611 5190 NM_000287 THC2461072 A_24_P148796 MST1 macrophage stimulating 1 (hepatocyte growth factor-like) NM_020998 ENST00000493836 4485 NM_020998 NP299055 (MST1), mRNA [NM_020998] A_24_P63136 P2RY13 purinergic receptor P2Y, G-protein coupled, 13 (P2RY13), NM_176894 ENST00000325602 53829 NM_176894 THC2474658 mRNA [NM_176894] A_32_P148122 immunoglobulin kappa variable 1D-33 [Source: HGNC BC095489 ENST00000390265 NP093301 Symbol; Acc: 5753] [ENST00000390265] A_23_P30900 Uncharacterized protein XM_003119089 ENST00000552745 XM_003119089 THC2538530 [Source: UniProtKB/TrEMBL; Acc: E7ET45] [ENST00000552745] A_23_P302550 RGS18 regulator of G-protein signaling 18 (RGS18), mRNA NM_130782 ENST00000367460 64407 NM_130782 THC2474032 [NM_130782] A_24_P75680 SLC4A8 solute carrier family 4, sodium bicarbonate cotransporter, NM_004858 ENST00000546663 9498 NM_004858 THC2617779 member 8 (SLC4A8), transcript variant 2, mRNA [NM_004858] A_33_P3381851 KRTAP10-10 keratin associated protein 10-10 (KRTAP10-10), mRNA NM_181688 ENST00000380095 353333 NM_181688 NP883181 [NM_181688] A_23_P2582 HDAC7 histone deacetylase 7 (HDAC7), transcript variant 1, mRNA NM_015401 ENST00000459625 51564 NM_015401 THC2506329 [NM_015401] A_23_P414978 NUDT14 nudix (nucleoside diphosphate linked moiety X)-type motif 14 NM_177533 ENST00000339418 256281 NM_177533 THC2529116 (NUDT14), mRNA [NM_177533] A_23_P251937 CPEB4 cytoplasmic polyadenylation element binding protein 4 NM_030627 ENST00000334035 80315 NM_030627 THC2503739 (CPEB4), mRNA [NM_030627] A_32_P38467 SNHG8 small nucleolar RNA host gene 8 (non-protein coding) (SNHG8), NR_003584 100093630 NR_003584 THC2722842 transcript variant 1, non-coding RNA [NR_003584] A_23_P114839 FHL3 four and a half LIM domains 3 (FHL3), mRNA [NM_004468] NM_004468 ENST00000477194 2275 NM_004468 THC2657002 A_33_P3261433 LOC100131473 PREDICTED: hypothetical protein LOC100131473 XM_001720331 100131473 XM_001720331 THC2660992 (LOC100131473), mRNA [XM_001720331] A_33_P3299487 AIM1L absent in melanoma 1-like (AIM1L), mRNA [NM_001039775] NM_001039775 ENST00000374207 55057 NM_001039775 THC2773713 A_23_P74668 C1orf158 chromosome 1 open reading frame 158 (C1orf158), mRNA NM_152290 ENST00000376210 93190 NM_152290 NP1155029 [NM_152290] A_24_P97342 PROK2 prokineticin 2 (PROK2), transcript variant 2, mRNA NM_021935 ENST00000353065 60675 NM_021935 THC2479819 [NM_021935] A_23_P396299 LOC100129827 hypothetical LOC100129827 (LOC100129827), non-coding RNA NR_034094 ENST00000529979 100129827 NR_034094 THC2480303 [NR_034094] A_33_P3724155 DERL3 Der1-like domain family, member 3 (DERL3), transcript variant NM_198440 ENST00000290730 91319 NM_198440 THC2488725 3, mRNA [NM_198440] A_33_P3251412 A_33_P3359856 MZT2A mitotic spindle organizing protein 2A [Source: HGNC ENST00000445782 653784 THC2544251 Symbol; Acc: 33187] [ENST00000445782] A_33_P3419691 GATS GATS, stromal antigen 3 opposite strand (GATS), transcript NR_028038 352954 NR_028038 THC2463982 variant 2, non-coding RNA [NR_028038] A_33_P3291821 ANKRD26P1 ankyrin repeat domain 26 pseudogene 1 (ANKRD26P1), non- NR_026556 ENST00000329373 124149 NR_026556 THC2621756 coding RNA [NR_026556] A_33_P3226788 A_33_P3494109 LOC146795 cDNA F1132815 fis, clone TESTI2002840. [AK057377] AK057377 146795 A_33_P3376644 SENP6 SUMO1/sentrin specific peptidase 6 (SENP6), transcript variant NM_015571 ENST00000447266 26054 NM_015571 THC2650795 1, mRNA [NM_015571] A_33_P3424057 PEG3 paternally expressed 3 (PEG3), transcript variant 1, mRNA NM_006210 ENST00000326441 5178 NM_006210 THC2462814 [NM_006210] A_33_P3714341 IGK mRNA for immunoglobulin kappa light chain, partial cds, AB363267 clone: F010−014L. [AB363267] A_33_P3285092 LOC100129763 cDNA FLJ44135 fis, clone THYMU2009134. [AK126123] AK126123 100129763 THC2486333 A_33_P3691916 FAM13A family with sequence similarity 13, member A (FAM13A), NM_014883 ENST00000264344 10144 NM_014883 THC2510194 transcript variant 1, mRNA [NM_014883] A_24_P461497 A_24_P400832 LOC100130950 hypothetical LOC100130950 (LOC100130950), non-coding RNA NR_034082 100130950 NR_034082 THC2632507 [NR_034082] A_33_P3336696 ND4L mitochondrially encoded NADH dehydrogenase 4L AK311996 ENST00000361335 4539 THC2595339 [Source: HGNC Symbol; Acc: 7460] [ENST00000361335] A_33_P3320538 NUPL1 nucleoporin like 1 [Source: HGNC Symbol; Acc: 20261] CR605945 ENST00000381745 9818 THC2526330 [ENST00000381745] A_24_P29001 LSM3 LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) NM_014463 ENST00000306024 27258 NM_014463 THC2466049 (LSM3), mRNA [NM_014463] A_23_P151506 PLEK2 pleckstrin 2 (PLEK2), mRNA [NM_016445] NM_016445 ENST00000216446 26499 NM_016445 THC2462892 A_23_P258381 SPSB4 splA/ryanodine receptor domain and SOCS box containing 4 NM_080862 ENST00000508126 92369 NM_080862 THC2632742 (SPSB4), mRNA [NM_080862] A_33_P3370930 LAMB1 laminin, beta 1 [Source: HGNC Symbol; Acc: 6486] ENST00000393559 3912 THC2637518 [ENST00000393559] A_33_P3209321 LOC729558 cDNA FLJ39676 fis, clone SMINT2009832. [AK096995] AK096995 729558 THC2616799 A_23_P200298 AGL amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase NM_000028 ENST00000294724 178 NM_000028 THC2461565 (AGL), transcript variant 4, mRNA [NM_000028] A_33_P3424489 immunoglobulin lambda variable 3-25 [Source: HGNC S73129 ENST00000390305 NP084490 Symbol; Acc: 5908] [ENST00000390305] A_33_P3317258 T cell receptor gamma variable 5 [Source: HGNC X15019 ENST00000390344 THC2556814 Symbol; Acc: 12290] [ENST00000390344] A_33_P3405213 PECAM1 platelet/endothelial cell adhesion molecule (PECAM1), mRNA NM_000442 ENST00000545548 5175 NM_000442 THC2557337 [NM_000442] A_33_P3220612 FAM89B family with sequence similarity 89, member B (FAM89B), NM_001098784 ENST00000377088 23625 NM_001098784 THC2494467 transcript variant 3, mRNA [NM_001098784] A_33_P3230259 NCAPH non-SMC condensin I complex, subunit H (NCAPH), mRNA NM_015341 23397 NM_015341 THC2461132 [NM_015341] A_33_P3308434 MORN1 MORN repeat containing 1 (MORN1), mRNA [NM_024848] NM_024848 ENST00000378525 79906 NM_024848 THC2519762 A_33_P3424217 major histocompatibility complex, class II, DQ beta 1 XM_003119092 ENST00000399670 XM_003119092 THC2560922 [Source: HGNC Symbol; Acc: 4944] [ENST00000399670] A_33_P3218120 LOC402036 PREDICTED: hCG1646661-like (LOC402036), mRNA XM_001719325 402036 XM_001719325 [XM_001719325] A_23_P50508 PLA2G4C phospholipase A2, group IVC (cytosolic, calcium-independent) NM_003706 ENST00000354276 8605 NM_003706 NP1152204 (PLA2G4C), transcript variant 1, mRNA [NM_003706] A_23_P76951 TMX1 thioredoxin-related transmembrane protein 1 (TMX1), mRNA NM_030755 ENST00000457354 81542 NM_030755 THC2466402 [NM_030755] A_23_P1206 RPS24 ribosomal protein S24 (RPS24), transcript variant c, mRNA NM_001026 ENST00000467106 6229 NM_001026 THC2572247 [NM_001026] A_33_P3250148 SP8 Sp8 transcription factor (SP8), transcript variant 2, mRNA NM_198956 ENST00000297210 221833 NM_198956 THC2481338 [NM_198956] A_23_P16415 LRP3 low density lipoprotein receptor-related protein 3 (LRP3), NM_002333 ENST00000431491 4037 NM_002333 THC2461289 mRNA [NM_002333] A_23_P98580 FADS2 fatty acid desaturase 2 (FADS2), mRNA [NM_004265] NM_004265 ENST00000523235 9415 NM_004265 THC2512429 A_23_P21800 immunoglobulin kappa variable 3-20 [Source: HGNC DQ187531 ENST00000492167 NP511624 Symbol; Acc: 5817] [ENST00000492167] A_33_P3373185 LOC399744 hypothetical LOC399744 (LOC399744), non-coding RNA NR_024497 ENST00000438516 399744 NR_024497 THC2594684 [NR_024497] A_24_P813550 immunoglobulin heavy variable 4-59 [Source: HGNC XM_003119589 ENST00000390629 XM_003119589 NP1077996 Symbol; Acc: 5654] [ENST00000390629] A_33_P3374253 PREDICTED: similar to hCG1645807 (LOC100127987), mRNA XM_001717762 XM_001717762 [XM_001717762] A_23_P75800 RAB3IL1 RAB3A interacting protein (rabin3)-like 1 (RAB3IL1), mRNA NM_013401 ENST00000394836 5866 NM_013401 THC2472895 [NM_013401] A_24_P38572 NOL6 nucleolar protein family 6 (RNA-associated) (NOL6), transcript NM_022917 ENST00000325914 65083 NM_022917 NP287178 variant alpha, mRNA [NM_022917] A_23_P134744 RNF122 ring finger protein 122 (RNF122), mRNA [NM_024787] NM_024787 ENST00000256257 79845 NM_024787 THC2476886 A_24_P152325 A_33_P3331882 CRTC1 CREB regulated transcription coactivator 1 (CRTC1), transcript NM_001098482 ENST00000262813 23373 NM_001098482 THC2472431 variant 3, mRNA [NM_001098482] A_33_P3361991 OR9A2 olfactory receptor, family 9, subfamily A, member 2 (OR9A2), NM_001001658 ENST00000350513 135924 NM_001001658 THC2603293 mRNA [NM_001001658] A_24_P917866 SET SET nuclear oncogene (SET), transcript variant 2, mRNA NM_003011 ENST00000322030 6418 NM_003011 THC2465434 [NM_003011] A_32_P224234 LOC645195 cDNA FLJ41456 fis, clone BRSTN2012320. [AK123450] AK123450 645195 THC2479813 A_23_P161968 SLC22A10 solute carrier family 22, member 10 (SLC22A10), mRNA NM_001039752 ENST00000332793 387775 NM_001039752 THC2480380 [NM_001039752] A_33_P3332135 PHOSPHO1 phosphatase, orphan 1 (PHOSPHO1), transcript variant 1, NM_001143804 ENST00000413580 162466 NM_001143804 THC2478263 mRNA [NM_001143804] A_23_P60227 CCIN calicin (CCIN), mRNA [NM_005893] NM_005893 ENST00000335119 881 NM_005893 THC2461601 A_23_P159650 COX7B cytochrome c oxidase subunit VIIb (COX7B), nuclear gene NM_001866 ENST00000373335 1349 NM_001866 THC2693234 encoding mitochondrial protein, mRNA [NM_001866] A_33_P3306352 C20orf108 chromosome 20 open reading frame 108 [Source: HGNC ENST00000437418 116151 THC2691510 Symbol; Acc: 16102] [ENST00000437418] A_33_P3395859 LOC147646 hypothetical protein LOC147646 (LOC147646), mRNA NM_001193623 147646 NM_001193623 THC2602398 [NM_001193623] A_33_P3232798 RAB11FIP1 RAB11 family interacting protein 1 (class I) (RAB11FIP1), NM_025151 ENST00000343853 80223 NM_025151 THC2751555 transcript variant 1, mRNA [NM_025151] A_33_P3386487 A_33_P3245620 A_24_P161144 ZNF843 zinc finger protein 843 (ZNF843), mRNA [NM_001136509] NM_001136509 283933 NM_001136509 THC2483860 A_33_P3314176 FAM46C family with sequence similarity 46, member C (FAM46C), NM_017709 ENST00000369448 54855 NM_017709 THC2496506 mRNA [NM_017709] A_33_P3258593 PRB1 proline-rich protein BstNI subfamily 1 (PRB1), transcript variant NM_005039 ENST00000240636 5542 NM_005039 THC2476439 1, mRNA [NM_005039] A_24_P375849 Q8BT90_MOUSE (Q8B190) 10, 11 days embryo whole body THC2555910 cDNA, RIKEN full-length enriched library, clone: 2810021H19 product: ribosomal protein S17, full insert sequence. (Fragment), partial (98%) [THC2555910] A_33_P3290235 LOC149950 hypothetical LOC149950 (LOC149950), non-coding RNA NR_034152 ENST00000375671 149950 NR_034152 THC2488463 [NR_034152] A_33_P3216448 COL11A2 collagen, type XI, alpha 2 (COL11A2), transcript variant 4, NM_001163771 ENST00000383088 1302 NM_001163771 THC2481257 mRNA [NM_001163771] A_23_P103690 FAM189B family with sequence similarity 189, member B (FAM189B), NM_006589 ENST00000487649 10712 NM_006589 NP1167666 transcript variant 1, mRNA [NM_006589] A_24_P303647 C7orf60 chromosome 7 open reading frame 60 (C7orf60), mRNA NM_152556 ENST00000297145 154743 NM_152556 THC2610927 [NM_152556] A_23_P209269 PPM1B protein phosphatase, Mg2+/Mn2+ dependent, 1B (PPM1B), NM_001033557 ENST00000409432 5495 NM_001033557 THC2491147 transcript variant 5, mRNA [NM_001033557] A_33_P3362933 GYPA glycophorin A (MNS blood group) (GYPA), mRNA [NM_002099] NM_002099 ENST00000508337 2993 NM_002099 NP082322 A_33_P3327663 SUSD4 sushi domain containing 4 [Source: HGNC Symbol; Acc: 25470] ENST00000366877 55061 THC2679732 [ENST00000366877] A_24_P166094 ARFIP1 ADP-ribosylation factor interacting protein 1 (ARFIP1), NM_001025595 ENST00000353617 27236 NM_001025595 THC2462556 transcript variant 1, mRNA [NM_001025595] A_33_P3351052 POU3F1 POU class 3 homeobox 1 (POU3F1), mRNA [NM_002699] NM_002699 ENST00000373012 5453 NM_002699 THC2498352 A_32_P58074 RPS3A ribosomal protein S3A (RPS3A), mRNA [NM_001006] NM_001006 ENST00000515818 6189 NM_001006 THC2559600 A_24_P48539 SIGLEC5 sialic acid binding Ig-like lectin 5 (SIGLEC5), mRNA NM_003830 ENST00000429354 8778 NM_003830 THC2472472 [NM_003830] A_33_P3222744 ZNF117 zinc finger protein 117 (ZNF117), mRNA [NM_015852] NM_015852 51351 NM_015852 THC2518471 A_33_P3210363 LOC100128191 hypothetical LOC100128191 (LOC100128191), non-coding RNA NR_027157 100128191 NR_027157 THC2492437 [NR_027157] A_23_P170901 PACRG PARK2 co-regulated (PACRG), transcript variant 1, mRNA NM_152410 ENST00000545186 135138 NM_152410 THC2691532 [NM_152410] A_24_P15502 A_33_P3570228 LOC644962 cDNA FLJ46065 fis, clone TBAES2007862. [AK127954] AK127954 644962 THC2485964 A_33_P3406873 NFASC neurofascin (NFASC), transcript variant 5, mRNA NM_001005389 ENST00000403080 23114 NM_001005389 NP1247431 [NM_001005389] A_33_P3291484 ST8SIA4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 NM_005668 7903 NM_005668 THC2531659 (ST8SIA4), transcript variant 1, mRNA [NM_005668] A_33_P3403851 O52K2_HUMAN (Q8NGK3) Olfactory receptor 52K2, partial THC2647746 (29%) [THC2647746] A_23_P61042 immunoglobulin heavy constant alpha 2 (A2m marker) XR_111480 ENST00000390539 XR_111480 NP1154471 [Source: HGNC Symbol; Acc: 5479] [ENST00000390539] A_33_P3214635 FECH ferrochelatase (FECH), nuclear gene encoding mitochondrial NM_001012515 ENST00000262093 2235 NM_001012515 THC2650625 protein, transcript variant 1, mRNA [NM_001012515] A_23_P132139 C21orf58 chromosome 21 open reading frame 58 (C21orf58), mRNA NM_058180 ENST00000417060 54058 NM_058180 THC2482412 [NM_058180] A_33_P3305790 NOS3 nitric oxide synthase 3 (endothelial cell) (NOS3), transcript NM_000603 ENST00000461406 4846 NM_000603 THC2520376 variant 1, mRNA [NM_000603] A_24_P335620 SLC7A5 solute carrier family 7 (amino acid transporter light chain, L NM_003486 ENST00000261622 8140 NM_003486 THC2545199 system), member 5 (SLC7A5), mRNA [NM_003486] A_24_P383999 RPS3A ribosomal protein S3A (RPS3A), mRNA [NM_001006] NM_001006 ENST00000515818 6189 NM_001006 THC2559600 A_24_P31275 ATP1B2 ATPase, Na+/K+ transporting, beta 2 polypeptide (ATP1B2), NM_001678 ENST00000250111 482 NM_001678 THC2559283 mRNA [NM_001678] A_33_P3389342 ARID5A AT rich interactive domain 5A (MRF1-like) (ARID5A), mRNA NM_212481 ENST00000359765 10865 NM_212481 THC2627646 [NM_212481] A_24_P349636 A_33_P3386132 C2orf49 chromosome 2 open reading frame 49 [Source: HGNC AK304268 ENST00000437250 79074 THC2507880 Symbol; Acc: 28772] [ENST00000437250] A_33_P3261074 A_24_P371053 ORMDL1 ORM1-like 1 (S. cerevisiae) (ORMDL1), transcript variant 1, NM_016467 ENST00000325795 94101 NM_016467 THC2466861 mRNA [NM_016467] A_23_P62115 TIMP1 TIMP metallopeptidase inhibitor 1 (TIMP1), mRNA NM_003254 ENST00000218388 7076 NM_003254 NP1132335 [NM_003254] A_23_P350719 PRSS30P protease, serine, 30 homolog (mouse), pseudogene (PRSS30P), NR_026864 ENST00000390681 124221 NR_026864 THC2484024 non-coding RNA [NR_026864] A_24_P104512 EVPL envoplakin (EVPL), mRNA [NM_001988] NM_001988 ENST00000301607 2125 NM_001988 THC2471184 A_23_P202034 GUCY2GP guanylate cyclase 2G homolog (mouse), pseudogene NR_028134 ENST00000490269 390003 NR_028134 THC2662526 (GUCY2GP), non-coding RNA [NR_028134] A_33_P3589819 LOC100507637 cDNA: FLJ22849 fis, clone KAIA987. [AK026502] AK026502 100507637 THC2515177 A_33_P3495962 SNORA71A AGENCOURT_6611325 NIH_MGC_106 cDNA clone BM918074 26777 IMAGE: 5485440 5′, mRNA sequence [BM918074] A_33_P3416622 NCRNA00322 PREDICTED: chromosome 21 open reading frame 136 XR_109689 100126693 XR_109689 THC2482602 (C21orf136), miscRNA [XR_109689] A_24_P358245 ATP8B5P ATPase, class I, type 8B, member 5, pseudogene (ATP8B5P), NR_003582 ENST00000430846 158381 NR_003582 THC2536226 transcript variant 2, non-coding RNA [NR_003582] A_23_P8900 COX6C cytochrome c oxidase subunit VIc (COX6C), nuclear gene NM_004374 ENST00000522940 1345 NM_004374 THC2509868 encoding mitochondrial protein, mRNA [NM_004374] A_33_P3391536 A_23_P55616 SLC14A1 solute carrier family 14 (urea transporter), member 1 (Kidd NM_001146037 ENST00000321925 6563 NM_001146037 THC2629557 blood group) (SLC14A1), transcript variant 4, mRNA [NM_001146037] A_33_P3292241 A_33_P3224020 ARAF2P v-raf murine sarcoma 3611 viral oncogene homolog BC033982 644000 THC2605425 pseudogene, mRNA (cDNA clone IMAGE: 5295529). [BC033982] A_33_P3387696 TMBIM4 transmembrane BAX inhibitor motif containing 4 (TMBIM4), NM_016056 ENST00000358230 51643 NM_016056 THC2544517 mRNA [NM_016056] A_33_P3238215 COBLL1 COBL-like 1 (COBLL1), mRNA [NM_014900] NM_014900 ENST00000493868 22837 NM_014900 THC2566941 A_23_P163025 RNASE3 ribonuclease, RNase A family, 3 (RNASE3), mRNA [NM_002935] NM_002935 ENST00000304639 6037 NM_002935 THC2477182 A_24_P173566 immunoglobulin lambda variable 3-1 [Source: HGNC X57818 ENST00000390319 NP1458222 Symbol; Acc: 5896] [ENST00000390319] A_24_P11436 TTC22 tetratricopeptide repeat domain 22 (TTC22), transcript variant NM_017904 ENST00000488771 55001 NM_017904 THC2655240 2, mRNA [NM_017904] A_33_P3253672 KCNH3 potassium voltage-gated channel, subfamily H (eag-related), NM_012284 ENST00000257981 23416 NM_012284 member 3 (KCNH3), mRNA [NM_012284] A_32_P128701 USP53 ubiquitin specific peptidase 53 (USP53), mRNA [NM_019050] NM_019050 ENST00000450251 54532 NM_019050 THC2516580 A_33_P3267640 HGFAC HGF activator (HGFAC), mRNA [NM_001528] NM_001528 ENST00000382774 3083 NM_001528 THC2478808 A_23_P63751 PRDX3 peroxiredoxin 3 (PRDX3), nuclear gene encoding mitochondrial NM_006793 ENST00000298510 10935 NM_006793 THC2782087 protein, transcript variant 1, mRNA [NM_006793] A_23_P79094 LILRA3 leukocyte immunoglobulin-like receptor, subfamily A (without NM_006865 ENST00000251390 11026 NM_006865 NP081039 TM domain), member 3 (LILRA3), transcript variant 1, mRNA [NM_006865] A_33_P3262156 SLC8A1 solute carrier family 8 (sodium/calcium exchanger), member 1 NM_021097 ENST00000403092 6546 NM_021097 THC2483436 (SLC8A1), transcript variant A, mRNA [NM_021097] A_33_P3216532 EPHB4 EPH receptor B4 (EPHB4), mRNA [NM_004444] NM_004444 ENST00000487222 2050 NM_004444 NP1473086 A_24_P287043 IFITM2 interferon induced transmembrane protein 2 (1-8D) (IFITM2), NM_006435 ENST00000527146 10581 NM_006435 THC2548091 mRNA [NM_006435] A_23_P421032 SEC14L4 SEC14-like 4 (S. cerevisiae) (SEC14L4), transcript variant 1, NM_174977 ENST00000320982 284904 NM_174977 THC2478128 mRNA [NM_174977] A_33_P3208970 ZNF683 zinc finger protein 683 (ZNF683), transcript variant 1, mRNA NM_001114759 ENST00000349618 257101 NM_001114759 THC2475548 [NM_001114759] A_23_P394605 SEC24A 5EC24 family, member A (S. cerevisiae) (SEC24A), mRNA NM_021982 ENST00000398844 10802 NM_021982 THC2493017 [NM_021982] A_32_P112910 UBL4B ubiquitin-like 4B (UBL4B), mRNA [NM_203412] NM_203412 ENST00000334179 164153 NM_203412 THC2477239 A_33_P3228642 ZNF584 zinc finger protein 584 [Source: HGNC Symbol; Acc: 27318] AK298929 ENST00000322834 201514 THC2518340 [ENST00000322834] A_32_P40547 MEG3 maternally expressed 3 (non-protein coding) (MEG3), transcript NR_002766 ENST00000452514 55384 NR_002766 THC2722032 variant 1, non-coding RNA [NR_002766] A_24_P295543 BLOC1S2 biogenesis of lysosomal organelles complex-1, subunit 2 NM_001001342 ENST00000370372 282991 NM_001001342 THC2467480 (BLOC1S2), transcript variant 2, mRNA [NM_001001342] A_33_P3324949 C3orf65 chromosome 3 open reading frame 65 (C3orf65), non-coding NR_027317 ENST00000296270 646600 NR_027317 THC2484692 RNA [NR_027317] A_23_P9485 ORM2 orosomucoid 2 (ORM2), mRNA [NM_000608] NM_000608 ENST00000412657 5005 NM_000608 THC2562815 A_33_P3310784 TM6SF1 transmembrane 6 superfamily member 1 (TM6SF1), transcript NM_023003 ENST00000379386 53346 NM_023003 THC2478123 variant 1, mRNA [NM_023003] A_23_P78595 CEACAM21 carcinoembryonic antigen-related cell adhesion molecule 21 NM_033543 ENST00000401445 90273 NM_033543 THC2603785 (CEACAM21), transcript variant 2, mRNA [NM_033543] A_33_P3274691 LOC619207 scavenger receptor protein family member (LOC619207), non- NR_002934 ENST00000356567 619207 NR_002934 NP1076594 coding RNA [NR_002934] A_33_P3406281 SAMHD1 SAM domain and HD domain 1 (SAMHD1), mRNA NM_015474 ENST00000262878 25939 NM_015474 [NM_015474] A_24_P52921 BCAT1 branched chain amino-acid transaminase 1, cytosolic (BCAT1), NM_005504 ENST00000544418 586 NM_005504 THC2739017 transcript variant 1, mRNA [NM_005504] A_33_P3265941 A_33_P3347772 2-Sep septin 2 [Source: HGNC Symbol; Acc: 7729] [ENST00000473479] AK025163 ENST00000473479 4735 THC2514366 A_33_P3326892 cDNA FLJ26718 fis, clone PNC03325 AK130228 ENST00000398957 NP852683 [Source: UniProtKB/TrEMBL; Acc: Q6ZP17] [ENST00000398957] A_33_P3289396 LOC729737 hypothetical LOC729737 (LOC729737), non-coding RNA NR_039983 ENST00000438516 729737 NR_039983 THC2577343 [NR_039983] A_24_P50437 cDNA clone IMAGE: 30404477, partial cds. [BC065737] BC065737 A_33_P3396010 AGER advanced glycosylation end product-specific receptor (AGER), NM_001206966 ENST00000438221 177 NM_001206966 NP868672 transcript variant 9, mRNA [NM_001206966] A_33_P3410279 DOCK9 dedicator of cytokinesis 9 [Source: HGNC Symbol; Acc: 14132] AK090793 ENST00000340449 23348 THC2485517 [ENST00000340449] A_33_P3294252 ATF1 activating transcription factor 1 (ATF1), mRNA [NM_005171] NM_005171 ENST00000262053 466 NM_005171 THC2552669 A_32_P86150 CTRB2 chymotrypsinogen B2 (CTRB2), mRNA [NM_001025200] NM_001025200 ENST00000303037 440387 NM_001025200 THC2562346 A_23_P159937 SLC6A8 solute carrier family 6 (neurotransmitter transporter, creatine), NM_005629 ENST00000253122 6535 NM_005629 THC2469137 member 8 (SLC6A8), transcript variant 1, mRNA [NM_005629] A_33_P3270346 KIR2DL5A killer cell immunoglobulin-like receptor, two domains, long NM_020535 ENST00000391731 57292 NM_020535 THC2489091 cytoplasmic tail, 5A (KIR2DL5A), mRNA [NM_020535] A_24_P38702 NKX2-3 NK2 homeobox 3 (NKX2-3), mRNA [NM_145285] NM_145285 ENST00000344586 159296 NM_145285 NP1246719 A_23_P7172 PGM2 phosphoglucomutase 2 (PGM2), mRNA [NM_018290] NM_018290 ENST00000512556 55276 NM_018290 THC2466583 A_33_P3351062 A_33_P3395743 VWA1 von Willebrand factor A domain containing 1 (VWA1), NM_022834 ENST00000476993 64856 NM_022834 THC2469429 transcript variant 1, mRNA [NM_022834] A_24_P148907 MAB21L2 mab-21-like 2 (C. elegans) (MAB21L2), mRNA [NM_006439] NM_006439 ENST00000317605 10586 NM_006439 THC2472779 A_33_P3401711 USH1G Usher syndrome 1G (autosomal recessive) (USH1G), mRNA NM_173477 ENST00000319642 124590 NM_173477 [NM_173477] A_33_P3401169 T cell receptor beta variable 21/OR9-2 (non-functional) ENST00000331828 THC2565247 [Source: HGNC Symbol; Acc: 12199] [ENST00000331828] A_32_P202859 H1FNT H1 histone family, member N, testis-specific (H1FNT), mRNA NM_181788 ENST00000335017 341567 NM_181788 THC2475276 [NM_181788] A_23_P168229 TXNDC5 thioredoxin domain containing 5 (endoplasmic reticulum) NM_030810 ENST00000439343 81567 NM_030810 THC2483613 (TXNDC5), transcript variant 1, mRNA [NM_030810] A_33_P3382887 A_23_P377882 KCNH2 potassium voltage-gated channel, subfamily H (eag-related), NM_172056 ENST00000430723 3757 NM_172056 THC2730451 member 2 (KCNH2), transcript variant 2, mRNA [NM_172056] A_24_P854492 MIAT myocardial infarction associated transcript (non-protein NR_003491 440823 NR_003491 THC2574058 coding) (MIAT), transcript variant 1, non-coding RNA [NR_003491] A_33_P3399468 cDNA, FLJ18157. [AK311115] AK311115 A_23_P335039 ZNF721 zinc finger protein 721 (ZNF721), mRNA [NM_133474] NM_133474 ENST00000338977 170960 NM_133474 THC2491441 A_33_P3393170 CAPN5 calpain 5 (CAPN5), mRNA [NM_004055] NM_004055 ENST00000360841 726 NM_004055 THC2669168 A_23_P19510 HLA-DQB2 major histocompatibility complex, class II, DQ beta 2 (HLA- NM_001198858 ENST00000416131 3120 NM_001198858 THC2477776 DQB2), mRNA [NM_001198858] A_23_P218126 immunoglobulin heavy constant gamma 1 (G1m marker) BC024289 ENST00000390549 NP852618 [Source: HGNC Symbol; Acc: 5525] [ENST00000390549] A_33_P3367701 TMEM164 transmembrane protein 164 (TMEM164), transcript variant 2, NM_032227 ENST00000288381 84187 NM_032227 THC2483947 mRNA [NM_032227] A_23_P43946 SARNP SAP domain containing ribonucleoprotein (SARNP), transcript NM_033082 ENST00000336133 84324 NM_033082 THC2468200 variant 1, mRNA [NM_033082] A_23_P143958 RPL22L1 ribosomal protein L22-like 1 (RPL22L1), mRNA NM_001099645 ENST00000494771 200916 NM_001099645 THC2463114 [NM_001099645] A_24_P95723 KIAA0125 KIAA0125 (KIAA0125), non-coding RNA [NR_026800] NR_026800 9834 NR_026800 THC2657912 A_33_P3360886 GRP33_ARTSA (P13230) Glycine-rich protein GRP33, partial THC2642603 (8%) [THC2642603] A_32_P114215 COMMD6 COMM domain containing 6 (COMMD6), transcript variant 1, NM_203497 ENST00000483290 170622 NM_203497 NP1189257 mRNA [NM_203497] A_33_P3291891 LOC100130825 PREDICTED: hypothetical protein LOC100130825 XM_001720026 100130825 XM_001720026 (LOC100130825), mRNA [XM_001720026] A_24_P382579 OXT oxytocin, prepropeptide (OXT), mRNA [NM_000915] NM_000915 ENST00000217386 5020 NM_000915 THC2480057 A_23_P127446 DPF2 D4, zinc and double PHD fingers family 2 (DPF2), mRNA NM_006268 ENST00000532052 5977 NM_006268 THC2604046 [NM_006268] A_33_P3409518 TUBBP5 tubulin, beta pseudogene 5 (TUBBP5), non-coding RNA NR_027156 643224 NR_027156 THC2493332 [NR_027156] A_33_P3352103 LYPLAL1 lysophospholipase-like 1 (LYPLAL1), mRNA [NM_138794] NM_138794 ENST00000366927 127018 NM_138794 THC2613276 A_23_P434518 LFNG LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase NM_001040168 ENST00000359574 3955 NM_001040168 THC2486300 (LFNG), transcript variant 2, mRNA [NM_001040168] A_23_P379630 SLC38A10 solute carrier family 38, member 10 (SLC38A10), transcript NM_138570 ENST00000288439 124565 NM_138570 THC2464913 variant 2, mRNA [NM_138570] A_24_P148235 RPS27 ribosomal protein S27 (RPS27), mRNA [NM_001030] NM_001030 ENST00000392558 6232 NM_001030 THC2596064 A_23_P253012 GRAMD1C GRAM domain containing 1C (GRAMD1C), transcript variant 1, NM_017577 ENST00000440446 54762 NM_017577 THC2614903 mRNA [NM_017577] A_24_P295999 CD4 CD4 molecule (CD4), transcript variant 1, mRNA [NM_000616] NM_000616 ENST00000011653 920 NM_000616 THC2470142 A_33_P3369245 LOC100129826 PREDICTED: hypothetical LOC100129826 (LOC100129826), XR_114456 100129826 XR_114456 THC2479538 miscRNA [XR_114456] A_33_P3235132 LOC400968 cDNA FLJ45884 fis, clone OCBBF3021166. [AK127783] AK127783 ENST00000412149 400968 THC2481983 A_24_P375599 A_33_P3220160 RAC2 cDNA FLJ39605 fis, clone SKNSH2005981, weakly similar to RAS- AK096924 ENST00000401529 5880 THC2510406 RELATED C3 BOTULINUM TOXIN SUBSTRATE 2. [AK096924] A_32_P220750 PLGLB1 plasminogen-like B1 (PLGLB1), mRNA [NM_001032392] NM_001032392 ENST00000324709 5343 NM_001032392 THC2555295 A_33_P3376958 LOC96610 BMS1 homolog, ribosome assembly protein (yeast) NR_027293 ENST00000390290 96610 NR_027293 NP162580 pseudogene (LOC96610), non-coding RNA [NR_027293] A_23_P410965 KIAA1522 KIAA1522 (KIAA1522), transcript variant 1, mRNA NM_020888 ENST00000401073 57648 NM_020888 THC2578126 [NM_020888] A_33_P3272479 NPM2 nucleophosmin/nucleoplasmin 2 (NPM2), mRNA [NM_182795] NM_182795 ENST00000520180 10361 NM_182795 NP1074998 A_33_P3379535 cDNA FLJ45698 fis, clone FEBRA2017811. [AK127601] AK127601 NP851257 A_23_P325726 ACOT11 acyl-CoA thioesterase 11 (ACOT11), transcript variant 1, mRNA NM_015547 ENST00000481208 26027 NM_015547 THC2707621 [NM_015547] A_33_P3298159 PTGDS prostaglandin D2 synthase 21 kDa (brain) (PTGDS), mRNA NM_000954 ENST00000224167 5730 NM_000954 THC2470120 [NM_000954] A_23_P33045 RPL26 ribosomal protein L26 (RPL26), mRNA [NM_000987] NM_000987 ENST00000293842 6154 NM_000987 THC2561695 A_33_P3399634 RASSF10 Ras association (RalGDS/AF-6) domain family (N-terminal) NM_001080521 644943 NM_001080521 member 10 (RASSF10), mRNA [NM_001080521] A_33_P3239347 NKX3-1 NK3 homeobox 1 (NKX3-1), mRNA [NM_006167] NM_006167 ENST00000380871 4824 NM_006167 THC2607070 A_33_P3411985 RABGAP1 RAB GTPase activating protein 1 [Source: HGNC ENST00000402311 23637 THC2679929 Symbol; Acc: 17155] [ENST00000402311] A_33_P3351180 immunoglobulin heavy constant alpha 1 [Source: HGNC XR_114797 ENST00000390547 XR_114797 NP852642 Symbol; Acc: 5478] [ENST00000390547] A_33_P3430391 LOC389273 cDNA FLJ27351 fis, clone TST05050. [AK130861] AK130861 ENST00000506021 389273 NP1157119 A_23_P126613 AQP10 aquaporin 10 (AQP10), mRNA [NM_080429] NM_080429 ENST00000484864 89872 NM_080429 THC2480695 A_24_P215804 CKLF chemokine-like factor (CKLF), transcript variant 1, mRNA NM_016951 ENST00000264001 51192 NM_016951 THC2503188 [NM_016951] A_33_P3257943 RPL26 ribosomal protein L26 (RPL26), mRNA [NM_000987] NM_000987 ENST00000293842 6154 NM_000987 THC2570124 A_33_P3267263 RNU1-5 RNA, U1 small nuclear 5 (RNU1-5), small nuclear RNA NR_004400 26863 NR_004400 THC2542861 [NR_004400] A_33_P3240512 KCTD12 potassium channel tetramerisation domain containing 12 NM_138444 ENST00000377474 115207 NM_138444 THC2567965 (KCTD12), mRNA [NM_138444] A_24_P932016 HUWE1 HECT, UBA and WWE domain containing 1 (HUWE1), mRNA NM_031407 ENST00000218328 10075 NM_031407 THC2470054 [NM_031407] A_23_P426305 AOC3 amine oxidase, copper containing 3 (vascular adhesion protein NM_003734 ENST00000308423 8639 NM_003734 THC2468389 1) (AOC3), mRNA [NM_003734] A_33_P3376925 A_24_P307306 A_23_P254756 CD164 CD164 molecule, sialomucin (CD164), transcript variant 1, NM_006016 ENST00000310786 8763 NM_006016 NP088058 mRNA [NM_006016] A_32_P194821 RPL21 ribosomal protein L21 (RPL21), mRNA [NM_000982] NM_000982 ENST00000473558 6144 NM_000982 THC2553670 A_33_P3257607 PPP1R12B protein phosphatase 1, regulatory (inhibitor) subunit 12B NM_001197131 4660 NM_001197131 (PPP1R12B), transcript variant 7, mRNA [NM_001197131] A_33_P3265222 KIAA1324 KIAA1324 (KIAA1324), mRNA [NM_020775] NM_020775 ENST00000529753 57535 NM_020775 THC2629991 A_33_P3376154 LOC100130825 PREDICTED: hypothetical protein LOC100130825 XM_001720026 100130825 XM_001720026 (LOC100130825), mRNA [XM_001720026] A_23_P164927 SYNGR4 synaptogyrin 4 (SYNGR4), mRNA [NM_012451] NM_012451 ENST00000344846 23546 NM_012451 THC2478295 A_33_P3340065 A_23_P25069 XM_003119523 ENST00000542925 XM_003119523 THC2503104 A_24_P272845 DOCK3 dedicator of cytokinesis 3 (DOCK3), mRNA [NM_004947] NM_004947 ENST00000266037 1795 NM_004947 THC2472118 A_23_P140675 EPB42 erythrocyte membrane protein band 4.2 (EPB42), transcript NM_000119 ENST00000397027 2038 NM_000119 NP1465858 variant 1, mRNA [NM_000119] A_33_P3245623 TSPY17P PREDICTED: testis specific protein, Y-linked 17 (pseudogene) XM_003118834 100132124 XM_003118834 (TSPY17P), mRNA [XM_003118834] A_33_P3263538 NEAT1 Human MEN1 region clone epsilon/beta mRNA, 3′ fragment. AF001893 283131 THC2583960 [AF001893] A_24_P363548 HIP1 huntingtin interacting protein 1 (HIP1), mRNA [NM_005338] NM_005338 ENST00000336926 3092 NM_005338 THC2501285 A_33_P3302210 LOC100129129 PREDICTED: hypothetical LOC100129129 (LOC100129129), XR_113108 ENST00000525867 100129129 XR_113108 THC2610893 partial miscRNA [XR_113108] A_23_P132910 RBM47 RNA binding motif protein 47 (RBM47), transcript variant 2, NM_019027 ENST00000510871 54502 NM_019027 THC2467007 mRNA [NM_019027] A_24_P316074 A_33_P3355418 AGBL1 ATP/GTP binding protein-like 1 (AGBL1), mRNA [NM_152336] NM_152336 ENST00000389298 123624 NM_152336 A_24_P212024 immunoglobulin kappa variable 1-27 [Source: HGNC AY867113 ENST00000498435 NP1400333 Symbol; Acc: 5735] [ENST00000498435] A_33_P3305320 LOC100289383 PREDICTED: protein capicua homolog (LOC100289383), mRNA XM_002344123 100289383 XM_002344123 THC2481163 [XM_002344123] A_24_P605563 immunoglobulin lambda constant 2 (Kern-Oz- marker) AY172962 ENST00000390323 NP493030 [Source: HGNC Symbol; Acc: 5856] [ENST00000390323] A_23_P145657 STAG3 stromal antigen 3 (STAG3), mRNA [NM_012447] NM_012447 ENST00000426455 10734 NM_012447 THC2471871 A_33_P3294217 UTF1 undifferentiated embryonic cell transcription factor 1 (UTF1), NM_003577 ENST00000304477 8433 NM_003577 THC2486743 mRNA [NM_003577] A_33_P3290403 IMPA2 inositol(myo)-1(or 4)-monophosphatase 2 (IMPA2), mRNA NM_014214 ENST00000383376 3613 NM_014214 THC2664101 [NM_014214] A_33_P3379039 IGLL5 immunoglobulin lambda-like polypeptide 5 (IGLL5), transcript NM_001178126 ENST00000390321 100423062 NM_001178126 NP492959 variant 1, mRNA [NM_001178126] A_32_P205110 FOXC1 forkhead box C1 (FOXC1), mRNA [NM_001453] NM_001453 ENST00000380874 2296 NM_001453 THC2495614 A_33_P3383034 UBA2 ubiquitin-like modifier activating enzyme 2 (UBA2), mRNA NM_005499 ENST00000439527 10054 NM_005499 THC2746225 [NM_005499] A_23_P170453 CST5 cystatin D (CST5), mRNA [NM_001900] NM_001900 ENST00000304710 1473 NM_001900 THC2477887 A_33_P3320953 CTXN1 cortexin 1 (CTXN1), mRNA [NM_206833] NM_206833 ENST00000318978 404217 NM_206833 THC2471562 A_24_P886040 DCP2 DCP2 decapping enzyme homolog (S. cerevisiae) (DCP2), NM_152624 ENST00000389063 167227 NM_152624 THC2497286 transcript variant 1, mRNA [NM_152624] A_33_P3312682 REXO1 REX1, RNA exonuclease 1 homolog (S. cerevisiae) (REXO1), NM_020695 ENST00000170168 57455 NM_020695 THC2612197 mRNA [NM_020695] A_33_P3864411 ARP3 actin-related protein 3 homolog B (yeast) pseudogene 5 AY026352 ENST00000541147 THC2487688 [Source: HGNC Symbol; Acc: 38682] [ENST00000541147] A_33_P3350748 KRT7 keratin 7 (KRT7), mRNA [NM_005556] NM_005556 ENST00000422319 3855 NM_005556 THC2465320 A_23_P117363 SERPINA6 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, NM_001756 ENST00000341584 866 NM_001756 NP705151 antitrypsin), member 6 (SERPINA6), mRNA [NM_001756] A_33_P3364959 isolate N1408L immunoglobulin lambda light chain variable DQ098707 THC2524123 region (IGLV2) mRNA, IGLV2-23*02 allele, partial cds. [DQ098707] A_33_P3326285 GAS5 growth arrest-specific 5 (non-protein coding) (GAS5), non- NR_002578 60674 NR_002578 THC2570454 coding RNA [NR_002578] A_33_P3371089 SGTB small glutamine-rich tetratricopeptide repeat (TPR)-containing, NM_019072 ENST00000381007 54557 NM_019072 THC2497751 beta (SGTB), mRNA [NM_019072] A_33_P3233906 RAMP1 receptor (G protein-coupled) activity modifying protein 1 NM_005855 ENST00000254661 10267 NM_005855 THC2464432 (RAMP1), mRNA [NM_005855] A_33_P3230037 FKSG58 (FKSG58) mRNA, complete cds. [AF336885] AF336885 NP316843 A_23_P254442 LOC155060 AI894139 pseudogene (LOC155060), non-coding RNA NR_036573 ENST00000378052 155060 NR_036573 THC2518474 [NR_036573] A_33_P3325429 mRNA for T cell receptor beta variable 5, partial cds, clone: un AB306153 NP404580 66. [AB306153] A_24_P24972 ribosomal protein L22 pseudogene 11 [Source: HGNC CR590757 ENST00000538228 THC2549395 Symbol; Acc: 35603] [ENST00000538228] A_33_P3710442 FLJ11710 cDNA FLJ11710 fis, clone HEMBA1005149. [AK021772] AK021772 79904 THC2653222 A_33_P3256257 KRTAP4-7 keratin associated protein 4-7 (KRTAP4-7), mRNA NM_033061 ENST00000391417 100132476 NM_033061 THC2488799 [NM_033061] A_23_P149775 ARHGAP12 Rho GTPase activating protein 12 (ARHGAP12), mRNA NM_018287 ENST00000396144 94134 NM_018287 NP1403916 [NM_018287] A_33_P3485976 cDNA FLJ37762 fis, clone BRHIP2024347, weakly similar to AK095081 ENST00000528482 THC2629979 GALECTIN-3. [AK095081] A_33_P3397180 LOC100129324 cDNA FLJ46397 fis, clone THYMU3003958. [AK128261] AK128261 100129324 THC2484056 A_23_P21495 FCGBP Fc fragment of IgG binding protein (FCGBP), mRNA NM_003890 ENST00000221347 8857 NM_003890 THC2466782 [NM_003890] A_33_P3311267 KRTAP19-2 keratin associated protein 19-2 (KRTAP19-2), mRNA NM_181608 ENST00000334055 337969 NM_181608 THC2488580 [NM_181608] A_23_P74799 SLC25A24 solute carrier family 25 (mitochondrial carrier; phosphate NM_213651 ENST00000370041 29957 NM_213651 THC2477421 carrier), member 24 (SLC25A24), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA [NM_213651] A_33_P3368950 LOC389333 hypothetical protein LOC389333 (LOC389333), mRNA NM_001161546 ENST00000434752 389333 NM_001161546 THC2603790 [NM_001161546] A_33_P3281444 immunoglobulin kappa variable 1D-43 [Source: HGNC DQ100647 ENST00000468879 THC2561290 Symbol; Acc: 5758] [ENST00000468879] A_33_P3424507 OR51F1 olfactory receptor, family 51, subfamily F, member 1 (OR51F1), NM_001004752 ENST00000380383 256892 NM_001004752 NP1461808 mRNA [NM_001004752] A_33_P3310976 A_33_P3258316 LOC100507269 PREDICTED: hypothetical protein LOC100507269 XM_003118986 100507269 XM_003118986 THC2558116 (LOC100507269), mRNA [XM_003118986] A_23_P7827 FAM26F family with sequence similarity 26, member F (FAM26F), mRNA NM_001010919 ENST00000368605 441168 NM_001010919 THC2606591 [NM_001010919] A_33_P3336223 ALU6_HUMAN (P39193) Alu subfamily SP sequence ENST00000398067 THC2521288 contamination warning entry, partial (18%) [THC2521288] A_33_P3420852 KIRREL2 kin of IRRE like 2 (Drosophila) (KIRREL2), transcript variant 3, NM_199180 ENST00000360202 84063 NM_199180 THC2603242 mRNA [NM_199180] A_33_P3227010 A_23_P162596 ACTR6 ARP6 actin-related protein 6 homolog (yeast) (ACTR6), mRNA NM_022496 ENST00000188312 64431 NM_022496 THC2519245 [NM_022496] A_33_P3303086 HNRPLL heterogeneous nuclear ribonucleoprotein L-like (HNRPLL), NM_138394 ENST00000272249 92906 NM_138394 NP1156896 transcript variant 1, mRNA [NM_138394] A_23_P201211 FCRL5 Fc receptor-like 5 (FCRL5), transcript variant 1, mRNA NM_031281 ENST00000461387 83416 NM_031281 THC2617135 [NM_031281] A_32_P162250 ARHGAP18 Rho GTPase activating protein 18 (ARHGAP18), mRNA NM_033515 ENST00000275189 93663 NM_033515 THC2461353 [NM_033515] A_24_P174341 CCNT2 cyclin T2 (CCNT2), transcript variant b, mRNA [NM_058241] NM_058241 ENST00000419781 905 NM_058241 THC2631629 A_23_P12784 FRAT2 frequently rearranged in advanced T-cell lymphomas 2 NM_012083 ENST00000371019 23401 NM_012083 THC2618275 (FRAT2), mRNA [NM_012083]

APPENDIX C FEMALES: Technology: Agilent.SingleColor.26652 # Created On: Tue Jan 31 14:14:22 EST 2012 Entrez Genomic RefSeq- UniGene ProbeName Gene Description Gb Accession EnsemblID GeneID Gene Name Coordinates Go Accession TIGRID ID A_23_P2683 RPAP3 Homo sapiens RNA NM_024604 ENST00000380650 79657 RN chr12:4806080 GO:0005488 NM_024604 THC2462582 Hs.437855 polymerase II associated polymerase 9-48057361 protein 3 (RPAP3), II associated transcript variant 1, protein 3 mRNA [NM_024604] A_32_P14850 nuclear pore complex XM_003118720 ENST00000429990 chr16:7442543 XM_003118720 THC2549472 Hs.448833 interacting protein- 6-74425495 like 2 [Source:HGNC Symbol;Acc:34409] [ENST00000429990] A_24_P497186 IRF2BP2 Homo sapiens interferon NM_182972 ENST00000366609 359948 interferon chr1:23474003 GO:0005634|GO:004549 NM_182972 THC2501773 Hs.350268 regulatory factor 2 regulatory 1-234740001 binding protein 2 factor (IRF2BP2), transcript 2 binding variant 1, mRNA protein 2 [NM_182972] A_33_P3344292 LOC644925 full-length cDNA clone CR618938 64492b hypothetical chr14:5503385 THC2779729 Hs.632349 CS0DI020YI21 of LOC644925 4-55033913 Placenta Cot 25- normalized of Homo sapiens (human). [CR618938] A_33_P3223631 LOC100132217 Homo sapiens cDNA AK128836 100132217 hypothetical chr7:63219509 THC2481823 Hs.520384 FLI46348 fis, LOC 63219568 clone TESTI4047569. 100132217 [AK128836] A_32_P815507 LOC100130920 Homo sapiens cDNA AK093639 100130920 hypothetical chr10:6568397 THC2487672 Hs.683904 FLI36320 fis, protein 6568338 clone LOC THYMU2005480, 100130920 [AK093639] A_23_P163113 PRPF39 Homo sapiens PRP39 NM_017922 ENST00000355846 55015 PRP39 pre- chr14:4558425 GO:0008380|GO:0006397| NM_017922 THC2483434 Hs.274337 pre-mRNA mRNA pro- 2-45584311 GO:0005622|GO:0005488| processing factor cessing factor GO:0005730|GO:0005634 39 homolog (S. 39 homolog cerevisiae) (S. cerevisiae) (PRPF39), mRNA [NM_017922] A_32_P34876 WDR93 Homo sapiens WD NM_020212 ENST00000268130 56964 WD repeat chr15:9028134 NM_020212 NP498805 Hs.177557 repeat domain 93 domain 93 5-90281404 (WDR93), mRNA [NM_020212] A_33_P3388745 LOC100132207 Homo sapiens cDNA AK123339 100132207 hypothetical chr3:12932767 THC2482232 Hs.633570 FLI41345 fis, LOC 2-129327731 clone BRAWH2002761. 100132207 [AK123339] A_23_P331598 IPO7 Homo sapiens NM_006391 ENST00000379719 10527 importin 7 chr11:9467009- GO:0005215|GO:0005625| NM_006391 THC2467487 Hs.523470 importin 7 9467068 GO:0008536|GO:0008565| (IPO7), mRNA GO:0005737|GO:0005643| [NM_006391] GO:0044419|GO:0007165| GO:0042393|GO:0005083| GO:0005634|GO:0006606| GO:0006886| A_23_P120048 BAZ2B Homo sapiens NM_013450 ENST00000392783 29994 bromo- chr2:16017598 GO:0005515|GO:0008270| NM_013450 THC2491976 Hs.470369 bromodomain domain 5-160175926 GO:0046872|GO:0045449| adjacent to zinc finger adjacent to GO:0005634|GO:0003677| domain, 2B (BAZ2B), zinc finger mRNA [NM_013450] domain, 2B A_23_P250800 ST3GAL6 Homo sapiens ST3 NM_006100 ENST00000177899 10402 ST3 beta- chr3:9851073 GO:0006664|GO:0030173| NM_006100 THC2493961 Hs.148716 beta-galactoside alpha- galactoside 8-98510797 GO:0008373|GO:0005794| 2,3-sialyltransferase alpha GO:0016020|GO:0009249| 6 (ST3GAL6), 2,3-sialyl GO:0006040|GO:0006486| mRNA [NM_006100] transferase 6 GO:0016021 A_23_P134454 CAV1 Homo sapiens caveolin NM_001753 ENST00000341049 857 caveolin 1, chr7:11620074 GO:0043627|GO:0019915| NM_001753 NP1154468 Hs.74034 1, caveolae protein, caveolae 2-116200801 GO:0010524|GO:0006940| 22 kDa (CAV1), protein, GO:0052547|GO:0070836| transcript variant 1, 22 kDa GO:0042802|GO:0005622| mRNA [NM_001753] GO:0016050|GO:0009925| GO:0044419|GO:0051260| GO:0032507|GO:0005938| GO:0010332|GO:0042632| GO:0005811|GO:0019905| GO:0033344|GO:0005794| GO:0009986|GO:0051384| GO:0019217|GO:0016504| GO:0051592|GO:0043234| GO:0048554|GO:0007519| GO:0005887|GO:0032570| GO:0006641|GO:0005925| GO:0050998|GO:0048471| GO:0051899|GO:0005886| GO:0005783|GO:0042524| GO:0005829|GO:0045807| GO:0043409|GO:0000188| GO:0005739|GO:0005737| GO:0033138|GO:0008104| GO:0045907|GO:0001960| GO:0045019|GO:0033484| GO:0015485|GO:0030857| GO:0033137|GO:0045908| GO:0006816|GO:0019900| GO:0001666|GO:0031116| GO:0007584|GO:0060056| GO:0051480|GO:0042493| GO:0005625|GO:0009967| GO:0031410|GO:0045768| GO:0046426|GO:0009612| GO:0032947|GO:0000139| GO:0007595|GO:0030193| GO:0001937|GO:0005901| GO:0000299|GO:0001570 A_23_P98431 HMBS Homo sapiens NM_000190 ENST00000537841 3145 hydroxy- chr11:1189641 GO:0031406|GO:0005739| NM_000190 THC2603650 Hs.82609 hydroxymethylbilane methylbil- 29-118964188 GO:0050662|GO:0000793| synthase (HMBS), ane synthase GO:0005737|GO:0043176| transcript variant 1, GO:0005634|GO:0004418| mRNA [NM_000190] GO:0016740|GO:0006783 A_33_P3269864 LOC284009 Homo sapiens NR_028335 ENST00000381977 284009 hypothetical chr17:2310351- NR_028335 THC2487357 Hs.632244 hypothetical LOC284009 LOC284009 2310292 (LOC284009), non-coding RNA [NR_028335] A_33_P3323607 CCDC129 coiled-coil domain ENST00000409717 223075 coiled-coil chr7:31553759- containing 129 [Source: domain 31553818 HGNC Symbol; containing Acc:27363] 129 [ENST00000409717] A_23_P48088 CD27 Homo sapiens NM_001242 ENST00000266557 939 CD27 chr12:6560640- GO:0005515|GO:0016064| NM_001242 THC2472153 Hs.355307 CD27 molecule molecule 6560699 GO:0045471|GO:0045579| (CD27), mRNA GO:0046330|GO:0005624| [NM_001242] GO:0006915|GO:0005576| GO:0006916|GO:0006917| GO:0006955|GO:0008588| GO:0016020|GO:0005887| GO:0043027|GO:0007166| GO:0004888 A_33_P3234222 TSPO2 Homo sapiens NM_001010873 ENST00000373161 222642 translocator chr6:41011969- GO:0016020|GO:0004872| NM_001010873 THC2482465 Hs.357392 translocator protein protein 2 41012028 GO:0016021 2 (TSPO2), transcript variant 1, mRNA [NM_001010873] A_33_P3235454 Q3SZ59_BOVIN chr15:0606827 THC2542270 (Q3SZ59) Ribosomal 40-060682799 protein L36a, partial (96%) [THC2542270] A_23_P5983 PLTP Homo sapiens NM_006227 ENST00000477313 5360 phospholipid chr20:4452770 GO:0006629|GO:0006869| NM_006227 NP1199660 Hs.439312 phospholipid transfer 1-44527642 GO:0005576|GO:0008289 transfer protein (PLTP), protein transcript variant 1, mRNA [NM_006227] A_33_P3388618 TNK1 Homo sapiens NM_003985 ENST00000311668 8711 tyrosine chr17:7292997- GO:0005515|GO:0007165| NM_003985 THC2629027 Hs.203420 tyrosine kinase, kinase, 7293056 GO:0030308|GO:0005737| non-receptor, 1 (TNK1), non-receptor, GO:0046777|GO:0016020| mRNA [NM_003985] 1 GO:0000166|GO:0004871| GO:0005524|GO:0004715| GO:0016740|GO:0019898| A_23_P104025 TSEN15 Homo sapiens NM_052965 ENST00000462677 116461 tRNA splicing chr1:18404289 GO:0006397|GO:0005515| NM_052965 THC2462261 Hs.548197 tRNA splicing endo- endonuclease 0-184042949 GO:0005730|GO:0005634| nuclease 15 homolog (S. 15 GO:0008033 cerevisiae) (TSEN15), homolog (S. transcript variant 1, cerevisiae) mRNA [NM_052965] A_23_P110846 CNOT8 Homo sapiens NM_004779 ENST00000517876 9337 CCR4-NOT chr5:15425581 GO:0005622|GO:0005515| NM_004779 THC2468160 Hs.26703 CCR4-NOT transcription transcription 3-154255872 GO:0006355|GO:0005737| complex, subunit complex, GO:0008285|GO:0003700| 8 (CNOT8), mRNA subunit 8 GO:0005634|GO:0003676 [NM_004779] A_33_P3364060 HR Homo sapiens NM_005144 ENST00000522016 55806 hairless chr8:21972885 GO:0005515|GO:0006355| NM_005144 THC2464466 Hs.272367 hairless homolog homolog 21972826 GO:0003700|GO:0042826| (mouse) (HR), transcript (mouse) GO:0003714|GO:0005634| variant 1, mRNA GO:0051291|GO:0043433| [NM_005144] GO:0046872|GO:0046966| GO:0016604|GO:0000118| GO:0042809|GO:0016481| GO:0008270 A_23_P112026 IDO1 Homo sapiens NM_002164 ENST00000523779 3620 indoleamine chr8:39785529- GO:0070233|GO:0032693| NM_002164 THC2489025 Hs.840 indoleamine 2,3-dioxy- 39785588 GO:0046007|GO:0019674| 2,3-dioxygenase genase 1 GO:0002534|GO:0032735| 1 (IDO1), GO:0046872|GO:0005829| mRNA GO:0005737|GO:0002678| [NM_002164] GO:0032496|GO:0007610| GO:0007565|GO:0004833| GO:0009055|GO:0005625| GO:0033555|GO:0002666| GO:0019441|GO:0019825| GO:0033754|GO:0016491| GO:0002830|GO:0034276| GO:0016597|GO:0055114| GO:0020037 A_33_P3222019 WSCD2 Homo sapiens NM_014653 ENST00000547525 9671 WSC domain chr12:1085895 GO:0016020|GO:0016021 NM_014653 THC2465113 Hs.143591 WSC domain containing 2 08-108589567 containing 2 (WSCD2), mRNA [NM_014653] A_23_P369815 FASLG Homo sapiens NM_000639 ENST00000367721 356 Fas chr1:17263568 GO:0008625|GO:0005164| NM_000639 THC2477997 Hs.2007 Fas ligand ligand (TNF 5172635744 GO:0008633|GO:0070265| (TNF superfamily, superfamily, GO:0048471|GO:0060554| member 6) (FASLG), member 6) GO:0005886|GO:0060555| mRNA GO:0007267|GO:0005576| [NM_000639] GO:0006925|GO:0005125| GO:0005615|GO:0007165| GO:0006955|GO:0005887| GO:0005901|GO:0046666| GO:0032496|GO:0016023| GO:0043123|GO:0009897 A_33_P3219682 yx87g09.r1 Soares N35358 ENST00000359838 chr6:14748688 THC2778743 Hs.575390 melanocyte 2NbHM 1-147486940 Homo sapiens cDNA clone IMAGE:268768 5′, mRNA sequence [N35358] A_33_P3335682 PPP1R14A Homo sapiens NM_033256 ENST00000347262 94274 protein chr19:3874199 GO:0005515|GO:0042325| NM_033256 NP383096 Hs.6315679 protein phos- phos- 6-38741937 GO:0005737|GO:0004864 phatase 1, regulatory phatase 1, (inhibitor) subunit regulatory 14A (PPP1R14A), (inhibitor) mRNA [NM_033256] subunit 14A A_23_P53137 HBG1 Homo sapiens NM_000559 ENST00000330597 3047 hemoglobin, chr11:5269593- GO:0005515|GO:0019825| NM_000559 NP094052 Hs.7123539 hemoglobin, gamma A 5269534 GO:0005833|GO:0006810| gamma A (HBG1), GO:0005344|GO:0046872| mRNA [NM_000559] GO:0020037|GO:0015671| A_24_P91094 RUNDC3A Homo sapiens NM_006695 ENST00000225441 10900 RUN domain chr17:4239379 GO:0005515|GO:0005083| NM_006695 THC2504630 Hs.500197 RUN domain containing 1-42393850 GO:0030250|GO:0007264| containing 3A GO:0009898|GO:0005829 3A (RUNDC3A), transcript variant 2, mRNA [NM_006695] A_23_P316531 GPR25 Homo sapiens NM_005298 ENST00000304244 2848 G protein- chr1:20084314 GO:0007165|GO:0007186| NM_005298 THC2646268 Hs.534316 G protein- coupled 5-200843204 GO:0005886|GO:0005887| coupled receptor receptor 25 GO:0004930|GO:0004872 25 (GPR25), mRNA [NM_005298] A_23_P150583 SCGB1A1 Homo sapiens NM_003357 ENST00000278282 7356 secretoglobin, chr11:6218982 GO:0043488|GO:0007566| NM_003357 THC2472230 Hs.523732 secretoglobin, family 1A, 3-62190532 GO:0032714|GO:0032713| family 1A, member 1 member 1 GO:0050727|GO:0005576| (uteroglobin) (uteroglobin) GO:0000122|GO:0019834| (SCGB1A1), GO:0042130|GO:0007165| mRNA [NM_003357] GO:0005737|GO:0005488| GO:0032696|GO:0032689 A_23_P121533 SPON2 Homo sapiens NM_012445 ENST00000431380 10417 spondin 2, chr4:1160797- GO:0006955|GO:0007411| NM_012445 THC2601265 Hs.635350 spondin 2, extra- extracellular 1160738 GO:0005509|GO:0005578| cellular matrix matrix GO:0005102|GO:0005576| protein (SPON2), protein GO:0007155 transcript variant 1, mRNA [NM_012445] A_23_P110196 HERC5 Homo sapiens NM_016323 ENST00000502913 51191 hect domain chr4:89426889- GO:0005622|GO:0048471| NM_016323 THC2472533 Hs.26663 hect and RLD 5 89426948 GO:0005737|GO:0016881| domain and GO:0019941|GO:0016874| RLD5(HERC5), GO:0000079|GO:0006464 mRNA [NM_016323] A_23_P109026 KCNK15 Homo sapiens NM_022358 ENST00000372861 60598 potassium chr20:4337959 GO:0005244|GO:0016020| NM_022358 THC2478658 Hs.528664 potassium channel, 3-43379652 GO:0005267|GO:0030955| channel, subfamily subfamily GO:0016021|GO:0006813| K, member K, member GO:0006811 15 (KCNK15), 15 mRNA [NM_022358] A_33_P3264346 chr16:0030501 THC2780215 84-003050243 A_33_P3260307 CARHSP1 Homo sapiens NM_001042476 ENST00000311052 23589 calcium chr16:8946862- GO:0005515|GO:0007242| NM_001042476 THC2468995 Hs.632184 calcium regulated regulated heat 8946803 GO:0006355|GO:0005737| heat stable protein 1, stable GO:0019902|GO:0003677 24 kDa (CARHSP1), protein 1, transcript variant 2, 24 kDa mRNA [NM_001042476] A_23_P422044 PCDHGA2 Homo sapiens NM_032009 ENST00000528330 56113 protocadherin chr5:14072084 GO:0005515|GO:0005886| NM_032009 NP362372 Hs.368160 protocadherin gamma 0-140720899 GO:0005509|GO:0005624| gamma subfamily A, 2 GO:0016021|GO:0007155| subfamily A, GO:0007156 2 (PCDHGA2), transcript variant 2, mRNA [NM_032009] A_23_P131024 ZBTB32 Homo sapiens NM_014383 ENST00000262630 27033 zinc finger chr19:3620786 GO:0005515|GO:0030097| NM_014383 THC2760977 Hs.99430 zinc and BTB 6-36207925 GO:0003714|GO:0003704| finger and BTB domain GO:0005634|GO:0000122| domain containing containing 32 GO:0000228|GO:0001817| 32(ZBTB32), GO:0003677|GO:0046872| mRNA [NM_014383] GO:0005622|GO:0042098| GO:0005654|GO:0008270| GO:0045449 A_33_P3346826 IL32 Homo sapiens NM_001012633 ENST00000528652 9235 interleukin chr16:3119014- GO:0006955|GO:0006952| NM_001012633 THC2531803 Hs.943 interleukin 32 3119073 GO:0005576|GO:0007155| 32(IL32), GO:0005615|GO:0005125 transcript variant 4, mRNA [NM_001012633] A_23_P105562 VWF Homo sapiens NM_000552 ENST00000261405 7450 von chr12:6058242- GO:0033093|GO:0005783| NM_000552 THC2468950 Hs.440848 von Willebrand Willebrand 6058183 GO:0031589|GO:0005518| factor (VWF), factor GO:0051087|GO:0005578| mRNA GO:0009611|GO:0030168| [NM_000552] GO:0005576|GO:0001890| GO:0002020|GO:0042803| GO:0001889|GO:0047485| GO:0001948|GO:0005178| GO:0019865|GO:0031091| GO:0051260|GO:0009897 A_33_P3354851 Human mRNA X58768 chr14:2263681 NP089254 Hs.495158 for T cell receptor V 1-22636870 alpha gene segment V-alpha- w29, clone IGRa07. [X58768] A_24_P272451 C17orf87 Homo sapiens AK057142 388325 chromosome chr17:5116499 GO:0016020|GO:0016021 THC2484848 Hs.462080 cDNA FLJ32580 17 open 5116440 fis, clone reading SPLEN2000270. frame 87 [AK057142] A_33_P3251252 chr3:04571892 7-045718868 A_23_P74290 GBP5 Homo sapiens NM_052942 ENST00000490568 115362 guanylate chr1:89726446- GO:0005886|GO:0000166| NM_052942 THC2666692 Hs.515726 guanylate binding binding 89726387 GO:0003924|GO:0005525 protein 5 protein 5 (GBP5), tran- script variant 1, mRNA [NM_052942] A_23_P108501 EPHA4 Homo sapiens NM_004438 ENST00000392071 2043 EPH chr2:22229077 GO:0005515|GO:0005524| NM_004438 THC2466360 Hs.371218 EPH receptor A4 receptor A4 6-222290717 GO:0007165|GO:0005003| (EPHA4), GO:0000166|GO:0016020| mRNA GO:0005887|GO:0007411| [NM_004438] GO:0007628|GO:0004872| GO:0006468|GO:0007169| GO:0016740 A_33_P3337609 GB chr2:09772605 NP113779 5-097726114 A_23_P106661 CMTM1 Homo sapiens NM_052999 ENST00000379490 113540 CKLF-like chr16:6661297 GO:0016020|GO:0006935| NM_052999 NP813866 Hs.698621 CKLF-like MARVEL 2-66613031 GO:0016021|GO:0005615| MARVEL trans- GO:0005125 transmembrane membrane domain containing 1 domain (CMTM1), trans- containing 1 cript variant 17, mRNA [NM_052999] A_23_P120316 MTHFD2 Homo sapiens NM_006636 ENST00000394053 10797 methylene chr2:74441985- GO:0000287|GO:0004477| NM_006636 THC2543784 Hs.469030 methylenetetra- tetrahydro- 74442044 GO:0005739|GO:0004488| hydrofolate de- folate- GO:0004487|GO:0016787| hydrogenase dehydrogen- GO:0005488|GO:0042301| (NADP+dependent) ase (NADP+ GO:0016491|GO:0046653| 2, methenyl- dependent) 2, GO:0009396|GO:0006730| tetrahydrofolate methenyl- GO:0055114 cyclohydrolase tetrahy- (MTHFD2), drofolate nuclear gene cyclohydrolase encoding mito- chondrial protein, transcript variant 1, mRNA [NM_006636] A_23_P163992 GRB7 Homo sapien NM_005310 ENST00000394204 2886 growth factor chr17:3790238 GO:0005515|GO:0007165| NM_005310 THC2490644 Hs.86859 growth factors receptor- 1-37902440 GO:0007173|GO:0005070 receptor-bound bound protein 7 protein 7 (GRB7), transcript variant 1, mRNA [NM_005310] A_23_P330561 C19orf59 Homo sapiens NM_174918 ENST00000333598 199675 chromosome chr19:7744452- GO:0016020|GO:001602| NM_174918 THC2475479 Hs.709539 chromosome 19 7744511 19 open reading open reading frame 59 (C19orf59), frame 59 mRNA [NM_174918] A_23_P113634 CBFB Homo sapiens NM_001755 ENST00000412916 865 core-binding chr16:6713463 GO:0005515|GO:0003700| NM_001755 THC2466980 Hs.460988 core-binding factor, beta 0-67134689 GO:0006366|GO:0003702| factor, subunit GO:0003713|GO:0005634 beta subunit (CBFB), transcript variant 2, mRNA [NM_001755] A_33_P3250394 LOC100510596 PREDICTED: XM_003120681 100510596 hypothetical chr11:363589 XM_003120681 THC2720990 Homo sapiens protein 4-3635953 hypothetical protein LOC LOC100510596 100510596 (LOC100510596), mRNA [XM_003120681] A_33_P3383174 LOC644366 PREDICTED: XM_003120886 644366 hypothetical chr17:4490806 XM_003120886 THC2652786 Hs.210896 Homo sapiens protein 1-44908002 hypothetical protein LOC644366 LOC644366 (LOC644366), mRNA [XM_003120886] A_24_P366122 ACBD4 Homo sapiens NM_024722 ENST00000376955 79777 acyl-CoA chr17:4321387 GO:0005488|GO:0000062 NM_024722 THC2605010 Hs.110298 acyl-CoA binding binding 2-43213931 domain containing domain 4 (ACBD4), containing transcript variant 4 2, mRNA [NM_024722] A_33_P3420695 chrY:00849285 3-008492794 A_23_P122144 UGT3A1 Homo sapiens NM_152404 ENST00000515801 133688 UDP glycosyl chr5:35954141- GO:0016020|GO:0008152| NM_152404 NP1157777 Hs.254699 UDP glyco- transferase 35954082 GO:0015020|GO:0016021 syltransferase 3 3 family, family, polypeptide polypeptide Al (UGT3A1), A1 transcript variant 1, mRNA [NM_152404] A_33_P3334205 TMEM184A Homo sapiens NM_001097620 ENST00000297477 202915 trans- chr7:1585889- GO:0016020|GO:0016021 NM_001097620 THC2573151 Hs.592174 transmembrane membrane 1585830 protein 184A protein (TMEM184A), 184A mRNA [NM_001097620] A_23_P87879 CD69 Homo sapiens NM_001781 ENST00000228434 CD69 chr12:9905320- GO:0016020|GO:0005887| NM_001781 THC2461298 Hs.208854 CD69 molecule 9905261 GO:0005529|GO:0009897| molecule (CD69), GO:0005488|GO:0005509| transcript variant 1, GO:0004888 mRNA [NM_001781] A_33_P3354646 PNLIPRP1 Homo sapiens NM_006229 ENST00000470678 5407 pancreatic chr10:11835137 GO:0016042|GO:0005515| NM_006229 THC2517682 Hs.73923 pancreatic lipase- 7-118351436 GO:0004806|GO:0016787| lipase-related related GO:0043434|GO:0051384| protein 1 protein 1 GO:0005576|GO:0009791| (PNLIPRP1), mRNA GO:0005615 [NM_006229] A_33_P3564409 melanoma AK094541 ENST00000481096 chrX:5193360 THC2626934 Hs.729070 antigen family D, 3-51933662 4B [Source: HGNC Symbol; Acc:22880] [ENST00000481096] A_33_P3287610 immunoglobulin DQ098743 ENST00000390313 chr22:2311482 NP1087705 lambda 3-23114882 variable 3-12 [Source: HGNC Symbol; Acc:5898] [ENST00000390313] A_23_P115366 CMPK1 Homo sapiens NM_016308 ENST00000371873 51727 cytidine chr1:47843918- GO:0006139|GO:0005737| NM_016308 THC2540218 Hs.11463 cytidine mono- 47843977 GO:0000166|GO:0004849| monophosphate phosphate GO:0004127|GO:0009220| (UMP-CMP) (UMP-CMP) GO:0005634|GO:0016776| kinase 1, kinase 1, GO:0005524|GO:0016740 cytosolic (CMPK1), cytosolic transcript variant 1, mRNA [NM_016308] A_33_P3416376 UI-H-FLl-bgt- BU633092 chr19:5116265 Hs.621823 o-17-0-UI.s1 6-51162715 NCI_CGAP_FL1 Homo sapiens cDNA clone UI-H-FLl-bgt-o- 17-0-UI 3′, mRNA sequence [BU633092] A_33_P3312030 ENST00000507296 chr4:15855898 9-158559048 A_33_P3275826 chr11:0006274 79-000627420 A_23_P109322 PCP4 Homo sapiens NM_006198 ENST00000468717 5121 Purkinje chr21:4130104 GO:0005634|GO:0007417| NM_006198 THC2617631 Hs.80296 Purkinje cell cell 7-41301106 GO:0005829 protein 4 (PCP4), protein 4 mRNA [NM_006198] A_33_P3239884 NCAM2 Homo sapiens NM_004540 ENST00000400546 4685 neural cell chr21:2291041 GO:0005515|GO:0030424| NM_004540 THC2471832 Hs.473450 neural adhesion 7-22910476 GO:0007608|GO:0007413| cell adhesion molecule GO:0005886|GO:0016021| molecule 2 GO:0007155|GO:0007158 2 (NCAM2), mRNA [NM_004540] A_23_P12343 GSTM3 Homo sapiens NM_000849 ENST00000488824 2947 glutathione chr1:11027967 GO:0043627|GO:0005737| NM_000849 THC2487629 Hs.2006 glutathione S-transferase 3-110279614 GO:0008065|GO:0008152| S-transferase mu 3 mu 3 (brain) GO:0005625|GO:0004364| (brain) (GSTM3), GO:0016740|GO:0042802 transcript variant 1, mRNA [NM_000849] A_33_P3228751 LOC388152 Homo sapiens NR_027001 ENST00000357253 388152 hypothetical chr15:8486915 NR_027001 THC2590266 Hs.681665 hypothetical LOC388152 2-84869093 LOC388152, (LOC388152) non-coding RNA [NR_027001] A_33_P3353330 Homo sapiens cDNA AK098147 ENST00000442126 chr22:3088873 THC2490419 FLJ40828 fis, clone 2-30888791 TRACH2011574. [AK098147] A_23_P85240 TLR7 Homo sapiens NM_016562 ENST00000380659 51284 toll-like chrX:12908260- GO:0032755|GO:0003725| NM_016562 THC2475229 Hs.659215 toll-like receptor 7 12908319 GO:0005515|GO:0003727| receptor 7 (TLR7), GO:0045416|GO:0007249| mRNA [NM_016562] GO:0002224|GO:0042221| GO:0007165|GO:0051607| GO:0045359|GO:0006954| GO:0035197|GO:0016020| GO:0052033|GO:0045087| GO:0045078|GO:0008144| GO:0045356|GO:0002282| GO:0016021|GO:0010008| GO:0004888 A_33_P3246733 MNT Homo sapiens NM_020310 ENST00000404961 4335 MAX chr17:2289691- GO:0006355|GO:0008285| NM_020310 THC2534076 Hs.632239 MAX binding binding 2289632 GO:0003700|GO:0006366| protein (MNT), protein GO:0007569|GO:0003714| mRNA [NM_020310] GO:0003713|GO:0051726| GO:0042981|GO:0007275| GO:0005634 A_23_P23850 DAB1 Homo sapiens NM_021080 ENST00000371231 1600 disabled chr1:5748069 GO:0005515|GO:0048471| NM_021080 THC2533734 Hs.477370 disabled homolog 1 8-57480639 GO:0007264|GO:0007275| homolog 1 (Drosophila) GO:0021813|GO:0021942| (Drosophila) (DAB1), GO:0030154|GO:0007399| mRNA [NM_021080] GO:0021589|GO:0007162| GO:0021799|GO:0045860| GO:0001764 A_23_P103775 LRRC8C Homo sapiens NM_032270 ENST00000370454 84230 leucine rich chr1:9018032 GO:0005515|GO:0016020| NM_032270 THC2474475 Hs.412836 leucine repeat 4-90180383 GO:0016021 rich repeat containing containing 8 8 family, family, member member C C (LRRC8CJ, mRNA [NM_032270] A_23_P104054 C1orf9 Homo sapiens NM_016227 ENST00000367723 51430 chromosome chr1:17258075 GO:0016020|GO:0016021 NM_016227 THC2481620 Hs.626306 chromosome 1 open 6-172580815 1 open reading reading frame 9 (C1orf9), frame 9 transcript variant 2, mRNA [NM_016227] A_33_P3400823 C1orf190 Homo sapiens NM_001013615 ENST00000371980 541468 chromosome chr1:4668680 NM_001013615 THC2476177 Hs.568642 chromosome 1 open 1 open 3-46686862 reading frame reading 190 (C1orf190), frame 190 mRNA [NM_001013615] A_23_P150064 MMRN2 Homo sapiens NM_024756 ENST00000443699 79812 multimerin 2 chr10:8869622 GO:0005576|GO:0005615| NM_024756 THC2465974 Hs.524479 multimerin 0-88696161 GO:0005604 2 (MMRN2), mRNA [NM_024756] A_23_P201918 ABCB10 Homo sapiens NM_012089 ENST00000344517 23456 ATP-binding chr1:22965277 GO:0005739|GO:0016020| NM_012089 THC2463247 Hs.17614 ATP-binding cassette, 0-229652711 GO:0000166|GO:0005743| cassette, sub- subfamily B GO:0042626|GO:0016021| family B (MDR/ (MDR/TAP), GO:0055085|GO:0043190| TAP), member 10 member 10 GO:0016887|GO:0005524 (ABCB10), nuclear gene encoding mito- chondrial protein, mRNA [NM_012089] A_33_P3293760 KRTAP10-8 Homo sapiens NM_198695 ENST00000334662 386681 keratin chr21:4603241 GO:0045095 NM_198695 THC2782326 Hs.528021 keratin associated 7-46032476 associated protein protein 10-8 10-8 (KRTAP10-8), mRNA [NM_198695] A_32_P93036 Synthetic construct CU678501 chr19:0454119 Homo sapiens 56-045411897 gateway clone IMAGE:100023427 3′ read APOE mRNA. [CU678501] A_33_P3466016 LOC200830 Homo sapiens AK054953 200830 hypothetical chr3:16098374 THC2511954 Hs.691402 cDNA FLJ30391 protein 7-160983806 fis, clone LOC200830 BRACE2008336. [AK054953] A_23_P103765 FCER1A Homo sapiens NM_002001 ENST00000368115 2205 Fc fragment chr1:15927603 GO:0001812|GO:0019370| NM_002001 THC2611062 Hs.897 Fc fragment of IgE, of IgE, high 4-159277595 GO:0045401|GO:0001820| high affinity affinity I, GO:0045425|GO:0005886| I, receptor receptor for; GO:0050731|GO:0007257| for; alpha alpha GO:0050850|GO:0043306| polypeptide polypeptide GO:0004872|GO:0019767| (FCER1A), GO:0005887|GO:0007166| mRNA [NM_002001] GO:0009897 A_33_P3411612 TMEM221 Homo sapiens NM_001190844 ENST00000341130 100130519 trans- chr19:1755606 GO:0016020|GO:0016021 NM_001190844 THC2532568 Hs.436603 transmembrane membrane 8-17556009 protein 221 protein 221 (TMEM221), mRNA [NM_001190844] A_33_P3378659 TARP Homo sapiens NM_001003799 ENST00000443402 445347 TCR chr7:38299809- NM_001003799 NP092351 Hs.534032 TCR gamma gamma 38299750 alternate reading alternate frame protein reading (TARP), nuclear frame gene encoding protein mitochondrial protein, transcript variant 1, mRNA [NM_001003799] A_33_P3212630 FAM90A10 Homo sapiens NM_001164447 ENST00000400118 441328 family chr8:7629451- GO:0008270|GO:0003676 NM_001164447 THC2482537 Hs.694406 family with with 7629510 sequence similarity sequence 90, member A10 similarity 90, (FAM90A10), member A10 mRNA [NM_001164447] A_23_P56736 TUBA3D Homo sapiens NM_080386 ENST00000321253 113457 tubulin, chr2:13224043 GO:0005515|GO:0051258| NM_080386 THC2628673 Hs.503749 tubulin, alpha alpha 3d 0-132240489 GO:0000166|GO:0005198| 3d (TUBA3D), GO:0005874|GO:0003924| mRNA [NM_080386] GO:0005525|GO:0007018 A_33_P3218435 DB073168 TESTI4 DB073168 ENST00000523591 chr5:17010762 Hs.631237 Homo sapiens 9-170107570 cDNA clone TESTI4016447 5′, mRNA sequence [DB073168] A_33_P3246010 Homo sapiens AK092494 chr16:8877547 THC2636441 Hs.592074 cDNA FLJ35175 4-88775415 fis, clone PLACE6013400. [AK092494] A_23_P113572 CD19 Homo sapien NM_001770 ENST00000537306 930 CD19 chr16:2895060 GO:0050853|GO:0005515| NM_001770 THC2473305 Hs.652262 CD19 molecule molecule 0-28950659 GO:0006968|GO:0005886| (CD19), transcripts GO:0005887|GO:0005057| variant 2, GO:0009897|GO:0007166 mRNA [NM_001770] A_23_P117662 HDC Homo sapiens NM_002112 ENST00000267845 3067 histidine chr15:5053422 GO:0006547|GO:0005625| NM_002112 THC2627567 Hs.1481 histidine de- decarboxylase 9-50534170 GO:0005626|GO:0004398| carboxylase GO:0016829|GO:0030425| (HDC), mRNA GO:0005829|GO:0001692| [NM_002112] GO:0030170|GO:0043025| GO:0016597|GO:0019752| GO:0006519|GO:0042423 A_33_P3374589 ATXN10 ataxin 10 ENST00000402380 25814 ataxin 10 chr22:4618955 THC2652118 [Source: HGNC 9-46189618 Symbol; Acc:10549] [ENST00000402380] A_33_P3239790 ZNF646 Homo sapiens NM_014699 ENST00000439353 9726 zinc chr16:3109154 GO:0005622|GO:0008270| NM_014699 THC2471197 Hs.119273 zinc finger finger 9-31091608 GO:0005634|GO:0003677| protein 646 protein GO:0046872|GO:0045449 (ZNF646), 646 mRNA [NM_014699] A_23_P209694 PAPOLG Homo sapiens NM_022894 ENST00000414060 64895 poly(A) chr2:61025238- GO:0006397|GO:0004652| NM_022894 THC2614617 Hs.387471 poly(A) poly- polymerase 61025297 GO:0000166|GO:0003723| merase gamma gamma GO:0016779|GO:0043631| (PAPOLG), GO:0005634|GO:0005524| mRNA [NM_022894] GO:0016740|GO:0006350 A_23_P145024 ADRB2 Homo sapiens NM_000024 ENST00000305988 154 adrenergic, chr5:14820808 GO:0051927|GO:0045453| adrenergic, beta-2-, 0-148208139 GO:0009409|GO:0004941| beta-2-, receptor, GO:0002024|GO:0002025| receptor, surface GO:0015459|GO:0043268| surface GO:0005764|GO:0032403| (ADRB2), GO:0042803|GO:0007171| mRNA [NM_000024] GO:0010765|GO:0045823| GO:0004935|GO:0005792| GO:0030501|GO:0008179| GO:0004930|GO:0008333| GO:0035240|GO:0006898| GO:0002032|GO:0043235| GO:0048633|GO:0007186| GO:0050873|GO:0005887| GO:0044424|GO:0007189| GO:0051930|GO:0030424| GO:0008284|GO:0005634| GO:0030425|GO:0051380| GO:0031649|GO:0016324| GO:0030279|GO:0040015| GO:0045986|GO:0008144| GO:0045909|GO:0045944| GO:0004872|GO:0043065| GO:0005730|GO:0005624| GO:0042383|GO:0005901| GO:0050728|GO:0043410| GO:0005768 A_23_P322845 PPAPDC1B Homo sapiens NM_001102559 ENST00000424479 84513 phosphatide chr8:38120995- GO:0016787|GO:0016020| NM_001102559 THC2464061 Hs.567619 phosphatide acid 38120936 GO:0016021 acid phosphatase phosphatase type 2 type 2 domain domain containing IB containing (PPAPDC1B), IB transcript variant 1, mRNA [NM_001102559] A_23_P23966 ZNF488 Homo sapiens NM_153034 ENST00000395702 118738 zinc chr10:4837350 GO:0016564|GO:0005622| NM_153034 THC2462545 Hs.27788 zinc finger finger 5-48373564 GO:0005515|GO:0048714| protein 488 protein GO:0014003|GO:0008270| (ZNF488), 488 GO:0005634|GO:0003677| mRNA [NM_153034] GO:0046872|GO:0045449 A_23_P122775 RTN4IP1 Homo sapiens NM_032730 ENST00000498091 84816 reticulon 4 chr6:10703128 GO:0005739|GO:0005488| NM_032730 NP411809 Hs.155839 reticulon 4 interacting 6-107031227 GO:0016491|GO:0008270| interacting protein 1 GO:0055114 protein 1 (RTN4IP1), nuclear gene encoding mito- chondrial protein, mRNA [NM_032730] A_33_P3393801 PDZK1IP1 Homo sapiens NM_005764 ENST00000371885 10158 PDZK1 chr1:47650734- GO:0016020|GO:0016021 NM_005764 THC2612502 Hs.431099 PDZK1 interacting 47650675 interacting protein 1 protein 1 (PDZKHP1), mRNA [NM_005764] A_23_P124003 P2RX2 Homo sapiens NM_170683 ENST00000343948 22953 purinergic chr12:1331982 GO:0046982|GO:0016020| NM_170683 NP1457348 Hs.258580 purinergic receptor 03-133198262 GO:0004931|GO:0010524| receptor P2X, P2X, GO:0001614|GO:0004872| ligand-gated ligand- GO:0016021|GO:0005524| ion channel, gated ion GO:0042803|GO:0050850| 2 (P2RX2), channel, 2 GO:0015276|GO:0006811 transcript variant 4, mRNA [NM_170683] A_23_P420417 TLCD1 Homo sapiens NM_138463 ENST00000394933 116238 TLC chr17:2705171 GO:0016020|GO:0016021 NM_138463 THC2473493 Hs.499952 TLC domain domain 5-27051656 containing 1 containing 1 (TLCD1), transcript variant 1, mRNA [NM_138463] A_23_P44207 ACOT12 Homo sapiens NM_130767 ENST00000506440 134526 acyl-CoA chr5:80626341- GO:0006629|GO:0004091| NM_130767 THC2477338 Hs.591756 acyl-CoA thioesterase 12 thioesterase 80626282 GO:0006637|GO:0005737| (ACOT12), 12 GO:0016787|GO:0003986| mRNA GO:0006084|GO:0005524| [NM_130767] GO:0005829 A_33_P3419180 LOC283547 Homo sapiens NR_039982 283547 hypothetical chr14:3930719 NR_039982 THC2503396 Hs.675941 hypothetical LOC283547 0-39307131 LOC283547 (LOC283547), non-coding RNA [NR_039982] A_23_P17330 UCKL1 Homo sapiens, NM_017859 ENST00000369908 54963 uridine- chr20:6257600 GO:0005737|GO:0000166| NM_017859 NP283210 Hs.504998 uridine- cytidine 2-62575943 GO:0016301|GO:0005783| cytidine kinase 1- GO:0004849|GO:0044419| kinase like 1 GO:0008152|GO:0016773| 1-like 1 GO:0005634|GO:0005524| (UCKL1), GO:0016740 transcript variant 1 mRNA [NM_017859] A_24_P110242 immunoglobulin ENST00000354689 chr16:3207749 THC2579601 heavy variable 0-32077549 3/OR16-8 (non-functional) [Source:HGNC Symbol;Acc:5643] [ENST00000438532] A_23_P15414 SCARF1 Homo sapiens NM_145352 ENST00000434376 8578 scavenger chr17:1537812- GO:0005515|GO:0006707| NM_145352 NP494816 Hs.647430 scavenger receptor 1537753 GO:0016020|GO:0030169| receptor class F, GO:0016021|GO:0007155| class F, member 1 GO:0016358|GO:0006898| member 1 GO:0005044 (SCARF1), transcript variant 5, mRNA [NM_145352] A_33_P3254121 RNASET2 ribonuclease T2 AK001769 ENST00000358165 8635 ribonuclease chr6:16734748 THC2479694 [Source: HGNC T2 7-167347428 Symbol; Acc:21686] [ENST00000358165] A_24_P920188 ZNF24 Homo sapiens NM_006965 ENST00000261332 7572 zinc chr18:3291274 GO:0016564|GO:0005622| NM_006965 THC2717584 Hs.S14802 zinc finger finger 8-32912689 GO:0005515|GO:0006355| protein protein 24 GO:0003700|GO:0016481| (ZNF24), GO:0008270|GO:0005634| mRNA GO:0046872 [NM_006965] A_33_P3416814 MGAT1 mannosyl ENST00000510962 4245 mannosyl chr5:18023780 (alpha-1,3-)- (alpha-1,3-)- 8-180237749 glycoprotein glycoprotein beta-l,2-N- beta 1,2-N- acetylglucosaminyl- acetyl- transferase glucosamin [Source: HGNC yltransfcrase Symbol; Acc:7044] [ENST00000510962] A_23_P30634 BACH Homo sapiens NM_021813 ENST00000257749 60468 BTB and chr6:90636664- GO:0043565|GO:0006355| NM_021813 THC2649840 Hs.269764 BTB and CNC CNC homo- 90636605 GO:0003700|GO:0046983| homology 1, logy 1, GO:0005634 basic leucine basic zipper leucine transcription zipper factor 2 transcription (BACH2), factor 2 transcript variant 1, mRNA [NM_021813] A_33_P3236340 LOC100133131 Homo sapiens AF289593 100133131 hypothetical chr4:6823580- NP426365 Hs.543740 clone pp7683 protein 6823521 unknown LOC100133131 mRNA. [AF289593] A_23_P80382 PRR5 Homo sapiens NM_015366 ENST00000432916 55615 proline chr22:4513326 GO:0007049 NM_015366 NP1183640 Hs.102336 proline rich 5 rich 5 7-45133326 (renal) (PRR5), (renal) transcript variant 2, mRNA [NM_015366] A_33_P3247534 LOC389834 Homo sapiens NR_027420 389834 ankyrin chr21:9917195- NR_027420 THC2524997 ankyrin repeat repeat 9917136 domain 57 domain 57 pseudogene pseudogene (LOC389834), non-coding RNA [NR_027420] A_23_P41424 SLC39A8 Homo sapiens NM_022154 ENST00000394833 64116 solute chr4:10318301 GO:0016020|GO:0046873| NM_022154 THC2465848 Hs.288034 solute carrier carrier 0-103182951 GO:0008270|GO:0006829| family 39 family 39 GO:0016021|GO:0055085| (zinc (zinc GO:0030001|GO:0006811 transporter), transporter), member 8 member 8 (SLC39A8), transcript variant 1, mRNA [NM_022154] A_24_P940776 BDP1 Homo sapiens NM_018429 ENST00000541414 55814 B double chr5:70862873- GO:0005634|GO:0003677| NM_018429 THC2613479 Hs.258272 B double prime 1, 70862932 GO:0045449 prime 1, subunit subunit of of RNA RNA poly- polymerase merase III III transcription transcription initiation initiation factor 1MB factor IIIB (BDP1), mRNA [NM_018429] A_33_P3382309 PRDM16 Homo sapiens NM_199454 ENST00000378398 63976 PR chr1:3350316- GO:0016564|GO:0003713| NM_199454 THC2487287 Hs.99500 PR domain domain 3350375 GO:0005634|GO:0046332| containing containing 16 GO:0000122|GO:0043457| 16 (PRDM16), GO:0046872|GO:0005622| transcript GO:0043565|GO:0050873| variant 2, GO:0017053|GO:0008270| mRNA [NM_199454] GO:0030512|GO:0045449| GO:0022008 A_23_P111804 PARP12 Homo sapiens NM_022750 ENST00000488726 64761 poly chr7:13972400 GO:0008270|GO:0005634| NM_022750 THC2462153 Hs.12646 poly (ADP- (ADP- 5-139723946 GO:0003676|GO:0046872| ribose) poly- ribose) GO:0016740|GO:0003950 merase family, polymerase member 12 family, (PARP12), member mRNA [NM_022750] 12 A_24_P941148 HAUS6 Homo sapiens NM_017645 ENST00000380502 54801 HAUS chr9:19053295- GO:0051297|GO:0003674| NM_017645 THC2525167 Hs.533468 HAUS augmin- 19053236 GO:0007067|GO:0007049| augmin-like like GO:0005813|GO:0005737| complex, complex, GO:0005874|GO:0005819| subunit 6 subunit 6 GO:0070652|GO:0005856| (HAUS6), GO:0051225|GO:0051301 mRNA [NM_017645] A_33_P3273369 SH3BP4 Homo sapiens NM_014521 ENST00000420127 23677 SH3- chr2:23596235 GO:0005515|GO:0008150| NM_014521 THC2777683 Hs.516777 SH3-domain domain 6-235962415 GO:0003674|GO:0007049| binding binding GO:0005905|GO:0016020| protein 4 protein 4 GO:0030136|GO:0005634| (SH3BP4), GO:0031410|GO:0005575| mRNA [NM_014521] GO:0004871|GO:0006897 A_33_P3318624 CTBP2 C-terminal BC052276 ENST00000530930 1488 C-terminal chr10:1268221 THC2484146 Hs.501345 binding binding 73-126822114 protein 2 [Source: protein 2 HGNC Symbol; Acc: 2495] [ENST00000530930] A_23_P132121 SIK1 Homo sapiens NM_173354 ENST00000270162 150094 salt- chr21:4483481 GO:0016564|GO:0005515| NM_173354 THC2468197 Hs.282113 salt-inducible inducible 9-44834760 GO:0000287|GO:0005634| kinase 1 kinase 1 GO:0007275|GO:0000122| (SIK1), GO:0005524|GO:0007243| mRNA [NM_173354] GO:0005829|GO:0007346| GO:0005737|GO:0007049| GO:0000166|GO:0004674| GO:0045595|GO:0006468| GO:0016740 A_23_P424734 EXOC3L1 Homo sapiens NM_178516 ENST00000314553 283849 exocyst chr16:6721859 GO:0003674|GO:0000145| NM_178516 THC2475659 Hs.647356 exocyst complex 9-67218459 GO:0030141|GO:0030072| complex component GO:0006887 component 3-like 1 3-like 1 (EXOC3L1), mRNA [NM_178516] A_23_P110234 CSN1S1 Homo sapiens NM_001890 ENST00000505782 1446 casein chr4:70810602- GO:0005515|GO:0005215| NM_001890 THC2759870 Hs.3155 casein alpha s1 70810661 GO:0006810|GO:0005576 alpha s1 (CSN1S1), transcript variant 1, mRNA [NM_001890] A_23_P68486 C20orf108 Homo sapiens NM_080821 ENST00000371384 116151 chromosome chr20:5494304 GO:0016020|GO:0016021 NM_080821 THC2468290 Hs.143736 chromosome 20 open 0-54943099 20 open reading reading frame 108 frame 108 (C20orf108), mRNA [NM_080821] A_33_P3358686 Q8IWC7_HUMAN chr17:0419999 THC2657523 (Q8IWC7) 71-041999912 LRRC37A protein, partial (5%) [THC2657523] A_23_P121596 PPBP Homo sapiens NM_002704 ENST00000296028 5473 pro-platelet chr4:74853358- GO:0008009|GO:0006955| NM_002704 THC2473736 Hs.2164 pro-platelet basic protein 74853299 GO:0015758|GO:0007186| basic (chemokine GO:0006935|GO:0051781| protein (C-X-C motif) GO:0031093|GO:0005576| (chemokine ligand 7) GO:0008083|GO:0005615| (C-X-C motif) GO:0042742|GO:0005355 ligand 7) (PPBP), mRNA [NM_002704] A_33_P3277259 PCYT2 Homo sapiens NM_001184917 ENST00000538721 5833 phosphate chr17:7986085 NM_001184917 THC2492265 Hs.569843 phosphate cytidylyl- 1-79860792 cytidylyltransferase transferase 2, ethanolamine 2, ethanolamine (PCYT2), transcript variant 1, mRNA [NM_001184917] A_33_P3330877 chr2:06242241 3-062422472 A_33_P3277883 LOC100129931 Homo sapiens NR_033828 100129931 hypothetical chr4:7035198- NR_033828 THC2623255 Hs.707753 hypothetical LOC100129931 7035139 LOC100129931 (LOC100129931), non-coding RNA [NR_033828] A_33_P3271460 GOLGA1 golgin Al ENST00000373551 2800 golgin A1 chr9:12766255 THC2748759 [Source: HGNC 8-127652199 Symbol; Acc: 4424] [ENST00000373551] A_33_P3267745 Q3W7R2_9ACTO chr9:13900997 THC2534319 (Q3W7R2) 8-139009919 ABC transporter, partial (4%) [THC2534319] A_24_P399980 HEPH Homo sapiens NM_014799 ENST00000343002 9843 hephaestin chrX:65486328- GO:0016020|GO:0005506| NM_014799 THC2461505 Hs.31720 hephaestin 65486387 GO:0005507|GO:0030218| (HEPH), GO:0016491|GO:0006826| transcript GO:0016021|GO:0046872| variant 2, GO:0006825|GO:0055114| mRNA [NM_014799] GO:0006811 A_33_P3356752 GPER Homo sapiens NM_001039966 ENST00000401670 2852 G protein- chr7:1132386- GO:0007165|GO:0005794| NM_001039966 THC2471419 Hs.20961 G protein- coupled 1132445 GO:0007186|GO:0005886| coupled estrogen GO:0005887|GO:0005783| estrogen receptor 1 GO:0004930|GO:0004872 receptor 1 (GPER), transcript variant 3, mRNA [NM_001039966] A_33_P3210069 chr16:0335737 50-033573809 A_33_P3376026 PREDICTED: XR_109245 ENST00000382225 chr16:3086692- XR_109245 THC2483708 Hs.666223 Homo sapiens 3086751 hypothetical LOC100128770 (LOC100128770), miscRNA [XR_109245] A_23_P156683 LTA Homo sapiens NM_000595 ENST00000383303 4049 lymphotoxin chr6:31541154i GO:0005164|GO:0007584| NM_000595 THC2609500 Hs.36 lymphotoxin alpha (TNF 31541213 GO:0007267|GO:0048147| alpha (TNF superfamily, GO:0005576|GO:0006917| superfamily, member 1) GO:0005125|GO:0005615| member 1) GO:0048535|GO:0007165| (LTA), GO:0016020|GO:0006959| transcript GO:0032496 variant 2, mRNA [NM_000595] A_33_P3350575 OC90 Homo sapiens NM_001080399 ENST00000443356 729330 otoconin 90 chr8:13303678 GO:0016042|GO:0008150| NM_001080399 Hs.653174 otoconin 90 7-133036728 GO:0003674|GO:0005509| (OC90), GO:0004623|GO:0005578| mRNA [NM_001080399] GO:0005576|GO:0006644 A_33_P3261937 RNASE13 Homo sapiens NM_001012264 ENST00000382951 440163 ribonuclease, chr14:2150104 GO:0005576|GO:0004522| NM_001012264 Hs.666729 ribonuclease, RNase A 9-21500990 GO:0003676 RNase A family, 13 family, 13 (non-active) (non-active) (RNASE13), mRNA [NM_001012264] A_23_P162734 RNF6 Homo sapiens NM_005977 ENST00000381570 6049 ring finger chr13:2678736 GO:0005515|GO:0006511| NM_005977 THC2466322 Hs.136885 ring finger protein 4-26787305 GO:0030424|GO:0004842| protein (C3H2C3 GO:0016563|GO:0005575| (C3H2C3 type) type) 6 GO:0003677|GO:0046872| 6 (RNF6), GO:0008150|GO:0005737| transcript GO:0030517|GO:0016605| variant 1, GO:0008270|GO:0045893 mRNA [NM_005977] A_23_P121806 ENOPH1 Homo sapiens NM_021204 ENST00000505846 58478 enolase- chr4:83381838- GO:0008967|GO:0000287| NM_021204 THC2501913 Hs.18442 enolase- phospha- 83381897 GO:0016787|GO:0019509| phosphatase 1 tase 1 GO:0008152|GO:0009086| (ENOPH1), GO:0008652|GO:0005575| mRNA [NM_021204] GO:0043874 A_33_P3297611 wn53g02.x1 AI924184 chr2:11925478 Hs.580542 NCI_CGAP_Lu19 4-119254843 Homo sapiens cDNA clone IMAGE: 2449202 3′, mRNA sequence [AI924184] A_23_P109171 BFSP1 Homo sapiens NM_001195 ENST00000536626 631 beaded chr20:1747462 GO:0005882|GO:0005515| NM_001195 THC2464659 Hs.129702 beaded filament filament 9-17474570 GO:0008150|GO:0005737| structural protein structural GO:0005212|GO:0016020| 1, filensin protein 1, GO:0005200|GO:0005856 (BFSP1), filensin transcript variant 1, mRNA [NM_001195] A_23_P404685 LCE1A Homo sapiens NM_178348 ENST00000335123 353131 late chr1:15280002 GO:0031424 NM_178348 NP1246950 Hs.534645 late cornified cornified 6-152800085 envelope 1A envelope (LCE1A), 1A mRNA [NM_178348] A_23_P51565 TNNI1 Homo sapiens NM_003281 ENST00000336092 7135 troponin 1 chr1:20138693 GO:0005861|GO:0006942| NM_003281 THC2568212 Hs.320890 troponin 1 type 1 6-201384353 GO:0003779|GO:0005523 type 1 (skeletal, (skeletal, slow) slow) (TNNI1), mRNA [NM_003281] A_24_P341535 LOC388152 Homo sapiens NR_027001 ENST00000442755 388152 hypothetical chr15:8487367 NR_027001 THC2526769 Hs.405809 hypothetical LOC388152 1-84873612 LOC388152 (LOC388152), non-coding RNA [NR_027001] A_23_P23728 SV2A Homo sapiens NM_014849 ENST00000369146 9900 synaptic chr1:14987605 GO:0005515|GO:0005215| NM_014849 THC2629537 Hs.516153 synaptic vesicle vesicle 1-149875992 GO:0030054|GO:0031594| glycoprotein 2A glyco- GO:0005783|GO:0006874| (SV2A), protein 2A GO:0031410|GO:0055085| mRNA [NM_014849] GO:0005737|GO:0016020| GO:0006836|GO:0030672| GO:0016021 A_33_P3341568 chr13:01924175 3-019241812 A_33_P3260747 NHSL2 NHS-like 2 BC033261 ENST00000373677 340527 NHS-like 2 chrX:71361153- THC2604813 Hs.397836 (Source: 71361212 HGNC Symbol; Acc: 33737] [ENST00000373677] A_23_P362759 PRDM5 Homo sapiens NM_018699 ENST00000428209 11107 PR domain chr4:12161630 GO:0005622|GO:0016575| NM_018699 THC2476650 Hs.666782 PR domain containing 5 8-121616249 GO:0016566|GO:0070491| containing 5 GO:0010843|GO:0008270| (PRDM5), GO:0000278|GO:0046872| mRNA [NM_018699] GO:0005634|GO:0045449| GO:0051567|GO:0016568 A_33_P3292844 NEUROG3 Homo sapiens NM_020999 ENST00000242462 50674 neurogenin 3 chr10:7133190 GO:0005737|GO:0003700| NM_020999 THC2483225 Hs.532682 neurogenin 3 1-71331842 GO:0003690|GO:0045666| (NEUROG3), GO:0045944|GO:0030855| mRNA [NM_020999] GO:0016563|GO:0007422| GO:0007275|GO:0005634| GO:0007417|GO:0045449 A_33_P3356811 LCE1E Homo sapiens NM_178353 ENST00000368771 353135 late chr1:15276011 GO:0031424 NM_178353 THC2643480 Hs.250236 late cornified cornified 9-152760178 envelope IE envelope (LCE1E), IE mRNA [NM_178353] A_33_P3355608 PCDHA7 Homo sapiens NM_031852 ENST00000378125 56141 protocadherin chr5:14021627 GO:0005515|GO:0005886| NM_031852 THC2709681 Hs.199343 protocadherin alpha 7 9-140216338 GO:0005887|GO:0005509| alpha 7 GO:0007155|GO:0007156| (PCDHA7), GO:0007399 transcript variant 2, mRNA [NM_031852] A_33_P3245489 ADAMTSL5 Homo sapiens NM_213604 ENST00000395467 339366 ADAMTS- chr19:1506798- GO:0005515|GO:0005578| NM_213604 THC2734163 Hs.371b74 ADAMTS-like 5 like 5 1506739 GO:0008270|GO:0005576| (ADAMTSL5), GO:0004222 mRNA [NM_213604] A_33_P3371727 SAT1 spermidine/ AK310078 ENST00000379253 6303 spermidine/ chrX:23802269 THC2523522 Hs.28491 spermine N1- spermine N1- 23802328 acetyltransferase 1 acetyl- [Source: HGNC transferase 1 Symbol; Acc: 10540] [ENST00000379253] A_23_P100711 PMP22 Homo sapiens NM_000304 ENST00000312280 5376 peripheral chr17:1513326 GO:0008285|GO:0016020| NM_000304 THC2500334 Hs.372031 peripheral myelin 7-15133208 GO:0043218|GO:0007 422| myelin protein 22 GO:0007268|GO:0016021| protein 22 GO:0005923|GO:0030154 | (PMP22), GO:0032288 transcript variant 1, mRNA [NM_000304] A_33_P3209591 AQP3 Homo sapiens NM_004925 ENST00000343952 360 aquaporin chr9:33442956- GO:0005215|GO:0007588| NM_004925 THC2670748 Hs.234642 aquaporin 3 3 (Gill 33442897 GO:0005886|GO:0033280| (Gill blood blood GO:0002684|GO:0055085| group) (AQP3), group) GO:0016323|GO:0045616| mRNA [NM_004925] GO:0051592|GO:0015250| GO:0006833|GO:0015254| GO:0016021|GO:0032526 A_33_P3423551 IER3 Homo sapiens NM_003897 ENST00000376382 8870 immediate chr6:30711635- GO:0005515|GO:0016020| NM_003897 THC2617196 Hs.76095 immediate early 30711576 GO:0006915|GO:0006916| early response 3 GO:0016021|GO:0009653 response 3 (IER3), mRNA [NM_003897] A_33_P3598363 LOC400662 Homo sapiens AK055411 400662 hypothetical chr18:7590075 THC2630304 Hs.531297 cDNA FLJ30849 LOC400662 3-75900812 fis, clone FEBRA2002882. [AK055411] A_23_P125772 SRPK3 Homo sapiens NM_014370 ENST00000370101 26576 SRSF chrX:15305086 GO:0007517|GO:0000166| NM_014370 THC2687284 Hs.104865 SRSF protein protein 6-153050925 GO:0004674|GO:0007275| kinase 3 kinase 3 GO:0006468|GO:0005575| (SRPK3), GO:0005524|GO:0030154| transcript GO:0016740 variant 1, mRNA [NM_014370] A_33_P3229869 LOC100128714 Homo sapiens NR_040082 ENST00000383019 100128714 hypothetical chr15:2626073 NR_040082 THC2487359 Hs.587854 hypothetical LOC100128714 6-26260795 LOC100128714 (LOC100128714), non-coding RNA [NR_040082] A_33_P3300152 LOC100506972 PREDICTED: XM_003118914 100506972 uncharacterized chr14:9593016 XM_003118914 THC2696735 Hs.675410 Homo sapiens protein 6-95930107 uncharacterized C14orf113-like protein C14orf113-like (LOC100506972), mRNA [XM_003118914] A_33_P3230798 MUSK muscle, skeletal, ENST00000374441 4593 muscle, chr9:11355015 THC2660930 receptor tyrosine skeletal, 4-113550213 kinase [Source: receptor HGNC Symbol; tyrosine Acc: 7525] kinase [ENST00000374441] A_33_P3256848 ADAM12 Homo sapiens NM_021641 ENST00000368676 8038 ADAM chr10:1277317 GO:0005515|GO:0017124| NM_021641 THC2487430 Hs.594537 ADAM metal- metal- 11-127731652 GO:0005886|GO:0006508| lopeptidase lopeptidase GO:0008270|GO:0008233| domain 12 domain 12 GO:0007520|GO:0005576| (ADAM12), GO:0016021|GO:0007155| transcript GO:0004222|GO:0046872 variant 2, mRNA [NM_021641] A_33_P3378545 DB092099 DB092099 chr14:8007804 Hs.589247 TESTI4 2-80077983 Homo sapiens cDNA clone TESTI4041634 5′, mRNA sequence [DB092099] A_33_P3294986 LIPE Homo sapiens NM_005357 ENST00000244289 3991 lipase, chr19:4290572 GO:0046340|GO:0005515| NM_005357 THC2470363 Hs.656980 lipase, hormone- hormone- 5-42905666 GO:0007565|GO:0004806| sensitive (LIPE), sensitive GO:0005886|GO:0042493| mRNA [NM_05357] GO:0005615|GO:0005829| GO:0016042|GO:0005737| GO:0016787|GO:0005901| GO:0008152|GO:0047372| GO:0006468|GO:0019433| GO:0033878|GO:0008202| GO:0008203 A_33_P3364582 TNXB Homo sapiens NM_019105 ENST00000404514 7148 tenascin XB chr6:32010593- GO:0005622|GO:0007165| NM_019105 THC2737940 Hs.485104 tenascin XB 32010534 GO:0030036|GO:0005178| (TNXB), GO:0032963|GO:0005578| transcript GO:0005576|GO:0007155| variant XB, GO:0005583|GO:0008201| mRNA [NM_019105] GO:0005615|GO:0048251 A_33_P3254996 DSCR9 Homo sapiens NR_026719 257203 Down chr21:3859283 GO:0008150|GO:0003674| NR_026719 THC2475035 Hs.720778 Down syndrome syndrome 4-38592893 GO:0005575 critical region critical gene 9 (non- region gene 9 protein coding) (nonprotein (DSCR9), coding) non-coding RNA [NR_026719] A_23_P119943 IGFBP2 Homo sapiens NM_000597 ENST00000490362 3485 insulin-like chr2:21752908 GO:0007565|GO:0007584| NM_000597 THC2466327 Hs.438102 insulin-like growth factor 6-217529145 GO:0042493|GO:0007568| growth factor binding GO:0006950|GO:0031994| binding protein 2, GO:0031995|GO:0051384| protein 2, 36 kDa 36 kDa GO:0005576|GO:0031410| (IGFBP2), GO:0001558|GO:0005615| mRNA [NM_000597] GO:0032870|GO:0009612| GO:0007165|GO:0016324| GO:0010226|GO:0043567| GO:0032526|GO:0032355 A_33_P3397865 TNNT1 Homo sapiens NM_003283 ENST00000291901 7138 troponin chr19:5564425 GO:0005515|GO:0031014| NM_003283 THC2560689 Hs.631558 troponin T T type 1 5-55644196 GO:0045932|GO:0005861| type 1 (skeletal, slow) GO:0003009|GO:0031444| (skeletal, slow) GO:0005523 (TNNT1), transcript variant 1, mRNA [NM_003283] A_33_P3214943 SPOCK2 Homo sapiens NM_001134434 ENST00000412663 9806 sparc/ chr10:7384618 GO:0007165|GO:0030198| NM_001134434 THC2529803 Hs.523009 sparc/osteonectin, osteonectin, 7-73846128 GO:0005509|GO:0005578| cwcv and kazal-like cwcv and GO:0045595|GO:0005576| domains kazal-like GO:0007416 proteoglycan domains (testican) 2 proteoglycan (SPOCK2), (testican) 2 transcript variant 1, mRNA [NM_001134434] A_24_P415601 RNH1 Homo sapiens NM_002939 ENST00000524464 6050 ribonuclease/ chr11:498093- GO:0005515|GO:0005737| NM_002939 NP1194622 Hs.530687 ribonuclease/ angiogenin 498034 GO:0032311|GO:0008428| angiogenin inhibitor 1 GO:0045765|GO:0006402 inhibitor 1 (RNH1), transcript variant 1, mRNA [NM_002939] A_33_P3386508 LOC100132273 Homo sapiens NR_034118 ENST00000417327 100132273 hypothetical chr22:4252049 NR_034118 THC2492791 Hs.709677 hypothetical LOC100132273 7-42520556 LOC100132273 (LOC100132273), non-coding RNA [NR_034118] A_23_P209962 SMC6 Homo sapiens NM_024624 ENST00000402989 79677 structural chr2:17851726- GO:0005622|GO:0005694| NM_024624 THC2610758 Hs.526728 structural maintenance of 17847762 GO:0006281|GO:0000166| maintenance of chromosomes 6 GO:0006310|GO:0005634| chromosomes 6 GO:0005524|GO:0006974 (SMC6), transcript variant 2, mRNA [NM_024624] A_23_P123672 TDRD7 Homo sapiens NM_014290 ENST00000422139 23424 tudor domain chr9:10025823 GO:0005737|GO:0047485| NM_014290 NP340636 Hs.193842 tudor containing 7 6-100258295 GO:0030529|GO:0005759| domain GO:0043186|GO:0003676| containing 7 GO:0007281 (TDRD7), mRNA [NM_014290] A_33_P3354176 MYOF myoferlin ENST00000371488 26509 myoferlin chr10:9518555 [Source: HGNC 7-95185498 Symbol; Acc: 3656] [ENST00000371488] A_24_P175187 SAMD9 Homo sapiens NM_017654 ENST00000379958 54809 sterile alpha chr7:92729841- GO:0005737 NM_017654 THC2464095 Hs.65641 sterile alpha motif domain 92729782 motif domain containing 9 containing 9 (SAMD9), transcript variant 1, mRNA [NM_017654] A_33_P3223467 VCPIP1 Homo sapiens NM_025054 ENST00000310421 80124 valosin chr8:67542631- GO:0007067|GO:0005737| NM_025054 THC2602555 Hs.632066 valosin containing 67542572 GO:0016567|GO:0005794| containing protein (p97)/ GO:0004843|GO:0005795| protein (p97)/ p47 complex GO:0005783|GO:0019941| p47 complex interacting GO:0016320|GO:0007030| interacting protein 1 GO:0008233|GO:0008234 protein 1 (VCPIP1), mRNA [NM_025054] A_33_P3355717 Homo sapiens AK097098 ENST00000408913 chr14:6926257 THC2475408 Hs.655774 cDNA FLJ39779 0-69262511 fis, clone SPLEN2001945. [AK097098] A_23_P40174 MMP9 Homo sapiens NM_004994 ENST00000545925 4318 matrix metal- chr20:4464512 GO:0043065|GO:0051549| NM_004994 THC2596473 Hs.297413 matrix lopeptidase 9 1-44645180 GO:0005509|GO:0005518| metallopeptidase 9 (gelatinase B, GO:0005578|GO:0005576| (gelatinase B, 92 kDa gela- GO:0005615|GO:0001501| 92 kDa gelatinase, tinase, 92 kDa GO:0030198|GO:0030574| 92 kDa type IV type IV GO:0008152|GO:0006508| collagenase) collagenase) GO:0030225|GO:0008233| (MMP9), GO:0008270|GO:0004222 mRNA [NM_004994] A_23_P311201 serine/arginine- XM_003119082 ENST00000344989 chr1:24291533- GO:0000244|GO:0008380| XM_003119082 THC2558154 Hs.652334 rich splicing 24291474 GO:0048025|GO:0003723| factor 10 [Source: GO:0006376|GO:0005634| HGNC Symbol; GO:0050733|GO:0005737| Acc: 16713] GO:0006406|GO:0000166| [ENST00000344989] GO:0016607|GO:0016482| GO:0005654|GO:0051082| GO:0045449 A_23_P112482 AQP3 Homo sapiens NM_004925 ENST00000494313 360 aquaporin 3 chr9:33441824- GO:0005215|GO:0007588| NM_004925 THC2604824 Hs.234642 aquaporin 3 (Gill blood 33441765 GO:0005886|GO:0033280| (Gill blood group) GO:0002684|GO:0055085| group) (AQP3), GO:0016323|GO:0045616| mRNA [NM_004925] GO:0051592|GO:0015250| GO:0006833|GO:0015254| GO:0016021|GO:0032526 A_33_P3272539 PLEKHG5 Homo sapiens NM_198681 ENST00000377725 57449 pleckstrin chr1:6528219- GO:0005622|GO:0005085| NM_198681 NP1205923 Hs.284232 pleckstrin homology homology 6528160 GO:0008624|GO:0008219| domain containing, domain GO:0048471|GO:0005737| family G (with RhoGef containing, GO:0035023|GO:0006915| domain) member 5 family G GO:0004871|GO:0043123| (PLEKHG5), (with RhoGef GO:0005089|GO:0005829 transcript variant 2, domain) mRNA [NM_198681] member 5 A_24_P56388 HIF1A Homo sapiens NM_181054 ENST00000394997 3091 hypoxia chr14:6221484 GO:0030949|GO:0003705| NM_181054 THC2465290 Hs.597216 hypoxia inducible inducible 5-62214904 GO:0051879|GO:0005634| factor 1, factor 1, GO:0001837|GO:0051541| alpha subunit alpha subunit GO:0043193|GO:0005737| (basic helix (basic helix- GO:0045941|GO:0046886| loop-helix loop-helix GO:0045944|GO:0042789| transcription transcription GO:0004871|GO:0045821| factor) (HIF1A), factor) GO:0035035|GO:0005667| transcript GO:0001666|GO:0006355| variant 2, GO:0046982|GO:0005730| mRNA [NM_181054] GO:0002248|GO:0043619| GO:0032722|GO:0010575| GO:0045766|GO:0043565| GO:0007165|GO:0032909| GO:0001938|GO:0051000| GO:0045648|GO:0032963| GO:0010634|GO:0032364| GO:0008134 A_33_P3423425 ZNF770 Homo sapiens NM_014106 ENST00000356321 54989 zinc finger chr15:3527062 GO:0005622|GO:0008270| NM_014106 THC2775225 Hs.730754 zinc finger protein 770 7-35270568 GO:0005634|GO:0003677| protein 770 GO:0046872|GO:0045449 (ZNF770), mRNA [NM_014106] A_33_P3367850 CHRM4 Homo sapiens NM_000741 ENST00000433765 1132 cholinergic chr11:4640672 GO:0005515|GO:0030054| NM_000741 THC2602240 Hs.248100 cholinergic receptor, 8-46406669 GO:0004930|GO:0008283| receptor, muscarinic 4 GO:0005624|GO:0007197| muscarinic 4 GO:0014069|GO:0032279| (CHRM4), GO:0005085|GO:0042383| mRNA [NM_000741] GO:0004981|GO:0005887| GO:0045211|GO:0043025| GO:0044424|GO:0043679| GO:0004872 A_23_P355471 TBXA2R Homo sapiens NM_201636 ENST00000411851 6915 thromboxane chr19:3599878- GO:0007165|GO:0007186| NM_201636 THC2485563 Hs.442530 thromboxane A2 receptor 3595904 GO:0005886|GO:0005887| A2 receptor GO:0004930|GO:0004961| (TBXA2R), GO:0004872 transcript variant b, mRNA [NM_201636] A_23_P114670 ARHGEF16 Homo sapiens NM_014448 ENST00000378378 27237 Rho guanine chr1:3397479- GO:0005622|GO:0005085| NM_014448 THC2470604 Hs.87435 Rho guanine nucleotide 3397538 GO:0008624|GO:0035023| nucleotide exchange GO:0006915|GO:0005089| exchange factor factor (GEF) GO:0005829 (GEF) 16 16 (ARHGEF16), mRNA [NM_014448] A_33_P3369956 ATXN2L Homo sapiens NM_148416 ENST00000382686 11273 ataxin 2-like chr16:2884738 GO:0008150|GO:0003674| NM_148416 NP589496 Hs.460499 ataxin 2-like 4-28847443 GO:0016020|GO:0005575| (ATXN2L), GO:0019898 transcript variant E, mRNA [NM_148416] A_23_P115407 GSTM1 Homo sapiens NM_146421 ENST00000489913 2944 glutathione chr1:11023167 GO:0005737|GO:0008152| NM_146421 THC2563659 Hs.301961 glutathione S- S-transferase 2-110231731 GO:0004364|GO:0016740 transferase mu mu 1 1 (GSTM1), transcript variant 2, mRNA [NM_146421] A_24_P411899 RNF19A Homo sapiens NM_183419 ENST00000341084 25897 ring finger chr8:10126985 GO:0005813|GO:0016020| NM_183419 THC2744210 Hs.292882 ring finger protein 19A 0-101269791 GO:0019941|GO:0016874| protein 19A GO:0000226|GO:0008270| (RNF19A), GO:0016021|GO:0046872| transcript GO:0006464|GO:0008134 variant 1, mRNA [NM_183419] A_33_P3245454 LOC389834 Homo sapiens NR_027420 389834 ankyrin repeat chr21:9921497- NR_027420 THC2474667 Hs.720653 ankyrin repeat domain 57 9921438 domain 57 pseudogene pseudogene (LOC389834), non-coding RNA [NR_027420] A_33_P3411848 CNFN Homo sapiens NM_032488 ENST00000222032 84518 cornifelin chr19:4289131 GO:0005737|GO:0031424| NM_032488 THC2478456 Hs.148590 cornifelin (CNFN), 8-42891259 GO:0001533 mRNA [NM_032488] A_33_P3312754 chr16:0797552 83-079755224 A_24_P96474 LDOC1L Homo sapiens NM_032287 ENST00000341255 84247 leucine zipper, chr22:4488879 NM_032287 THC2462399 Hs.332795 leucine zipper, down-regulated 1-44888732 down-regulated in cancer in cancer 1-like 1-like (LDOC1L), mRNA [NM_032287] A_23_P123393 KCNQ3 Homo sapiens NM_004519 ENST00000519589 3786 potassium chr8:13314152 GO:0005244|GO:0016020| NM_004519 NP1473798 Hs.374023 potassium voltage-gated 8-133141469 GO:0008076|GO:0005249| voltage-gated channel, KQT- GO:0007268|GO:0030955| channel, like subfamily, GO:0016021|GO:0055085| KQT-like member 3 GO:0006813|GO:0006811 subfamily, member 3 (KCNQ3), transcript variant 1, mRNA [NM_004519] A_24_P709377 LOC654433 Homo sapiens NR_015377 654433 hypothetical chr2:11402424 NR_015377 THC2472587 Hs.656660 hypothetical LOC654433 8-114024307 LOC654433 (LOC654433), non-coding RNA [NR_015377] A_23_P250571 DMXL1 Homo sapiens NM_005509 ENST00000514595 1657 Dmx-like 1 chr5:11858447 GO:0005515 NM_005509 NP1159462 Hs.181042 Dmx-like 1 3-118584532 (DMXL1), mRNA [NM_005509] A_33_P3327470 Q6I984_HUMAN chr19:0495423 THC2606816 (Q6I984) 03-049542244 Acidic neurotropism 6 alpha (Fragment), complete [THC2606816] A_33_P3334404 CA6 carbonic anhydrase JF432775 ENST00000319474 765 carbonic chr1:9011597- THC2490642 Hs.100322 VI [Source: anhydrase 9011656 HGNC Symbol; VI Acc: 1380] [ENST00000319474] A_33_P3308432 MORN1 MORN repeat ENST00000449373 79906 MORN chr1:2310557- THC2519762 containing 1 repeat 2310498 [Source: containing 1 HGNC Symbol; Acc: 25852] [ENST00000449373] A_33_P3383524 LOC91948 Homo sapiens NR_024172 91948 hypothetical chr15:9828595 NR_024172 THC2567547 Hs.130423 hypothetical LOC91948 7-98285898 LOC91948 (LOC91948), transcript variant 1, non-coding RNA [NR_024172] A_33_P3230290 ACAP3 Homo sapiens NM_030649 ENST00000492936 116983 ArfGAP with chr1:1227895- GO:0008060|GO:0032312| NM_030649 THC2462386 Hs.535257 ArfGAP with coiled-coil, 1227836 GO:0008270|GO:0046872 coiled-coil, ankyrin repeat ankyrin repeat and PH and PH domains domains 3 3 (ACAP3), mRNA [NM_030649] A_33_P3222783 SURF4 Homo sapiens NM_033161 ENST00000537106 6836 surfeit 4 chr9:13623177 GO:0005515|GO:0008150| NM_033161 THC2539228 Hs.512465 surfeit 4 6-136231717 GO:0003674|GO:0005793| (SURF4), GO:0016020|GO:0005783| mRNA [NM_033161] GO:0016021 A_23_P215956 MYC Homo sapiens NM_002467 ENST00000454617 4609 v-myc chr8:12875326 GO:0006879|GO:0005515| NM_002467 THC2468611 Hs.202453 v-myc myelocyto- 8-128753327 GO:0008284|GO:0003700| myelocytomatosis matosis viral GO:0006357|GO:0005819| viral oncogene oncogene GO:0032204|GO:0007050| homolog (avian) homolog GO:0005634 (MYC), (avian) mRNA [NM_002467] A_33_P3401084 chr17:0373082 91-037308350 A_23_P109913 CXCR6 Homo sapiens NM_006564 ENST00000438735 10663 chemokine chr3:45989385- GO:0007165|GO:0007186| NM_006564 THC2485202 Hs.34526 chemokine (C-X-C motif) 45989443 GO:0005886|GO:0016494| (C-X-C motif) receptor 6 GO:0005887|GO:0004930| receptor 6 GO:0016493|GO:0015026| (CXCR6), GO:0019079 mRNA [NM_006564] A_24_P363896 COL27A1 Homo sapiens NM_032888 ENST00000357257 85301 collagen, chr9:11707289 GO:0005581|GO:0005576| NM_032888 THC2493513 Hs.494892 collagen, type type XXVII, 5-117072954 GO:0007155|GO:0005201 XXVII, alpha 1 alpha 1 (COL27A1), mRNA [NM_032888] A_33_P3378284 COX6B2 Homo sapiens NM_144613 ENST00000326529 125965 cytochrome c chr19:5586141 GO:0005739|GO:0005758| NM_144613 NP1157598 Hs.550544 cytochrome c oxidase subunit 6-55861357 GO:0004129|GO:0030061 oxidase subunit VIb polypep- VIb polypeptide tide 2 (testis) 2 (testis) (COX6B2), mRNA [NM_144613] A_23_P210425 MYL9 Homo sapiens NM_181526 ENST00000279022 10398 myosin, chr20:3517754 GO:0006937|GO:0003774| NM_181526 THC2598537 Hs.504687 myosin, light light chain 1-35177600 GO:0005509|GO:0016459| chain 9, 9, regulatory GO:0005859|GO:0008307 regulatory (MYL9), transcript variant 2, mRNA [NM_181526] A_33_P3326025 KANK3 KN motif AY203940 ENST00000381056 256949 KN motif chr19:8398739- THC2556942 and ankyrin and ankyrin 8398680 repeat domains repeat 3 [Source: domains 3 HGNC Symbol; Acc: 24796] [ENST00000381056] A_23_P104563 CPT1A Homo sapiens NM_001031847 ENST00000539743 1374 carnitine chr11:6852712 GO:0006629|GO:0005792| NM_001031847 THC2464485 Hs.503043 carnitine palmitoyl- 2-68527063 GO:0006635|GO:0004095| palmitoyl- transferase GO:0005743|GO:0005741| transferase 1A 1A (liver) GO:0005739|GO:0050796| (liver) (CPT1A), GO:0016020|GO:0006631| nuclear gene GO:0006810|GO:0006006| encoding mito- GO:0042755|GO:0016021| chondrial protein, GO:0016740|GO:0008415 transcript variant 2, mRNA [NM_001031847] A_33_P3314810 AF059569 chr6:00014365 THC2733494 actin binding 9-000143718 protein MAYVEN {Homo sapiens} (exp = −1; wgp = 0; cg = 0), partial (29%) [THC2733494] A_24_P28811 C2orf14 Homo sapiens NR_023391 ENST00000439137 100132708 chromosome chr2:13143819 NR_023391 THC2535623 Hs.710729 chromosome 2 open reading 6-131438255 open reading 2 frame 14 frame 14 (C2orf14), non-coding RNA [NR_023391] A_33_P3260426 SPRR2A Homo sapiens NM_005988 ENST00000392653 6700 small- chr1:15302898 GO:0005737|GO:0008544| NM_005988 THC2517261 Hs.355542 small proline-rich proline 5-153028926 GO:0005488|GO:0031424| protein 2A rich protein GO:0001533 (SPRR2A), 2A mRNA [NM_005988] A_23_P210886 BCL2L1 Homo sapiens NM_138578 ENST00000420653 598 BCL2-like 1 chr20:3025338 GO:0042542|GO:0014070| NM_138578 THC2507989 Hs.516966 BCL2-like 1 3-30253324 GO:0008284|GO:0043434| (BCL2L1), GO:0005741|GO:0005634| nuclear gene GO:0001836|GO:0007283| encoding GO:0007281|GO:0042802| mitochondrial GO:0005739|GO:0005622| protein, GO:0005829|GO:0051789| transcript GO:0043524|GO:0001541| variant 1, GO:0010035|GO:0034097| mRNA [NM_138578] GO:0006979|GO:0043027| GO:0008634|GO:0009314| GO:0046902|GO:0001666| GO:0010288|GO:0043065| GO:0046982|GO:0051881| GO:0010243|GO:0046898| GO:0045768|GO:0001701| GO:0009566|GO:0016020| GO:0016021|GO:0040007| GO:0008584 A_33_P3209581 IQSEC3 Homo sapiens NM_001170738 ENST00000552304 440073 IQ motif chr12:176547- NM_001170738 NP437544 Hs.536319 IQ motif and and Sec7 208312 Sec7 domain 3 domain 3 (IQSEC3), transcript variant 1, mRNA [NM_001170738] A_33_P3211965 UI-E-EJO-ahi-b- BM674043 chr16:3083274 Hs.681104 22-O-UI.sl UI-E-EJO 3-30832684 Homo sapiens cDNA clone UI-E-EJO-ahi-b- 22-O-UI 3′, mRNA sequence [BM674043] A_24_P185036 FTSJD1 Homo sapiens NM_018348 ENST00000434935 55783 FtsJ methyl- chr16:7131689 GO:0016020|GO:0008168| NM_018348 THC2464150 Hs.72782 FtsJ methyltransferase transferase 5-71316836 GO:0016021|GO:0003676| domain containing domain GO:0032259|GO:0016740 1 (FTSJD1), containing 1 transcript variant 1, mRNA [NM_018348] A_23_P21425 GPR119 Homo sapiens NM_178471 ENST00000276218 139760 G protein- chrX:12951873 GO:0007165|GO:0007186| NM_178471 THC2479570 Hs.496762 G protein-coupled coupled 1-129518672 GO:0005886|GO:0001619| receptor 119 receptor 119 GO:0004930|GO:0004872| (GPR119), GO:0016021|GO:0030073| mRNA [NM_178471] GO:0008289 A_23_P63896 FAS Homo sapiens NM_000043 ENST00000355740 355 Fas (TNF chr10:9077454 GO:0008624|GO:0008633| NM_000043 THC2522452 Hs.244139 Fas (TNF receptor 5-90774604 GO:0005886|GO:0031264| receptor superfamily, GO:0042981|GO:0005576| superfamily, member 6) GO:0005625|GO:0006916| member 6) (FAS), GO:0042802|GO:0005829| transcript GO:0007165|GO:0006955| variant 1, GO:0006461|GO:0016021| mRNA [NM_000043] GO:0019900|GO:0004888| GO:0010940 A_33_P3367924 PABPN1L Homo sapiens NM_001080487 ENST00000411789 390743 poly(A) chr16:8893284 GO:0005737|GO:0003723 NM_001080487 Hs.730522 poly(A) binding 4-88932785 binding protein, protein, nuclear 1-like nuclear 1- (cytoplasmic) like (PABPN1L), (cytoplasmic) mRNA [NM_001080487] A_23_P11697 HMGB4 Homo sapiens NM_145205 ENST00000522796 127540 high chr1:34329965- GO:0005694|GO:0005634| NM_145205 THC2471340 Hs.568628 high mobility mobility 34330024 GO:0003677 group box 4 group (HMGB4), box 4 transcript variant 1, mRNA [NM_145205] A_23_P162322 WNT10B Homo sapiens NM_003394 ENST00000301061 7480 wingless- chr12:4935949 GO:0007165|GO:0005578| NM_003394 NP1456377 Hs.91985 wingless-type type 6-49359437 GO:0007275|GO:0005576| MMTV integration MMTV GO:0004871|GO:0007223 site family, integration member 10B site family, (WNT10B), member 10B mRNA [NM_003394] A_33_P3316691 chr18:0144495 14-014449573 A_23_P410613 C12orf23 Homo sapiens NM_152261 ENST00000280756 90488 chromosome chr12:1073675 GO:0016020|GO:0016021 NM_152261 THC2499724 Hs.257664 chromosome 12 12 open 33-107367592 open reading reading frame 23 (C12orf23), frame 23 mRNA [NM_152261] A_24_P751074 ETS1 Homo sapiens NM_005238 ENST00000392668 2113 v-ets erythro- chr11:1283286 GO:0043565|GO:0006955| NM_005238 THC2609159 Hs.369438 v-ets erythroblastosis blastosis 79-128328656 GO:0030578|GO:0008285| virus E26 oncogene virus E26 GO:0003700|GO:0045648| homolog 1 oncogene GO:0048870|GO:0010552| (avian) (ETS1), homolog 1 GO:0005634|GO:0045893| transcript variant 2, (avian) GO:0051272|GO:0008134 mRNA [NM_005238] A_23_P11543 FUCA1 Homo sapiens NM_000147 ENST00000371479 2517 fucosidase, chr1:24171909- GO:0005737|GO:0005975| NM_000147 THC2518697 Hs.370858 fucosidase, alpha L-1, 24171850 GO:0004560|GO:0016798| alpha-L-1, tissue tissue GO:0008152|GO:0005529| (FUCA1), GO:0006027|GO:0005625| mRNA [NM_000147] GO:0006004|GO:0005764 A_33_P3422030 FXYD5 FXYD domain ENST00000392218 53827 FXYD chr19:3565077 containing ion domain 3-35650832 transport regulators containing [Source: HGNC ion transport Symbol; Acc: 4029] regulator 5 [ENST00000392218] A_33_P3275199 JRK Homo sapiens NM_003724 ENST00000422119 8629 jerky chr8:14373908 GO:0008150|GO:0003674| NM_003724 THC2526551 Hs.535903 jerky homolog homolog 5-143739026 GO:0005737|GO:0030529| (mouse) (JRK), (mouse) GO:0005634|GO:0005575| transcript variant 1, GO:0003729|GO:0003677| mRNA [NM_003724] GO:0045449 A_23_P123071 CAV2 Homo sapiens NM_001233 ENST00000498493 858 caveolin 2 chr7:11614038 GO:0051219|GO:0030133| NM_001233 THC2788990 Hs.212332 caveolin 2 9-116140448 GO:0048471|GO:0005886| (CAV2), transcript GO:0007268|GO:0005634| variant 1, GO:0051259|GO:0006906| mRNA [NM_001233] GO:0042803|GO:0070836| GO:0005829|GO:0005622| GO:0005737|GO:0060161| GO:0048278|GO:0005811| GO:0019905|GO:0007088| GO:0005794|GO:0009986| GO:0005624|GO:0048741| GO:0031234|GO:0043234| GO:0005887|GO:0001937| GO:0005901|GO:0007005| GO:0007029 A_33_P3411315 KRTAP3-3 Homo sapiens NM_033185 ENST00000391586 85293 keratin chr17:3915011 GO:0005198|GO:0045095 NM_033185 THC2485385 Hs662759 keratin associated associated 2-39150053 protein 3-3 protein 3-3 (KRTAP3-3), mRNA [NM_033185] A_33_P3255176 chr1:02655164 3-026551702 A_33_P3283485 LOC440337 PREDICTED: XR_111632 440337 hypothetical chr16:6427992- XR_111632 THC2688565 Hs.683875 Homo sapiens LOC440337 6428051 hypothetical LOC440337 (LOC440337), misc- RNA [XR_111632] A_23_P106773 SULT1A2 Homo sapiens NM_177528 ENST00000395630 6799 sulfotransferase chr16:2860332 GO:0006629|GO:0005737| NM_177528 THC2495029 Hs.546304 sulfotransferase family, 6-28603267 GO:0006584|GO:0004062| family, cytosolic, cytosolic, GO:0009309|GO:0016740| 1A, phenol- 1A, phenol- GO:0008202 preferring, preferring, member 2 member 2 (SULT1A2), transcript variant 2, mRNA [NM_177528] A_33_P3305023 WWOX Homo sapiens NM_130844 51741 WW domain chr16:7813403 GO:0050662|GO:0005794| NM_130844 THC2619560 Hs.461453 WW domain containing 6-78134095 GO:0030178|GO:0048705| containing oxidore- oxidoreductase GO:0005634|GO:0006917| ductase (WWOX), GO:0001649|GO:0005739| transcript variant 3, GO:0005737|GO:0016491| mRNA [NM_130844] GO:0046983|GO:0008202| GO:0055114 A_33_P3357651 KRTAP10- Homo sapiens NM_198699 ENST00000452870 386685 keratin chr21:4611754 GO:0045095 NM_198699 THC2483182 Hs.297526 12 keratin associated associated 3-46117602 protein 10-12 protein 10-12 (KRTAP10-12), mRNA [NM_198699] A_23_P151598 CPNE6 Homo sapiens NM_006032 ENST00000537691 9362 copine VI chr14:2454473 GO:0006629|GO:0030424| NM_006032 THC2488672 Hs.6132 copine VI (neuronal) 4-24544793 GO:0005215|GO:0005509| (neuronal) (CPNE6), GO:0001786|GO:0007268| mRNA GO:0005624|GO:0016192| [NM_006032] GO:0030425|GO:0007399 A_33_P3288871 SLC38A1 solute carrier DC378344 ENST00000550173 81539 solute chr12:4666359 Hs.719858 family 38, carrier 7-46663538 member 1 family 38, [Source: HGNC member 1 Symbol; Acc: 13447] [ENST00000550173] A_23_P155514 AHSG Homo sapiens NM_001622 ENST00000541510 197 alpha-2- chr3:18633883 GO:0005515|GO:0050766| NM_001622 THC2469134 Hs.324746 alpha-2-HS- HS- 2-186338891 GO:0006907|GO:0001501| glycoprotein glycoprotein GO:0004869|GO:0019210| (AHSG), GO:0046627|GO:0050727| mRNA [NM_001622] GO:0005576|GO:0006953| GO:0030502|GO:0005615 A_23_P253221 ARHGEF4 Homo sapiens NM_032995 ENST00000525839 50649 Rho guanine chr2:13180476 GO:0007242|GO:0008624| NM_032995 THC2487810 Hs.469935 Rho guanine nucleotide 2-131804821 GO:0005886|GO:0035023| nucleotide ex- exchange GO:0019904|GO:0006915| change factor factor GO:0005575|GO:0042995| (GEF) 4 (GEF) 4 GO:0005829|GO:0005085| (ARHGEF4), GO:0005622|GO:0005737| transcript variant 2, GO:0005089 mRNA [NM_032995] A_33_P3237784 PORCN Homo sapiens NM_203473 ENST00000326194 64840 porcupine chrX:48379104- GO:0005515|GO:0009100| NM_203473 THC2483690 Hs.386453 porcupine homolog 48379163 GO:0016020|GO:0005783| homolog (Drosophila) GO:0030176|GO:0016021| (Drosophila) GO:0016055|GO:0016740| (PORCN), GO:0008415 transcript variant B, mRNA [NM_203473] A_23_P115824 HNRNPH3 Homo sapiens NM_012207 ENST00000265866 3189 heterogeneous chr10:7010270 GO:0008380|GO:0005515| NM_012207 THC2509619 Hs.643472 heterogeneous nuclear 2-70102761 GO:0000166|GO:0000398| nuclear ribonucleo- GO:0003723|GO:0005634| ribonucleoprotein protein GO:0030530 H3 (2H9) H3(2H9) (HNRNPH3), transcript variant 2H9, mRNA [NM_012207] A_23_P209799 MYO7B Homo sapiens NM_001080527 ENST00000494959 4648 myosin VIIB chr2:12839448 GO:0016324|GO:0003774| NM_001080527 THC2604874 Hs.154578 myosin VIIB 7-128394948 GO:0005886|GO:0000166| (MY07B), GO:0003779|GO:0016459| mRNA [NM_001080527] GO:0005856|GO:0005524 A_33_P3281435 immunoglobulin AF035035 ENST00000471857 chr2:90260191- THC2548990 Hs.574701 kappa variable 90260248 1D-8 [Source: HGNC Symbol; Acc: 57591 [ENST00000471857] A_33_P3235029 MGC3.5.1.2.1.H09.F.1 DR731407 chr14:2090887 Hs.556125 NIH_MGC_331 4-20908933 Homo sapiens cDNA clone MGC3.5.1.2.1.H09, mRNA sequence [DR731407] A_24_P48069 DOK4 Homo sapiens NM_018110 ENST00000340099 55715 docking protein chr16:5750619 GO:0000165|GO:0005158| NM_018110 THC2467241 Hs.279832 docking protein 4 3-57506134 GO:0005066|GO:0007169| 4 (DOK4), GO:0007399 mRNA [NM_018110] A_33_P3236591 RLTPR Homo sapiens NM_001013838 ENST00000398282 146206 RGD motif, chr16:6769139 NM_001013838 THC2720275 Hs.611432 RGD motif, leucine rich 7-67691456 leucine rich repeats, repeats, tropo- tropomodulin modulin domain domain and and proline- proline-rich rich containing containing (RLTPR), mRNA [NM_001013838] A_23_P24234 OPN4 Homo sapiens NM_001030015 ENST00000372071 94233 opsin 4 chr10:8842611 GO:0005502|GO:0018298| NM_001030015 THC2482526 Hs.283922 opsin 4 (OPN4), 7-88426176 GO:0007165|GO:0016020| transcript GO:0007186|GO:0042752| variant 2, GO:0048511|GO:0016021| mRNA [NM_001030015] GO:0007602|GO:0007601| GO:0050896|GO:0008020 A_23_P96633 CXorf48 Homo sapiens NM_001031705 ENST00000344129 54967 chromosome chrX:13429076 NM_001031705 THC2487724 Hs.272804 chromosome X X open 2-134290704 open reading reading frame 48 frame 48 (CXorf48), transcript variant 1, mRNA [NM_001031705] A_33_P3281437 immunoglobulin AF035035 LNbT00000471857 chr2:90260030- NP1465439 Hs.574701 kappa variable 90260089 1D-8 [Source: HGNC Symbol; Acc: 5759] [ENST00000471857] A_33_P3221489 KIRREL Homo sapiens NM_018240 ENST00000359209 55243 kin of chr1:15806529 GO:0005886|GO:0016021 NM_018240 NP436211 Hs.657006 kin of IRRE IRRE like 3-158065352 like (Drosophila) (Drosophila) (KIRREL), mRNA [NM_018240] A_23_P148047 PTGER4 Homo sapiens NM_000958 ENST00000302472 5734 prostaglandin chr5:40693563- GO:0007165|GO:0006955| NM_000958 THC2463869 Hs.199248 prostaglandin E E receptor 40693622 GO:0030278|GO:0007186| receptor 4 4 (subtype GO:0005886|GO:0004930| (subtype EP4) EP4) GO:0007188|GO:0004872| (PTGER4), GO:0016021|GO:0004957 mRNA [NM_000958] A_24_P203056 BCL7A Homo sapiens NM_020993 ENST00000538010 605 B-cell CLL/ chr12:1224997 GO:0003674|GO:0016481| NM_020993 THC2777702 Hs.530970 B-cell CLL/ lymphoma 7A 58-122499817 GO:0005575 lymphoma 7A (BCL7A), transcript variant 1, mRNA [NM_020993] A_23_P116624 SLC6A5 Homo sapiens NM_004211 ENST00000298923 9152 solute carrier chr11:2067395 GO:0015375|GO:0015816| NM_004211 THC2480373 Hs.136557 solute carrier family 6 3-20676268 GO:0016020|GO:0005887| family 6 (neurotrans- GO:0005328|GO:0006836| (neurotransmitter mitter GO:0007268|GO:0015293 transporter, transporter, glycine), member glycine), 5 (SLC6A5), member 5 mRNA [NM_004211] A_23_P214977 SEC63 Homo sapiens NM_007214 ENST00000459782 11231 SEC63 chr6:10819237 GO:0016020|GO:0006457| NM_007214 THC2688372 Hs.26904 SEC63 homolog homolog 4-108192315 GO:0005783|GO:0031072| (S. cerevisiae) (S. cerevisiae) GO:0006612|GO:0004872| (SEC63), GO:0051082|GO:0016021| mRNA [NM_007214] GO:0015031 A_33_P3327592 RNF13 Homo sapiens NM_007282 ENST00000392894 11342 ring finger chr3:14967986 GO:0005515|GO:0005737| NM_007282 THC2483942 Hs.12333 ring finger protein 13 6-149679925 GO:0008270|GO:0005634| protein 13 GO:0046872 (RNF13), transcript variant 1, mRNA [NM_007282] A_33_P3388958 SNX32 Homo sapiens NM_152760 ENST00000308342 254122 sorting chr11:6562111 GO:0005515|GO:0007154| NM_152760 THC2478732 Hs.591950 sorting nexin nexin 32 0-65621169 GO:0035091|GO:0015031 32 (SNX32), mRNA [NM_152760] A_23_P78750 SLC17A7 Homo sapiens NM_020309 ENST00000543531 57030 solute carrier chr19:4993357 GO:0030054|GO:0031410| NM_020309 THC2757650 Hs.375616 solute carrier family 17 5-49933516 GO:0015319|GO:0031402| family 17 (sodium- GO:0060076|GO:0055085| (sodium- dependent GO:0015321|GO:0016020| dependent inorganic GO:0006836|GO:0006817| inorganic phosphate GO:0042137|GO:0030672| phosphate cotransporter), GO:0016021|GO:0006814| cotransporter), member 7 GO:0019717|GO:0006811| member 7 GO:0015293 (SLC17A7), mRNA [NM_020309] A_33_P3422265 LOC729305 PREDICTED: XR_114546 ENST00000513405 729305 hypothetical chr11:1346063 XR_114546 THC2678881 Hs.148365 Homo sapiens LOC729305 50-134606409 hypothetical LOC729305 (LOC729305), partial miscRNA [XR_114546] A_33_P3369944 ADAM21 Homo sapiens NM_003813 ENST00000530196 8747 ADAM chr14:7092600 GO:0007338|GO:0016020| NM_003813 THC2637652 Hs.178748 ADAM metallopep- 3-70926062 GO:0006508|GO:0008270| metallopeptidase tidase GO:0008233|GO:0016021| domain 21 domain 21 GO:0004222|GO:0046872 (ADAM21), mRNA [NM_003813] A_33_P3216483 LOC644277 PREDICTED: XR_110541 ENST00000528953 644277 hypothetical chr11:1113272 XR_110541 Hs.577348 Homo sapiens LOC644277 69-111327328 hypothetical LOC644277 (LOC644277), miscRNA [XR_110541] A_24_P218074 ZNF467 Homo sapiens NM_207336 ENST00000302017 168544 zinc finger chr7:14946240 GO:0005622|GO:0008270| NM_207336 THC2463585 Hs.726477 zinc finger protein 467 6-149462347 GO:0005634|GO:0003677| protein 467 GO:0046872|GO:0045449 (ZNF467), mRNA [NM_207336] A_33_P3357879 chr10:1332746 91-133274632 A_33_P3400643 LOC643529 Homo sapiens NR_038382 643529 hCG2024094 chr10:9159740 NR_038382 THC2641103 HS.618956 hCG2024094 2-91597461 (LOC643529), non-coding RNA [NR_038382] A_33_P3371785 DTNA Homo sapiens NM_001128175 ENST00000315456 1837 dystrobrevin, chr18:3240758 GO:0005515|GO:0007165| NM_001128175 THC2748155 Hs.643454 dystrobrevin, alpha 0-32407639 GO:0005737|GO:0030054| alpha (DTNA), GO:0005509|GO:0006941| transcript GO:0045202|GO:0008270| variant 9, GO:0007274 mRNA [NM_001128175] A_23_P327022 MDFIC Homo sapiens NM_199072 ENST00000257724 29969 MyoD chr7:11465863 GO:0005737|GO:0030111| NM_199072 THC2564826 Hs.427236 MyoD family family 1-114658690 GO:0044419|GO:0030332| inhibition domain inhibitor GO:0005730|GO:0005634| containing domain GO:0007257|GO:0030957| (MDFIC), containing GO:0045449|GO:0050434 transcript variant 1, mRNA [NM_199072] A_23_P100660 SERPINF1 Homo sapiens NM_002615 ENST00000254722 5176 serpin pepti- chr17:1680668- GO:0042470|GO:0050769| NM_002615 NP1187984 Hs.532768 serpin dase 1680727 GO:0008283|GO:0004867| peptidase inhibitor, GO:0050728|GO:0016525| inhibitor, clade F clade F GO:0007275|GO:0005576| (alpha-2 (alpha-2 GO:0005615 antiplasmin, antiplasmin, pigment pigment epithelium epithelium derived factor), derived factor), member 1 member 1 (SERPINF1), mRNA [NM_002615] A_23_P318300 ZAK Homo sapiens NM_133646 ENST00000338983 51776 sterile chr2:17409175 GO:0009314|GO:0008219| NM_133646 THC2572394 Hs.444451 sterile alpha alpha 6-174091815 GO:0043065|GO:0000287| motif and motif and GO:0008283|GO:0006950| leucine zipper leucine zipper GO:0005634|GO:0007257| containing containing GO:0005524|GO:0030154| kinase AZK kinase AZK GO:0007243|GO:0042802| (ZAK), GO:0000186|GO:0005737| transcript variant 2, GO:0007049|GO:0000166| mRNA [NM_133646] GO:0004674|GO:0000075| GO:0007050|GO:0000077| GO:0004713|GO:0004709| GO:0016740 A_23_P95165 SEMA4B Homo sapiens NM_020210 ENST00000332496 10509 sema chr15:9077153 GO:0016020|GO:0007275| NM_020210 THC2469032 Hs.474935 sema domain, domain, 2-90771591 GO:0004872|GO:0016021| immunoglobulin immunoglo- GO:0030154|GO:0007399 domain (Ig), bulin domain transmembrane (Ig), trans- domain (TM) membrane and short domain (TM) cytoplasmic domain, and short (semaphorin) 4B cytoplasmic (SEMA4B), domain, transcript variant 1, (semaphorin) mRNA [NM_020210] 4B A_21_P300847 DIO3OS Homo sapiens AF469204 64150 DIO3 opposite chr14:1020251 NP1139581 Hs.525597 clone 6 strand 11-102025052 DIO3AS mRNA, (nonprotein partial sequence; coding) alternatively spliced. [AF469204] A_33_P3386775 ADAM11 Homo sapiens NM_002390 ENST00000355638 4185 ADAM chr17:4285786 GO:0005178|GO:0005886| NM_002390 THC2477011 Hs.6088 ADAM metallopepti- 9-42857928 GO:0007229|GO:0006508| metallopeptidase dase domain GO:0008270|GO:0016021| domain 11 11 GO:0004222 (ADAM11), mRNA [NM_002390] A_33_P3410296 DPYSL4 Homo sapiens NM_006426 ENST00000368629 10570 dihydro- chr10:1340185 GO:0005737|GO:0016810| NM_006426 THC2730511 Hs.100058 dihydropyrimidinase- pyrimidinase- 22-134018581 GO:0007399 like 4 (DPYSL4), like 4 mRNA [NM_006426] A_23_P59677 RINT1 Homo sapiens NM_021930 ENST00000497979 60561 RAD 50 chr7:10520799 GO:0005515|GO;0007049| NM_021930 THC2467373 Hs.531388 RAD50 interactor interactor 1 9-105208058 GO:0005737|GO:0016020| 1 (RINT1), GO:0005783|GO:0031572| mRNA [NM_021930] GO:0016192|GO:0015031| GO:0019898 A_24_P274270 STAT1 Homo sapiens NM_139266 ENST00000540176 6772 signal of chr2:19184173 GO:0005515|GO:0042542| NM_139266 THC2545270 Hs.642990 signal transducer transducer 3-191841674 GO:0007260|GO:0014070| and activator and activator GO:0030424|GO:0003700| of transcription transcription 1, GO:0006366|GO:0008015| 1, 91 kDa (STAT1), 91 kDa GO:0019221|GO:0007249| transcript variant GO:0043434|GO:0005634| beta, GO:0051591|GO:0030425| mRNA [NM_139266] GO:0005737|GO:0044419| GO:0005062|GO:0032496| GO:0004871|GO:0034097| GO:0031663|GO:0032869| GO:0006355|GO:0006919| GO:0007584|GO:0042493| GO:0005509|GO:0005730| GO:0006917|GO:0009615| GO:0048661|GO:0009612| GO:0043565|GO:0007165| GO:0043330 A_33_P3242416 chr1:22373879 4-223738735 A_33_P3377399 ENST00000520078 chr8:10681042 6-106810367 A_23_P84230 OTP Homo sapiens NM_032109 ENST00000306422 23440 orthopedia chr5:76924844- GO:0043565|GO:0021985| NM_032109 THC2477504 Hs.202247 orthopedia homeobox 76924785 GO:0006355|GO:0003700| homeobox (OTP), GO:0021879|GO:0021979| mRNA [NM_032109] GO:0002052|GO:0007275| GO:0005634|GO:0007399| A_23_P395632 R3HDML Homo sapiens NM_178491 ENST00000217043 140902 R3H domain chr20:4296993 GO:0005576|GO:0030414 NM_178491 THC2485270 Hs.580807 R3H domain containing-like 4-42972055 containing-like (R3HDML), mRNA [NM_178491] A_32_P211248 LOC100131138 Homo sapiens NR_036513 100131138 hypothetical chr12:1113751 NR_036513 THC2471096 Hs.152129 hypothetical LOC100131138 93-111375252 LOC100131138 (LOC100131138), non-coding RNA [NR_036513] A_24_P194420 CCDC134 Homo sapiens NM_024821 ENST00000255784 79879 coiled-coil chr22:4220934 GO:0005576 NM_024821 THC2474399 Hs.474991 coiled-coil domain 6-42209405 domain containing containing 134 134 (CCDC134), mRNA [NM_024821] A_33_P3287105 chr1:16120913 6-161209077 A_33_P3245841 chr1:16141679 2-161416733 A_33_P3300308 MAP1LC3A Homo sapiens NM_032514 ENST00000397709 84557 microtubule- chr20:3314764 GO:0005515|GO:0005737| NM_032514 THC2673701 Hs.632273 microtubule- associated 4-33147703 GO:0005776|GO:0008429| associated protein 1 GO:0019941|GO:0031090| protein 1 light chain GO:0005874|GO:0006914| light chain 3 3 alpha GO:0031410|GO:0031225| alpha (MAP1LC3A), GO:0000045|GO:0005829 transcript variant 1, mRNA [NM_032514] A_24_P213643 TSPAN10 Homo sapiens NM_031945 ENST00000328585 83882 tetraspanin 10 chr17:7961254 GO:0016020|GO:0016021 NM_031945 NP1074767 Hs.208219 tetraspanin 10 6-79612605 (TSPAN10), mRNA [NM_031945] A_33_P3354539 CHURC1 Homo sapiens NM_145165 ENST00000359118 91612 churchill chr14:6540170 GO:0045941|GO:0016563| NM_145165 Hs.325531 churchill domain domain 7-65401766 GO:0008270|GO:0007275| containing 1 containing 1 GO:0046872 (CHURC1), transcript variant 1, mRNA [NM_145165] A_23_P164258 PIPOX Homo sapiens NM_016518 ENST00000323372 51268 pipecolic chr17:2738343 GO:0008115|GO:0050031| NM_016518 NP212032 Hs.462585 pipecolic acid acid oxidase 5-27383494 GO:0046653|GO:0016491| oxidase (PIPOX), GO:0055114|GO:0005777 mRNA [NM_016518] A_23_P308603 SRC Homo sapiens NM_005417 ENST00000445403 6714 v-src sarcoma chr20:3603349 GO:0005515|GO:0005886| NM_005417 THC2628771 Hs.195659 v-src sarcoma (Schmidt- 6-36033555 GO:0007265|GO:0005524| (Schmidt- Ruppin GO:0007243|GO:0005829| Ruppin A-2) A-2) viral GO:0007172|GO:0000166| viral oncogene oncogene GO:0044419|GO:0005070| homolog homolog GO:0005901|GO:0006468| (avian) (SRC), (avian) GO:0042169|GO:0004715| transcript variant 1, GO:0070555|GO:0016740 mRNA [NM_005417] A_32_P129288 RAB1B Homo sapiens NM_030981 ENST00000314965 81876 RAB1B, chr11:6604466 GO:0005515|GO:0005737| NM_030981 THC2469371 Hs.300816 RAB1B, member RAS 5-66044724 GO:0005794|GO:0016020| member RAS oncogene GO:0000166|GO:0007264| oncogene family family GO:0015031|GO:0005525 (RAB1B), mRNA [NM_030981] A_33_P3264731 Uncharacterized ENST00000400948 chr1:22869970 THC2613385 protein [Source: 3-228699644 UniProtKB/TrEMBL; Acc: A8MVZ5] [ENST00000400948] A_33_P3229452 FLJ44477 Homo sapiens AK126441 401157 FLJ44477 chr4:14376828 THC2484299 Hs.531403 cDNA FLJ44477 protein 4-143768343 fis, clone UTERU2031703. [AK126441] A_24_P194931 SMEK2 Homo sapiens NM_020403 ENST00000272313 57223 SMEK chr2:55776250- GO:0005515|GO:0005813| NM_020403 THC2468527 Hs.516182 SMEK homolog 2, 55776191 GO:0005737|GO:0005634 homolog 2, suppressor of suppressor of mek1 mek1 (Dictyostelium) (Dictyostelium) (SMEK2), transcript variant 2, mRNA [NM_020463] A_33_P3238521 LOC100131884 Homo sapiens AK097701 ENST00000307499 100131884 capicua chr4:12032661 THC24811M Hs 730223 cDNA FLJ40382 homolog 9-120326677 fis, clone (Drosophila) TESTI2035775. pseudogene [AK097701] A_33_P3386019 ENST00000552575 chr7:57084356- 57084297 A_23_P53276 TIMELESS Homo sapiens NM_003920 ENST00000229201 8914 timeless chr12:5681100 GO:0005515|GO:0000790| NM_003920 THC2788675 Hs.118631 timeless homolog homolog 4-56810945 GO:0046982|GO:0033261| (Drosophila) (Drosophila) GO:0030324|GO:0005634| (TIMELESS), GO:0007275|GO:0042803| mRNA [NM_003920] GO:0006974|GO:0007049| A_33_P3390042 LOC143188 Homo sapiens NR_015409 143188 hypothetical chr10:1146148 GO:0007067|GO:0009582| NR_015409 THC2602015 Hs.287723 hypothetical LOC143188 04-114614863 GO:0042127|GO:0007623| LOC143188 GO:0016481|GO:0048754| (LOC143188), GO:0002009|GO:0051301 non-coding RNA [NR_015409] A_33_P3357573 MAML3 Homo sapiens NM_018717 ENST00000327122 55534 mastermind- chr4:14081080 GO:0016607|GO:0003713| NM_018717 THC2481167 Hs.586165 mastermind-like like 3 6-140810747 GO:0007219|GO:0045944| 3 (Drosophila) (Drosophila) GO:0005634|GO:0045449 (MAML3), mRNA [NM_018717] A_24_P173823 PBX1 Homo sapiens NM_002585 ENST00000420696 5087 pre-B-cell chr1:16482097 GO:0005515|GO:0008284| NM_002585 THC2491993 Hs.557097 pre-B-cell leukemia 6-164821035 GO:0006694|GO:0001658| leukemia homeobox 1 GO:0003700|GO:0030325| homeobox 1 GO:0001655|GO:0048706| (PBX1), GO:0048538|GO:0005634| transcript GO:0009954|GO:0030326| variant 1, GO:0009952|GO:0048536| mRNA GO:0030154|GO:0005737| [NM_002585] GO:0030278|GO:0045944| GO:0009887|GO:0007548| GO:0035162|GO:0005667| GO:0006355|GO:0046982| GO:0005730|GO:0043565| GO:0045665 A_33_P3211078 HMGA2 Homo sapiens NM_003484 ENST00000537275 8091 high mobility chr12:6621910 GO:0005515|GO:0006355| NM_003484 NP1474910 Hs.505924 high mobility group AT- 1-66219160 GO:0005694|GO:0006325| group AT- hook 2 GO:0005634|GO:0007275| hook 2 (HMGA2), GO:0003677|GO:0007049| transcript variant 2, GO:0007067|GO:0003680| mRNA [NM_003484] GO:0000785|GO:0040008| GO:0051301 A_32_P227317 DDX11L2 Homo sapiens NR_024005 84771 DEAD/H chr2:11435759 NR_024005 Hs.712940 DEAD/H (Asp- (Asp-Glu Ala- 9-114357540 Glu-Ala-Asp/ Asp/His) box His) box poly- polypeptide peptide 11 11 like 2 like 2 (DDX11L2), transcript variant 2, non-coding RNA [NR_024005] A_33_P3362371 RTN3 Homo sapiens NM_201430 ENST00000543123 10313 reticulon 3 chr11:6344900 GO:0005515|GO:0005794| NM_201430 THC2541012 Hs.473761 reticulon 3 6-63449065 GO:0016020|GO:0005783| (RTN3), GO:0044419|GO:0006950| transcript variant 4, GO:0005730|GO:0006915| mRNA [NM_201430] GO:0005634|GO:0016021| GO:0016192|GO:0005615 A_25_P112135 TRAM1 Homo sapiens NM_014294 ENST00000262213 23471 translocation chr8:71485966- GO:0005515|GO:0016020| NM_014244 THC2719697 Hs.491988 translocation associated 71485907 GO:0005783|GO:0006613| associated membrane GO:0005789|GO:0004872| membrane protein 1 GO:0016021|GO:0015031| protein 1 GO:0055085 (TRAM1), mRNA [NM_014294] A_23_P116512 PRR5L Homo sapiens NM_024841 ENST00000389693 79899 proline chr11:3648643 NM_024841 THC2490143 Hs.19987 proline rich rich 5 like 8-36486497 5 like (PRR5L), transcript variant 2, mRNA [NM_024841] A_23_P406385 FBXL16 Homo sapiens NM_153350 ENST00000324361 146330 F-box and chr16:742597- GO:0019941 NM_153350 THC2462888 Hs.513244 F-box and leucine rich 742538 leucine-rich repeat repeat protein protein 16 16 (FBXL16), mRNA [NM_153350] A_33_P3381613 chr7:06432891 6-064328857 A_23_P75288 ATAD1 Homo sapiens NM_032810 ENST00000328142 84896 ATPase chr10:8951305 GO:0017111|GO:0000166| NM_032810 THC2466494 Hs.435948 ATPase family, family, AAA 8-89512999 GO:0005524 AAA domain domain containing 1 containing 1 (ATAD1), mRNA [NM_032810] A_23_P384857 GB chr6:02793296 NP274062 5-027933024 A_23_P401106 PDE2A Homo sapiens NM_002599 ENST00000429363 5138 phosphodi- chr11:7228730 GO:0005515|GO:0007165| NM_002599 THC2466953 Hs.503163 phosphodiesterase esterase 2A, 9-72287250 GO:0016787|GO:0016020| 2A, cGMP- cGMP- GO:0004118|GO:0019898 stimulated stimulated (PDE2A), transcript variant 1, mRNA [NM_002599] A_23_P3312 ISLR Homo sapiens NM_005545 ENST00000249842 307 1 immuno chr15:7446912 GO:0005515|GO:0005576| NM_005545 THC2469953 Hs.699822 immunoglobulin globulin 1-74469180 GO:0007155 superfamily superfamily containing containing leucine-rich leucine- repeat (ISLR), rich repeat transcript variant 1, mRNA [NM_005545] A_23_P29257 H1F0 Homo sapiens NM_005318 ENST00000340857 3005 H1 histone chr22:3820314 GO:0005794|GO:0005694| NM_005318 THC2513918 Hs.226117 H1 histone family, 7-38203206 GO:0006334|GO:0005634| family, member member 0 GO:0005856|GO:0000786| 0 (H1F0), GO:0003677 mRNA [NM_005318] A_23_P103601 MAN1C1 Homo sapiens NM_020379 ENST00000263979 57134 mannosidase, chr1:26110835- GO:0030173|GO:0005794| NM_020379 NP1210903 Hs.197043 mannosidase, alpha, class 26110894 GO:0016020|GO:0016798| alpha, class 1C, 1C, member 1 GO:0008152|GO:0005509| member 1 GO:0004571|GO:0016021| (MAN1C1), GO:0006487 mRNA [NM_020379] A_23_P6943 GPR15 Homo sapiens NM_005290 ENST00000284311 2838 G protein- chr3:98251643- GO:0007165|GO:0007186| NM_005290 THC2479762 Hs.563128 G protein- coupled 98251702 GO:0005886|GO:0045028| coupled receptor 15 GO:0005887|GO:0004930| receptor 15 GO:0004872 (GPR15), mRNA [NM_005290] A_33_P3404336 PREDICTED: XM_002343592 chr17:8021499 XM_002343592 THC2483688 Hs.676976 Homo sapiens 1-80215050 hypothetical protein LOC100289105 (LOC100289105), mRNA [XM_002343592] A_33_P3353906 chr5:17815761 2-178157671 A_23_P257478 CYP21A2 Homo sapiens NM_000500 ENST00000547683 1589 cytochrome chr6:32009191- GO:0005792|GO:0006694| NM_000500 THC2469155 Hs.654479 cytochrome P450, P450, family 32009250 GO:0016020|GO:0005783| family 21, 21, subfamily GO:0004509|GO:0009055| subfamily A, A, polypep- GO:0005496|GO:0046872| polypeptide 2 tide 2 GO:0055114|GO:0020037| (CYP21A2), GO:0019898 transcript variant 1, mRNA [NM_000500] A_32_P334325 RIMBP2 Homo sapiens NM_015347 ENST00000392375 23504 RIMS chr12:1309216 GO:0030054|GO:0005886| NM_015347 THC2782045 Hs.657441 RIMS binding binding 67-130921608 GO:0045202 protein 2 protein 2 (RIMBP2), mRNA [NM_015347] A_23_P2705 LPAR6 Homo sapiens NM_005767 ENST00000345941 10161 lysophospha- chr13:4898573 GO:0007165|GO:0007186| NM_005767 THC2461047 Hs.123464 lysophosphatidic tidic acid 0-48985671 GO:0005886|GO:0045028| acid receptor 6 receptor 6 GO:0004930|GO:0004872| (LPAR6), GO:0016021 transcript variant 1, mRNA [NM_005767] A_23_P118633 SPATA20 Homo sapiens NM_022827 ENST00000512071 64847 spermato- chr17:4863298 GO:0005515|GO:0007275| NM_022827 THC2610588 Hs.103147 spermatogenesis genesis ass- 5-48633044 GO:0007283|GO:0003824| associated 20 ociated 20 GO:0030154 (SPATA20), mRNA [NM_022827] A_24_P19544 STK39 Homo sapiens NM_013233 ENST00000355999 27347 serine chr2:16881092 GO:0005515|GO:0006950| NM_013233 THC2630318 Hs.276271 serine threonine threonine 1-168810862 GO:0005624|GO:0005634| kinase 39 kinase 39 GO:0005524|GO:0016323| (STK39), GO:0005737|GO:0016324| mRNA [NM_013233] GO:0000166|GO:0004702| GO:0006468|GO:0005856| GO:0016740 A_23_P398854 DOK7 Homo sapiens NM_173660 ENST00000515886 285489 docking chr4:3496146- GO:0030054|GO:0005886| NM_173660 THC2474438 Hs.122110 docking protein protein 7 3496205 GO:0005158|GO:0045202| 7 (DOK7), GO:0019898 transcript variant 1, mRNA [NM_73660] A_33_P3399181 chr17:0046431 32-004643191 A_23_P202496 NOC3L Homo sapiens NM_022451 ENST00000371350 64318 nucleolar chr10:9609309 GO:0016607|GO:0005730| NM_022451 THC2463979 Hs.74899 nucleolar complex complex 7-96093038 GO:0045444|GO:0005634 associated 3 associated 3 homolog homolog (S. cerevisiae) (S. cerevisiae) (NOC3L), mRNA [NM_022451] A_23_P75149 SFXN4 Homo sapiens NM_213649 ENST00000330036 119559 sideroflexin 4 chr10:120900750- GO:0005739|GO:0016020| NM_213649 NP1135821 Hs.655168 sideroflexin 4 120900691 GO:0005506|GO:0008324| (SFXN4), GO:0006826|GO:0016021| mRNA [NM_213649] GO:0055085|GO:0006812 A_33_P3382849 ACR Homo sapiens NM_001097 ENST00000527761 49 acrosin chr22:5118322 GO:0005515|GO:0043159| NM_001097 THC2478327 Hs.370870 acrosin (ACR), 2-51183281 GO:0004252|GO:0005507| mRNA [NM_001097] GO:0005798|GO:0042806| GO:0048545|GO:0007339| GO:0003677|GO:0005537| GO:0009607|GO:0043234| GO:0004040|GO:0007190| GO:0002077|GO:0008144| GO:0006508|GO:0008270| GO:0008233|GO:0007341 A_33_P3283897 LOC100130761 Homo sapiens AK095511 100130761 hypothetical chr2:16229078 THC2687374 Hs.638437 cDNA FLJ38192 LOC100130761 7-162290846 fis, clone FCBBF1000270. [AK095511] A_33_P3370787 EPHB2 Homo sapiens NM_004442 ENST00000374625 2048 EPH receptor chr1:23240041- GO:0031290|GO:0048013| NM_004442 THC2642207 Hs.523329 EPH receptor B2 23240100 GO:0005102|GO:0021952| B2 (EPHB2), GO:0018108|GO:0048593| transcript variant 2, GO:0005524|GO:0007399| mRNA [NM_004442] GO:0000902|GO:0005005| GO:0048168|GO:0000166| GO:0016020|GO:0005887| GO:0043025|GO:0009887| GO:0050771|GO:0004872| GO:0007612|GO:0021631| GO:0008046|GO:0016740| GO:0048170 A_33_P3279353 AZU1 Homo sapiens NM_001700 ENST00000334630 566 azurocidin 1 chr19:831799- GO:0008347|GO:0004252| NM_001700 THC2476639 Hs.72885 azurocidin 1 831858 GO:0042582|GO;0003824| (AZU1), GO:0007205|GO:0045348| mRNA [NM_001700] GO:0050766|GO:0006954| GO:0006935|GO:0006508| GO:0008201|GO:0001774| GO:0042535|GO:0006916| GO:0005576|GO:0050725| GO:0045785|GO:0050930| GO:0050829|GO:0050754| GO:0042117|GO:0015643| GO:0043114|GO:0045123| GO:0048246 A_23_P320739 MEF2C Homo sapiens NM_002397 ENST00000510942 4208 myocyte chr5:88016876- GO:0045885|GO:0005515| NM_002397 THC2465936 Hs.649965 myocyte enhancer enhancer 88016817 GO:0006355|GO:0003700| factor 2C factor 2C GO:0003702|GO:0006915| (MEF2C), GO:0010553|GO:0005634| transcript variant 1, GO:0007275|GO:0010552| mRNA [NM_002397] GO:0030154|GO:0007399| GO:0043565|GO:0007517| GO:0016607 A_24_P391604 KRTAP6-3 Homo sapiens NM_181605 ENST00000391624 337968 keratin chr21:3196499 GO:0005882 NM_181605 NP1462383 Hs.553691 keratin associated 3-31965052 associated protein 6-3 protein 6-3 (KRTAP6-3), mRNA [NM_181605] A_23_P250982 ISOC1 Homo sapiens NM_016048 ENST00000173527 51015 isochorismatase chr5:12844936 GO:0008152|GO:0003824| NM_016048 THC2466517 Hs.483296 isochorismatase domain 7-128449426 GO:0005777 domain containing 1 containing 1 (ISOC1), mRNA [NM_016048] A_33_P3260455 chr1:24749782 6-247497885 A_23_P169437 LCN2 Homo sapiens NM_005564 ENST00000373017 3934 lipocalin 2 chr9:13091424 GO:0005215|GO:0005488| NM_005564 NP1247777 Hs.204238 lipocalin 2 4-130914303 GO:0006810|GO:0005576 (LCN2), mRNA [NM_005564] A_23_P122906 AUTS2 Homo sapiens NM_015570 ENST00000406775 26053 autism chr7:70257414- GO:0008150|GO:0003674| NM_015570 NP651821 Hs.21631 autism susceptibility susceptibility 70257473 GO:0005575 candidate 2 candidate 2 (AUTS2), transcript variant 1, mRNA [NM_015570] A_33_P3240333 PITX1 Homo sapiens NM_002653 ENST00000265340 5307 paired-like chr5:13436482 GO:0043565|GO:0035137| NM_002653 THC2620379 Hs.84136 paired-like homeo- 5-134364766 GO:0006355|GO:0003700| homeodomain 1 domain 1 GO:0051216|GO:0021983| (PITX1), GO:0005730|GO:0007275| mRNA [NM_002653] GO:0005634|GO:0014707| GO:0009653|GO:0048625 A_21_P86021 SELENBP1 Homo sapiens NM_003944 ENST00000463664 8991 selenium chr1:15133690 GO:0008430|GO:0005737| NM_003944 NP1180129 Hs.632460 selenium binding binding 6-151336847 GO:0016020|GO:0005634| protein 1 protein 1 GO:0015031|GO:0019898| (SELENBP1), GO:0005829 mRNA [NM_003944] A_24_P130792 NSUN4 Homo sapiens NM_199044 ENST00000475281 387338 NOP2/Sun chr1:46810756- GO:0008168|GO:0016740 NM_199044 THC2552243 Hs.163424 NOP2/Sun domain 46810815 domain family, family, member 4 member 4 (NSUN4), mRNA [NM_199044] A_32_P104746 ZFYVE28 Homo sapiens NM_020972 ENST00000290974 57732 zinc finger, chr4:2271519- GO:0005515|GO:0005737| NM_020972 THC2623946 Hs.292056 zinc finger, FYVE 2271460 GO:0016020|GO:0031901| FYVE domain domain GO:0007175|GO:0008270| containing 28 containing 28 GO:0032266|GO:0046872| (ZFYVE28), GO:0005829|GO:0005768 transcript variant 2, mRNA [NM_020972] A_24_P135628 Uncharacterized CR599847 ENST00000335083 chr10:4776943 NP1185779 Hs.463110 protein [Source: 3-47769492 UniProtKB/TrEMBL; Acc: A6NF06] [ENST00000335083] A_23_P2129 TMEM126B Homo sapiens NM_018480 ENST00000530783 55863 transmembrane chr11:8534524 GO:0008150|GO:0003674| NM_018480 THC2619491 Hs.525063 transmembrane protein 126B 3-85345302 GO:0016020|GO:0016021| protein 126B GO:0005575 (TMEM126B), transcript variant 1, mRNA [NM_018480] A_33_P3396139 CTLA4 Homo sapiens NM_005214 ENST00000302823 1493 cytotoxic T- chr2:20473856 GO:0005515|GO:0048471| NM_005214 THC2476969 Hs.247824 cytotoxic T- lymphocyte- 4-204738623 GO:0045334|GO:0005794| lymphocyte- associated GO:0050777|GO:0016020| associated protein 4 GO:0005887|GO:0045590| protein 4 GO:0009897|GO:0042130 (CTLA4), transcript variant 1, mRNA [NM_005214] A_32_P230868 FAM65A Homo sapiens NM_024519 ENST00000422602 79567 family with chr16:6758046 GO:0005488 NM_024519 THC2468574 Hs.152717 family with sequence 0-67580519 sequence similarity 65, similarity 65, member A member A (FAM65A), transcript variant 1, mRNA [NM_024519] A_23_P89981 CYP2F1 Homo sapiens NM_000774 ENST00000439903 1572 cytochrome chr19:4163418 GO:0005792|GO:0070330| NM_000774 NP098390 Hs.558318 cytochrome P450, P450, family 5-41634244 GO:0005783|GO:0009055| family 2, 2, subfamily GO:0009636|GO:0018931| subfamily F, F, polypeptide GO:0046872|GO:0016020| polypeptide 1 1 GO:0019825|GO:0005789| (CYP2F1), GO:0019898|GO:0020037| mRNA [NM_000774] GO:0055114 A_33_P3307363 LPHN2 Homo sapiens NM_012302 ENST00000370728 23266 latrophilin 2 chr1:82458036- GO:0005886|GO:0007218| NM_012302 THC2601192 Hs.24212 latrophilin 2 82458095 GO:0004930|GO:0016524| (LPHN2), GO:0005529|GO:0016021 mRNA [NM_012302] A_24_P286527 RABL5 Homo sapiens NM_022777 ENST00000422177 64792 RAB, member chr7:10095712 GO:0000166|GO:0005525 NM_022777 THC2463773 Hs.389104 RAB, member RAS oncogene 6-100957067 RAS oncogene family-like 5 family-like 5 (RABL5), transcript variant 1, mRNA [NM_022777] A_23_P254797 BPIL1 Homo sapiens NM_025227 ENST00000170150 80341 bactericidal/ chr20:3160836 GO:0005576|GO:0008289 NM_025227 THC2474857 Hs.257045 bactericidal/ per meability- 8-31609120 permeability- increasing increasing protein-like 1 protein-like 1 (BPIL1), mRNA [NM_025227] A_33_P3289466 chr14:0503609 85-050360926 A_33_P3297245 RRAS2 Homo sapiens NM_012250 22800 related RAS chr11:1429952 GO:0005622|GO:0005515| NM_012250 THC2744937 Hs.502004 related RAS viral (r-ras) 5-14299466 GO:0007165|GO:0030335| viral (r-ras) oncogene GO:0005886|GO:0000166| oncogene homolog 2 GO:0009987|GO:0005783| homolog 2 GO:0003924|GO:0007265| (RRAS2), GO:0005525 transcript variant 1, mRNA [NM_012250] A_33_P3277826 ZSCAN1 zinc finger AY280370 ENST00000391700 284312 zinc finger chr19:5854973 THC2483242 Hs.643437 and SCAN and SCAN 8-58549797 domain domain containing 1 containing 1 [Source: HGNC Symbol; Acc: 23712] [ENST00000391700] A_33_P3265872 Q9AHE7_9RHIZ ENST00000419668 chr7:92546426- THC2660495 (Q9AHE7) Amide/ 92546485 urea-binding FmdD-like protein, partial (5%) [THC2660495] A_24_P20630 LEF1 Homo sapiens NM_016269 ENST00000503879 51176 lymphoid chr4:10896880 GO:0005515|GO:0014070| NM_016269 THC2603330 Hs.555947 lymphoid enhancer- 5-108968746 GO:0030111|GO:0003705| enhancer- binding GO:0001756|GO:0016563| binding factor 1 GO:0005634|GO:0030879| factor 1 GO:0001837|GO:0030326| (LEF1), GO:0005737|GO:0045944| transcript GO:0060021|GO:0042475| variant 1, GO:0048468|GO:0007155| mRNA [NM_016269] GO:0045449|GO:0005667| GO:0021542|GO:0001822| GO:0008301|GO:0005730| GO:0001890|GO:0000122| GO:0045843|GO:0043565| GO:0010226|GO:0003682| GO:0048341|GO:0043588 A_33_P3388865 LRRC10 Homo sapiens NM_201550 ENST00000361484 376132 leucine rich chr12:7000384 GO:0005739|GO:0005515| NM_201550 THC2480475 Hs.448708 leucine rich repeat 4-70003785 GO:0005634|GO:0005856 repeat containing 10 containing 10 (LRRC10), mRNA [NM_201550] A_33_P3346048 POM121L1P Homo sapiens NR_024591 ENST00000427789 25812 POM121 chr22:2298624 NR_024591 THC2463379 Hs.546584 POM121 membrane 8-22986189 membrane glycoprotein- glycoprotein- like 1, like 1, pseudogene pseudogene (POM121LlP), non-coding RNA [NR_024591] A_24_P30194 IFIT5 Homo sapiens NM_012420 ENST00000371795 24138 interferon- chr10:9117955 GO:0008150|GO:0005488| NM_012420 THC2634773 Hs.252839 interferon-induced induced 9-91179618 GO:0005575 protein with protein with tetratricopeptide tetratrico- repeats 5 peptide (IFIT5), repeats 5 mRNA [NM_012420] A_24_P100190 NCRNA00315 PREDICTED: XR_109683 ENST00000441947 246704 non-protein chr21:4672327 XR_109683 THC2485435 Hs.171428 Homo sapiens coding 4-46723215 chromosome 21 RNA 315 open reading frame 93 (C21orf93), misc- RNA [XR_109683] A_33_P3357964 chr16:0026523 89-002652330 A_21_P140069 FBXL3 Homo sapiens NM_012158 ENST00000355619 26224 F-box chr13:7757993 GO:0005515|GO:0005737| NM_012158 THC2468176 Hs.508284 F-box and and leucine 9-77579880 GO:0004842|GO:0016567| leucine-rich rich repeat GO:0019941|GOD000151| repeat protein protein 3 GO:0005634 3 (FBXL3), mRNA [NM_012158] A_23_P21086 LGI3 Homo sapiens NM_139278 ENST00000520124 203190 leucine-rich chr8:22004762- GO:0005515|GO:0005576| NM_139278 NP1467703 Hs.33470 leucine-rich repeat LGI 22004703 GO:0019717|GO:0008021 repeat LGI family, family, member 3 member 3 (LGI3), mRNA [NM_139278] A_33_P3244347 PC Homo sapiens, NM_001040716 ENST00000393960 5091 pyruvate chr11:6661615 GO:0031406|GO:0008610| NM_001040716 THC2463909 Hs.89890 pyruvate carboxylase carboxylase 7-66616098 GO:0030145|GO:0016874| (PC), nuclear gene GO:0005743|GO:0006094| encoding mito- GO:0006107|GO:0005625| chondrial protein, GO:0005524|GO:0046872| transcript variant 3 GO:0005739|GO:0005737| mRNA GO:0000166|GO:0005759| [NM_001040716] GO:0008152|GO:0004736| GO:0009374 A_23_P78762 HSD17B14 Homo sapiens NM_016246 ENST00000263278 51171 hydroxysteroid chr19:4933754 GO:0006629|GO:0005515| NM_016246 THC2620516 Hs.18788 hydroxysteroid (17- (17-beta) 1-49335939 GO:0006706|GO:0005737| beta) dehydrogenase dehydro- GO:0004303|GO:0016491| 14 (HSD17B14), genase 14 GO:0047045|GO:0055114| mRNA [NM_016246] GO:0005829 A_23_P116797 C12orf10 Homo sapiens NM_021640 ENST00000550199 60314 chromosome chr12:5370051 GO:0005739|GO:0003674| NM_021640 THC2620574 Hs.655988 chromosome 12 12 open 2-53700571 GO:0043473|GO:0005634| open reading reading frame GO:0005575 frame 10 10 (C12orf10), mRNA [NM_021640] A_24_P117147 KIR3DL1 Homo sapiens NM_013289 ENST00000400847 3811 killer cell chr19:5533331 GO:0006955|GO:0005886| NM_013289 THC2470697 Hs.645228 killer cell immunoglo- 1-55340821 GO:0005887|GO:0004872| immunoglobulin- bulin-like GO:0030109 like receptor, receptor, three domains, three domains, long cytoplasmic long cyto- tail, 1 (KIR3DL1), plasmic tail, 1 mRNA [NM_013289] A_33_P3391275 LOC284749 Homo sapiens NR_026958 284749 hypothetical chr20:4699925 NR_026958 THC2619139 Hs.299080 hypothetical LOC284749 5-46999314 LOC284749 (LOC284749), non-coding RNA [NR_026958] A_33_P3255716 LOC285095 PREDICTED: XM_001722643 ENST00000401641 285095 hypothetical chr2:24283627 XM_001722643 THC2726347 Homo sapiens protein 6-242836217 hypothetical LOC285095 protein LOC285095, transcript variant 1 (LOC285095), mRNA [XM_001722643] A_23_P256784 MUC2 Homo sapiens NM_002457 ENST00000441003 4583 mucin 2, chr11:1103558- GO:0005515|GO:0070703| NM_002457 THC2461569 Hs.315 mucin 2, oligomeric 1103831 GO:0070702|GO:0005576 oligomeric mucus/ mucus/gel- gel-forming forming (MUC2), mRNA [NM_002457] A_33_P3316522 DEFB124 Homo sapiens NM_001037500 ENST00000317676 245937 defensin, chr20:3005336 GO:0005576|GO:0042742 NM_001037500 THC2769744 Hs.381373 defensin, beta beta 124 8-30053309 124 (DEFB124), mRNA [NM_001037500] A_23_P416894 PION Homo sapiens NM_017439 ENST00000482866 54103 pigeon chr7:76940446- NM_017439 THC2493049 Hs.186649 pigeon homolog homolog 76940387 (Drosophila) (PION), (Drosophila) mRNA [NM_017439] A_33_P3665553 LOC100233156 Homo sapiens AK126241 100233156 tektin 4 chrUn_gl00021 THC2508069 Hs.595418 cDNA FLJ44253 fis, pseudogene 8:60884-60825 clone TKIDN2009092. [AK126241] A_33_P3386770 PREDICTED: XM_003120088 ENST00000532625 chr8:14487231 XM_003120088 Hs.449407 Homo sapiens 6-144872375 putative IQ motif and ankyrin repeat domain- containing protein LOC642574-like (LOC100508128), mRNA [XM_003120088] A_24_P417352 immunoglobulin BX161420 ENST00000390559 chr14:1063212 NP1181174 Hs.510635 heavy constant 43-106321184 mu [Source: HGNC Symbol; Acc: 5541] [ENST00000390559] A_33_P3308626 MON1B Homo sapiens NM_014940 ENST00000320859 22879 MON1 chr16:7722949 NM_014940 THC2466642 Hs.513743 MON1 homolog homolog B 8-77229557 B (yeast) (yeast) (MON1B), mRNA [NM_014940] A_33_P3225278 Homo sapiens, BC039705 chr4:730227- Hs.623860 clone IMAGE: 730168 4940607, mRNA. [BC039705] A_24_P281636 Homo sapiens AY010113 ENST00000532821 chr11:8951545 Hs.445846 unknown mRNA 0-89515509 sequence. [AY010113] A_33_P3227703 chr22:0248201 18-024820059 A_23_P48481 RAD51B Homo sapiens NM_133510 ENST00000468382 5890 RAD51 chr14:6887819 GO:0017111|GO:0006281| NM_133510 THC2753750 Hs.172587 RAD51 homolog homolog B 2-68934895 GO:0000166|GO:0005634| B (S. cerevisiae) (S. cerevisiae) GO:0005524|GO:0003677| (RAD51B), GO:0006974|GO:0008094| transcript variant 2, GO:0007131 mRNA [NM_133510] A_24_P350622 KIR2DL4 Homo sapiens NM_002255 ENST00000400852 3805 killer cell chr19:5531768 GO:0007165|GO:0006968| NM_002255 NP365687 Hs.661219 killer cell immunoglo- 8-55320335 GO:0005886|GO:0005887| immunoglobulin-like bulin-like GO:0004888 receptor, two receptor, two domains, long domains, long cytoplasmic tail, cytoplasmic 4 (KIR2DL4), tail, 4 transcript variant 1, mRNA [NM_002255] A_33_P3226085 immunoglobulin AF063703 ENST00000390315 chr22:2315471 THC2464004 Hs.449585 lambda variable 9-23154778 3-10[Source: HGNC Symbol; Acc: 5897] [ENST00000390315] A_33_P3312209 chr5:01749869 5-017498754 A_23_P115022 TMEM125 Homo sapiens NM_144626 ENST00000432792 128218 transmembrane chr1:43739605- GO:0008150|GO:0003674| NM_144626 THC2464236 Hs.104476 transmembrane protein 125 43739664 GO:0016020|GO:0016021| protein 125 GO:0005575 (TMEM125), mRNA [NM_144626] A_33_P3323699 NPPA natriuretic ENST00000376476 4878 natriuretic chr1:11908277- THC2538172 peptide A [Source: peptide A 11908218 HGNC Symbol; Acc: 79391 [ENST00000376476] A_24_P319923 MYLK Homo sapiens NM_053025 ENST00000418370 4638 myosin light chr3:12333122 GO:0005516|GO:0000287| NM_053025 NP500946 Hs.477375 myosin light chain kinase 0-123331161 GO:0000166|GO:0005509| chain kinase GO:0004687|GO:0006468| (MYLK), GO:0003779|GO:0005524| transcript GO:0016740 variant 1, mRNA [NM_053025] A_33_P3415820 THBS1 Homo sapiens NM_003246 ENST00000397591 7057 thrombo- chr15:3987454 GO:0010670|GO:0043499| NM_003246 THC2470159 Hs.164226 thrombospondin 1 spondin 1 6-39874605 GO:0043032|GO:0032914| (THBS1), GO:0042802|GO:0034605| mRNA [NM_003246] GO:0010763|GO:0032026| GO:0048603|GO:0005509| GO:0030169|GO:0010748| GO:0043394|GO:0010751| GO:0051592|GO:0043536| GO:0005178|GO:0010754| GO:0043236|GO:0010759| GO:0032570|GO:0010757| GO:0070051|GO:0070052| GO:0043537|GO:0009897| GO:0010811|GO:0002040| GO:0051895|GO:0000187| GO:0006955|GO:0050921| GO:0007050|GO:0031093| GO:0007155|GO:0001968| GO:0008201|GO:0030511| GO:0001666|GO:0050431| GO:0002605|GO:0051918| GO:0006915|GO:0005577| GO:0045727|GO:0006916| GO:0005576|GO:0002544| GO:0043652|GO:0002581| GO:0045766|GO:0009749| GO:0031012|GO:0018149| GO:0001937|GO:0005198| GO:0030194|GO:0032695| GO:0016525|GO:0040037| GO:0042327 A_33_P3263027 Novel protein BE266556 ENST00000370707 chrX:13505713 Hs.611445 [Source: UniProtKB/ 1-135057190 TrEMBL; Acc: Q5JPQ1] [ENST00000370707] A_33_P3332112 FAS Homo sapiens NM_000043 ENST00000540197 355 Fas (TNF chr10:9077414 GO:0008624|GO:0008633| NM_000043 NP1173846 Hs.244139 Fas (TNF receptor 8-90774207 GO:0005886|GO:0031264| receptor superfamily, superfamily, GO:0042981|GO:0005576| member 6) member 6) GO:9005625|GO:0006916| (FAS), transcript GO:0042802|GO:0005829| variant 1, GO:0007165|GO:0006955| mRNA [NM_000043] GO:0006461|GO:0016021| GO:0019900|GO:0004888| GO:0010940 A_33_P3554053 NCRNA00106 UI-H-EDl-axv-n-20- BQ009527 751580 non-protein chrX:1517725- Hs.495569 0-UI.s1 NCI_CGAP_ED1 coding 1517666 Homo sapiens RNA 106 cDNA clone IMAGE: 5834323 3′, mRNA sequence [BQ009527] A_33_P3374504 thioredoxin BC099923 ENST00000334363 chr22:1988271 THC2482873 Hs.443430 reductase 2 5-19882656 [Source: HGNC Symbol; Acc: 18155] [ENST00000334363] A_33_P3313635 601344576F1 BE561442 chr16:3019490 THC2528843 Hs.569588 NIH_MGC_8 9-30194896 Homo sapiens cDNA clone IMAGE:3677250 5′, mRNA sequence [BE561442] A_33_P3275235 AKT1 Homo sapiens NM_005163 ENST00000402615 v-akt murine chr14:1052360 GO:0007242|GO:0009408| NM_005163 NP1242654 Hs.525622 v-akt murine thymoma 34-105235975 GO:0042640|GO:0030307| thymoma viral viral oncogene GO:0034405|GO:0008643| oncogene homolog 1 GO:0007281|GO:0042802| homolog 1 GO:0010907|GO:0046889| (AKT1), transcript GO:0030163|GO:0046777| variant 1, GO:0046329|GO:0008637| mRNA [NM_005163] GO:0000166|GO:0015758| GO:0018105|GO:0010765| GO:0046326|GO:0005856| GO:0000060|GO:0030334| GO:0045884|GO:0005975| GO:0005547|GO:0005819| GO:0010748|GO:0001890| GO:0030027|GO:0070141| GO:0032270|GO:0045792| GO:0007186|GO:0051000| GO:0030030|GO:0045600| GO:0043491|GO:0005654| GO:0019899|GO:0008286| GO:0016567|GO:0005886| GO:0031999|GO:0032436| GO:0005634|GO:0006924| GO:0032094|GO:0045429| GO:0005829|GO:0032880| GO:0005737|GO:0006954| GO:0040018|GO:0009725| GO:0030235|GO:0008633| GO:0001568|GO:0045725| GO:0043325|GO:0005625| GO:0005524|GO:0006417| GO:0031659|GO:0004674| GO:0048009|GO:0006469| GO:0006464|GO:0016740| A_33_P3228271 CST3 cystatin C BX647523 ENST00000398411 1471 cystatin C chr20:2360876 GO:0004869|GO:0010703| THC2521202 Hs.304682 [Source: HGNC 3-23608704 GO:0010711|GO:0010466| Symbol; Acc: 2475] GO:0005576|GO:0006952| [ENST00000398411] GO:0002020|GO:0030414| GO:0005615|GO:0010716| GO:0001540|GO:0034103| GO:0060313|GO:0060311| GO:004 3206 A_23_P104741 KIRREL3 Homo sapiens NM_032531 ENST00000525144 84623 kin or chr11:1262934 GO:0030097|GO:0005515| NM_032531 NP1136546 Hs.376015 kin of IRRE like 3 IRRE like 3 70-126293411 GO:0005886|GO:0005576| (Drosophila) (Drosophila) GO:0016021 (KIRREL3), transcript variant 1, mRNA [NM_032531] A_23_P400515 KIF17 Homo sapiens NM_020816 ENST00000247986 57576 kinesin chr1:20990700- GO:0005515|GO:0005871| NM_020816 THC2781237 Hs.130411 kinesin family family 20990641 GO:0000166|GO:0031503| member 17 member 17 GO:0005874|GO:0016192| (KIF17), transcript GO:0015031|GO:0003777| variant 1, GO:0005524|GO:0007018 mRNA [NM_020816] A_33_P3259861 REREP3 Homo sapiens NR_033735 646396 arginine-gluta- chr15:2254669 NR_033735 THC2607431 Hs.451294 arginine-glutamic mic acid 1-22546750 acid dipeptide (RE) dipeptide repeats pseudogene (RE) repeats 3 (REREP3), pseudogene 3 non-coding RNA [NR_033735] A_33_P3253804 CEBPD Homo sapiens NM_005195 ENST00000542385 1052 CCAAT/ chr8:48649932- GO:0043565|GO:0006355| NM_005195 THC2568931 Hs.440829 CCAAT/enhancer enhancer 48649873 GO:0003700|GO:0006366| binding protein binding protein GO:0046983|GO:0005634 (C/EBP), delta (C/EBP), delta (CEBPD), mRNA [NM_005195] A_23_P349416 ERBB3 Homo sapiens NM_001982 ENST00000551242 2065 v-erb-b2 chr12:5649616 GO:0005886|GO:0051048| NM_001982 NP136988 Hs.118681 v-erb-b2 erythroblastic erythroblastic 0-56496219 GO:0005634|GO:0007409| leukemia viral leukemia viral GO:0005615|GO:0042803| oncogene homolog 3 oncogene GO:0007507|GO:0014037| (avian) (ERBB3), homolog 3 GO:0016323|GO:0043524| transcript variant 1, (avian) GO:0016324|GO:0030296| mRNA [NM_001982] GO:0000166|GO:0019838| GO:0046326|GO:0045211| GO:0042127|GO:0042476| GO:0009968|GO:0032869| GO:0046982|GO:0060056| GO:0042493|GO:0021545| GO:0005576|GO:0014068| GO:0018108|GO:0005524| GO:0016328|GO:0043235| GO:0007162|GO:0005887| GO:0007519|GO:0042060| GO:0007623|GO:0043586| GO:0004714|GO:0007169| GO:0004716|GO:0016740| GO:0004888 A_33_P3313519 CHRFAM7A Homo sapiens NM_139320 ENST00000299847 89832 CHRNA7 chr15:3065354 GO:0005230|GO:0045211| NM_139320 THC2500519 Hs.510853 CHRNA7 (cholinergic 4-30653485 GO:0016021|GO:0006811 (cholinergic receptor, receptor, nicotinic, alpha 7, nicotinic, exons 5-10) and alpha 7, FAM7A (family exons 5-10) with sequence and FAM7A similarity 7A, exons (family with A-E) fusion sequence (CHRFAM7A), similarity transcript variant 1, 7A, exons mRNA[NM_139320] A-E) fusion A_23_P78152 MIS12 Homo sapiens NM_024039 ENST00000381165 79003 MIS12, MIND chr17:5393710- GO:0005515|GO:0007067| NM_024039 THC2462610 Hs.267194 MIS12, MIND kinetochore 5393769 GO:0007049|GO:0051382| kinetochore complex complex GO:0007059|GO:0005634| component, homolog component, GO:0000444|GO:0000775| (S. pombe) (MIS12), homolog GO:0051301 mRNA [NM_024039] (S. pombe) A_24_P288915 coiled-coil domain AK093811 ENST00000445752 chr17:1850695 THC2483620 Hs.721149 containing 144B 4-18506895 (CCDC144B), non- coding RNA [Source: RefSeq DNA; Acc: NR_036647l [ENST00000445752] A_23_P337033 GMEB2 Homo sapiens NM_012384 ENST00000266068 26205 glucocorticoid chr20:6221954 GO:0005737|GO:0006366| NM_012384 THC2463374 Hs.473286 glucocorticoid modulatory modulatory 6-62219487 GO:0005488|GO:0003702| element binding element GO:0008270|GO:0005634| protein 2 binding GO:0003677|GO:0046872| (GMEB2), protein 2 GO:0045449 mRNA [NM_012384] A_33_P3250750 Synthetic construct CU677518 chr12:1205350 Homo sapiens 66-120535125 gateway clone IMAGE: 100018551 3′ read RAB35 mRNA. [CU677518] A_33_P3296067 CDC14C Homo sapiens NR_003595 168448 CDC14 cell chr7:48886139- GO:0006470|GO:0016787| NR_003595 Hs.567757 CDC14 cell division cycle 48886081 GO:0016020|GO:0005730| division cycle 14 14 homolog GO:0005634|GO:0016021| homolog C C (S. GO:0008138|GO:0004725 (S. cerevisiae) cerevisiae) (CDC14C), non-coding RNA [NR_003595] A_33_P3218564 chr14:0196254 95-019625436 A_23_P171336 NXF3 Homo sapiens NM_022052 ENST00000497850 56000 nuclear RNA chrX:10233085 GO:0005622|GO:0005515| NM_022052 THC2635545 Hs.60386 nuclear RNA export factor 3 3-102330794 GO:0005737|GO:0000166| export factor 3 GO:0016973|GO:0006810| (NXF3), GO:0042272|GO:0005634| mRNA [NM_022052] GO:0003729 A_23_P1833 B3GAT1 Homo sapiens NM_054025 ENST00000312527 27087 beta-1,3- chr11:1342487 GO:0015018|GO:0030145| NM_054025 THC2470938 Hs.381050 beta-1,3-glucuronyl- glucuronyl- 53-134248694 GO:0005794|GO:0016020| transferase 1 transferase 1 GO:0008499|GO:0005975| (glucuronosyltransferase (glucuronosyl- GO:0016021|GO:0046872| P) (B3GAT1), transferase P) GO:0016740 transcript variant 2, mRNA [NM_054025] A_23_P41365 SMR3A Homo sapiens NM_012390 ENST00000226460 26952 submaxillary chr4:71232551- GO:0005576 NM_012390 THC2508570 Hs.701334 submaxillary gland gland androgen 71232610 androgen regulated regulated protein 3A protein 3A (SMR3A), mRNA [NM_012390] A_33_P3280950 LOC144571 Homo sapiens NR_026971 144571 hypothetical chr12:9220592- NR_026971 THC2505447 Hs.592432 hypothetical LOC144571 9220651 LOC144571 (LOC144571), non-coding RNA [NR_026971] A_33_P3274618 LOC731275 Homo sapiens NR_029401 ENST00000427210 731275 hypothetical chr1:24324540 NR_029401 THC2508557 Hs.722350 hypothetical LOC731275 8-243245349 LOC731275 (LOC731275), non-coding RNA [NR_029401] A_23_P127233 SMNDC1 Homo sapiens NM_005871 ENST00000369603 10285 survival motor chr10:1120529 GO:0008380|GO:0006397| NM_005871 THC2461341 Hs.632093 survival motor neuron domain 32-112052873 GO:0005515|GO:0000245| neuron domain containing 1 GO:0005737|GO:0015030| containing 1 GO:0016607|GO:0003723| (SMNDC1), GO:0006915|GO:0005681| mRNA [NM_005871] GO:0005634|GO:0006917 A_24_P76300 zinc finger AB095924 ENST00000317656 chr19:5820918 THC2476043 Hs.649031 protein 154 [Source: 7-58209128 HGNC Symbol; Acc: 12939] [ENST00000512439] A_23_P104617 GYLTL1B Homo sapiens NM_152312 ENST00000530437 120071 glycosyl- chr11:4595042 GO:0005794|GO:0016020| NM_152312 THC2479774 Hs.86543 glycosyltransferase- transferase- 7-45950486 GO:0016757|GO:0016021| like 1B (GYLTL1B), like IB GO:0046716 mRNA [NM_152312] A_33_P3303772 SLC6A3 Homo sapiens NM_001044 ENST00000270349 6531 solute carrier chr5:1393704- GO:0021984|GO:0007608| NM_001044 NP107244 Hs.406 solute carrier family 6 1393645 GO:0005886|GO:0045471| family 6 (neuro- (neurotrans- GO:0042220|GO:0051591| transmitter transporter, mitter trans- GO:0032403|GO:0042053| dopamine), member 3 porter, do- GO:0042416|GO:0005737| (SLC6A3), pamine), GO:0008144|GO:0010039| mRNA [NM_001044] member 3 GO:0006836|GO:0007626| GO:0040018|GO:0019717| GO:0015293|GO:0005330| GO:0060134|GO:0015872| GO:0042493|GO:0007568| GO:0035240|GO:0007595| GO:0005887|GO:0042420| GO:0015844|GO:0035094 A_23_P501933 CACNG6 Homo sapiens, NM_145814 ENST00000352529 59285 calcium chan- chr19:5451579 GO:0005244|GO:0016020| NM_145814 NP520196 Hs.631560 calcium channel, nel, voltage- 5-54515854 GO:0005245|GO:0005509| voltage-dependent, dependent, GO:0006816|GO:0016021| gamma subunit 6 gamma GO:0005891|GO:0006811 (CACNG6) subunit 6 transcript variant 1, mRNA [NM_145814] A_33_P3244361 chrX:07343682 8-073436887 A_33_P3369844 CD24 Homo sapiens NM_013230 100133941 CD24 chrY:21152726- GO:0005515|GO:0043627| NM_013230 THC2546089 Hs.644105 CD24 molecule molecule 21152667 GO:0043499|GO:0030262| (CD24), GO:0006800|GO:0050731| mRNA [NM_013230] GO:0031528|GO:0031225| GO:0031362|GO:0032597| GO:0007406|GO:0031175| GO:0032913|GO:0008637| GO:0030296|GO:0002904| GO:0032600|GO:0046641| GO:0002329|GO:0002842| GO:0016055|GO:0034119| GO:0042632|GO:0019901| GO:0002523|GO:0030889| GO:0048488|GO:0007274| GO:0001959|GO:0002768| GO:0045121|GO:0009897| GO:0045730|GO:0045577| GO:0008624|GO:0060170| GO:0005886|GO:0002863| GO:0031295|GO:0002237| GO:0033625|GO:0007204| GO:0050850|GO:0042103| GO:0042104|GO:0006955| GO:0030856|GO:0043406| GO:0043408|GO:0007159| GO:0046014|GO:0004871| GO:0007157|GO:0001775| GO:0001666|GO:0005624| GO:0033634|GO:0034107| GO:0042325|GO:0034109| GO:0045665|GO:0016477| GO:0030246|GO:0008629 A_33_P3281478 chr15:0308734 72-030873413 A_23_P153616 MADCAM1 Homo sapiens NM_130760 ENST00000215637 8174 mucosal chr19:505192- GO:0005515|GO:0007165| NM_130760 THC2621878 Hs.102598 mucosal vascular vascular 505251 GO:0006955|GO:0005886| addressin cell addressin cell GO:0030216|GO:0005624| adhesion molecule adhesion GO:0016021|GO:0007155 1 (MADCAM1), molecule 1 transcript variant 1, mRNA [NM_130760] A_33_P3354203 NELL1 NEL-like 1 AB085898 ENST00000534263 4745 NEL-like chr11:2130560 THC2486544 Hs.657172 (chicken) [Source: 1 (chicken) 0-21305659 HGNC Symbol; Acc: 7750] [ENST00000534263] A_33_P3240078 A_23_P502047 CHRD Homo sapiens NM_003741 ENST00000545352 8646 chordin chr3:18410749 GO:0007389|GO:0030336| NM_003741 NP1473743 Hs.166186 chordin (CHRD), 3-184107552 GO:0001707|GO:0033504| mRNA[NM_003741] GO:0021919|GO:0005576| GO:0009953|GO:0007417| GO:0005615|GO:0001702| GO:0045785|GO:0030514| GO:0001501|GO:0045668| GO:0019955|GO:0030900| GO:0045545|GO:0008201 A_23_P51761 OR6K2 Homo sapiens NM_001005279 ENST00000359610 81448 olfactory re- chr1:15866994 GO:0007608|GO:0007165| NM_001005279 NP1461786 Hs.554489 olfactory receptor, ceptor, 5-158669886 GO:0004984|GO:0007186| family 6, family 6, GO:0005886|GO:0004872| subfamily K, subfamily K, GO:0016021|GO:0050896 member 2 (OR6K2), member 2 mRNA [NM_001005279] A_33_P3363560 TMEM51 Homo sapiens NM_001136216 ENST00000376014 55092 transmembrane chr1:15546776- GO:0016020|GO:0016021 NM_001136216 THC2478353 Hs.465305 transmembrane protein 51 15546835 protein 51 (TMEM51), transcript variant 1, mRNA [NM_001136216] A_33_P3335920 SYNE1 Homo sapiens NM_182961 ENST00000367255 23345 spectrin repeat chr6:1524435 GO:0008219|GO:0006997| NM_182961 NP1154489 Hs.12967 spectrin repeat containing, 8 7-152443528 GO:0005794|GO:0003779| containing, nuclear nuclear GO:0005634|GO:0005635| envelope 1 (SYNE1), envelope 1 GO:0030017|GO:0042692| transcript variant 1, GO:0005737|GO:0045211| mRNA [NM_182961] GO:0007030|GO:0016021| GO:0005856|GO:0005521 A_23_P120902 LGALS2 Homo sapiens NM_006498 ENST00000215886 3957 lectin, chr22:3796632 GO:0005529|GO:0016936 NM_006498 THC2474966 Hs.531776 lectin, galactoside- galactoside- 9-37966270 binding, soluble, binding, 2 (LGALS2), soluble, 2 mRNA [NM_006498] A_23_P107454 KRTAP3-1 Homo sapiens NM_031958 ENST00000391588 83896 keratin chr17:3916490 GO:0005198|GO:0045095 NM_031958 THC2488283 Hs.307027 keratin associated associated 2-39164843 protein 3-1 protein 3-1 (KRTAP3-1), mRNA [NM_031958] A_33_P3310706 DB043695 TESTI2 DB043695 chr10:1232863 Hs.576915 Homo sapiens cDNA 85-123286444 clone TESTI2031475 5′, mRNA sequence [DB043695] A_23_P130435 LIM2 Homo sapiens NM_030657 ENST00000221973 3982 lens intrinsic chr19:5188338 GO:0005212|GO:0030054| NM_030657 THC2481842 Hs.162754 lens intrinsic membrane 7-51883328 GO:0016020|GO:0007043| membrane protein 2, protein 2, GO:0016021 19 kDa (LIM2), 19 kDa transcript variant 1, mRNA [NM_030657] A_23_P119593 EPHX3 Homo sapiens NM_024794 ENST00000435261 79852 epoxide chr19:1533787 GO:0008150|GO:0016787| NM_024794 THC2653397 Hs.156457 epoxide hydrolase hydrolase 3 0-15337811 GO:0005575 3 (EPHX3), transcript variant 1, mRNA [NM_024794] A_32_P42574 C1orf198 Homo sapiens NM_032800 ENST00000366663 84886 chromosome 1 chr1:23097300 NM_032800 THC2468585 Hs.520494 chromosome 1 open reading 4-230972945 open reading frame frame 198 198 (C1orf198), transcript variant 1, mRNA [NM_032800] A_23_P23947 MAP3K8 Homo sapiens NM_005204 ENST00000263056 1326 mitogen-acti- chr10:3074998 GO:0005515|GO:0007165| NM_005204 THC2465022 Hs.432453 mitogen-activated vated protein 0-30750039 GO:0007049|GO:0005737| protein kinase kinase kinase GO:0000287|GO:0000166| kinase kinase 8 kinase 8 GO:0004674|GO:0006468| (MAP3K8), GO:0005524|GO:0004709| mRNA [NM_005204] GO:0016740|GO:0005829 A_23_P339954 Nuclear pore XM_003118719 ENST00000355290 chr16:2866949 XM_003118719 THC2516834 Hs.710214 complex-interacting 4-28669553 protein-like 2 [Source: UniProtKB/ Swiss- Prot; Acc: A6NHN6] [ENST00000355290] A_23_P211355 DGCR8 Homo sapiens NM_022720 ENST00000351989 54487 DiGeorge chr22:2009891 GO:0005622|GO:0005515| NM_022720 THC2741608 Hs.643452 DiGeorge syndrome syndrome 6-20098975 GO:0003725|GO:0005737| critical region gene critical GO:0031053|GO:0005730| 8 (DGCR8), region GO:0005634 transcript variant 1, gene 8 mRNA [NM_022720] A_24_P60845 ACHE Homo sapiens NM_000665 ENST00000422451 43 acetyl- chr7:10049006 GO:0048471|GO:0003990| NM_000665 THC2604591 Hs.154495 acetylcholinesterase cholinesterase 6-100490007 GO:0030054|GO:0005886| (ACHE), transcript GO:0008283|GO:0004104| variant E4-E6, GO:0005518|GO:0050714| mRNA [NM_000665] GO:0045202|GO:0005634| GO:0031225|GO:0042803| GO:0001540|GO:0042166| GO:0017171|GO:0007155| GO:0005794|GO:0005605| GO:0009611|GO:0005576| GO:0042982|GO:0007416| GO:0006260|GO:0007517| GO:0032223|GO:0002076| GO:0043237|GO:0001507| GO:0019898 A_33_P3388527 chr17:0793675 38-079367597 A_33_P3322428 MARK4 Homo sapiens NM_001199867 ENST00000262893 57787 MAP/micro- chr19:4578366 GO:0005515|GO:0008017| NM_001199867 NP105710 Hs.34314 MAP/microtubule tubule affinity- 8-45783727 GO:0043130|GO:0043005| affinity-regulating regulating GO:0005813|GO:0043015| kinase 4 (MARK4), kinase 4 GO:0001578|GO:0050321| transcript GO:0005524|GO:0007399| variant 1, mRNA GO:0043068|GO:0000166| [NM_001199867] GO:0004674|GO:0006468| GO:0016740 A_33_P3284152 LOC285191 Homo sapiens AK096937 ENST00000407635 285191 hypothetical chr2:24162848 THC2622724 Hs.729906 cDNA FLJ39618 fis, protein 0-241628539 clone SMINT2000824. LOC285191 [AK096937] A_33_P3233981 NASP Homo sapiens NM_002482 ENST00000481782 4678 nuclear chr1:46083827- GO:0006260|GO:0005515| NM_002482 THC2496068 Hs.319334 nuclear autoantigenic autoantigenic 46083886 GO:0007049|GO:0005737| sperm protein sperm protein GO:0043486|GO:0008283| (histone-binding) (histone- GO:0001824|GO:0051879| (NASP), transcript binding) GO:0005634|GO:0015031 variant 2, mRNA [NM_002482] A_33_P3283906 NIP7 Homo sapiens NM_016101 ENST00000254941 51388 nuclear import chr16:6937681 GO:0005515|GO:0042255| NM_016101 THC2482970 Hs.730815 nuclear import 7 homolog 6-69376875 GO:0003723|GO:0005730| 7 homolog (S. cerevisiae) GO:0005634 (S. cerevisiae) (NIP7), transcript variant 1, mRNA [NM_016101] A_24_P258235 OR5L2 Homo sapiens NM_001004739 ENST00000378397 26338 olfactory chr11:5559519 GO:0007608|GO:0007165| NM_001004739 THC2604332 Hs.528356 olfactory receptor, receptor, 3-55595252 GO:0004984|GO:0007186| family 5, subfamily family 5, GO:0005886|GO:0004872| L, member 2 subfamily L, GO:0016021|GO:0050896 (OR5L2), mRNA member 2 [NM_001004739] A_33_P3218491 chr19:0459975 17-045997576 A_23_P114414 LONRF3 Homo sapiens NM_001031855 ENST00000371628 79836 LON peptidase chrX:11815168 GO:0005515|GO:0004176| NM_001031855 THC2485491 Hs.144266 LON peptidase N-terminal do- 0-118151739 GO:0006508|GO:0008270| N-terminal domain main and ring GO:0046872 and ring finger 3 finger 3 (LONRF3), transcript variant 1, mRNA [NM_001031855] A_24_P945096 CACNA1I Homo sapiens NM_021096 ENST00000336649 8911 calcium chan- chr22:4008542 GO:0005515|GO:0007165| NM_021096 THC2600930 Hs.125116 calcium channel, nel, voltage- 3-40085482 GO:0005244|GO:0016020| voltage-dependent, dependent, 1 GO:0008332|GO:0005509| T type, alpha 1I type, alpha 1I GO:0006816|GO:0016021| subunit (CACNA1I), subunit GO:0055085|GO:0005891| transcript variant 1, GO:0006811 mRNA [NM_021096] A_33_P3296687 KRT33A Homo sapiens NM_004138 ENST00000007735 3883 keratin 33A chr17:3950243 GO:0005882|GO:0005515| NM_004138 Hs.512579 keratin 33A 0-39502371 GO:0005198 (KRT33A), mRNA [NM_004138] A_23_P24135 TACR2 Homo sapiens NM_001057 ENST00000373306 6865 tachykinin chr10:7116478 GO:0004995|GO:0007588| NM_001057 THC2620435 Hs.88372 tachykinin receptor receptor 2 5-71164726 GO:0007165|GO:0006936| 2 (TACR2), GO:0005886|GO:0005887| mRNA [NM_001057] GO:0004930|GO:0007217| GO:0004872 A_23_P143526 S100B Homo sapiens NM_006272 ENST00000291700 6285 S100 calcium chr21:4801915 GO:0008283|GO:0005509| NM_006272 THC2605292 Hs.422181 S100 calcium binding 8-48019099 GO:0048156|GO:0005634| binding protein protein B GO:0007409|GO:0007417| B (S100B), GO:0001726|GO:0042803| mRNA [NM_006272] GO:0048154|GO:0005737| GO:0007611|GO:0008270| GO:0048306 A_33_P3366667 EYA1 Homo sapiens eyes NM_000503 ENST00000388740 2138 eyes absent chr8:72110532- GO:0005515|GO:0021984| NM_000503 THC2472858 Hs.491997 absent homolog 1 homolog 1 72110473 GO:0007389|GO:0001657| (Drosophila) (EYA1), (Drosophila) GO:0001658|GO:0007605| transcript variant 3, GO:0048704|GO:0005634| mRNA [NM_000503] GO:0045739|GO:0006302| GO:0005737|GO:0010212| GO:0009887|GO:0042474| GO:0042473|GO:0004725| GO:0045449|GO:0043066| GO:0000287|GO:0016576| GO:0042472|GO:0006974| GO:0045165|GO:0016787| GO:0008152|GO:0045664| GO:0016568 A_23_P27215 UBB Homo sapiens NM_018955 ENST00000302182 7314 ubiquitin B chr17:1628550 GO:0005515|GO:0008624| NM_018955 THC2583951 Hs.730603 ubiquitin B (UBB), 5-16285564 GO:0016567|GO:0051437| mRNA [NM_018955] GO:0006915|GO:0005634| GO:0006916|GO:0051436| GO:0030433|GO:0031145| GO:0005829|GO:0042062| GO:0005737|GO:0007049| GO:0045941|GO:0048167| GO:0007411|GO:0022627| GO:0030528|GO:0005654 A_23_P215331 CRHR2 Homo sapiens NM_001883 ENST00000506074 1395 corticotropin chr7:30695225- GO:0005515|GO:0015056| NM_001883 THC2485141 Hs.546246 corticotropin releasing 30694667 GO:0007186|GO:0005886| releasing hormone hormone GO:0005887|GO:0007188 receptor 2 receptor 2 (CRHR2), transcript variant 1, mRNA[NM_001883] A_24_P228550 TUBB1 Homo sapiens NM_030773 ENST00000217133 81027 tubulin, chr20:5760124 GO:0051258|GO:0000166| NM_030773 THC2472803 Hs.303023 tubulin, beta 1 beta 1 4-57601303 GO:0005874|GO:0005200| (TUBB1), GO:0003924|GO:0005525| mRNA [NM_030773] GO:0051225|GO:0007018 A_33_P3250253 LOC100131150 Homo sapiens AK096194 100131150 hypothetical chr11:6700807 THC2480126 Hs.124147 cDNA FLJ38875 protein 6-67008135 fis, clone LOC100131150 MESAN2013936. [AK096194] A_33_P3417880 NKAPL Homo sapiens NM_001007531 ENST00000343684 222698 NFKB chr6:28228606- NM_001007531 THC2472731 Hs.239181 NFKB activating activating 28228665 protein-like protein-like (NKAPL), mRNA [NM_001007531] A_24_P404033 C15orf38 Homo sapiens NM_182616 ENST00000460685 348110 chromosome 15 chr15:9044489 NM_182616 THC2490900 Hs.728822 chromosome 15 open reading 9-90444840 open reading frame 38 frame 38 (C15orf38), mRNA [NM_182616] A_24_P24053 immunoglobulin JF810271 ENST00000390632 chr14:1071311 NP1166771 Hs.705292 heavy variable 81-107131122 3-66 [Source: HGNC Symbol; Acc: 5619] [ENST00000390632] transcript variant 1, A_33_P3230264 GPC3 Homo sapiens NM_001164617 ENST00000394299 2719 glypican 3 chrX:13266988 GO.0030513|GO:0001658| NM_001164617 THC2583194 Hs.644108 glypican 3 (GPC3), 6-132669827 GO:0008285|GO:0005886| mRNA GO:0005887|GO:0005578| [NM_001164617] GO:0009887|GO:0043395| GO:0005576|GO:0031225| GO:0005615|GO:0045926 A_33_P3221019 ZAN Homo sapiens NM_173059 ENST00000546213 7455 zonadhesin chr7:10035296 GO:0005515|GO:0016337| NM_173059 NP104330 Hs.307004 zonadhesin (ZAN), 4-100353023 GO:0005886|GO:0016021| transcript variant 6, GO:0007339 mRNA [NM_173059] A_23_P83094 TLE4 Homo sapiens NM_007005 ENST00000376520 7091 transducin-like chr9:82341057- GO:0008150|GO:0003674| NM_007005 THC2471161 Hs.444213 transducin-like enhancer of 82341116 GO:0005634|GO:0016055| enhancer of split split 4 (E(sp1) GO:0045449 4 (E(sp1) homolog, homolog, Drosophila) (TLE4), Drosophila) mRNA [NM_007005] A_33_P3394769 TMEM8C Homo sapiens NM_001080483 ENST00000339996 389827 transmembrane chr9:13637976 GO:0016020|GO:0016021 NM_001080483 THC2645713 Hs.512467 transmembrane protein 8C 7-136379708 protein 8C (TMEM8C), mRNA [NM_001080483] A_23_ P122007 C5orf30 Homo sapiens NM_033211 ENST00000510890 90355 chromosome 5 chr5:10261381 NM_033211 THC2461293 Hs.482976 chromosome 5 open reading 2-102613871 open reading frame 30 frame 30 (C5orf30), mRNA [NM_033211] A_33_P3231428 Homo sapiens AK126714 chr20:2044594- THC2480753 Hs.677538 cDNA FLJ44760 fis, 6-20445887 clone BRACE3031579. [AK126714] A_24_P175176 PHTF2 Homo sapiens NM_020432 ENST00000248550 57157 putative chr7:77586179- GO:0005783|GO:0005634| NM_020432 THC2483055 Hs.203965 putative homeo- homeodomain 77586238 GO:0003677|GO:0045449 domain transcription transcription factor 2 (PHTF2), factor 2 transcript variant 2, mRNA [NM_020432] A_24_P109069 SYT15 Homo sapiens NM_181519 ENST00000503753 83849 synaptotagmin chr10:4696398 GO:0005886|GO:0016021 NM_181519 THC2602435 Hs.696346 synaptotagmin XV 3-46963924 XV (SYT15), transcript variant b, mRNA [NM_181519] A_23_P167856 TMEM63B Homo sapiens NM_018426 ENST00000323267 55362 transmembrane chr6:441228800 GO:0016020|GO:0016021 NM_018426 THC2462238 Hs.414473 transmembrane protein 63B 44122939 protein 63B (TMEM63B), mRNA [NM_018426] A_33_P3221528 IREB2 Homo sapiens NM_004136 ENST00000258886 3658 iron-responsive chr15:7879350 GO:0010468|GO:0051539| NM_004136 THC2534298 Hs.436031 iron-responsive element 7-78793566 GO:0005506|GO:0003723| element binding binding GO:0034101|GO:0006782| protein 2 (IREB2), protein 2 GO:0009791|GO:0006417| mRNA [NM_004136] GO:0046872|GO:0005829| GO:0006879|GO:0050892| GO:0005737|GO:0008152| GO:0030350 A_33_P3306452 COBW domain XR_114261 ENST00000465474 chr9:70434183- XR_114261 THC2536071 Hs.635227 containing 5 [Source: 70434124 HGNC Symbol; Acc: 24584] [ENST00000465474] A_33_P3339915 REXO1L1 Homo sapiens NM_172239 ENST00000425429 254958 REX1, RNA chr8:86788048- GO:0005622|GO:0005737| NM_172239 THC2603070 Hs.373854 REX1, RNA exonuclease 1 86787989 GO:0004527|GO:0016787| exonuclease 1 homolog (S. GO:0005634|GO:0003676 homolog (S. cerevisiae)- cerevisiae)-like 1 like 1 (REXO1L1), mRNA [NM_172239] A_33_P3326817 chr2:03883025 6-038830315 A_23_P143774 MOV10L1 Homo sapiens NM_018995 ENST00000545383 54456 Mov10l1, chr22:5059941 GO:0000287|GO:0008283| NM_018995 THC2473678 Hs.62880 Mov10l1, Moloney Moloney 8-50599477 GO:0003723|GO:0004386| leukemia virus leukemia virus GO:0007275|GO:0007283| 10-like 1, homolog 10-like 1, GO:0045786|GO:0005524| (mouse) (MOV10L1), homolog GO:0007281|GO:0004004| transcript variant 1, (mouse) GO:0005622|GO:0007517| mRNA [NM_018995] GO:0000166|GO:0016787 A_33_P3263284 LOC100130238 Homo sapiens NR_024563 100130238 hypothetical chr12:1328574 NR_024563 THC2629253 hypothetical LOC100130238 26-132857485 LOC100130238 (LOC100130238), non-coding RNA [NR_024563] A_23_P140170 SEC23A Homo sapiens NM_006364 ENST00000307712 10484 Sec23 homolog chr14:3950172 GO:0005515|GO:0048471| NM_006364 THC2508310 Hs.272927 Sec23 homolog A A (S. 8-39501669 GO:0005794|GO:0030127| (S. cerevisiae) cerevisiae) GO:0005783|GO:0006886| (SEC23A), GO:0005829|GO:0006888| mRNA [NM_006364] GO:0000139|GO:0016020| GO:0008270|GO:0016192| GO:0016044|GO:0019898 A_33_P3364741 MRC2 Homo sapiens NM_006039 ENST00000303375 9902 mannose chr17:6077082 GO:0016020|GO:0005488| NM_006039 THC2608201 Hs.7835 mannose receptor, receptor, C 7-60770886 GO:0005509|GO:0005529| Ctype 2 (MRC2), type 2 GO:0004872|GO:0016021| mRNA [NM_006039] GO:0006897 A_33_P3499692 LOC645261 Homo sapiens AF258587 645261 PP565 chr5:86344779- NP1472476 PP565 mRNA, 86344720 complete cds. [AF258587] A_33_P3359748 SARS Homo sapiens NR_034073 ENST00000369923 6301 seryl-tRNA chr1:10977943 NR_034073 THC2493814 Hs.531176 seryl-tRNA synthetase 2-109779491 synthetase (SARS), transcript variant 3, non-coding RNA [NR_034073] A_23_P110473 NAIP Homo sapiens NM_004536 ENST00000517649 4671 NLR family, chr5:70264650- GO:0005622|GO:0017111| NM_004536 THC2464586 Hs.654500 NLR family, apoptosis 70264591 GO:0000166|GO:0006915| apoptosis inhibitory inhibitory GO:0008270|GO:0006916| protein (NAIP), protein GO:0046872|GO:0007399 transcript variant 1, mRNA [NM_004536] A_24_P56689 ZNF205 Homo sapiens NM_003456 ENST00000219091 7755 zinc finger chr16:3169835- GO:0005622|GO:0005515| NM_003456 THC2470721 Hs.592088 zinc finger protein protein 205 3169894 GO:0006355|GO:0008270| 205 (ZNF205), GO:0005634|GO:0003677| transcript variant 1, GO:0046872 mRNA [NM_003456] A_33_P3216869 CRABP1 Homo sapiens NM_004378 ENST00000299529 1381 cellular retinoic chr15:7864036 GO:0007165|GO:0005215| NM_004378 THC2464817 Hs.346950 cellular retinoic acid binding 1-78640420 GO:0005737|GO:0016918| acid binding protein protein 1 GO:0006810|GO:0007275| 1 (CRABP1), GO:0019841|GO:0008289 mRNA [NM_004378] A_23_P130653 RTBDN Homo sapiens NM_031429 ENST00000322912 83546 retbindin chr19:1293635 GO:0005576 NM_031429 THC2482585 Hs.21162 retbindin (RTBDN), 7-12936298 transcript variant 2, mRNA [NM_031429] A_32_P393316 RAPGEF3 Homo sapiens NM_001098531 ENST00000405493 10411 Rap guanine chr12:4812851 GO:0005622|GO:0005085| NM_001098531 THC2696603 Hs.8578 Rap guanine nucleotide nucleotide 4-48128455 GO:0051056|GO:0005952| exchange factor exchange GO:0030552|GO:0016020| (GEF) 3 (RAPGEF3), factor (GEF) GO:0008603|GO:0000166| transcript variant 1, 3 GO:0008283|GO:0005624| mRNA [NM_001098531] GO:0001932|GO:0012505 A_23_P163492 BAIAP3 Homo sapiens NM_003933 ENST00000397489 8938 BAI1-ass- chr16:1398879- GO:0008022|GO:0007269 NM_003933 THC2622475 Hs.458427 BAI1-associated ociated 1398938 protein 3 (BAIAP3), protein 3 transcript variant 1, mRNA [NM_003933] A_33_P3270451 TXNDC5 Homo sapiens NM_030810 ENST00000439343 81567 thioredoxin chr6:7883436- GO:0005783|GO:0006892| NM_030810 THC2520615 Hs.150837 thioredoxin domain domain 7883377 GO:0005788|GO:0045454| containing 5 containing 5 GO:0006916|GO:0016853| (endoplasmic reticulum) (endoplasmic GO:0016044 (TXNDC5), reticulum) transcript variant 1, mRNA [NM_030810] A_23_P42241 OR5V1 Homo sapiens NM_030876 ENST00000377154 81696 olfactory chr6:29323467- GO:0007608|GO:0007165| NM_030876 THC2602991 Hs.666316 olfactory receptor, receptor, 29323408 GO:0004984|GO:0007186| family 5, family 5, GO:0005886|GO:0004872| subfamily V, subfamily V, GO:0016021|GO:0050896 member 1 (OR5V1), member 1 mRNA [NM_030876] A_32_P722809 immunoglobulin BC034142 ENST00000453166 chr2:89999481- NP073702 Hs.449621 kappa variable 89999540 2D-28 [Source: HGNC Symbol; Acc: 5799] [ENST00000453166] A_33_P3411805 ENST00000412714 chr13:1918462 2-19184563 A_23_P207967 CTIF Homo sapiens NM_014772 ENST00000382998 981 1 CBP80/20- chr18:4638918 GO:0005515|GO:0048471| NM_014772 THC2507982 Hs.145230 CBP80/20-dependent dependent 3-46389242 GO:0016070|GO:0000184| translation initiation translation GO:0006446 factor (CTIF), initiation transcript variant 1, factor mRNA [NM_014772] A_33_P3358957 PAPL Homo sapiens NM_001004318 ENST00000331256 390928 iron/zinc chr19:3960141 GO:0016787|GO:0005506| NM_001004318 THC2482977 Hs.448934 iron/zinc purple purple acid 9-39601478 GO:0003993|GO:0008270| acid phosphatase-like phosphatase GO:0005576|GO:0046872 protein (PAPL), like protein mRNA [NM_001004318] A_33_P3215288 LOC284757 Homo sapiens AK128288 284757 hypothetical chr20:5889449 THC2481282 Hs.534781 cDNA FLJ46426 fis, protein 4-58894553 clone THYMU3013897. LOC284757 [AK128288] A_23_P115842 CCAR1 Homo sapiens NM_018237 ENST00000540210 55749 cell division chr10:7055099 GO:0048471|GO:0007049| NM_018237 THC2468937 Hs.49853 cell division cycle cycle and 8-70551057 GO:0005737|GO:0005794| and apoptosis regulator apoptosis GO:0000398|GO:0006915| 1 (CCAR1), regulator 1 GO:0005634|GO:0003676| mRNA [NM_018237] GO:0045449 A_33_P3284197 POMGNT1 Homo sapiens NM_017739 ENST00000371992 55624 protein chr1:46654450- GO:0005792|GO:0003827| NM_017739 THC2537515 Hs.525134 protein O-linked O-linked 46654391 GO:0030145|GO:0005794| mannose beta 1, mannose beta GO:0016020|GO:0006493| 2-N-acetylglucosaminyl- 1,2 N-acetyl- GO:0000139|GO:0016757| transferase glucosamin- GO:0047223|GO:0016021| (POMGNT1), yltransferase GO:0006487 transcript variant 1, mRNA [NM_017739] A_33_P3231888 C5orf15 Homo sapiens NM_020199 ENST00000451255 56951 chromosome 5 chr5:13329196 GO:0016020|GO:0016021 NM_020199 THC2469485 Hs.730670 chromosome 5 open reading 6-133291907 open reading frame frame 15 15 (C5orf15), mRNA [NM_020199] A_23_P204850 RB1 Homo sapiens NM_000321 ENST00000267163 5925 retinoblastoma chr13:4905584 GO:0051219|GO:0016564| NM_000321 THC2601211 Hs.408528 retinoblastoma 1 1 5-49055904 GO:0030308|GO:0003700| (RB1), GO:0008285|GO:0005634| mRNA [NM_000321] GO:0050681|GO:0043353| GO:0000083|GO:0016514| GO:0045944|GO:0044419| GO:0051318|GO:0035189| GO:0045445|GO:0007050| GO:0006338|GO:0019900| GO:0000785|GO:0031625| GO:0003713|GO:0005819| GO:0043550|GO:0000122| GO:0045786|GO:0045651| GO:0045749|GO:0016605| GO:0000075|GO:0005654| GO:0006469|GO:0051146| GO:0030521|GO:0051301| GO:0000279|GO:0008134 A_33_P3393091 DA197111 BRASW1 DA197111 chr2:13212155 Hs.712140 Homo sapiens cDNA 9-132121618 clone BRASW1000106 5′, mRNA sequence [DA197111] A_33_P3399291 GUK1 Homo sapiens NM_001242840 ENST00000493209 2987 guanylate chr1:22833457 GO:0000166|GO:0016301| NM_001242840 NP1277184 Hs.376933 guanylate kinase kinase 1 9-228334638 GO:0004385|GO:0019206| 1 (GUK1), GO:0005524|GO:0016740| transcript variant 5, GO:0006163|GO:0005829 mRNA [NM_001242840] A_33_P3378056 TFAP2A transcription factor M61156 ENST00000478375 7020 transcription chr6:10402318- GO:0003700|GO:0006357| THC2493408 Hs.519880 AP-2 alpha (activating factor AP-2 10402259 GO:0003713|GO:0046983| enhancer binding protein alpha GO:0048705|GO:0005634| 2 alpha) (activating GO:0007398|GO:0048701| [Source: HGNC Symbol; enhancer GO:0021506 Acc: 11742] binding protein [ENST00000478375] 2 alpha) A_33_P3355266 TINAGL1 Homo sapiens NM_022164 ENST00000481165 64129 tubulointer- chr1:32052808- GO:0004197|GO:0006955| NM_022164 THC2584652 Hs.199368 tubulointerstitial stitial ne- 32052867 GO:0016197|GO:0006508| nephritis antigen- phritis anti- GO:0030247|GO:0005576| like 1 (TINAGL1), gen like 1 GO:0005201|GO:0005044 transcript variant 1, mRNA [NM_022164] A_33_P3271594 TRIM54 Homo sapiens NM_032546 ENST00000380075 57159 tripartite motif chr2:27530243- GO:0005515|GO:0030018| NM_032546 THC2602749 Hs.516036 tripartite motif containing 54 27530302 GO:0005874|GO:0007275| containing 54 GO:0046872|GO:0030154| (TRIM54), GO:0005622|GO:0007165| transcript variant 1, GO:0005737|GO:0007026| mRNA [NM_032546] GO:0008270|GO:0004871| GO:0005856|GO:0007017 A_33_P3300877 chr17:0810129 21-081012862 A_33_P3394599 HMG20B Homo sapiens NM_006339 ENST00000487894 10362 high mobility chr19:3578051- GO:0005515|GO:0007049| NM_006339 THC2580877 Hs.406534 high mobility group group 20B 3578110 GO:0006355|GO:0003700| 208 (HMG20B), GO:0005634|GO:0016568 mRNA [NM_006339] A_33_P3394605 HMG20B Homo sapiens NM_006339 ENST00000402569 10362 high mobility chr19:3578660- GO:0005515|GO:0007049| NM_006339 THC2515693 Hs.406534 high mobility group group 20B 3578719 GO:0006355|GO:0003700| 20B (HMG20B), GO:0005634|GO:0016568 mRNA [NM_006339] A_23_P2601 HSP90B1 Homo sapiens heat NM_003299 ENST00000421266 7184 heat shock chr12:1043415 GO:0042470|GO:0001666| NM_003299 THC2465650 Hs.192374 shock protein protein 36-104341595 GO:0005792|GO:0051208| 90 kDa beta (Grp94), 90 kDa beta GO:0048471|GO:0005783| member 1 (HSP90B1), (Grp94), GO:0003723|GO:0005509| mRNA [NM_003299] member 1 GO:0046790|GO:0006916| GO:0030433|GO:0015031| GO:0005524|GO:0005829| GO:0000166|GO:0006457| GO:0005789|GO:0005788| GO:0051082|GO:0050750 A_33_P3248024 Homo sapiens AK311432 ENST00000446816 chr2:96874597- THC2556209 Hs.58648 cDNA, FLJ18474. 96874656 [AK311432] A_33_P3326275 Homo sapiens AK026773 chr2:47799886- THC2554846 Hs.287726 cDNA: FLJ23120 fis, 47799945 clone LNG07989. [AK026773] A_24_P631848 LOC100132147 Homo sapiens BC036435 ENST00000451828 100132147 hypothetical chr1:16860558- Hs.645945 cDNA clone LOC100132147 16860499 IMAGE: 4816083, partial cds. [BC036435] A_24_P228130 CCL3L3 Homo sapiens NM_001001437 ENST00000425833 414062 chemokine chr17:3452326 GO:0008009|GO:0006955| NM_001001437 THC2605779 Hs.512304 chemokine (C-C motif) (C-C motif) 0-34523201 GO:0008285|GO:0006954| ligand 3-like 3 ligand 3- GO:0006935|GO:0005576| (CCL3L3), like 3 GO:0005615 mRNA [NM_001001437] A_33_P3229335 HIST3H2BB Homo sapiens NM_175055 ENST00000369160 128312 histone chr1:22864619 GO:0005694|GO:0006334| NM_175055 THC2785974 Hs.376691 histone cluster 3, cluster 3, 2-228646251 GO:0005634|GO:0000786| H2bb (HIST3H2BB), H2bb GO:0003677 mRNA [NM_175055] A_23_P26557 C16orf59 Homo sapiens NM_025108 ENST00000483320 80178 chromosome chr16:2514795- NM_025108 THC2601798 Hs.534491 chromosome 16 16 open 2514854 open reading frame reading 59 (C16orf59), frame 59 mRNA [NM_025108] A_24_P288298 KIR2DL4 Homo sapiens killer NM_002255 ENST00000396293 3805 killer cell chr19:5532533 GO:0007165|GO:0006968| NM_002255 NP365687 Hs.661219 cell immunoglobulin-like immuno- 7-55325396 GO:0005886|GO:0005887| receptor, two domains, globulin- GO:0004888 long cytoplasmic tail, like receptor, 4 (KIR2DL4), two domains, transcript variant 1, long cyto- mRNA [NM_002255] plasmic tail, 4 A_33_P3369266 CR997556 RZPD CR997556 chr2:11434510 Hs.682246 no. 9016 Homo sapiens 9-114345168 cDNA clone RZPDp9016l2412 5′, mRNA sequence [CR997556] A_23_P502343 ADAM33 Homo sapiens NM_025220 ENST00000444535 80332 ADAM chr20:3649151- GO:0016020|GO:0006508| NM_025220 NP1168293 Hs.173716 ADAM metallopeptidase metallo- 3649092 GO:0008270|GO:0008233| domain 33 (ADAM33), peptidase GO:0016021|GO:0004222| transcript variant 1, domain 33 GO:0046872 mRNA [NM_025220] A_23_P26468 RHBDL1 Homo sapiens NM_003961 ENST00000219551 9028 rhomboid, chr16:726855- GO:0007165|GO:0016020| NM_003961 THC2606656 Hs.137572 rhomboid, veinlet- veinlet-like 726988 GO:0004252|GO:0005887| like 1 (Drosophila) 1 (Drosophila) GO:0005624|GO:0008233 (RHBDL1), mRNA [NM_003961] A_23_P71649 MUSK Homo sapiens NM_005592 ENST00000189978 4593 muscle, chr9:11356307 GO:0005515|GO:0007275| NM_005592 NP1245860 Hs.521653 muscle, skeletal, skeletal, 5-113563134 GO:0005524|GO:0007517| receptor tyrosine receptor GO:0000166|GO:0016020| kinase (MUSK), tyrosine kinase GO:0005887|GO:0007528| transcript variant 1, GO:0004872|GO:0006468| mRNA [NM_005592] GO:0004714|GO:0007169| GO:0016740 A_23_P65768 RSL24D1 Homo sapiens NM_016304 ENST00000260443 51187 ribosomal chr15:5547422 GO:0005622|GO:0003735| NM_016304 THC2535982 Hs.274772 ribosomal L24 domain L24 domain 8-55474169 GO:0042254|GO:0005730| containing 1 containing 1 GO:0005840|GO:0005634| (RSL24D1), GO:0006412 mRNA [NM_016304] A_33_P3229328 NBPF6 Homo sapiens NM_001143988 ENST00000294652 653149 neuroblastoma chr1:10899334 GO:0005737 NM_001143988 THC2493504 Hs.712226 neuroblastoma break- breakpoint 3-108993401 point family, member family, 6 (NBPF6), member 6 transcript variant 2, mRNA [NM_001143988] A_32_P8813 LOC283663 Homo sapiens NR_024433 283663 hypothetical chr15:5759980 NR_024433 THC2513469 Hs.181297 hypothetical LOC283663 LOC283663 0-57599859 (LOC283663), non-coding RNA [NR_024433] A_23_P138262 PADI4 Homo sapiens NM_012387 ENST00000375448 23569 peptidyl chr1:17685353- GO:0018101|GO:0005737| NM_012387 THC2472236 Hs.522969 peptidyl arginine arginine 17685783 GO:0016787|GO:0005509| deiminase, type deiminase, GO:0005634|GO:0004668| IV (PADI4), type IV GO:0045449|GO:0006464| mRNA [NM_012387] G0:0016568 A_33_P3296169 CDCA7 Homo sapiens NM_031942 ENST00000496441 83879 cell division chr2:17423238 GO:0042127|GO:0005634| NM_031942 NP1165009 Hs.470654 cell division cycle cycle 7-174232446 GO:0045449 associated 7 associated 7 (CDCA7), transcript variant 1, mRNA [NM_031942] A_33_P3398877 ZDH11_HUMAN chr5:00085115 THC2515810 (Q9H8X9) Probable 6-000851097 palmitoyltransferase ZDHHC11 (Zinc finger DHHC domain-containing protein 11) (DHHC-11) (Zinc finger protein 399), complete [THC2515810] A_23_P31816 DEFA3 Homo sapiens NM_005217 ENST00000535841 1668 defensin, chr8:6873570- GO:0050832|GO:0031640| NM_005217 THC2468638 Hs.654448 defensin, alpha 3, alpha 3, 6873511 GO:0005576|GO:0009615| neutrophil-specific neutrophil- GO:0005615|GO:0042742 (DEFA3), mRNA specific [NM_005217] A_23_P81717 FRMD1 Homo sapiens NM_024919 ENST00000468647 79981 FERM chr6:16845729 GO:0005488|GO:0005856 NM_024919 THC2478439 Hs.266746 FERM domain domain 9-168457240 containing 1 containing 1 (FRMD1), transcript variant 1, mRNA [NM_024919] A_24_P161581 SHISA7 Homo sapiens NM_001145176 ENST00000376325 729956 shisa homolog chr19:5594904 GO:0016020|GO:0016021 NM_001145176 THC2658872 Hs.6664 shisa homolog 7 7 (Xenopus 6-55948987 (Xenopus laevis) laevis) (SHISA7), mRNA [NM_001145176] A_33_P3274001 chr6:10893964 8-108939589 A_23_P200780 TGFBR3 Homo sapiens NM_003243 ENST00000532540 7049 transforming chr1:92148947- GO:0055010|GO:0005886| NM_003243 THC2463693 Hs.482390 transforming growth growth factor, 92148888 GO:0050680|GO:0046332| factor, beta receptor beta receptor GO:0034673|GO:0005615| III (TGFBR3), III GO:0007243|GO:0005114| transcript variant 1, GO:0043231|GO:0060317| mRNA [NM_003243] GO:0060318|GO:0006955| GO:0034695|GO:0060021| GO:0007179|GO:0008201| GO:0032354|GO:0050431| GO:0005576|GO:0030509| GO:0015026|GO:0030165| GO:0060038|GO:0070123| GO:0034699|GO:0060347| GO:0001889|GO:0016477| GO:0005887|GO:0016049| GO:0060389|GO:0051271| GO:0009897 A_33_P3333708 chrX:00614442 7-006144368 A_33_P3319581 FIGNL2 Homo sapiens NM_001013690 401720 fidgetin- chr12:5221384 GO:0017111|GO:0000166| NM_001013690 THC2614540 Hs.648218 fidgetin-like 2 like 2 7-52213788 GO:0005524 (FIGNL2), mRNA [NM_001013690] A_33_P3258013 UBE3B ubiquitin protein CR614569 ENST00000340074 89910 ubiquitin chr12:1099283 THC2484472 Hs.374067 ligase E3B [Source: protein 40-109928399 HGNC Symbol; ligase E3B Acc: 13478] [ENST00000340074] A_23_P351148 SH2D1B Homo sapiens SH2 NM_053282 ENST00000359567 117157 SH2 domain chr1:16236590 GO:0005515|GO:0008150| NM_053282 THC2487991 Hs.350581 domain containing 1B containing 4-162365845 GO:0003674|GO:0005575 (SH2D1B), mRNA 1B [NM_053282] A_23_P103034 CRYBA4 Homo sapiens NM_001886 ENST00000466315 1413 crystallin, chr22:2702432 GO:0003674|GO:0005212| NM_001886 THC2467739 Hs.57690 crystallin, beta A4 beta A4 2-27024381 GO:0043010|GO:0005625| (CRYBA4), GO:0007601 mRNA [NM_001886] A_33_P3401826 CMPK2 Homo sapiens NM_207315 ENST00000478738 129607 cytidine chr2:6988526- GO:0005739|GO:0000166| NM_207315 THC2601942 Hs.7155 cytidine monophosphate monophosphate 6988467 GO:0016301|GO:0004127| (UMP-CMP) kinase (UMP-CMP) GO:0006221|GO:0005524| 2, mitochondrial kinase 2, GO:0016740 (CMPK2), nuclear gene mitochondrial encoding mitochondrial protein, mRNA [NM_207315] A_33_P3422298 {pseudogene} IgV lambda S77011 chr22:2326176 Hs.547600 IJ psi C lambda 5-23261824 6 = lg lambda chain surface Ig receptor VJC region {truncated light chain constant region} [human, B lymphoma cell line OCI LY8, mRNA Partial, 623 nt]. [S77011] A 24 P85200 C14orf43 Homo sapiens NM_194278 ENST00000286523 9748 chromosome 14 chr14:7418225 GO:0005634|GO:0003677| NM_194278 THC2656133 Hs.594157 chromosome 14 open reading 2-74182193 GO:0045449 open reading frame 43 frame 43 (C14orf43), transcript variant 1, mRNA [NM_194278] A_23_P116765 LALBA Homo sapiens NM_002289 ENST00000301046 3906 lactalbumin, chr12:4896288 GO:0005989|GO:0007165| NM_002289 THC2481150 Hs.72938 lactalbumin, alpha- alpha- 3-48962335 GO:0005509|GO:0007267| (LALBA), GO:0004461|GO:0005576| mRNA [NM_002289] GO:0006917|GO:0005615| GO:0042742 A_33_P3407105 YTHDF1 Homo sapiens YTH NM_017798 ENST00000342761 54915 YTH chr20:6183420 NM_017798 THC2465870 Hs.11747 domain family, domain 5-61834146 member 1(YTHDF1), family, mRNA [NM_017798] member 1 A_33_P3235098 FAM22D Homo sapiens NM_001009610 ENST00000372321 728130 family with chr10:8912761 NM_001009610 THC2543079 Hs.701044 family with sequence sequence 8-89127677 similarity 22, similarity 22, member D member D (FAM22D), mRNA [NM_001009610] A_33_P3342081 PRDM1 Homo sapiens PR NM_001198 ENST00000369096 639 PR domain chr6:10655766 GO:0010628|GO:0005622| NM_001198 THC2470627 Hs.436023 domain containing 1, containing 1, 2-106557721 GO:0045165|GO:0003700| with ZNF domain with ZNF GO:0001893|GO:0001892| (PRDM1), domain GO:0008270|GO:0005634| transcript variant 1, GO:0000122|GO:0046872| mRNA [NM_001198] GO:0045449 A_33_P3303355 chrX:10335807 THC2554141 4-103358133 A_33_P3768930 MYE4344 Myeloma BF175071 THC2543611 Hs.636467 (MYE) cDNA library Homo sapiens cDNA, mRNA sequence [BF175071] A_24_P225468 ANP32E Homo sapiens acidic NM_030920 ENST00000369116 81611 acidic (leucine- chr1:15019113 GO:0005515|GO:0005737| NM_030920 THC2467881 Hs.656466 (leucine-rich) nuclear rich) nuclear 6-150191077 GO:0016023|GO:0005634| phosphoprotein 32 phosphoprotein GO:0019212 family, member E 32 family, (ANP32E), member E transcript variant 1, mRNA [NM_030920] A_23_P108157 TJP3 Homo sapiens tight NM_014428 ENST00000262968 27134 tight junction chr19:3746516- GO:0005515|GO:0030054| NM_014428 THC2608759 Hs.25527 junction protein 3 protein 3 3746575 GO:0005886|GO:0005923 (zona occludens 3) (zona (TJP3), mRNA occludens 3) [NM_014428] A_32_P85591 H2BFXP Homo sapiens H2B NR_003238 767811 H2B histone chrX:10323132 NR_003238 THC2587717 Hs.496530 histone family, family, 1-103231580 member X, member X, pseudogene (H2BFXP), pseudogene non-coding RNA [NR_003238] A_33_P3409625 SORBS3 Homo sapiens sorbin NM_005775 ENST00000428103 10174 sorbin and chr8:22432948- GO:0030054|GO:0031589| NM_005775 THC2745544 Hs.528572 and SH3 domain SH3 domain 22433007 GO:0005634|GO:0000122| containing 3 containing 3 GO:0005737|GO:0051495| (SORBS3), GO:0017166|GO:0051496| transcript variant 1, GO:0005200|GO:0005856| mRNA [NM_005775] GO:0043410|GO:0005925| GO:0008134 A_33_P3317168 EPS8L3 Homo sapiens NM_139053 ENST00000369805 79574 EPS8-like 3 chr1:11029276 GO:0005737 NM_139053 THC2462418 Hs.485352 EPS8-like 3 2-110292703 (EPS8L3), transcript variant 1, mRNA [NM_139053] A_23_P11507 ZZZ3 Homo sapiens zinc NM_015534 ENST00000476275 26009 zinc finger, chr1:78030621- GO:0008270|GO:0005634| NM_015534 THC2461379 Hs.480506 finger, ZZ-type ZZ-type 78030562 GO:0003677|GO:0046872| containing 3 (ZZZ3), containing 3 GO:0045449 mRNA [NM_015534] A_33_P3381127 FAS Homo sapiens Fas NM_000043 ENST00000355740 355 Fas (TNF chr10:9077451- GO:0008624|GO:0008633| NM_000043 THC2522452 Hs.244139 (TNF receptor super- receptor 7-90774576 GO:0005886|GO:0031264| family,member 6) (FAS), superfamily, GO:0042981|GO:0005576| transcript variant 1, member 6) GO:0005625|GO:0006916| mRNA GO:0042802|GO:0005829| [NM_000043] GO:0007165|GO:0006955| GO:0006461|GO:0016021| GO:0019900|GO:0004888| GO:0010940 A_23_P416212 HSPB9 Homo sapiens NM_033194 ENST00000355067 94086 heat shock chr17:4027514 GO:0005515|GO:0006950 NM_033194 THC2634040 Hs.620611 heat shock protein, protein, alpha- 8-40275207 alpha-crystallin- crystallin- related, B9 (HSPB9), related, B9 mRNA [NM_033194] A_33_P3414242 MOG Homo sapiens NM_001008229 ENST00000396704 4340 myelin chr6:29633982- GO:0005886|GO:0016021| NM_001008229 NP1465457 Hs.141308 myelin oligodendrocyte oligodendrocyte 29634041 GO:0007417 glycoprotein (MOG), glycoprotein transcript variant beta2, mRNA [NM_001008229] A_23_P143734 CYP2D6 Homo sapiens NM_000106 ENST00000542856 1565 cytochrome chr22:4252396 GO:0005792|GO:0070330| NM_000106 NP1462558 Hs.648256 cytochrome P450, P450, family 8-42523909 GO:0017144|GO:0016020| family 2, sub- 2, subfamily GO:0005783|GO:0009055| family D, poly- D, polypeptide GO:0046872|GO:0055114| peptide 6 (CYP2D6), 6 GO:0020037|GO:0019898 transcript variant 1, mRNA [NM_000106] A_24_P272917 USP17 Homo sapiens NM_001105662 ENST00000421288 391627 ubiquitin chr4:9361479- GO:0006511|GO:0005730| NM_001105662 THC2525229 Hs.631527 ubiquitin specific specific 9361538 GO:0006915|GO:0008233| peptidase 17 peptidase 17 GO:0005634|GO:0008234| (USP17), GO:0004221 mRNA [NM_001105662] A_23_P94819 RPH3AL Homo sapiens NM_006987 ENST00000540633 9501 rabphilin chr17:62615- GO:0008092|GO:0017137| NM_006987 THC2486836 Hs.651925 rabphilin 3A- 3A-like 62556 GO:0045744|GO:0031410| like (without C2 (without GO:0042593|GO:0006887| domains) (RPH3AL), C2 domains) GO:0006886|GO:0046872| transcript variant 1, GO:0017158|GO:0005737| mRNA [NM_006987] GO:0016020|GO:0030274| GO:0008270|GO:0030667 A_33_P3351474 SMARCAD1 Homo sapiens NM_001128429 ENST00000394961 56916 SWI/SNF- chr4:95210929- GO:0005515|GO:0004386| NM_001128429 THC2461621 Hs.410406 SWI/SNF-related, related, matrix- 95210988 GO:0005730|GO:0005634| matrix-associated associated GO:0003677|GO:0005524| actin-dependent actin-dependent GO:0016363|GO:0045941| regulator of chromatin, regulator of GO:0000166|GO:0016787| subfamily a, chromatin, GO:0051260|GO:0000018| containing DEAD/H subfamily a, GO:0009117|GO:0016568 box 1 (SMARCAD1), containing transcript variant 1, DEAD/H box 1 mRNA [NM_001128429] A_33_P3317317 KRTAP5-4 Homo sapiens NM_001012709 ENST00000328953 387267 keratin chr11:1642696- GO:0045095 NM_001012709 NP1461693 Hs.539087 keratin associated associated 1642637 protein 5-4 protein 5-4 (KRTAP5-4), mRNA [NM_001012709] A_33_P3234794 ARHGAP40 Homo sapiens Rho NM_001164431 ENST00000373345 343578 Rho GTPase chr20:3727239 GO:0005622|GO:0007165| NM_001164431 THC2749375 Hs.451997 GTPase activating activating 8-37272457 GO:0005096 protein 40 protein 40 (ARHGAP40), mRNA [NM_001164431] A_33_P3290588 ASPSCR1 Homo sapiens AK127159 79058 alveolar soft chr17:7996571 GO:0005515|GO:0008150| THC2485264 Hs.298351 cDNA FLJ45222 fis, part sarcoma 8-79905777 GO:0003674|GO:0016020| clone BRCAN2019953. chromosome GO:0005575|GO:0019898 [AK127159] region, candidate 1 A_33_P3296991 FLJ42393 Homo sapiens NR_024413 ENST00000392468 401105 hypothetical chr3:18789786 NR_024413 THC2481460 Hs.679026 hypothetical LOC401105 5-187897924 LOC401105 (FLJ42393), non-coding RNA [NR_024413] A_33_P3211423 PANK3 pantothenate BX648891 ENST00000239231 79646 pantothenate chr5:16797566 GO:0004594|GO:0005737| THC2570326 Hs.388400 kinase 3 [Source: kinase 3 2-167975603 GO:0000166|GO:0015937| HGNC Symbol; GO:0005524|GO:0016740 Acc: 19365] [ENST00000239231] A_33_P3231086 Q6P1G7_MOUSE chr20:0626891 THC2631347 (Q6P1G7) Myoneurin 40-062689199 (In vitro fertilized eggs cDNA, RIKEN full-length enriched library, clone: 7420457K05 product: myoneurin, full insert sequence), partial (4%) [THC2631347] A_23_P132159 USP18 Homo sapiens NM_017414 ENST00000215794 11274 ubiquitin chr22:1865961 GO:0006511|GO:0004843| NM_017414 THC2471774 Hs.38260 ubiquitin specific specific 8-18659677 GO:0008233|GO:0005634| peptidase 18 (USP18), peptidase 18 GO:0008234|GO:0004221 mRNA [NM_017414] A_23_P50052 C18orf12 PREDICTED: XR_109479 84322 chromosome 18 chr18:4577894 XR_109479 NP340945 Hs.334493 Homo sapiens open reading 7-45779006 chromosome 18 open frame 12 reading frame 12 (C18orf12), misc RNA [XR_109479] A_23_P168993 ADRB3 Homo sapiens NM_000025 ENST00000345060 155 adrenergic, chr8:37821117- GO:0005515|GO:0005886| NM_000025 THC2474800 Hs.2549 adrenergic, beta-3-, beta-3-, 37821058 GO:0004930|GO:0005975| receptor (ADRB3), receptor GO:0051379|GO:0006091| mRNA [NM_000025] GO:0042803|GO:0006898| GO:0015052|GO:0002032| GO:0043235|GO:0051380| GO:0007165|GO:0006112| GO:0005887|GO:0004872| GO:0007189|GO:0043410 A_33_P3360077 LOC100130745 Homo sapiens AK128206 100130745 hypothetical chr7:1506804- THC2483234 Hs.634078 cDNA FLJ46338 fis, LOC100130745 1506745 clone TESTI4046328. [AK128206] A_33_P3376828 CMTM7 Homo sapiens NM_138410 ENST00000454304 112616 CKLF-like chr3:32490977- GO:0016020|GO:0006935| NM_138410 THC2464715 Hs.440494 CKLF-like MARVEL MARVEL 32491036 GO:0016021|GO:0005615| transmembrane domain transmembrane GO:0005125 containing 7 (CMTM7), domain transcript variant 1, containing 7 mRNA [NM_138410] A_33_P3258324 chr19:0159628 62-015962803 A_23_P3038 GPX2 Homo sapiens NM_002083 ENST00000389614 2877 glutathione chr14:6540645 GO:0004602|GO:0008430| NM_002083 THC2578470 Hs.2704 glutathione peroxidase peroxidase 2 5-65406396 GO:0005737|GO:0001659| 2 (gastrointestinal) (GPX2), (gastro- GO:0002862|GO:0051702| mRNA [NM_002083] intestinal) GO:0009609|GO:0016491| GO:0009055|GO:0006979| GO:0055114 A_33_P3364211 Homo sapiens AK126423 chr3:73674377- Hs.434900 cDNA FLJ44459 fis, 73674436 clone UTERU2024656. [AK126423] A_33_P3377994 WNK4 Homo sapiens NM_032387 ENST00000316085 65266 WNK lysine chr17:4094681 GO:0005515|GO:0006821| NM_032387 THC2488534 Hs.105448 WNK lysine deficient deficient 4-40946873 GO:0030054|GO:0005524| protein kinase 4 protein GO:0007243|GO:0005737| (WNK4), kinase 4 GO:0008104|GO:0000166| mRNA [NM_032387] GO:0004674|GO:0050794| GO:0006468|GO:0005923| GO:0016740|GO:0006811 A_23_P145218 butyrophilin, sub- BC166633 ENST00000297020 chr6:26431721- NP319744 Hs.729655 family 2, member A3 26431780 [Source: HGNC Symbol; Acc: 13229] [ENST00000297020] A_24_P392925 GLTPD2 Homo sapiens NM_001014985 ENST00000331264 388323 glycolipid chr17:4693360- GO:0005737|GO:0051861| NM_001014985 THC2495934 Hs.721461 glycolipid transfer transfer protein 4693419 GO:0017089|GO:0046836 protein domain domain containing 2 (GLTPD2), containing 2 mRNA [NM_001014985] A_23_P12128 TSHB Homo sapiens NM_000549 ENST00000369517 7252 thyroid chr1:11557668 GO:0051592|GO:0043627| NM_000549 THC2666358 Hs.406687 thyroid stimulating stimulating 2-115576741 GO:0007186|GO:0005179| hormone, beta (TSHB), hormone, beta GO:0033189|GO:0007267| mRNA [NM_000549] GO:0005576|GO:0009653 A_32_P360193 DNHD1 Homo sapiens NM_144666 ENST00000532027 144132 dynein heavy chr11:6569440- GO:0030286|GO:0016020| NM_144666 THC2574634 Hs.720080 dynein heavy chain chain 6569499 GO:0016021|GO:0003777| domain 1 (DNHD1), domain 1 GO:0007018 transcript variant 1, mRNA [NM_144666] A_23_P11843 LRRN2 Homo sapiens NM_201630 ENST00000367175 10446 leucine rich chr1:20458641 GO:0005515|GO:0007165| NM_201630 THC2471115 Hs.26312 leucine rich repeat 2-204586353 GO:0016020|GO:0004872| repeat neuronal 2 neuronal 2 GO:0016021|GO:0007155 (LRRN2), transcript variant 2, mRNA [NM_201630] A_23_P38328 DBF4B DBF4 homolog AK023149 ENST00000439818 80174 DBF4 chr17:4280961 GO:0007049|GO:0008270| THC2479406 B (S. cerevisiae) homolog B 1-42809670 GO:0005634|GO:0003676| [Source: HGNC (S. cerevisiae) GO:0046872 Symbol; Acc: 17883] [ENST00000439818] A_33_P3297030 LOC100129974 Homo sapiens AK128440 100129974 hypothetical chr17:441183- THC2485946 Hs.461819 cDNA FLJ46583 fis, protein 441124 clone THYMU3043482. LOC100129974 [AK128440] A_33_P3222942 GPR78 Homo sapiens G NM_080819 27201 G protein- chr4:8589448- GO:0007165|GO:0007186| NM_080819 THC2481606 Hs.350588 protein-coupled coupled 8589507 GO:0005886|GO:0004930| receptor 78 (GPR78), receptor 78 GO:0004872|GO:0016021 mRNA [NM_080819] A_33_P3392677 chr7:06631363 THC2539584 0-066313689 A_32_P481377 KRTAP11-1 Homo sapiens NM_175858 ENST00000332378 337880 keratin chr21:3225328 GO:0005198|GO:0045095 NM_175858 THC2490936 Hs.407654 keratin associated associated 3-32253224 protein 11-1 protein 11-1 (KRTAP11-1), mRNA [NM_175858] A_24_P183864 IMPA1 Homo sapiens NM_005536 ENST00000256108 3612 inositol(myo)- chr8:82570477- GO:0007165|GO:0005737| NM_005536 THC2466293 Hs.656694 inositol(myo)-1(or 4)- 1(or4)-mono- 82570418 GO:0010226|GO:0000287| monophosphatase phosphatase GO:0016787|GO:0006661| 1 (IMPA1), 1 GO:0006796|GO:0031403| transcript variant 1, GO:0008934|GO:0042802 mRNA [NM_005536] A_23_P380614 ATP9A Homo sapiens NM_006045 ENST00000338821 10079 ATPase, chr20:5021341 GO:0006754|GO:0000287| NM_006045 THC2510679 Hs.649234 ATPase, class II, class II, 8-50213359 GO:0016787|GO:0016020| type 9A (ATP9A), type 9A GO:0015914|GO:0000166| mRNA [NM_006045] GO:0008152|GO:0004012| GO:0016820|GO:0016021| GO:0005524|GO:0015662 A_24_P130363 C18orf1 Homo sapiens NM_181482 ENST00000359446 753 chromosome chr18:1365255 GO:0008150|GO:0003674| NM_181482 THC2552483 Hs.149363 chromosome 18 18 open 0-13652609 GO:0005886|GO:0016021 open reading frame reading frame 1 1 (C18orf1), transcript variant a2, mRNA [NM_181482] A_33_P3264746 chr22:0170113 55-017011414 A_32_P4228 chromosome 20 XR_109647 ENST00000427835 chr20:1179103 XR_109647 THC2559950 Hs 560990 open reading frame 6-11790977 61 [Source: HGNC Symbol; Acc: 16194] [ENST00000427835] A_33_P3417990 VRK2 Homo sapiens NM_006296 ENST00000394539 7444 vaccinia chr2:58373548- GO:0005515|GO:0046777| NM_006296 THC2485121 Hs.728198 vaccinia related related 58373607 GO:0016020|GO:0000166| kinase 2 kinase 2 GO:0005783|GO:0004674| (VRK2), GO:0005624|GO:0016021| transcript variant 1, GO:0005524|GO:0016740 mRNA [NM_006296] A_33_P3255131 KCTD19 Homo sapiens NM_001100915 ENST00000304372 146212 potassium chr16:6732345 GO:0005515|GO:0016020| NM_001100915 THC2528087 Hs.299127 potassium channel channel tetra- 2-67323393 GO:0008076|GO:0005249| tetramerisation domain merisation GO:0006813 containing 19 domain (KCTD19), containing 19 mRNA [NM_001100915] A_23_P217384 AP1S2 Homo sapiens NM_003916 ENST00000329235 8905 adaptor-related chrX:15844638- GO:0005515|GO:0030131| NM_003916 THC2618612 Hs.653504 adaptor-related protein com- 15844579 GO:0005794|GO:0006892| protein complex 1, plex 1, sigma GO:0031410|GO:0006886| sigma 2 subunit 2 subunit GO:0005829|GO:0006897| (AP1S2), mRNA GO:0005905|GO:0016020| [NM_003916] GO:0008565|GO:0030130| GO:0016044 A_24_P117942 TOMM20L Homo sapiens NM_207377 ENST00000360945 387990 translocase of chr14:5887411 GO:0005739|GO:0016020| NM_207377 NP1214232 Hs.592307 translocase of outer outer 6-58874175 GO:0005742|GO:0016021| mitochondrial membrane mitochondrial GO:0006605 20 homolog (yeast)- membrane 20 like (TOMM20L), homolog nuclear gene encoding (yeast)-like mitochondrial protein, mRNA [NM_207377] A_23_P75867 OR10A4 Homo sapiens NM_207186 ENST00000379829 283297 olfactory re- chr11:6898050- GO:0007608|GO:0007165| NM_207186 THC2611959 Hs.448685 olfactory receptor, ceptor, 6898109 GO:0004984|GO:0007186| family 10, subfamily family 10, GO:0005886|GO:0004872| A, member 4 (OR10A4), subfamily A, GO:0016021|GO:0050896 mRNA[NM_207186] member 4 A_33_P3416366 CHAF1A Homo sapiens NM_005483 ENST00000344143 10036 chromatin chr19:4431965- GO:0006260|GO:0007049| NM_005483 THC2515229 Hs.79018 chromatin assembly assembly 4432024 GO:0006461|GO:0006281| factor 1, subunit A factor 1, GO:0005678|GO:0003682| (p150) (CHAF1A), subunit A GO:0006335|GO:0005634| mRNA [NM_005483] (p150) GO:0051082|GO:0045449| GO:0006974 A_33_P3385662 PREDICTED: Homo XM_003118682 chr15:1003328 XM_003118682 Hs.730017 sapiens Golgin subfamily 14-100332873 A member 8A-like (LOC644800), mRNA [XM_003118682] A_33_P3409210 PREDICTED: Homo XM_003119962 ENST00000502514 chr5:17737889 XM_003119962 THC2696085 Hs.710582 sapiens hypothetical 7-177378956 protein LOC100509198 (LOC100509198), mRNA [XM_003119962] A_33_P3287562 BCAP29 Homo sapiens B-cell NM_018844 ENST00000005259 55973 B-cell receptor- chr7:10726083 GO:0016020|GO:0005783| NM_018844 THC2519372 Hs.303787 receptor-associated associated 2-107260891 GO:0006915|GO:0016021| protein 29 (BCAP29), protein 29 GO:0016192|GO:0006886 transcript variant 2, mRNA [NM_018844] A_23_P427217 JMJD1C Homo sapiens NM_032776 ENST00000542921 221037 jumonji chr10:6492827 GO:0046966|GO:0005622| NM_032776 THC2501681 Hs.413416 jumonji domain domain 9-64928220 GO:0005515|GO:0006355| containing containing 1C GO:0005506|GO:0016491| 1C (JMJD1C), GO:0008270|GO:0005634| transcript variant 1, GO:0016702|GO:0046872| mRNA [NM_032776] GO:0055114|GO:0016568 A_33_P3232038 RBAK- Homo sapiens NM_001204513 ENST00000498308 100533952 RBAK- chr7:5112794- NM_001204513 THC2464334 Hs.396178 LOC389458 RBAK-LOC389458 LOC389458 5112853 readthrough readthrough (RBAK-LOC389458), mRNA [NM_001204513] A_33_P3259708 CMA1 Homo sapiens NM_001836 ENST00000206446 1215 chymase chr14:2497477 GO:0005622|GO:0004252| NM_001836 THC2480549 Hs.135626 chymase 1, mast 1, mast roll 1-24974712 GO:0050727|GO:0006508| cell (CMA1), mRNA GO:0008233|GO:0005576| [NM_001836] GO:0050720 A_23_P17844 PVALB Homo sapiens NM_002854 ENST00000404171 5816 parvalbumin chr22:3720973 GO:0030424|GO:0005737| NM_002854 THC2464797 Hs.295449 parvalbumin (PVALB), 9-37196953 GO:0005509 mRNA [NM_002854] A_33_P3387561 OSCAR Homo sapiens NM_206818 ENST00000391760 126014 osteoclast chr19:5459909 GO:0005886|GO:0004872| NM_206818 NP957263 Hs.347655 osteoclast associated, associated, 8-54599039 GO:0016021 immunoglobulin-like immunoglo- receptor (OSCAR), bulin-like transcript variant 1, receptor mRNA [NM_206818] A_33_P3399268 IL15RA interleukin 15 ENST00000379971 3601 interleukin 15 chr10:5995250- receptor, alpha [Source: receptor, alpha 5995191 HGNC Symbol; Acc: 5978] [ENST00000379971] A_33_P3379763 chr18:0121022 30-012102171 A_33_P3312544 GABRB1 gamma-aminobutyric AK296023 ENST00000381582 2560 gamma-amino- chr4:47034971- Hs.27283 acid (GABA) A butyric acid 47035030 receptor, beta 1 (GABA) A [Source: HGNC Symbol; receptor, beta 1 Acc: 4081] [ENST00000381582] A_23_P135257 PRSS3 Homo sapiens NM_002771 ENST00000477653 5646 protease, chr9:33797923- GO:0005515|GO:0004252| NM_002771 THC2480679 Hs.654513 protease, serine, 3 serine, 3 33797982 GO:0043542|GO:0007586| (PRSS3), GO:0005509|GO:0006508| transcript variant 2, GO:0008233|GO:0005576| mRNA [NM_002771] GO:0005615|GO:0031638 A_24_P935345 NINP6167 [Source: XM_003118774 ENST00000378432 chr19:4078079 XM_003118774 THC2482404 Hs.676497 UniProtKB/TrEMBL; 5-40780736 Acc: Q6UXV6] [ENST00000378432] A_33_P3233055 UI-H-BW1-anr-f-12- BF515046 chr4:38664825- Hs.720773 0-UI.s1 NCI_CGAP_Sub7 38664766 Homo sapiens cDNA clone IMAGE: 3083302 3′, mRNA sequence [BF515046] A_33_P3263319 immunoglobulin heavy AY172958 ENST00000390551 chr14:1062356- NP594088 Hs.510635 constant gamma 3 53-106235594 (G3m marker) [Source: HGNC Symbol; Acc: 5527] [ENST00000390551] A_33_P3378702 Homo sapiens AK127786 chr3:9862279- cDNA FLJ45887 fis, 9862220 clone OCBBF3021502. [AK127786] A_33_P3324495 ZFP41 Homo sapiens zinc NM_173832 ENST00000330701 286128 zinc finger chr8:14434481 GO:0005622|GO:0008270| NM_173832 THC2498694 Hs.668016 finger protein 41 protein 41 6-144344875 GO:0007275|GO:0005634| homolog (mouse) homolog GO:0007283|GO:0003677| (ZFP41), mRNA (mouse) GO:0046872|GO:0045449| [NM_173832] GO:0030154 A_33_P3327158 LOC100131432 Homo sapiens AK127761 100131432 hypothetical chr11:4507313 THC2657439 Hs.640116 cDNA FLJ45862 fis, LOC100131432 0-45073071 clone OCBBF3000830. [AK127761] A_23_P128215 SOCS2 Homo sapiens NM_003877 ENST00000549206 8835 suppressor of chr12:9396979 GO:0005515|GO:0007242| NM_003877 THC2495423 Hs.485572 suppressor of cytokine cytokine 9-93969858 GO:0005148|GO:0005159| signaling 2 (SOCS2), signaling 2 GO:0005131|GO:0007568| mRNA [NM_003877] GO:0043434|GO:0060396| GO:0006916|GO:0001558| GO:0007259|GO:0005737| GO:0008269|GO:0019941| GO:0005070|GO:0009968| GO:0032355 A_24_P280497 FBRSL1 Homo sapiens NM_001142641 ENST00000261673 57666 fibrosin-like 1 chr12:1331597 NM_001142641 THC2541094 Hs.411138 fibrosin-like 1 54-133159813 (FBRSL1), mRNA [NM_001142641] A_23_P212383 SACM1L Homo sapiens SAC1 NM_014016 ENST00000455997 22908 SAC1 chr3:45786011- GO:0008150|GO:0005794| NM_014016 THC2610192 Hs.156509 suppressor of actin suppressor 45786070 GO:0016787|GO:0016020| mutations 1-like (yeast) of actin GO:0005783|GO:0046856| (SACM1L), mRNA mutations 1- GO:0004437|GO:0005789| [NM_014016] like (yeast) GO:0030176|GO:0016021 A_33_P3342569 Putative UPF0607 XM_001723085 ENST00000359888 chr10:3165225 XM_001723085 THC2485807 Hs.730227 protein FLJ37424 6-31652197 [Source: UniProtKB/ Swiss-Prot; Acc: Q8N9G6] [ENST00000359888] A_23_P48455 AMN Homo sapiens NM_030943 ENST00000541086 81693 amnionless chr14:1033970 GO:0007588|GO:0008104| NM_030943 THC2462398 Hs.534494 amnionless homolog homolog 53-103397112 GO:0016020|GO:0045177| (mouse) (AMN), (mouse) GO:0007275|GO:0016021 mRNA [NM_030943] A_33_P3339202 chr1:03197477 6-031974835 A_23_P500271 IRF5 Homo sapiens NM_001098627 ENST00000412326 3663 interferon chr7:12858932 GO:0006355|GO:0003700| NM_001098627 THC2489805 Hs.521181 interferon regulatory regulatory 3-128589382 GO:0005634 factor 5 (IRF5), factor 5 transcript variant 3, mRNA [NM_001098627] A_33_P3245133 chr7:05643708 6-056437027 A_23_P136870 MAGEA6 Homo sapiens NM_175868 ENST00000329342 4105 melanoma chrX:15187016 GO:0005515|GO:0008150| NM_175868 THC2461617 Hs.441113 melanoma antigen antigen 9-151870228 GO:0003674|GO:0005575 family A, 6 (MAGEA6), family A, 6 transcript variant 2, mRNA [NM_175868] A_33_P3246950 BX117927 BX117927 ENST00000434321 chr7:13894064- THC2685258 Hs.127078 Soares_NFL_T_GBC_Sl 13894005 Homo sapiens cDNA clone IMAGE998E153901, mRNA sequence [BX117927] A_33_P3265593 LOC100132790 Homo sapiens AK128756 100132790 hypothetical chr9:70348758- THC2481891 cDNA FLJ44869 fis, LOC100132790 70348817 clone BRAMY2015516. [AK128756] A_23_P87310 LMO1 Homo sapiens NM_002315 ENST00000335790 4004 LIM domain chr11:8245980- GO:0003700|GO:0008283| NM_002315 THC2613726 Hs.654426 LIM domain only only 1 8245921 GO:0008270|GO:0007275| 1 (rhombotin 1) (LMO1), (rhombotin 1) GO:0005634|GO:0046872 mRNA [NM_002315] A_23_P325562 SLC1A7 Homo sapiens NM_006671 ENST00000488036 6512 solute carrier chr1:53552968- GO:0016020|GO:0005313| NM_006671 THC2475068 Hs.104637 solute carrier family 1 family 1 53552909 GO:0006810|GO:0006835| (glutamate transporter), (glutamate GO:0017153|GO:0016021| member 7 (SLC1A7), transporter), GO;0015293 mRNA [NM_006671] member 7 A_33_P3311621 LOC338739 Homo sapiens NR_034027 338739 hypothetical chr11:3321178 NR_034027 THC2502233 Hs.423476 hypothetical LOC338739 LOC338739 1-33211840 (LOC338739), non- coding RNA [NR_034027] A_24_P324011 KCTD2 Homo sapiens NM_015353 ENST00000322444 23510 potassium chr17:7306130 GO:0005515|GO:0016020| NM_015353 THC2538745 Hs.514468 potassium channel channel te- 0-73061359 GO:0008076|GO:0005249| tetramerisation domain tramerisation GO:0006813 containing 2 (KCTD2), domain mRNA [NM_015353] containing 2 A_24_P69439 SLC25A32 Homo sapiens solute NM_030780 ENST00000297578 81034 solute carrier chr8:10441093 GO:0005739|GO:0005215| NM_030780 THC2467509 Hs.607819 carrier family 25, member family 25, 7-104410878 GO:0016020|GO:0005488| 32 (SLC25A32), member 32 GO:0015884|GO:0005743| nuclear gene encoding GO:0016021|GO:0008517| mitochondrial protein, GO:0055085 mRNA [NM_030780] A_23_P62890 GBP1 Homo sapiens NM_002053 ENST00000370473 2633 guanylate chr1:89518848- GO:0005886|GO:0000166| NM_002053 THC2468230 Hs.62661 guanylate binding binding 89518789 GO:0003924|GO:0005525 protein 1, interferon- protein 1, inducible (GBP1), interferon- mRNA [NM_002053] inducible A_33_P3252286 CRLF1 Homo sapiens NM_004750 ENST00000392386 9244 cytokine chr19:18704107 GO:0019955|GO:0005576| NM_004750 THC2465094 Hs.114948 cytokine receptorlike receptor 6-1870404 GO:0004872|GO:0005615 factor 1 (CRLF1), like factor 1 mRNA [NM_004750] A_33_P3351351 ARHGEF10 Rho guanine nucleo- BC040474 ENST00000382795 9639 Rho guanine chr8:1806922- THC2482286 Hs.98594 tide exchange factor nucleotide ex- 1806981 (GEF) 10 [Source: change factor HGNC Symbol; (GEF) 10 Acc: 14103] [ENST00000382795] A_23_P215566 AHR Homo sapiens NM_001621 ENST0000242057 196 aryl hydro- chr7:17384999- GO:0003700|GO:0006366| NM_001621 THC2472989 Hs.171189 aryl hydrocarbon carbon re- 17385058 GO:0045899|GO:0051879| receptor (AHR), ceptor GO:0006950|GO:0006915| mRNA [NM_001621] GO:0005634|GO:0007165| GO:0005737|GO:0007049| GO:0004879|GO:0009410| GO:0045893|GO:0008134 A_24_P190472 SLPI Homo sapiens NM_003064 ENST00000338380 6590 secretory chr20:4388227 GO:0004867|GO:0005576 NM_003064 THC2736360 Hs.517070 secretory leukocyte leukocyte 9-43882220 peptidase inhibitor peptidase (SLPI), mRNA inhibitor [NM_003064] A_33_P3310296 PKIG protein kinase ENST00000372887 11142 protein kinase chr20:4325277 (cAMP-dependent, (cAMP- 1-43252830 catalytic) inhibitor dependent, gamma [Source: catalytic) HGNC Symbol; Acc: 9019] inhibitor [ENST00000372887] gamma A_24_P852756 HLA-DQA2 Homo sapiens NM_020056 ENST00000447735 3118 major histo- chr6:32714597- GO:0006955|GO:0005886| NM_020056 THC2481749 Hs.591798 major histocompatibility compatibility 32714656 GO:0005887|GO:0002504| complex, class II, DQ complex, class GO:0042613|GO:0032395 alpha 2 (HLA-DQA2), II DQ alpha 2 mRNA [NM_020056] A_33_P3460043 C8orf56 Homo sapiens NR_027071 ENST00000436771 157556 chromosome chr8:10414525 NR_027071 THC2481642 Hs.459124 chromosome 8 open 8 open 2-104145193 reading frame 56 reading frame (C8orf56), non- 56 coding RNA [NR_027071] A_33_P3368109 Q6V5H5_9BRAS chr9:09898207 THC2686826 (Q6V5H5) Pollen 0-098982129 coat oleosin-glycine rich protein, partial (13%) [THC2686826] A_33_P3363799 NCAM1 Homo sapiens NM_001242607 ENST00000316851 4684 neural cell chr11:1131490 GO:0005515|GO:0030424| NM_001242607 THC2514411 Hs.503878 neural cell adhesion adhesion 74-113149133 GO:0034109|GO:0005886| molecule 1 molecule 1 GO:0005576|GO:0031225| (NCAM1), transcript GO:0016021|GO:0007155| variant 5, mRNA GO:0009897|GO:0007166| [NM_001242607] GO:0050850 A_33_P3213767 CCDC157 Homo sapiens BC018040 ENST00000399824 550631 coiled-coil chr22:3076271 THC2498791 Hs.505597 cDNA clone domain 5-30762774 IMAGE: 4798973. containing 157 [BC018040] A_33_P3243439 GPR162 Homo sapiens G NM_019858 ENST00000311268 27239 G protein- chr12:6936523- GO:0007165|GO:0007186| NM_019858 THC2463040 Hs.631654 protein-coupled coupled 6936582 GO:0005886|GO:0004930| receptor 162 (GPR162), receptor 162 GO:0004872|GO:0016021 transcript variant A-2, mRNA [NM_019858] A_33_P3215640 PI16 Homo sapiens NM_153370 ENST00000373674 221476 peptidase chr6:36932552- GO:0016020|GO:0005576| NM_153370 THC2644566 Hs.25391 peptidase inhibitor 16 inhibitor 16 36932611 GO:0016021|GO:0030414 (PI16), transcript variant 1, mRNA [NM_153370] A_24_P178300 PRR21 Homo sapiens NM_001080835 ENST00000486799 643905 proline rich 21 chr2:24098137 NM_001080835 NP418173 Hs.693479 proline rich 21 6-240981317 (PRR21), mRNA [NM_001080835] A_24_P301837 HRH3 Homo sapiens NM_007232 ENST00000370797 11255 histamine chr20:6079178 GO:0014070|GO:0005886| NM_007232 THC2603572 Hs.251399 histamine receptor receptor H3 6-60791727 GO:0014050|GO:0014053| H3 (HRH3), GO:0045776|GO:0007194| mRNA [NM_007232] GO:0004969|GO:0007204| GO:0007269|GO:0008144| GO:0043209|GO:0007613| GO:0004872|GO:0007612| GO:0019717|GO:0050679| GO:0014061|GO:0004930| GO:0014063|GO:0007165| GO:0050890|GO:0007420| GO:0007187|GO:0005887| GO:0042756|GO:0042755 A_23_P98022 SIRT1 Homo sapiens NM_012238 ENST00000432464 23411 sirtuin 1 chr10:6967756 GO:0006344|GO:0034339| NM_012238 THC2463434 Hs.369779 sirtuin 1 (SIRT1), 0-69677619 GO:0006343|GO:0045599| transcript variant 1, GO:0016811|GO:0070403| mRNA [NM_012238] GO:0005634|GO:0005635| GO:0007283|GO:0046872| GO:0043433|GO:0030154| GO:0042802|GO:0003950| GO:0006471|GO:0042393| GO:0002039|GO:0005737| GO:0044419|GO:0042127| GO:0033158|GO:0016481| GO:0031937|GO:0009267| GO:0016575|GO:0017136| GO:0034983|GO:0003714| GO:0007569|GO:0010904| GO:0019213|GO:0005730| GO:0042981|GO:0001542| GO:0007275|GO:0051097| GO:0045768|GO:0008022| GO:0006974|GO:0006260| GO:0006281|GO:0007517| GO:0050872|GO:0016605| GO:0043518|GO:0005654| GO:0008270|GO:0006642 A_24_P62800 KLHDC8A Homo sapiens NM_018203 ENST00000539253 55220 kelch domain chr1:20530574 NM_018203 THC2644485 Hs.10414 kelch domain containing containing 8A 7-205305688 8A (KLHDC8A), mRNA [NM_018203] A_24_P373768 GIPR Homo sapiens NM_000164 ENST00000304207 2696 gastric chr19:4618146 GO:0016519|GO:0007186| NM_000164 THC2485294 Hs.658534 gastric inhibitory poly- inhibitory 0-46184896 GO:0005886|GO:0007584| peptide receptor (GIPR), polypeptide GO:0016021|GO:0007189| mRNA [NM_000164] receptor GO:0006091|GO:0007204 A_23_P363313 SLC16A11 Homo sapiens NM_153357 ENST00000308009 162515 solute carrier chr17:6945224- GO:0005886|GO:0016021| NM_153357 THC2479120 Hs.336564 solute carrier family family 16, 6945165 GO:0055085|GO:0015 293 16, member 11 member 11 (monocarboxylic acid (monocar- transporter 11) boxylic acid (SLC16A11), transporter mRNA [NM_153357] 11) A_23_P317347 ESCO1 Homo sapiens NM_057911 ENST00000383276 114799 establishment chr18:1910980 GO:0003684|GO:0007049| NM_057911 THC7490390 Hs.464733 establishment of of cohesion 6-19109747 GO:0006281|GO:0003887| cohesion 1 homolog 1 homolog 1 GO:0008270|GO:0005634| 1 (S. cerevisiae) (S. cerevisiae) GO:0046872|GO:0016740| (ESCO1), GO:0008415 mRNA [NM_057311] A_24_P309415 TMEM123 Homo sapiens NM_052932 ENST00000398136 114908 transmembrane chr11:1022675 GO:0016020|GO:0004872| NM_052932 THC2536867 Hs.503709 transmembrane protein protein 123 45-102267486 GO:0016021|GO:0070267| 123 (TMEM123), GO:0009897 mRNA [NM_052932] A_33_P3380462 GPR88 Homo sapiens G NM_022049 ENST00000315033 54112 G protein- chr1:10100569 GO:0007165|GO:0007186| NM_022049 THC2478325 Hs.170053 protein-coupled receptor coupled 6-101005755 GO:0005886|GO:0004930| 88 (GPR88), mRNA receptor 88 GO:0004872|GO:0016021| [NM_022049] GO:0005575 A_24_P243396 TCOF1 Homo sapiens NM_001008657 ENST00000394269 6949 Treacher chr5:14976365 GO:0005515|GO:0005215| NM_001008657 THC2482504 Hs.519672 Treacher Collins- Collins- 4-149763713 GO:0001501|GO:0006810| Franceschetti Franceschetti GO:0005730|GO:0005634 syndrome 1 syndrome 1 (TCOF1), transcript variant 3, mRNA [NM_001008657] A_33_P3235360 chr 16:0053122 47-005312188 A_33_P3760937 LOC497256 Homo sapiens AK094988 497256 hypothetical chr9:90459517- THC2509358 Hs.584108 cDNA FLJ37669 fis, LOC497256 90459458 clone BRHIP2011891. [AK094988] A_33_P3240679 BRD3 bromodomain ENST00000371842 8019 bromodomain chr0:13602109 THC2757877 containing 3 containing 3 4-136921035 [Source: HGNC Symbol; Acc: 1104] [ENST00000371842] A_33_P3365002 TUBB2A Homo sapiens NM_001069 ENST00000489942 7280 tubulin, chr6:3154964- GO:0005515|GO:0051258| NM_001069 THC2558431 Hs.654543 tubulin, beta 2A beta 2A 3154905 GO:0007067|GO:0000166| (TUBB2A), mRNA GO:0005198|GO:0030182| [NM_001069] GO:0005874|GO:0003924| GO:0005525|GO:0007018 A_24_P296070 COG3 Homo sapiens NM_031431 ENST00000349995 83548 component chr13:4611017 GO:0005515|GO:0005801| NM_031431 NP1155335 Hs.507948 component of of oligomeric 9-46110238 GO:0005794|GO:0033365| oligomeric golgi golgi GO:0006890|GO:0050821| complex complex 3 GO:0006891|GO:0006886| 3 (COG3), mRNA GO:0006888|GO:0016020| [NM_031431] GO:0008565|GO:0017119| GO:0006486|GO:0019898 A_24_P339514 CYP2B6 Homo sapiens NM_000767 ENST00000324071 1555 cytochrome chr19:4152419 GO:0005792|GO:0070330| NM_000767 THC2479074 Hs.1360 cytochrome P450, family P450, family 3-41524252 GO:0019825|GO:0016020| 2, subfamily B, poly- 2, subfamily GO:0005783|GO:0005789| peptide 6 (CYP2B6), B, polypeptide GO:0009055|GO:0046872| mRNA [NM_000767] 6 GO:0055114|GO:0020037| GO:0019898 A_23_P145006 SCGB3A2 Homo sapiens NM_054023 ENST00000507160 117156 secretoglobin, chr5:14726166 GO:0005515|GO:0005576 NM_054023 THC2472125 Hs.483765 secretoglobin, family family 3A, 2-147261721 3A, member 2 member 2 (SCGB3A2), mRNA [NM_054023] A_33_P3410849 C8orf58 Homo sapiens NM_001013842 ENST00000381191 541565 chromosome chr8:22460863- NM_001013842 THC2609844 Hs.730863 chromosome 8 open 8 open reading 22460922 reading frame 58 frame 58 (C8orf58), transcript variant 1, mRNA [NM_001013842] A_33_P3227217 SNORA81 Homo sapiens NR_002989 ENST00000475409 677847 small nucleolar chr3:18650458 NR_002989 THC2509600 Hs.688848 small nucleolar RNA, RNA, H/ACA 2-186504641 H/ACA box 81 box 81 (SNORA81), small nucleolar RNA [NR_002989] A_23_P18372 B3GNT5 Homo sapiens NM_032047 ENST00000326505 84002 UDP- chr3:18299093 GO:0005622|GO:0009247| NM_032047 THC2462855 Hs.718506 UDP-GlcNAcbeta: Gal GlcNAc: 3-182990992 GO:0005794|GO:0016020| beta-1,3-N-acetylglucos- betaGal GO:0016757|GO:0008457| aminyl-transferase beta-1,3-N- GO:0007275|GO:0006486| 5 (B3GNT5), acetylgluco- GO:0016021|GO:0008917| mRNA [NM_032047] saminyl- GO:0007417|GO:0008378 transferase 5 A_23_P207336 PPY Homo sapiens NM_002722 ENST00000225992 5539 pancreatic chr17:4201851 GO:0009306|GO:0001664| NM_002722 THC2463069 Hs.730974 pancreatic polypeptide polypeptide 2-42018263 GO:0005179|GO:0007586| (PPY), mRNA GO:0005576 [NM_002722] A_33_P3376762 LOC388152 Homo sapiens NR_027001 ENST00000442755 388152 hypothetical chr15:8487365 NR_027001 THC2489238 Hs.546614 hypothetical LOC388152 LOC388152 9-84873600 (LOC388152), non- coding RNA [NR_027001] A_23_P420942 metallothionein 1E AF495759 ENST00000330439 chr16:5666061 THC2476324 [Source: HGNC Symbol; 4-56660673 Acc: 7397] [ENST00000330439] A_23_P113237 CRLF2 Homo sapiens NM_001012288 ENST00000400841 64109 cytokine chrX:1321318- GO:0005886|GO:0005576| NM_001012288 THC2484352 Hs.287729 cytokine receptor-like receptor-like 1317569 GO:0004872|GO:0016021 factor 2 (CRLF2), factor 2 transcript variant 2, mRNA [NM_001012288] A_33_P3326423 POLL Homo sapiens NM_001174084 ENST00000370162 27343 polymerase chr10:1033387 GO:0030145|GO:0003887| NM_001174084 THC2585456 Hs.523230 polymerase (DNA (DNA 81-103338722 GO:0016779|GO:0005634| directed), lambda directed), GO:0016446|GO:0003677| (POLL), transcript lambda GO:0006974|GO:0016829| variant 1, mRNA GO:0046872|GO:0005622| [NM_001174084] GO:0006260|GO:0006289| GO:0016740 A_33_P3324894 huntingtin AK130532 ENST00000376938 chr12:1233345 THC2487969 interacting protein 1 93-123334652 related [Source: HGNC Symbol; Acc: 18415] [ENST00000376938] A_33_P3352349 KRTAP9-1 Homo sapiens NM_001190460 ENST00000377723 728318 keratin chr17:3934676 NM_001190460 Hs.727478 keratin associated associated 7-39346826 protein 9-1 (KRTAP9-1), protein 9-1 mRNA [NM_001190460] A_23_P309224 AGK Homo sapiens NM_018238 ENST00000355413 55750 acylglycerol chr7:14135318 GO:0005739|GO:0031966| NM_018238 THC2466706 Hs.730694 acylglycerol kinase kinase 4-141353243 GO:0016020|GO:0000166| (AGK), nuclear GO:0004143|GO:0047620| gene encoding GO:0046834|GO:0005524| mitochondrial protein, GO:0016740|GO:0007205| mRNA [NM_018238] GO:0001729 A_33_P3242355 Homo sapiens cDNA BC027847 chr10:1351379 THC2610223 Hs.551860 clone IMAGE:5200632, 70-135137911 partial cds. [BC027847] A_23_P11652 USP1 Homo sapiens NM_003368 ENST00000371146 7398 ubiquitin chr1:62917270- GO:0005515|GO:0004197| NM_003368 NP1179127 Hs.35086 ubiquitin specific specific 62917329 GO:0006511|GO:0016579| peptidase 1 (USP1), peptidase 1 GO:0004843|GO:0006282| transcript variant 1, GO:0008233|GO:0005654| mRNA [NM_003368] GO:0005634|GO:0004221| GO:0009411|GO:0006974 A_32_P159192 immunoglobulin X85155 ENST00000390247 chr2:89278046- Hs.449621 kappa variable 3-7 89277987 (non-functional) [Source: HGNC Symbol; Acc: 5821] [ENST00000390247] A_23_P318581 KIAA1430 Homo sapiens NM_020827 ENST00000458385 57587 KIAA1430 chr4:18608146 NM_020827 THC2502160 Hs.535734 KIAA1430 (KIAA1430), 2-186081403 mRNA [NM_020827] A_33_P3229067 HIST1H2BN Homo sapiens NM_003520 ENST00000396980 8341 histone chr6:27806454- GO:0005694|GO:0006334| NM_003520 THC2481405 Hs.673851 histone cluster 1, cluster 1, 27806513 GO:0005634|GO:0000786| H2bn (HIST1H2BN), H2bn GO:0003677 mRNA [NM_003520] A_23_P113005 EFNA1 Homo sapiens NM_004428 ENST00000469878 1942 ephrin-Al chr1:15510676 GO:0000187|GO:0048013| NM_004428 THC2506968 Hs.516664 ephrin-Al (EFNA1), 7-155106826 GO:0046875|GO:0005886| transcript variant 1. GO:0005887|GO:0030182| mRNA [NM_004428] GO:0007267|GO:0031225| GO:0050770 A_33_P3337009 PPCS phosphopanto- ENST00000372560 79717 phosphopanto- chr1:42923068- THC2535535 thenoylcysteine syn- thenoylcysteine 42923127 thetase [Source: HGNC synthetase Symbol; Acc: 25686] [ENST00000372560] A_23_P81262 PCDHB4 Homo sapiens NM_018938 ENST00000194152 56131 protocadherin chr5:14050441 GO:0016339|GO:0005515| NM_018938 THC2491639 Hs.591250 protocadherin beta 4 beta 4 0-140504469 GO:0005737|GO:0005886| (PCDHB4), mRNA GO:0005887|GO:0005509| [NM_018938] GO:0007268|GO:0007155| GO:0007416|GO:0007156 A_23_P58729 SLC34A1 Homo sapiens NM_003052 ENST00000513614 6569 solute carrier chr5:17682566 GO:0010288|GO:0055062| NM_003052 THC2605001 Hs.936 solute carrier family family 34 8-176825727 GO:0031526|GO:0031402| 34 (sodium phosphate), (sodium GO:0015321|GO:0016020| member 1 (SLC34A1), phosphate), GO:0046849|GO:0005887| transcript variant 1, member 1 GO:0006817|GO:0006814| mRNA [NM_003052] GO:0046689|GO:0046686| GO:0006811|GO:0015293 A_23_P135730 ZNF627 Homo sapiens zinc NM_145295 ENST00000361113 199692 zinc finger chr19:1172930 GO:0005622|GO:0006355| NM_145295 THC2618823 Hs.526665 finger protein 627 protein 627 3-11729362 GO:0008270|GO:0005634| (2NF627), mRNA GO:0003677|GO:0046872 [NM_145295] A_33_P3325634 C19orf69 Homo sapiens NM_001130514 ENST00000378187 100170765 chromosome chr19:4195007 NM_001130514 Hs.649452 chromosome 19 19 open 0-41950129 open reading frame reading 69 (C19orf69), mRNA frame 69 [NM_001130514] A_33_P3263423 TLR5 Homo sapiens toll- NM_003268 ENST00000407096 7100 toll-like chr1:22330588 GO:0005515|GO:0007165| NM_003268 THC2626166 Hs.604542 like receptor 5 (TLR5), receptor 6-223305827 GO:0005149|GO:0006954| mRNA [NM_003268] GO:0005886|GO:0045087| GO:0007249|GO:0016021| GO:0004888 A_23_P73780 IRAK1 Homo sapiens NM_001569 ENST00000393682 3654 interleukin-1 chrX:15327690 GO:0016563|GO:0051259| NM_001569 THC2539008 Hs.522819 interleukin-1 receptor- receptor- 0-153276841 GO:0042803|GO:0005829| associated kinase 1 associated GO:0045323|GO:0004704| (IRAKI), kinase 1 GO:0045941|GO:0046777| transcript variant 1, GO:0051092|GO:0000166| mRNA (NM_001569] GO:0002755|GO:0032496| GO:0007178|GO:0031663| GO:0070555|GO:0070498| GO:0005149|GO:0000287| GO:0007250|GO:0046982| GO:0034134|GO:0006916| GO:0032088|GO:0005524| GO:0007165|GO:0001959| GO:0004674|GO:0016740 A_23_P408955 E2F2 Homo sapiens NM_004091 ENST00000361729 1870 E2F chr1:23832992- GO:0005667|GO:0006355| NM_004091 THC2471250 Hs.194333 E2F transcription transcription 23832933 GO:0006367|GO:0003700| factor 2 (E2F2), factor 2 GO:0003702|GO:0051726| mRNA [NM_004091] GO:0006915|GO:0005654| GO:0005634|GO:0008134 A_33_P3351259 LOC100130560 Homo sapiens AK127462 100130560 hypothetical chr15:9091074 THC2485942 Hs.711988 cDNA FLJ45554 fis. protein 4-90910803 clone BRTHA2038353. LOC100130560 [AK127462] A_24_P143076 FAM109A Homo sapiens NM_144671 ENST00000450786 144717 family with chr12:1117992 NM_144671 THC2491205 Hs.173088 family with sequence sequence 00-111799141 similarity 109, similarity 109, member A member A (FAM109A), transcript variant 2, mRNA [NM_144671] A_33_P3271316 RPP25 Homo sapiens NM_017793 ENST00000322177 54913 ribonuclease chr15:7524751 GO:0005515|GO:0016787| NM_017793 THC2616120 Hs.8562 ribonuclease P/MRP P/MRP 25 5-75247456 GO:0004526|GO:0003723| 25 kDa subunit (RPP25), kDa subunit GO:0005634|GO:0008033 mRNA [NM_017793] A_24_P402836 ZNF141 Homo sapiens zinc NM_003441 ENST00000240499 7700 zinc finger chr4:367324- GO:0005622|GO:0006355| NM_003441 THC2597064 Hs.654355 finger protein 141 protein 141 367383 GO:0003704|GO:0008270| (ZNF141). mRNA GO:0005634|GO:0009653| [NM_003441] GO:0003677|GO:0046872 A_24_P1054 TONSL Homo sapiens NM_013432 ENST00000422691 4796 tonsoku-like, chr8:14566385 GO:0005515|GO:0005737| NM_013432 THC2478718 Hs.675285 tonsoku-like, DNA DNA repair 5-145662425 GO:0003714|GO:0042994 repair protein (TONSL), protein mRNA [NM_013432] A_23_P140760 GPR97 Homo sapiens G NM_170776 ENST00000450388 222487 G protein- chr16:5771982 GO:0005886|GO:0007218| NM_170776 THC2474792 Hs.383403 protein-coupled receptor coupled 6-57722310 GO:0004930|GO:0016021 97 (GPR97), mRNA receptor 97 [NM_170776] A_33_P3233700 LOC100128675 Homo sapiens NR_024561 100128675 hypothetical chr19:3556613 NR_024561 THC2488071 Hs.633989 hypothetical LOC100128675 8-35566079 LOC100128675 (LOC100128675), transcript variant 1, non-coding RNA [NR_024561] A_33_P3383606 KCP Homo sapiens NM_001135914 ENST00000476647 375616 kielin/chordin- chr7:12851699 GO:0005515|GO:0030513| NM_001135914 THC2609353 Hs.371746 kielin/chordin-like like protein 0-128516931 GO:0005576|GO:0005615 protein (KCP), transcript variant 1, mRNA [NM_001135914] A_33_P3339531 CHADL Homo sapiens NM_138481 ENST00000216241 150356 chondroad- chr22:4162559 GO:0005515|GO:0005578| NM_138481 THC2630437 Hs.344488 chondroadherin-like herin-like 8-41625539 GO:0005576 (CHADL), mRNA [NM_138481] A_23_P133338 CDHR2 Homo sapiens NM_017675 ENST00000416365 54825 cadherin- chr5:17601762 GO:0005515|GO:0030308| NM_017675 THC2476495 Hs.4205 cadherin-related related family 1-176017680 GO:0030054|GO:0005886| family member 2 member 2 GO:0005509|GO:0016021| (CDHR2), transcript GO:0007155|GO:0007156 variant 2, mRNA [NM_017675] A_33_P3227934 LOC100130430 Homo sapiens AK126997 100130430 hypothetical chr16:1358740- THC2488009 cDNA FLJ45052 fis, LOC100130430 1358681 clone BRAWH3022542. [AK126997] A_24_P390495 CX3CL1 Homo sapiens NM_002996 ENST00000006053 6376 chemokine chr16:5741802 GO:0008009|GO:0005886| NM_002996 THC2692786 Hs.531668 chemokine (C-X3-C (C-X3-C 5-57418084 GO:0009986|GO:0030595| motif) ligand 1 motif) GO:0019221|GO:0005576| (CX3CL1), ligand 1 GO:0006952|GO:0005615| mRNA [NM_002196] GO:0050902|GO:0051041| GO:0006955|GO:0006935| GO:0050729|GO:0016021| GO:0007155 A_23_P84995 MTMR8 Homo sapiens NM_017677 ENST00000247400 55613 myotubularin chrX:6354876 GO:0016791|GO:0016787| NM_017677 THC2479596 Hs.442892 myotubularin related related 5-63548706 GO:0016311|GO:0005634| protein 8 (MTMR8), protein 8 GO:0005635|GO:0004725 mRNA [NM_017677] A_24_P79070 GNG8 Homo sapiens NM_033258 ENST00000300873 94235 guanine chr19:4713740 GO:0007165|GO:0009755| NM_033258 THC2743270 Hs.283961 guanine nucleotide nucleotide 4-47137345 GO:0007186|GO:0005886| binding protein (G binding protein GO:0005834|GO:0003924| protein), gamma 8 (G protein), GO:0005576|GO:0004871| (GNG8), mRNA gamma 8 GO:0007399 [NM_033258] A_33_P3249818 CEACAM18 Homo sapiens NM_001080405 ENST00000451626 729767 carcinoem- chr19:5198635 GO:0016020|GO:0016021 NM_001080405 Hs.653111 carcinoembryonic bryonic 2-51986411 antigen-related antigen-related cell adhesion cell adhesion molecule 18 molecule 18 (CEACAM18), mRNA [NM_001080405] A_33_P3289848 CDX1 Homo sapiens NM_001804 ENST00000394298 1044 caudal type chr5:14956318 GO:0043565|GO:0007389| NM_001804 THC2474742 Hs.1545 caudal type homeobox 1 4-149563243 GO:0006355|GO:0003700| homeobox 1 (CDX1), GO:0045944|GO:0009887| mRNA [NM_001804] GO:0005634|GO:0009952 A_32_P134290 ZCCHC2 Homo sapiens NM_017742 ENST00000269499 54877 zinc finger, chr18:6024552 GO:0005515|GO:0005737| NM_017742 THC2470691 Hs.114191 zinc finger, CCHC CCHC domain 5-60245584 GO:0007154|GO:0008270| domain containing 2 containing 2 GO:0035091|GO:0003676| (ZCCHC2), mRNA GO:0046872 [NM_017742] A_23_P86801 RAPSN Homo sapiens NM_032645 ENST00000352508 5913 receptor- chr11:4746436 GO:0005515|GO:0005737| NM_032645 NP091080 Hs.81218 receptor-associated associated 4-47464305 GO:0031594|GO:0030054| protein of the protein of the GO:0005794|GO:0005886| synapse (RAPSN), synapse GO:0045211|GO:0033130| transcript variant 2, GO:0007268|GO:0008270| mRNA [NM_032645] GO:0005856|GO:0046872 A_23_P50799 OR10H2 Homo sapiens NM_013939 ENST00000305899 26538 olfactory chr19:1583970 GO:0007608|GO:0007165| NM_013939 THC2481403 Hs.247694 olfactory receptor, receptor, 0-15839759 GO:0004984|GO:0007186| family 10, family 10, GO:0005886|GO:0004872| subfamily H, member subfamily H, GO:0016021|GO:0050896 2 (OR10H2), member 2 mRNA [NM_013939] A_33_P3304819 chr7:10525824 4-105258303 A_33_P3258747 C21orf63 Homo sapiens NM_058187 ENST00000469079 59271 chromosome 21 chr21:3378526 GO:0016020|GO:0005529| NM_058187 NP650911 Hs.208358 chromosome 21 open reading 1-33785320 GO:0016021 open reading frame frame 63 63 (C21orf63), mRNA [NM_058187] A_23_P21230 TRIM37 Homo sapiens NM_015294 ENST00000262294 4591 tripartite chr17:5707617 GO:0005622|GO:0005515| NM_010204 THC2466521 Hs 579079 tripartite motif motif 0-57076117 GO:0048471|GO:0005737| containing 37 containing 37 GO:0005270|GO:0040872| (TRIM37), transcript GO:0005777 variant 1, mRNA [NM_015294] A_33_P3411325 Q8IVL_HUMAN chr16:0322527 THC2668129 (Q8IVL5) 63-032252704 Leprecan-like 1 protein, partial (3%) [THC2668129] A_33_P3276142 DNM1P46 Homo sapiens NR_003260 ENST00000448059 196968 DNM1 chr15:1003400 NR_003260 THC2593283 Hs.567763 DNM1 pseudogene pseudogene 46 38-100339979 46 (DNM1P46), non-coding RNA [NR_003260] A_33_P3374117 anoctamin 7-like 1 BU656309 ENST00000475369 chr1:16543682- THC2713054 Hs.162595 [Source: HGNC 16543623 Symbol; Acc: 32248] [ENST00000475369] A_24_P626951 immunoglobulin AF078945 ENST00000479981 chr2:89399588- NP074934 Hs.649954 kappa variable 1-16 89399529 [Source: HGNC Symbol; Acc: 57321 [ENST00000479981] A_23_P77980 SLC4A1 Homo sapiens NM_000342 ENST00000262418 6521 solute carrier chr17:4232856 GO:0006820|GO:0005215| NM_000342 THC2474664 Hs.443948 solute carrier family family 4, anion 7-42327888 GO:0008509|GO:0030018| 4, anion exchanger, exchanger, GO:0030506|GO:0006873| member 1 member 1 GO:0003779|GO:0008022| (erythrocyte mem- (erythrocyte GO:0042803|GO:0016323| brane protein band membrane GO:0005452|GO:0016020| 3, Diego blood protein band GO:0005887|GO:0030863| group) (SLC4A1), 3, Diego blood GO:0043495 mRNA [NM_000342] group) A_33_P3391387 LOC100268168 Homo sapiens NR_026682 100268168 hypothetical chr5:17238252 NR_026682 THC2484612 hypothetical LOC100268168 1-172382462 LOC100268168 (LOC100268168), transcript variant 1, non-coding RNA [NR_026682] A_33_P3454968 LOC645553 Homo sapiens BC062328 645553 hypothetical chr19:4669242 THC2502232 Hs.613068 cDNA clone LOC645553 9-46692370 IMAGE: 5478640, partial cds. [BC062328] A_23_P82959 FOXH1 Homo sapiens NM_003923 ENST00000292541 8928 forkhead chr8:14569964 GO:0048318|GO:0007368| NM_003923 THC2479690 Hs.708365 forkhead box H1 box H1 9-145699590 GO:0003700|GO:0016563| (FOXH1), mRNA GO:0019904|GO:0035054| [NM_003923] GO:0070412|GO:0005634| GO:0000122|GO:0032444| GO:0043565|GO:0045941| GO:0045944|GO:0007179 A_23_P125204 OR10G8 Homo sapiens NM_001004464 ENST00000431524 219869 olfactory re- chr11:1239011 GO:0007608|GO:0007165| NM_001004464 Hs.553635 olfactory receptor, ceptor, 15-123901174 GO:0004984|GO:0007186| family 10, subfamily G, family 10, GO:0005886|GO:0004872| member 8 (OR10G8), subfamily G, GO:0016021|GO:0050896 mRNA [NM_001004464] member K A_33_P3315899 chr20:0191931 30-019193071 A_33_P3295838 C17orf53 Homo sapiens NM_001171251 ENST00000253405 78995 chromosome 17 chr17:4222596 NM_001171251 THC2488121 Hs.437059 chromosome 17 open reading 6-42226025 open reading frame frame 53 53 (C17orf53), transcript variant 2, mRNA [NM_001171251] A_33_P3332627 chr7:05724552 5-057245466 A_33_P3253440 PQLC3 Homo sapiens PQ NM_152391 ENST00000487471 130814 PQ loop repeat chr2:11318091- GO:0016020|GO:0016021 NM_152391 THC2553661 Hs.274415 loop repeat containing containing 3 11318150 3 (PQLC3), mRNA [NM_152391] A_23_P202988 AASDHPPT Homo sapiens NM_015423 ENST00000534152 60496 aminoadipate- chr11:1059689 GO:0005515|GO:0005737| NM_015423 THC2469513 Hs.524009 aminoadipate- semi-aldehyde 76-105969035 GO:0000287|GO:0009059| semialdehyde dehydro- GO:0008897|GO:0016740| dehydrogenase- genase- GO:0005829 phosphopantetheinyl phospho- transferase pantetheiryl (AASDHPPT), transferase mRNA [NM_015423] A_33_P3334895 GRIN2A Homo sapiens NM_001134408 ENST00000396575 2903 glutamate chr16:9857277- GO:0043005|GO:0030054| NM_001134408 THC2475567 Hs.411472 glutamate receptor, receptor, 9857218 GO:0005886|GO:0045471| ionotropic, N-methyl ionotropic, N- GO:0005234|GO:0017146| D-aspartate 2A methyl D- GO:0045202|GO:0022843| (GRIN2A), aspartate 2A GO:0001964|GO:0042417| transcript variant 3, GO:0008104|GO:0048167| mRNA GO:0004972|GO:0045211| [NM_001134408] GO:0048169|GO:0042165| GO:0006816|GO:0004872| GO:0007613|GO:0019717| GO:0050839|GO:0006811| GO:0022008|GO:0005262| GO:0043065|GO:0000287| GO:0042177|GO:0033058| GO:0042493|GO:0005509| GO:0060079|GO:0009611| GO:0014069|GO:0030431| GO:0042734|GO:0042428| GO:0035235|GO:0001975| GO:0005887|GO:0008542| GO:0048511|GO:0001508| GO:0016595|GO:0051930 A_33_P3291567 TSNARE1 Homo sapiens NM_145003 ENST00000307180 203062 t-SNARE chr8:14331089 GO:0005515|GO:0016020| NM_145003 THC2478827 Hs.370931 t-SNARE domain domain 8-143310839 GO:0016021|GO:0016192 containing 1 containing 1 (TSNARE1), mRNA [NM_145003] A_33_P3314974 LOC100130522 Homo sapiens NR_028339 100130522 hypothetical chr18:7792042 NR_028339 THC2628455 Hs.352602 hypothetical LOC100130522 6-77920485 LOC100130522 (LOC100130522), transcript variant 1, non coding RNA [NR_028339] A_33_P3315824 chr10:0022643 49-002264408 A_33_P3269678 LOC541471 Homo sapiens NR_015395 541471 hypothetical chr2:11212464 NR_015395 THC2609308 hypothetical LOC541471 6-112124587 LOC541471 (LOC541471), transcript variant 1, non-coding RNA [NR_015395] A_33_P3298750 Homo sapiens BC012881 chr20:4731953 THC2488638 cDNA clone 7-47319596 IMAGE:3463076. [BC012881] A_33_P3384958 LPPR4 Homo sapiens NM_014839 ENST00000263178 9890 lipid phosphate chr1:99771632- GO:0042577|GO:0016787| NM_014839 NP1249191 Hs.13245 lipid phosphate phosphatase- 99771691 GO:0016020|GO:0046839| phosphatase-related related protein GO:0005887|GO:0008195| protein type 4 type 4 GO:0007409|GO:0009897 (LPPR4), transcript variant 1, mRNA [NM_014839] A_24_P80338 NEK4 Homo sapiens NM_003157 ENST00000233027 6787 NIMA (never chr3:52744873- GO:0007067|GO:0007049| NM_003157 THC2467290 Hs.631921 NIMA (never in in mitosis gene 52744814 GO:0000287|GO:0000166| mitosis gene a)-related a)-related GO:0004674|GO:0005730| kinase 4 (NEK4), kinase 4 GO:0006468|GO:0005634| transcript variant 1, GO:0005524|GO:0016740| mRNA [NM_003157] GO:0051301 A_23_P100220 ESRP2 Homo sapiens NM_024939 ENST00000251366 80004 epthelial chr16:6826311 GO:0006397|GO:0000166| NM_024939 THC2464692 Hs.592053 epithelial splicing splicing 3-68263054 GO:0043484|GO:0005634| regulatory protein 2 regulatory GO:0003729 (ESRP2), mRNA protein 2 [NM_024939] A_33_P3392740 ATOH8 Homo sapiens AL831857 ENST00000463422 84913 atonal chr2:85999972- THC2601465 Hs.135569 mRNA; cDNA homolog 8 86000031 DKFZp761E2117 (Drosophila) (from clone DKFZp761E2117). [AL831857] A_33_P3251901 APBB2 Homo sapiens NM_004307 ENST00000316212 323 amyloid beta chr4:40812316- GO:0007242|GO:0043066| NM_004307 THC2536043 Hs.479602 amyloid beta (A4) (A4) precursor 40812257 GO:0030308|GO:0043065| precursor protein- protein-binding, GO:0045202|GO:0005634| binding, family B, family B, GO:0045749|GO:0030027| member 2 (APBB2), member 2 GO:0030426|GO:0005737| transcript variant 1, GO:0001540|GO:0016020| mRNA [NM_004307] GO:0007411|GO:0030198| GO:0007050|GO:0001764| GO:0045449|GO:0008134 A_24_P181422 CATSPER2 Homo sapiens NM_172097 ENST00000415968 117155 cation channel, chr15:4393190 GO:0005515|GO:0005262| NM_172097 THC2475220 Hs.662284 cation channel, sperm 8-43931849 GO:0007283|GO:0055085| sperm associated 2 associated 2 GO:0030154|GO:0019861| (CATSPER2), GO:0005929|GO:0006816| transcript variant 4, GO:0016021|GO:0006811 mRNA [NM_172097] A_33_P3403494 LOC646743 Homo sapiens NR_033930 ENST00000414595 646743 hypothetical chr2:13129599 NR_033930 THC2606454 Hs.125706 hypothetical LOC646743 9-131295940 LOC646743 (LOC646743), non-coding RNA [NR_033930] A_23_P57118 TGM3 Homo sapiens NM_003245 ENST00000381458 7053 transgluta- chr20:2320506- GO:0051262|GO:0000287| NM_003245 THC2474581 Hs.2022 transglutaminase 3 minase 3 (E 2320565 GO:0016746|GO:0005509| (E polypeptide, polypeptide, GO:0031424|GO:0003924| protein-glutamine- protein- GO:0005525|GO:0031069| gamma-glutamyltrans- glutamine- GO:0031234|GO:0005737| ferase) (TGM3), gamma- GO:0018149|GO:0003810| mRNA [NM_003245] glutamyl- GO:0043163|GO:0019003| transferase) GO:0006464|GO:0008415 A_23_P163567 SMPD3 Homo sapiens NM_018667 ENST00000219334 55512 sphingomyelin chr16:6839230 GO:0007049|GO:0006685| NM_018667 THC2475296 Hs-368421 sphingomyelin phos- phosphodie- 9-68392250 GO:0000137|GO:0005794| phodiesterase 3, neutral sterase 3, GO:0000287|GO:0016787| membrane (neutral neutral GO:0005886|GO:0004767| sphingomyelinase II) membrane GO:0007275|GO:0016021| (SMPD3), (neutral GO:0030072 mRNA [NM_018667] sphingo- myelinase II) A_33_P3395310 BX096650 BX096650 chr4:54244117- Hs.717171 Soares_testis_NHT 54244058 Homo sapiens cDNA clone IMAGp998C184111, mRNA sequence [BX096650] A_33_P3256677 CCDC101 Homo sapiens NM_138414 ENST00000317058 112869 coiled-coil chr16:2860217 GO:0005634|GO:0045449 NM_138414 THC2464282 Hs.655476 coiled-coil domain domain 1-28602230 containing 101 containing 101 (CCDC101), mRNA [NM_138414] A_33_P3399208 major histocompatibility AF298582 ENST00000466304 THC2587029 Hs.77961 complex, class I, B (Source: HGNC Symbol; Acc: 4932] [ENST00000466304] A_24_P112160 UPK3B Homo sapiens NM_030570 ENST00000334348 80761 uroplakin 3B chr7:76143315- GO:0005886|GO:0010629| NM_030570 THC2644791 Hs.488861 uroplakin 3B (UPK3B), 76143374 GO:0016021 transcript variant 1, mRNA [NM_030570] A_33_P3221384 chr2:13303318 6-133033245 A_33_P3399064 RN5-8S1 Homo sapiens NR_003285 100008587 RNA, 5.8S chrU:n_gl00022 NR_003285 THC2581399 Hs.631413 RNA, 5.8S ribosomal 1 ribosomal 1 0:156050- (RN5-8S1), ribosomal 156109 RNA [NR_003285] A_33_P3418055 ZNF235 Homo sapiens zinc NM_004234 ENST00000359844 9310 zinc finger chr19:4479162 GO:0005622|GO:0006355| NM_004234 THC2477654 Hs.724032 finger protein 235 protein 235 4-44791565 GO:0008270|GO:0005634| (ZNF235), mRNA GO:0003677|GO:0046872 [NM_004234] A_23_P64173 CARD16 Homo sapiens caspase NM_001017534 ENST00000525374 114769 caspase chr11:1049152 GO:0005622|GO:0005515| NM_001017534 THC2625119 Hs.348365 recruitment domain recruitment 86-104915227 GO:0004197|GO:0004869| family, member 16 domain GO:0006508|GO:0042981| (CARD16), family, GO:0030414 transcript variant 1, member 16 mRNA [NM_001017534] A_33_P3620488 CATSPERG Homo sapiens cation NM_021185 ENST00000492088 57828 cation channel, chr19:3886149 GO:0016020|GO:0016021 NM_021185 NP1144122 Hs.324335 channel, sperm- sperm- 9-38861558 associated, associated, gamma (CATSPERG), gamma mRNA [NM_021185] A_33_P3374833 PLDN Homo sapiens pallidin NM_012388 ENST00000220531 26258 pallidin chr15:4590182 GO:0016081|GO:0006892| NM_012388 THC2552297 Hs.730623 homolog homolog 9-45901888 GO:0030318|GO:0005575| (mouse) (PLDN), (mouse) GO:0030349|GO:0042802| mRNA [NM_012388] GO:0032816|GO:0005737| GO:0006944|GO:0016020| GO:0007596|GO:0033299| GO:0043473|GO:0005768| GO:0019898 A_33_P3365506 ENST00000513564 chr4:34670959- 34671018 A_32_P192474 PRRT1 Homo sapiens proline- NM_030651 ENST00000375152 80863 proline-rich chr6:32116446- GO:0009607|GO:0016020| NM_030651 THC2463883 Hs.699821 rich transmembrane transmembrane 32116387 GO:0016021 protein 1 (PRRT1), protein 1 mRNA [NM_030651] A_23_P71752 ZFAND5 Homo sapiens zinc NM_006007 ENST00000488164 7763 zinc finger, chr9:74969825- GO:0048705|GO:0005575| NM_006007 THC2469722 Hs.406096 finger, AN1-type AN1-type 74969766 GO:0001701|GO:0003677| domain 5 (ZFAND5), domain 5 GO:0046872|GO:0003674| transcript variant c, GO:0008150|GO:0010761| mRNA [NM_006007] GO:0003016|GO:0048745| GO:0060324|GO:0008270| GO:0048008|GO:0001944 A_23_P354341 CD160 Homo sapiens CD160 NM_007053 ENST00000369290 11126 CD160 chr1:14569646 GO:0006968|GO:0005886| NM_007053 NP159654 Hs.488237 molecule (CD160), molecule 5-145696406 GO:0008283|GO:0005102| mRNA [NM_007053] GO:0004872|GO:0046658| GO:0007166|GO:0032393 A_33_P3512350 LOC339807 Homo sapiens NR_034023 339807 hypothetical chr2:64843555- NR_034023 THC2627404 Hs.434736 hypothetical LOC339807 64843614 LOC339807 (LOC339807), non-coding RNA [NR_034023] A_33_P3258699 DUX4 Homo sapiens NM_033178 ENST00000507734 22947 double chrUn_gl00022 GO:0043565|GO:0006355| NM_033178 THC2493180 Hs.553518 double homeobox 4 homeobox 4 8:77296-77355 GO:0003700|GO:0005634 (DUX4), mRNA [NM_033178] A_33_P3229288 ACE Homo sapiens NM_000789 ENST00000290863 1636 angiotensin 1 chr17:6157491 GO:0031404|GO:0005886| NM_000789 THC2470503 Hs.298469 angiotensin 1 converting 5-61574974 GO:0014910|GO:0005615| converting enzyme enzyme GO:0046872|GO:0019229| (peptidyl-dipeptidase A) (peptidyl GO:0042312|GO:0003081| 1 (ACE), transcript dipepti- GO:0002019|GO:0008144| variant 1, mRNA dase A) GO:0006508|GO:0004180| [NM_000789] GO:0008241|GO:0043171| GO:0050482|GO:0042277| GO:0001666|GO:0031711| GO:0001822|GO:0005624| GO:0005576|GO:0060218| GO:0001974|GO:0042447| GO:0008217|GO:0002005| GO:0008233|GO:0008270| GO:0016021|GO:0032943| GO:0008237|GO:0009897| GO:0005768 A_23_P210581 KCNG1 Homo sapiens NM_002237 ENST00000506387 3755 potassium chr20:4962032 GO:0005515|GO:0005244| NM_002237 THC2507184 Hs.118695 potassium voltage- voltage-gated 2-49620263 GO:0016020|GO:0008076| gated channel, sub- channel, GO:0005249|GO:0030955| family G, member subfamily G, GO:0016021|GO:0055085| 1 (KCNG1), mRNA member 1 GO:0006813|GO:0006811 [NM_002237] A_23_P25475 SOAT2 Homo sapiens sterol NM_003578 ENST00000301466 8435 sterol O- chr12:5351815 GO:0042632|GO:0006629| NM_003578 THC2480345 Hs.656544 O-acyltransferase 2 acyltrans- 2-53518211 GO:0033344|GO:0005792| (SOAT2), mRNA ferase 2 GO:0005783|GO:0007584| [NM_003578] GO:0010742|GO:0005624| GO:0034379|GO:0030299| GO:0005903|GO:0034736| GO:0016020|GO:0015485| GO:0005789|GO:0034435| GO:0016021|GO:0000062| GO:0034737|GO:0016740| GO:0008202|GO:0034738| GO:0008203|GO:0008415 A_33_P3230990 SCUBE1 Homo sapiens signal NM_173050 ENST00000381243 80274 signal peptide, chr22:4359934 GO:0005886|GO:0046982| NM_173050 THC2475362 Hs.133995 peptide, CUB domain, CUB domain, 7-43599288 GO:0005509|GO:0005576| EGF-like 1 EGF like 1 GO:0009791|GO:0005615| (SCUBE1), GO:0007512|GO:0042802| mRNA [NM_173050] GO:0006954|GO:0007596| GO:0051260|GO:0045446| GO:0009897|GO:0019897 A_23_P333129 DUX4L4 Homo sapiens NM_001177376 ENST00000538692 441056 double chr4:19099337 NM_001177376 Hs.725918 double homeobox 4 homeobox 9-190993446 like 4 (DUX4L4), 4 like 4 mRNA [NM_001177376] A_23_P45345 HTATSF1 Homo sapiens HIV- NM_014500 ENST00000415377 27336 HIV-1 Tat chrX:13559421 GO:0005515|GO:0003711| NM_014500 THC2756195 Hs.204475 1 Tat specific factor specific 6-135594275 GO:0006357|GO:0000166| 1 (HTATSF1), factor 1 GO:0003702|GO:0003723| transcript variant 2, GO:0005730|GO:0005634| mRNA [NM_014500] GO:0019079|GO:0045449 A_33_P3258339 C17orf76 Homo sapiens NM_001113567 ENST00000409887 388341 chromosome chr17:1634663 NM_001113567 THC2473528 Hs.25425 chromosome 17 open 17 open 4-16346575 reading frame 76 reading (C17orf76), transcript frame 76 variant 1, mRNA [NM_001113567] A_24_P196592 MMP28 Homo sapiens NM_001032278 ENST00000250144 79148 matrix chr17:3410630 GO:0008152|GO:0005509| NM_001032278 THC2778644 Hs.380710 matrix metallopeptidase metallopepti- 0-34106073 GO:0006508|GO:0005578| 28 (MMP28), dase 28 GO:0008270|GO:0008233| transcript variant 3, GO:0005576|GO:0004222 mRNA [NM_001032278] A_33_P3287379 COG8 Homo sapiens NM_032382 ENST00000306875 84342 component of chr16:6936493 GO:0005794|GO:0016020| NM_032382 THC2467033 Hs.130849 component of oligomeric 7-69364878 GO:0017119|GO:0015031| oligomeric golgi golgi GO:0019898 complex 8 (COG8), complex 8 mRNA [NM_032382] A_33_P3225512 OAS2 Homo sapiens 2′-5′- NM_002535 ENST00000392583 4939 2′-5′-oligo- chr12:1134484 GO:0005792|GO:0005783| NM_002535 THC2474929 Hs.414332 oligoadenylate adenylate 29-113448488 GO:0001730|GO:0003723| synthetase 2, synthetase 2, GO:0016779|GO:0005634| 69/71 kDa (OAS2), 69/71 kDa GO:0005524|GO:0006401| transcript variant 2, GO:0005739|GO:0006139| mRNA [NM_002535] GO:0006955|GO:0000166| GO:0016020|GO:0016740 A_33_P3227252 chr6:00014586 THC2481163 3-000145922 A_23_P317207 ATXN7L2 Homo sapiens NM_153340 ENST00000463678 127002 ataxin 7- chr1:11003388 NM_153340 THC2475985 Hs.118248 ataxin 7-like 2 like 2 8-110033947 (ATXN7L2), mRNA [NM_153340] A_23_P160226 HEATR8 Homo sapiens NM_001039464 ENST00000421030 374977 HEAT chr1:55175863- GO:0016020|GO:0005488| NM_001039464 NP509977 Hs.412482 HEAT repeat repeat con- 55175922 GO:0016021 containing 8 (HEATR8), taining 8 transcript variant 1, mRNA [NM_001039464] A_33_P3225572 chr7:02727850 9-027278450 A_33_P3378318 chr10:0430509 05-043050964 A_33_P3372666 PDGFA Homo sapiens NM_033023 ENST00000405692 5154 platelet-derived chr7:557091- GO:0010544|GO:0031089| NM_033023 THC2477221 Hs.535898 platelet-derived growth growth factor 557032 GO:0043498|GO:0050730| factor alpha poly- alpha poly- GO:0005518|GO:0007267| peptide (PDGFA), peptide GO:0014910|GO:0048146| transcript variant 2, GO:0009790|GO:0005615| mRNA [NM_033023] GO:0042803|GO:0010035| GO:0032956|GO:0009887| GO:0051781|GO:0007179| GO:0032526|GO:0032355| GO:0001942|GO:0001775| GO:0001666|GO:0048839| GO:0010033|GO:0030335| GO:0048286|GO:0046982| GO:0009986|GO:0048407| GO:0042493|GO:0045740| GO:0010512|GO:0050919| GO:0005576|GO:0002053| GO:0001525|GO:0005161| GO:0005902|GO:0016020| GO:0030031|GO:0042060| GO:0043588|GO:0048008| GO:0008083 A_32_P134968 SPTB Homo sapiens NM_001024858 ENST00000335612 6710 spectrin, beta, chr14:6521307 GO:0005515|GO:0043234| NM_001024858 THC2475546 Hs.417303 spectrin, beta, erythro- erythrocytic 4-65213015 GO:0008091|GO:0005737| cytic (SPTB), GO:0051015|GO:0031235| transcript variant 1, GO:0005200|GO:0014731| mRNA [NM_001024858] GO:0015629|GO:0005938| GO:0051693|GO:0005829 A_33_P3377786 LOC649887 PREDICTED: XM_003121052 649887 ETS domain chr14:1060129 XM_003121052 THC2484830 Homo sapiens ETS containing 62-106012903 domain-containing protein Elk-1- protein Elk-1-like like (LOC649887), mRNA [XM_003121052] A_23_P90357 TBXA2R Homo sapiens NM_001060 ENST00000375190 6915 thromboxane chr19:3594819- GO:0007165|GO:0007186| NM_001060 THC2641607 Hs.442530 thromboxane A2 A2 receptor 3594760 GO:0005886|GO:0005887| receptor (TBXA2R), GO:0004930|GO:0004961| transcript variant a, GO:0004872 mRNA [NM_001060] A_33_P3262580 ENTPD1 ectonucleoside AJ133134 ENST00000371206 953 ectonucleoside chr10:9760533 THC2486629 triphosphate di- triphosphate 7-97605396 phosphohydrolase 1 diphospho- [Source: HGNC Symbol; hydrolase 1 Acc: 3363] [ENST00000371206] A_33_P3359012 DUSP8 Homo sapiens dual NM_004420 ENST00000331588 1850 dual specificity chr11:1575341- GO:0000188|GO:0005737| NM_004420 THC2474457 Hs.41688 specificity phosphatase phosphatase 8 1575282 GO:0006470|GO:0016787| 8 (DUSP8), GO:0005634|GO:0017017| mRNA [NM_004420] GO:0004725 A_33_P3367447 ALDH3B1 Homo sapiens NM_001161473 ENST00000007633 221 aldehyde chr11:6779351 GO:0006629|GO:0006066| NM_001161473 NP1157844 Hs.523841 aldehyde dehydrogenase dehydrogenase 6-67793575 GO:0016491|GO:0006081| 3 family, member 3 family, GO:0004028|GO:0055114| B1 (ALDH3B1), member B1 GO:0004030 transcript variant 3, mRNA [NM_001161473] A_33_P3391167 ENST00000537481 chr7:56872218- 56872277 A_33_P3358019 chr9:13443152 1-134431580 A_33_P3416097 F13A1 Homo sapiens NM_000129 ENST00000441301 2162 coagulation chr6:6222326- GO:0005737|GO:0018149| NM_000129 THC2668771 Hs.335513 coagulation factor factor XIII, 6222267 GO:0007596|GO:0003810| XIII, Al polypeptide Al polypeptide GO:0005509|GO:0031093| (F13A1), mRNA GO:0005576|GO:0016740| [NM_000129] GO:0008415 A_33_P3239864 ANKDD1A ankyrin repeat and AK307698 ENST00000319597 348094 ankyrin repeat chr15:6522377 THC2477872 Hs.207157 death domain containing and death 5-65223834 1A [Source: HGNC domain Symbol; Acc: 28002] containing 1A [ENST00000319597] A_24_P357100 RASD2 Homo sapiens NM_014310 ENST00000216127 23551 RASD chr22:3594961 GO:0005622|GO:0007165| NM_014310 THC2471776 Hs.474711 RASD family, family, 0-35949669 GO:0005737|GO:0005886| member 2 (RASD2), member 2 GO:0000166|GO:0007264| mRNA [NM_014310] GO:0003924|GO:0007626| GO:0031225|GO:0005575| GO:0005525 A_23_P142070 TSPAN16 Homo sapiens NM_012466 ENST00000316737 26526 tetraspanin 16 chr19:1141191 GO:0016020|GO:0016021 NM_012466 THC2483075 Hs.579784 tetraspanin 16 2-11411971 (TSPAN16), mRNA [NM_012466] A_33_P3349552 CASKIN1 Homo sapiens NM_020764 ENST00000382453 57524 CASK chr16:2228170- GO:0007165|GO:0005737| NM_020764 THC2648696 Hs.643537 CASK interacting interacting 2228111 GO:0019904 protein 1 (CASKIN1), protein 1 mRNA [NM_020764] A_33_P3272823 MAG Homo sapiens NM_002361 ENST00000262624 4099 myelin chr19:3580285 GO:0005515|GO:0005886| NM_002361 THC2517997 Hs.643440 myelin associated associated 8-35802917 GO:0043209|GO:0005529| glycoprotein (MAG), glycoprotein GO:0050771|GO:0016021| transcript variant 1, GO:0007155 mRNA [NM_002361] A_23_P30464 PRR7 Homo sapiens NM_030567 ENST00000502922 80758 proline rich 7 chr5:17688314 GO:0030054|GO:0005886| NM_030567 THC2480457 Hs.534492 proline rich 7 (synaptic) 4-176883203 GO:0045211|GO:0045202| (synaptic) (PRR7), GO:0016021 transcript variant 1, mRNA [NM_030567] A_33_P3390950 LOC100128338 Homo sapiens AK125852 100128338 hypothetical chr8:14482410 THC2513064 Hs.493171 cDNA FLJ43864 fis, LOC100128338 6-144824165 clone TESTI4007799. [AK125852] A_33_P3424612 immunoglobulin XM_003120829 ENST00000483158 chr2:89326850- XM_003120829 NP1455229 Hs.449621 kappa variable 3-11 89326791 [Source: HGNC Symbol; Acc: 5815] [ENST00000483158] A_33_P3263287 LOC100129111 Homo sapiens AK126895 100129111 hypothetical chr11:8059834- THC2638098 Hs.627496 FLJ44947 fis, clone LOC100129111 8059775 BRAMY4001913. cDNA [AK126895] A_23_P112187 FIBCD1 Homo sapiens NM_032843 ENST00000372338 84929 fibrinogen C chr9:13377855 GO:0007165|GO:0016020| NM_032843 THC2474476 Hs.133205 fibrinogen C domain domain 6-133778497 GO:0005102|GO:0016021| containing 1 (FIBCD1), containing 1 GO:0005615 transcript variant 1, mRNA [NM_032843] A_23_P49674 ARHGEF15 Homo sapiens Rho NM_173728 ENST00000421050 22899 Rho guanine chr17:8224944- GO:0005622|GO:0005085| NM_173728 THC2464188 Hs.443109 guanine nucleotide nucleotide 8225003 GO:0035023|GO:0005089| exchange factor (GEF) exchange GO:0005096 15 (ARHGEF15), factor transcript variant 1, (GEF) 15 mRNA [NM_173728] A_33_P3290955 KIAA1875 Homo sapiens NR_024207 ENST00000488801 340390 KIAA1875 chr8:14517263 NR_024207 THC2582104 Hs.272822 KIAA1875 2-145172680 (KIAA1875), non-coding RNA [NR_024207] A_23_P103465 PLA2G5 Homo sapiens NM_000929 ENST00000465698 5322 phospholipase chr1:20417423- GO:0019370|GO:0048471| NM_000929 NP1143075 Hs.319438 phospholipase A2, A2, group V 20417482 GO:0005794|GO:0005886| group V(PLA2G5), GO:0009986|GO:0006663| mRNA [NM_000929] GO:0005509|GO:0005576| GO:0051591|GO:0016042| GO:0016787|GO:0047498| GO:0006644|GO:0034097| GO:0008201|GO:0050482 A_23_P3602 NUDT7 Homo sapiens NM_001105663 ENST00000268533 283927 nudix chr16:7777592 GO:0030145|GO:0000287| NM_001105663 THC2521963 Hs.282665 nudix (nucleoside (nucleoside 1-77775980 GO:0016787|GO:0009132| diphosphate linked diphosphate GO:0016818|GO:0005777 moiety X)-type motif linked moiety 7 (NUDT7), X)-type motif 7 transcript variant 1, mRNA [NM_001105663] A_33_P3421571 RAPH1 Homo sapiens Ras NM_213589 ENST00000374493 65059 Ras association chr2:20430425 GO:0007165|GO:0005737| NM_213589 THC2472794 Hs.471162 association (RalGDS/ (RalGDS/ 0-204304191 GO:0007160|GO:0005886| AF-6) and pleckstrin AF-6) and GO:0005634|GO:0030175| homology domains 1 pleckstrin GO:0005856|GO:0030027 (RAPH1), homology transcript variant 1, domains 1 mRNA [NM_213589] A_23_P137046 NYX Homo sapiens NM_022567 ENST00000378220 60506 nyctalopin chrX:41334570- GO:0005622|GO:0005515| NM_022567 THC2484608 Hs.302019 nyctalopin (NYX), 41334629 GO:0003674|GO:0005578| mRNA[NM_022567] GO:0005576|GO:0007601| GO:0050896 A_23_P217088 AK1 Homo sapiens NM_000476 ENST00000476274 203 adenylate chr9:13063071 GO:0005515|GO:0006139| NM_000476 THC2510014 Hs.175473 adenylate kinase 1 kinase 1 2-130630653 GO:0005737|GO:0046034| (AK1), mRNA GO:0000166|GO:0005634| [NM_000476] GO:0004017|GO:0019206| GO:0005524|GO:0016740| GO:0005829 A_33_P3306624 HCRT Homo sapiens NM_001524 ENST00000293330 3060 hypocretin chr17:4033746 GO:0005791|GO:0048471| NM_001524 THC2659783 Hs.158348 hypocretin (orexin) (orexin) 5-40337406 GO:0030054|GO:0051928| neuropeptide precursor neuropeptide GO:0060079|GO:0043267| (HCRT), mRNA precursor GO:0046928|GO:0045202| [NM_001524] GO:0007200|GO:0007268| A_33_P3374903 chr14:0357045 GO:0051970|GO:0051971| 38-035704597 GO:0007204|GO:0007205| A_33_P3399755 chr15:0434232 GO:0008021|GO:0031771| 26-043423167 GO:0031772|GO:0005737| GO:0007218|GO:0042755| GO:0008156|GO:0005184| GO:0030141 A_23_P207811 PAIP1 Homo sapiens NM_006451 ENST00000306846 10605 poly(A) chr5:43526482- GO:0005515|GO:0005737| NM_006451 THC2476788 Hs.482038 poly(A) binding binding protein 43526423 GO:0016070|GO:0003723| protein interacting interacting GO:0008494|GO:0048255| protein 1 (PAIP1), protein 1 GO:0006417|GO:0006413 transcript variant 1, mRNA [NM_006451] A_23_P217712 ARSD Homo sapiens NM_001669 ENST00000217890 414 arylsulfatase D chrX:2835852- GO:0016787|GO:0008152| NM_001669 NP164738 Hs.528631 arylsulfatase D 2833682 GO:0005509|GO:0004065| (ARSD), mRNA GO:0005764 [NM_001669] A_33_P3415923 FMNL3 Homo sapiens NM_175736 ENST00000352151 91010 formin-like 3 chr12:5003881 GO:0005515|GO:0030036| NM_175736 THC2475096 Hs.179838 formin-like 3 4-50038755 GO:0017048|GO:0003779| (FMNL3), GO:0016043 transcript variant 1, mRNA [NM_175736] A_24_P277155 HLTF Homo sapiens NM_003071 ENST00000310053 6596 helicase-like chr3:14874845 GO:0005515|GO:0006357| NM_003071 THC2465857 Hs.3068 helicase-like transcription 0-148748391 GO:0003702|GO:0016874| transcription factor factor GO:0016563|GO:0004386| (HLTF), GO:0005634|GO:0016818| transcript variant 1, GO:0003677|GO:0005524| mRNA [NM_003071] GO:0046872|GO:0006350| GO:0000166|GO:0016787| GO:0019941|GO:0008270| GO:0016887|GO:0016568 A_33_P3314978 LOC100130522 Homo sapiens NR_028340 100130522 hypothetical chr18:7793616 NR_028340 THC2622038 hypothetical LOC100130522 3-77936222 LOC100130522 (LOC100130522), transcript variant 3, non-coding RNA [NR_028340] complement A_23_P2492 C1S Homo sapiens NM_001734 ENST00000360817 716 complements chr12:7178093- GO:0004252|GO:0045087| NM_001734 THC2553139 Hs.458355 component 1, s component 1, 7178152 GO:0006958|GO:0005509| subcomponent (C1S), s subcompo- GO:0006508|GO:0010001| transcript variant 2, nent GO:0008233|GO:0005576| mRNA [NM_001734] GO:0051591 A_33_P3387781 OR2L1P Homo sapiens NR_002145 26247 olfactory chr1:24815419 NR_002145 NP1174289 Hs.684887 olfactory receptor, receptor, 7-248154256 family 2, subfamily family 2, L, member 1 pseudogene subfamily L, (OR2L1P), member 1 non-coding RNA pseudogene [NR_002145] A_23_P14072 KRT8 Homo sapiens NM_002273 ENST00000550170 3856 keratin 8 chr12:5329108 GO:0005515|GO:0005737| NM_002273 THC2514651 Hs.533782 keratin 8 (KRT8), 5-53291026 GO:0005198|GO:0044419| mRNA [NM_002273] GO:0007010|GO:0045095 A_24_P945147 RABEP1 Homo sapiens NM_004703 ENST00000262477 9135 rabaptin, RAB chr17:5288797- GO:0005515|GO:0005737| NM_004703 THC2493766 Hs.592121 rabaptin, RAB GTPase 5288856 GO:0006944|GO:0006915| GTPase binding binding GO:0055037|GO:0015031| effector protein 1 effector GO:0008083|GO:0005769| (RABEP1), protein 1 GO:0006897|GO:0005096 transcript variant 1, mRNA[NM_004703] A_33_P3408305 CERS3 Homo sapiens NM_178842 ENST00000538112 204219 ceramide chr15:1009428 GO:0043565|GO:0008610| NM_178842 THC2475513 Hs.662371 ceramide synthase synthase 3 05-100942746 GO:0006355|GO:0005737| 3 (CERS3), GO:0003700|GO:0016020| mRNA [NM_178842] GO:0030148|GO:0005634| GO:0050291|GO:0016021 A_33_P3299329 Human A25969 NP321619 Hs.511728 mRNA for T-cell receptor V beta gene segment V- beta-7, clone IGRb18. [X58812] A_33_P3248982 FAIM2 Homo sapiens Fas NM_012306 ENST00000320634 23017 Fas apoptotic chr12:5026073 GO:0005515|GO:0030054| NM_012306 THC2511959 Hs.567424 apoptotic inhibitory inhibitory 9-50260680 GO:0005886|GO:0045211| molecule 2 (FAIM2), molecule 2 GO:0045202|GO:0006915| mRNA [NM_012306] GO:0006916|GO:0016021| GO:0007417 A_23_P145569 SLC22A1 Homo sapiens NM_153187 ENST00000539263 6580 solute carrier chr6:16056088 GO:0005515|GO:0005215| NM_153187 THC2636461 Hs.117367 solute carrier family 22 5-160564617 GO:0015695|GO:0005886| family 22 (organic (organic GO:0015075|GO:0005887| cation transporter), cation GO:0005624|GO:0055085| member 1 transporter), GO:0015101 (SLC22A1), member 1 transcript variant 2, mRNA [NM_153187] A_33_P3314441 FBXL17 Homo sapiens NM_001163315 ENST00000542267 64839 F-box and chr5:10719562 GO:0019941 NM_001163315 THC2473457 Hs.657225 F-box and leucine- leucine rich 8-107195569 rich repeat protein 17 repeat (FBXL17), protein 17 mRNA [NM_001163315] A_33_P3322879 chr7:02923873 0-029238671 A_33_P3361422 CYP27A1 Homo sapiens NM_000784 ENST00000494263 1593 cytochrome chr2:21967995 GO:0005739|GO:0031073| NM_000784 Hs.516700 cytochrome P450, P450, family 1-219680010 GO:0030343|GO:0016020| family 27, sub- 27, subfamily GO:0047749|GO:0005759| family A, polypeptide A, polypeptide GO:0005743|GO:0009055| 1 (CYP27A1), 1 GO:0046872|GO:0055114| nuclear gene en- GO:0020037|GO:0008203 coding mitochondrial protein, mRNA [NM_000784] A_33_P3419419 PIK3C2B phosphoinositide- ENST00000367184 5287 phosphoino- chr1:20443595 THC2703322 3-kinase, class 2, sitide 3-kinase, 9-204435900 beta polypeptide class 2, beta [Source: HGNC polypeptide Symbol; Acc: 8972] [ENST00000367184] A_33_P3231572 LOC100130456 Homo sapiens AK095012 100130456 hypothetical chr7:1089796- THC2486189 Hs.683861 cDNA FLJ37693 fis, LOC100130456 1089855 clone BRHIP2014954. [AK095012] A_33_P3303865 FAM120C Homo sapiens NM_198456 ENST00000477084 54954 family with chrX:54208993- NM_198456 THC2635554 Hs.86045 family with sequence sequence 54208934 similarity 120C similarity (FAM120C), 120C transcript variant 2, mRNA [NM_198456] A_32_P109683 PAGE2B Homo sapiens P NM_001015038 ENST00000374971 389860 P antigen chrX:55102473- NM_001015038 THC2476714 Hs.293317 antigen family, family, 55102532 member 2B (PAGE2B), member 2B mRNA [NM_001015038] A_33_P3311543 Q3MF38_ANAVT chr15:0678997 THC2489055 (Q3MF38) 41-067899800 Extracellular solute- binding protein, family 3 precursor, partial (7%) [THC2489055] A_23_P59099 OR11A1 Homo sapiens NM_013937 ENST00000377149 26531 olfactory chr6:29394698- GO:0007608|GO:0007165| NM_013937 THC2487340 Hs.676010 olfactory receptor, receptor, 29394639 GO:0004984|GO:0007186| family 11, family 11, GO:0005886|GO:0004872| subfamily A, member subfamily A, GO:0016021|GO:0050896 1 (OR11A1), member 1 mRNA [NM_013937] A_33_P3373560 SPTAN1 Homo sapiens NM_001130438 ENST00000372721 6709 spectrin, chr9:13138890 GO:0008091|GO:0005516| NM_001130438 THC2567178 Hs.372331 spectrin, alpha, alpha, non- 6-131388965 GO:0005737|GO:0005509| non erythrocytic erythrocytic 1 GO:0005200|GO:0005624| 1 (alpha-fodrin) (alpha-fodrin) GO:0003779|GO:0005856| (SPTAN1), GO:0005938|GO:0051693| transcript variant 1, GO:0005829 mRNA [NM_001130438] A_24_P56837 ASB16 Homo sapiens NM_080863 ENST00000293414 92591 ankyrin repeat chr17:4225639 GO:0005515|GO:0007242| NM_080863 THC2761159 Hs.534517 ankyrin repeat and SOCS box 0-42256449 GO:0019941 and SOCS box containing 16 containing 16 (ASB16), mRNA [NM_080863] A_33_P3358104 CD300E Homo sapiens NM_181449 ENST00000412268 342510 CD300e chr17:7261335 GO:0006955|GO:0005886| NM_181449 THC2480696 Hs.158954 CD300e molecule molecule 8-72613299 GO:0004872|GO:0016021 (CD300E), mRNA [NM_181449] A_33_P3390177 FLJ34208 Homo sapiens NR_033929 401106 hypothetical chr3:19420909 NR_033929 THC2503254 Hs.407087 hypothetical LOC401106 4-194209153 LOC401106 (FLJ34208), non-coding RNA [NR_033929] A_33_P3253501 HIST2H2BF Homo sapiens NM_001161334 ENST00000369167 440689 histone cluster chr1:14978361 GO:0005694|GO:0006334| NM_001161334 THC2541318 Hs.632451 histone cluster 2, 2, H2bf 7-149783558 GO:0005634|GO:0000786| H2bf (HIST2H2BF), GO:0003677 transcript variant 2, mRNA [NM_001161334] A_33_P3277611 TMEM8C Homo sapiens NM_001080483 ENST00000339996 389827 transmembrane chr9:13637987 GO:0016020|GO:0016021 NM_001080483 THC2645713 Hs.512467 transmembrane protein 8C 1-136379812 protein 8C (TMEM8C), mRNA [NM_001080483] A_33_P3393537 PTAFR Homo sapiens NM_001164722 ENST00000539896 5724 platelet- chr1:28520418- GO:0005886|GO:0048015| NM_001164722 THC2513589 Hs.77542 platelet-activating activating 28520359 GO:0001875|GO:0001816| factor receptor factor receptor GO:0007165|GO:0006955| (PTAFR), GO:0032959|GO:0004992| transcript variant 2, GO:0005543|GO:0006954| mRNA [NM_001164722] GO:0006935|GO:0007186| GO:0005887|GO:0032496| GO:0004872 A_33_P3370881 LOC100508761 PREDICTED: XM_003119737 100508761 hypothetical chr19:4241327 XM_003119737 THC2650123 Hs.590950 Homo sapiens protein 2-42413213 hypothetical protein LOC100508761 LOC100508761 (LOC100508761), mRNA [XM_003119737] A_32_P2392 GOLGA8A Homo sapiens NM_181077 ENST00000509311 23015 golgin A8 chr15:3467339 GO:0005794|GO:0016020| NM_181077 THC2537280 Hs.720151 golgin A8 family, family, 3-34673334 GO:0019898 member A member A (GOLGA8A), transcript variant 1, mRNA [NM_181077] A_24_P212234 SLC6A18 Homo sapiens NM_182632 ENST00000296821 348932 solute carrier chr5:1244392- GO:0005886|GO:0005887| NM_182632 NP398860 Hs.213284 solute carrier family family 6, 1244451 GO:0005328|GO:0006865| 6, member 18 member 18 GO:0006836|GO:0015293 (SLC6A18), mRNA [NM_182632] A_33_P3316239 LOC100130419 Homo sapiens AK126781 100130419 hypothetical chr19:4564036 THC2629820 Hs.651773 cDNA FLJ44830 fis, protein 1-45640420 clone BRACE3047018. LOC100130419 [AK126781] A_33_P3308456 HOXB13-AS1 Homo sapiens NR_024103 ENST00000422730 360205 HOXB13 chr17:4680059 GO:0005634 NR_024103 THC2623344 Hs.236557 HOXB13 antisense antisense RNA 3-46800652 RNA 1 (non-protein 1 (non-protein coding) (HOXB13- coding) AS1), non-coding RNA [NR_024103] A_33_P3289456 ENST00000438148 chr2:10576182 3-105761882 A_33_P3378212 MED25 Homo sapiens NM_030973 ENST00000312881 81857 mediator chr19:5034017 GO:0005634|GO:0045449 NM_030973 THC2481955 Hs.656639 mediator complex complex 3-50340232 subunit 25 (MED25), subunit 25 mRNA [NM_030973] A_23_P128930 PSMC6 Homo sapiens NM_002806 ENST00000445930 5706 proteasome chr14:5318784 GO:0006511|GO:0000502| NM_002806 THC2469599 Hs.156171 proteasome (prosome, (prosome, 5-53187904 GO:0051437|GO:0005634| macropain) 26S macropain) GO:0051436|GO:0005524| subunit, ATPase, 26S subunit, GO:0031145|GO:0030163| 6 (PSMC6), ATPase, 6 GO:0005737|GO:0000166| mRNA[NM_002806] GO:0016787|GO:0030674| GO:0016887 A_24_P327499 TTI1 Homo sapiens Tel2 NM_014657 ENST00000449821 9675 Tel2 chr20:3663103 GO:0005488 NM_014657 THC246716H Hs.655481 interacting protein 1 interacting 5-36627677 homolog (S. pombe) protein 1 (TTI1), homolog mRNA [NM_014657] (S. pombe) A_23_P433111 C5orf35 Homo sapiens NM_153706 ENST00000463805 133383 chromosome 5 chr5:56209808- NM_153706 THC2475697 Hs.85950 chromosome 5 open reading 56210738 open reading frame frame 35 35 (C5orf35), transcript variant 1, mRNA [NM_153706] A_23_P119102 VASP Homo sapiens NM_003370 ENST00000245932 7408 vasodilator- chr19:4602973 GO:0005515|GO:0017124| NM_003370 NP1201349 Hs.515469 vasodilator-stimulated stimulated 8-46029797 GO:0030036|GO:0030054| phosphoprotein phosphoprotein GO:0005886|GO:0031258| (VASP), GO:0031527|GO:0001843| mRNA [NM_003370] GO:0003779|GO:0015629| GO:0005829|GO:0005737| GO:0007411|GO:0005925 A_33_P3405022 LETM1 Homo sapiens NM_012318 ENST00000302787 3954 leucine zipper- chr14:0456008 GO:0005739|GO:0005515| NM_012318 THC2538032 Hs.120165 leucine zipper-EF- EF-hand 28-045600769 GO:0016020|GO:0005509| hand containing containing GO:0005743|GO:0016021| transmembrane transmembrane GO:0042407 protein 1 (LETM1), protein 1 nuclear gene encoding mitochondrial protein, mRNA [NM_012318] A_23_P3204 MAPK6 Homo sapiens NM_002748 ENST00000261845 5597 mitogen- chr15:5235805 GO:0007165|GO:0007049| NM_002748 THC2469096 Hs.411847 mitogen-activated activated 5-52358114 GO:0000166|GO:0004674| protein kinase 6 protein GO:0006468|GO:0005524| (MAPK6), mRNA kinase 6 GO:0016740|GO:0004707 [NM_002748] A_23_P128993 GZMH Homo sapiens NM_033423 ENST00000382548 2999 granzyme H chr14:2507576 GO:0005737|GO:0004252| NM_033423 NP1073090 Hs.348264 granzyme H (cathepsin G- 8-25075709 GO:0019835|GO:0006508| (cathepsin G-like like 2, protein GO:0006915|GO:0008233 2, protein h-CCPX) h-CCPX) (GZMH), mRNA [NM_033423] A_24_P181254 OLFM4 Homo sapiens NM_006418 ENST00000219022 10562 olfactomedin 4 chr13:5362609 GO:0005515|GO:0005576| NM_006418 NP080242 Hs.508113 olfactomedin 4 5-53626154 GO:0007155|GO:0005615 (OLFM4), mRNA [NM_006418] A_23_P165952 ACTR5 Homo sapiens NM_024855 ENST00000243903 79913 ARP5 actin- chr20:3739618 GO:0005515|GO:0005524| NM_024855 THC2470844 Hs.371585 ARP5 actin-related related protein 9-37400210 GO:0045449 protein 5 homolog 5 homolog (yeast) (ACTR5), (yeast) mRNA [NM_024855] A_33_P3408O47 LOC100289308 PREDICTED: XM_003119817 100289308 hypothetical chr20:2346523 XM_003119817 Hs.589889 Homo sapiens protein 8-23465297 hypothetical protein LOC100289308 LOC100289308 (LOC100289308), mRNA [XM_003119817] A_33_P3318377 ENST00000398049 chr10:1274454 29-127445488 A_23_P159237 GPR20 Homo sapiens G NM_005293 ENST00000377741 2843 G protein- chr8:14236670 GO:0007165|GO:0007186| NM_005293 THC2604553 Hs.188859 protein-coupled coupled 4-142366645 GO:0005886|GO:0005887| receptor 20 (GPR20), receptor 20 GO:0004930|GO:0004872 mRNA [NM_005293] A_33_P3285077 COMMD8 Homo sapiens NM_017845 ENST00000381571 54951 COMM chr4:47455136- GO:0005515 NM_017845 THC2632032 Hs.23956 COMM domain domain 47455077 containing 8 containing 8 (COMMD8), mRNA [NM_017845] A_23_P14493 DNAAF2 Homo sapiens NM_018139 ENST00000298292 55172 dynein, chr14:5009235 GO:0005515|GO:0060286| NM_018139 THC2753351 Hs.231761 dynein, axonemal, axonemal, 1-50092292 GO:0005737|GO:0060285| assembly factor 2 assembly GO:0032526|GO:0070286| (DNAAF2), factor 2 GO:0042221 transcript variant 1, mRNA [NM_018139] A_33_P3335257 TMEM146 Homo sapiens NM_152784 ENST00000381614 257062 transmembrane chr19:5771011- GO:0016020|GO:0016021 NM_152784 THC2478921 Hs.631842 transmembrane protein 146 5771070 protein 146 (TMEM146), mRNA [NM_152784] A_33_P3216438 SPATA21 Homo sapiens NM_198546 ENST00000335496 374955 spermato- chr1:16725197- GO:0005509 NM_198546 THC2485745 Hs.705501 spermatogenesis genesis 16725138 associated 21 associated 21 (SPATA21), mRNA [NM_198546] A_24_P66528 SRP9 Homo sapiens NM_003133 ENST00000366838 6726 signal re- chr1:22597100 GO:0005786|GO:0005515| NM_003133 THC2546497 Hs.511425 signal recognition cognition 9-225971068 GO:0005737|GO:0005785| particle 9 kDa particle GO:0006614|GO:0008312| (SRP9), transcript 9 kDa GO:0005047|GO:0045900 variant 2, mRNA [NM_003133] A_23_P94095 ANKRD46 Homo sapiens NM_198401 ENST00000520311 157567 ankyrin repeat chr8:10153343 GO:0016020|GO:0016021 NM_198401 THC2465801 Hs.700353 ankyrin repeat domain 46 1-101533372 domain 46 (ANKRD46), mRNA [NM_198401] A_23_P358542 KIFC2 Homo sapiens NM_145751 ENST00000301331 90990 kinesin family chr8:14569914 GO:0005515|GO:0000166| NM_145754 THC2464318 Hs.528713 kinesin family member C2 9-145699208 GO:0005874|GO:0003777| member C2 GO:0005524|GO:0007018 (KIFC2), mRNA [NM_145754] A_33_P3255290 JAKMIP2 Homo sapiens NM_014790 ENST00000333010 9832 janus kinase chr5:14699754 GO:0005794 NM_014790 THC2471193 Hs.184323 janus kinase and and micro- 2-146997483 microtubule interacting tubule Protein 2 (JAKMIP2), interacting mRNA [NM_014790] protein 2 A_23_P140384 CTSG Homo sapiens NM_001911 ENST00000216336 1511 cathepsin G chr14:2504284 GO:0005515|GO:0006955| NM_001911 THC2786321 Hs.421724 cathepsin G (CTSG), 7-25042788 GO:0009986|GO:0005886| mRNA [NM_001911] GO:0004252|GO:0006508| GO:0008233|GO:0042742 A_32_P165340 SRP9 Homo sapiens NM_003133 ENST00000366839 6726 signal chr1:22597804 GO:0005786|GO:0005515| NM_003133 THC2549862 Hs.511425 signal recognition recognition 3-225978102 GO:0005737|GO:0005785| particle 9 kDA particle 9 GO:0006614|GO:0008312| (SRP9), transcript kDa GO:0005047|GO:0045900 variant 2, mRNA [NM_003133] A_24_P76854 KRTAP2-1 Homo sapiens NM_001123387 ENST00000391419 81872 keratin chr17:3920300 GO:0045095 NM_001123387 NP307251 Hs.528921 keratin associated associated 4-39202945 Protein 2-1 protein 2-1 (KRTAP2-1), mRNA [NM_001123387] A_23_P166633 ITGB5 Homo sapiens NM_002213 ENST00000460797 3693 integrin, chr3:12448255 GO:0005515|GO:0008305| NM_002213 THC2469552 Hs.536663 integrin, beta 5 beta 5 0-124482491 GO:0007160|GO:0005886| (ITGB5), mRNA GO:0007229|GO:0004872| [NM_002213] GO:0016021|GO:0007155 A_33_P3252414 TH Homo sapiens NM_199292 ENST00000381178 7054 tyrosine chr11:2185218- GO:0005515|GO:0033162| NM_199292 THC2475255 Hs.435609 tyrosine hydroxylase hydroxylase 2185159 GO:0030424|GO:0045471| (TH), transcript GO:0008016|GO:0005634| variant 1, mRNA GO:0048596|GO:0046872| [NM_199292] GO:0005829|GO:0005739| GO:0042418|GO:0005737| GO:0043195|GO:0001963| GO:0043204|GO:0007613| GO:0007626|GO:0007612| GO:0001666|GO:0007617| GO:0009072|GO:0035240| GO:0031410|GO:0048545| GO:0008198|GO:0005790| GO:0008021|GO:0008199| GO:0003007|GO:0004511| GO:0006585|GO:0043473| GO:0042421|GO:0009898| GO:0042755|GO:0042136| GO:0042462|GO:0007601| GO:0016597|GO:0055114 A_33_P3238410 SBF1 Homo sapiens NM_002972 ENST00000356279 6305 SET binding chr22:5089964 GO:0016791|GO:0006470| NM_002972 THC2491636 Hs.589924 SET binding factor factor 1 8-50899589 GO:0005634|GO:0016021| 1 (SBF1), mRNA GO:0008138 [NM_002972] A_33_P3369716 Q9VKG5_DROME ENST00000360485 chr12:6882570 THC2679405 (Q9VKG5) 0-68825641 CG14930-PA (AT28291p), Partial (5%) [THC2679405] A_23_P160849 FCER1G Homo sapiens NM_004106 ENST00000289902 2207 Fc fragment chr1:16118887 GO:0005515|GO:0019863| NM_004106 THC2463219 Hs.433300 fragment of IgE, of IgE, high 5-161188934 GO:0005886|GO:0005887| high affinity 1, affinity 1, GO:0007166|GO:0004888 receptor for; gamma receptor for; Fcpolypeptide (FCER1G), gamma mRNA[NM_004106] polypeptide A_33_P3384229 chr14:0398399 05-039839846 A_23_P376172 C1orf64 Homo sapiens NM_178840 ENST00000329454 149563 chromosome chr1:16332535- NM_178840 NP1140283 Hs.29190 chromosome 1 open 1 open 16332594 reading frame 64 reading frame (C1orf64), mRNA 64 [NM_178840] A_33_P3332052 SLC26A11 Homo sapiens NM_001166347 ENST00000361193 284129 solute carrier chr17:7819965 GO:0008509|GO:0005215| NM_001166347 THC2569879 Hs.4866 solute carrier family family 26, 2-78199711 GO:0005794|GO:0005886| 26, member 11 member 11 GO:0005783|GO:0008272| (SLC26A11), GO:0008271|GO:0016021| transcript variant 1, GO:0015380|GO:0055085| mRNA[NM_001166347] GO:0006811 A_24_P18621 AEBP2 Homo sapiens AE NM_153207 ENST00000435841 121536 AE binding chr12:1967291 GO:0005622|GO:0006355| NM_153207 THC2463191 Hs.126497 binding Protein 2 protein 2 6-19672975 GO:0003714|GO:0008270| (AEBP2), transcript GO:0005634|GO:0003677| variant 1, mRNA GO:0046872|GO:0016568 [NM_153207] A_33_P3348670 LOC100510141 PREDICTED: XM_003120401 100510141 secreted chr3:49034710- XM_003120401 Homo sapiens frizzled- 49034651 secreted frizzled- related related protein 5-like protein (LOC100510141), 5-like mRNA [XM_003120401] A_33_P3423954 CBX2 Homo sapiens NM_032647 ENST00000269399 84733 chromobox chr17:7775588 GO:0031519|GO:0016564| NM_032647 THC2486616 Hs.368410 chromobox homolog homolog 2 9-77755948 GO:0005515|GO:0003682| 2 (CBX2), transcript GO:0016481|GO:0005634| variant 2, mRNA GO:0000122|GO:0003677| [NM_032647] GO:0000785|GO:0016568| GO:0006333 A_33_P3346508 chr14:1045782 89-104578348 A_33_P3413958 OR7E47P Homo sapiens BC042060 ENST00000546390 26628 olfactory chr8:01177767 THC2501952 Hs.524431 olfactory receptor, receptor, 5-011777616 family 7, family 7, subfamily E, subfamily E, member 47 Pseudogene, member 47 mRNA (cDNA clone Pseudogene IMAGE: 5590288). [BC042060] A_33_P3388588 CDNA_FLJ27068 AK130578 ENST00000378340 chr16:8923535 NP852605 Hs.513818 fis, clone SPL01475 2-89235411 [Source: UniProtKB/ TrEMBL; Acc: Q 6ZNV2] [ENST00000378340] A_24_P357847 LOC100510044 immunoglobulin XM_003120829 ENST00000390252 100510044 immuno- chr2:89384737- XM_003120829 NP1170004 Hs.449621 kappA variable 3-15 globulin 89384678 [Source: HGNC Symbol; kappa Acc: 5816] locus-like [ENST00000390252] A_33_P3215422 LYL1 Homo sapiens NM_005583 ENST00000264824 4066 lymphoblastic chr19:1321153 GO:0030528|GO:0005634| NM_005583 THC2700985 Hs.46446 lymphoblastic leukemia leukemia 8-13211479 GO:0003677|GO:0045449 derived sequence 1 derived (LYL1), mRNA sequence 1 [NM_005583] A_23_P24004 IFIT2 Homo sapiens NM_001547 ENST00000371826 3433 interferon- chr10:9106839 GO:0008150|GO:0005488| NM_001547 THC2463173 Hs.437609 interferon-induced induced 7-91068456 GO:0005575 protein with tetra- protein with tricopeptide repeats 2 tetratricopep- (IFIT2), mRNA tide [NM_001547] repeats 2 A_33_P3276758 chr16:0330707 39-033070798 A_23_P24365 ANKRD49 Homo sapiens NM_017704 ENST00000302755 54851 ankyrin repeat chr11:9423250 NM_017704 THC2464810 Hs.29052 ankyrin repeat domain 49 1-94232560 domain 49 (ANKRD49), mRNA [NM_017704] A_33_P3410895 POR P450 (cytochrome) ENST00000421059 5447 P450 (cyto- chr7:75544784- THC2629558 oxidoreductase [Source: chrome) 75544843 HGNC Symbol; oxidoreductase Acc: 9208] [ENST00000421059] A_24_P361643 C19orf55 Homo sapiens NM_001039887 ENST00000544158 148137 chromosome chr19:3625969 NM_001039887 THC2475926 Hs.527982 chromosome 19 open 19 open 6-36259755 reading frame 55 reading (C19orf55), mRNA frame 55 [NM_001039887] A_33_P3216938 AMPD3 adenosine mono- EF537581 ENST00000527261 272 adenosine chr11:1033013 Hs.501890 phosphate deaminase monophosphate 6-10330195 3 [Source: HGNC deaminase 3 Symbol; Acc: 470] [ENST00000527261] A_33_P3352687 LOC100133161 Homo sapiens NR_028326 ENST00000450789 100133161 hypothetical chr11:128915- NR_028326 THC2531619 Hs.512417 hypothetical LOC100133161 128856 LOC100133161 (LOC100133161), non-coding RNA [NR_028326] A_33_P3399985 immunoglobulin AJ272081 ENST00000462693 chr2:90044286- NP1474898 Hs.535593 kappa variable 90044345 2D-24 (non-functional) [Source: HGNC Symbol; Acc: 5797] [ENST00000462693] A_23_P84596 MZB1 Homo sapiens NM_016459 ENST00000503351 51237 marginal zone chr5:13872360 GO:0005737|GO:0006915| NM_016459 THC2605618 Hs.409563 marginal zone B B and B1 cell- 2-138723543 GO:0005576 and B1 cell-specific specific protein protein (MZB1), mRNA [NM_016459] A_33_P3379454 UHRF1 Homo sapiens NM_013282 ENST00000543616 29128 ubiquitin-like chr19:4960895- GO:0005515|GO:0003700| NM_013282 THC2462675 Hs.108106 ubiquitin-like with with PHD 4960954 GO:0006357|GO:0003702| PHD and ring and ring finger GO:0008283|GO:0016874| finger domains 1 domains 1 GO:0005634|GO:0046872| (UHRF1), GO:0006974|GO:0007049| transcript variant 2, GO:0006281|GO:0019941| mRNA [NM_013282] GO:0008270|GO:0045449 A_33_P3215112 C2CD4C Homo sapiens C2 NM_001136263 ENST00000332235 126567 C2 calcium- chr19:405567- NM_001136263 THC2615089 Hs.223770 calcium-dependent dependent 405508 domain containing 4C domain (C2CD4C), mRNA containing 4C [NM_001136263] A_23_P117380 FAM181A Homo sapiens NM_138344 ENST00000267594 90050 family with chr14:9439578 NM_138344 THC2478030 Hs.525550 family with sequence sequence 4-94395843 similarity 181, similarity 181, member A (FAM181A), member A transcript variant 1, mRNA [NM_138344] A_23_P56288 LENG8 Homo sapiens NM_052925 ENST00000542665 114823 leukocyte chr19:5497292 GO:0005515 NM_052925 NP1402212 Hs.502378 leukocyte receptor receptor 2-54972981 cluster (LRC) cluster member 8 (LENG8), (LRC) mRNA [NM_052925] member 8 A_33_P3235491 chr22:0298777 03-029877644 A_33_P3211327 LOC100130348 Uncharacterized protein AK124141 ENST00000334821 100130348 hypothetical chr11:6485616 THC2626263 Hs.98170 [Source: UniProtKB/ LOC100130348 3-64856104 TrEMBL; Acc: E9PME8] [ENST00000334821] A_33_P3233869 Homo sapiens, BC043411 ENST00000437267 chr1:14318413 THC2493596 Hs.446446 clone IMAGE: 7-143184078 6155889, mRNA. [BC043411] A_33_P3321793 UI-CF-EC1-abx-d-10- BM973477 chr17:5024626- Hs.681925 0-UI.sl UI-CF-EC1 5024685 Homo sapiens cDNA clone UI-CF-EC1-abx-d-10- O-UI 3′, mRNA sequence [BM973477] A_33_P3273364 YIPF2 Homo sapiens NM_024029 ENST00000253031 78992 Yip1 domain chr19:1103378 GO:0030133|GO:0016020| NM_024029 THC2462992 Hs.720136 Yip1 domain family, family, 4-11033725 GO:0016021 member 2 (YIPF2), member 2 mRNA [NM_024029] A_24_P330385 SLC22A17 Homo sapiens NM_016609 ENST00000474774 51310 solute carrier chr14:2381680 GO:0005215|GO:0016020| NM_016609 THC2735825 Hs.373498 solute carrier family family 22, 8-23816749 GO:0016021|GO:0055085| 22, member 17 member 17 GO:0006811 (SLC22A17), transcript variant 2, mRNA [NM_016609] A_33_P3248602 DUX4 Homo sapiens NM_033178 ENST00000507734 22947 double chrUn_gl00022 GO:0043565|GO:0006355| NM_033178 THC2493180 Hs.553518 double homeobox 4 homeobox A 8:77296-77355 GO:0003700|GO:0005634 (DUX4), mRNA [NM_033178] A_24_P368943 EVX1 Homo sapiens even- NM_001989 ENST00000496902 2128 even-skipped chr7:27285959- GO:0043565|GO:0006355| NM_001989 THC2484995 Hs.369879 skipped homeobox 1 homeobox 1 27286018 GO:0003700|GO:0045944| (EVX1), mRNA GO:0007275|GO:0005634| [NM_001989] GO:0009792|GO:0021913 A_24_P319640 LOC151534 Homo sapiens NR_024606 151534 hypothetical chr2:74731712- NR_024606 THC2475501 Hs.516124 hypothetical LOC151534 74731771 LOC151534 (LOC151534), non-coding RNA [NR_024606] A_23_P41987 GFRA3 Homo sapiens NM_001496 ENST00000378362 2676 GDNF family chr5:13758839 GO:0005886|GO:0005102| NM_001496 THC2473100 Hs.58042 GDNF family receptor 5-137588336 GO:0031225|GO:0048485| receptor alpha 3 alpha 3 GO:0007165|GO:0007411| (GFRA3), mRNA GO:0048666|GO:0007422| [NM_001496] GO:0004872|GO:0001764| GO:0008046|GO:0009897| GO:0019898 A_33_P3577120 Homo sapiens BC033227 chr16:2032527- THC2642808 Hs.620382 hypothetical protein 2032586 LOC283868, mRNA (cDNA clone IMAGE: 5089285), partial cds. [BC033227] A_33_P3329104 chr19:0078066 44-007806703 A_23_P336198 GLCCI1 Homo sapiens NM_138426 ENST00000482540 113263 glucocorticoid chr7:8128578- GO:0005515|GO:0005737 NM_138426 THC2601241 Hs.131673 glucocorticoid induced induced 8128637 transcript 1 transcript 1 (GLCCI1), mRNA [NM_138426] A_24_P418203 CNTNAP3 Homo sapiens NM_033655 ENST00000323947 79937 contactin chr9:39171403- GO:0007165|GO:0008037| NM_033655 THC2569253 Hs.658328 contactin associated associated 39166052 GO:0005886|GO:0005102| protein-like 3 protein-like 3 GO:0005576|GO:0016021| (CNTNAP3), mRNA GO:0007155 [NM_033655] A_33_P3398719 immunoglobulin ENST00000390293 chr22:2270758 NP186136 lambda variable 5-48 1-22707640 (non-functional) [Source: HGNC Symbol; Acc: 5925] [ENST00000390293] A_23_P51711 CELA2B Homo sapiens NM_015849 ENST00000488764 51032 chymotrypsin- chr1:15813857 GO:0004252|GO:0006508| NM_015849 THC2462641 Hs.631871 chymotrypsin-like like elastase 15813916 GO:0008233|GO:0005576 elastase family, family, member 2B member 2 (CELA2B), mRNA [NM_015849] A_33_P3248137 OLFML2A Homo sapiens NM_182487 ENST00000342100 169611 olfactomedin- chr9:12757263 GO:0031012|GO:0016020| NM_182487 THC2738863 Hs.357004 olfactomedin-like 2A like 2A 2-127572691 GO:0030198|GO:0050840| (OLFML2A), mRNA GO:0005576|GO:0042803 [NM_182487] A_24_P72750 SPIN1 Homo sapiens NM_006717 ENST00000375859 10927 spindlin 1 chr9:91093209- GO:0007049|GO:0007276| NM_006717 THC2517348 Hs.146804 spindlin 1 (SPIN1), 91093268 GO:0005819|GO:0007275| mRNA [NM_006717] GO:0005634 A_23_P372368 NCRNA00257 Homo sapiens NR_033800 257357 non-protein chr21:4068649 NR_033800 THC2478660 Hs.729612 non-protein coding coding RNA 8-40686439 RNA 257 257 (NCRNA00257), non-coding RNA [NR_033800] A_33_P3369146 ATP2B3 Homo sapiens NM_001001344 ENST00000393842 492 ATPase, Ca++ chrX:15282762 GO:0005516|GO:0000287| NM_001001344 THC2478163 Hs.533956 ATPase, Ca++ transporting, 3-152827682 GO:0005794|GO:0005886| transporting, plasma plasma GO:0005509|GO:0005524| membrane 3 membrane 3 GO:0005388|GO:0006754| (ATP2B3), transcript GO:0016787|GO:0000166| variant 2, mRNA GO:0008152|GO:0016820| [NM_001001344] GO:0006816|GO:0016021| GO:0006812 A_33_P3712341 CXCL12 Homo sapiens NM_001033886 ENST00000374426 6387 chemokine chr10:4488045 GO:0008009|GO:0008015| NM_001033886 NP1463957 Hs.522891 chemokine (C-X-C (C-X-C motif) 3-44880394 GO:0006874|GO:0005576| motif) ligand 12 ligand 12 GO:0009615|GO:0005615| (CXCL12), transcript GO:0007165|GO:0006955| variant 3, mRNA GO:0006935|GO:0007186| [NM_001033886] GO:0008064|GO:0090026| GO:0004871|GO:0007155| GO:0008083 A_23_P41166 B3GALNT1 Homo sapiens NM_001038628 ENST00000392781 8706 beta-1,3- chr3:16080234 GO:0009312|GO:0005794| NM_001038628 THC2490103 Hs.418062 beta-1,3-N-acetyl- N-acetyl- 8-160802289 GO:0000287|GO:0016020| galactosaminyltrans- galactosam GO:0016757|GO:0008499| ferase 1 (globoside inyltransferase GO:0006486|GO:0016021| blood group) 1 (globo- GO:0047273|GO:0008378 (B3GALNT1), side blood- transcript variant 5, group) mRNA [NM_001038628] A_33_P3377763 FLJ36000 Homo sapiens NR_027084 ENST00000468381 284124 hypothetical chr17:2190948 NR_027084 THC2595453 Hs.514016 hypothetical FLJ36000 7-21909546 FLJ36000 (FLJ36000), non-coding RNA [NR_027084] A_33_P3346461 NLR family, XM_003118467 ENST00000504546 chr5:68919510- XM_003118467 THC2688955 Hs.710305 apoptosis inhibitory 68919569 protein [Source: HGNC Symbol; Acc: 7634] [ENST00000508794] A_33_P3619221 ZMYND8 Homo sapiens NM_183047 ENST00000461685 23613 zinc finger, chr20:4583949 GO:0005515|GO:0008270| NM_183047 NP1154284 Hs.446240 zinc finger, MYND- MYND-type 1-45839432 GO:0046872 type containing 8 containing 8 (ZMYND8), transcript variant 1, mRNA [NM_183047] A_33_P3384710 C17orf63 Homo sapiens NM_018182 ENST00000341217 55731 chromosome 17 chr17:2708534 NM_018182 THC2461997 Hs.564533 chromosome 17 open reading 7-27085288 open reading frame frame 63 63 [C17orf63], transcript variant 2, mRNA [NM_018182] A_24_P54178 TMED5 Homo sapiens NM_016040 ENST00000370290 50999 transmembrane chr1:93617749- GO:0005793|GO:0016020| NM_016040 THC2578839 Hs.482873 transmembrane emp24 emp24 protein 93617690 GO:0005783|GO:0006810| protein transport transport GO:0016021 domain containing 5 domain (TMED5), containing 5 transcript variant 1, mRNA [NM_016040] A_33_P3354935 CSF1 Homo sapiens NM_172212 ENST00000369802 1435 colony chr1:11046930 GO:0005515|GO:0048471| NM_172212 Hs.591402 colony stimulating factor stimulating 2-110469361 GO:0008284|GO:0005886| 1 (macrophage) factor 1 GO:0005157|GO:0046579| (CSF1), transcript (macrophage) GO:0005615|GO:0030154| variant 4, mRNA GO:0042803|GO:0048873| [NM_172212] GO:0030278|GO:0045657| GO:0045860|GO:0042476| GO:0040018|GO:0030097| GO:0030335|GO:0010744| GO:0045672|GO:0005576| GO:0045651|GO:0005125| GO:0010628|GO:0043235| GO:0003006|GO:0032270| GO:0032946|GO:0042117| GO:0016021|GO:0008083| GO:0042488|GO:0001954 A_33_P3322945 SPDYC Homo sapiens NM_001008778 ENST00000377185 387778 speedy chr11:6494040 GO:0007049|GO:0019901| NM_001008778 THC2607520 Hs.450642 speedy homolog C homolog C 5-64940464 GO:0005634 (Xenopus laevis) (Xenopus (SPDYC), mRNA laevis) [NM_001008778] A_24_P419028 MOP-1 Homo sapiens AB014771 643616 MOP-1 chr4:82390257- NP373383 Hs.679418 mRNA for MOP-1, 82390198 complete cds. [AB014771] A_33_P3371144 chr17:0794548 68-079454809 A_24_P273865 MED20 Homo sapiens NM_004275 ENST00000467535 9477 mediator chr6:41873366- GO:0005515|GO:0006357| NM_004275 THC2624422 Hs.278434 mediator complex complex 41873307 GO:0003899|GO:0016592| subunit 20 (MED20), subunit 20 GO:0005634|GO:0016455| mRNA [NM_004275] GO:0045449 A_23_P134935 DUSP4 Homo sapiens NM_001394 ENST00000240100 1846 dual specificity chr8:29194441- GO:0010033|GO:0006470| NM_001394 THC2466297 Hs.417962 dual specificity phosphatase 4 29194382 GO:0016787|GO:0000165| phosphatase 4 (DUSP4), GO:0008330|GO:0005654| transcript variant 1, GO:0005634|GO:0017017| mRNA [NM_001394] GO:0004725 A_33_P3247473 KRTAP23-1 Homo sapiens NM_181624 ENST00000334160 337963 keratin ass- chr21:3172090 GO:0005882|GO:0003824 NM_181624 NP815333 Hs.553688 keratin associated ociated pro- 6-31720847 protein 23-1 tein 23-1 (KRTAP23-1), mRNA [NM_181624] A_33_P3345132 ZNF578 Homo sapiens NM_001099694 147660 zinc finger chr19:5301931 GO:0005622|GO:0008270| NM_001099694 THC2742978 Hs.157287 zinc finger protein protein 578 9-53019378 GO:0005634|GO:0003677| 578 (ZNF578), GO:0046872|GO:0045449 mRNA [NM_001099694] A_32_P100830 KIF19 Homo sapiens NM_153209 ENST00000389916 124602 kinesin family chr17:7235187 GO:0000166|GO:0005874| NM_153209 THC2686967 Hs.372773 kinesin family member 19 8-72351937 GO:0003777|GO:0005524| member 19 (KIF19), GO:0007018 mRNA [NM_153209] A_33_P3350259 FAM129C Homo sapiens NM_001098524 ENST00000352727 199786 family with chr19:1765294 NM_001098524 NP814710 Hs.434133 family with sequence sequence 6-17653005 similarity 129, similarity 129, member C member C (FAM129C), transcript variant 2, mRNA [NM_001098524] A_33_P3318646 CALY Homo sapiens NM_015722 ENST00000467611 50632 calcyon neu- chr10:1351389 GO:0045807|GO:0005886| NM_015722 THC2647449 Hs.148680 calcyon neuron- ron-specific 91-135138932 GO:0032051|GO:0005887| specific vesicular vesicular GO:0031410|GO:0097212| protein (CALY), protein GO:0050780|GO:0048268 mRNA[NM_015722] A_33_P3419970 NPB Homo sapiens NM_148896 ENST00000333383 256933 neuropeptide chr17:7986071 GO:0005515|GO:0001664| NM_148896 Hs.708916 neuropeptide B B 7-79860776 GO:0007218|GO:0005576 (NPB), mRNA [NM_148896] A_23_P14564 GPR65 Homo sapiens G NM_003608 ENST00000267549 8477 G protein- chr14:8847802 GO:0007165|GO:0006955| NM_003608 THC2476461 Hs.443243 protein-coupled coupled 5-88478084 GO:0007186|GO:0005886| receptor 65 receptor 65 GO:0005887|GO:0004930| (GPR65), mRNA GO:0006915|GO:0007275| [NM_003608] GO:0004872 A_23_P391857 ESRRB Homo sapiens NM_004452 ENST00000261532 2103 estrogen-related chr14:7696625 GO:0043565|GO:0006355| NM_004452 THC2489574 Hs.435845 estrogen-related receptor beta 6-76966315 GO:0003700|GO:0003707| receptor beta (ESRRB), GO:0008270|GO:0005634| mRNA [NM_004452] GO:0005496|GO:0046872 A_33_P3220105 LOC644246 Homo sapiens NR_034172 ENST00000398275 644246 hypothetical chr17:4427104 NR_034172 THC2648285 Hs.644600 hypothetical LOC644246 4-44271103 LOC644246 (LOC644246), non-coding, RNA [NR_034172] A_32_P82623 AGBL3 Homo sapiens NM_178563 ENST00000359383 340351 ATP/GTP chr7:13467406 GO:0005737|GO:0006508| NM_178563 THC2636775 Hs.648616 ATP/GTP binding binding 1-134678302 GO:0008270|GO:0008233| protein-like 3 protein-like 3 GO:0046872|GO:0008237| (AGBL3), mRNA GO:0004181 [NM_178563] A_24_P191417 NAB1 Homo sapiens NM_005966 ENST00000337386 4664 NGFI-A chr2:19155709 GO:0016564|GO:0014037| NM_005966 THC2620109 Hs.730686 NGFI-A binding protein binding 5-191557154 GO:0006355|GO:0001958| 1 (EGR1 binding protein 1 GO:0005794|GO:0005886| protein 1) (NAB1), (EGR1 GO:0042552|GO:0045682| mRNA [NM_005966] binding GO:0016481|GO:0005634 protein 1) A_33_P3237552 FIBCD1 Homo sapiens NM_032843 ENST00000253018 84929 fibrinogen C chr9:13377939 GO:0007165|GO:0016020| NM_032843 THC2474476 Hs.133205 fibrinogen C domain domain 4-133779335 GO:0005102|GO:0016021| containing 1 containing 1 GO:0005615 (FIBCD1), transcript variant 1, mRNA [NM_032843] A_33_P3325547 C10orf53 Homo sapiens NM_182554 ENST00000535836 282966 chromosome 10 chr10:5091688 NM_182554 THC2486180 Hs.131287 chromosome 10 open reading 3-50916942 open reading frame frame 53 53 (C10orf53), transcript variant 1, mRNA [NM_182554] A_33_P32688167 chr10:0824199 55-082420014 A_33_P3351836 C2orf73 chromosome 2 ENST00000414747 129852 chromosome 2 chr2:54610272- THC2774850 open reading frame open reading 54610331 73 [Source: HGNC frame 73 2 Symbol; Acc: 26861] [ENST00000414747] A_33_P3285754 chr9:09044080 4-090440863 A_33_P3360823 C10orf88 Homo sapiens NM_024942 ENST00000481909 80007 chromosome chr10:1246911 NM_024942 THC2471563 Hs.501286 chromosome 10 10 open 39-124691080 open reading frame reading 88 (C10orf88), frame 88 mRNA [NM_024942] A_33_P3359250 MAD2L2 MAD2 mitotic arrest ENST00000376664 10459 MAD2 mitotic chr1:11735986- NP1247987 deficient-like 2 arrest deficient- 11735927 (yeast) [Source: HGNC like 2 (yeast) Symbol; Acc: 6764] [ENST00000376664] A_23_P410507 PSPN Homo sapiens NM_004158 ENST00000245810 5623 persephin chr19:6375594- GO:0001658|GO:0005576| NM_004158 THC2530481 Hs.248159 persephin (PSPN), 6375535 GO:0007417|GO:0008083| mRNA [NM_004158] GO:0005615 A_33_P3311750 CCDC144A Homo sapiens NM_014695 ENST00000456009 9720 coiled-coil chr17:1663884 NM_014695 THC2478811 Hs.721149 coiled-coil domain domain con- 4-16638903 containing 144A taining 144A (CCDC144A), mRNA [NM_014695] A_23_P29153 RTDR1 Homo sapiens NM_014433 ENST00000216036 27156 rhabdoid tumor chr22:2340166 GO:0008150|GO:0005488| NM_014433 THC2476489 Hs.526920 rhabdoid tumor deletion region 8-23401609 GO:0005575 deletion region gene gene 1 1 (RTDR1), mRNA [NM_014433] A_33_P3424591 immunoglobulin CR611254 ENST00000390549 chr14:1062078 NP232832 Hs.510635 heavy constant 69-106207810 gamma 1 (G1m marker) [Source: HGNC Symbol; Acc: 5525] [ENST00000390549] A_23_P76488 EMP1 Homo sapiens NM_001423 ENST00000256951 2012 epithelial chr12:1336956 GO:0008544|GO:0005886| NM_001423 THC2465394 Hs.719042 epithelial membrane membrane 2-13369621 GO:0008283|GO:0030855| protein 1 (EMP1), protein 1 GO:0016049|GO:0005624| mRNA [NM_001423] GO:0007275|GO:0016021 A_33_P3278033 TUSC1 Homo sapiens NM_001004125 ENST00000358022 286319 tumor Chr9:25677740- NM_001004125 THC2472152 Hs.26268 tumor suppressor suppressor 25677681 candidate 1 candidate 1 (TUSC1), mRNA [NM_001004125] A_23_P167168 IGJ Homo sapiens NM_144646 ENST00000254801 3512 immunoglo- chr4:71521933- GO:0006955|GO:0005576| NM_144646 THC2469801 Hs.643431 immunoglobulin bulin J 71521874 GO:0003823 J polypeptide, linker polypeptide, protein for immuno- linker protein globulin alpha and for immuno- mu polypeptides (IGJ), globulin alpha mRNA [NM_144646] and mu polypeptides A_33_P3360728 BLVRB Homo sapiens NM_000713 ENST00000263368 645 biliverdin chr19:4095376 GO:0050662|GO:0005737| NM_000713 THC2468607 Hs.515785 biliverdin reductase reductase 0-40953701 GO:0042602|GO:0005488| B (flavin reductase B (flavin GO:0004074|GO:0016491| (NADPH)) reductase GO:0044237|GO:0055114 (BLVRB), mRNA (NADPH)) [NM_000713] A_33_P3329419 DNM1 Homo sapiens NM_004408 ENST00000475805 1759 dynamin 1 chr9:13101315 GO:0005515|GO:0005737| NM_004408 THC2563095 Hs.522413 dynamin 1 (DNM1), 8-131013217 GO:0003774|GO:0016787| transcript variant 1, GO:0000166|GO:0005874| mRNA [NM_004408] GO:0003924|GO:0005856| GO:0005525|GO:0006898 A_33_P3395209 chr15:0322013 16-032201257 A_33_P3239854 ALKBH5 Homo sapiens alkB, NM_017758 ENST00000261650 54890 alkB, chr17:1811175 GO:0016020|GO:0016021 NM_017758 THC2510263 Hs.730752 alkylation repair alkylation 4-18111813 homolog 5 (E. coli) repair homolog (ALKBH5), 5 (E. coli) mRNA [NM_017758] A_33_P3345474 Homo sapiens, BC036832 ENST00000381051 chr22:4650150 THC2609961 clone IMAGE: 1-46501560 3890870, mRNA. [BC036832] A_33_P3217218 AGPAT5 Homo sapiens 1-acyl- NM_018361 55326 l-acylglycerol- chr8:6618891- GO:0005739|GO:0016020| NM_018361 THC2603763 Hs.624002 glycerol-3-phosphate 3-phosphate 6618950 GO:0008152|GO:0016021| O-acyltransferase O-acyl-trans- GO:0008654|GO:0005575| 5 (lysophosphatidic ferase 5(lyso- GO:0003841|GO:0046027| acid acyltransferase, phosphatidic GO:0016740|GO:0008415| epsilon) (AGPAT5), acid acyltrans- GO:0005829 mRNA [NM_018361] ferase, epsilon) A_23_P7074 C4orf14 Homo sapiens NM_032313 ENST00000264230 84273 chromosome chr4:57829743- GO:0005622|GO:0005743| NM_032313 THC2509962 Hs.8715 chromosome 4 4 open reading 57829684 GO:0005525 open reading frame frame 14 14 (C4orf14), mRNA [NM_032313] A_33_P3394203 YIPF3 Yip1 domain family, ENST00000372417 25844 Yip1 domain chr6:43481455- THC2559426 member 3 [Source: family, 43481396 HGNC Symbol; member 3 Acc: 21023] [ENST00000372417] A_33_P3271171 CNOT3 CCR4-NOT AL133647 ENST00000358389 4849 CCR4-NOT chr19:5465707 THC2755730 transcription complex, transcription 0-54657129 subunit 3 [Source: complex, HGNC Symbol; subunit 3 Acc: 7879] [ENST00000358389] A_33_P3314231 CRYBA2 Homo sapiens NM_005209 ENST00000295728 1412 crystallin, chr2:21985497 GO:0008150|GO:0003674| NM_005209 THC2464517 Hs.415790 crystallin, beta beta A2 6-219854917 GO:0005212|GO:0005575| A2 (CRYBA2), GO:0042803 transcript variant 1, mRNA [NM_005209] A_33_P3422248 nae18g06.xl BF733045 chr18:5895116- THC2703203 Hs.650086 NCI_CGAP_Ov18 5895057 Homo sapiens cDNA clone IMAGE: 3435827 3′similar to contains Alu repetitive element;, mRNA sequence [BF733045] A_33_P3251205 immunoglobulin AF194657 ENST00000390316 chr22:2316202 NP078180 Hs.449585 lambda variable 2-23162081 3-9 (gene/pseudogene) [Source: HGNC Symbol; Acc: 5918] [ENST00000390316] A_33_P3222139 SREBF1 Homo sapiens sterol NM_001005291 ENST00000338854 6720 sterol regula- chr17:1771536 GO:0005515|GO:0006629| NM_001005291 THC2507720 Hs.592123 regulatory element tory element 3-17715304 GO:0003700|GO:0005794| binding transcription binding GO:0006357|GO:0032810| factor 1 (SREBF1), transcription GO:0003702|GO:0005783| transcript variant 1, factor 1 GO:0005634|GO:0031410| mRNA GO:0005635|GO:0016020| [NM_001005291] GO:0005789|GO:0016021| GO:0045449|GO:0008202| GO:0008203|GO:0009267 A_32_P221305 LOC389634 Homo sapiens NR_024420 ENST00000420040 J89634 hypothetical chr12:8509646- NR_024420 THC2545092 Hs.434403 hypothetical non-coding LOC389634 8509587 LOC389634 (LOC389634), RNA [NR_024420] A_33_P3318444 RNF222 Homo sapiens ring NM_001146684 ENST00000399398 643904 ring finger chr17:8296576- GO:0005515|GO:0016020| NM_001146684 Hs.526550 finger protein 222 protein 222 8296517 GO:0008270|GO:0016021| (RNF222), mRNA GO:0046872 [NM_001146684] A_23_P501822 JUP Homo sapiens NM_002230 ENST00000547817 3728 junction chr17:3991120 GO:0030057|GO:0008092| NM_002230 THC2754348 Hs.514174 junction plakoglobin plakoglobin 9-39911150 GO:0030018|GO:0042153| (JUP), transcript GO:0019901|GO:0005886| variant 1, mRNA GO:0019903|GO:0005624| [NM_002230] GO:0005625|GO:0015629| GO:0051291|GO:0016328| GO:0016327|GO:0005829| GO:0005916|GO:0005737| GO:0016337|GO:0005198| GO:0009898|GO:0019898 A_33_P3266848 Q8NH44_HUMAN chr12:0489543 THC2605882 (Q8NH44) Seven 72-048954431 transmembrane helix receptor, complete [THC2605882] A_33_P3321225 ENST00000433238 chr20:3514107 1-35141012 A_33_P3270360 OR1S1 Homo sapiens NM_001004458 ENST00000309433 219959 olfactory recep- chr11:5798299 GO:0007608|GO:0007165| NM_001004458 Hs.553645 olfactory receptor, tor, family 1, 3-57983052 GO:0004984|GO:0007186| family 1, subfamily S, GO:0005886|GO:0004872| subfamily S, member 1 GO:0016021|GO:0050896 member 1 (OR1S1), mRNA [NM_001004458] A_33_P3245160 GB chr17:0030573 NP511209 72-003057313 A_33_P3274164 DOT1L DOT1-like, histone AB058717 ENST00000221482 84444 DOT1-like, chr19:2228287- THC2541364 Hs.713641 H3 methyltransferase histone H3 2228346 (S. cerevisiae) methyltrans- [Source: HGNC ferase Symbol; Acc: 24948] (S. cerevisiae) [ENST00000221482] A_23_P78734 MYH14 Homo sapiens NM_001077186 ENST00000440075 79784 myosin, heavy chr19:5081331 GO:0005516|GO:0003774| NM_001077186 NP861691 Hs.467142 myosin, heavy chain chain 14, 7-50813376 GO:0000166|GO:0008360| 14, non-muscle non-muscle GO:0003779|GO:0016459| (MYH14), transcript GO:0005524 variant 1, mRNA [NM_001077186] A_23_P111517 WBSCR17 Homo sapiens NM_022479 ENST00000467723 64409 Williams- chr7:71177978- GO:0004653|GO:0030145| NM_022479 THC2491805 Hs.488591 Williams-Beuren Beuren 71178037 GO:0005794|GO:0016020| syndrome chromosome syndrome GO:0016757|GO:0005509| region 17 (WBSCR17), chromosome GO:0005529|GO:0016021 mRNA [NM_022479] region 17 A_33_P3399474 ARP3_BOVIN chr2:11464727 THC2499666 (P61157) Actin- 8-114647337 like protein 3 (Actin-related protein 3) (Actin-2), partial (58%) [THC2499666] A_32_P52785 DAAM2 Homo sapiens NM_015345 ENST00000398904 23500 dishevelled chr6:39872302- GO:0030036|GO:0017048| NM_015345 THC2495474 Hs.357128 dishevelled associated associated 39872361 GO:0003779|GO:0016043 activator of morpho- activator genesis 2 (DAAM2), of morpho- transcript variant 2, genesis 2 mRNA [NM_015345] A_24_P374319 RAP2C Homo sapiens NM_021183 ENST00000342983 57826 RAP2C, chrX:13133803 GO:0005622|GO:0007165| NM_021183 THC2493165 Hs.119889 RAP2C, member member of 7-131337978 GO:0005886|GO:0000166| of RAS oncogene RAS oncogene GO:0007264|GO:0003924| family (RAP2C), family GO:0005525 mRNA [NM_021183] A_33_P3285470 BAI1 Homo sapiens NM_001702 ENST00000323289 575 brain specific chr8:14362628 GO:0005515|GO:0008285| NM_001702 THC2700493 Hs.194654 brain-specific angio- angiogenesis 7-143626346 GO:0005886|GO:0016527| genesis inhibitor 1 inhibitor 1 GO:0007218|GO:0005911| (BAI1), mRNA GO:0005887|GO:0007422| [NM_001702] GO:0007409|GO:0007155 A_23_P319133 DNAJC10 Homo sapiens NM_018981 ENST00000264065 54431 DnaJ (Hsp40) chr2:18364307 GO:0006457|GO:0005783| NM_018981 THC2485027 Hs.516632 DnaJ (Hsp40) homolog, homolog, 5-183643134 GO:0031072|GO:0005788| subfamily C, member subfamily C, GO:0045454|GO:0005576| 10 (DNAJC10), member 10 GO:0051082 mRNA [NM_018981] A_23_P353574 NEK7 Homo sapiens NM_133494 ENST00000493790 140609 NIMA (never chr1:19828867 GO:0005515|GO:0005737| NM_133494 THC2475637 Hs.728964 NIMA (never in in mitosis 4-198288733 GO:0000287|GO:0000166| mitosis gene a)- gene a)-related GO:0004674|GO:0006468| related kinase 7 kinase 7 GO:0005524|GO:0016740 (NEK7), mRNA [NM_133494] A_32_P218228 FAM109B Homo sapiens NM_001002034 ENST00000321753 150368 family with chr22:4247475 NM_001002034 THC2602221 Hs.368312 family with sequence 4-42474813 sequence similarity similarity 109, 109, member B member B (FAM109B), mRNA [NM_001002034] A_33_P3348046 PREDICTED: XM_001127670 chr1:22010994 XM_001127670 Homo sapiens 8-220109889 similar to hCG1985805 (LOC728528), mRNA [XM_001127670] A_33_P3428642 DMWD Homo sapiens NM_004943 ENST00000270223 1762 dystrophia chr19:4628741- GO:0003674|GO:0007126| NM_004943 THC2474876 Hs.515474 dystrophia myotonica, myotonica, 946287360 GO:0005575 WD repeat containing WD repeat (DMWD), mRNA containing [NM_00943] A_33_P3328123 LOC100127919 PREDICTED: XM_001719900 100127919 developmental chr12:9342916 XM_001719900 Homo sapiens pluripotency- 6-93429225 developmental associated pluripotency-associated protein 3 protein 3 like pseudogene (LOC100127919), mRNA [XM_001719900] A_33_P3404123 KRTAP9-7 keratin associated XM_003120879 ENST00000391154 1005057211 keratin associ- chr17:3943227 GO:0045095 XM_003120879 protein 9-7 [Source: ated protein 4-39432 333 HGNC Symbol; 9-7 Acc: 18915] [ENST00000391354] A_33_P3369667 LOC100288549 PREDICTED: XR_110595 100288549 hypothetical chr15:8276769 XR_110595 THC2491431 Homo sapiens LOC100288549 4-82767753 hypothetical LOC100288549 (LOC100288549), partial miscRNA [XR_110595] A_33_P3367396 FAM177B Homo sapiens NM_207408 ENST00000360827 400823 family with chr1:22292347 NM_207468 THC2482628 Hs.697608 family with sequence sequence 9-222923538 similarity 177, similarity 177, member B (FAM177B), member B mRNA [NM_207468] A_33_P3221114 JAKMIP1 Homo sapiens NM_144720 ENST00000409831 152789 janus kinase chr4:6055837- GO:0005737|GO:0016020| NM_144720 NP498568 Hs.479066 janus kinase and and microtu- 6055778 GO:0030529|GO:0003723| microtubule interacting bule interacting GO:0005874|GO:0050811| protein 1 (JAKMIP1), protein 1 GO:0015031|GO:0005856| transcript variant 2, GO:0019898|GO:0000300 mRNA [NM_144720] A_33_P3245066 SLC35E2B Homo sapiens NM_001110781 ENST00000480991 728661 solute carrier chr1:1595787- GO:0016020|GO:0016021 NM_001110781 THC2514091 Hs.655255 solute carrier family family 35, 1595728 35, member E2B member E2B (SLC35E2B), mRNA [NM_001110781] A_33_P3329444 MAMSTR Homo sapiens NM_182574 ENST00000356751 284358 MEF2 acti- chr19:4921631 GO:0005634|GO:0003676| NM_182574 THC2487203 Hs.191815 MEF2 activating motif vating motif 5-49216256 GO:0045449 and SAP domain and SAP domain containing transcriptional containing regulator (MAMSTR), transcriptional transcript variant 2, regulator mRNA [NM_182574] A_23_P201979 CREM Homo sapiens NM_183013 ENST00000460270 1390 cAMP chr10:3550124 GO:0005667|GO:0006355| NM_183013 THC2478984 Hs.200250 cAMP responsive responsive 2-35501301 GO:0003700|GO:0006687| element modulator element GO:0005634|GO:0007275| (CREM), transcript modulator GO:0007283|GO:0030154| variant 19, mRNA GO:0048384|GO:0043565| [NM_183013] GO:0007165|GO:0008140| GO:0046983|GO:0006631| GO:0006006|GO:0042752 A_23_P71513 EFR3A Homo sapiens NM_015137 ENST00000407309 23167 EFR3 homolog chr8:13302515 GO:0005886|GO:0005488 NM_015137 THC2603295 Hs.204564 EFR3 homolog A A 7-133025216 (S. cerevisiae) (EFR3A), (S. cerevisiae) mRNA [NM_015137] A_23_P315122 EMX1 Homo sapiens NM_004097 ENST00000491023 2016 empty spiracles chr2:73161417- GO:0043565|GO:0021796| NM_004097 THC2602195 Hs.516090 empty spiracles homeo- homeobox 1 73161476 GO:0006355|GO:0003700| box 1 (EMX1), mRNA GO:0007420|GO:0042493| [NM_004097] GO:0030182|GO:0005634| GO:0009791 A_33_P3605969 Homo sapiens cDNA BC071847 chr1:41848710 GO:0043565|GO:0006355| THC2705939 Hs.559677 clone IMAGE: 3936577, 41848651 GO:0005737|GO:0003700| **** WARNING: GO:0005634 chimeric clone ****. [BC071847] A_33_P3272628 FCER1G Fc fragment of IgE, ENST00000367992 2207 Fc fragment of chr1:16119043 high affinity I, receptor IgE, high 0-161190489 for; gamma polypeptide affinity I, [Source:HGNC receptor for; Symbol; Acc: 3611] gamma [ENST00000367992] polypeptide A_33_P3342096 ZHX3 Homo sapiens NM_015035 ENST00000373262 23051 zinc fingers chr20:3983211 GO:0043565|GO:0005622| NM_015035 THC2682470 Hs.380133 zinc fingers and and homeo- 1-39832052 GO:0005515|GO:0005737| homeoboxes 3 (ZHX3), boxes 3 GO:0003700|GO:0008270| mRNA [NM_015035] GO:0005634|GO:0045892| GO:0046872 A_23_P148641 TTTY12 Homo sapiens NR_001551 ENST00000413466 83867 testis-specific chrY:7678307- NR_001551 THC2482065 Hs.667616 testis-specific transcript, transcript, 7678366 Y-linked 12 (nonprotein Y-linked 12 coding) (TTTY12), (nonprotein non-coding RNA coding) [NR_001551] A_23_PI28663 SACS Homo sapiens NM_014363 ENST00000382298 26278 spastic ataxia chr13:2390309 GO:0003674|GO:0006457| NM_014363 NP843920 Hs.159492 spastic ataxia of of Charlevoix- 8-23903039 GO:0031072|GO:0005575| Charlevoix-Saguenay Saguenay GO:0005524 (sacsin) (SACS), (sacsin) mRNA [NM_014363] A_33_P3376090 OR1J4 Homo sapiens NM_001004452 ENST00000340750 26219 olfactory chr9:12528218 GO:0007608|GO:0007165| NM_001004452 THC2503950 Hs.632679 olfactory receptor, family receptor, 1-125282240 GO:0004984|GO:0007186| 1, subfamily J, member family 1, GO:0005886|GO:0004872| 4 (OR1J4), mRNA subfamily J, GO:0016021|GO:0050896 [NM_001004452] member 4 A_33_P3278159 chr6:00402491 8-004024977 A_33_P3403942 C20orf123 Homo sapiens NM_080721 ENST00000279028 128506 chromosome chr20:4516999 GO:0016020|GO:0016021 NM_080721 THC2608629 Hs.526636 chromosome 20 open 20 open 5-45169936 reading frame 123 reading (C20orf123), mRNA frame 123 [NM_080721] A_32_P59302 HIVEP3 human immuno- BC080552 ENST00000372583 59269 human chr1:41972662- GO:0005622|GO:0005737| THC2628065 Hs.403972 deficiency virus immuno- 41972603 GO:0045941|GO:0016563| type 1 enhancer deficiency GO:0008270|GO:0005634| binding protein 3 virus type 1 GO:0003677|GO:0046872 [Source: HGNC enhancer Symbol; Acc: 13561] binding [ENST00000372583] protein 3 A_24_P36847 DHX9 Homo sapiens NM_001357 ENST00000485081 1660 DEAH (Asp- chr1:18285625 GO:0003725|GO:0005515| NM_001357 THC2508412 Hs.191518 DEAH (Asp-Glu-Ala-His) Glu-Ala-His) 6-182856315 GO:0005813|GO:0070934| box polypeptide 9 box polypep- GO:0005730|GO:0005634| (DHX9), transcript tide 9 GO:0003677|GO:0005524| variant 1, mRNA GO:0034605|GO:0004004| [NM_001357] GO:0005622|GO:0005737| GO:0004003|GO:0016787| GO:0000166|GO:0000398| GO:0030529|GO:0070937 A_24_P166661 TMEM60 Homo sapiens NM_032936 ENST00000257663 85025 transmembrane chr7:77423590- GO:0016020|GO:0016021 NM_032936 THC2632847 Hs.19025 transmembrane protein protein 60 77423531 60 (TMEM60), mRNA [NM_032936] A_24_P538403 ROCK1 Homo sapiens NM_005406 ENST00000399799 6093 Rho-associated, chr18:1853029 GO:0007242|GO:0030036| NM_005406 THC2555942 Hs.306307 Rho-associated, coiled-coil 1-18530232 GO:0007266|GO:0050900| coiled-coil containing containing GO:0050901|GO:0046872| protein kinase 1 protein GO:0005829|GO:0042802| (ROCK1), mRNA kinase 1 GO:0005622|GO:0000910| [NM_005406] GO:0005737|GO:0043524| GO:0000166|GO:0022614| GO:0005794|GO:0005814| GO:0032060|GO:0006915| GO:0005524|GO:0016020| GO:0004674|GO:0006468| GO:0008270|GO:0017049| GO:0016740|GO:0019898 A_24_P242036 RRP7B Homo sapiens NR_002184 ENST00000458605 91695 ribosomal chr22:4297032 NR_002184 THC2463180 Hs.728878 ribosomal RNA RNA pro- 3-42970264 processing 7 homo- cessing 7 log B (S. cerevisiae) homolog B (RRP7B), non-coding (S. cerevisiae) RNA [NR_002184] A_33_P3345294 chr6:10963656 2-109636621 A_23_P82929 NOV Homo sapiens NM_002514 ENST00000259526 4856 nephroblastoma chr8:12043643 GO:0031012|GO:0030424| NM_002514 THC2467525 Hs.235935 nephroblastoma overexpressed 5-120436494 GO:0043025|GO:0005576| overexpressed gene gene GO:0008083|GO:0001558| (NOV), mRNA GO:0030425|GO:0005520 [NM_002514] A_33_P3339436 LOC145845 Homo sapiens NR_024264 145845 hypothetical chr15:3715683 NR_024264 THC2606039 Hs.302693 hypothetical LOC145845 6-37156777 LOC145845 (LOC145845), non- coding RNA [NR_024264] A_23_P79816 EMILIN3 Homo sapiens NM_052846 ENST00000332312 90187 elastin chr20:3998911 GO:0005737|GO:0005578| NM_052846 THC2472361 Hs.726525 elastin microfibril microfibril 2-39989053 GO:0005576 interfacer 3 interfacer 3 (EMILIN3), mRNA [NM_052846] A_33_P3422712 chrX:13779376 0-137793819 A_33_P3806721 JMJD5 Homo sapiens NM_001145348 ENST00000540888 79831 jumonji chr16:2723193 GO:0008150|GO:0003674| NM_001145348 THC2632015 Hs.145717 jumonji domain domain 2-27231991 GO:0005575 containing 5 containing 5 (JMJD5), transcript variant 1, mRNA [NM_001145348] A_24_P766716 CMKLR1 Homo sapiens NM_001142343 ENST00000312143 1240 chemokine- chr12:1086819 GO:0007165|GO:0006955| NM_001142343 THC2699717 Hs.197143 chemokine-like like receptor 1 43-108681884 GO:0001501|GO:0007186| receptor 1 (CMKLR1), GO:0006935|GO:0005886| transcript variant 1, GO:0005887|GO:0004930| mRNA [NM_001142343] GO:0004950|GO:0004872 A_23_P78571 COX6B2 Homo sapiens NM_144613 ENST00000326529 125965 cytochrome c chr19:5586216 GO:0005739|GO:0005758| NM_144613 THC2491158 Hs.550544 cytochrome c oxidase oxidase subunit 7-55862108 GO:0004129|GO:0030061 subunit VIb polypeptide VIb polypep- 2 (testis) (COX6B2), tide 2 (testis) mRNA [NM_144613] A_24_P942030 VAMP4 Homo sapiens NM_003762 ENST00000415773 8674 vesicle-asso- chr1:17167004 GO:0005794|GO:0016020| NM_003762 THC2463491 Hs.6651 vesicle-associated ciated mem- 5-171669986 GO:0000139|GO:0016021| membrane protein 4 brane protein GO:0016192|GO:0005764| (VAMP4), transcript 4 GO:0005768 variant 1, mRNA [NM_003762] A_33_P3423220 LOC100507050 Homo sapiens NM_001195528 100507050 hypothetical chr11:7495302 NM_001195528 Hs.577323 hypothetical LOC100507050 2-74953081 LOC441617 (LOC441617), mRNA [NM_001195528] A_23_P82979 LAMC3 Homo sapiens NM_006059 ENST00000462567 10319 laminin, chr9:13396728 GO:0005515|GO:0016020| NM_006059 THC2471485 Hs.201805 laminin, gamma 3 gamma 3 4-133967341 GO:0005198|GO:0005576| (LAMC3), mRNA GO:0007155|GO:0005604 [NM_006059] A_32_P129669 FRMPD3 PREDICTED: XM_003121034 ENST00000439554 84443 FERM and chrX:10684803 XM_003121034 THC2648260 Hs.496546 Homo sapiens PDZ domain 8-106848097 FERM and PDZ containing 3 domain-containing protein 3-like (LOC100510062), mRNA [XM_003121034] A_23_P360240 MYEOV Homo sapiens NM_138768 ENST00000535653 26579 myeloma over- chr11:6906441 NM_138768 THC2470814 Hs.523848 myeloma overexpressed expressed (in 0-69064469 (in a subset of t(11;14) a subset of positive multiple t(11;14) posi- myelomas) (MYEOV), tive multiple mRNA [NM_138768] myelomas) A_23_P208788 C19orf33 Homo sapiens NM_0033520 ENST00000301246 64073 chromosome chr19:3879558 GO:0008150|GO:0005730| NM_033520 THC2480610 Hs.631544 chromosome 19 open 19 open 1-38795640 GO:0005634 reading frame 33 reading frame (C19orf33), mRNA 33 [NM_033520] A_33_P70927 PAGE2 Homo sapiens P NM_207339 ENST00000374968 203569 P antigen chrX:55117033- NM_207339 Hs.662489 antigen family, member family, 55117813 2 (prostate associated) member 2 (PAGE2), mRNA (prostate [NM_207339] associated) A_23_P131676 CXCR7 Homo sapiens NM_020311 ENST00000272928 57007 chemokine chr2:23749078 GO:0005515|GO:0008150| NM_020311 THC2461058 Hs.471751 chemokine (C-X-C (C-X-C motif) 3-237490842 GO:0007165|GO:0007186| motif) receptor 7 receptor 7 GO:0005886|GO:0004930| (CXCR7), mRNA GO:0044419|GO:0004872| [NM_020311] GO:0016021 A_33_P3384694 chr4:13586548 7-135865546 A_33_P3397314 LOC644587 PREDICTED: XM_001713909 644587 hypothetical chr9:44018222- XM_001713909 THC2496050 Hs.529800 Homo sapiens protein 44018163 hypothetical protein LOC644587 LOC644587 (LOC644587), mRNA [XM_001713909] A_33_P3219578 ZIC1 Human clone U79264 7545 Zic family chr3:14712739 NP1167104 Hs.598590 23814 mRNA sequence. member 1 6-147127337 [U79264] A_33_P3411925 WDR18 Homo sapiens WD NM_024100 ENST00000251289 57418 WD repeat chr19:9945 NM_024100 THC2468321 Hs.325321 repeat domain 18 domain 18 10-994569 (WDR18), mRNA [NM_024100] A_33_P3413993 SERPING1 serpin peptidase ENST00000405496 710 serpin pepti- chr11:5736494 THC2538564 inhibitor, clade G dase inhibitor, 2-57365001 (C1 inhibitor), member clade G 1 [Source: HGNC (C1 inhibitor), Symbol; Acc: 1228] member 1 [ENST00000405496] A_23_P107465 KRT31 Homo sapiens NM_002277 ENST00000393998 3881 keratin 31 chr17:3955006 GO:0005882|GO:0005515| NM_002277 THC2475978 Hs.41696 keratin 31 (KRT31), 5-39550006 GO:0008544|GO:0005200 mRNA[NM_002277] A_33_P3322859 HES6 Homo sapiens NM_018645 ENST00000409160 55502 hairy and chr2:23914731 GO:0003712|GO:0005667| NM_018645 THC2685338 Hs.42949 hairy and enhancer of enhancer of 5-239147256 GO:0003700|GO:0006357| split 6 (Drosophila) split 6 GO:0007275|GO:0005634| (HES6), transcript (Drosophila) GO:0030154|GO:0007399 variant 1, mRNA [NM_018645] A_33_P3407601 Q39AC8_BURS3 chr17:0208411 THC2753069 (Q39AC8) Cytochrome 37-020841078 B561, partial (9%) [THC2753069] A_33_P3256334 PRB3 Homo sapiens NM_006249 ENST00000279573 5544 proline-rich chr12:1142018 GO:0008150|GO:0007186| NM_006249 THC2479522 Hs.73031 proline-rich protein protein BstNl 5-11420126 GO:0005576|GO:0016021| BstNl subfamily 3 subfamily 3 GO:0008368 (PRB3), mRNA [NM_006249] A_33_P3359223 C9orf173 Homo sapiens NM_001004353 ENST00000388931 441476 chromosome 9 chr9:14014787 NM_001004353 THC2482952 Hs.372640 chromosome 9 open open reading 5-140147934 reading frame 173 frame 173 (C9orf173), mRNA [NM_001004353] A_33_P3327192 DA142060 BRALZ2 DA142060 ENST00000453179 chr6:24751871- Hs.582960 Homo sapiens cDNA 24751930 clone BRALZ2017105 5′, mRNA sequence [DA142060] A_33_P3301970 STRADB Homo sapiens NM_018571 ENST00000392249 55437 STE20-related chr2:20234326 GO:0005515|GO:0007254| NM_018571 NP1466986 Hs.652338 STE20-related kinase kinase adaptor 4-202343323 GO:0005634|GO:0006916| adaptor beta (STRADB), beta GO:0046320|GO:0005524| transcript variant 1, GO:0032147|GO:0000902| mRNA [NM_018571] GO:0005737|GO:0007049| GO:0004672|GO:0000166| GO:0006611|GO:0006468 A_33_P3277096 Lymphocyte antigen AJ315539 ENST00000383417 chr6:31680458 NP1164470 Hs.247883 6 complex, locus 31680399 G6ELymphocyte antigen 6 complex, locus G6E, isoform CRA_a [Source: UniProtKB/TrEMBL; Acc: A2ABS3] [ENST00000383417] A_33_P3351279 GPR37L1 Homo sapiens G NM_004767 ENST00000367282 9283 G protein- chr1:20209857 GO:0008150|GO:0007165| NM_004767 THC2464423 Hs.132049 protein-coupled receptor coupled 5-202098634 GO:0007186|GO:0005886| 37 like 1 (GPR37L1), receptor GO:0004930|GO:0004872| mRNA [NM_004767] 37 like 1 GO:0016021 A_33_P3316410 FAM 66A Homo sapiens NR_026789 ENST00000526690 100133172 family with chr8:12219964- NR_026789 THC2571715 Hs.721640 family with sequence sequence 12220023 similarity 66, member similarity 66, A (FAM66A), non- member A coding RNA [NR_026789] A_33_P3350232 Homo sapiens cDNA AK127825 chr14:7696139 THC2487473 Hs.686950 FLJ45928 fis, clone 4-76961335 PLACE6019674. [AK127825] A_23_P15798 KRTAP4-12 Homo sapiens NM_031854 ENST00000455597 83755 keratin chr17:3927957 GO:0045095 NM_031854 NP1465556 Hs.572443 keratin associated associated 6-39279517 protein 4-12 protein 4-12 (KRTAP4-12), mRNA [NM_031854] A_33_P3287418 RTDR1 rhabdoid tumor ENST00000406876 27156 rhabdoid tumor chr22:2347844 THC2656235 deletion region gene 1 deletion region 4-23478385 [Source: HGNC gene 1 Symbol; Acc: 13437] [ENST00000406876] A_23_P420831 TRIM10 Homo sapiens NM_052828 ENST00000448645 10107 tripartite motif chr6:30119937- GO:0005622|GO:0005515| NM_052828 THC2474017 Hs.709483 tripartite motif containing 10 30119878 GO:0008150|GO:0003674| containing 10 (TRIM10), GO:0005737|GO:0030218| transcript variant 2, GO:0008270|GO:0046872 mRNA[NM_052828] A_33_P3272347 LOC100128107 Homo sapiens cDNA AK123720 100128107 hypothetical chr19:4689378 THC2512220 Hs.707277 FLJ41726 fis, clone protein 0046893721 HLUNG2014449. LOC100128107 [AK123720] A_33_P3713035 LOC221814 Homo sapiens AL122087 221814 hypothetical chr7:15874795- THC2606193 Hs.592173 mRNA; cDNA protein 15874736 DKFZp564C0371 LOC221814 (from clone DKFZp564C0371) [AL122087] A_33_P3293049 HLA-DQA1 Homo sapiens NM_002122 ENST00000374949 3117 major histo- chr6:32610501- GO:0006955|GO:0016020| NM_002122 THC2462487 Hs.387679 major histocompatibility compatibility 32610560 GO:0005886|GO:0005887| complex, class II, complex, GO:0002504|GO:0042613| DQ alpha 1 (HLA- class II, GO:0016021|GO:0032395 DQA1), mRNA DQ alpha 1 [NM_002122] A_23_P154771 DUSP15 Homo sapiens NM_080611 ENST00000486996 128853 dual specificity chr20:3044939 GO:0005515|GO:0005737| NM_080611 NP349912 Hs.585017 dual specificity phosphatase 15 7-30449338 GO:0006470|GO:0016787| phosphatase 15 GO:0005886|GO:0008138| (DUSP15), transcript GO:0004725 variant 1, mRNA [NM_080611] A_23_P213832 SPINK7 Homo sapiens NM_032566 ENST00000514646 84651 serine peptidase chr5:14769368 GO:0005515|GO:0004867| NM_032566 THC2734765 Hs.244569 serine peptidase inhibitor, Kazal 0-147693739 GO:0005576|GO:0030414 inhibitor, Kazal type 7 type 7 (putative) (SPINK7), (putative) mRNA [NM_032566] A_32_P2452 TMTC1 Homo sapiens NM_175861 ENST00000256062 83857 transmembrane chr12:2965392 GO:0016020|GO:0005488| NM_175861 THC2470774 Hs.401954 transmembrane and and tetratrico- 2-29653863 GO:0016021 tetratricopeptide repeat peptide repeat containing 1 (TMTC1), containing 1 transcript variant 2, mRNA [NM_175861] A_33_P3226605 PSIP1 Homo sapiens PC4 NM_033222 ENST00000380733 11168 PC4and SFRS1 chr9:15464389- GO:0019047|GO:0044419| NM_033222 THC2466817 Hs.708514 and SFRS1 interacting interacting 15464330 GO:0005634|GO:0019059| protein 1 (PSIP1), protein 1 GO:0003677|GO:0045449| transcript variant 2, GO:0005829 mRNA [NM_033222] A_24_P384397 RAVER1 Homo sapiens NM_133452 ENST00000331131 125950 ribonucleo- chr19:1043185 GO:0005515|GO:0005737| NM_133452 THC2467692 Hs.707428 ribonucleoprotein, protein, 0-10431791 GO:0000166|GO:0003723| PTB-binding 1 PTB-binding 1 GO:0005634 (RAVER1), mRNA [NM_133452] A_33_P3245818 PQLC1 PQ loop repeat AK126188 ENST00000466449 80148 PQ loop chr18:7770374 GO:0016020|GO:0016021 THC2483810 Hs.288284 containing 1 [Source: repeat con- 2-77703683 HGNC Symbol; taining 1 Acc: 26188] [ENST00000466449] A_23_P319423 KCNK5 Homo sapiens NM_003740 ENST00000359534 8645 potassium chr6:39156880- GO:0007588|GO:0005244| NM_003740 THC2529678 Hs.444448 potassium channel, channel, 39156821 GO:0016020|GO:0005887| subfamily K, member subfamily K, GO:0005267|GO:0030955| 5 (KCNK5), mRNA member 5 GO:0006813|GO:0006811 [NM_003740] A_33_P3793307 LOC339803 Homo sapiens NR_(Rf.49f. 339803 hypothetical chr2:61368978- NR_036496 THC2480323 Hs.252433 hypothetical LOC339803 61368919 LOC339803 (LOC339803), non- coding RNA [NR_036496] A_23_P94186 LYPD2 Homo sapiens NM_205545 ENST00000359228 137797 LY6/PLAUR chr8:14383247 GO:0005886|GO:0031225 NM_205545 THC2481314 Hs.441280 LY6/PLAUR domain domain 7-143831850 containing 2 (LYPD2), containing 2 mRNA [NM_205545] A_33_P3354771 MEF2BNB Homo sapiens cDNA AK057161 729991 MEF2B chr19:1928899 THC2479428 FLJ32599 fis, clone neighbor 0-19288931 STOMA1000047. [AK057161] A_23_P141005 AMFR Homo sapiens NM_001144 ENST00000492830 267 autocrine motil- chr16:5639575 GO:0000209|GO:0005515| NM_001144 THC2477387 Hs.295137 autocrine motility ity factor 7-56395698 GO:0006511|GO:0004842| factor receptor receptor GO:0005783|GO:0016874| (AMFR), mRNA GO:0006928|GO:0030176| [NM_001144] GO:0030433|GO:0051259| GO:0046872|GO:0030968| GO:0007165|GO:0016020| GO:0000299|GO:0004872| GO:0008270|GO:0016021 A_23_P22682 ARMCX1 Homo sapiens NM_016608 ENST00000538894 51309 armadillo chrX:10080941 GO:0016020|GO:0005488| NM_016608 THC2490823 Hs.9728 armadillo repeat repeat con- 6-100809475 GO:0016021 containing, X-linked taining, 1 (ARMCX1), X-linked 1 mRNA [NM_016608] A_33_P3295523 RAC3 Homo sapiens NM_005052 ENST00000306897 5881 ras-related C3 chr17:7999201 GO:0005515|GO:0030036| NM_005052 THC2474710 Hs.45002 ras-related C3 botulinum 8-79992077 GO:0007264|GO:0003924| botulinum toxin toxin sub- GO:0005525|GO:0031175| substrate 3 (rho strate 3 (rho GO:0030027|GO:0012505| family, small GTP family, small GO:0030426|GO:0005622| binding protein Rac3) GTP binding GO:0005737|GO:0031941| (RAC3), mRNA protein Rac3) GO:0000166|GO:0016020| [NM_005052] GO:0030031|GO:0050885| GO:0043025 A_32_P110390 TMEM171 Homo sapiens NM_173490 ENST00000287773 134285 transmembrane chr5:72424286- GO:0016020|GO:0016021 NM_173490 THC2480044 Hs.162246 transmembrane protein protein 171 72424345 171 (TMEM171), transcript variant 1, mRNA [NM_173490] A_33_P3217719 TLE1 Homo sapiens NM_005077 ENST00000376472 7088 transducin-like chr9:84225208- GO:0007165|GO:0005667| NM_005077 THC2594224 Hs.197320 transducin-like enhancer of 84225149 GO:0003714|GO:0003682| enhancer of split 1 split 1 (E(sp1) GO:0030178|GO:0016481| (E(sp1) homology. homolog, GO:0009887|GO:0007275| Drosophila) (TLE1), Drosophila ) GO:0005634|GO:0000122| mRNA [NM_005077] GO:0008134 A_33_P3222664 PREDICTED: XM_001718031 chr6:29800627- XM_001718031 Homo sapiens 29800568 hypothetical protein LOC100133214 (LOC100133214), mRNA [XM_001718031] A_33_P3379396 KRT1 Homo sapiens NM_006121 ENST00000252244 3848 keratin 1 chr12:5306857 GO:0005515|GO:0008544| NM_006121 THC2464701 Hs.80828 keratin 1 (KRT1), 9-53068520 GO:0005886|GO:0005529| mRNA [NM_006121] GO:0005200|GO:0045765| GO:0004872|GO:0045095| GO:0005856|GO:0042730| GO:0006979|GO:0001867 A_33_P3336273 NAV3 Homo sapiens NM_014903 ENST00000541270 89795 neuron chr12:7860462 GO:0005640|GO:0017111| NM_014903 NP843482 Hs.655301 neuron navigator 3 navigator 3 9-78604688 GO:0016020|GO:0000166| (NAV3), mRNA GO:0005634|GO:0005635 [NM_014903] A_23_P50389 NAT14 Homo sapiens NM_020378 ENST00000205194 57106 N-acetyltrans- chr19:5599851 GO:0006352|GO:0008080| NM_020378 THC2462041 Hs.31854 N-acetyltransferase 14 ferase 1-55998570 GO:0016020|GO:0016563| (GCN5-related, putative) 14(GCN5- GO:0008152|GO:0005634| (NAT14), mRNA related, GO:0016021|GO:0003677| [NM_020378] putative) GO:0045449|GO:0016740| GO:0008415 A_33_P3255434 MEG3 Homo sapiens NR_003531 ENST00000398461 55384 maternally chr14:1013272 NR_003531 THC2467619 Hs.728839 maternally expressed 3 expressed 3 86-101327345 (non-protein coding) (nonprotein (MEG3), transcript coding) variant 3, non- coding RNA [NR_003531] A_33_P3289976 chr9:06734366 2-067343603 A_33_P3415648 PREDICTED: XR_113106 ENST00000536864 chr12:8543467- XR_113106 THC2478567 Hs.434403 Homo sapiens 8543408 hypothetical LOC649305 (LOC649305), miscRNA [XR_113106] A_33_P3353996 PPP1R3G Homo sapiens NM_001145115 648791 protein chr6:5087402- NM_001145115 THC2779444 Hs.653089 protein phosphatase phosphatase 1, 5087461 1, regulatory (inhibitor) regulatory subunit 3G (inhibitor) (PPP1R3G), mRNA subunit 3G [NM_001145115] A_33_P3667484 LOC648740 Homo sapiens NR_024438 ENST00000491397 648740 actin, beta chr1:10411381 NR_024438 THC2482509 Hs.721681 actin, beta pseudogene pseudogene 2-104113871 (LOC648740), non-coding RNA [NR_024438] A_24_P61753 KIAA0664 Homo sapiens NM_015229 ENST00000435359 23277 KIAA0664 chr17:2593491 GO:0005488 NM_015229 THC2466243 Hs.22616 KIAA0664 2593432 (KIAA0664), mRNA [NM_015229] A_33_P3225522 OAS2 Homo sapiens 2′-5′- NM_001032731 ENST00000449768 4939 2′-5′- chr12:1134265 GO:0005792|GO:0005783| NM_001032731 THC2473802 Hs.414332 oligoadenylate synthetase oligoadenylate 50-113426609 GO:0001730|GO:0003723| 2, 69/71 kDa (OAS2), synthetase 2, GO:0016779|GO:0005634| transcript variant 3, 69/71 kDa GO:0005524|GO:0006401| mRNA [NM_001032731] GO:0005739|GO:0006139| GO:0006955|GO:0000166| GO:0016020|GO:0016740 A_33_P3270826 THEM5 Homo sapiens NM_182578 ENST00000453881 284486 thioesterase chr1:15181964 GO:0016787 NM_182578 THC2651404 Hs.132648 thioesterase superfamily superfamily 2-151819583 member 5 (THEM5), member 5 mRNA [NM_182578] A_33_P3260053 AIF1L Homo sapiens NM_001185095 ENST00000372312 83543 allograft chr9:13399576 GO:0051015|GO:0005884| NM_001185095 THC2520939 Hs.4944 allograft inflammatory inflammatory 6-133995825 GO:0005509|GO:0005925 factor 1-like (AIF1L), factor 1-like transcript variant 3, mRNA [NM_001185095] A_23_P417921 DNAJC5G Homo sapiens DnaJ NM_173650 ENST00000296097 285126 DnaJ (Hsp40) chr2:27504211- GO:0016020|GO:0006457| NM_173650 THC2478898 Hs.116303 (Hsp40) homology homo log, 27504270 GO:0031072|GO:0051082| subfamily C, member sub-family C, GO:0031225 5 gamma (DNAJC5G), member 5 mRNA [NM_173650] gamma A_23_P80827 FYTTD1 Homo sapiens NM_001011537 ENST00000241502 84248 forty-two-three chr3:19751030 NM_001011537 THC2469496 Hs.277533 forty-two-three domain domain 1-197510360 containing 1 (FYTTD1), containing 1 transcript variant 2, mRNA [NM_001011537] A_33_P3315021 ribosomal protein AK055264 ENST00000416673 chr2:11436843 THC2520247 Hs.720253 L23a pseudogene 7 1-114368372 [Source: HGNC Symbol; Acc: 17336] [ENST00000416673] A_33_P3212350 CARD11 Homo sapiens AK097139 84433 caspase chr7:3082928- GO:0050700|GO:0005515| THC2480953 Hs.665701 cDNA FLJ39820 fis, recruitment 3082869 GO:0045577|GO:0005886| clone SPLEN2010625. domain family, GO:0030890|GO:0004385| [AK097139] member 11 GO:0042981|GO:0001819| GO:0005829|GO:0005622| GO:0045086|GO:0007165| GO:0005737|GO:0051092| GO:0045061|GO:0042101| GO:0050776|GO:0042102| GO:0045580|GO:0045121| GO:0043123 A_33_P3227077 LOC100132024 PREDICTED: XM_001718709 100132024 hypothetical chr15:3081455 XM_001718709 Hs.631706 Homo sapiens protein 6-30814497 hypothetical protein LOC100132024 LOC100132024 (LOC100132024), mRNA [XM_001718709] A_23_P76622 DCT Homo sapiens NM_001922 ENST00000377021 1638 dopachrome chr13:9509580 GO:0005792|GO:0042470| NM_001922 NP220864 Hs.301865 dopachrome tautomerase tautomerase 5-95095746 GO:0005507|GO:0046872| (dopachrome delta- (dopachrome GO:0005829|GO:0004167| isomerase, tyrosine- delta-, GO:0006583|GO:0008544| related protein 2) isomerase GO:0016020|GO:0008152| (DCT), transcript tyrosine- GO:0016491|GO:0008270| variant 1, mRNA related GO:0016021|GO:0016853 [NM_001922] protein 2) A_33_P3400292 chr12:0068620 06-006861947 A_33_P3347040 LOC100131094 Homo sapiens NM_001242901 ENST00000381796 100131094 hypothetical chr19:4685870- NM_001242901 THC2483730 Hs.678135 hypothetical LOC100131094 4685929 LOC100131094 (LOC100131094), mRNA [NM_001242901] A_24_P319647 FCRL2 Homo sapiens NM_030764 ENST00000392274 79368 Fc receptor- chr1:15773673 GO:0005886|GO:0005070| NM_030764 NP458656 Hs.437393 Fc receptor-like 2 like 2 6-157736677 GO:0007267|GO:0005625| (FCRL2), mRNA GO:0004872|GO:0016021 [NM_030764] A_33_P3330175 chr9:06670801 3-066707954 A_23_P157513 MOS Homo sapiens NM_005372 ENST00000311923 4342 v-mos Moloney chr8:57025995- GO:0005515|GO:0000166| NM_005372 THC2602727 Hs.533432 v-mos Moloney murine sarcoma 57025936 GO:0004674|GO:0006468| murine sarcoma viral viral oncogene GO:0005524|GO:0016740 oncogene homolog (MOS), homolog mRNA [NM_005372] A_33_P3315303 KRT73 Homo sapiens NM_175068 ENST00000305748 319101 keratin 73 chr12:5300141 GO:0005198|GO:0045095 NM_175068 THC2481292 Hs.55410 keratin 73 (KRT73), 7-53001358 mRNA [NM_175068] 4-32063533 A_24_P144346 PREDICTED: XM_002346274 ENST00000426099 chr16:3206347 XM_002346274 NP492523 Hs.460661 Homo sapiens ig heavy chain V-III region VH26-like (LOC100132941), mRNA [XM_002346274] A_33_P3406828 TEKT4P2 Uncharacterized protein AK096952 ENST00000400839 100132288 tektin 4 chr21:0099096 THC2509411 Hs.632605 [Source: UniProtKB/ pseudogene 2 86-009909627 TrEMBL; Acc:B 7WNX9] [ENST00000400839] A_33_P3406265 chr7:02556042 0-025560361 A_24_P165864 P2RY14 Homo sapiens NM_014879 ENST00000309170 9934 purinergic chr3:15093011 GO:0007165|GO:0045029| NM_014879 THC2476449 Hs.2465 purinergic receptor P2Y, receptor 8-150930059 GO:0006955|GO:0007186| G-protein coupled, P2Y, G-protein GO:0005886|GO:0045028| 14 (P2RY14), transcript coupled, 14 GO:0004930|GO:0004872| variant 2, mRNA GO:0016021 [NM_014879] A_33_P3287396 LOC100127940 Homo sapiens cDNA AK090626 ENST00000514988 100127940 hypothetical chr7:228654- THC2485700 Hs.638549 FLJ33307 fis, clone LOC100127940 228595 BNGH42004076. [AK090626] A_23_P142255 SHD Homo sapiens Src NM_020209 ENST00000543264 56961 Src homology chr19:4290646- GO:0005515 NM_020209 NP228054 Hs.7423 homology 2 domain 2 domain 4290705 containing transforming containing protein D (SHD), transforming mRNA [NM_020209] protein D A_24_P215240 ENKUR Homo sapiens NM_145010 ENST00000376363 219670 enkurin, TRPC chr10:2528462 GO:0019861|GO:0005929| NM_145010 NP841402 Hs.534486 enkurin, TRPC channel 5-25279530 GO:0005516|GO:0017124 channel interacting interacting protein (ENKUR), protein mRNA [NM_145010] A_33_P3246838 Homo sapiens AY312959 ENST00000390477 chr14:2293325 NP1073023 Hs.74647 T-cell receptor delta 5-22933314 chain HA/801 mRNA, complete cds. [AY312959] A_33_P3359869 chr20:0625122 65-062512324 A_33_P3309849 chr18:0752393 80-075239439 A_23_P90273 CHST8 Homo sapiens NM_022467 ENST00000262622 64377 carbohydrate chr19:3426429 GO:0016051|GO:0006790| NM_022467 THC2603946 Hs.165724 carbohydrate (N- (N-acetylgal- 2-34264351 GO:0005794|GO:0016020| acetylgalactosamine 4-0) actosamine 4-0) GO:0042446|GO:0001537| sulfotransferase 8 sulfotransferase GO:0016021|GO:0007417| (CHST8), transcript 8 GO:0016740|GO:0030166 variant 3, mRNA [NM_022467] A_33_P3312504 PSD4 Homo sapiens NM_012455 ENST00000409656 23550 pleckstrin and chr2:11395884 GO:0005622|GO:0005086| NM_012455 NP649911 Hs.516306 pleckstrin and Sec7 Sec7 domain 8-113958907 GO:0005886|GO:0032012 domain containing 4 containing 4 (PSD4), mRNA [NM_012455] A_24_P64407 HMX2 Homo sapiens H6 NM_005519 ENST00000339992 3167 H6 family chr10:1249091 GO:0043565|GO:0008284| NM_005519 THC2478985 Hs.444756 family homeobox 2 homeobox 2 35-124909194 GO:0006355|GO:0042472| (HMX2), mRNA GO:0003700|GO:0007420| [NM_005519] GO:0007275|GO:0005634| GO:0030154|GO:0007399 A_24_P348083 C18orf23 PREDICTED: XR_111773 147341 chromosome 18 chr18:4391494 XR_111773 NP1164839 Hs.730381 Homo sapiens open reading 3-43915002 chromosome 18 open frame 23 reading frame 23 (C18orf23), miscRNA [XR_111773] A_33_P3245248 TERC Homo sapiens NR_001566 7012 telomerase chr3:16948269 NR_001566 THC2687501 Hs.436182 telomerase RNA RNA 5-169482636 component (TERC), component telomerase RNA [NR_001566] A_33_P3347869 C3 Homo sapiens NM_000064 ENST00000463520 718 complement chr19:6686195- GO:0006957|GO:0007165| NM_000064 THC2569813 Hs.529053 complement component component 3 6686136 GO:0050766|GO:0006954| 3 (C3), mRNA GO:0007186|GO:0004866| [NM_000064] GO:0006958|GO:0005102| GO:0005576|GO:0001798| GO:0005615 A_24_P472455 ARF6 Homo sapiens ADP- NM_001663 382 ADP-ribo- chr14:5036317 GO:0005515|GO:0035020| NM_001663 THC2492454 Hs.525330 ribosylation factor 6 sylation 1-50363230 GO:0005886|GO:0007264| (ARF6), mRNA factor 6 GO:0003924|GO:0006928| [NM_001663] GO:0015031|GO:0031529| GO:0005622|GO:0005737| GO:0000166|GO:0030838| GO:0007155|GO:0016192| GO:0005938|GO:0005794| GO:0005624|GO:0006915| GO:0005525|GO:0001726| GO:0001889|GO:0030866| GO:0048261|GO:0055037| GO:0005769|GO:0019898 A_33_P3218797 PPDPF pancreatic progenitor ENST00000370177 79144 pancreatic chr20:6215293 THC2522513 cell differentiation and progenitor cell 4-62152993 proliferation factor differentiation homolog (zebrafish) and [Source: HGNC proliferation Symbol; Acc: 16142] factor homo- [ENST00000370177] log (zebrafish) A_24_P88079 MUC6 Homo sapiens NM_005961 ENST00000421673 4588 mucin 6, chr11:1015874- GO:0030277|GO:0005576| NM_005961 NP081518 Hs.528432 mucin 6, oligomeric oligomcric 1015815 GO:0005201 mucus/gel-forming mucus/ (MUC6), mRNA gel-forming [NM_005961] A_23_P31376 LRRN3 Homo sapiens NM_018334 ENST00000308478 54674 leucine rich chr7:11076477 GO:0005515|GO:0000187| NM_018334 THC2462585 Hs.3781 leucine rich repeat repeat 1-110764830 GO:0016020|GO:0016021| neuronal 3 (LRRN3), neuronal 3 GO:0006897 transcript variant 3, mRNA [NM_018334] A_23_P375524 LCE1D Homo sapiens late NM_178352 ENST00000326233 353134 late chr1:15277033 GO:0031424 NM_178352 THC2694544 Hs.490235 cornified envelope 1D comified 1-152770390 (LCE1D), mRNA envelope ID [NM_178352] A_33_P3297468 SLC34A3 Homo sapiens NM_001177317 ENST00000538474 142680 solute carrier chr9:14012907 GO:0005903|GO:0016324| NM_001177317 THC2774767 Hs.432442 solute carrier family family 34 0-140129129 GO:0005436|GO:0015321| 34 (sodium phosphate), (sodium GO:0016020|GO:0030643| member 3 (SLC34A3), phosphate), GO:0006817|GO:0016021| transcript variant 2, member 3 GO:0031402|GO:0006814| mRNA [NM_001177317] GO:0015293|GO:0006811 A_33_P3409099 ATXN1 Homo sapiens NM_000332 ENST00000450222 6310 ataxin 1 chr6:16302089- GO:0016564|GO:0006396| NM_000332 THC2613205 Hs.434961 ataxin 1 (ATXN1), 16302030 GO:0008219|GO:0003723| transcript variant 1, GO:0005730|GO:0005634| mRNA ]NM_000332] GO:0043621|GO:0008022| GO:0016363|GO:0042802| GO:0008266|GO:0005737| GO:0034046|GO:0042272| GO:0016481|GO:0005654| GO:0051168|GO:0042405 A_33_P3256685 TTF2 Homo sapiens NM_003594 ENST00000369466 8.158 transcription chr1:11764502 GO:0008380|GO:0005515| NM_003594 THC2684205 Hs.486818 transcription termination termination 2-117645081 GO:0006353|GO:0006397| factor, RNA factor, RNA GO:0008026|GO:0004386| polymerase II (TTF2), polymerase II GO:0005634|GO:0003717| mRNA [NM_003594] GO:0003677|GO:0005524| GO:0008023|GO:0005737| GO:0016787|GO:0000166| GO:0008270|GO:0005681| GO:0045449|GO:0008094 A_23_P933 RWDD3 Homo sapiens RWD NM_015485 ENST00000495272 25950 RWD domain chr1:95712438- GO:0005515|GO:0005737| NM_015485 THC2622910 Hs.709591 domain containing 3 containing 3 95712497 GO:0005634 (RWDD3), transcript variant 1, mRNA [NM_015485] A_33_P3351559 ETNK1 Homo sapiens NM_018638 55500 ethanolamine chr12:2284333 GO:0004305|GO:0006646| NM_018638 THC2711794 Hs.29464 ethanolamine kinase 1 kinase 1 7-22843396 GO:0005737|GO:0000166| (ETNK1), transcript GO:0005524|GO:0016740 variant 1, mRNA [NM_018638] A_33_P3381777 TREML1 Homo sapiens NM_178174 ENST00000426005 340205 triggering chr6:41117457- GO:0005515|GO:0005737| NM_178174 NP1465593 Hs.117331 triggering receptor receptor 41117398 GO:0009986|GO:0005886| expressed on myeloid expressed on GO:0045087|GO:0031091| cells-like 1 (TREML1), myeloid cells- GO:0030168|GO:0004872| mRNA [NM_178174] like 1 GO:0016021 A_24_P42389 OTUD6A Homo sapiens OTU NM_207320 ENST00000338352 139562 OTU domain chrX:69283505- NM_207320 THC2491103 Hs.447381 domain containing 6A containing 6A 69283564 (OTUD6A), mRNA [NM_207320] A_23_P62932 ATP1B1 Homo sapiens NM_001677 ENST00000367816 481 ATPase, chr1:16910187 GO:0005515|GO:0001666| NM_001677 THC2470205 Hs.291196 ATPase, Na+/K+ trans- Na+/K+ 7-169101936 GO:0005886|GO:0030955| porting, beta 1 poly- transporting, GO:0031402|GO:0005890| peptide (ATP1B1), beta GO:0016323|GO:0006754| mRNA [NM_001677] 1polypeptide GO:0016324|GO:0005901| GO:0016021|GO:0006814| GO:0006813|GO:0005391| GO:0006811 A_33_P3380383 TIFAB Homo sapiens NM_001099221 ENST00000537858 497189 TRAF- chr5:13478466 NM_001099221 THC2658671 Hs.552091 TRAF-interacting interacting 4-134784605 protein with forkhead- protein with associated domain, forkhead- family member B associated (TIFAB), mRNA domain, [NM_001099221] family member B A_33_P3270317 SLC18A3 Homo sapiens NM_003055 ENST00000374115 6572 solute carrier chr10:5082065 GO:0060201|GO:0015870| NM_003055 THC2477087 Hs.654374 solute carrier family family 18 6-50820715 GO:0016020|GO:0005887| 18 (vesicular acetyl- (vesicular GO:0005277|GO:0005624| choline), member 3 acetylcholine), GO:0055085 (SLC18A3), mRNA member 3 [NM_003055] A_33_P3321432 FAM198B Homo sapiens NM_016613 ENST00000393807 51313 family with chr4:15904621 GO:0005794|GO:0016020| NM_016613 THC2461168 Hs.567498 family with sequence sequence 5-159046156 GO:0016021 similarity 198, similarity 198, member B (FAM198B), member B transcript variant 2, mRNA [NM_016613] A_33_P3259865 C1orf220 Homo sapiens NR_033186 ENST00000319387 400798 chromosome 1 chr1:17851796 NR_033186 THC2483231 Hs.668085 chromosome 1 open open reading 5-178518024 reading frame 220 frame 220 (C1orf220), non-coding RNA [NR_033186] A_33_P3213419 LOC100129447 Homo sapiens cDNA AK054946 100129447 hypothetical chr12:1135284 THC2483097 Hs.661564 FLJ30384 fis, clone protein 30-113528489 BRACE2008114. LOC100129447 [AK054946] A_23_P328808 GPR132 Homo sapiens G NM_013345 ENST00000551869 29933 G protein- chr14:1055159 GO:0007165|GO:0000082| NM_013345 THC2688586 Hs.532504 protein-coupled receptor coupled 58-105515899 GO:0007186|GO:0005886| 132 (GPR132), mRNA receptor 132 GO:0004930|GO:0006950| [NM_013345] GO:0004872|GO:0016021 A_33_P3407606 Q275K3_MYCFV chrX:06481322 THC2725860 (Q275K3) Phage 3-064813282 integrate, partial (4%) [THC2725860] A_33_P3324409 chr11:0490075 10-049007451 A_33_P3249364 TMTC1 transmembrane and AK055962 ENST00000381224 83857 transmembrane chr12:2981287 THC2511165 Hs.401954 tetratricopeptide repeat and tetratrico- 3-29812814 containing 1 [Source: peptide repeat HGNC Symbol; containing 1 Acc: 24099] [ENST00000381224] A_23_P146885 UTS2R Homo sapiens NM_018949 ENST00000313135 2837 urotensin 2 chr17:8033323 GO:0005886|GO:0046005| NM_018949 THC2646256 Hs.192720 urotensin 2 receptor receptor 7-80333296 GO:0030307|GO:0004930| (UTS2R), mRNA GO:0042493|GO:0008015| [NM_018949] GO:0048146|GO:0045776| GO:0010841|GO:0045777| GO:0003105|GO:0007204| GO:0045766|GO:0007165| GO:0045907|GO:0007186| GO:0003080|GO:0001604| GO:0004872|GO:0016021| GO:0055037|GO:0003077| GO:0005769 A_23_P204144 KRT85 Homo sapiens NM_002283 ENST00000544265 3891 keratin 85 chr12:5275448 GO:0005515|GO:0008544| NM_002283 THC2479571 Hs.182507 keratin 85 (KRT85), 3-52754424 GO:0005198|GO:0045095 mRNA [NM_002283] A_33_P3280666 PHF21B Homo sapiens PHD NM_138415 ENST00000396103 112885 PHD finger chr22:4527902 GO:0005515|GO:0008270| NM_138415 NP1147183 Hs.254097 finger protein 21B protein 21B 5-45278966 GO:0046872 (PHF21B), transcript variant 1, mRNA [NM_138415] A_32_P219368 WTAP Homo sapiens NM_152858 ENST00000337387 9589 Wilms tumor chr6:16016967 GO:0008380|GO:0006397| NM_152858 THC2515074 Hs.446091 Wilms tumor 1 1 associated 8-160169737 GO:0031965|GO:0007049| associated protein protein GO:0005730|GO:0005654| (WTAP), transcript GO:0005634 variant 3, mRNA [NM_152858] A_33_P3877739 SMCR2 ag52hl2.x5 AI821758 140768 Smith-Magenis chr17:1757962 Hs.369680 Gessler Wilms syndrome 5-17579684 tumor Homo sapiens chromosome cDNA clone IMAGE: region, 1126631 3′, mRNA (candidate 2 sequence non-protein [AI821758] coding) A_24_P155502 INHBC Homo sapiens NM_005538 ENST00000309668 3626 inhibin, beta C chr12:5784412 GO:0005179|GO:0005576| NM_005538 THC2482175 Hs.632722 inhibin, beta C 5-57844184 GO:0008083|GO:0005160 (INHBC), mRNA [NM_005538] A_33_P3413701 ERAP1 Homo sapiens NM_001040458 ENST00000443439 51752 endoplasmic chr5:96110275- GO:0005138|GO:0005515| NM_001040458 THC2533844 Hs.684061 endoplasmic reticulum reticulum 96110216 GO:0005783|GO:0005576| aminopeptidase 1 aminopeptidase GO:0001525|GO:0005151| (ERAP1), transcript 1 GO:0046872|GO:0005829| variant 2, mRNA GO:0009617|GO:0006955| [NM_001040458] GO:0016020|GO:0019885| GO:0004177|GO:0045088| GO:0008235|GO:0006508| GO:0008217|GO:0045444| G 0:0005788|GO:0008270| GO:0008233|GO:0016021| GO:0006509 A_33_P3403773 ZNF569 Homo sapiens zinc NM_152484 ENST00000316950 148266 zinc finger chr19:3790213 GO:0005622|GO:0006355| NM_152484 THC2472283 Hs.511848 finger protein 569 protein 569 8-37902079 GO:0008270|GO:0005634| (2NF569), mRNA GO:0003677|GO:0046872 [NM_152484] A_33_P3871347 SNED1 Homo sapiens sushi, NM_001080437 ENST00000342631 25992 sushi, nidogen chr2:24203238 GO:0007160|GO:0005509 NM_001080437 THC2471466 Hs.471834 nidogen and EGF- and EGF-like 8-242032447 like domains 1 domains 1 (SNED1), mRNA [NM_001080437] A_23_P168306 WASF1 Homo sapiens NM_003931 ENST00000392589 8936 WAS protein Chr6:11042118 GO:0005739|GO:0005515| NM_003931 THC2482774 Hs.75850 WAS protein family, family, 5-110421126 GO:0005737|GO:0006461| member 1 (WASF1), member 1 GO:0030041|GO:0006928| transcript variant 1, GO:0005741|GO:0003779| mRNA [NM_003931] GO:0015629|GO:0030027 A_33_P3299110 ARHGAP42 Homo sapiens Rho NM_152432 ENST00000298815 143872 Rho GTPase chr11:1008615 GO:0005622|GO:0007165| NM_152432 THC2655447 Hs.269837 GTPase activating activating 97-100861656 GO:0005096 protein 42 (ARHGAP42), protein 42 mRNA [NM_152432] A_23_P169494 ORM1 Homo sapiens NM_000607 ENST00000477456 5004 orosomucoid 1 chr9:11708713 GO:0005515|GO:0006954| NM_000607 THC2558758 Hs.522356 orosomucoid 1 (ORM1), 0-117087340 GO:0002682|GO:0005576| mRNA [NM_000607] GO:0006953|GO:0005615 A_33_P3387756 C20orf201 Homo sapiens NM_001007125 ENST00000308906 198437 chromosome 20 chr20:6271499 NM_001007125 THC2617670 Hs.570316 chromosome 20 open open reading 6-62714937 reading frame 201 frame 201 (C20orf201), mRNA [NM_001007125] A_23_P150407 CREB3L1 Homo sapiens NM_052854 ENST00000530244 90993 cAMP chr11:4634275 GO:0043565|GO:0006986| NM_052854 THC2501749 Hs.405961 cAMP responsive responsive 9-46342818 GO:0006355|GO:0003700| element binding element GO:0016020|GO:0005783| protein 3-like 1 binding GO:0046983|GO:0005634| (CREB3L1), mRNA protein GO:0016021 [NM_052854] 3-like 1 A_33_P3557274 LOC644686 Homo sapiens cDNA AK130436 644686 hypothetical chr2:63745412- NP852640 Hs.689344 FLJ26926 fis, clone protein 63745353 RCT05265. LOC644686 [AK130436] A_33_P3343845 CBX7 Homo sapiens NM_175709 ENST00000490741 23492 chromobox chr22:3952977 GO:0005515|GO:0003682 | NM_175709 THC2534858 Hs.356416 chromobox homolog 7 homolog 7 8-39529719 GO:0005634|GO:0000785| (CBX7), mRNA GO:0045449|GO:0016568| [NM_175709] GO:0006333 A_33_P3331687 GPSM1 Homo sapiens G-protein NM_001145638 ENST00000392944 26086 G-protein chr9:13925293 GO:0005515|GO:0007165| NM_001145638 THC2464217 Hs.239370 signaling modulator 1 signaling 6-139252995 GO:0005737|GO:0008277| (GPSM1), transcript modulator 1 GO:0005794|GO:0005886| variant 1, mRNA GO:0005783|GO:0007275| [NM_001145638] GO:0030154|GO:0007399| GO:0005829|GO:0005096 A_23_P217528 KLF8 Homo sapiens NM_007250 ENST00000358094 11279 Kruppel-like chrX:56311439- GO:0005622|GO:0008270| NM_007250 THC2473486 Hs.646614 Kruppel-like factor factor 8 56311498 GO:0005634|GO:0003677| 8 (KLF8), transcript GO:0046872|GO:0045449 variant 1, mRNA [NM_007250] A_33_P3330683 chr2:13708701 1-137086952 A_33_P3312802 RPL13AP17 Homo sapiens NR_003680 ENST00000450028 399670 ribosomal chr7:77988714- NR_003680 Hs.568045 ribosomal protein protein L13a 77988773 L13a pseudogene 17 pseudogene 17 (RPL13AP17), non- coding RNA [NR_003680] A_33_P3274080 chrY:02445063 4-024450575 A_23_P154488 PNPT1 Homo sapiens NM_033109 ENST00000402246 87178 polyribo- chr2:55864694- GO:0005739|GO:0006396| NM_033109 THC2463838 Hs.388733 polyribonucleotide nucleotide 55863476 GO:0005758|GO:0004654| nucleotidyltransferase nucleo- GO:0000175|GO:0003723| 1 (PNPT1), mRNA tidyltrans- GO:0006402|GO:0016740 [NM_033109] ferase 1 A_23_P74609 G0S2 Homo sapiens NM_015714 ENST00000367029 50486 G0/G1switch 2 chr1:20984959 GO:0003674|GO:0007049| NM_015714 THC2463882 Hs.432132 G0/G1switch 2 (G0S2), 7-209849656 GO:0005575 mRNA [NM_015714] A_33_P3280099 CACNA1B calcium channel, ENST00000371367 774 calcium chr9:14092716 NP238281 voltage-dependent, N channel, 3-140927222 type, alpha 1B subunit voltage- [Source: HGNC dependent, N Symbol; Acc: 1389] type, alpha 1B [ENST00000371367] subunit A_23_P106069 T cell receptor X58747 ENST00000390428 chr14:2223716 NP1171923 Hs.455888 alpha variable 6 5-22237224 [Source: HGNC Symbol; Acc: 12144] [ENST00000390428] A_23_P4400 KRTAP4-11 Homo sapiens NM_033059 ENST00000391413 653240 keratin chr17:3927383 GO:0045095 NM_033059 THC2488192 Hs.30701 keratin associated associated 8-39273779 protein 4-11 (KRTAP4-11), protein 4-11 mRNA [NM_033059] A_23_P12526 TP53BP2 Homo sapiens [NM_005426] NM_005426 ENST00000391878 7159 tumor protein chr1:22396829 GO:0005515|GO:0007165| NM_005426 THC2485922 Hs.523968 tumor protein p53 p53 binding 0-223968231 GO:0048471|GO:0017124| binding protein, 2 protein, 2 GO:0005737|GO:0051059| (TP53BP2), transcript GO:0005070|GO:0006915| variant 2, mRNA GO:0005634|GO:0006917| GO:0045786 A_33_P3286157 TNFRSF4 Homo sapiens NM_003327 ENST00000497869 7293 tumor necrosis chr1:1146781- GO:0045859|GO:0005515| NM_003327 THC2619418 Hs.129780 tumor necrosis factor factor receptor 1146722 GO:0005886|GO:0030890| receptor superfamily, superfamily, GO:0042981|GO:0050710| member 4 member 4 GO:0043433|GO:0006955| (TNFRSF4), mRNA GO:0006968|GO:0005031| [NM_003327] GO:0006954|GO:0032582| GO:0042098|GO:0005887| GO:0051024|GO:0004872| GO:0009897 A_33_P3408877 A_23_P217079 DPM2 Homo sapiens NM_003863 ENST00000495270 8818 dolichyl- chr9:13069765 GO:0005515|GO:0004582| NM_003863 THC2532187 Hs.108973 dolichyl-phosphate phosphate 5-130697596 GO:0005783|GO:0009059| mannosyltransferase mannosyl- GO:0016254|GO:0018406| polypeptide 2, transferase GO:0031501|GO:0030176| regulatory subunit polypeptide 2, GO:0000506|GO:0035269| (DPM2), mRNA regulatory GO:0016020|GO:0005789| [NM_003863] subunit GO:0016021 A_23_P94533 CTSL1 Homo sapiens NM_001912 ENST00000375894 1514 cathepsin LI chr9:90345326 GO:0004197|GO:0042277| NM_001912 THC2576582 Hs.418123 cathepsin LI (CTSL1), 90345385 GO:0030984|GO:0004177| transcript variant 1, GO:0006508|GO:0008233| mRNA [NM_001912] GO:0005625|GO:0005576| GO:0005764 A_33_P3409765 MGAM maltase-glucoamylase ENST00000312952 8972 maltase-gluco- chr7:14177391 (alpha-glucosidase) amylase (alpha- 3-141773972 [Source: HGNC glucosidase) Symbol; Acc: 7043] [ENST00000312952] A_23_P50872 NDUFB7 Homo sapiens NM_004146 ENST00000215565 4713 NADH chr19:1468275 GO:0005739|GO:0003954| NM_004146 THC2467693 Hs.532853 NADH dehydrogenase dehydrogenase 9-14677745 GO:0005747|GO:0016020| (ubiquinone) 1 beta (ubiquinone) GO:0070469|GO:0006810| subcomplex, 7, 18 kDa 1 beta sub- GO:0006120|GO:0005743| (NDUFB7), nuclear complex, 7, 18 GO:0022900|GO:0008137 gene encoding mito- kDa chondrial protein, mRNA [NM_004146] A_23_P254702 DEK Homo sapiens NM_003472 ENST00000397239 7913 DEK chr6:18225006- GO:0042393|GO:0007165| NM_003472 THC2556705 Hs.484813 DEK oncogene oncogene 18224948 GO:0051789|GO:0006357| (DEK), transcript GO:0003704|GO:0005634| variant 1, mRNA GO:0019079|GO:0003677 [NM_003472] A_23_P160751 FCRL2 Homo sapiens Fc NM_030764 ENST00000368181 79368 Fc receptor- chr1:15771651 GO:0005886|GO:0005070| NM_030764 NP1165213 Hs.437393 receptor-like 2 (FCRL2), like 2 9-157716460 GO:0007267|GO:0005625| mRNA [NM_030764] GO:0004872|GO:0016021 A_33_P3285715 GLI4 GLI family zinc finger AB209654 ENST00000523812 2738 GLI family chr8:14435711 NP1473078 Hs.400533 4 [Source: HGNC zinc finger 4 5-144357174 Symbol; Acc: 4320] [ENST00000523812] A_33_P3294177 LOC100131043 Homo sapiens cDNA AK124222 100131043 hypothetical chr6:36723389 THC2479958 Hs.372129 FLJ42228 fis, Clone LOC100131043 36723330 THYMU2041252. [AK124222] A_33_P3222852 Homo sapiens AY203941 chr19:3560292 NP1212925 Hs.404342 LP3317 mRNA, 9-35602988 complete cds. [AY203941] A_23_P74330 MGC4473 Homo sapiens NR_024160 ENST00000420691 79100 hypothetical chr1:16876191 NR_024160 THC2618569 Hs.250624 hypothetical LOC79100 9-168761978 LOC79100(MGC4473), non-coding RNA [NR_024160] A_32_P448360 C17orf65 Homo sapiens NM_178542 ENST00000303061 339201 chromosome 17 chr17:4225403 NM_178542 THC2473822 Hs.656564 chromosome 17 open open reading 1-42253972 reading frame 65 frame 65 (C17orf65), mRNA [NM_178542] A_33_P3251322 MTMR14 Homo sapiens cDNA AK128312 64419 myotubularin chr3:9742908- THC2484657 FLJ46453 fis. clone related protein 9742967 THYMU3019916. 14 [AK128312] A_33_P3421867 MDGA1 MAM domain AK126965 ENST00000373401 266727 MAM domain chr6:37606891- GO:0003674|GO:0005886| THC2632760 Hs.437993 containing glycosyl- containing 37606832 GO:0007420|GO:0007275| phosphatidylinositol glycosyl- GO:0001764|GO:0046658| anchor 1 phosphat GO:0030154|GO:0021527| [Source: HGNC idylinositol GO:0007399 Symbol; Acc: 19267] anchor 1 [ENST00000373401] A_33_P3350202 MOCS3 Homo sapiens NM_014484 ENST00000244051 27304 molybdenum chr20:4957772 GO:0005515|GO:0016779| NM_014484 THC2472488 Hs.159410 molybdenum cofactor cofactor 8-49577787 GO:0034227|GO:0005524| synthesis 3 (MOCS3), synthesis 3 GO:0008033|GO:0005829| mRNA [NM_014484] GO:0002098|GO:0005737| GO:0000166|GO:0018192| GO:0006777|GO:0008152| GO:0004792|GO:0042292| GO:0016740 A_33_P3226395 LOC389634 Homo sapiens NR_024420 ENST00000420040 389634 hypothetical chr12:8509640- NR_024420 THC2545092 Hs.434403 hypothetical LOC389634 8509581 LOC389634 (LOC389634), non-coding RNA [NR_024420] A_23_P146654 BAG1 Homo sapiens mRNA NM_004323 ENST00000379707 573 BCL2- chr9:33255124- GO:0005515|GO:0005737| NM_004323 THC2494891 Hs.377484 BCL2-associated associated 33255065 GO:0030182|GO:0006915| athanogene (BAG1), athanogene GO:0006916|GO:0005634| transcript variant 1, GO:0005057|GO:0005856| [NM_004323] GO:0007166|GO:0005829 A_33_P3883912 ZCCHC10 Homo sapiens NM_017665 ENST00000324170 54819 zinc finger, chr5:13233275 GO:0008270|GO:0003676| NM_017665 THC2522779 Hs.29700 zinc finger, CCHC CCHC domain 6-132332697 GO:0046872 domain containing containing 10 10 (ZCCHC10), mRNA [NM_017665] A_24_P818268 chr15:0743575 34-074357593 A_23_P362893 TEAD1 Homo sapiens TEA NM_021961 ENST00000361985 7003 TEA domain chr11:1296522 GO:0007507|GO:0005515| NM_021961 THC2462665 Hs.655331 domain family family member 5-12965284 GO:0005667|GO:0006355| member 1 (SV40 1 (SV40 tran- GO:0003700|GO:0045944| transcriptional enhancer scriptional GO:0016563|GO:0005634 factor) (TEAD1), enhancer mRNA [NM_021961] factor) A_33_P3284854 FLJ25694 Homo sapiens cDNA AK127969 100128202 hypothetical chr13:6441494 THC2479781 FLJ46084 fis, clone protein 7-64414888 TESTI2006543. FLJ25694 [AK127969] A_33_P3245183 HRH1 Homo sapiens NM_001098213 ENST00000431010 3269 histamine chr3:11304879- GO:0007165|GO:0006954| NM_001098213 THC2706949 Hs.1570 histamine receptor receptor H1 11304938 GO:0005886|GO:0005887| H1 (HRH1), transcript GO:0004930|GO:0007268| variant 1, mRNA GO:0007200|GO:0004872| [NM_001098213] GO:0004969|GO:0045429 A_33_P3211238 VWCE Homo sapiens von NM_152718 ENST00000301770 220001 von Willebrand chr11:6102620 GO:0005509|GO:0005576 NM_152718 THC2474163 Hs.60640 Willebrand factor C factor C and 6-61026147 and EGF domains EGF domains (VWCE), mRNA [NM_152718] A_24_P209171 SH3BGRL2 Homo sapiens SH3 NM_031469 ENST00000369838 83699 SH3 domain chr6:80412808- GO:0017124|GO:0005634 NM_031469 THC2780746 Hs.302772 domain binding binding 80412867 glutamic acid-rich glutamic protein like 2 acid-rich (SH3BGRL2), mRNA protein [NM_031469] like 2 A_33_P3235987 PIN4 Homo sapiens NM_006223 ENST00000373662 5303 protein chrX:71416695- GO:0005739|GO:0005737| NM_006223 THC2548393 Hs.655623 protein (peptidylproryl (peptidyl- 71416754 GO:0006457|GO:0005759| cis/trans isomerase) prolyl GO:0005819|GO:0005730| NIMA-interacting, 4 cis/trans GO:0003755|GO:0005634| (parvulin) (PIN4), isomerase) GO:0016853|GO:0003677 nuclear gene encoding NIMA inter- mitochondrial protein, acting,4 transcript variant 1, (parvulin) mRNA [NM_006223] A_33_P3342235 CDC42EP5 Homo sapiens NM_145057 ENST00000301200 148170 CDC42 effector chr19:5497627 GO:0005515|GO:0005737| NM_145057 THC2470448 Hs.415791 CDC42 effector protein protein (Rho 0-54976211 GO:0030838|GO:0005886| (Rho GTPase binding) GTPase GO:0008360|GO:0007254| 5 (CDC42EP5), binding) 5 GO:0031274|GO:0017049| mRNA [NM_145057] GO:0007266|GO:0005856| GO:0019898 A_33_P3417086 NIPAL1 Homo sapiens NM_207330 ENST00000295461 152519 NIPA-like chr4:48039016- GO:0016020|GO:0016021 NM_207330 THC2479335 Hs.134190 NIPA like domain domain 48039075 containing 1 (NIPAL1), containing 1 mRNA [NM_20733C] A_33_P3422654 LOC100133985 Homo sapiens NR_024444 ENST00000414141 100133985 hypothetical chr2:70351510- NR_024444 THC2658593 Hs.135528 hypothetical LOC100133985 70351451 LOC100133985 (LOC100133985), non-coding RNA [NR_024444] A_33_P3273534 KRT81 Homo sapiens NM_002281 ENST00000327741 3887 keratin 81 chr12:5267975 GO:0005515|GO:0005198| NM_002281 THC2466812 Hs.658118 keratin 81 (KRT81), 8-52679699 GO:0045095 mRNA [NM_002281] A_33_P3281018 DB074148TESTI4 DB074148 chr7:15879941 Hs.722879 Homo sapiens cDNA 8-158799477 clone TESTI4017688 5′, mRNA sequence [DB074148] A_33_P3361513 NLE1 Homo sapiens NM_001014445 ENST00000360831 54475 notchless chr17:3346234 GO:0007219|GO:0005730| NM_001014445 NP1176229 Hs.85570 notchless homolog 1 homolog 1 1-33462282 GO:0001826|GO:0005634 (Drosophila) (NLE1), (Drosophila) transcript variant 2, mRNA [NM_001014445] A_33_P3412847 ENST00000450152 chr10:3975104- THC2765998 3975163 A_23_P432034 CCDC117 Homo sapiens NM_173510 ENST00000249064 150275 coiled-coil chr22:2918475 NM_173510 THC2496139 Hs.406460 coiled-coil domain domain 2-29184811 containing 117 containing 117 (CCDC117), mRNA [NM_173510] A_33_P3376365 HES2 hairy and enhancer BC012091 ENST00000377836 54626 hairy and chr1:6473312- THC2485116 Hs.118727 of split 2 (Drosophila) enhancer of 6473253 [Source: HGNC split 2 Symbol; Acc: 16005] (Drosophila) [ENST00000377836] A_33_P3887888 FLJ44511 Homo sapiens NR_033963 441307 hypothetical chr7:563781- NR_033963 THC2627801 Hs.521334 hypothetical LOC441307 LOC441307 563840 (FLJ44511), non- coding RNA [NR_033963] A_23_P111092 OR2H1 Homo sapiens NM_030883 ENST00000461453 26716 olfactory chr6:29430022- GO:0007608|GO:0007165| NM_030883 THC2734737 Hs.434715 olfactory receptor, receptor, 29430081 GO:0004984|GO:0007186| family 2, subfamily family 2, GO:0005886|GO:0004872| H, member 1 subfamily H, GO:0016021|GO:0050896 (OR2H1), mRNA member 1 [NM_030883] A_23_P89601 KRT32 Homo sapiens NM_002278 ENST00000225899 3882 keratin 32 chr17:3961616 GO:0005882|GO:0005515| NM_002278 THC2482607 Hs.41752 keratin 32 (KRT32), 3-39616104 GO:0008544|GO:0005198 mRNA[NM_002278] A_33_P3304878 WDFY4 Homo sapiens NM_020945 ENST00000374161 57705 WDFY chr10:5003052 GO:0016020|GO:0005488| NM_020945 THC2481073 Hs.287379 WDFY family family 2-50030581 GO:0016021 member 4 (WDFY4), member 4 mRNA [NM_020945] A_33_P3347099 FLJ 36000 Homo sapiens NR_027084 284124 hypothetical chr17:2190986 NR_027084 THC2503236 Hs.310247 hypothetical FLJ36000 8-21909927 FLJ36000 (FLJ36000), non-coding RNA [NR_027084] A_33_P3318861 DYTN Homo sapiens NM_001093730 ENST00000452335 391475 dystrotelin chr2:20751640 GO:0005886|GO:0005509| NM_001093730 Hs.640667 dystrotelin (DYTN), 8-207516349 GO:0008270 mRNA [NM_001093730] A_33_P3263902 MXI1 Homo sapiens NM_005962 ENST00000393134 4601 MAX chr10:1119859 GO:0008285|GO:0003714| NM_005962 THC2526907 Hs.501023 MAX interactor 1 interactor 1 81-111986040 GO:0030528|GO:0042994| (MXI1), transcript GO:0005634|GO:0003677| variant 1, mRNA GO:0045449 [NM_005962] A_33_P3350413 SVIL supervillin AK310272 ENST00000538146 6840 supervillin chr10:2976915 Hs.499209 [Source: HGNC 1-29769092 Symbol; Acc: 11480] [ENST00000538146] A_23_P218793 XPNPEP3 Homo sapiens X- NM_022098 ENST00000428799 63929 X-prolyl chr22:4132276 GO:0005739|GO:0030145| NM_022098 THC2473423 Hs.529163 prolyl aminopeptidase aminopeptidase 9-41322828 GO:0009987|GO:0004177| (aminopeptidase P) 3, (amino- GO:0008233|GO:0046872| putative (XPNPEP3), peptidase P) GO:0008237 nuclear gene encoding 3, putative mitochondrial protein, transcript variant 1, mRNA [NM_022098] A_23_P101084 SPATA22 Homo sapiens NM_032598 ENST00000541913 84690 spermato- chr17:3346555- NM_032598 THC2485663 Hs.351068 spermatogenesis genesis 3346496 associated associated 22 22 (SPATA22), transcript variant 2, mRNA [NM_032598] A_23_P250245 CD72 Homo sapiens CD72 NM_001782 ENST00000490239 971 CD72 molecule chr9:35610744- GO:0016020|GO:0005887| NM_001782 THC2472427 Hs.116481 molecule (CD72), 35610685 GO:0005529|GO:0005102| mRNA [NM_001782] GO:0007155|GO:0004888 A_33_P3334843 Homo sapiens AF318333 ENST00000331659 chr3:17151019 THC2482830 Hs.684469 ppl3439 mRNA, 9-171510140 complete cds. [AF318333] A_24_P753476 LOC340508 Homo sapiens NR_002942 340508 growth arrest- chr9:99838292- NR_002942 THC2627745 Hs.680438 growth arrest-specific specific 2 99838233 2 like 1 pseudogene like 1 (LOC340508), non- pseudogene coding RNA [NR_002942] A_23_P215751 NDUFA5 Homo sapiens NM_005000 ENST00000355749 4698 NADH chr7:12318122 GO:0005739|GO:0005747| NM_005000 THC2605956 Hs.651219 NADH dehydrogenase dehydrogenase 8-123181169 GO:0016020|GO:0070469| (ubiquinone) 1 alpha (ubiquinone) 1 GO:0016651|GO:0006810| subcomplex, 5, alpha sub- GO:0006120|GO:0005743| 13 kDa (NDUFA5), complex, 5, GO:0008137 nuclear gene encoding 13 kDa mitochondrial protein, mRNA [NM_005000] A_23_P218505 LHB Homo sapiens NM_000894 ENST00000391870 3972 luteinizing chr19:4951946 GO:0007165|GO:0007186| NM_000894 THC2475008 Hs.154704 luteinizing hormone hormone beta 4-49519405 GO:0006701|GO:0005179| beta polypeptide polypeptide GO:0007267|GO:0005625| (LHB), mRNA GO:0005576|GO:0008584 [NM_000894] A_33_P3361398 C19orf26 chromosome 19 ENST00000382477 255057 chromosome 19 chr19:1229297- THC2671154 open reading frame open reading 1229238 26 [Source: HGNC frame 26 Symbol; Acc: 28617] [ENST00000382477] A_23_P72697 GPIHBP1 Homo sapiens NM_178172 ENST00000330824 338328 glycosyl- chr8:14429896 GO:0008035|GO:0009986| NM_178172 THC2475436 Hs.426410 glycosylphosphatidylinositol phosphat 6-144299025 GO:0005886|GO:0034364| anchored high density idylinositol GO:0006869|GO:0016021| lipoprotein binding anchored high GO:0046658|GO:0008289 protein 1 (GPIHBP1), density lipo- mRNA [NM_178172] protein binding protein 1 A_33_P3336262 KIAA1751 chromosome 1 XM_003119800 ENST00000412120 85452 KIAA1751 chr1:1853767- XM_003119800 THC2488615 Hs.259619 open reading frame 1853708 222 [Source: HGNC Symbol; Acc: 27917] [ENST00000412120] A_33_P3770642 LOC503519 Homo sapiens NR_038851 503519 hypothetical chr15:2637143 NR_038851 THC2605757 Hs.371380 hypothetical LOC503519 7-26371496 LOC503519 (LOC503519), non-coding RNA [NR_038851] A_32_P200237 LOC157740 Homo sapiens AJ291676 157740 hypothetical chr8:11141291- THC2480673 Hs.591395 mRNA for chromosome protein C8orf9 11141232 8 open reading frame 9 (c80RF9). [AJ291676] A_23_P372834 AQP1 Homo sapiens NM_198098 ENST00000311813 358 aquaporin 1 chr7:30965057- GO:0005515|GO:0043005| NM_198098 NP1203192 Hs.76152 aquaporin 1 (Colton (Colton 30965115 GO:0005215|GO:0007588| blood group) blood group) GO:0043627|GO:0015696| (AQP1), transcript GO:0015670|GO:0055085| variant 1, mRNA GO:0032809|GO:0016323| [NM_198098] GO:0016324|GO:0016020| GO:0005887|GO:0015250| GO:0051739|GO:0043679| GO:0006833|GO:0009725 A_23_P46627 ADIP0R1 Homo sapiens NM_015999 ENST00000436244 51094 adiponectin chr1:20291032 GO:0006629|GO:0030308| NM_015999 NP1189273 Hs.5298 adiponectin receptor 1 receptor 1 5-202910266 GO:0019395|GO:0009755| (ADIPOR1), transcript GO:0046982|GO:0016020| variant 1, mRNA GO:0042562|GO:0004872| [NM_015999] GO:0016021|GO:0042802 A_23_P58407 UGT2B15 Homo sapiens UDP NM_001076 ENST00000338206 7366 UDP chr4:69512817- GO:0005792|GO:0006805| NM_001076 NP095455 Hs.150207 glucuronosyltransferase glucuronosyl- 69512758 GO:0016020|GO:0005783| 2 family, polypeptide transferase 2 GO:0008152|GO:0015020| B15 (UGT2B15), family, poly- GO:0016021|GO:0008202 mRNA [NM_001076] peptide B15 A_33_P3373329 TDRD1 Homo sapiens NM_198795 ENST00000369280 56155 tudor domain chr10:1159859 GO:0005515|GO:0007275| NM_198795 NP336945 Hs.333132 tudor domain containing containing 1 09-115985968 GO:0007283|GO:0031047| 1 (TDRD1), mRNA GO:0003676|GO:0007281| [NM_19879S] GO:0046872|GO:0030154| GO:0033391|GO:0005737| GO:0007126|GO:0034587| GO:0008270|GO:0043186| GO:0043046 A_33_P3414789 FSD1 Homo sapiens NM_024333 ENST00000221856 79187 fibronectin type chr19:4323373- GO:0005622|GO:0007067| NM_024333 THC2693421 Hs.28144 fibronectin type III III and SPRY 4323432 GO:0007049|GO:0005813| and SPRY domain domain GO:0005737|GO:0005874| containing 1 (FSD1), containing 1 GO:0005634|GO:0051301 mRNA [NM_024333] A_33_P3663142 FLJ12334 Homo sapiens NR_033875 400946 hypothetical chr2:20084652- NR_033875 THC2507883 Hs.289062 hypothetical LOC400946 20084711 LOC400946(FLJ12334), non-coding RNA [NR_033875] A_23_P315991 OR10A5 Homo sapiens NM_178168 ENST00000379831 144124 olfactory chr11:6866954- GO:0007608|GO:0007165| NM_178168 THC2482026 Hs.447478 olfactory receptor, receptor, 6867013 GO:0004984|GO:0007186| family 10, subfamily family 10, GO:0005886|GO:0004872| A, member 5 subfamily A, GO:0016021|GO:0050896 (OR10A5), mRNA member 5 [NM_178168] A_32_P77102 LOC100128420 Homo sapiens NR_038461 ENST00000454385 100128420 hypothetical chrX:13572449 NR_038461 THC2660884 Hs.152595 hypothetical LOC100128420 4-135724553 LOC100128420 (LOC100128420), transcript variant 1, non-coding RNA [NR_038461] A_33_P3335576 chr7:07675162 4-076751683 A_23_P29655 C3orf14 Homo sapiens NM_020685 ENST00000542214 57415 chromosome 3 chr3:62319086- NM_020685 THC2464841 Hs.47166 chromosome 3 open open reading 62319145 reading frame 14 frame 14 (C3orf14), mRNA [NM_020685] A_23_P209055 CD22 Homo sapiens NM_001771 ENST00000419549 933 CD22 molecule chr19:3583755 GO:0005515|GO:0005886| NM_001771 THC2486527 Hs.579691 CD22 molecule 5-35837614 GO:0005887|GO:0005529| (CD22), transcript GO:0007155|GO:0009897 variant 1, mRNA [NM_001771] A_33_P3261097 chr16:0780797 75-078079716 A_23_P217917 GSTM4 Homo sapiens NM_147148 ENST00000493171 2948 glutathione chr1:11020162 GO:0005737|GO:0008152| NM_147148 NP1456583 Hs.348387 glutathione S- S-transferase 8-110201686 GO:0004364|GO:0016740 transferase mu 4 mu 4 (GSTM4), transcript variant 2, mRNA [NM_147148] A_24_P350228 SLC22A23 Homo sapiens NM_021945 ENST00000380298 63027 solute carrier chr6:3410447- GO:0005215|GO:0016020| NM_021945 THC2504541 Hs.713588 solute carrier family family 22, 3324203 GO:0016021|GO:0055085| 22, member 23 member 23 GO:0006811 (SLC22A23), transcript variant 2, mRNA[NM_021945] A_23_P140290 RTN1 Homo sapiens NM_021136 ENST00000433623 6252 reticulon 1 chr14:6006995 GO:0007165|GO:0016020| NM_021136 NP1212773 Hs.368626 reticulon 1 (RTN1), 5-60069808 GO:0005783|GO:0030182| transcript variant 1, GO:0030176|GO:0016021| mRNA [NM_021136] GO:0004871 A_33_P3300267 VIT Homo sapiens NM_053276 ENST00000389975 5212 vitrin chr2:37041517- GO:0005578|GO:0005576 NM_053276 NP481077 Hs.137415 vitrin (VIT), 37041576 transcript variant 1, mRNA [NM_053276] A_33_P3410650 SPAG8 Homo sapiens NM_001039592 ENST00000471631 26206 sperm asso- chr9:35810496- GO:0008150|GO:0003674| NM_001039592 THC2690029 Hs.256747 sperm associated ciated 35810437 GO:0016020|GO:0001669 antigen 8 (SPAG8), antigen 8 transcript variant 1, mRNA [NM_001039592] A_33_P3287716 LOC100129292 Homo sapiens cDNA AK128048 100129292 hypothetical chr20:4309499 THC2624161 Hs.635587 FLJ46168 fis, clone protein 5-43095054 TESTI4003279. LOC100129292 [AK128048] A_23_P328545 GABRP Homo sapiens NM_014211 ENST00000539175 2568 gamma- chr5:17024045 GO:0031404|GO:0005230| NM_014211 THC2463912 Hs.26225 gamma-aminobutyric aminobutyric 3-170240512 GO:0030054|GO:0005886| acid (GABA) A acid (GABA) GO:0004890|GO:0045211| receptor, pi A receptor, pi GO:0034707|GO:0045202| (GABRP), mRNA GO:0016021|GO:0005254| [NM_014211] GO:0005216|GO:0006811 A_33_P3295415 ZBTB3 Homo sapiens NM_024784 ENST00000394807 79842 zinc finger and chr11:6251948 GO:0005622|GO:0005515| NM_024784 THC2477256 Hs.147554 zinc finger and BTB BTB domain 8-62519429 GO:0008270|GO:0005634| domain containing containing 3 GO:0003677|GO:0046872| 3 (ZBTB3), GO:0045449 mRNA [NM_024784] A_33_P3221761 MLL4 Homo sapiens NM_014727 ENST00000341701 9757 myeloid/ chr19:3621178 GO:0005515|GO:0035097| NM_014727 THC2491229 Hs.92236 myeloid/lymphoid or lymphoid or 2-36211841 GO:0006355|GO:0003700| mixed-lineage leukemia mixed-lineage GO:0008168|GO:0008270| 4 (MLL4), mRNA leukemia 4 GO:0005634|GO:0048096| [NM_014727] GO:0042800|GO:0046872| GO:0016740|GO:0016568 A_33_P3377380 peptidylprolyl AK093659 ENST00000450157 chr1:39990685- THC2586785 Hs.472508 isomerase E-like 39990626 pseudogene (PPIEL), non-coding RNA [Source: RefSeq DNA; Acc: NR_003929] [ENST00000450157] A_23_P76983 C14orf45 Homo sapiens NM_025057 ENST00000394009 80127 chromosome 14 chr14:7453231 NM_025057 THC2475241 Hs.644621 chromosome 14 open open reading 7-74532376 reading frame 45 frame 45 (C14orf45), mRNA [NM_025057] A_33_P3268174 KBTBD6 Homo sapiens NM_152903 ENST00000379485 89890 kelch repeat chr13:4170194 GO:0005515|GO:0008150| NM_152903 THC2492106 Hs.534040 kelch repeat and BTB and BTB 0-41701881 GO:0003674|GO:0005575 (POZ) domain con- (POZ) domain taining 6 (KBTBD6), containing 6 mRNA [NM_152903] A_33_P3333677 chr15:0227062 20-022706161 A_24_P182281 HHLA3 Homo sapiens NM_001036646 ENST00000531950 11147 HERV- chr1:70820653 GO:0005515 NM_001036646 THC2694482 Hs.142245 HERV-H LTR- H LTR- 70820712 associating 3 (HHLA3), associating 3 transcript variant 3, mRNA [NM_001036646] A_23_P68601 CST7 Homo sapiens NM_003650 ENST00000376835 8530 cystatin F chr20:2493807 GO:0006955|GO:0005737| NM_003650 THC2772477 Hs.143212 cystatin F (leukocystatin) (leukocystatin) 4-24939601 GO:0004869|GO:0005576 (CST7), mRNA [NM_003650] A_33_P3242136 FGF1 Homo sapiens NR_026696 ENST00000489937 2246 fibroblast chr5:14207733 GO:0050679|GO:0005515| NR_026696 THC2662054 Hs.483635 fibroblast growth growth factor 6-142077277 GO:0030324|GO:0005578| factor 1 (acidic) 1 (acidic) GO:0005730|GO:0005576| (FGF1), transcript GO:0005634|GO:0007275| variant 8, non- GO:0001525|GO:0001759| coding RNA GO:0009653|GO:0005615| [NR_026696] GO:0030154|GO:0007243| GO:0045785|GO:0007399| GO:0007165|GO:0005737| GO:0008543|GO:0051781| GO:0008201|GO:00080 83 A_23_P89380 SLC4A1 Homo sapiens NM_000342 ENST00000399246 6521 solute carrier chr17:4232661 GO:0006820|GO:0005215| NM_000342 THC2474785 Hs.443948 solute carrier family family 4, anion 6-42326557 GO:0008509|GO:0030018| 4, anion exchanger, exchanger, GO:0030506|GO:0006873| member 1 (erythrocyte member 1 GO:0003779|GO:0008022| membrane protein (erythrocyte GO:0042803|GO:0016323| band 3, Diego membrane GO:0005452|GO:0016020| blood group) protein band GO:0005887|GO:0030863| (SLC4A1), mRNA 3, Diego GO:0043495 [NM_000342] blood group) A_24_P945293 VPS24 Homo sapiens NM_016079 ENST00000263856 51652 vacuolar chr2:86730587- GO:0005515|GO:0007049| NM_016079 THC2493800 Hs.591582 vacuolar protein protein 86730551 GO:0005737|GO:0016020| sorting 24 homolog sorting 24 GO:0031902|GO:0031225| (S. cerevisiae) (VPS24), homolog GO:0015031|GO:0051301| transcript variant 1, (S. cerevisiae) GO:0005829|GO:0005768 mRNA[NM_016079] A_33_P3288649 HOXA10 Homo sapiens NM_018951 ENST00000381834 3206 homeobox A10 chr7:27213023- GO:0043565|GO:0005515| NM_018951 NP1400322 Hs.110637 homeobox A10 27211789 GO:0005667|GO:0006355| (HOXA10), transcript GO:0001501|GO:0003700| variant 1, mRNA GO:0009954|GO:0007275| [NM_018951] GO:0005634|GO:0030326| GO:0007283|GO:0019952 A_24_P64344 BLNK Homo sapiens B- NM_013314 ENST00000393898 29760 B-cell linker chr10:9795674 GO:0005622|GO:0005515| NM_013314 NP1463979 Hs.665244 cell linker (BLNK), 5-97956686 GO:0007242|GO:0005737| transcript variant 1, GO:0006954|GO:0005886| mRNA [NM_013314] GO:0006959|GO:0005070| GO:0030183|GO:0005068 A_33_P3422822 GJC2 Homo sapiens gap NM_20435 ENST00000366714 57165 gap junction chr1:22834746 GO:0005243|GO:0030054| NM_020435 Hs.100072 junction protein, gamma protein, 4-228347523 GO:0005886|GO:0007267| 2, 47 kDa (GJC2), gamma 2, GO:0005922|GO:0016021 mRNA[NM_020435] 47 kDa A_23_P90911 RDH14 Homo sapiens NM_020905 ENST00000381249 57665 retinol de- chr2:18736163- GO:0005783|GO:0005488| NM_020905 THC2606653 Hs.708385 retinol dehydrogenase hydrogenase 18736104 GO:0016491|GO:0055114 14 (all-trans/9-cis/11-cis) 14 (all-trans/ (RDH14), mRNA 9-cis/11-cis) [NM_020905] A_33_P3277805 chr15:0207868 79-020786820 A_23_P107051 TCAP Homo sapiens NM_003673 ENST00000309889 8557 titin-cap chr17:3782274 GO:0030240|GO:0030018| NM_003673 THC2512009 Hs.77628 titin-cap (telethonin) (telethonin) 0-37822799 GO:0001756|GO:0030916| (TCAP), mRNA GO:0045214|GO:0006950| [NM_003673] GO:0060048|GO:0030017| GO:0007512|GO:0031432| GO:0048739|GO:0005737| GO:0047485|GO:0006461| GO:0050982|GO:0003009| GO:0008307|GO:0030241| GO:0055008|GO:0070080 A_33_P3417222 CD72 CD72 molecule AK309268 ENST00000378430 971 CD72 molecule chr9:35616995- THC2629213 Hs.116481 [Source: HGNC 35616936 Symbol; Acc: 1696] [ENST00000378430] A_33_P3210848 ELFN1 Homo sapiens NM_001128636 392617 extracellular chr7:1787400- GO:0005515|GO:0016020| NM_001128636 THC2649267 Hs.42896 extracellular leucine- leucine-rich 1787459 GO:0016021 rich repeat and fibro- repeat and nectin type III fibronectin type domain containing 1 III domain (ELFN1), mRNA containing 1 [NM_001128636] A_33_P3395384 RPH3A Homo sapiens NM_001143854 ENST00000389385 22895 rabphilin chr12:1133349 GO:0005515|GO:0005215| NM_001143854 THC2472425 Hs.21239 rabphilin 3A homolog 3A homolog 02-113334961 GO:0017137|GO:0030054| (mouse) (RPH3A), (mouse) GO:0016020|GO:0045202| transcript variant 1, GO:0030672|GO:0008270| mRNA GO:0006886|GO:0046872| [NM_001143854] GO:0019898 A_33_P3315258 CHD1L Homo sapiens NM_004284 ENST00000254086 9557 chromodomain chr1:14673612 GO:0005515|GO:0006281| NM_004284 NP1075670 Hs.191164 chromodomain helicase helicase DNA 8-146736187 GO:0004003|GO:0016787| DNA binding protein binding protein GO:0000166|GO:0004386| 1-like (CHD1L), 1-like GO:0006338|GO:0005634| mRNA [NM_004284] GO:0016887|GO:0005524| GO:0003677|GO:0006974 A_33_P3288135 CPLX2 complexin 2 ENST00000506642 10814 complexin 2 chr5:17526479 [Source: HGNC 2-175264851 Symbol; Acc: 2310] [ENST00000506642] A_23_P39251 PLIN5 Homo sapiens NM_001013706 ENST00000381848 440503 perilipin 5 chr19:4523409- GO:0012511 NM_001013706 THC2604749 Hs.131034 perilipin 5 (PLIN5), 4523350 mRNA [NM_001013706] A_33_P3412295 LOC645645 Homo sapiens cDNA AK126090 645645 hypothetical chr1:23575206 THC2626252 Hs.159711 FLJ44102 fis, clone protein 2-235752121 TESTI4044035. LOC645645 [AK126090] A_33_P3294603 SLC22A31 Homo sapiens solute NM_001242757 146429 solute carrier chr16:8926261 GO:0016020|GO:0016021| NM_001242757 THC2667705 Hs.447544 carrier family 22, family 22, 5-89262556 GO:0055085|GO:0006811 member 31 (SLC22A31), member 31 mRNA [NM_001242757] A_32_P157927 immunoglobulin kappa S62210 ENST00000390243 chr2:89185420- NP836564 Hs.592929 variable 4-1 [Source: 89185479 HGNC Symbol; Acc: 5834] [ENST00000390243] A_23_P12858 C10orf27 Homo sapiens chromo- NM_152710 ENST00000536955 219793 chromosome chr10:7253406 GO:0005515|GO:0005737| NM_152710 THC2619930 Hs.386698 some 10 open reading 10 open 0-72534001 GO:0007275|GO:0005634| frame 27 (C10orf27), reading GO:0007283|GO:0030154| mRNA [NM_152710] frame 27 GO:0005829 A_33_P3244640 GRK5 Homo sapiens FP2025 AF370369 2869 G protein- chr10:1212170 NP1212828 Hs.524625 mRNA. complete cds. coupled recep- 16-121217075 [AF370369] tor kinase 5 A_33_P3293524 NEURL Homo sapiens neural- NM_004210 ENST00000369780 9148 neuralized chr10:1053522 GO:0005515|GO:0048471| NM_004210 THC2463576 Hs.730611 ized homolog (Drosophila) homolog 43-105352302 GO:0009605|GO:0005737| (NEURL), mRNA (Drosophila) GO:0007595|GO:0005886| [NM_004210] GO:0007288|GO:0008270| GO:0030317|GO:0046872| GO:0007399 A_33_P3368830 LY9 Homo sapiens lympho- NM_001033667 ENST00000368039 4063 lymphocyte chr1:16077242 GO:0005515|GO:0003674| NM_001033667 THC2602337 Hs.403857 cyte antigen 9 (LY9), antigen 9 2-160772481 GO:0016064|GO:0016020| transcript variant 2, GO:0016021|GO:0007155 mRNA [NM_001033667[ A_24_P226069 FGFBP2 Homo sapiens fibroblast NM_031950 ENST00000259989 83888 fibroblast chr4:15964292- GO:0019838|GO:0005576| NM_031950 THC2473947 Hs.98785 growth factor binding growth factor 15964233 GO:0005615 protein 2 (FGFBP2), binding mRNA [NM_031950] protein 2 A_23_P329870 RHBDF2 Homo sapiens rhom- NM_024599 ENST00000313080 79651 rhomboid 5 chr17:7446703 GO:0016020|GO:0005783| NM_024599 NP434208 Hs.464157 boid 5 homolog 2 homolog 2 7-74466978 GO:0016021 (Drosophila) (Drosophila) (RHBDF2), transcript variant 1, mRNA [NM_024599] A_33_P3629678 COL5A1 Homo sapiens collagen, NM_000093 ENST00000371817 1289 collagen, chr9:13773632 GO:0005515|GO:0005581| NM_000093 THC2469461 Hs.210283 type V, alpha 1 type V, 7-137736386 GO:0035313|GO:0001568| (COL5A1), mRNA alpha 1 GO:0048407|GO:0043394| [NM_000093] GO:0048592|GO:0005576| GO:0005588|GO:0005604| GO:0003007|GO:0005178| GO:0051128|GO:0030199| GO:0045112|GO:0043588| GO:0043206|GO:0032964| GO:0007155|GO:0008201| GO:0005201 A_33_P3218741 chr15:0893465 03-089346562 A_32_P170444 SUB1 Homo sapiens SUB1 NM_006713 ENST00000265073 10923 SUB1 chr5:32603930- GO:0005515|GO:0005667| NM_006713 THC2526142 Hs.229641 homolog (S. cerevisiae) homolog 32603989 GO:0006357|GO:0003697| (SUB1), mRNA (S. cerevisiae) GO:0003713|GO:0005730| [NM_006713] GO:0005634|GO:0003677 A_33_P3382709 LEMD3 Homo sapiens LEM NM_014319 ENST00000308330 23592 LEM chr12:6564198 GO:0030514|GO:0005515| NM_014319 THC2462620 Hs.728281 domain containing 3 domain 7-65642046 GO:0016020|GO:0000166| (LEMD3), transcript containing 3 GO:0005637|GO:0005624| variant 1, mRNA GO:0032926|GO:0005634| [NM_014319] GO:0016021|GO:0005635| GO:0003677|GO:0005639 A_23_P149368 FCRL1 Homo sapiens Fc NM_052938 ENST00000495126 115350 Fc receptor- chr1:15776560 GO:0005886|GO:0004872| NM_052938 THC2478058 Hs.656112 receptor-like 1 (FCRL1), like 1 2-157765543 GO:0016021 transcript variant 1, mRNA[NM_052938] A_24_P321525 RERG Homo sapiens RAS- NM_032918 ENST00000536465 85004 RAS-like, chr12:1526097 GO:0030308|GO:0008285| NM_032918 THC2462986 Hs.199487 like, estrogen-regulated, estrogen- 0-1526097 GO:0007264|GO:0030331| growth inhibitor (RERG), regulated, GO:0003924|GO:0005634| transcript variant 1, growth GO:0005525|GO:0005829| mRNA [NM_032918] inhibitor GO:0005622|GO:0007165| GO:0005737|GO:0000166| GO:0016020|GO:0009725| GO:0019003 A_33_P3420446 LRRD1 Homo sapiens leucine- NM_001161528 ENST00000430130 401387 leucine-rich chr7:91774317- GO:0005515|GO:0007165 NM_001161528 Hs.671729 rich repeats and death repeats and 91774258 domain containing 1 death domain (LRRD1), mRNA containing 1 [NM_001161528] A_33_P3372563 ABCC10 Homo sapiens ATP- NM_033450 ENST00000372512 89845 ATP-binding chr6:43412934- GO:0005886|GO:0000166| NM_033450 THC2678120 Hs.55879 binding cassette, subfamily cassette, 43412993 GO:0042626|GO:0016021| C (CFTR/MRP), member subfamily C GO:0055085|GO:0016887| 10 (ABCC10), transcript (CFTR/MRP), GO:0005524 variant MRP7A, mRNA member 10 [NM_033450] A_33_P3396746 KIF26B kinesin family member BC042481 ENST00000479506 55083 kinesin chr1:24553495 THC2488603 Hs.368096 26B [Source: HGNC family 8-245535017 Symbol; Acc: 25484] member 26B [ENST00000479506] A_33_P3248900 FLJ45445 Homo sapiens hypo- NR_028324 ENST00000425496 399844 hypothetical chr19:197281- NR_028324 THC2466370 Hs.638866 thetical LOC399844 LOC399844 197222 (FLJ45445), non-coding RNA [NR_028324] A_33_P3261353 BCORP1 Homo sapiens BCL6 NR_033732 ENST00000400605 286554 BCL6 chrY:21621987- NR_033732 NP1134333 Hs.211713 corepressor pseudogene 1 corepressor 21621928 (BCORP1), transcript variant pseudogene 1 1, non-coding RNA [NR_033732] A_33_P3365501 chr2:00019420 5-000194146 A_23_P58390 C4orf32 Homo sapiens chromo- NM_152400 ENST00000309733 132720 chromosome 4 chr4:11310996 GO:0016020|GO:0016021 NM_152400 THC2471790 Hs.23439 some 4 open reading frame open reading 9-113110028 32 (C4orf32), mRNA frame 32 [NM_152400] A_24_P374962 STAG3L1 Homo sapiens stromal NM_018991 ENST00000457631 54441 stromal chr7:74996711- NM_018991 THC2475336 Hs.632310 antigen 3-like 1 antigen 3 74996770 (STAG3L1), transcript like 1 variant 1, mRNA [NM_018991] A_33_P3237270 ENST00000446887 chr6:15948586 9- 159485810 A_33_P3264404 LOC100132593 Homo sapiens cDNA AK098270 100132593 hypothetical chr7:10181866 THC2486891 Hs.661011 FLJ40951 fis, clone LOC100132593 5-101818724 UTERU2010124. [AK098270] A_33_P3345614 chr19:0128117 57-012811816 A_33_P3316671 chr7:13561463 7-135614696 A_24_P234792 CSNK1G3 Homo sapiens casein NM_001044723 ENST00000395412 1456 casein kinase chr5:12295207 GO:0007165|GO:0005737| NM_001044723 THC2610386 Hs.129206 kinase 1, gamma 3 1, gamma 3 2-122952131 GO:0000166|GO:0004674| (CSNK1G3), transcript GO:0006468|GO:0016055| variant 4, mRNA GO:0005524|GO:0016740| [NM_001044723] GO:0006464 A_33_P3258320 chr19:0097854 THC2659926 02-009785343 A_23_P131139 DIRC1 Homo sapiens disrupted NM_052952 ENST00000308100 116093 disrupted in chr2:18959933 NM_052952 THC2479514 Hs.470892 in renal carcinoma 1 renal carcinoma 1-189599277 (DIRC1), mRNA 1 [NM_052952] A_33_P3507542 LEPREL2 Homo sapiens leprecan- NM_014262 ENST00000536140 10536 leprecan- chr12:6948951- GO:0031418|GO:0005506| NM_014262 THC2484662 Hs.631655 like 2 (LEPREL2), like 2 6949010 GO:0019797|GO:0005783| mRNA [NM_014262] GO:0016705|GO:0016702| GO:0046872|GO:0055114 A_23_P92035 SETD5 Homo sapiens SET NM_001080517 ENST00000466826 55209 SET domain chr3:9517207- NM_001080517 THC2521629 Hs.288164 domain containing 5 containing 5 9517266 (SETD5), mRNA [NM_001080517] A_23_P205370 ASB2 Homo sapiens ankyrin NM_016150 ENST00000315988 51676 ankyrin repeat chr14:9440066 GO:0007242|GO:0019941 NM_016150 THC2471932 Hs.510327 repeat and SOCS box and SOCS box 0-94400601 containing 2 (ASB2), containing 2 transcript variant 2, mRNA [NM_016150] A_23_P90296 DYRK1B Homo sapiens dual- NM_004714 ENST00000323039 9149 dual-specificity chr19:4031640 GO:0005515|GO:0000166| NM_004714 THC2463639 Hs.130988 specificity tyrosine-(Y)- tyrosine-(Y)- 4-40316345 GO:0004674|GO:0003713| phosphorylation regulated phosphorylation GO:0007520|GO:0006468| kinase 1B (DYRK1B), regulated GO:0005634|GO:0004713| transcript variant a, kinase 1B GO:0045893|GO:0005524| mRNA [NM_004714] GO:0016740 A_23_P115331 AHDC1 Homo sapiens AT NM_001029882 ENST00000374011 27245 AT hook, chr1:27861300- GO:0003677 NM_001029882 THC2470530 Hs.469280 hook, DNA binding DNA binding 27861242 motif, containing 1 motif, (AHDC1), mRNA containing 1 [NM_001029882] A_32_P122240 ASCL5 PREDICTED: XM_940966 647219 achaete-scute chr1:20108393 XM_940966 THC2659820 Hs.721460 Homo sapiens achaete- complex 0-201083871 scute complex homolog homolog 5 5 (Drosophila) (ASCL5), (Drosophila) mRNA [XM_940966] A_23_P87013 TAGLN Homo sapiens transgelin NM_001001522 ENST00000392951 6876 transgelin chr11:1170745 GO:0005515|GO:0005737| NM_001001522 THC2537883 Hs.410977 (TAGLN), transcript 74-117074963 GO:0007517|GO:0003779 variant 1, mRNA [NM_001001522] A_23_P318943 NCRNA00311 Homo sapiens non- NR_038859 ENST00000366314 197196 non-protein chr16:8531947 NR_038859 Hs.679002 protein coding RNA 311 coding 7-85319536 (NCRNA00311), non- RNA 311 coding RNA [NR_038859] A_23_P16523 GDF15 Homo sapiens growth NM_004864 ENST00000252809 9518 growth chr19:1849989 GO:0007165|GO:0007267| NM_004864 THC2532749 Hs.616962 differentiation factor 15 differentiation 0-18499949 GO:0007179|GO:0005576| (GDF15), mRNA factor 15 GO:0008083|GO:0005615| [NM_004864] GO:0005125 A_23_P208293 PVRL2 Homo sapiens polio- NM_001042724 ENST00000252483 5819 poliovirus chr19:4539232 GO:0005886|GO:0009986| NM_001042724 THC2582406 Hs.655455 virus receptor-related 2 receptor-related 1-45392380 GO:0019064|GO:0007286| (herpesvirus entry mediator 2 (herpesvirus GO:0051856|GO:0015026| B) (PVRL2), transcript entry mediator GO:0033005|GO:0042803| variant delta, mRNA B) GO:0060370|GO:0005915| [NM_001042724] GO:0005911|GO:0042271| GO:0002860|GO:0016021| GO:0046814|GO:0007155| GO:0050839|GO:0002891| GO:0007156 A_33_P3310588 chr22:0243707 43-024370802 A_33_P3424754 immunoglobulin lambda AY685380 ENST00000390294 chr22:2271255 NP1471093 Hs.655198 variable 1-47 [Source: 0-22712608 HGNC Symbol; Acc: 5880] [ENST00000390294] A_24_P52293 OR2A25 Homo sapiens olfactory NM_001004488 ENST00000408898 392138 olfactory chr7:14377173 GO:0007608|GO:0007165| NM_001004488 THC2741807 Hs.553787 receptor, family 2, receptor, 2-143771791 GO:0004984|GO:0007186| subfamily A, member 25 family 2, GO:0005886|GO:0004872| (OR2A25), mRNA subfamily A, GO:0016021|GO:0050896 [NM_001004488] member 25 A_33_P3364308 OTOA Homo sapiens otoancorin, BC040551 146183 otoancorin chr16:2175864 GO:0016324|GO:0005886| THC2608175 mRNA (cDNA clone 1-21758700 GO:0007605|GO:0005578| IMAGE: 5298475), with GO:0005576|GO:0031225 apparent retained intron. [BC040551] A_32_P15706 LOC100510012 PREDICTED: XM_003119034 100510012 hypothetical chr7:45849739- XM_003119034 Homo sapiens hypo- protein 45849798 thetical protein LOC100510012 LOC100510012 (LOC100510012), mRNA [XM_003119034] A_33_P3344504 APBA2 amyloid beta (A4) AK124794 ENST00000382938 321 amyloid beta chr15:2939461 THC2479001 Hs.618112 precursor protein-binding, (A4) precursor 7-29394676 family A, member 2 protein-binding, [Source: HGNC Symbol; family A, Acc: 579] member 2 [ENST00000382938] A_24_P226008 MGLL Homo sapiens mono- NM_007283 ENST00000536024 11343 monoglyceride chr3:12741383 GO:0006629|GO:0006954| NM_007283 THC2534201 Hs.277035 glyceride lipase (MGLL), lipase 2-127411122 GO:0016787|GO:0004622| transcript variant 1, GO:0047372 mRNA [NM_007283] A_33_P3402211 LOC100506220 PREDICTED: XR_110895 ENST00000534168 100506220 hypothetical chr11:7815494 XR_110895 THC2652947 Hs.666398 Homo sapiens hypo- LOC100506220 9-78155008 thetical LOC100506220 (LOC100506220), partial miscRNA [XR_110895] A_33_P3364661 RHOA ras homolog gene DC392227 ENST00000265538 387 ras homolog chr3:49449897- Hs.714276 family, member A gene family, 49449838 [Source: HGNC member A Symbol; Acc: 667] [ENST00000265538] A_33_P3815064 LOC283575 Homo sapiens cDNA AK092322 283575 hypothetical chr14:7753578 Hs.651736 FLJ35003 fis, clone protein 3-77535842 OCBBF2011960. LOC283575 [AK092322] A_33_P3213288 AIF1 Homo sapiens allograft NM_004847 199 allograft chr6:31584267- GO:0051015|GO:0008285| NM_004847 THC2484669 Hs.76364 inflammatory factor 1 inflammatory 31584326 GO:0006954|GO:0005884| (AIF1), transcript variant factor 1 GO:0005509|GO:0006950| 2, mRNA [NM_004847] GO:0032587|GO:0007050| GO:0005634|GO:0051017 A_23_P218892 EIF4G1 Homo sapiens eukaryo- NM_182917 ENST00000422614 1981 eukaryotic chr3:18404956 GO:0005515|GO:0016281| NM_182917 THC2545784 Hs.433750 tic translation initiation translation 6-184049761 GO:0005737|GO:0016070| factor 4 gamma, initiation GO:0044419|GO:0003723| 1 (EIF4G1), transcript factor 4 GO:0006446|GO:0003743| variant 1, mRNA gamma, 1 GO:0005829 [NM_182917] A_23_P316612 GLIS1 Homo sapiens GLIS NM_147193 ENST00000312233 148979 GLIS family chr1:53971989- GO:0005622|GO:0005737| NM_147193 THC2478516 Hs.306691 family zinc finger 1 zinc finger 1 53971930 GO:0045941|GO:0045944| (GLIS1), mRNA GO:0003704|GO:0005730| [NM_147193] GO:0008270|GO:0005634| GO:0000122|GO:0003677| GO:0046872 A_24_P293114 SPTBN4 Homo sapiens spectrin, NM_020971 ENST00000352632 57731 spectrin, beta, chr19:4108202 GO:0005515|GO:0030424| NM_020971 THC2487198 Hs.32706 beta, non-erythrocytic 4 non-erythro- 6-41082085 GO:0008091|GO:0007605| (SPTBN4), transcript cytic 4 GO:0030506|GO:0003779| variant sigma 1, mRNA GO:0007409|GO:0019226| [NM_020971] GO:0016363|GO:0051693| GO:0005829|GO:0009566| GO:0005737|GO:0016605| GO:0043203|GO:0005200| GO:0007628|GO:0030534| GO:0040018|GO:0016192| GO:0005856|GO:0005938| GO:0007016 A_33_P3842770 LOC644450 Homo sapiens hypo- BC022881 644450 hypothetical chrUn_gl00022 Hs.652926 thetical protein LOC644450 1:61093-61034 LOC644450, mRNA (cDNA clone IMAGE: 4606942), partial cds. [BC022881] A_33_P3259017 CSNK1G2 Homo sapiens casein NM_001319 ENST00000313975 1455 casein kinase chr19:1980390- GO:0051219|GO:0042277| NM_001319 THC2641108 Hs.651905 kinase 1, gamma 2 1, gamma 2 1980449 GO:0000287|GO:0005625| (CSNK1G2), mRNA GO:0005524|GO:0005829| [NM_001319] GO:0007165|GO:0005737| GO:0001948|GO:0046777| GO:0000166|GO:0004674| GO:0016055|GO:0016740 A_33_P3397323 ZNF441 Homo sapiens zinc NM_152355 ENST00000357901 126068 zinc finger chr19:1189478 GO:0005622|GO:0008270| NM_152355 THC2601626 Hs.675132 finger protein 441 protein 441 6-11894845 GO:0005634|GO:0003677| (ZNF441), mRNA GO:0046872|GO:0045449 [NM_152355] A_33_P3222218 NEURL1B Homo sapiens neural- NM_001142651 ENST00000369800 54492 neuralized chr5:17211323 GO:0005515|GO:0019941| NM_001142651 Hs.91521 ized homolog 1B homolog 1B 9-172113298 GO:0016874|GO:0008270| (Drosophila) (NEURL1B), (Drosophila) GO:0046872 mRNA [NM_001142651] A_33_P3325935 PQBP1 Homo sapiens polyglu- NM_001167989 ENST00000376566 10084 polyglut- chrX:48760354- GO:0005515|GO:0006355| NM_001167989 THC2468728 Hs.534384 tamine binding protein amine binding 48760413 GO:0005737|GO:0003713| 1 (PQBP1), transcript protein 1 GO:0005730|GO:0005634| variant 8, mRNA GO:0003677 [NM_001167989] A_33_P3325349 TSPAN5 Homo sapiens tetra- NM_005723 ENST00000305798 10098 tetraspanin 5 chr4:99393471- GO:0016020|GO:0016021 NM_005723 THC2462540 Hs.118118 spanin 5 (TSPAN5), 99393412 mRNA [NM_005723] A_23_P897 C1orf1l6 Homo sapiens chromo- NM_023938 ENST00000359470 79098 chromosome chr1:20719228 GO:0005737|GO:0004872 NM_023938 THC2603168 Hs.32417 some 1 open reading 1 open reading 8-207192229 frame 116 (C1orf116), frame 116 transcript variant 1, mRNA [NM_023938] A_24_P411121 TNFRSF18 Homo sapiens tumor NM_148901 ENST00000379265 8784 tumor necrosis chr1:1140761- GO:0007165|GO:0005031| NM_148901 THC2640940 Hs.212680 necrosis factor receptor factor receptor 1139819 GO:0005886|GO:0006915| superfamily, member 18 superfamily, GO:0006916|GO:0005576| (TNFRSF18), transcript member 18 GO:0004872|GO:0016021 variant 2, mRNA [NM_148901] A_33_P331345 Uncharacterized protein XR_110308 ENST00000383146 chr22:1615736 XR_110308 THC2474682 Hs.729828 [Source: UniProtKB/ 5-16157306 TrEMBL; Acc: B5MBW5] [ENST00000383146] A_33_P3353941 PIK3CD Homo sapiens phosphoino- NM_005026 ENST00000361110 5293 phosphoinosi chr1:9787045- GO:0005515|GO:0048015| NM_005026 THC2485816 Hs.518451 sitide-3-kinase, catalytic, tide-3-kinase, 9787104 GO:0005524|GO:0007165| delta polypeptide (PIK3CD), catalytic, GO:0046854|GO:0000166| mRNA [NM_005026] delta poly- GO:0046934|GO:0016303| peptide GO:0016773|GO:0006468| GO:0005942|GO:0004428| GO:0016740 A_24_P113131 BZRAP1 Homo sapiens benzo- NM_004758 ENST00000343736 9256 benzodiazapine chr17:5637865 GO:0005739|GO:0008150| NM_004758 THC2615957 Hs.112499 diazapine receptor (peri- receptor 9-56378600 GO:0005737|GO:0030156 pheral) associated protein 1 (peripheral) (BZRAP1), transcript associated variant 1, mRNA protein 1 [NM_004758] A_23_P65466 RAB2B Homo sapiens RAB2B, NM_032846 ENST00000304034 84932 RAB2B, chr14:2192798 GO:0005794|GO:0005886| NM_032846 THC2462467 Hs.22399 member RAS oncogene member RAS 7-21927928 GO:0000166|GO:0000139| family (RAB2B), transcript oncogene GO:0007264|GO:0005783| variant 1, mRNA family GO:0005789|GO:0016192| [NM_032846] GO:0015031|GO:0005525 A_24_P357468 T cell receptor alpha D13077 ENST00000390434 chr14:2231530 NP089255 Hs.697099 variable 8-2 [Source: 0-22315359 HGNC Symbol; Acc: 12147] [ENST00000390434] A_24_P321511 GOLT1B Homo sapiens golgi NM_016072 ENbT00000229314 51026 golgi chr12:2167046 GO:0005794|GO:0016020| NM_016072 THC2466175 Hs.62275 transport 1B (GOLT1B), transport IB 8-21670527 GO:0005783|GO:0016021| mRNA [NM_016072] GO:0004871|GO:0043123| GO:0016192|GO:0015031 A_33_P3415663 MBLAC2 Homo sapiens metallo- NM_203406 ENST00000546270 153364 metallo-beta- chr5:89754201- GO:0016787|GO:0008270| NM_203406 THC2736661 Hs.64004 beta-lactamase domain lactamase 89754142 GO:0046872 containing 2 (MBLAC2), domain mRNA [NM_203406] containing 2 A_23_P334173 LY75 Homo sapiens lympho- NM_002349 ENST00000263636 4065 lymphocyte chr2:16066024 GO:0006955|GO:0006954| NM_002349 THC2470974 Hs.153563 cyte antigen 75 (LY75), antigen 75 7-160660188 GO:0016020|GO:0005887| mRNA [NM_002349] GO:0005488|GO:0005529| GO:0004872|GO:0006897 A_33_P3357163 PPIEL Homo sapiens peptidyl- NR_003929 728448 peptidyl- chr1:40013341- NR_003929 THC2553158 Hs.472508 prolyl isomerase E-like prolyl iso- 40013282 pseudogene (PPIEL), non- merase E-like coding RNA [NR_003929] pseudogene A_33_P3302325 CR737729 CR737729 chr1:20740205- Hs.679084 Soares_NFL_T_GBC_S1 20740264 Homo sapiens cDNA clone IMAGp971D0264; IMAGE: 1578179 5′, mRNA sequence [CR737729] A_24_P313822 PAK4 Homo sapiens p21 NM_005884 ENST00000358801 10298 p21 protein chr19:3966833 GO:0005515|GO:0007165| NM_005884 THC2739290 Hs.20447 protein (Cdc42/Rac)- (Cdc42/Rac)- 7-39668396 GO:0005794|GO:0000166| activated kinase 4 (PAK4), activated GO:0004674|GO:0006928| transcript variant 1, kinase 4 GO:0006468|GO:0005524| mRNA [NM_005884] GO:0016740 A_33_P3259740 PREDICTED: XR_110159 ENST00000415242 chr18:7440240 XR_110159 THC2490934 Hs.514963 Homo sapiens FLJ44881 1-74402460 (FLJ44881), misc RNA [XR_110159] A_33_P3341259 LEAP2 liver expressed anti- AJ409065 ENST00000483190 116842 liver expressed chr5:13220931 THC2510296 Hs.337588 microbial peptide 2 antimicrobial 5-132209374 [Source: HGNC peptide 2 Symbol; Acc: 29571] [ENST00000483190] A_33_P3247057 C17orf109 Homo sapiens chromo- NM_001162995 ENST00000375215 643008 chromosome chr17:7363742 NM_001162995 THC2532809 Hs.528605 some 17 open reading 17 open 5-73637484 frame 109 (C17orf109), reading transcript variant 1, frame 109 mRNA [NM_001162995] A_23_P252236 KLKB1 Homo sapiens kallikrein NM_000892 ENST00000511406 3818 kallikrein B, chr4:18717844 GO:0005737|GO:0006954| NM_000892 THC2474351 Hs.237642 B, plasma (Fletcher factor) plasma 5-187178504 GO:0004252|GO:0007596| 1 (KLKB1), mRNA (Fletcher GO:0002542|GO:0051919| [NM_000892] factor) 1 GO:0006508|GO:0031639| GO:0008233|GO:0005576| GO:0005615 A_24_P84781 Homo sapiens cDNA AK021933 chr7_gl000195 THC2473856 Hs.636816 FLJ11871 fis, clone _random:3101 HEMBA1007052. 8-30959 [AK021933] A_23_P258944 DNAJB9 Homo sapiens DnaJ NM_012328 ENST00000249356 4189 DnaJ (Hsp40) chr7:10821451 GO:0005737|GO:0006457| NM_012328 THC2665858 Hs.6790 (Hsp40) homolog, sub- homolog, 5-108214574 GO:0005783|GO:0031072| family B, member 9 subfamily B, GO:0005730|GO:0005634| (DNAJB9), mRNA member 9 GO:0051082 [NM_012328] A_24_P142495 KRTAP1-3 Homo sapiens keratin NM_030966 ENST00000344363 81850 keratin chr17:3919064 GO:0008150|GO:0005576| NM_030966 NP367289 Hs.534495 associated protein 1-3 associated 8-39190589 GO:0045095|GO:0030280 (KRTAP1-3), mRNA protein 1-3 [NM_030966] A_33_P3411388 UNCX Homo sapiens UNC NM_001080461 ENST00000316333 340260 UNC chr7:1276434- GO:0043565|GO:0007389| NM_001080461 Hs.232272 homeobox (UNCX), homeobox 1276493 GO:0006355|GO:0003700| mRNA [NM_001080461] GO:0001502|GO:0045595| GO:0005634|GO:0021516| GO:0007399 A_23_P25155 GPR84 Homo sapiens G NM_020370 ENST00000551809 53831 G protein- chr12:5475642 GO:0008150|GO:0007165| NM_020370 THC2475172 Hs.306199 protein-coupled receptor coupled 3-54756364 GO:0007186|GO:0005886| 84 (GPR84), mRNA receptor 84 GO:0004930|GO:0004872| [NM_020370] GO:0016021 A_23_P259955 GDF5 Homo sapiens growth NM_000557 ENST00000374372 8200 growth chr20:3402220 GO:0005515|GO:0035136| NM_000557 THC2483977 Hs.1573 differentiation factor 5 differentia- 6-34022147 GO:0035129|GO:0007267| (GDF5), mRNA tion factor 5 GO:0042981|GO:0005576| [NM_000557] GO:0030326|GO:0005125| GO:0005615|GO:0040014| GO:0007179|GO:0032332| GO:0008083|GO:0040007 A_23_P14708 ZNF280D Homo sapiens zinc NM_017661 ENST00000267807 54816 zinc finger chr15:5692307 GO:0005622|GO:0008270| NM_017661 THC2464733 Hs.511477 finger protein 280D protein 7-56923018 GO:0005634|GO:0003677| (ZNF280D), transcript 280D GO:0046872|GO:0045449 variant 1, mRNA [NM_017661] A_23_P209652 INO80D Homo sapiens INO80 NM_017759 ENST00000233270 54891 INO80 chr2:20686966 NM_017759 THC2699199 Hs.445036 complex subunit D complex 8-206869609 (INO80D), mRNA subunit D [NM_017759] A_24_P399500 PCP2 Homo sapiens Purkinje NM_174895 ENST00000311069 126006 Purkinje chr19:7696581- GO:0007165|GO:0005096 NM_174895 THC2476340 Hs.591400 cell protein 2 (PCP2), cell protein 2 7696522 mRNA [NM_174895] A_33_P3270639 chr15:0201935 28-020193469 A_33_P3321369 LOC145757 PREDICTED: XR_109231 145757 hypothetical chr15:1014141 XR_109231 THC2646184 Hs.730396 Homo sapiens hypothetical LOC145757 36-101414195 LOC145757 (LOC145757), miscRNA [XR_109231] A_23_P120435 WFDC3 Homo sapiens WAP NM_080614 ENST00000467679 140686 WAP four- chr20:4440412 GO:0004867|GO:0005576| NM_080614 NP819189 Hs.419126 four-disulfide core domain disulfide 0-44404061 GO:0030414 3 (WFDC3), mRNA core domain 3 [NM_080614] A_23_P129629 MT3 Homo sapiens metal- NM_005954 ENST00000200691 4504 metallothionein chr16:5662493 GO:0001666|GO:0016209| NM_005954 THC2602129 Hs.73133 lothionein 3 (MT3), mRNA 3 3-56624991 GO:0050768|GO:0008283| [NM_005954] GO:0005507|GO:0019430| GO:0008270|GO:0006875| GO:0046872|GO:0008021 A_23_P319557 chromosome 21 open AF426268 ENST00000328344 chr21:4666346 THC2484291 Hs.375832 reading frame 89 8-46663527 [Source: HGNC Symbol; Acc: 16425] [ENST00000328344] A_23_P154330 TXNDC9 Homo sapiens thioredoxin NM_005783 ENST00000264255 10190 thioredoxin chr2:99935957- GO:0005515|GO:0008150| NM_005783 THC2468294 Hs.536122 domain containing 9 domain 99935898 GO:0005575 (TXNDC9), mRNA containing 9 [NM_005783] A_33_P3741678 LOC284926 full-length cDNA clone CR624447 284926 hypothetical chr22:4664907 THC2492227 Hs.594938 CS0DB004YM09 of protein 5-46649134 Neuroblastoma Cot 10- LOC284926 normalized of Homo sapiens (human). [CR624447] A_33_P3283669 ATP1A3 Homo sapiens ATPase, NM_152296 ENST00000545399 478 ATPase, chr19:4247080 GO:0000287|GO:0005794| NM_152296 THC2493019 Hs.515427 Na+/K+ transporting, alpha Na+/K+ 5-42470746 GO:0005886|GO:0005783| 3 polypeptide (ATP1A3), transporting, GO:0015077|GO:0030955| mRNA [NM_152296] alpha 3 GO:0031402|GO:0005890| polypeptide GO:0005524|GO:0006754| GO:0016787|GO:0000166| GO:0008152|GO:0016820| GO:0016021|GO:0006814| GO:0006813|GO:0005391 A_23_P17430 RBM38 Homo sapiens RNA NM_017495 ENST00000356208 55544 RNA chr20:5598362 GO:0006397|GO:0007049| NM_017495 THC2469261 Hs.236361 binding motif protein binding 2-55983681 GO:0005737|GO:0000166| 38 (RBM38), transcript motif protein GO:0003723|GO:0043484| variant 1, mRNA 38 GO:0005634|GO:0005829 [NM_017495] A_33_P3303729 chr7:05655983 THC2715632 7-056559896 A_23_P76364 CD9 Homo sapiens CD9 NM_001769 ENST00000540891 928 CD9 chr12:6342625- GO:0005515|GO:0030913| NM_001769 THC2511652 Hs.114286 molecule (CD9), mRNA molecule 6344426 GO:0005886|GO:0007342| [NM_001769] GO:0005887|GO:0031092| GO:0030168|GO:0006928| GO:0007155 A_23_P164773 FCER2 Homo sapiens Fc NM_002002 ENST00000346664 2208 Fc fragment chr19:7761956- GO:0005886|GO:0051712| NM_002002 THC2607080 Hs.465778 fragment of IgE, low of IgE, low 7761799 GO:0005529|GO:0005576| affinity II, receptor affinity II, GO:0002925|GO:0019863| for (CD23) (FCER2), receptor for GO:0005178|GO:0005488| transcript variant 1, (CD23) GO:0005887|GO:0051000| mRNA [NM_002002] GO:0004872|GO:0051773| GO:0009897 A_33_P3309999 DCAF12L2 Homo sapiens DDB1 NM_001013628 ENST00000360028 340578 DCB1 and chrX:12529862 NM_001013628 THC2635368 Hs.181867 and CUL4 associated CUL4 ass- 9-125298570 factor 12-like 2 ociated factor (DCAF12L2), mRNA 12-like 2 [NM_001013628] A_23_P94647 OR1L3 Homo sapiens olfactory NM_001005234 ENST00000304820 26735 olfactory chr9:12543770 GO:0007608|GO:0007165| NM_001005234 NP1461799 Hs.626839 receptor, family 1, sub- receptor, 8-125437767 GO:0004984|GO:0007186| family L, member 3 family 1, GO:0005886|GO:0004872| (OR1L3), mRNA subfamily L, GO:0016021|GO:0050896 [NM_001005234] member 3 A_33_P3359724 C1orf194 chromosome 1 open BG717688 ENST00000369942 127003 chromosome chr1:10964937 THC2719823 Hs.446962 reading frame 194 1 open reading 9-109649320 [Source: HGNC frame 194 Symbol; Acc: 32331] [ENST00000369942] A_33_P3386062 LOC283585 Homo sapiens NR_038445 283585 hypothetical chr14:8738870 NR_038445 THC2608384 Hs.381998 hypothetical LOC283585 0-87388759 LOC283585 (LOC283585), non-coding RNA [NR_038445] A_23_P116435 IGF2AS Homo sapiens insulin- NR_028044 ENST00000445504 51214 insulin-like chr11:2169765- NR_028044 THC2478168 Hs.716962 like growth factor 2 growth factor 2169824 antisense (IGF2AS), 2 antisense transcript variant 1, non-coding RNA [NR_028044] A_33_P3321906 GB chr7:14814305 NP1252190 9-148143118 A_33_P3236310 NOBOX Homo sapiens NOBOX NM_001080413 ENST00000467773 135935 NOBOX chr7:14409691 GO:0043565|GO:0006355| NM_001080413 THC2602516 Hs.558628 oogenesis homeobox oogenesis 0-144096851 GO:0001541|GO:0003700| (NOBOX), mRNA homeobox GO:0048477|GO:0045944| [NM_001080413] GO:0007275|GO:0005634| GO:0030154 A_24_P370172 LILRA5 Homo sapiens leukocyte NM_181879 ENST00000432233 353514 leukocyte chr19:5482277 GO:0006955|GO:0016020| NM_181879 THC2490917 Hs.710986 immunoglobulin-like re- immunoglo- 7-54822718 GO:0005576|GO:0004872| ceptor, subfamily A (with bulin-like GO:0016021 TM domain), member 5 receptor, (LILRA5), transcript subfamily A variant 3, mRNA (with TM [NM_181879] domain), member 5 A_23_P10156 CHMP6 Homo sapiens chromatin NM_024591 ENST00000325167 79643 chromatin chr17:7897350 GO:0047485|GO:0016020| NM_024591 THC2467426 Hs.514560 modifying protein 6 modifying 8-78973567 GO:0031902|GO:0031225| (CHMP6), mRNA protein 6 GO:0015031|GO:0012505| [NM_024591] GO:0005768 A_23_P48109 NINJ2 Homo sapiens ninjurin NM_016533 ENST00000305108 4815 ninjurin 2 chr12:674505- GO:0005515|GO:0016020| NM_016533 THC2613843 Hs.656450 2 (NINJ2), mRNA 674446 GO:0005887|GO:0042246| [NM_016533] GO:0007155|GO:0007399| GO:0007158 A_33_P3246203 LOC148696 Homo sapiens hypo- NR_026817 148696 hypothetical chr1:20799588 NR_026817 NP1167943 Hs.125511 thetical LOC148696 LOC148696 7-207995946 (LOC148696), non- coding RNA [NR_026817] A_24_P186943 ELN Homo sapiens elastin NM_000501 ENST00000320399 2006 elastin chr7:73474764- GO:0007585|GO:0008283| NM_000501 NP414382 Hs.647061 (ELN), transcript variant 73474823 GO:0008015|GO:0005578| 1, mRNA [NM_000501] GO:0009887|GO:0030023| GO:0005576 A_33_P3341731 chr11:0677228 14-067722755 A_32_P170397 HCG1998685 AK057625 ENST00000309874 chr15:4218802 THC2627263 Hs.650238 [Source: UniProtKB/ 5-42188084 TrEMBL; Acc: Q8TCB4] [ENST00000309874] A_33_P3237704 chr9:06648933 9-066489280 A_23_P17130 C2orf88 Homo sapiens chromo- NM_001042519 ENST00000450357 84281 chromosome chr2:19106449 GO:0005576 NM_001042519 THC2740834 Hs.389311 some 2 open reading 2 open 5-191064554 frame 88 (C2orf88), reading transcript variant 1, frame 88 mRNA [NM_001042519] A_33_P3325068 SIRT3 sirtuin 3 [Source: HGNC AK074992 ENST00000529937 23410 sirtuin 3 chr11:224126- THC2482940 Hs.716456 Symbol; Acc: 14931] 224067 [ENST00000529937] A_33_P3222069 SPHK1 Homo sapiens sphingo- NM_182965 ENST00000545180 8877 sphingosine chr17:7438386 GO:0005516|GO:0007242| NM_182965 THC2474958 Hs.68061 sine kinase 1 (SPHK1), kinase 1 7-74383926 GO:0019722|GO:0030307| transcript variant 2, GO:0006670|GO:0048146| mRNA [NM_182965] GO:0007205|GO:0008481| GO:0005829|GO:0005737| GO:0017050|GO:0000166| GO:0045987|GO:0004143| GO:0000287|GO:0030335| GO:0005624|GO:0006916| GO:0005625|GO:0005524| GO:0003677|GO:0045766| GO:0045931|GO:0046521| GO:0016740 A_24_P46953 SGK3 Homo sapiens serum/ NM_013257 ENST00000262211 23678 serum/gluco- chr8:67773851- GO:0005515|GO:0007154| NM_013257 THC2464125 Hs.613417 glucocorticoid regulated corticoid regu- 67773910 GO:0000166|GO:0004674| kinase family, member lated kinase GO:0006950|GO:0016023| 3 (SGK3), transcript family, GO:0006916|GO:0006468| variant 1, mRNA member 3 GO:0035091|GO:0005524| [NM_013257] GO:0016740|GO:0005769 A_23_P79587 ALPP Homo sapiens alkaline NM_001632 ENST00000485563 250 alkaline chr2:23324719 GO:0000287|GO:0016787| NM_001632 THC2470635 Hs.284255 phosphatase, placental phosphatase, 8-233247257 GO:0009986|GO:0005886| (ALPP), mRNA placental GO:0004035|GO:0008152| [NM_001632] GO:0008270|GO:0031225| GO:0016021 A_33_P3375476 KLHDC4 Homo sapiens kelch NM_017566 FNST0000270583 54758 kelch domain chr16:8774147 NM_017566 NP163336 Hs.123450 domain containing 4 containing 4 8-87741419 (KLHDC4), transcript variant 1, mRNA [NM_017566] A_33_P3368560 AHSA2 Homo sapiens AHA1, BC050395 130872 AHA1, chr2:61416001- THC2533385 Hs.655602 activator of heat shock activator of 61416060 90 kDa protein ATPase heat shock homolog 2 (yeast), 90 kDa protein mRNA (cDNA clone ATPase IMAGE: 5735095), homolog 2 partial cds. [BC050395] (yeast) A_33_P3713357 ALCAM Homo sapiens activated NM_001627 ENST00000491388 214 activated chr3:10529461 GO:0030424|GO:0007165| NM_001627 THC2462127 Hs.591293 leukocyte cell adhesion leukocyte 3-105294672 GO:0008045|GO:0016020| molecule (ALCAM), cell adhesion GO:0043025|GO:0005102| mRNA [NM_001627] molecule GO:0016021|GO:0007155| GO:0009897 A_33_P3277178 SCO-spondin homo- AK093431 ENST00000472850 chr7:14952403 THC2488338 Hs.632022 log (Bos taurus) 8-149524097 [Source: HGNC Symbol; Acc: 21998] [ENST00000472850] A_23_P382488 LRRC16B Homo sapiens leucinem NM_13836C ENST00000342740 90668 leucine rich chr14:2453839 NM_138360 THC2679710 Hs.26135 rich repeat containing repeat con- 9-24538589 16B (LRRC16B), taining 163 RNA [NM_138360] A_23_P23839 LGR6 Homo sapiens leucine- NM_001017403 ENST00000367277 59352 leucine-rich chr1:20228852 GO:0005515|GO:0007165| NM_001017403 NP704842 Hs.497402 rich repeat containing G repeat con- 9-202288588 GO:0007186|GO:0005886| protein-coupled receptor taining G pro- GO:0004872|GO:0016021| 6 (LGR6), transcript tein-coupled GO:0016500 variant 1, mRNA receptor 6 [NM_001017403] A_33_P3641714 C19orf66 Homo sapiens chromo- NM_018381 ENST00000397881 55337 chromosome chr19:1020352 NM_018381 THC2489089 Hs.655613 some 19 open reading 19 open 4-10203583 frame 66 (C19orf66), reading frame mRNA [NM_018381] 66 A_33_P3294826 CRABP2 Homo sapiens cellular NM_001199723 ENST00000368220 1382 cellular retinoic chr1:15667560 NM_001199723 Hs.405662 retinoic acid binding acid binding 5-156675546 protein 2 (CRABP2), protein 2 transcript variant 2, mRNA [NM_001199723] A_33_P3235117 LOC100133286 Homo sapiens hypo- NR_040084 ENST00000535199 100133286 hypothetical chr21:3744724 NR_040084 Hs.728809 thetical LOC100133286 LOC100133286 5-37447186 (LOC100133286), non- coding RNA [NR_040084] A_32_P219942 ZIC5 Homo sapiens Zic NM_033132 ENST00000397451 85416 Zic family chr13:1006157 GO:0005622|GO:0001843| NM_033132 THC2666554 Hs.508570 family member 5 (ZIC5), member 5 40-100615681 GO:0008270|GO:0007275| mRNA [NM_033132] GO:0005634|GO:0030900| GO:0003677|GO:0046872| GO:0030154|GO:0007399 A_33_P3364964 LOC100129596 PREDICTED: XNR_110585 100129596 hypothetical chr8:14604575 XR_110585 THC2489577 Hs.639990 Homo sapiens hypo- LOC100129596 6-146045697 thetical LOC100129596 (LOC100129596), misc RNA [XR_110585] A_33_P3323486 Synthetic construct DNA, AB529256 chr11:5523513 NP511198 clone: PF1KE0827, Homo 5-55235191 sapiens OR4A13P gene for Putative olfactory receptor, family 4, subfamily A, member 13, without stop codon, in Flexi system. [AB529256] A_23_P18017 CPA3 Homo sapiens carbo- NM_001870 ENST0000029G046 1359 carboxy- chr3:14861446 GO:0006508|GO:0008270| NM_001870 THC2472745 Hs.646 xypeptidase A3 (mast peptidase 5-148614524 GO:0008233|GO:0005634| cell) (CPA3), mRNA A3 (mast cell) GO:0030141|GO:0046872| [NM_001870] GO:0042629|GO:0008237| GO:0004181 A_32_P206899 DNAH2 Homo sapiens dynein, NM_020877 ENST00000389173 146754 dynein, chr17:7736930- GO:0005929|GO:0001539| NM_020877 THC2524546 Hs.367649 axonemal, heavy chain axonemal, 7736989 GO:0000166|GO:0005874| 2 (DNAH2), mRNA heavy GO:0005858|GO:0035085| [NM_020877] chain 2 GO:0003777|GO:0016887| GO:0005524|GO:0007018 A_33_P3338152 HIF3A hypoxia inducible AB118749 ENST00000457865 64344 hypoxia chr19:4681568 GO:0007165|GO:0001666| THC2485400 Hs.420830 factor 3, alpha subunit inducible 0-46815739 GO:0006355|GO:0005737| [Source: HGNC factor 3, GO:0003700|GO:0006366| Symbol; Acc: 15825] alpha subunit GO:0005634|GO:0004871 [ENST00000457865] A_32_P195401 FAM117B Homo sapiens family NM_173511 ENST00000303116 150864 family with chr2:20363437 NM_173511 THC2629531 Hs.471130 with sequence similarity sequence 5-203634434 117, member B similarity 117, (FAM117B), mRNA member B [NM_173511] A_33_P3394175 T cell receptor beta AB306151 ENST00000390363 chr7:14223965 NP285403 Hs.511735 variable 9 [Source: HGNC 1-142239592 Symbol; Acc: 12246] [ENST00000390363] A_33_P3337742 A_33_P3327491 chr19:0194789 29-019478988 A_33_P3231670 RNF208 Homo sapiens ring NM_031297 727800 ring finger chr9:14011475 NM_031297 Hs.512767 finger protein 208 protein 208 8-140114699 (RNF208), mRNA [NM_031297] A_23_P257583 DENND2A Homo sapiens DENN/ NM_015689 ENST00000496613 27147 DENN/ chr7:14021851 NM_015689 THC2601539 Hs.6385 MADD domain MADD 8-140218459 containing 2A domain (DENND2A), containing 2A mRNA [NM_015689] A_33_P3339173 SRP9 Homo sapiens signal NM_001130440 ENST00000366839 6726 signal chr1:22597724 GO:0005786|GO:0005515| NM_001130440 THC2561622 Hs.706900 recognition particle 9 recognition 3-225977302 GO:0005737|GO:0005785| kDa (SRP9), transcript particle 9 kDa GO:0006614|GO:0008312| variant 1, mRNA GO:0005047|GO:0045900 [NM_001130440] A_24_P409595 MAPK8IP1 Homo sapiens mitogen- NM_005456 ENST00000549634 9479 mitogen- chr11:4592720 GO:0005515|GO:0043005| NM_005456 THC2467596 Hs.234249 activated protein kinase activated 3-45927262 GO:0048471|GO:0006355| 8 interacting protein 1 protein kinase GO:0031434|GO:0031435| (MAPK8IP1), mRNA 8 interacting GO:0005634|GO:0006916| [NM_005456] protein 1 GO:0007258|GO:0005829| GO:0007165|GO:0005737| GO:0046329|GO:0016020| GO:0004860|GO:0019894| GO:0043508|GO:0008432| GO:0016192|GO:0005078 A_33_P3818959 SAMD11 Homo sapiens sterile NM_152486 ENST00000342066 148398 sterile alpha chr1:879580- GO:0005634 NM_152486 THC2480231 Hs.335293 alpha motif domain motif domain 879639 containing 11 containing 11 (SAMD11), mRNA [NM_152486] A_23_P47410 ESAM Homo sapiens endo- NM_138961 ENST00000464067 90952 endothelial cell chr11:1246235 GO:0005515|GO:0030054| NM_138961 THC2481228 Hs.173840 thelial cell adhesion adhesion 64-124623505 GO:0005912|GO:0005886| molecule (ESAM), molecule GO:0016021|GO:0005923| mRNA [NM_138961] GO:0007156 A_33_P3238623 LOC729723 Homo sapiens hypo- NR_034113 729723 hypothetical chr2:25258973- NR_034113 THC2491470 Hs.436366 thetical LOC729723 LOC729723 25259032 (LOC729723), non- coding RNA [NR_034113] A_33_P3278187 SLC35D2 Homo sapiens solute NM_007001 ENST00000375259 11046 solute carrier chr9:99122496- GO:0008150|GO:0005794| NM_007001 NP1465624 Hs.494556 carrier family 35, mem- family 35, 99122437 GO:0016020|GO:0005338| ber D2 (SLC35D2), member D2 GO:0008643|GO:0016021| mRNA [NM_007001] GO:0005575 A_33_P3224710 TFEC Homo sapiens trans- NM_012252 ENST00000393485 22797 transcription chr7:11558016 GO:0034605|GO:0003700| NM_012252 THC2474951 Hs.125962 cription factor EC factor EC 0-115580101 GO:0003714|GO:0003713| (TFEC), transcript GO:0005634|GO:0045449 variant 1, mRNA [NM_012252] A_33_P3372647 immunoglobulin lambda DQ098690 ENST00000390301 chr22:2278659 THC2560012 Hs.474325 variable l-36 [Source: 7-22786656 HGNC Symbol; Acc: 5876] [ENST00000390301] A_23_P85783 PHGDH Homo sapiens phospho- NM_006623 ENST00000369407 26227 phosphogly- chr1:12028552 GO:0010468|GO:0048037| NM_006623 THC2565900 Hs.487296 glycerate dehydrogenase cerate dehydro- 9-120285588 GO:0021510|GO:0019530| (PHGDH), mRNA genase GO:0008652|GO:0009055| [NM_006623] GO:0022402|GO:0031175| GO:0004617|GO:0051287| GO:0021782|GO:0007420| GO:0021915|GO:0006544| GO:0016491|GO:0006564| GO:0006566|GO:0055114| GO:0022008|GO:0006541| GO:0009448 A_23_P98532 ZDHHC5 Homo sapiens zinc NM_015457 ENST00000529480 25921 zinc finger, chr11:5746834 GO:0016020|GO:0008270| NM_015457 THC2616547 Hs.27239 finger, DHHC-type con- DHHC type 0-57468399 GO:0016021|GO:0046872| taining 5 (ZDHHC5), containing 5 GO:0016740|GO:0008415 mRNA[NM_015457] A_33_P3250767 chr17:0001814 12-000181353 A_23_P215900 SCARA3 Homo sapiens scavenger NM_016240 ENST00000301904 51435 scavenger chr8:27530383- GO:0009650|GO:0005794| NM_016240 THC2471428 Hs.128856 receptor class A, member receptor 27530442 GO:0016020|GO:0005783| 3 (SCARA3), class A, GO:0016021|GO:0006979| transcript variant 1, member 3 GO:0005044 mRNA [NM_016240] A_33_P3405754 CEP104 centrosomal protein 104 BC050721 ENST00000378223 9731 centrosomal chr1:3759797- THC2489059 Hs.509017 kDa [Source: HGNC protein 104 kDa 3759738 Symbol; Acc: 24866] [ENST00000378223] A_33_P3366431 LCN1 Homo sapiens lipocalin NM_002297 ENST00000540044 3933 lipocalin 1 chr9:13841576 GO:0005515|GO:0005215| NM_002297 THC2508562 Hs.530311 1 (tear prealbumin) (tear prealbumin) 5-138415823 GO:0004869|GO:0050909| (LCN1), mRNA GO:0006810|GO:0006508| [NM_002297] GO:0005576|GO:0050896 A_33_P3279861 Homo sapiens clone AF194718 chr22:2306358 NP079543 Hs.728758 1120 immunoglobulin 1-23241800 lambda light chain variable region mRNA, partial cds. [AF194718] A_33_P3240200 DPCD Homo sapiens deleted NM_015448 ENST00000370149 25911 deleted in chr10:1033693 GO:0005515 NM_015448 THC2757023 Hs.658128 in primary ciliary primary ciliary 50-103369409 dyskinesia homolog dyskinesia (mouse) (DPCD), homolog mRNA [NM_015448] (mouse) A_23_P123164 OR6W1P Homo sapiens olfactory NR_002140 ENST00000496192 89883 olfactory receptor, Chr7:14275972 NR_002140 THC2484218 Hs.339818 receptor, family 6, family 6, 0-142759661 subfamily W, member subfamily W, 1 pseudogene (OR6W1P), member 1 non-coding RNA pseudogene [NR_002140] A_33_P3296181 CCL3L3 Homo sapiens chemo- NM_001001437 ENST00000394484 414062 chemokine chr17:3452413 GO:0008009|GO:0006955| NM_001001437 THC2605779 Hs.512304 kine (C-C motif) ligand (C-C motif) 9-34524080 GO:0008285|GO:0006954| 3-like 3 (CCL3L3), ligand 3-Mke 3 GO:0006935|GO:0005576| mRNA [NM_001001437] GO:0005615 A_23_P152066 UBR1 Homo sapiens ubiquitin NM_174916 ENST00000382177 197131 ubiquitin protein chr15:4323534 GO:0005515|GO:0030163| NM_174916 THC2461626 Hs.591121 protein ligase E3 com- ligase E3 0-43235281 GO:0006511|GO:0005737| ponent n-recognin 1 component GO:0004842|GO:0000502| (UBR1), mRNA n-recognin 1 GO:0016874|GO:0000151| [NM_174916] GO:0008270|GO:0046872| GO:0005829 A_33_P3274105 C2orf63 chromosome 2 open ENST00000403506 130162 chromosome 2 chr2:55451395- THC2573429 reading frame 63 open reading 55451336 [Source: HGNC Symbol; frame 63 Acc: 26453] [ENST00000403506] A_33_P3238310 C21orf7 Homo sapiens chromo- NM_020152 ENST00000492930 56911 chromosome 21 chr21:3046484 GO:0005515|GO:0005634| NM_020152 THC2521637 Hs.222802 some 21 open reading open reading 2-30464901 GO:0005829 frame 7 (C21orf7), frame 7 mRNA [NM_020152] A_33_P3226560 HSU07000 breakpoint chr22:0188444 THC2481061 cluster protein {Homo 69-018844410 sapiens}region (exp = −l; wgp = 0; cg = 0), par- tial (11%) [THC2481061] A_33_P3394405 LOC727721 DB238770 TRACH3 DB238770 727721 hypothetical chr1:9241884- THC2652642 Hs.699065 Homo sapiens cDNA LOC727721 9241825 clone TRACH3034794 5′, mRNA sequence [DB238770] A_33_P3242693 SLC22A11 Homo sapiens solute NM_018484 ENST00000428570 55867 solute carrier chr11:6433893 GO:0005515|GO:0016324| NM_018484 NP852739 Hs.220844 carrier family 22 family 22 7-64338996 GO:0005886|GO:0005452| (organic anion/urate (organic anon/ GO:0015347|GO:0005887| transporter), member 11 urate trans- GO:0015711|GO:0055085| (SLC22A11), mRNA porter), member GO:0009897|GO:0006811 [NM_018484] 11 A_33_P3230788 MUSK muscle, skeletal, ENST00000374440 4593 muscle, skeletal, chr9:11346837 THC2697013 receptor tyrosine kinase receptor 3-113468432 [Source :HGNC tyrosine kinase Symbol; Acc: 7525] [ENST00000374440] A_23_P103532 GPR161 Homo sapiens NM_153832 ENST00000493800 23432 G protein- chr1:16806589 GO:0007165|GO:0007186| NM_153832 THC2628589 Hs.632453 protein-coupled receptor coupled 1-168065832 GO:0005886|GO:0004930| G 161 (GPR161), receptor 161 GO:0007275|GO:0004872| transcript variant 2, GO:0016021 mRNA [NM_153832] A_33_P3234317 RRAS2 Homo sapiens related NM_012250 ENST00000545643 22800 related RAS chr11:1429953 GO:0005622|GO:0005515| NM_012250 THC2603796 Hs.502004 RAS viral (r-ras) oncogene viral (r-ras) 8-14299479 GO:0007165|GO:0030335| homolog 2 (RRAS2), oncogene GO:0005886|GO:0000166| transcript variant 1, homolog, 2 GO:0009987|GO:0005783| mRNA [NM_012250] GO:0003924|GO:0007265| GO:0005525 A_32_P511713 C11orf42 Homo sapiens chromo- NM_173525 ENST00000316375 160298 chromosome chr11:6231561- NM_173525 THC2484466 Hs.278221 some 11 open read- 11 open 6231620 ing frame 42 (C11orf42), reading frame mRNA [NM_173525] 42 A_23_P164999 CDC34 Homo sapiens cell NM_004359 ENST00000215574 997 cell division chr19:541675- GO:0005515|GO:0051246| NM_004359 THC2746781 Hs.514997 division cycle 34 cycle 34 541734 GO:0004842|GO:0000082| homolog (S. cerevisiae) homolog GO:0016567|GO:0000166| (CDC34), mRNA (S. cerevisiae) GO:0006270|GO:0019941| [NM_004359] GO:0016874|GO:0005634| GO:0005524 A_33_P3284686 SSBP3 Homo sapiens single NM_001009955 FNST00000357475 23648 single stranded chr1:54693957- GO:0003697|GO:0030528| NM_001009955 THC2482506 Hs.658676 stranded DNA binding DNA binding 54692804 GO:0005634|GO:0003677| protein 3 (SSBP3), protein 3 GO:0045449 transcript variant 3, mRNA [NM_001009955] A_32_P89827 LOC374491 Homo sapiens TPTE NR_002815 ENST00000453498 374491 TPTE and PTEN chr13:2517168 NR_002815 THC2498037 Hs.406779 and PTEN homo- homologous 8-25171747 logous inositol lipid inositol lipid phosphatase pseudo- phosphatase gene (LOC374491), pseudogene non-coding RNA [NR_002815] A_23_P90679 STRAD B Homo sapiens STE20- NM_018571 ENST00000466770 55437 STE20-related chr2:20234482 GO:0005515|GO:0007254| NM_018571 NP1466986 Hs.652338 related kinase adaptor kinase 3-202344882 GO:0005634|GO:0006916| beta (STRADB), adaptor beta GO:0046320|GO:0005524| transcript variant 1, GO:0032147|GO:0000902| mRNA [NM_018571] GO:0005737|GO:0007049| GO:0004672|GO:0000166| GO:0006611|GO:0006468 A_32_P191004 ATAD2B Homo sapiens ATPase NM_017552 ENST00000238789 54454 ATPase family, chr2:23971968- GO:0017111|GO:0000166| NM_017552 THC2606751 Hs.467862 family, AAA domain AAA domain 23971909 GO:0005524 containing 2B containing 2B (ATAD2B), transcript variant 1, mRNA [NM_017552] A_24_P22939 ADAMTSL5 Homo sapiens NM_213604 ENST00000395467 339366 ADAMTS- chr19:1506006- GO:0005515|GO:0005578| NM_213604 THC2477262 Hs.371674 ADAMTS-like 5 like 5 1505947 GO:0008270|GO:0005576| (ADAMTSL5), GO:0004222 mRNA [NM_213604] A_33_P3315704 chr9:03561747 4-035617533 A_32_P2634 full-length cDNA CR604707 chr10:4895288 Hs.661155 clone CSODI009YC01 0-48952939 of Placenta Cot 25- normalized of Homo sapiens (human). [CR604707] A_33_P3221898 LOC339240 Homo sapiens keratin NR_001443 ENST00000445433 339240 keratin chr17:2042430 GO:0005576 NM_001443 THC2773065 Hs.420616 pseudogene (LOC339240), pseudogene 3-20424244 non-coding RNA [NR_001443] A_23_P21747 CABP5 Homo sapiens calcium NM_019855 ENST00000293255 56344 calcium chr19:4853343 GO:0007165|GO:0005737| NM_019855 NP186400 Hs.117694 binding protein 5 binding 4-48533375 GO:0005509|GO:0005575 (CABP5), mRNA protein 5 [NM_019855] A_33_P3236259 BX398892 Homo sapiens BX398892 ENST00000452342 chr2:20254198- Hs.224673 PLACENTA COT 20254257 25-NORMALIZED Homo sapiens cDNA clone CS0DI066YG03 5-PRIME, mRNA sequence [BX398892] A_33_P3210443 LOC145216 Homo sapiens hypo- NR_038436 145216 hypothetical chr14:1043227 NR_038436 NP1154465 Hs.578091 thetical LOC145216 LOC145216 81-104322840 (LOC145216), non- coding RNA [NR_038436] A_33_P3265359 HES6 Homo sapiens hairy NM_018645 ENST00000409160 55502 hairy and chr2:23914700 GO:0003712|GO:0005667| NM_018645 THC2489573 Hs.42949 and enhancer of split6 enhancer of 6-239146947 GO:0003700|GO:0006357| (Drosophila) (HES6), split 6 GO:0007275|GO:0005634| transcript variant 1, (Drosophila) GO:0030154|GO:0007399 mRNA[NM_018645] A_33_P3321657 HSPG2 Homo sapiens heparan NM_005529 ENST00000374695 3339 heparan chr1:22148799- GO:0048738|GO:0005515| NM_005529 THC2571330 Hs.562227 sulfate proteoglycan 2 sulfate pro- 22148740 GO:0001958|GO:0008104| (HSPG2), mRNA teoglycan 2 GO:0030198|GO:0007420| [NM_005529] GO:0002062|GO:0060351| GO:0005605|GO:0048704| GO:0005576|GO:0007155 A_33_P3257817 Homo sapiens cDNA AK091697 ENST00000330539 chr8:37592362- THC2485861 Hs.588388 FLJ34378 fis, clone 37592303 FEBRA2018051. [AK091697] A_24_P925314 GM2A Homo sapiens GM2 NM_000405 ENST00000357164 2760 GM2 chr5:15064966 GO:0006629|GO:0032428| NM_000405 THC2504387 Hs.483873 ganglioside activator ganglioside 2-150649721 GO:0009313|GO:0051345| (GM2A), transcript activator GO:0019915|GO:0006689| variant 1, mRNA GO:0030149|GO:0019377| [NM_000405] GO:0005764|GO:0030290| GO:0005739|GO:0005737| GO:0016004|GO:0045179| GO:0005889|GO:0006869| GO:0050885|GO:0007611| GO:0050877|GO:0009898| GO:0005319 A_24_P239177 MUC4 Homo sapiens mucin NM_018406 ENST00000479406 4585 mucin 4, cell chr3:19551483 GO:0005515|GO:0008150| NM_018406 THC2583776 Hs.369646 4, cell surface asso- surface 9-195514780 GO:0005176|GO:0030197| ciated (MUC4), associated GO:0016020|GO:0007160| transcript variant 1, GO:0005887|GO:0005578| mRNA [NM_018406] GO:0005576|GO:0007155 A_24_P334640 PAQR8 Homo sapiens progestin NM_133367 ENST00000360726 85315 progestin and chr6:52271880- GO:0048477|GO:0005886| NM_133367 THC2495245 Hs.239388 and adipoQ receptor adipoQ receptor 52271939 GO:0007275|GO:0004872| family member VIII family GO:0016021|GO:0005496| (PAQR8), mRNA member VIII GO:0030154 [NM_133367] A_24_P139901 GYPC Homo sapiens glyco- NM_002101 ENST00000409836 2995 glycophorin C chr2:12745365 GO:0005515|GO:0006493| NM_002101 THC2523220 Hs.59138 phorin C (Gerbich (Gerbich 4-127453713 GO:0005886|GO:0005887| blood group) (GYPC), blood group) GO:0009887|GO:0030863| transcript variant 1, GO:0006487 mRNA [NM_002101] A_33_P3333488 HAGH Homo sapiens hydroxy- NM_001040427 ENST00000397356 3029 hydroxyacyl- chr16:1859176- GO:0005739|GO:0005737| NM_001040427 THC2503851 Hs.157394 acylglutathione hydrolase glutathione 1859117 GO:0016787|GO:0005975| (HAGH), transcript hydrolase GO:0006750|GO:0005759| variant 2, mRNA GO:0008270|GO:0004416| [NM_001040427] GO:0046872 A_33_P3235841 SLC22A20 Homo sapiens solute NR_033396 ENST00000529062 440044 solute carrier chr11:6500949 GO:0016020|GO:0016021| NR_033396 THC2502028 Hs.532372 carrier family 22, family 22, 8-65009557 GO:0055085|GO:0006811 member 20 (SLC22A20), member 20 transcript variant 2, non-coding RNA [NR_033396] A_33_P3283300 FAM204A chromosome 10 open ENST00000469758 63877 family with chr10:1200818 THC2631812 reading frame 84 sequence 77-120081818 [Source: HGNC similarity 204, Symbol; Acc: 25794] member A [ENST00000469758] A_33_P3397520 KRTAP10-12 Homo sapiens keratin NM_198699 ENST00000400365 386685 keratin chr21:4611744 GO:0045095 NM_198699 THC2483182 Hs.297526 associated protein 10-12 associated 8-46117507 (KRTAP10-12), protein 10-12 mRNA [NM_198699] A_33_P3262555 MEX3D Homo sapiens mex-3 NM_001174118 ENST00000388824 399664 mex-3 homo- chr19:1555636- GO:0005515|GO:0005737| NM_001174118 THC2473313 Hs.436495 homolog D (C. elegans) log D 1555577 GO:0003723|GO:0008270| (MEX3D), transcript (C. elegans) GO:0005634|GO:0046872 variant 2, mRNA [NM_001174118] A_33_P3423825 Q4AIS5_9CHLB chr6:03329118 THC2681947 (Q4AIS5) Zymogen 2-033291123 granule protein 16 precursor, partial (8%) [THC2681947] A_33_P3418194 LYNX1 Homo sapiens Ly6/ NM_023946 ENST00000335822 66004 Ly6/ chr8:14384581 GO:0005886|GO:0005576| NM_023946 THC2479368 Hs.158665 neurotoxin 1 (LYMX1), neurotoxin 1 5-143845756 GO:0031225 transcript variant 1, mRNA[NM_023946] A_33_P3289034 PKD2L1 Homo sapiens poly- NM_016112 ENST00000353274 9033 polycystic chr10:1020498 GO:0008092|GO:0007165| NM_016112 THC2480195 Hs.159241 cystic kidney disease kidney disease 40-102049781 GO:0005886|GO:0005783| 2-like 1 (PKD2L1), 2-like 1 GO:0005509|GO:0016021| mRNA [NM_016112] GO:0005227|GO:0006812 A_24_P390833 MPPE1 Homo sapiens metallo- NM_023075 ENST00000399978 65258 metallo- chr18:1188869 GO:0016787|GO:0016020| NM_023075 NP1162383 Hs.712666 phosphoesterase 1 phosphoe sterase 7-11886995 GO:0016021|GO:0046872 (MPPE1), transcript 1 variant 1, mRNA [NM_023075] A_32_P494620 LHFPL5 Homo sapiens lipoma- NM_182548 ENST00000373853 222662 lipoma chr6:35782332- GO:0016324|GO:0016020| NM_182548 THC2483295 Hs.367947 HMGIC fusion partner- HMGIC 35782391 GO:0007605|GO:0060088| like 5 (LHFPL5), fusion GO:0016021 mRNA[NM_182548] partnerlike 5 A_32_P399187 LOC146336 Homo sapiens NR_027242 146336 hypothetical chr16:1115380- NR_027242 THC2478752 Hs.250557 hypothetical LOC146336 1115321 LOC146336 (LOC146336), non- coding RNA [NR_027242] A_33_P3279124 FAM21C Homo sapiens family NM_001169107 ENST00000434114 253725 family with chr10:4625045 NM_001169107 THC2572798 Hs.365286 with sequence similarity sequence 8-46250517 21, member C similarity 21, (FAM21C), transcript member C variant 3, mRNA [NM_001169107] A_33_P3554318 TRIM3 Homo sapiens tripartite NM_006458 ENST00000532542 10612 tripartite motif chr11:6470292- GO:0005622|GO:0005737| NM_006458 THC2622264 Hs.591992 motif containing 3 containing 3 6470233 GO:0008270|GO:0015031| (TRIM3), transcript GO:0008022|GO:0046872| variant 1, mRNA GO:0005769|GO:0007399 [NM_006458] A_32_P79434 PTPRN2 Homo sapiens protein NM_002847 ENST00000389418 5799 protein tyrosine chr7:15733197 GO:0005515|GO:0006470| NM_002847 THC2484697 Hs.490789 tyrosine phosphatase, phosphatase, 2-157331913 GO:0016787|GO:0016020| receptor type, N receptor type, GO:0005887|GO:0005001| polypeptide 2 N polypeptide 2 GO:0004872 (PTPRN2), transcript variant 1, mRNA [NM_002847] A_33_P3352085 Q6IMN1_HUMAN chr13:1145233 THC2591638 (Q6IMN1) Growth 45-114523286 arrest-specific 6, partial (13%) [THC2591638] A_33_P3239587 MXRA7 Homo sapiens matrix- NM_001008529 ENST00000375036 439921 matrix- chr17:7467571 GO:0016020|GO:0016021 NM_001008529 THC2468893 Hs.250723 remodelling associated remodelling 2-74675653 7 (MXRA7), transcript associated 7 variant 2, mRNA [NM_001008529] A_33_P3371270 TUG1 Homo sapiens taurine NR_002323 55000 taurine chr22:3137524 NR_002323 THC2533843 upregulated 1 (non- upregulated 1-31375300 protein coding) (TUG1), 1 (non- non-coding RNA protein coding) [NR_002323] A_33_P3311285 LMNA Homo sapiens lamin NM_170707 ENST00000347559 4000 lamin A/C chr1:15610977 GO:0005515|GO:0005737| NM_170707 THC2495163 Hs.594444 A/C (LMNA), transcript 4-156109833 GO:0005886|GO:0005198| variant 1, mRNA GO:0006998|GO:0005634| [NM_170707] GO:0007283|GO:0005626| GO:0016363|GO:0005638 A_24_P204727 immunoglobulin+ Z18824 ENST00000390624 chr14:1069939 NP120643 Hs.703936 heavy variable 3-48 89-106993930 [Source: HGNC Symbol; Acc: 5606] 8 ENST00000390624] A_33_P3293785 KRTAP10-3 Homo sapiens keratin NM_198696 ENST00000391620 386682 keratin chr21:4597796 GO:0045095 NM_198696 NP815036 Hs.688630 associated protein 10-3 associated 5-45977906 (KRTAP10-3), mRNA protein 10-3 [NM_198696] A_23_P31984 ACTL7A Homo sapiens actin- NM_006687 ENST00000333999 10881 actin-like 7A chr9:11162584 GO:0005515|GO:0005737| NM_006687 THC2472182 Hs.123530 like 7A (ACTL7A), 8-111625907 GO:0005200|GO:0009434| mRNA [NM_006687] GO:0005856|GO:0001673 A_33_P3396129 KATNB1 Homo sapiens mRNA AB209250 10300 katanin p80 chr16:5779021 THC2603047 Hs.275675 for katanin p80 subunit (WD repeat 9-57790278 B 1 variant protein. containing) [AB209250] subunit B 1 A_33_P3336720 HAMP Homo sapiens hepcidin NM_021175 ENST00000222304 57817 hepcidin anti- chr19:3577598 GO:0006879|GO:0006955| NM_021175 THC2478089 Hs.8821 antimicrobial peptide microbial peptide 6-35776045 GO:0005737|GO:0045179| (HAMP), mRNA GO:0005179|GO:0050832| [NM_021175] GO:0031640|GO:0005576| GO:0042742 A_33_P3343305 chr19:0403919 99-040391940 A_23_P67127 TMEM145 Homo sapiens trans- NM_173633 ENST00000301204 284339 transmembrane chr19:4282914 GO:0016020|GO:0016021 NM_173633 THC2483750 Hs.382075 membrane protein 145 protein 145 1-42829200 (TMEM145), mRNA [NM_173633] A_33_P3415859 NLRC3 NLR family, CARD AK090476 ENST00000324659 197358 NLR family, chr16:3612970- THC2563500 Hs.728268 domain containing 3 CARD domain 3612911 [Source: HGNC containing 3 Symbol; Acc: 29889] [ENST00000324659] A_33_P3321293 IQGAP3 Homo sapiens IQ NM_178229 ENST00000361170 128239 IQ motif con- chr1:15649525 GO:0005622|GO:0005099| NM_178229 THC2464087 Hs.591495 motif containing GTPase taining GTPase 7-156495198 GO:0051056|GO:0007165| activating protein 3 activating GO:0005516 (IQGAP3), mRNA protein 3 [NM_178229] A_33_P3213392 HCG2045795Novel ENST00000375713 chr13:1122783 THC2752485 protein [Source: 96-112278455 UniProtKB/TrEMBL; Acc: Q5T400] [ENST00000375713] A_33_P3275435 LOC100216545 Homo sapiens hypo- NR_024586 100216545 hypothetical chr7:10465105 NR_024586 Hs.631150 thetical LOC100216545 LOC100216545 2-104650993 (LOC100216545), non- coding RNA [NR_024586] A_33_P3408244 SPRNP1 Homo sapiens shadow NR_033789 ENST00000450958 399833 shadow of prion chr10:1353813 NR_033789 THC2482646 Hs.660426 of prion protein homo- protein homolog 93-135381334 log (zebrafish) pseudo- (zebrafish) gene 1 (SPRNP1), pseudogene 1 non-coding RNA [NR_033789] A_24_P312692 APIS Homo sapiens apoptosis NM_006595 ENST00000378852 8539 apoptosis chr11:4336536 GO:0005737|GO:0017134| NM_006595 THC2656401 Hs.435771 inhibitor 5 (API5), inhibitor 5 7-43365426 GO:0005488|GO:0006915| transcript variant 2, GO:0006916|GO:0005681| mRNA [NM_006595] GO:0005634 A_23_P253791 CAMP Homo sapiens cathelicidin NM_004345 ENST00000296435 820 cathelicidin chr3:48266856- GO:0050829|GO:0042581| NM_004345 THC2473094 Hs.51120 antimicrobial peptide antimicrobial 48266915 GO:0005576 (CAMP), mRNA peptide [NM_004345] A_24_P413941 C2orf69 Homo sapiens chromo- NM_153689 ENST00000319974 205327 chromosome 2 chr2:20079267 GO:0005576 NM_153689 THC2462315 Hs.471040 some 2 open reading open reading 0-200792729 frame 69 (C2orf69), frame 69 mRNA [NM_153689] A_33_P3409337 C14orf45 Homo sapiens chromo- NM_025057 ENST00000492247 80127 chromosome 14 chr14:7452389 NM_025057 THC2620212 Hs.644621 some 14 open reading open reading 6-74523955 frame 45 (C14orf45), frame 45 mRNA [NM_025057] A_23_P61050 MLKL Homo sapiens mixed NM_152649 ENST00000308807 197259 mixed lineage chr16:7470603 GO:0005515|GO:0006468| NM_152649 THC2471524 Hs.119878 lineage kinase domain- kinase domain- 8-74705979 GO:0004713|GO:0005524 like (MLKL), transcript like variant 1, mRNA [NM_152649] A_33_P3327818 AL157466 ENST00000366116 chr9:3452364- THC2612300 Hs.664105 3452305 A_33_P3338793 KCNC3 Homo sapiens potas- NM_004977 ENST00000477616 3748 potassium chr19:5081905 GO:0005515|GO:0008219| NM_004977 THC2481537 Hs.467146 sium voltage-gated voltage-gated 0-50818991 GO:0005244|GO:0016020| channel, Shaw-related channel, Shaw- GO:0008076|GO:0005249| subfamily, member 3 related subfamily, GO:0030955|GO:0016021| (KCNC3), mRNA member 3 GO:0055085|GO:0006813| [NM_004977] GO:0006811 A_33_P3292739 USP17L2 Homo sapiens ubiquitin NM_201402 ENST00000333796 377630 ubiquitin specific chr8:11994918- GO:0006511|GO:0006915| NM_201402 THC2525229 Hs.531448 specific peptidase 17- peptidase 17- 11994859 GO:0008233|GO:0005634| like 2 (USP17L2), like 2 GO:0008234|GO:0004221 mRNA [NM_201402] A_23_P81103 SFRP2 Homo sapiens secreted NM_003013 ENST00000274063 6423 secreted chr4:15470288 GO:0005515|GO:0031668| NM_003013 THC2621036 Hs.481022 frizzled-related protein frizzled- 4-154702825 GO:0001756|GO:0007275| 2 (SFRP2), mRNA related protein 2 GO:0005576|GO:0016055| [NM_003013] GO:0030154 A_24_P278192 AK1 Homo sapiens adenylate NM_000476 ENST00000373176 203 adenylate kinase chr9:13062923 GO:0005515|GO:0006139| NM_000476 THC2468589 Hs.175473 kinase 1 (AK1), 1 5-130629176 GO:0005737|GO:0046034| mRNA [NM_000476] GO:0000166|GO:0005634| GO:0004017|GO:0019206| GO:0005524|GO:0016740| GO:0005829 A_33_P3395675 immunoglobulin lambda EU937523 ENST00000390323 chr22:2324333 NP093469 Hs.625768 constant 2 (Kern-Oz- 6-23243395 marker) [Source: HGNC Symbol; Acc: 5856] [ENST00000390323] A_23_P141863 ZNF544 Homo sapiens zinc NM_014480 ENST00000415203 27300 zinc finger chr19:5877419 GO:0005622|GO:0006355| NM_014480 THC2464356 Hs.438994 finger protein 544 protein 544 9-58774259 GO:0008270|GO:0005634| (ZNF544), mRNA GO:0003677|GO:0046872 [NM_014480] A_23_P87082 ROBO3 Homo sapiens round- NM_022370 ENST00000524971 64221 roundabout, axon chr11:1247498 GO:0016020|GO:0006935| NM_022370 THC2480495 Hs.435621 about, axon guidance guidance recep- 24-124750352 GO:0007411|GO:0007275| receptor, homolog 3 tor, homolog 3 GO:0004872|GO:0016021| (Drosophila) (ROBO3), (Drosophila) GO:0030154|GO:0007399 mRNA [NM_022370] A_23_P28707 OGFR Homo sapiens opioid NM_007346 ENST00000370461 11054 opioid growth chr20:6144521 GO:0005737|GO:0016020| NM_007346 NP208924 Hs.67896 growth factor receptor factor receptor 3-61445272 GO:0005634|GO:0004872| (OGFR), mRNA GO:0005575|GO:0001558| [NM_007346] GO:0004985 A_33_P3393245 FTSJD2 Homo sapiens FtsJ NM_015050 ENST00000373420 23070 FtsJ methyl- chr6:37446962- GO:0005622|GO:0005515| NM_015050 THC2670365 HvS20102 methyltransferase domain transferase 37447021 GO:0008168|GO:0005634| containing 2 (FTSJD2), domain GO:0003676|GO:0032259| mRNA [NM_01S0S0] containing 2 GO:0016740 A_23_P305140 C10orf32 Homo sapiens chromo- NM_144591 ENST00000369883 110012 chromosome 10 chr10:1046238 NM_144591 THC2472913 Hs.34492 some 10 open reading open reading 52-104623911 frame 32 (C10orf32), frame 32 transcript variant 2, mRNA[NM_144591] A_33_P3404759 chr1:24332762 2-243327563 A_23_P157628 DEFB4A Homo sapiens defensin, NM_004942 ENST00000302247 1673 defensin, chr8:7754081- GO:0006955|GO:0007186| NM_004942 THC2478963 Hs.105924 beta 4A (DEFB4A), beta 4A 7754140 GO:0006935|GO:0005576| mRNA [NM_004942] GO:0042742 A_33_P3325952 Homo sapiens cDNA AK022213 chr12:1238878 FLJ12151 fis, clone 12-123887753 MAMMA1000431. [AK022213] A_33_P3384133 C17orf99 Homo sapiens chromo- NM_001163075 ENST00000340363 100141515 chromosome 17 chr17:7616217 GO:0005576 NM_001163075 THC2479539 Hs.633034 some 17 open reading open reading 5-76162234 frame 99 (C17orf99), frame 99 mRNA [NM_001163075] A_24_P231546 FAM178B Homo sapiens family NM_016490 ENST00000490605 51252 family with chr2:97541686- NM_016490 Hs.107922 with sequence similarity sequence 97541627 178, member B similarity 178, (FAM178B), member B transcript variant B, mRNA [NM_016490] A_32_P29954 NCRNA00168 Homo sapiens non- NR_033387 ENST00000421697 642394 non-protein chr10:1599022- NR_033387 THC2689654 Hs.568831 protein coding RNA coding RNA 1599081 168 (NCRNA00168), 168 non-coding RNA [NR033387] A_33_P3279362 GRIK1-AS1 Homo sapiens GRIK1 NR_027021 ENST00000455392 642976 GRIK1 antisense chr21:3112117 NR_027021 antisense RNA 1 (non- RNA 1 (non- 4-31121233 protein coding) protein coding) (GRIK1-AS1), non- coding RNA [NR_027021] A_33_P3629131 CDRT3 DKFZp686P15240_r1 BX484257 94145 CMT1A chr17:1537409 Hs.697356 686 (synonym:hlcc3) duplicated 0-15374149 Homo sapiens cDNA region clone DKFZp686P15240 transcript 3 5′, mRNA sequence [BX484257] A_33_P3331282 LOC648987 Homo sapiens hypo- NR_034085 648987 hypothetical chr5:43016241- NR_034085 THC2492334 Hs.649468 thetical LOC648987 LOC648987 43016182 (LOC648987), transcript variant 1, non- coding RNA [NR_034085] A_33_P3301346 RBM44 RNA binding ENST00000491996 375316 RNA binding chr2:23874345 motif protein 44 motif protein 44 2-238743511 [Source: HGNC Symbol; Acc: 24756] [ENST00000491996] A_33_P3272990 FKBP8 Homo sapiens FK506 NM_012181 ENST00000453489 23770 FK506 binding chr19:1864280 GO:0005739|GO:0007242| NM_012181 THC2783704 Hs.173464 binding protein 8, 38 protein 8, 38 1-18642742 GO:0016020|GO:0006457| kDa (FKBP8), mRNA kDa GO:0005488|GO:0044419| [NM_012181] GO:0005509|GO:0003755| GO:0006915|GO:0016021| GO:0016853 A_33_P3220422 POM121L12 Homo sapiens POM121 NM_182595 ENST00000408890 285877 POM121 mem- chr7:53104196- NM_182595 THC2480958 Hs.381970 membrane glycoprotein- brane glyco 53104255 like 12 (POM121L12), protein-like 12 mRNA [NM_182595] A_24_P322771 TFF1 Homo sapiens trefoil NM_003225 ENST00000291527 7031 trefoil factor 1 chr21:4378349 GO:0030277|GO:0005975| NM_003225 THC2463848 Hs.162807 factor 1 (TFF1), mRNA 9-43783440 GO:0010039|GO:0007586| [NM_003225] GO:0006950|GO:0043434| GO:0005576|GO:0032355| GO:0008083|GO:0005615 A_23_P120364 PPDPF Homo sapiens pancreatic NM_024299 ENST00000370178 79144 pancreatic pro- chr20:6215344 GO:0007275|GO:0030154 NM_024299 THC2580274 Hs.79625 progenitor cell differ- genitor cell diff- 0-62153499 entiation and proliferation erentiation and factor homolog (zebra- proliferation fish) (PPDPF), factor homo- mRNA [NM_024299] log (zebrafish) A_23_P140848 MPHOSPH6 Homo sapiens M- NM_005792 ENST00000258169 10200 M-phase phos- chr16:8218221 GO:0005515|GO:0005737| NM_005792 THC2461936 Hs.344400 phase phosphoprotein 6 phoprotein 6 5-82182156 GO:0000087|GO:0005730| (MPHOSPH6), GO:0005634 mRNA [NM_005792] A_33_P3261505 EPG5 Homo sapiens ectopic NM_020964 ENST00000540322 57724 ectopic P- chr18:4342778 NM_020964 THC2604384 Hs.514843 P-granules autophagy granules auto- 1-43427722 protein 5 homolog phagy protein (C. elegans) (EPG5), 5 homolog mRNA [NM_020964] (C. elegans) A_33_P3421108 OPAP_DROME ENST00000507296 chr4:15855892 THC2680858 (P23488) Male-specific 6-158558984 opa-containing protein precursor (Protein dromsopa), partial (23%) [THC2680858] A_23_P250164 HGD Homo sapiens homo- NM_000187 ENST00000283871 3081 homogentisate chr3:12034726 GO:0006559|GO:0006520| NM_000187 THC2691554 Hs.368254 gentisate 1,2-dioxygenase 1,2-dioxygenase 2-120347203 GO:0004411|GO:0005506| (HGD), mRNA GO:0016491|GO:0006572| [NM_000187] GO:0046872|GO:0055114 A_33_P3275835 TOR2A Homo sapiens torsin NM_001134430 ENST00000336067 27433 torsin family chr9:13049663 GO:0017111|GO:0005179| NM_001134430 THC2485391 Hs.444106 family 2, member A 2, member A 8-130496579 GO:0000166|GO:0005783| (TOR2A), transcript GO:0051085|GO:0005576| variant 3, mRNA GO:0005524 [NM_001134430] A_33_P3306948 LRP6 Homo sapiens low NM_002336 ENST00000538239 4040 low density chr12:1226912 GO:0005515|GO.0005886| NM_002336 THC2652456 Hs.584775 density lipoprotein lipoprotein 3-12269064 GO:0030178|GO:0005624| receptor-related protein receptor- GO:0007275|GO:0009952| 6 (LRP6), mRNA related GO:0001702|GO:0006897| [NM_002336] protein 6 GO:0005041|GO:0042074| GO:0035116|GO:0004872| GO:0016021|GO:0035115| GO:0060070|GO:0042733 A_33_P3289167 2BTB32 Homo sapiens zinc NM_014383 ENST00000392197 27033 zinc finger chr19:3620666 GO:0005515|GO:0030097| NM_014383 THC2475057 Hs.99430 finger and BTB and BTB 7-36206726 GO:0003714|GO:0003704| domain containing 32 domain GO:0005634|GO:0000122| (ZBTB32), mRNA containing 32 GO:0000228|GO:0001817| [NM_014383] GO:0003677|GO:0046872| GO:0005622|GO:0042098| GO:0005654|GO:0008270| GO:0045449 A_33_P3326553 TMEM82 Homo sapiens trans- NM_001013641 ENST00000375782 388595 transmembrane chr1:16074418- GO:0016020|GO:0016021 NM_001013641 THC2477712 Hs.454828 membrane protein 82 protein 82 16074477 (TMEM82), mRNA [NM_001013641] A_23_P130169 TBKBP1 Homo sapiens TBK1 NM_014726 ENST00000361722 9755 TBK1 binding chr17:4578854 GO:0045087 NM_014726 THC2618682 Hs.94790 binding protein 1 protein 1 9-45788608 (TBKBP1), mRNA [NM_014726] A_33_P3232945 F2RL1 Homo sapiens coagu- NM_005242 ENST00000296677 2150 coagulation chr5:76130985- GO:0005794|GO:0005886| NM_005242 THC2464357 Hs.154299 lation factor II (throm- factor II 76131044 GO:0004930|GO:0015057| bin) receptor-like 1 (thrombin) GO:0005102|GO:0007204| (F2RL1), mRNA receptor-like GO:0002690|GO:0050927| [NM_005242] 1 GO:0007165|GO:0007186| GO:0030193|GO:0005887| GO:0004872 A_33_P3381870 EPB49 Homo sapiens erythro- NM_001978 ENST00000358242 2039 erythrocyte chr8:21939976- GO:0005737|GO:0007010| NM_001978 THC2463142 Hs.106124 cyte membrane protein membrane 21940035 GO:0003779|GO:0015629| band 4.9 (dematin) protein band GO:0051017|GO:0051693 (EPB49), transcript 4.9 (dematin) variant 1, mRNA [NM_001978] A_33_P3404889 LPHN2 latrophilin 2 [Source: AB018329 ENST00000370725 23266 latrophilin 2 chr1:82452653- NP1249049 Hs.24212 HGNC Symbol; 82452712 Acc:18582] [ENST00000370725] A_33_P3789693 MGC24103 PREDICTED: XR 108934 158295 hypothetical chr9:16526545- XR 108934 NP1159657 Hs.664877 Homo sapiens hypo- MGC24103 16526486 thetical MGC24103 (MGC24103), miscRNA [XR 108934] A_24_P253723 C17orf91 Homo sapiens chromo- NR_028502 84981 chromosome chr17:1615641- NR_028502 THC2662960 Hs.597755 some 17 open reading 17 open reading 1615582 frame 91 (C17orf91), frame 91 transcript variant 1, non-coding RNA [NR_028502] A_33_P3282181 ARHGAP4 Homo sapiens Rho NM_001164741 ENST00000404127 393 Rho GTPase chrX:15317302 GO:0008624|GO:0006915| NM_001164741 THC2528773 Hs.701324 GTPase activating aclivating 8-153172969 GO:0005634|GO:0007266| protein 4 (ARHGAP4), protein 4 GO:0005100|GO:0005829| transcript variant 1, GO:0005085|GO:0005622| mRNA [NM_001164741] GO:0007165|GO:0005737| GO:0005070|GO:0007010| GO:0005925|GO:0005096 A_32_P150876 LOC339290 Homo sapiens hypo- NR_015389 339290 hypothetical chr18:5245815- NR_015389 THC2499959 Hs.643553 thetical LOC339290 LOC339290 5245874 (LOC339290), non- coding RNA [NR_015389] A_24_P148151 TSNAX Homo sapiens translin- NM_005999 ENST00000475168 7257 translin- chr1:23170169 GO:0043565|GO:0048471| NM_005999 THC2467018 Hs.13318 associated factor X associated 2-231701751 GO:0005737|GO:0008565| (TSNAX), mRNA factor X GO:0007275|GO:0005634| [NM_005999] GO:0007283|GO:0030154 A_23_P52986 VWCE Homo sapiens von NM_152718 ENST00000335613 220001 von Willebrand chr11:6102584 GO:0005509|GO:0005576 NM_152718 THC2474163 Hs.60640 Willebrand factor C factor C and 0-61025781 and EGF domains EGF domains (VWCE), mRNA [NM_152718] A_23_P200741 DPT Homo sapiens dermato- NM_001937 ENST00000367817 1805 dermatopontin chr1:16866480 GO:0005515|GO:0008285| NM_001937 THC2466283 Hs.80552 pontin (DPT), mRNA 7-168664748 GO:0030199|GO:0005578| [NM_001937] GO:0005576|GO:0007155 A_33_P3339865 CALML5 Homo sapiens calmo- NM_017422 ENST00000380332 51806 calmodulin- chr10:5540719- GO:0005515|GO:0007165| NM_017422 THC2476793 Hs.180142 dulin-like 5 (CALML5), like 5 5540660 GO:0008544|GO:0005509 mRNA [NM_017422] A_33_P3349591 LOC100129461 Homo sapiens cDNA BC133670 100129461 hypothetical chr6:5043050- THC2497217 Hs.131700 clone IMAGE: 40108878. LOC100129461 5043109 [BC133670] A_33_P3396275 C15orf62 Homo sapiens chromo- NM_001130448 ENST00000344320 643338 chromosome chr15:4106312 GO:0005739 NM_001130448 THC2606201 Hs.631715 some 15 open reading 15 open 3-41063182 frame 62 (C15orf62), reading mRNA [NM_001130448] frame 62 A_23_P301995 LIN9 Homo sapiens lin-9 (LIN9), NM_173083 ENST00000366807 286826 lin-9 chr1:22645393 GO:0006260|GO:0007049| NM_173083 THC2484578 Hs.120817 homolog (C. elegans) homolog 7-226453300 GO:0005654|GO:0005634 mRNA [NM_173083] (C. elegans) A_33_P3245660 chr10:0832623 91-083262450 A_33_P3238543 LOC92659 Homo sapiens hypo- NR_015454 92659 hypothetical chr17:7988854 NR_015454 THC2602138 Hs.336958 thetical LOC92659 LOC92659 8-79888607 (LOC92659), non-coding RNA [NR_015454] A_33_P3243652 LOC100131831 Homo sapiens cDNA AK129685 100131831 hypothetical chr19:1395092 THC2704187 Hs.625909 FLJ26174 fis, clone LOC100131831 1-13950862 ADG03920. [AK129685] A_33_P3277970 LOC285299 PREDICTED: XM_003119204 285299 FSHD region chrUn_gl00022 XM_003119204 Hs.722640 Homo sapiens FSHD gene 2 family, 2:84037-83978 region gene 2 family, member C- member C-like, like transcript variant 2 (LOC285299), mRNA [XM_003119204] A_23_P25445 FAM186B Homo sapiens family NM_032130 ENST00000257894 84070 family with chr12:4998152 GO:0043234 NM_032130 THC2706486 Hs.524406 with sequence similarity sequence 7-49981468 186, member B similarity 186, (FAM186B), transcript member B variant 1, mRNA [NM_032130] A_23_P30264 IPO11 Homo sapiens importin NM_016338 ENST00000512177 51194 importin 11 chr5:61897649- GO:0005515|GO:0005737| NM_016338 THC2757834 Hs.482269 11 (IPO11), transcript 61923013 GO:0008565|GO:0005634| variant 2, mRNA GO:0006886 [NM_016338] A_33_P3302070 GB chr22:0409659 NP1243929 09-040965968 A_33_P3252141 TMX3 Homo sapiens thiore- NM_019022 ENST00000299608 54495 thioredoxin- chr18:6634102 GO:0016020|GO:0005783| NM_019022 THC2491286 Hs.440534 doxin-related transmem- related trans- 0-66340961 GO:0003756|GO:0045454| brane protein 3 (TMX3), membrane GO:0016021|GO:0016853 mRNA [NM_019022] protein 3 A_33_P3351524 chr4:00958855 2-009588493 A_33_P3324675 chr19:0002987 01-000298642 A_33_P3326235 HBM Homo sapiens hemo- NM_001003938 ENST00000472539 3042 hemoglobin, chr16:216693- GO:0019825|GO:0005833| NM_001003938 THC2477716 Hs.647389 globin, mu (HBM), mu 216752 GO:0006810|GO:0005344| mRNA [NM_001003938] GO:0046872|GO:0020037| GO:0015671 A_33_P3270636 SHISA5 Homo sapiens shisa NM_016479 ENST00000417841 51246 shisa homolog chr3:48511187- GO:0031965|GO:0016020| NM_016479 NP1190817 Hs.414579 homolog 5 (Xenopus 5 (Xenopus 48511128 GO:0005783|GO:0006915| laevis) (SHISA5), laevis) GO:0005634|GO:0016021| mRNA [NM_016479] GO:0004871|GO:0043123 A_23_P207507 ABCC3 Homo sapiens ATP- NM_003786 ENST00000503337 8714 ATP-binding chr17:4876870 GO:0005215|GO:0016020| NM_003786 THC2482842 Hs.463421 binding cassette, sub- cassette, sub- 1-48768760 GO:0000166|GO:0005887| family C (CFTR/MRP), family C GO:0042626|GO:0005624| member 3 (ABCC3), (CFTR/MRP), GO:0008514|GO:0055085| transcript variant 1, member 3 GO:0016887|GO:0005524 mRNA [NM_003786] A_33_P3394868 LOC388588 Homo sapiens hypo- NM_001163724 ENST00000444870 388588 hypothetical chr1:3692432- GO:0016020|GO:0016021 NM_001163724 THC2729239 Hs.22047 thetical protein protein 3692491 LOC388588 LOC388588 (LOC388588), mRNA [NM_001163724] A_24_P171182 ACBD3 Homo sapiens acyl- NM_022735 ENST00000366812 64746 acyl-CoA chr1:22633333 GO:0005739|GO:0005515| NM_022735 THC2610270 Hs.520207 CoA binding domain binding do- 2-226333273 GO:0006694|GO:0005794| containing 3 (ACBD3), main con- GO:0016020|GO:0000062 mRNA [NM_022735] taining 3 A_33_P3423270 TMEM40 Homo sapiens trans- NM_018306 ENST00000435218 55287 trans- chr3:12775584- GO:0016020|GO:0016021 NM_018306 THC2474070 Hs.475502 membrane protein 40 membrane 12775525 (TMEM40), mRNA protein 40 [NM_018306] A_33_P3691615 Homo sapiens cDNA AK094945 ENST00000507023 chr4:17859814 THC2609012 Hs.435077 FLJ37626 fis, clone 7-178598206 BRCOC2014748. [AK094945] A_23_P166306 CBS Homo sapiens cysta- NM_000071 ENST00000398168 875 cystathionine- chr21:4447337 GO:0019343|GO:0070814| NM_000071 THC2468454 Hs.533013 thionine-beta-synthase beta-synthase 8-44473319 GO:0006535|GO:0005730| (CBS), transcript variant GO:0008652|GO:0005634| 1, mRNA [NM_000071] GO:0046872|GO:0042803| GO:0016829|GO:0005829| GO:0005737|GO:0043418| GO:0030170|GO:0008152| GO:0004122|GO:0006565| GO:0019448|GO:0031625| GO:0020037 A_32_P58407 KCND3 potassium voltage-gated AF070632 ENST00000369697 3752 potassium chr1:11231361 GO:0005515|GO:0005250| THC2610807 Hs.23729 channel, Shal-related sub- voltage-gated 8-112313559 GO:0043005|GO:0005244| family, member 3 channel, Shal- GO:0030955|GO:0055085| [Source: HGNC Symbol; related sub- GO:0046872|GO:0042383| Acc: 6239] family, GO:0005249|GO:0008076| [ENST00000369697] member 3 GO:0043025|GO:0008270| GO:0016021|GO:0006813| GO:0006811 A_23_P118693 FOXN1 Homo sapiens forkhead NM_003593 ENST00000226247 8456 forkhead chr17:2686500 GO:0043565|GO:0003700| NMJD03593 THC2485086 Hs.663679 box N1 (FOXN1), mRNA box N1 6-26865065 GO:0008544|GO:0006357| [NM_003593] GO:0030216|GO:0003704| GO:0009887|GO:0007275| GO:0006952|GO:0005634| GO:0050673 A_23_P354217 TMEM151A Homo sapiens trans- NM_153266 ENST00000327259 256472 transmembrane chr11:6606384 GO:0016020|GO:0016021 NM_153266 THC2474571 Hs.399779 membrane protein 151A protein 151A 3-66063902 (TMEM151A), mRNA [NM_153266] A_23_P138541 AKR1C3 Homo sapiens aldo- NM_003739 ENST00000439082 8644 aldo-keto reduc- chr10:5147789- GO:0005622|GO:0047718| NM_003739 THC2463182 Hs.78183 keto reductase family tase family 1, 5147848 GO:0005737|GO:0004033| 1, member C3 (3-alpha member C3 GO:0006693|GO:0047026| hydroxysteroid (3-alpha hydro- GO:0050327|GO:0047115| dehydrogenase, type xysteroid de- GO:0016491|GO:0047017| II) (AKR1C3), mRNA hydrogenase, GO:0047045|GO:0055114 [NM_003739] type II) A_23_P87011 TAGLN Homo sapiens trans- NM_001001522 ENST0000392951 6876 transgelin chr11:1170751 GO:0005515|GO:0005737| NM_001001522 THC2499202 Hs.410977 gelin (TAGLN), trans- 55-117075214 GO:0007517|GO:0003779 cript variant 1, mRNA [NM_001001522] A_23_P68851 KREMEN1 Homo sapiens kringle NM_001039570 ENST00000400338 83999 kringle chr22:2954250 GO:0003674|GO:0007154| NM_001039570 THC2471664 Hs.229335 containing transmembrane containing 5-29542564 GO:0016020|GO:0005624| protein 1 (KREMEN1), transmembrane GO:0016021|GO:0016055 transcript variant 3, protein 1 mRNA [NM_001039570] A_24_P256155 NKX1-2 Homo sapiens NK1 NM_001146340 390010 NK1 homeo- chr10:1261361 GO:0043565|GO:0006355| NM_001146340 Hs.712041 homeobox 2 (NKX1-2), box 2 73-126136114 GO:0003700|GO:0007275| mRNA [NM_001146340] GO:0005634 A_33_P3235204 ELMOD3 Homo sapiens ELMO/ NM_032213 ENST00000486908 84173 ELMO/ chr2:85617562- GO:0006909|GO:0005856 NM_032213 THC2741273 Hs.269990 CED-12 domain con- CED-12 domain 85617621 taining 3 (ELMOD3), containing 3 transcript variant 1, mRNA [NM_032213] A_33_P3353365 SLC17A4 solute carrier family BC109207 ENST00000397076 10050 solute carrier chr6:25776995- THC2487373 Hs.282931 17 (sodium phosphate), family 17 25777054 member 4[Source: HGNC (sodium Symbol; Acc: 10932] phosphate), [ENST00000397076] member 4 A_33_P3318267 LOC100131193 Homo sapiens hypo- NR_024580 ENST00000414656 100131193 hypothetical chr9:13969867 NR_024580 THC2481660 Hs.668138 thetical LOC100131193 LOC100131193 3-139698614 (LOC100131193), non- coding RNA [NR_024580] A_23_P98350 BIRC3 Homo sapiens bacu- NM_001165 ENST00000263464 330 baculoviral chr11:1022083 GO:0005515|GO:0004842| NM_001165 THC2463921 Hs.127799 loviral IAP repeat IAP repeat 56-102208415 GO:0005634|GO:0006916| containing 3 (BIRC3), containing 3 GO:0042981|GO:0007283| transcript variant 1, GO:0051291|GO:0046872| mRNA [NM_001165] GO:0005622|GO:0043234| GO:0005737|GO:0008270| GO:0045121|GO:0007166 A_23_P104509 FAM53B Homo sapiens family NM_014661 ENST00000280780 9679 family with chr10:1263703 GO:0008150|GO:0003674| NM_014661 THC2475876 Hs.129195 with sequence similarity sequence 89-126370330 GO:0005575 53, member B similarity 53, (FAM53B), mRNA member B [NM_014661] A_33_P3243248 ZNFX1 zinc finger, NFX1- ENST00000469991 57169 zinc finger, Chr20:4786120 type containing 1 NFXl-type 1-47861142 [Source: HGNC Symbol; containing 1 Acc: 29271] [ENST00000469991] A_33_P3378047 SESTD1 Homo sapiens SEC14 NM_178123 ENST00000428443 91404 SEC14 and chr2:17997371 GO:0005515 NM_178123 Hs.30977 and spectrin domains 1 spectrin 8-179973659 (SESTD1), mRNA domains 1 [NM_178123] A_23_P338168 FBXL19 Homo sapiens F-box NM_001099784 ENST00000338343 54620 F-box and chr16:3095917 GO:0005515|GO:0019941| NM_001099784 THC2686436 Hs.152149 and leucine-rich repeat leucine rich 7-30959236 GO:0008270|GO:0003677| protein 19 (FBXL19), repeat GO:0046872 mRNA [NM_001099784] protein 19 A_33_P3362068 LOC100129149 full-length cDNA CR595361 100129149 hypothetical chr2:37899733- THC2688744 Hs.369574 clone CS0DI084YD11 of protein 37899792 Placenta Cot 25-normal- LOC100129149 ized of Homo sapiens (human). [CR595361] A_33_P3233834 IL6ST Homo sapiens inter- NM_001190981 ENST00000542298 3572 interleukin 6 chr5:55260096- GO:0005138|GO:0004921| NM_001190981 NP1400573 Hs.532082 leukin 6 signal signal transducer 55260037 GO:0008284|GO:0005886| transducer (gp130, (gp130, GO:0004924|GO:0004923| oncostatin M receptor) oncostatin GO:0042803|GO:0070110| (IL6ST), transcript M receptor) GO:0014911|GO:0002675| variant 3, mRNA GO:0042102|GO:0004872| [NM_00119C981] GO:0004897|GO:0034097| GO:0002821|GO:0008593| GO:0010613|GO:0070106| GO:0007584|GO:0042517| GO:0004915|GO:0051481| GO:0005977|GO:0042511| GO:0005896|GO:0005576| GO:0070120|GO:0045768| GO:0007259|GO:0010575| GO:0005127|GO:0045669| GO:0007165|GO:0048861| GO:0005900|GO:0016021| GO:0045509|GO:0006642| GO:0009897 A_23_P54576 KIFC3 Homo sapiens kinesin NM_005550 ENST00000539578 3801 kinesin family chr16:5779465 GO:0005871|GO:0005794| NM_005550 NP1473422 Hs.23131 family member C3 member C3 1-57794283 GO:0000166|GO:0005874| (KIFC3), transcript GO:0007030|GO:0003777| variant 1, mRNA GO:0007601|GO:0005524| [NM_005550] GO:0007018 A_23_P435407 GPC4 Homo sapiens glypican NM_001448 ENST00000536418 2239 glypican 4 chrX:13243548 GO:0005886|GO:0008283| NM_001448 THC2475418 Hs.58367 4 (GPC4), mRNA 8-132435429 GO:0005887|GO:0005578| [NM_001448] GO:0043395|GO:0005576| GO:0031225|GO:0009653| GO:0005615 A_24_P649747 BMS1 Homo sapiens BMS1 NM_014753 ENST00000374518 9790 BMS1 chr10:4331752 GO:0000166|GO:0042255| NM_014753 THC2585704 Hs.10848 homolog, ribosome homolog, 2-43317581 GO:0005730|GO:0005634| assembly protein (yeast) ribosome GO:0005524 (BMS1), mRNA assembly [NM_014753] protein (yeast) A_24_P510357 immunoglobulin S76132 ENST00000390312 chr22:2310163 NP1087720 Hs.625768 lambda variable 2-14 1-23101690 [Source: HGNC Symbol; Acc: 5888] [ENST00000390312] A_23_P156620 ZNF184 Homo sapiens zinc NM_007149 ENST00000377419 7738 zinc finger chr6:27419044- GO:0005622|GO:0006355| NM_007149 THC2489060 Hs.158174 finger protein 184 protein 184 27418985 GO:0005737|GO:0008270| (ZNF184), mRNA GO:0005634|GO:0003677| [NM_007149] GO:0046872 A_33_P3290672 SELT Homo sapiens seleno- NM_016275 51714 seleno- chr3:15034817 GO:0008430|GO:0001514| NM_016275 THC2731852 Hs.369052 protein T (SELT), protein T 4-150348233 GO:0045454 mRNA [NM_016275] A_33_P3325275 NRSN2 Homo sapiens neurensin NM_024958 ENST00000382285 80023 neurensin 2 chr20:334382- GO:0030133|GO:0008150| NM_024958 THC2605727 Hs.416024 2 (NRSN2), mRNA 334441 GO:0003674|GO:0005886| [NM_024958] GO:0043025|GO:0016021 A_33_P3313411 ARHGAP33 Homo sapiens Rho NM_001172630 ENST00000007510 115703 Rho GTPase chr19:3627892 GO:0005622|GO:0005515| NM_001172630 NP107616 Hs.515364 GTPase activating activating 5-36278984 GO:0007165|GO:0005737| protein 33 protein 33 GO:0005886|GO:0035091| (ARHGAP33), transcript GO:0015031|GO:0030675| variant 2, mRNA GO:0005096 [NM_001172630] A_33_P3248749 RSPH9 radial spoke head 9 AK055407 ENST00000372154 221421 radial spoke chr6:43640091- THC2478697 homolog head 9 homo- 43640150 (Chlamydomonas) log (Chlamydo- [Source: HGNC monas) Symbol; Acc: 21057] [ENST00000372154] A_23_P258912 MYOM2 Homo sapiens myo- NM_003970 ENST00000520298 9172 myomesin chr8:2093070- GO:0032982|GO:0006936| NM_003970 THC2644431 Hs.443683 mesin (M-protein) 2, 165 (M-protein) 2093129 GO:0008307 kDa (MYOM2), mRNA 2, 165 kDa [NM_003970] A_33_P3245908 C10orf128 Homo sapiens chromo- NM_001010863 ENST00000453436 170371 chromosome chr10:5036394 GO:0016020|GO:0016021 NM_001010863 NP1203955 Hs.385493 some 10 open reading 10 open 9-50363890 frame 128 (C10orf128), reading frame mRNA 128 [NM_001010863] A_33_P3252146 HMX3 Homo sapiens H6 NM_001105574 ENST00000357878 340784 H6 family chr10:1248971 GO:0043565|GO:0006355| NM_001105574 Hs.531194 family homeobox 3 homeobox 3 88-124897247 GO:0042472|GO:0003700| (HMX3), mRNA GO:0007566|GO:0007420| [NM_001105574] GO:0060135|GO:0050885| GO:0005634|GO:0030154| GO:0007399 A_23_P43157 MYBL1 Homo sapiens v-myb NM_001080416 ENST00000522677 4603 v-myb myelo- chr8:67474765- GO:0006355|GO:0016563| NM_001080416 THC2621930 Hs.445898 myeloblastosis viral blastosis viral 67474706 GO:0005730|GO:0005634| oncogene homolog oncogene GO:0003677 (avian)-like 1 (MYBL1), homolog transcript variant 1, (avian)-like 1 mRNA [NM_001080416] A_33_P3252441 ENST00000440582 chr17:3925806 6-39258007 A_33_P3387901 SLC25A19 Homo sapiens solute NM_001126121 ENST00000402418 60386 solute carrier chr17:7327961 GO:0005739|GO:0005215| NM_001126121 THC2634425 Hs.514470 carrier family 25 family 25 2-73279553 GO:0016020|GO:0005488| (mitochondrial thi- (mitochondrial GO:0030302|GO:0005743| amine pyrophosphate thiamine GO:0016021|GO:0055085| carrier), member 19 pyrophosphate GO:0030233 (SLC25A19), nuclear carrier), gene encoding mito- member 19 chondrial protein, trans- cript variant 1, mRNA [NM_001126121] A_23_P326319 C16orf45 Homo sapiens chromo- NM_033201 ENST00000300006 89927 chromosome 16 chr16:1568160 GO:0005515 NM_033201 THC2497958 Hs.401798 some 16 open reading open reading 8-15681667 frame 45 (C16orf45), frame 45 transcript variant 1, mRNA [NM_033201] A_33_P3281795 MGLL Homo sapiens mono- NM_007283 ENST00000265052 11343 monoglyceride chr3:12740797 GO:0006629|GO:0006954| NM_007283 THC2532122 Hs.277035 glyceride lipase (MGLL), lipase 0-127407911 GO:0016787|GO:0004622| transcript variant 1, GO:0047372 mRNA [NM_007283] A_23_P43490 CDKN2A Homo sapiens cyclin- NM_058197 ENST00000530628 1029 cyclin- chr9:21968098- GO:0033088|GO:0005515| NM_058197 THC2696182 Hs.512599 dependent kinase inhib- dependent kin- 21968039 GO:0048103|GO:0030308| itor 2A (melanoma, p16, ase inhibitor 2A GO:0003700|GO:0008285| inhibits CDK4) (CDKN2A), (melanoma, p16, GO:0001652|GO:0045736| transcript variant 3, inhibits CDK4) GO:0006364|GO:0009303| mRNA [NM_058197] GO:0005634|GO:0005737| GO:0000082|GO:0031647| GO:0008637|GO:0051444| GO:0007050|GO:0055105| GO:0046822|GO:0006355| GO:0051059|GO:0019901| GO:0006919|GO:0007569| GO:0010389|GO:0005730| GO:0030889|GO:0032088| GO:0006917|GO:0042326| GO:0010149|GO:0007049| GO:0008544|GO:0006309| GO:0004861|GO:0000075| GO:0005654|GO:0001953 A_23_P19291 TUBB2A Homo sapiens tubulin, NM_001069 ENST00000333628 7280 tubulin, beta chr6:3154094- GO:0005515|GO:0051258| NM_001069 THC2495718 Hs.654543 beta 2A (TUBB2A), 2A 3154035 GO:0007067|GO:0000166| mRNA [NM_001069] GO:0005198|GO:0030182| GO:0005874|GO:0003924| GO:0005525|GO:0007018 A_33_P3213006 KRTAP1-3 Homo sapiens keratin NM_030966 ENST00000377747 81850 keratin chr17:0391860 GO:0008150|GO:0005576| NM_030966 THC2487206 Hs.534495 associated protein 1-3 associated 24-039185965 GO:0045095|GO:0030280 (KRTAP1-3), mRNA protein 1-3 [NM_030966] A_23_P84929 SLC38A5 Homo sapiens solute NM_033518 ENST00000462359 92745 solute carrier chrX:48317923- GO:0015816|GO:0015171| NM_033518 THC2461839 Hs.195155 carrier family 38, mem- family 38, 48317363 GO:0005886|GO:0006865| ber 5 (SLC38A5), member 5 GO:0015187|GO:0016021 mRNA [NM_033518] A_23_P500410 ATP6V1G2 Homo sapiens ATPase, NM_130463 ENST00000303892 534 ATPase, H+ chr6:31512332- GO:0005515|GO:0042470| NM_130463 THC2504847 Hs.249227 H+ transporting, lyso- transporting, 31512273 GO:0016820|GO:0016471| somal 13 kDa, V1 sub- lysosomal 13 GO:0015992|GO:0006811 unit G2 (ATP6V1G2), kDa, V1 sub- transcript variant 1, unit G2 mRNA [NM_130463] A_33_P3363305 chr11:0712797 48-071279807 A_24_P366787 FLJ42875 Homo sapiens hypo- NR_024371 ENST00000321336 440556 hypothetical chr1:2983914- NR_024371 THC2478677 Hs.531041 thetical LOC440556 LOC440556 2980821 (FLJ42875), transcript variant 2, non- coding RNA [NR_024371] A_23_P392470 NR3C2 Homo sapiens nuclear NM_000901 ENST00000358102 4306 nuclear receptor chr4:14900042 GO:0005515|GO:0006355| NM_000901 THC2640620 Hs.163924 receptor subfamily 3, subfamily 3, 3-149000364 GO:0003700|GO:0005783| group C, member 2 group C, GO:0003707|GO:0005634| (NR3C2), transcript member 2 GO:0046872|GO:0043565| variant 1, mRNA GO:0007165|GO:0005737| [NM_000901] GO:0016020|GO:0004872| GO:0008270|GO:0005496| GO:0019898 A_32_P834166 LOC100128843 Homo sapiens DNA AF128541 100128843 hypothetical chr12:1334135 THC2641609 Hs.657680 polymerase epsilon LOC100128843 70-133413511 catalytic subunit iso- form a (POLE1) mRNA, partial cds. [AF128541] A_33_P3335506 FCRL5 Fc receptor-like 5 AF343662 ENST00000368190 83416 Fc receptor- chr1:15749367 THC2478268 Hs.415950 [Source: HGNC like 5 3-157493614 Symbol; Acc: 18508] [ENST00000368190] A_33_P3332396 TMEM53 Homo sapiens trans- NM_024587 ENST00000372243 79639 transmembrane chr1:45125906- GO:0005794|GO:0005886| NM_024587 THC2507947 Hs.22157 membrane protein 53 protein 53 45125847 GO:0016021|GO:0005925 (TMEM53), mRNA [NM_024587] A_33_P3421611 Q96I88_HUMAN ENST00000423354 chr2:43460474- THC2552587 (Q96I88) THADA 43460533 protein (Fragment), partial (8%) [THC2552587] A_23_P255663 MANEA Homo sapiens manno- NM_024641 ENST00000358812 79694 mannosidase, chr6:96056776- GO:0005794|GO:0016787| NM_024641 THC2492910 Hs.730770 sidase, endo alpha endo-alpha 96056835 GO:0016020|GO:0016021| (MANEA), mRNA GO:0004569 [NM_024641] A_33_P3339109 POLR1C polymerase (RNA) CA416988 ENST00000512472 9533 polymerase chr6:43487252- THC2626465 Hs.731098 1 polypeptide C, 30 (RNA) 1 43487311 kDa (Source: HGNC polypeptide Symbol; Acc: 201941 C, 30 kDa [ENST00000512472] A_24_P316019 Putative golgin sub- XM_003118656 ENST00000333156 chr15:3085112 XM_003118656 THC2557844 Hs.568189 family A member 6- 4-30851438 like protein 11 [Source: UniProtKB/Swiss-Prot; Acc: A6NCC3] [ENST00000333156] A_33_P3257279 TMEM145 Homo sapiens trans- NM_173633 ENST00000301204 284339 transmembrane chr19:4282913 GO:0016020|GO:0016021 NM_173633 THC2483750 Hs.382075 membrane protein 145 protein 145 7-42829196 (TMEM145), mRNA [NM_173633] A_23_P4494 DSC2 Homo sapiens des- NM_024422 ENST00000399347 1824 desmocollin 2 chr18:2865160 GO:0030057|GO:0005515| NM_024422 THC2462770 Hs.95612 mocollin 2 (DSC2), 9-28650796 GO:0030054|GO:0005886| transcript variant Dsc2a, GO:0005509|GO:0016021| mRNA [NM_024422] GO:0007155|GO:0007156 A_33_P3358213 PADI6 Homo sapiens peptidyl NM_207421 ENST00000434762 353238 peptidyl chr1:17728136- GO:0018101|GO:0005737| NM_207421 THC2488002 Hs.531598 arginine deiminase, type arginine 17728195 GO:0016787|GO:0005509| VI (PADI6), mRNA deiminase, GO:0005634|GO:0045111| [NM_207421] type VI GO:0004668|GO:0006464 A_33_P3369761 PDP1 Homo sapiens pyruvate NM_001161779 ENST00000396200 54704 pyruvate chr8:94938235- GO:0005739|GO:0008287| NM_001161779 THC2466932 Hs.22265 dehyrogenase phosphatase dehyrogenase 94938294 GO:0006470|GO:0004741| catalytic subunit 1 phosphatase GO:0000287|GO:0016787| (PDP1), nuclear gene catalytic GO:0005759|GO:0005509| encoding mitochondrial subunit 1 GO:0004724|GO:0032403 protein, transcript variant 2, mRNA [NM_001161779] A_33_P3244828 chr14:1022317 THC2779931 82-102231841 A_33_P3272352 HCG1988162 Un- ENST00000397064 chr2:37440789 characterized protein 37440848 [Source: UniProtKB/ TrEMBL; Acc: A8MTT3] [ENST00000397064] A_33_P3257678 HIST2H3A Homo sapiens histone NM_001005464 ENST00000369158 333932 histone cluster chr1:14982462 NM_001005464 THC2479197 Hs.706618 cluster 2, H3a 2, H3a 6-149824685 (HIST2H3A), mRNA [NM_001005464] A_33_P3354322 GPX1 Homo sapiens gluta- NM_201397 ENST00000419783 2876 glutathione chr3:49394667- GO:0006629|GO:0051897| NM_201397 Hs.76686 thione peroxidase 1 peroxidase 1 49394608 GO:0042542|GO:0060047| (GPX1), transcript GO:0017124|GO:0009650| variant 2, mRNA GO:0001659|GO:0002862| [NM_201397] GO:0007605|GO:0006749| GO:0001836|GO:0005829| GO:0005739|GO:0004602| GO:0043523|GO:0005737| GO:0008430|GO:0042311| GO:0018158|GO:0045444| GO:0043403|GO:0043154| GO:0042744|GO:0009410| GO:0033194|GO:0010332| GO:0014902|GO:0051702| GO:0060055|GO:0008631| GO:0009611|GO:0009636| GO:0010269|GO:0006916| GO:0006917|GO:0008539| GO:0033599|GO:0043534| GO:0001885|GO:0009609| GO:0016491|GO:0040029| GO:0006641|GO:0045454| GO:0051450|GO:0055114 A_33_P3379463 LYPLA2 Homo sapiens lyso- NM_007260 ENST00000374506 11313 lysophos- chr1:24121848- GO:0006629|GO:0005737| NM_007260 THC2602100 Hs.533479 phospholipase II pholipase II 24121907 GO:0016787|GO:0006631 (LYPLA2), mRNA [NM_007260] A_23_P500206 IL17RE Homo sapiens interleukin NM_153483 ENST00000295980 132014 interleukin 17 chr3:9957731- GO:0005737|GO:0016020| NM_153483 THC2478460 Hs.390823 17 receptor E (IL17RE), receptor E 9957790 GO:0005576|GO:0004872| transcript variant 5, GO:0016021 mRNA [NM_153483] A_33_P3256785 CARM1 Homo sapiens coacti- NM_199141 ENST00000344150 10498 coactivator- chr19:1103328 GO:0005515|GO:0006355| NM_199141 THC2493442 Hs.323213 vator-associated arginine associated 0-11033339 GO:0005737|GO:0044419| methyltransferase 1 arginine GO:0016571|GO:0003713| (CARM1), mRNA methyl GO:0005634|GO:0008276| [NM_199141] transferase 1 GO:0008469|GO:0016740| GO:0034970|GO:0016568 A_33_P3319331 PRDM2 Homo sapiens cDNA AK123605 7799 PR domain chr1:14146910- GO:0005622|GO:0006355| THC2632509 FLJ41611 fis, clone containing 2, 14146969 GO:0005794|GO:0003700| CTONG3002020. with ZNF GO:0008168|GO:0008270| [AK123605] domain GO:0005634|GO:0046872| GO:0016740|GO:0018024 A_33_P3221960 IL18RAP Homo sapiens interleukin NM_003853 ENST00000264260 8807 interleukin 18 chr2:10306869 GO:0006954|GO:0016020| NM_003853 THC2489002 Hs.158315 18 receptor accessory receptor 5-103068754 GO:0045087|GO:0016021| protein (IL18RAP), accessory GO:0007166|GO:0004888 mRNA [NM_003853] protein A_33_P3233125 PSD Homo sapiens pleckstrin NM_002779 ENST00000020673 5662 pleckstrin and chr10:1041624 GO:0005622|GO:0007165| NM_002779 THC2491352 Hs.154658 and Sec7 domain con- Sec7 domain 36-104162377 GO:0005086|GO:0030182| taining (PSD), mRNA containing GO:0032012|GO:0016021| [NM_002779] GO:0005575|GO:0004871 A_33_P3388883 chr1:14487327 3-144873214 A_23_P39453 MEX3D Homo sapiens mex- NM_203304 ENST000004O2693 399664 mex-3 homolog chr19:1555264- GO:0005515|GO:0005737| NM_203304 THC2473313 Hs.436495 3 homolog D (C. elegans) D (C. elegans) 1555205 GO:0003723|GO:0008270| (MEX3D), transcript GO:0005634|GO:0046872 variant 1, mRNA [NM_203304] A_33_P3420862 PAGE2B Homo sapiens P NM_001015038 ENST00000453343 389860 P antigen family, chrX:55103897- NM_001015038 THC2476714 Hs.293317 antigen family, member 2B 55103956 member 2B (PAGE2B), mRNA [NM_001015038] A_33_P3424861 FAM118A Homo sapiens family NM_001104595 ENST00000216214 55007 family with chr22:4573679 GO:0016020|GO:0016021 NM_001104595 THC2595955 Hs.265018 with sequence similarity sequence 5-45736854 118, member A similarity 118, (FAM118A), transcript member A variant 1, mRNA [NM_001104595] A_33_P3408665 chr11n_gl00021 7:000049977- 000050036 A_24_P188800 1-Mar Homo sapiens NM_017923 ENST00000339875 55016 membrane- chr4:16444926 GO:0016020|GO:0019941| NM_017923 THC2483811 HS.S92804 membrane- associated ring 2-164449203 GO:0016874|GO:0008270| associated ring finger finger(C3HC4) GO:0031410|GO:0016021| (C3HC4) 1 (MARCH1), 1 GO:0046872 transcript variant 2, mRNA [NM_017923] A_23_P2077 OR4C3 Homo sapiens olfactory NM_001004702 ENST00000395239 256144 olfactory chr11:4834713 GO:0007608|GO:0007165| NM_001004702 NP1461863 Hs.553656 receptor, family 4, sub- receptor, 7-48347196 GO:0004984|GO:0007186| family C, member 3 family 4, GO:0005886|GO:0004872| (OR4C3), mRNA subfamily C, GO:0016021|GO:0050896 [NM_001004702] member 3 A_23_P414308 FLCN Homo sapiens folliculin NM_144606 ENST00000389169 201163 folliculin chr17:1712472 GO:0005515|GO:0005737 NM_144606 THC2629147 Hs.31652 2, (FLCN), transcript 7-17124668 variant mRNA [NM_144606] A_23_P303891 LCE1C Homo sapiens late NM_178351 ENST00000368768 353133 late cornified chr1:15277789 GO:0031424 NM_17835] NP1250118 Hs.516429 cornified envelope 1C envelope 1C 4-152777835 (LCE1C), mRNA [NM_178351] A_32_PI16556 ZNF469 Homo sapiens zinc NM_001127464 ENST00000437464 84627 zinc finger chr16:8850708 GO:0005622|GO:0008270| NM_001127464 THC2497481 Hs.54925 finger protein 469 protein 469 7-88507146 GO:0005634|GO:0003677| (ZNF469), mRNA GO:0046872|GO:0045449 [NM_001127464] A_33_P3366780 Q9UQ53_HUMAN chr5:17922434 GO:0005794|GO:0016758| THC2478738 (Q9UQ53) UDP- 2-179224283 GO:0016020|GO:0005975| N-acetylglucosamine: GO:0006491|GO:0016021| alpha-l,3-D-mannoside GO:0046872|GO:0008454 beta-l,4-N-acetylglucosa- minyltransferase IV (Aminyltransferase), partial (94%) [THC2478738] A_23_P413788 FUT11 Homo sapiens fucosyl NM_173540 ENST00000372841 170384 fucosyl- chr10:7553558 GO:0046920|GO:0005794| NM_173540 THC2473454 Hs.588854 transferase 11 (alpha transferase 6-75535645 GO:0016020|GO:0000139| (1,3) fucosyltransferase) 11 (alpha (1,3) GO:0016757|GO:0006486| (FUT11), mRNA fucosyl- GO:0016027 [NM_173540] transferase) A_33_P3311907 TBC1D7 Homo sapiens TBC1 NM_001143965 ENST00000379291 51256 TBC1 domain chr6:13325400- GO:0005622|GO:0032313| NM_001143965 THC2546522 Hs.484678 domain family, member family, 13325341 GO:0005097|GO:0005096 7 (TBC1D7), transcript member 7 variant 3, mRNA [NM_001143965] A_23_P56328 PLVAP Homo sapiens plasma- NM_031310 ENST00000252590 83483 plasmalemma chr19:1746270 GO:0048471|GO:0005737| NM_031310 NP499212 Hs.107125 lemma vesicle ass- vesicle 1-17462642 GO:0005886|GO:0005901| ociated protein (PLVAP), associated GO:0016021|GO:0042803 mRNA [NM_031310] protein A_23_P20248 MAP2K1 Homo sapiens mitogen- NM_002755 ENST00000307102 5604 mitogen- chr15:6678322 GO:0005515|GO:0048471| NM_002755 THC2560714 Hs.145442 activated protein kinase activated 4-66783283 GO:0005886|GO:0008283| kinase 1 (MAP2K1), protein kinase GO:0045597|GO:0006928| mRNA [NM_002755] kinase 1 GO:0032839|GO:0007265| GO:0051291|GO:0048678| GO:0032402|GO:0005829| GO:0000187|GO:0000166| GO:0030182|GO:0043204| GO:0006935|GO:0047496| GO:0004728|GO:0005938| GO:0006979|GO:0017016| GO:0004708|GO:0048313| GO:0030335|GO:0005794| GO:0005874|GO:0051384| GO:0034111|GO:0031435| GO:0005625|GO:0005524| GO:0033267|GO:0007067| GO:0032320|GO:0004674| GO:0030216|GO:0048812| GO:0003056|GO:0032968| GO:0004713|GO:0016740 A_24_P366566 OR5H1 Homo sapiens olfactory NM_001005338 ENST00000354565 26341 olfactory chr3:97852262- GO:0007608|GO:0007165| NM_001005338 THC2603706 Hs.537383 receptor, family 5, receptor, 97852321 GO:0004984|GO:0007186| subfamily H, member family 5, GO:0005886|GO:0004872| 1 (OR5H1), mRNA subfamily H, GO:0016021|GO:0050896 [NM_001005338] member 1 A_33_P3337318 HNRNPA2B1 heterogeneous nuclear BX641084 ENST00000490912 3181 heterogeneous chr7:26241033- THC2503695 ribonucleoprotein A2/B1 nuclear ribo- 26240974 [Source: HGNC Symbol; nucleoprotein Acc: 5033] A2/B1 [ENST00000490912] A_24_P247273 chromosome 11 open ENST00000391480 chr11:1910450- reading frame 89 1910391 [Source: HGNC Symbol; Acc: 35118] [ENST00000391480] A_23_P142631 FKBP1B Homo sapiens FK506 NM_054033 ENST00000496149 2281 FK506 binding chr2:24286286- GO:0010459|GO:0003755| NM_054033 NP090150 Hs.709461 binding protein IB, protein 1B, 24286345 GO:0005102|GO:0033017| 12.6 kDa (FKBP1B), 12.6 kDa GO:0005528|GO:0010881| transcript variant 2, GO:0014808|GO:0034704| mRNA [NM_054033] GO:0019227|GO:0022417| GO:0005829|GO:0009749| GO:0006939|GO:0042026| GO:0005737|GO:0042098| GO:0006458|GO:0032234| GO:0060314|GO:0032513| GO:0051775|GO:0016853| GO:0030073|GO:0005219 A_24_P169073 FAM131C Homo sapiens family NM_182623 ENST00000375662 348487 family with chr1:16384334- NM_182623 THC2475284 Hs.126825 with sequence similarity sequence 16384275 131, member C similarity 131, (FAM131C), mRNA member C [NM_182623] A_23_P37623 GOLGA8A Homo sapiens golgin NM_181077 ENST00000543376 23015 golgin A8 chr15:3467222 GO:0005794|GO:0016020| NM_181077 THC2473197 Hs.720151 A8 family, member A family, 4-34672165 GO:0019898 (GOLGA8A), transcript member A variant 1, mRNA [NM_181077] A_33_P3347976 MIB1 Homo sapiens mind- NM_020774 ENST00000261537 57534 mindbomb chr18:1945066 GO:0005515|GO:0004842| NM_020774 THC2512091 Hs.140903 bomb homolog 1 homolog 1 4-19450723 GO:0001568|GO:0016567| (Drosophila) (MIB1), (Drosophila) GO:0005886|GO:0016874| mRNA [NM_020774] GO:0001756|GO:0031410| GO:0001701|GO:0046872| GO:0001841|GO:0045807| GO:0001947|GO:0007507| GO:0005737|GO:0045665| GO:0007219|GO:0019941| GO:0008270 A_33_P3262069 OR2AG2 Homo sapiens olfactory NM_001004490 ENST00000338569 338755 olfactory chr11:6789602- GO:0007608|GO:0007165| NM_001004490 NP1461805 Hs.534614 receptor, family 2, receptor, 6789543 GO:0004984|GO:0007186| subfamily AG, family 2, GO:0005886|GO:0004872| member 2 (OR2AG2), subfamily AG, GO:0016021|GO:0050896 mRNA member 2 [NM_001004490] A_33_P3354975 MTMR9LP Homo sapiens myotubu- NR_026850 ENST00000403496 339483 myotubularin chr1:32697727- NR_026850 THC2547854 Hs.471067 larin related protein related 32697668 9-like, pseudogene protein 9- (MTMR9LP), non- like, coding RNA pseudogene [NR_026850] A_23_P205031 COL4A2 Homo sapiens collagen, NM_001846 ENST00000360467 1284 collagen, chr13:1111652 GO:0005515|GO:0005581| NM_001846 THC2549560 Hs.508716 type IV, alpha 2 type IV, 61-111165320 GO:0030198|GO:0016525| (COL4A2), mRNA alpha 2 GO:0005587|GO:0005576| [NM_001846] GO:0005201 A_33_P3296567 PRRC2B Homo sapiens proline- NM_013318 ENST00000422467 84726 proline-rich chr9:13434308 NM_013318 THC2515770 Hs.495349 rich coiled-coil 2B coiled coil 4-134346175 (PRRC2B), mRNA 2B [NM_013318] A_33_P3306163 LGALS3 Homo sapiens lectin, NM_001177388 ENST00000254301 3958 lectin, chr14:5560502 GO:0005515|GO:0019863| NM_001177388 THC2788354 Hs.531081 galactoside-binding, galactoside- 6-55605085 GO:0005737|GO:0001501| soluble, 3 (LGALS3), binding, GO:0005886|GO:0030198| transcript variant 3, soluble, 3 GO:0005578|GO:0005529| mRNA [NM_001177388] GO:0005634|GO:0030154 A_23_P112774 PTP4A3 Homo sapiens protein NM_032611 ENST00000520105 11156 protein tyrosine chr8:14244143 GO:0006470|GO:0016787| NM_032611 THC2463792 Hs.43666 tyrosine phosphatase phosphatase 3-142441492 GO:0005886|GO:0004727| type IVA, member 3 type IVA, GO:0005769|GO:0042802 (PTP4A3), transcript member 3 variant 1, mRNA [NM_032611] A_33_P3299047 chr1:01656936 0-016569301 A_24_P229871 chromosome 17 open BC101214 ENST00000321800 chr17:7174668 NP1465661 Hs.464079 reading frame 54 3-71746624 [Source: HGNC Symbol; Acc: 26863] [ENST00000321800] A_33_P3385656 FNDC9 Homo sapiens fibro- NM_001001343 ENST00000312349 408263 fibronectin chr5:15676866 GO:0016020|GO:0016021 NM_001001343 THC2644705 Hs.437066 nectin type III domain type III 7-156768608 containing 9 (FNDC9), domain mRNA [NM_001001343] containing 9 A_33_P3348151 chr9:04384864 0-043848699 A_23_P1473 PRF1 Homo sapiens perforin NM_005041 ENST00000441259 5551 perforin 1 chr10:7235798 GO:0006968|GO:0005886| NM_005041 THC2462167 Hs.2200 1 (pore forming (pore forming 8-72357929 GO:0045471|GO:0019835| protein) (PRF1), protein) GO:0005509|GO:0016023| transcript variant 1, GO:0007623|GO:0006915| mRNA [NM_005041] GO:0005576|GO:0016021 A_33_P3277378 OSM oncostatin M [Source: ENST00000403389 5008 oncostatin M chr22:3066166 HGNC Symbol; Acc: 8506] 9-30661610 [ENST00000403389] A_32_P176911 NCRNA00239 Homo sapiens non- NR_026774 145200 non-protein chr14:1021987 NR_026774 THC2704597 Hs.150840 protein coding RNA coding 16-102198775 239 (NCRNA00239), RNA 239 non-coding RNA [NR_026774] A_23_P371765 C21orf56 Homo sapiens chromo- NM_032261 ENST00000291672 84221 chromosome 21 chr21:4758185 GO:0005515|GO:0008150| NM_032261 THC2602807 Hs.381214 some 21 open reading open reading 4-47581585 GO:0003674|GO:0005575 frame 56 (C21orf56), frame 56 transcript variant 2, mRNA [NM_032261] A_24_P295963 SLC38A2 Homo sapiens solute NM_018976 ENST00000549258 54407 solute carrier chr12:4675276 GO:0015171|GO:0005886| NM_018976 THC2461149 Hs.221847 carrier family 38, family 38, 9-46752710 GO:0006865|GO:0016021| member 2 (SLC38A2), member 2 GO:0031402|GO:0006814| mRNA [NM_018976] GO:0015293|GO:0006811 A_33_P3275801 DES Homo sapiens desmin NM_001927 ENST00000373960 1674 desmin chr2:22029140 GO:0005515|GO:0030018| NM_001927 THC2525325 Hs.594952 (DES), mRNA 0-220291459 GO:0008016|GO:0045202| [NM_001927] GO:0005626|GO:0005622| GO:0042383|GO:0005737| GO:0006936|GO:0043292| GO:0007010|GO:0005200| GO:0045098|GO:0005856 A_23_P131785 BPI Homo sapiens NM_001725 ENST00000262865 671 bactericidal/ chr20:3696570 GO:0032717|GO:0032715| NM_001725 THC2470545 Hs.529019 bactericidal/permeability- per meability- 9-36965768 GO:0043031|GO:0032720| increasing protein (BPI), increasing GO:0005576|GO:0008368| mRNA [NM_001725] protein GO:0008289|GO:0001530| GO:0005737|GO:0006955| GO:0016020|GO:0005887| GO:0042742 A_23_P211680 MLC1 Homo sapiens megalen- NM_015166 ENST00000311597 23209 megalencephalic chr22:5049800 GO:0008150|GO:0003674| NM_015166 NP1141647 Hs.517729 cephalic leukoencephal- leukoence- 7-50497948 GO:0016020|GO:0000299| opathy with subcortical phalopathy GO:0016021|GO:0005216| cysts 1 (MLC1), transcript with subcortical GO:0006811 variant 1, mRNA cysts 1 [NM_015166] A_23_P27424 ZNF418 Homo sapiens zinc NM_133460 ENST00000425570 147686 zinc finger chr19:5843373 GO:0005622|GO:0006355| NM_133460 THC2658428 Hs.660728 finger protein 418 protein 418 5-58433676 GO:0008270|GO:0005634| (ZNF418), mRNA GO:0003677|GO:0046872 [NM_13346C] A_23_P142403 TM6SF2 Homo sapiens trans- NM_001001524 ENST00000269990 53345 transmembrane chr19:1937889 GO:0008150|GO:0003674| NM_001001524 THC2675957 Hs.531624 membrane 6 superfamily 6 superfamily 5-19378836 GO:0016020|GO:0016021 member 2 (TM6SF2), member 2 mRNA [NM_001001524] A_24_P820037 SLC6A17 Homo sapiens solute NM_001010898 ENST00000450985 388662 solute carrier chr1:11074368 GO:0016020|GO:0005887| NM_001010898 THC2473133 Hs.128382 carrier family 6, family 6, 9-110743748 GO:0005328|GO:0006836| member 17 (SLC6A17), member 17 GO:0015293 mRNA [NM_001010898] A_33_P3246613 CCDC78 Homo sapiens coiled- NM_001031737 ENST00000478979 124093 coiled-coil chr16:772645- NM_001031737 NP708886 Hs.381943 coil domain containing domain 772586 78 (CCDC78), containing 78 mRNA [NM_001031737] A_33_P3283061 LOC100128348 Homo sapiens cDNA AK12K12K 100128348 hypothetical chr16:3334743 THC2723408 Hs.637572 FU46249 fis, clone protein 5-33347376 TESTI4021377. LOC100128348 [AK128128] A_23_P430670 CHST5 Homo sapiens carbo- NM_024533 ENST00000336257 23563 carbohydrate chr16:7556280 GO:0006790|GO:0005794| NM_024533 NP175264 Hs.710689 hydrate (N-acetylgluco- (N-acetylglucos- 8-75562749 GO:0016020|GO:0005975| samine 6-O) sulfotrans- amine 6-O) GO:0031228|GO:0006044| ferase 5 (CHST5), sulfotransferase GO:0006477|GO:0016021| mRNA [NM_024533] 5 GO:0001517|GO:0016740 A_33_P3352827 SLAMF1 Homo sapiens signaling NM_003037 ENST00000355199 6504 signaling chr1:16060712 GO:0005515|GO:0046649| NM_003037 THC2478679 Hs.523660 lymphocytic activation lymphocytic 6-160607067 GO:0008284|GO:0005886| molecule family mem- activation mole- GO:0044419|GO:0016021| ber 1 (SLAMF1), cule family GO:0003823|GO:0009897| mRNA [NM_003037] member 1 GO:0004888 A_33_P3330125 DIABLO Homo sapiens diablo, NM_138929 ENST00000413918 56616 diablo, IAP- chr12:1227108 GO:0008625|GO:0005739| NM_138929 THC2640072 Hs.169611 IAP-binding mitochondrial binding mito- 82-122710823 GO:0005515|GO:0005737| protein (DIABLO), chondrial GO:0008635|GO:0008631| nuclear gene encoding protein GO:0006917|GO:0005829 mitochondrial protein, transcript variant 3, mRNA [NM_138929] A_23_P356122 ZNF451 Homo sapiens zinc NM_001031623 ENST00000357489 26036 zinc finger chr6:57033933- GO:0005622|GO:0008270| NM_001031623 THC2466864 Hs.485628 finger protein 451 protein 451 57033992 GO:0005634|GO:0003677| (ZNF451), transcript GO:0046872|GO:0045449 variant 1, mRNA [NM_001031623] A_33_P3471466 C14orf166B Homo sapiens chromo- NM_194287 ENST00000460005 145497 chromosome chr14:7730425 GO:0005515 NM_194287 NP101062 Hs.147276 some 14 open reading 14 open reading 4-77304313 frame 166B (C14orf166B, frame 166B mRNA [NM_194287] A_33_P3382493 SIGLEC14 Homo sapiens sialic NM_001098612 ENST00000360844 100049587 sialic acid chr19:5214691 GO:0005515|GO:0016020| NM_001098612 THC2508498 Hs.707374 acid binding Ig-like binding Ig- 5-52146856 GO:0005529|GO:0016021| lectin 14 (SIGLEC14), like lectin 14 GO:0007155 mRNA [NM_001098612] A_23_P138805 CHORDC1 Homo sapiens cysteine NM_012124 ENST00000533724 26973 cysteine and chr11:8993510 GO:0008150|GO:0003674| NM_012124 THC2466458 Hs.22857 and histidine-rich do- histidine- 4-89935045 GO:0008270|GO:0005575| main (CHORD) con- rich domain GO:0046872 taining 1 (CHORDC1), (CHORD) transcript variant 1, containing 1 mRNA [NM_012124] A_23_P431346 PRR15 Homo sapiens proline NM_175887 ENST00000319694 222171 proline rich chr7:29606158- GO:0007275 NM_175887 THC2464800 Hs.728338 rich 15 (PRR15), 15 29606217 mRNA [NM_175887] A_23_P330908 DERL1 Homo sapiens Der1- NM_024295 ENST00000524119 79139 Der1-like chr8:12402671 GO:0005515|GO:0006986| NM_024295 THC2497250 Hs.241576 like domain family, domain 7-124026658 GO:0019060|GO:0042288| member 1 (DERL1), family, GO:0005783|GO:0030970| transcript variant 1, member 1 GO:0030176|GO:0015031| mRNA [NM_024295] GO:0030433|GO:0030968| GO:0016020|GO:0044419| GO:0004872|GO:0016021 A_23_P116235 MDK Homo sapiens midkine NM_001012334 ENST00000407067 4192 midkine (neurite chr11:4640523 GO:0007165|GO:0030325| NM_001012334 NP1464770 Hs.82045 (neurite growth-pro- growth-pro- 1-46405290 GO:0009611|GO:0051781| moting factor 2) (MDK), moting factor 2) GO:0007275|GO:0005576| transcript variant 1, GO:0008201|GO:0008083| mRNA [NM_001012334] GO:0030154|GO:0007399 A_33_P3337026 SLC6A8 solute carrier family U17986 ENST00000328897 6535 solute carrier chrX:15295944 THC2489031 Hs.540696 6 (neurotransmitter family 6 0-152959499 transporter, creatine), (neurotrans- member 8 [Source: HGNC mitter transporter, Symbol; Acc: 11055] creatine), [ENST00000328897] member 8 A_33_P3295814 chr7:07324526 1-073245202 A_33_P3247095 ENST00000447610 chr11:1076431 95-107643254 A_24_P225719 MOBKL3 Homo sapiens MOB1, NM_015387 ENST00000323303 25843 MOB1, Mps chr2:19841714 GO:0005515|GO:0048471| NM_015387 THC2467915 Hs.633165 Mps One Binder kinase One Binder 8-198417207 GO:0005737|GO:0005794| activator-like 3 (yeast) kinase acti- GO:0016020|GO:0006810| (MOBKL3), transcript vator-like GO:0005624|GO:0008270| variant 1, mRNA 3 (yeast) GO:0046872|GO:0019898 [NM_015387] A_33_P3256095 chr1:22264735 THC2572285 9-222647300 A_23_P51117 ETAA1 Homo sapiens Ewing NM_019002 ENST00000272342 54465 Ewing tumor- chr2:67637076- GO:0005737 NM_019002 THC2671527 Hs.353022 tumor-associated antigen associated 67637135 1 (ETAA1), mRNA antigen 1 [NM_019002] A_24_P208045 EDEM3 Homo sapiens ER NM_025191 ENST00000318130 80267 ER degradation chr1:18466001 GO:0006986|GO:0016020| NM_025191 THC2493079 Hs.523811 degradation enhancer, enhancer, man- 7-184659958 GO:0005783|GO:0005509| mannosidase alpha like nosidase alpha- GO:0004571|GO:0006516| 3 (EDEM3), mRNA like 3 GO:0005788|GO:0043161| [NM_025191] GO:0004569 A_33_P3308586 DUXA Homo sapiens double NM_001012729 ENST00000376239 503835 double chr19:5766315 GO:0043565|GO:0006355| NM_001012729 Hs.585857 homeobox A (DUXA), homeobox A 3-57663094 GO:0003700|GO:0005634 mRNA [NM_001012729] A_33_P3264444 PFDN6 prefoldin subunit 6 CR609151 ENST00000482292 10471 prefoldin chr6:33265875- THC2557117 Hs.446374 [Source: HGNC subunit 6 33265934 Symbol; Acc: 4926] [ENST00000482292] A_33_P3379669 RNF208 Homo sapiens ring NM_031297 ENST00000392827 727800 ring finger chr9:14011516 GO:0005515|GO:0008270| NM_031297 THC2473148 Hs.512767 finger protein 208 protein 208 4-140115105 GO:0046872 (RNF208), mRNA [NM_031297] A_23_P87329 NAT10 Homo sapiens N- NM_024662 ENST00000531159 55226 N-acetyl- chr11:3416799 GO:0005515|GO:0003674| NM_024662 NP1154163 Hs.577281 acetyltransferase 10 transferase 10 0-34168049 GO:0008080|GO:0000166| (GCN5-related) (NAT 10), (GCN5-related) GO:0008152|GO:0005730| transcript variant 1, GO:0005634|GO:0005524| mRNA [NM_024662] GO:0016740|GO:0008415 A_23_P212126 COLQ Homo sapiens collagen- NM_080538 ENST00000383788 8292 collagen like chr3:15492044- GO:0030054|GO:0008105| NM_080538 NP423138 Hs.146735 like tail subunit (single tail subunit 15491985 GO:0005605|GO:0001507| strand of homotrimer) (single strand GO:0045202|GO:0042135| of asymmetric acetyl- of homotrimer) GO:0005615 cholinesterase (COLQ), of asymmetric transcript variant II, acetyl- mRNA [NM_080538] cholinesterase A_33_P3378360 PRELID1 Homo sapiens PRELI NM_013237 ENST00000504594 27166 PRELI chr5:17673360 GO:0005739|GO:0006955| NM_013237 NP1177384 Hs.279529 domain containing 1 domain 5-176733664 GO:0007275 (PRELID1), mRNA containing 1 [NM_013237] A_33_P3340862 TMEM88B Homo sapiens trans- NM_001146685 643965 transmembrane chr1:1363048- GO:0016020|GO:0016021 NM_001146685 Hs.729765 membrane protein 88B protein 88B 1363107 (TMEM88B), mRNA [NM_001146685] A_23_P142125 HRC Homo sapiens histidine NM_002152 ENST00000252825 3270 histidine rich chr19:4965530 GO:0006936|GO:0008016| NM_002152 NP852745 Hs.436885 rich calcium binding calcium 1-49654792 GO:0005509|GO:0033018| protein (HRC), binding GO:0033017|GO:0055074 mRNA [NM_002152] protein A_33_P3209386 TXNDC17 Homo sapiens thio- NM_032731 ENST00000250101 84817 thioredoxin chr17:6547783- GO:0005515|GO:0005737| NM_032731 THC2602739 Hs.408236 redoxin domain con- domain 6547842 GO:0004601|GO:0009055| taining 17 (TXNDC17), containing 17 GO:0047134|GO:0033209| mRNA [NM_032731] GO:0005829 A_23_P372848 P2RX1 Homo sapiens pur- NM_002558 ENST00000225538 5023 purinergic chr17:3800243- GO:0005515|GO:0005886| NM_002558 THC2488665 Hs.41735 inergic receptor P2X, receptor P2X, 3800184 GO:0016265|GO:0002554| ligand-gated ion ligand-gated GO:0051291|GO:0019228| channel, 1 (P2RX1), ion channel, GO:0042803|GO:0043270| mRNA [NM_002558] 1 GO:0045211|GO:0008144| GO:0051924|GO:0001614| GO:0033198|GO:0051260| GO:0004872|GO:0046513| GO:0019717|GO:0046982| GO:0004931|GO:0006919| GO:0035249|GO:0030168| GO:0005524|GO:0007320| GO:0007165|GO:0043234| GO:0031240|GO:0005887| GO:0003056|GO:0008217| GO:0045121|GO:0008270| GO:0050896 A_24_P125283 HDAC5 Homo sapiens histone NM_001015053 ENST00000225983 10014 histone chr17:4215422 GO:0032869|GO:0016575| NM_001015053 THC2465832 Hs.438782 deacetylase 5 (HDAC5), deacetylase 5 3-42154164 GO:0016566|GO:0006342| transcript variant 3, GO:0043393|GO:0010553| mRNA [NM_001015053] GO:0010843|GO:0005634| GO:0010552|GO:0010832| GO:0051091|GO:0005737| GO:0000118|GO:0006954| GO:0016787|GO:0070491| GO:0030183|GO:0014898| GO:0090051|GO:0006338| GO:0004407|GO:0045449| GO:0008134 A_33_P3337259 WASH5P Homo sapiens WAS NR_033266 375690 WAS protein chr19:61457- NR_033266 THC2492043 Hs.521961 protein family homolog family homo- 61398 5 pseudogene (WASH5P), log 5 pseudogene non-coding RNA [NR_033266] A_33_P3226105 chr22:0204752 80-020475221 A_23_P421526 ODF4 Homo sapiens outer NM_153007 ENST00000328248 146852 outer dense chr17:8248725- GO:0016020|GO:0009434| NM_153007 THC2483718 Hs.186045 dense fiber of sperm fiber of 8248784 GO:0007275|GO:0016021| tails 4 (ODF4), sperm tails 4 GO:0007283|GO:0030154| mRNA [NM_153007] GO:0001520 A_33_P3362153 LOC388564 Homo sapiens hypo- NM_001190764 ENST00000444469 388564 hypothetical chr19:5589067 NM_001190764 THC2582711 Hs.534672 thetical protein protein 2-55890613 LOC388564 LOC388564 (LOC388564), mRNA[NM_001190764] A_23_P136413 MMP17 Homo sapiens matrix NM_016155 ENST00000360564 4326 matrix metal- chr12:1323362 GO:0005886|GO:0005887| NM_016155 THC2473946 Hs.709245 metallopeptidase 17 lopeptidase 17 44-132336301 GO:0008152|GO:0005509| (membrane-inserted) (membrane- GO:0006508|GO:0005578| (MMP17), mRNA inserted) GO:0008270|GO:0008233| [NM_016155] GO:0005576|GO:0031225| GO:0008047|GO:0004222 A_23_P307310 ACAN Homo sapiens aggrecan NM_013227 ENST00000439576 176 aggrecan chr15:8941777 GO:0005515|GO:0001501| NM_013227 THC2764092 Hs.2159 (ACAN), transcript variant 1-89417830 GO:0005540|GO:0006508| 2, mRNA [NM_013227] GO:0005578|GO:0005529| GO:0005576|GO:0007155| GO:0005201 A_33_P3374398 Homo sapiens cDNA AK097103 chr17:7260016 THC2605561 Hs.93825 FLJ39784 fis, clone 7-72600226 SPLEN2002314. [AK097103] A_24_P358321 immunoglobulin kappa U21012 ENST00000491977 chr2:89986891- NP1132773 Hs.731091 variable 2D-29[ 89986950 Source: HGNC Symbol; Acc: 5800] [ENST00000491977] A_33_P3381235 LOC100127888 Homo sapiens hypo- NR_024470 ENST00000411824 100127888 hypothetical chr20:6129443 NR_024470 THC2620832 thetical LOC100127888 LOC100127888 9-61294380 (LOC100127888), non-coding RNA [NR_024470] A_33_P3333560 chr1:20749553 6-207495477 A_33_P3645888 SNORA71C ax39a01.xl Proliferating BG943532 677839 small nucleolar chr20:3705825 THC2500898 Hs.711516 Human Erythroid Cells RNA, H/ACA 5-37058196 (LCB: ax library) Homo box 71C sapiens cDNA clone ax39a01 random, mRNA sequence [BG943532] A_33_P3291459 LOC100507547 Homo sapiens hypo- NR_037169 ENST00000487140 100507547 hypothetical chr6:32120638 NR_037169 NP1168591 Hs.549204 thetical LOC100507547 LOC100507547 32120579 (LOC100507547), transcript variant 1, non-coding RNA [NR_037169] A_33_P3366614 chr2:14702180 1-147021860 A_33_P3228609 LOC151009 Homo sapiens hypo- NR_027244 151009 hypothetical chr2:11113462 NR_027244 THC2497499 Hs.516403 thetical LOC151009 LOC151009 0-111134561 (LOC151009), non- coding RNA [NR_027244] A_33_P3302373 SZT2 Homo sapiens seizure NM_015284 ENST00000372442 23334 seizure chr1:43918245- NM_015284 THC2522911 Hs.643560 threshold 2 homolog threshold 2 43918304 (mouse) (SZT2), homolog mRNA [NM_015284] (mouse) A_24_P239076 IGLL1 Homo sapiens immuno- NM_020070 ENST00000330377 3543 immuno- chr22:2391571 GO:0006955|GO:0016020| NM_020070 THC2471192 Hs.348935 globulin lambda-like globulin 0-23915651 GO:0005576 polypeptide 1 (IGLL1), lambda-like transcript variant 1, polypeptide 1 mRNA [NM_020070] A_24_P12435 NCOA7 Homo sapiens nuclear NM_181782 ENST00000368357 135112 nuclear receptor chr6:12625187 GO:0005622|GO:0005515| NM_181782 THC2461012 Hs.171426 receptor coactivator 7 coactivator 7 9-126251938 GO:0016998|GO:0005634| (NCOA7), transcript GO:0045449 variant 1, mRNA [NM_181782] A_23_P348208 SPRR1A Homo sapiens small NM_005987 ENST00000368762 6698 small proline- chr1:15295789 GO:0005737|GO:0018149| NM_005987 NP1464433 Hs.46320 proline-rich protein 1A rich protein 7-152957956 GO:0008544|GO:0005198| (SPRR1A), transcript 1A GO:0031424|GO:0030674| variant 2, mRNA GO:0001533 [NM_005987] A_33_P3366456 HDGFL1 Homo sapiens hepatoma NM_138574 ENST00000230012 154150 hepatoma chr6:22570614- NM_138574 THC2474651 Hs.629246 derived growth factor- derived 22570673 like 1 (HDGFL1), growth mRNA [NM_138574] factor-like 1 A_33_P3386297 Homo sapiens MSTP159 AF190162 chrX:13524023 THC2488126 Hs.689084 (MST159) mRNA, 8-135240297 complete cds. [AF190162] A_33_P3309468 PTPRS Homo sapiens protein NM_002850 ENST00000372412 5802 protein tyrosine chr19:5205578- GO:0005515|GO:0006470| NM_002850 THC2517908 Hs.644384 tyrosine phosphatase, phosphatase, 5205519 GO:0016787|GO:0016020| receptor type, S receptor type, GO:0005887|GO:0005001| (PTPRS), transcript S GO:0004872|GO:0007155 variant 1, mRNA [NM_002850] A_23_P16096 PPAN Homo sapiens peter NM_020230 ENST00000466025 56342 peter pan chr19:1021874 GO:0008380|GO:0005515| NM_020230 THC2534071 Hs.14468 pan homolog (Drosophila) homolog 4-10218803 GO:0005730|GO:0005634 (PPAN), mRNA (Drosophila) [NM_020230] A_33_P3302245 TMEM59L Homo sapiens trans- NM_012109 ENST00000262817 25789 transmembrane chr19:1873160 GO:0016020|GO:0005624| NM_012109 THC2601975 Hs.329850 membrane protein protein 59-like 2-18731661 GO:0016021 59-like (TMEM59L), mRNA [NM_012109] A_24_P208345 SLC45A3 Homo sapiens solute NM_033102 ENST00000367145 85414 solute carrier chr1:20562709 GO:0016020|GO:0016021| NM_033102 NP1165434 Hs.278695 carrier family 45, family 45, 6-205627037 GO:0055085 member 3 (SLC45A3), member 3 mRNA [NM_033102] A_33_P3391517 SNX22 sorting nexin 22 BC030225 ENST00000380278 79856 sorting nexin chr15:6444616 THC2621916 Hs.708268 [Source: HGNC 22 9-64446228 Symbol; Acc: 16315] [ENST00000380278] A_33_P3328289 A_23_P85693 GBP2 Homo sapiens guanylate NM_004120 ENST00000463660 2634 guanylate binding chr1:89578160- GO:0006955|GO:0005886| NM_004120 THC2660155 Hs.386567 binding protein 2, protein 2, inter- 89575896 GO:0000166|GO:0003924| interferon-inducible feron-inducible GO:0005525 (GBP2), mRNA [NM_004120] A_33_P3294159 CALY Homo sapiens calcyon NM_015722 ENST00000368556 50632 calcyon neuron- chr10:1351415 GO:0045807|GO:0005886| NM_015722 THC2605646 Hs.148680 neuron-specific vesicular specific 09-135141450 GO:0032051|GO:0005887| protein (CALY), mRNA vesicular GO:0031410|GO:0007212| [NM_015722] protein GO:0050780|GO:0048268 A_24_P287756 NUDT21 Homo sapiens nudix NM_007006 ENST00000535563 11051 nudix (nucleoside chr16:5646358 GO:0005515|GO:0005813| NM_007006 THC2532864 Hs.528834 (nucleoside diphosphate diphosphate 5-56463526 GO:0042382|GO:0042826| linked moiety X)-type linked moiety GO:0016787|GO:0000398| motif 21 (NUDT21), X)-type motif GO:0003723|GO:0005634 mRNA [NM_007006] 21 A_33_P3336822 immunoglobulin lambda U09907 ENST00000390297 chr22:2273547 NP426024 Hs.561078 variable 1-44 [Source: 8-22735537 HGNC Symbol; Acc: 5879] [ENST00000390297] A_23_P361654 immunoglobulin kappa BC073764 ENST00000492446 chr2:90139373- THC2551789 Hs.449621 variable 10-16 [Source: 90139432 HGNC Symbol; Acc: 5748] [ENST00000492446] A_32_P115558 yb85d04.s1 Stratagene liver T53825 chr17:0162859 THC2576794 Hs.702098 (#937224) Homo sapiens 23-016285864 cDNA clone IMAGE:77959 3′ similar to similar to gb:M26880 UBIQUITIN (HUMAN), mRNA sequence [T53825] A_33_P3344574 SFTPA2 Homo sapiens surfactant NM_001098668 ENST00000372325 729238 surfactant chr10:8131568 GO:0007585|GO:0005488| NM_001098668 Hs.523084 protein A2(SFTPA2), protein A2 2-81315623 GO:0005509|GO:0005578| mRNA [NM_001098668] GO:0005529|GO:0005576| GO:0005615 A_23_P432056 RTN4RL1 Homo sapiens reticulon NM_178568 ENST00000331238 146760 reticulon 4 chr17:1840616- GO:0005515|GO:0031103| NM_178568 THC2602362 Hs.22917 4 receptor like 1 receptor-like 1 1840557 GO:0005886|GO:0045121| (RTN4RL1), mRNA GO:0004872|GO:0046658| [NM_178568] GO:0009897 A_23_P19243 AKIRIN2-AS1 Homo sapiens NR_002767 55389 AKIRIN2 chr6:88410191- NR_002767 THC2539344 Hs.662132 AKIRIN2 antisense RNA antisense RNA 88410132 1 (non-protein coding) 1 (non-protein (AKIRIN2-AS1), non- coding) coding RNA [NR_002767] A_33_P3417502 WNT3A Homo sapiens wingless- NM_033131 ENST00000366753 89780 wingless-type chr1:22824794 GO:0030097|GO:0005515| NM_033131 NP1459415 Hs.336930 type MMTV integration MMTV 6-228248005 GO:0048103|GO:0007368| site family, member 3A integration GO:0042472|GO:0001756| (WNT3A), mRNA site family, GO:0005578|GO:0007267| [NM_033131] member 3A GO:0030879|GO:0021874| GO:0005576|GO:0007275| GO:0007409|GO:0001701| GO:0005615|GO:0007223| GO:0001947|GO:0021766| GO:0045595|GO:0004871| GO:0048343|GO:0005201 A_33_P3331326 chr13:0281946 69-028194728 A_33_P3229863 LOC100128714 Homo sapiens hypo- NR_040082 ENST00000383019 100128714 hypothetical chr15:2629819 NR_040082 THC2487359 thetical LOC100128714 LOC100128714 7-26298256 (LOC100128714), non- coding RNA [NR_040082] A_33_P3309501 LOC100507184 PREDICTED: XM_003118917 100507184 hypothetical chr14:1013250 XM_003118917 THC2474208 Hs.728839 Homo sapiens hypo- protein 72-101325131 thetical protein LOC100507184 LOC100507184 (LOC100507184), mRNA [XM_003118917] A_33_P3275422 C14orf70 Homo sapiens chromo- NR_024096 ENST00000360899 283601 chromosome 14 chr14:1011389 NR_024096 THC2483476 Hs.379802 some 14 open reading open reading 94-101139053 frame 70 (C14orf70), frame 70 non-coding RNA [NR_024096] A_32_P3914 WIPF3 Homo sapiens WAS/ NM_001080529 ENST00000409290 644150 WAS/WASL chr7:29955838- NM_001080529 Hs.709280 WASL interacting protein interacting 29955897 family, member 3 (WIPF3), protein family, mRNA [NM_001080529] member 3 A_33_P3290443 SCARNA9 Homo sapiens small NR_002569 ENSTOOOOO530422 619383 small Cajal chr11:9345497 NR_002569 THC2562327 Cajal body-specific body-specific 3-93455032 RNA 9 (SCARNA9), guide RNA 9 RNA [NR_002569] A_33_P3322388 SPRR2D Homo sapiens small NM_006945 ENST00000439437 6703 small proline- chr1:15301266 GO:0005737|GO:0008544| NM_006945 THC2480904 Hs.505327 proline-rich protein 2D rich protein 3-153012604 GO:0031424|GO:0001533 (SPRR2D), mRNA 2D [NM_006945] A_33_P3234472 LOC284751 Homo sapiens hypo- NR_034124 284751 hypothetical chr20:4893139 NR_034124 Hs.282325 thetical LOC284751 LOC284751 7-48931456 (LOC284751), non- coding RNA [NR_034124] A_23_P128598 TUBA3C Homo sapiens tubulin, NM_006001 ENST00000360801 7278 tubulin, chr13:1975119 NM_006001 THC2490161 Hs.349695 alpha 3c (TUBA3C), alpha 3c 7-19751138 mRNA [NM_006001] A_33_P3416231 HOXA9 Homo sapiens home- NM_152739 ENST00000242050 3205 homeobox chr7:27203204 GO:0005515|GO:0005667| NM_152739 THC2746857 Hs.659350 obox A9 (HOXA9), A9 27203145 GO:0006355|GO:0003700| mRNA [NM_152739] GO:0016563|GO:0048706| GO:0060216|GO:0005634| GO:0007275|GO:0009954| GO:0030879|GO:0009952| GO:0043565|GO:0005737| GO:0035115 A_23_P70095 CD74 Homo sapiens CD74 NM_001025158 ENST00000523813 972 CD74 molecule, chr5:14979228 GO:0042289|GO:0016064| NM_001025158 THC2590686 Hs.436568 molecule, major histo- major 1-149792222 GO:0005886|GO:0005783| compatibility complex, histocompati- GO:0008283|GO:0043030| class II invariant chain bility complex, GO:0006886|GO:0005764| (CD74), transcript class II in- GO:0042802|GO:0005622| variant 3, mRNA variant chain GO:0000187|GO:0019886| [NM_001025158] GO:0006955|GO:0001516| GO:0019883|GO:0045581| GO:0045582|GO:0043066| GO:0005794|GO:0005771| GO:0006952|GO:0045059| GO:0045058|GO:0007165| GO:0006461|GO:0019955| GO:0051085|GO:0045060| GO:0016021|GO:0009897 A_33_P3297978 MYO1E Homo sapiens myosin NM_004998 ENST00000288235 4643 myosin IE chr15:5942870 GO:0030048|GO:0005516| NM_004998 THC2468472 Hs.654506 IE (MYO1E), mRNA 8-59428649 GO:0006807|GO:0042623| [NM_004998] GO:0001822|GO:0003779| GO:0016459|GO:0001701| GO:0005524|GO:0000146| GO:0000166|GO:0035166| GO:0048008|GO:0001570 A_33_P3251462 C20orf141 Homo sapiens chromo- NM_080739 ENST00000380589 128653 chromosome 20 chr20:2796282- GO:0016020|GO:0016021 NM_080739 THC2476421 Hs.352187 some 20 open reading open reading 2796341 frame 141 (C20orf141), frame 141 mRNA [NM_0807391 A_33_P3223592 APOE Homo sapiens apolipo- NM_000041 ENST00000252486 348 apolipo- chr19:4541259 GO:0010468|GO:0006707| NM_000041 THC2465276 Hs.654439 protein E (APOE). protein E 0-45412649 GO:0046911|GO:0048844| mRNA [NM_000041] GO:0002021|GO:0005615| GO:0042803|GO:0034361| GO:0048168|GO:0034364| GO:0034363|GO:0034362| GO:0043025|GO:0034447| GO:0042632|GO:0005794| GO:0016209|GO:0046982| GO:0043691|GO:0031232| GO:0007271|GO:0006898| GO:0051651|GO:0034372| GO:0007186|GO:0051000| GO:0034375|GO:0006641| GO:0000302|GO:0043537| GO:0042159|GO:0005319| GO:0042158|GO:0006629| GO:0010544|GO:0051044| GO:0007263|GO:0005886| GO:0045541|GO:0045471| GO:0017127|GO:0042627| GO:0010873|GO:0019934| GO:0010875|GO:0030425| GO:0008034|GO:0005737| GO:0030516|GO:0001540| GO:0005543|GO:0034384| GO:0034382|GO:0043407| GO:0042311|GO:0007010| GO:0034380|GO:0008201| GO:0005770|GO:0032488| GO:0055088|GO:0048156| GO:0006874|GO:0046907| GO:0006916|GO:0005576| GO:0006917|GO:0033700| GO:0032805|GO:0001937| GO:0050728|GO:0006869| GO:0030828|GO:0050750 A_23_P202769 DNAJC4 Homo sapiens DnaJ NM_005528 ENST00000543791 3338 DnaJ (Hsp40) chr11:6400025 GO:0006986|GO:0016020| NM_005528 THC2583429 Hs.172847 (Hsp40) homolog, sub- homolog, 1-64000310 GO:0006457|GO:0031072| family C, member 4 subfamily C, GO:0005624|GO:0051082| (DNAJC4), mRNA member 4 GO:0016021 [NM_005528] A_23_P46222 TRIM46 tripartite motif con- BC069416 ENST00000368385 80128 tripartite motif chr1:15515236 THC2472412 Hs.287735 taining 46 [Source: HGNC containing 46 1-155152920 Symbol; Acc: 19019] [ENST00000368385] A_23_P33607 C17orf42 Homo sapiens chromo- NM_024683 ENST00000306049 79736 chromosome 17 chr17:2922756 GO:0003676 NM_024683 THC2470414 Hs.317340 some 17 open reading open reading 5-29227506 frame 42 (C17orf42), frame 42 mRNA [NM_024683] A_33_P3257714 RPS23 Homo sapiens ribosomal NM_001025 ENST00000296674 6228 ribosomal protein chr5:81569349- GO:0005622|GO:0003674| NM_001025 THC2494905 Hs.527193 protein S23 (RPS23), S23 81569290 GO:0003735|GO:0022627| mRNA [NM_001025] GO:0005840|GO:0006414| GO:0005829 A_24_P203072 PHF16 Homo sapiens PHD NM_014735 ENST00000218343 9767 PHD finger chrX:46919911- GO:0043981|GO:0005515| NM_014735 THC2464683 Hs.371977 finger protein 16 protein 16 46919970 GO:0043983|GO:0043982| (PHF16), transcript GO:0043966|GO:0043984| variant 1, mRNA GO:0000123|GO:0008270| [NM_014735] GO:0046872 A_33_P3369128 LOC100132966 Homo sapiens cDNA AK124556 100132966 hypothetical chr1:14391467 THC2585044 Hs.730332 FLJ42565 fis, clone LOC100132966 1-143914730 BRACE3007472. [AK124556] A_23_P38167 GPRC5C Homo sapiens G pro- NM_022036 ENST00000342648 55890 G protein- chr17:7244341 GO:0005515|GO:0007165| NM_022036 THC2493229 Hs.446438 tein-coupled receptor, coupled re- 3-72443472 GO:0007186|GO:0005886| family C, group 5, ceptor, family GO:0005887|GO:0004930| member C (GPRC5C), C, group 5, GO:0004872|GO:0031410 transcript variant 1, member C mRNA [NM_022036] A_23_P26294 TPSG1 Homo sapiens tryptase NM_012467 ENST00000234798 25823 tryptase chr16:1271739- GO:0016020|GO:0004252| NM_012467 THC2478934 Hs.592076 gamma 1 (TPSG1), gamma 1 1271680 GO:0005887|GO:0006508| mRNA [NM_012467] GO:0008233 A_33_P3304707 immunoglobulin Z46314 ENST00000390317 chr22:2316557 NP165804 Hs.625768 lambda variable 2-8 4-23165633 [Source: HGNC Symbol; Acc: 5895] [ENST00000390317] A_33_P3382944 YJEFN3 Homo sapiens YjeF NM_198537 ENST00000397179 374887 YjeF N- chr19:1964833 NM_198537 THC2501471 Hs.729508 N-terminal domain con- terminal 4-19648393 taining 3 (YJEFN3), domain nuclear gene encoding containing 3 mitochondrial protein, transcript variant 1, mRNA [NM_198537] A_23_P78289 FAM104A Homo sapiens family NM_032837 ENST00000405159 84923 family with chr17:7120360 NM_032837 THC2468706 Hs.103555 with sequence similarity sequence 6-71203547 104, member A similarity 104, (FAM104A), member A transcript variant 2, mRNA [NM_032837] A_24_P75917 CCDC144A Homo sapiens coiled- NM_014695 ENST00000420937 9720 coiled-coil chr17:1661285 NM_014695 THC2483620 Hs.721149 coil domain containing domain 2-16612911 144A (CCDC144A), containing mRNA [NM_014695] 144A A_32_P356316 HLA-DOA Homo sapiens major NM_002119 ENST00000229829 3111 major histo- chr6:32972029- GO:0019886|GO:0006955| NM_002119 THC2653816 Hs.631991 histocompatibility compatibility 32971970 GO:0005886|GO:0002504| complex, class II, DO complex, class GO:0045580|GO:0042613| alpha (HLA-DOA), II, DO alpha GO:0016021|GO:0032395 mRNA [NM_002119] A_23_P257815 CD180 Homo sapiens CD180 NM_005582 ENST00000256447 4064 CD180 chr5:664787 GO:0005515|GO:0006954| NM_005582 THC2471609 Hs.87205 molecule (CD180), molecule 52 66478693 GO:0005886|GO:0045087| mRNA [NM_005582] GO:0004872|GO:0016021 A_33_P3328284 chr12:1046808 91-104680832 A_33_P3210379 SCGB3A1 Homo sapiens secret- NM_052863 ENST00000512120 92304 secretoglobin, chr5:18001716 GO:0030308|GO:0042127| NM_052863 THC2608654 Hs.62492 oglobin, family 3A, family 3A, 5-180017106 GO:0005576|GO:0005615| member 1 (SCGB3A1), member 1 GO:0005125 mRNA[NM_052863] A_33_P3271635 HLA-DPB1 Homo sapiens major NM_002121 ENST00000402095 3115 major histo- chr6:33048489- GO:0006955|GO:0016020| NM_002121 THC2541762 Hs.485130 histocompatibility compatibility 33048537 GO:0005886|GO:0002504| complex, class II, DP complex, class GO:0042613|GO:0016021 beta 1 (HLA-DPB1), II, DP beta 1 mRNA [NM_002121] A_33_P3237125 ANKRD54 Homo sapiens ankyrin NM_138797 ENST00000498417 129138 ankyrin repeat chr22:3822800 NM_138797 THC2555662 Hs.135259 repeat domain 54 domain 54 2-38227943 (ANKRD54), transcript variant 1, mRNA [NM_138797] A_33_P3378384 DNM1P46 Homo sapiens DNM1 NR_003260 ENST00000341853 196968 DNM1 chr1 5:1003400 NR_003260 THC2485999 Hs.585319 pseudogene 46 pseudogene 46 36-100339983 (DNM1P46), non-coding RNA [NR_003260] A_33_P3550894 GATA2 Homo sapiens GATA NM_001145661 ENST00000430265 2624 GATA chr3:12819960 GO:0006355|GO:0003700| NM_001145661 NP099465 Hs.367725 binding protein 2 binding 6-128199547 GO:0001709|GO:0021983| (GATA2), transcript protein 2 GO:0005730|GO:0001892| variant 1, mRNA GO:0005634|GO:0010552| [NM_001145661] GO:0046872|GO:0045766| GO:0043565|GO:0050766| GO:0030182|GO:0048469| GO:0008270|GO:0008134 A_33_P3370364 PRLHR Homo sapiens prolactin NM_004248 ENST00000369169 2834 prolactin chr10:1203530 GO:0007631|GO:0007165| NM_004248 THC2605922 Hs.248119 releasing hormone receptor releasing 20-120352961 GO:0007565|GO:0004983| (PRLHR), mRNA hormone receptor GO:0007186|GO:0005886| [NM_004248] GO:0005887|GO:0004930| GO:0042445|GO:0004872| GO:0017046 A_24_P412734 PRSS36 Homo sapiens protease, NM_173502 ENST00000268281 146547 protease, chr16:3115173 GO:0005737|GO:0004252| NM_173502 THC2477817 Hs.256632 serine, 36 (PRSS36), serine, 36 0-31151671 GO:0006508|GO:0005578| mRNA [NM_173502] GO:0008233|GO:0005576 A_23_P397238 FKBP1A Homo sapiens FK506 NM_054014 ENST00000381715 2280 FK506 binding chr20:135258 GO:0055010|GO:0046332| NM_054014 THC2472790 Hs.471933 binding protein 1A, protein 1A, 1352530 GO:0022417|GO:0005829| 12 kDa (FKBP1A), 12 kDa GO:0032092|GO:0042026| transcript variant 2, GO:0005737|GO:0006458| mRNA [NM_054014] GO:0048185|GO:0060314| GO:0031398|GO:0005024| GO:0004871|GO:0043206| GO:0043123|GO:0014802| GO:0003755|GO:0005528| GO:0032925|GO:0034205| GO:0060347|GO:0007183| GO:0042110|GO:0034713| GO:0032513|GO:0050776| GO:0016853|GO:0005219 A_33_P3269844 LRRC26 Homo sapiens leucine NM_001013653 ENST00000371542 389816 leucine rich chr9:14006328 GO:0005515|GO:0005737| NM_001013653 THC2675561 Hs.669977 rich repeat containing repeat 0-140063221 GO:0016020|GO:0016021| 26 (LRRC26), mRNA containing 26 GO:0005856 [NM_001013653] A_23_P161769 FXYD2 Homo sapiens FXYD NM_021603 ENST00000532984 486 FXYD chr11:1176910 03- GO:0005215|GO:0016020| NM_021603 THC2718763 Hs.413137 domain containing ion domain con- 117690944 GO:0030955|GO:0016021| transport regulator 2 taining ion trans- GO:0031402|GO:0006814| (FXYD2), transcript port regulator 2 GO:0005890|GO:0006813| variant b, mRNA GO:0005216|GO:0006811| [NM_021603] GO:0005391 A_33_P3219850 Q4RKH8_TETNG chr17:0752538 THC2702109 (Q4RKH8) Chromosome 78-075253819 21 SCAF15029, whole genome shotgun sequence, partial (4%) [THC2702109] A_33_P3271395 LOC100129534 Homo sapiens small NR_024489 100129534 small nuclear chr1:2281912- NR_024489 THC2481166 Hs.655313 nuclear ribonucleo- ribonucleoprotein 2281853 protein polypeptide polypeptide N N pseudogene pseudogene (LOC100129534), non-coding RNA [NR_024489] A_23_P45099 HLA-DRB5 Homo sapiens major NM_002125 ENST00000374975 3127 major histo- chr6:32485465- GO:0006955|GO:0016020| NM_002125 THC2478372 Hs.534322 histocompatibility compatibility 32485406 GO:0005886|GO:0002504| complex, class II, DR complex, class GO:0042613|GO:0016021 beta 5 (HLA-DRB5), II, DR beta 5 mRNA [NM_002125] A_33_P3242039 chr12:1066337 92-106633851 A_33_P3351606 LOC100130155 Homo sapiens hypo- NR_034102 ENST00000524060 100130155 hypothetical chr8:65290622- NR_034102 THC2738263 Hs.7023 thetical LOC100130155 LOC100130155 65290681 (LOC100130155), non- coding RNA [NR_034102] A_33_P3282614 C9orf173 Homo sapiens chromo- NM_001004353 ENST00000388931 441476 chromosome 9 chr9:14014785 NM_001004353 THC2488587 Hs.372640 some 9 open reading open reading 6-140147915 frame 173 (C9orf173), frame 173 mRNA [NM_001004353] A_33_P3236902 mucin 3A, cell surface XM_001716644 ENST00000483366 chr7:10055007 XM_001716644 NP853252 Hs.489354 associated [Source: HGNC 5-100550134 Symbol; Acc: 7513] [ENST00000483366] A_23_P4474 IER3IP1 Homo sapiens imme- NM_016097 ENST00000256433 51124 immediate chr18:4468193 GO:0005794|GO:0016020| NM_016097 THC2468751 Hs.130917 diate early response 3 early response 0-44681874 GO:0005783|GO:0016021 interacting protein 1 3 interacting (IER3IP1), mRNA protein 1 [NM_016097] A_33_P3258061 PALM3 Homo sapiens para- NM_001145028 ENST00000340790 342979 paralemmin 3 chr19:1416423 GO:0005737|GO:0005886| NM_001145028 THC2610963 Hs.444298 lemmin 3 (PALM3), 8-14164179 GO:0000166|GO:0031225| mRNA [NM_001145028] GO:0005524 A_33_P3236858 TGFB1I1 Homo sapiens trans- NM_001042454 ENST00000394858 7041 transforming chr16:3148920 GO:0005515|GO:0008285| NM_001042454 THC2609995 Hs.513530 forming growth factor growth factor 5 31489264 GO:0030054|GO:0006366| beta 1 induced transcript beta 1 induced GO:0045599|GO:0010718| 1 (TGFB1I1), transcript 1 GO:0005634|GO:0050681| transcript variant 1, GO:0016363|GO:0046872| mRNA [NM_001042454] GO:0005622|GO:0005737| GO:0030855|GO:0016055| GO:0007155|GO:0005856| GO:0030579|GO:0030512| GO:0030511|GO:0003713| GO:0070411|GO:0045165| GO:0016331|GO:0008270| GO:0045893|GO:0005925| GO:0030521 A_33_P3227761 chr4:07100821 0-071008151 A_23_P47004 DHX32 Homo sapiens DEAH NM_018180 ENST00000284690 55760 DEAH (Asp- chr10:1275276 GO:0005739|GO:0016787| NM_018180 THC2461938 Hs.370292 (Asp-Glu-Ala-His) box Glu-Ala-His) 12-127526940 GO:0000166|GO:0004386| polypeptide 32 (DHX32), box polypeptide GO:0005634|GO:0005524 mRNA [NM_018180] 32 A_33_P3280575 Synthetic construct Homo CU691877 chr13:0248958 sapiens gateway clone 73-024895814 IMAGE: 100021124 3′ read C1QTNF9 mRNA. [CU691877] A_23_ P140190 KIAA0125 Homo sapiens NM_026800 ENST00000484511 9834 KIAA0125 chr14:1063881 NR_026800 THC2483256 Hs.649259 KIAA0125 (KIAA0125), 26-106388185 non-coding RNA [NM_026800] A_33_P3320782 ATXN7 Homo sapiens ataxin NM_000333 ENST00000398590 6314 ataxin 7 chr3:63986252- GO:0005622|GO:0005515| NM_000333 THC2471545 Hs.729041 7 (ATXN7), transcript 63986311 GO:0016578|GO:0008219| variant SCA7a, mRNA GO:0006997|GO:0005737| [NM_000333] GO:0005730|GO:0008270| GO:0005634|GO:0007601| GO:0045449|GO:0016363 A_33_P3233871 F12 Homo sapiens NM_000505 ENST00000253496 2161 coagulation chr5:17682920 GO:0016540|GO:0004252| NM_000505 THC2473799 Hs.1321 coagulation factor XII factor XII 1-176829142 GO:0051919|GO:0005576| (Hageman factor) (F12), (Hageman GO:0005615|GO:0051787| mRNA [NM_000505] factor) GO:0051605|GO:0051788| GO:0005488|GO:0010756| GO:0030194|GO:0002542| GO:0007597|GO:0045087| GO:0006508|GO:0008233| GO:0070009|GO:0031638 A_32_P47701 EEF1A1 Homo sapiens euka- NM_001402 ENST00000488500 1915 eukaryotic chr6:74228782- GO:0005515|GO:0005853| NM_001402 NP1154415 Hs.535192 ryotic translation elongation translation 74228723 GO:0005737|GO:0000166| factor 1 alpha 1(EEF1A1), elongation GO:0003924|GO:0005525| mRNA [NM_001402] factor 1 alpha 1 GO:0003746|GO:0006414| GO:0005829 A_23_P435444 PCDHGA7 Homo sapiens proto- NM_032087 56108 protocadherin chr5:14076488 GO:0005515|GO:0005886| NM_032087 THC2601387 Hs.368160 cadherin gamma sub- gamma sub- 0-140764939 GO:0005509|GO:0016021| family A, 7 (PCDHGA7), family A, 7 GO:0007155|GO:0007156 transcript variant 2, mRNA [NM_032087] A_33_P3358233 NES Homo sapiens nestin NM_006617 ENST00000368223 10763 nestin chr1:15663948 GO:0005882|GO:0005622| NM_006617 NP286942 Hs.527971 (NES), mRNA 1-156639422 GO:0005737|GO:0005198| [NM_006617] GO:0042493|GO:0010212| GO:0031667|GO:0007417| GO:0005856 A_33_P3440264 LOC100132273 Homo sapiens hypo- NR_034118 ENST00000417327 100132273 hypothetical chr22:4252048 NR_034118 THC2492791 Hs.709677 thetical LOC100132273 LOC100132273 6-42520545 (LOC100132273), non- coding RNA [NR_034118] A_33_P3216372 IQGAP2 Homo sapiens IQ NM_006633 ENST00000504477 10788 IQ motif chr5:76003795- GO:0005622|GO:0005099| NM_006633 THC2461535 Hs.291030 motif containing GTPase containing 76003854 GO:0051056|GO:0007165| activating protein 2 GTPase GO:0005516|GO:0003779| (IQGAP2), mRNA activating GO:0015629|GO:0005095 [NM_006633] protein 2 A_33_P3308101 Homo sapiens cDNA AK128836 ENST00000434161 chr7:56879807- THC2481823 Hs.520384 FLJ46348 fis, clone 56879748 TESTI4047569. [AK128836] A_33_P3355783 LOC100507482 Uncharacterized protein XM_003119184 ENST00000398976 100507482 hypothetical chr11:6153478 XM_003119184 NP852509 Hs.676126 [Source: UniProtKB/ protein 7-61534846 TrEMBL; Acc: E7ES44] LOC100507482 [ENST00000398976] A_33_P3235189 ANKRD13B Homo sapiens ankyrin NM_152345 ENST00000493506 124930 ankyrin repeat chr17:2793923 NM_152345 NP1146859 Hs.662164 repeat domain 13B domain 13B 1-27939290 (ANKRD13B), mRNA [NM_152345] A_33_P3216232 ITGB1BP1 Homo sapiens integrin NM_004763 ENST00000483795 9270 integrin beta chr2:9545927- GO:0005515|GO:0005737| NM_004763 THC2501038 Hs.467662 beta 1 binding protein 1 1 binding 9545868 GO:0016477|GO:0016020| (ITGB1BP1), transcript protein 1 GO:0007160|GO:0001726| variant 1, mRNA GO:0030027|GO:0007243| [NM_004763] GO:0005829 A_33_P3262969 COL4A6 collagen, type IV, alpha BT007228 ENST00000461897 1288 collagen, chrX:10751236 THC2480759 Hs.145586 6 [Source: HGNC type IV, 9-107512310 Symbol; Acc: 2208] alpha 6 [ENST00000461897] A_33_P3411477 NCCRP1 Homo sapiens non- NM_001001414 ENST00000339852 342897 non-specific chr19:3969246 GO:0005515|GO:0030163 NM_001001414 NP1155945 Hs 726934 specific cytotoxic cell cytotoxic cell 1-39692520 receptor protein 1 homo- receptor pro- log (zebrafish) tein 1 homo- (NCCRP1), mRNA log (zebra fish) [NM_001001414] A_23_P108294 PPAP2C Homo sapiens phos- NM_177543 ENST00000327790 8612 phosphatidic chr19:282253- GO:0042392|GO:0016787| NM_177543 THC2554424 Hs.465506 phatidic acid phosphatase acid phos- 282194 GO:0005886|GO:0004721| type 2C (PPAP2C), phatase type 2C GO:0016021|GO:0008195 transcript variant 3, mRNA [NM_177543] A_24_P305570 RIN2 Homo sapiens Ras NM_018993 ENST00000255006 54453 Ras and Rab chr20:1998254 GO:0005515|GO:0017112| NM_018993 THC2463477 Hs.472270 and Rab interactor 2 interactor 2 1-19982600 GO:0007165|GO:0005737| (RIN2), transcript GO:0005083|GO:0007264| variant 2, mRNA GO:0005575|GO:0006897| [NM_018993] GO:0005096 A_33_P3226154 immunoglobulin kappa AY538254 ENST00000390237 chr2:89156970- NP1073961 Hs.449621 constant [Source: HGNC 89156911 Symbol; Acc: 5716] [ENST00000390237] A_33_P3416707 PTK2 PTK2 protein tyrosine ENST00000342207 5747 PTK2 chr8:14174485 kinase 2 [Source: HGNC protein 5-141744796 Symbol; Acc: 9611] tyrosine [ENST00000342207] kinase 2 A_33_P3231076 LOC100132707 Homo sapiens hypo- NR_024477 ENST00000411526 100132707 hypothetical chr7:15473842 NR_024477 THC2512332 Hs.586358 thetical LOC100132707 LOC100132707 9-154738488 (LOC100132707), tran- script variant 2, non-coding RNA [NR_024477] A_23_P411723 PLAG1 Homo sapiens pleio- NM_002655 ENST00000316981 5324 pleiomorphic chr8:57074013- GO:0005622|GO:0003700| NM_002655 THC2649104 Hs.14968 morphic adenoma gene adenoma gene 57073954 GO:0008270|GO:0005634| 1 (PLAG1), transcript 1 GO:0046872|GO:0045449 variant 1, mRNA [NM_002655] A_32_P63848 OXCT1 Homo sapiens 3-oxo- NM_000436 ENST00000546045 5019 3-oxoacid chr5:41730530- GO:0005739|GO:0046952| NM_000436 THC2620135 Hs.278277 acid CoA transferase 1 CoA 41730471 GO:0005759|GO:0008152| (OXCT1), nuclear gene transferase 1 GO:0008260|GO:0042803| encoding mitochondrial GO:0016740 protein, mRNA [NM_000436] A_33_P3324805 LOC100130345 PREDICTED: XM_001716484 100130345 cadherin- chr3:63738330- XM_001716484 Hs.534738 Homo sapiens cadherin- related family 63738271 related family member member 3-like 3 like (LOC100130345), mRNA [XM_001716484] A_24_P305467 GATAD2A Homo sapiens GATA NM_017660 ENST00000358713 54815 GATA zinc chr19:1961947 GO:0043565|GO:0016564| NM_017660 THC2496807 Hs.118964 zinc finger domain con- finger domain 3-19619532 GO:0006306|GO:0003700| taining 2A (GATAD2A), containing 2A GO:0016607|GO:0016581| mRNA [NM_017660] GO:0005730|GO:0008270| GO:0005634|GO:0030674| GO:0045892|GO:0046872 A_23_P312920 POU2AF1 Homo sapiens POU NM_006235 ENST00000393067 5450 POU class chr11:1112230 GO:0005515|GO:0006366| NM_006235 THC2464202 Hs.654525 class 2 associating factor 1 2 associating 63-111223004 GO:0006959|GO:0003713| (POU2AF1), mRNA factor 1 GO:0005634|GO:0003677| [NM_006235] GO:0045449 A_23_P118516 FAM18B1 Homo sapiens family NM_016078 ENST00000428082 51030 family with chr17:1870928 GO:001b020|GO:0016021 NM_016078 THC2557159 Hs.87295 with sequence similarity sequence 3-18709342 18, member B1 similarity 18, (FAM18B1), member B1 mRNA [NM_016078] A_33_P3424467 CNST Homo sapiens consortin, NM_152609 ENST00000366513 163882 consortin, chr1:24683180 GO:0043234|GO:0016020| NM_152609 THC2600974 Hs.368353 connexin sorting protein connexin 2-246831861 GO:0016021 (CNST), transcript sorting protein variant 1, mRNA [NM_152609] A_33_P3370521 XM_001721393 ENST00000427872 chr1:12087655 XM_001721393 THC2698492 Hs.568526 4-120876495 A_33_P3330663 GB chr8:04811417 NP109356 5-048114116 A_24_P367421 TCAAP1Q12860HGSC BM147583 chr15:0327920 THC2535859 Hs.730231 Pediatric acute myelo- 25-032791965 genous leukemia cell (FAB M1) Baylor- project = TCAA Homo sapiens cDNA clone TCAAP1286, mRNA sequence [BM147583] A_23_P311010 SPRY3 Homo sapiens sprouty NM_005840 ENST00000302805 10251 sprouty chrX:1550120 GO:0005515|GO:0003674| NM_005840 THC2615136 Hs.381912 homolog 3 (Drosophila) homolog 3 3 8-155012097 GO:0005737|GO:0016020| (SPRY3), mRNA (Drosophila) GO:0007275|GO:0009966| [NM_005840] GO:0019898 A_23_P326080 DEFA4 Homo sapiens defensin, NM_001925 ENST00000297435 1669 defensin, chr8:6793424- GO:0050832|GO:0031640| NM_001925 THC2478179 Hs.591391 alpha 4, corticostatin alpha 4, 6793365 GO:0005576|GO:0005615| (DEFA4), mRNA corticostatin GO:0042742 [NM_001925] A_33_P3300975 HOXC4 Homo sapiens home- NM_014620 ENST00000430889 3221 homeobox C4 chr12:5444975 GO:0043565|GO:0006355| NM_014620 THC2474518 Hs.549040 obox C4 (HOXC4), 5-54449814 GO:0003700|GO:0051216| transcript variant 1, GO:0007275|GO:0005634| mRNA [NM_014620] GO:0009952|GO:0048562 A_33_P3299739 CLDN19 Homo sapiens claudin NM_001123395 ENST00000372539 149461 claudin 19 chr1:43200754- GO:0000287|GO:0030054| NM_001123395 THC2482498 Hs.496270 19 (CLDN19), transcript 43200695 GO:0005886|GO:0005634| variant 2, mRNA GO:0019227|GO:0042802| [NM_001123395] GO:0043297|GO:0016323| GO:0005737|GO:0016338| GO:0005198|GO:0005923| GO:0016021|GO:0007601| GO:0050896 A_23_P502808 PRIMA1 Homo sapiens proline NM_178013 ENST00000477603 145270 proline rich chr14:9420365 GO:0030054|GO:0005886| NM_178013 THC2489283 Hs.432401 rich membrane anchor membrane 0-94203591 GO:0045202|GO:0016021| 1 (PRIMA1), mRNA anchor 1 GO:0042135 [NM_178013] A_33_P3327888 chromosome 8 open XM_002346128 ENST00000507535 chr8:14094467 XM_002346128 NP1462426 Hs.283098 reading frame 17 0-140944729 [Source: HGNC Symbol; Acc: 17737] [ENST00000507535] A_33_P3309365 FLJ40434 Homo sapiens hypo- NR_002314 163742 hypothetical chr1:53904127- NR_002314 THC2482167 Hs.722531 thetical FLJ40434 FLJ40434 53904068 (FLJ40434), non-coding RNA [NR_002314] A_24_P342591 RERE Homo sapiens arginine- NM_012102 ENST00000467350 473 arginine- chr1:8413045- GO:0043565|GO:0008267| NM_012102 Hs.463041 glutamic acid dipeptide glutamic acid 8412986 GO:0006355|GO:0003700| (RE) repeats (RERE), dipeptide GO:0000118|GO:0008270| transcript variant 1, (RE) repeats GO:0007275|GO:0006338| mRNA [NM_012102] GO:0005634|GO:0006607| GO:0046872 A_33_P3281468 STARD9 Homo sapiens StAR- NM_020759 ENST00000290607 57519 StAR-related chr15:4297934 GO:0000166|GO:0003777| NM_020759 THC2602580 Hs.122061 related lipid transfer lipid transfer 0-42979399 GO:0005524|GO:0007018 (START) domain con- (START) taining 9 (STARD9), domain con- mRNA [NM_020759] taining 9 A_33_P3213888 C17orf109 Homo sapiens chromo- NM_001162995 ENST00000375215 643008 chromosome chr17:7363012 NM_001162995 THC2532809 Hs.528605 some 17 open reading 17 open reading 4-73630183 frame 109 (C17orf109), frame 109 transcript variant 1, mRNA [NM_001162995] A_33_P3403082 NCRNA00176 Homo sapiens non- NR_027686 284739 non-protein chr20:6267107 NR_027686 Hs.97840 protein coding RNA 176 coding RNA 176 2-62671131 (NCRNA00176), transcript variant 1, non-coding RNA [NR_027686] A_23_P210274 MOBKL3 Homo sapiens MOB1, NM_015387 ENST00000497443 25843 MOB1, Mps chr2:19841503 GO:0005515|GO:0048471| NM_015387 THC2499735 Hs.633165 Mps One Binder kinase One Binder 3-198415092 GO:0005737|GO:0005794| activator-like 3 (yeast) kinase GO:0016020|GO:0006810| (MOBKL3), transcript activator-like 3 GO:0005624|GO:0008270| variant 1, mRNA (yeast) GO:0046872|GO:0019898 [NM_015387] A_24_P933794 LOC646513 Homo sapiens clone AY358802 646513 VLGN1945 chr22:3083157 NP862031 Hs.565803 DNA96880 VLGN1945 4-30831633 (UNQ1945) mRNA, complete cds. [AY358802] A_33_P3377760 DA946325 SPLEN2 DA946325 chr6:17077378 Hs.583059 Homo sapiens cDNA 3-170773842 clone SPLEN2022065 5′, mRNA sequence [DA946325] A_33_P3313625 chr13:0501947 75-050194716 A_24_P84898 FEN1 Homo sapiens flap NM_004111 ENST00000305885 2237 flap structure- chr11:6156402 GO:0005515|GO:0009650| NM_004111 THC2469346 Hs.409065 structure-specific en- specific 9-61564087 GO:0030145|GO:0000287| danuclease 1 (FEN1), endonuclease 1 GO:0008409|GO:0048015| mRNA [NM_004111] GO:0005634|GO:0006302| GO:0003684|GO:0005739| GO:0006260|GO:0003690| GO:0004519|GO:0016787| GO:0004523|GO:0043137| GO:0017108|GO:0008309 A_32_P14843 nuclear pore complex XM_003118720 ENST00000429990 chr16:7442551 XM_003118720 THC2556353 Hs.448833 interacting protein-like 2 9-74425578 [Source: HGNC Symbol; Acc: 34409] [ENST00000429990] A_23_P395954 SSH2 slingshot homolog 2 AB072358 ENST00000394848 85464 slingshot chr17:2797513 THC2543332 Hs.654754 (Drosophila) [Source: homolog 2 5-27975076 HGNC Symbol; (Drosophila) Acc: 30580] [ENST00000394848] A_24_P376556 CYCS Homo sapiens cyto- NM_018947 ENST00000409764 54205 cytochrome chr7:25158296- GO:0005515|GO:0008635| NM_018947 THC2535070 Hs.437060 chrome c, somatic c, somatic 25158264 GO:0070469|GO:0000159| (CYCS), nuclear gene GO:0006915|GO:0005634| encoding mitochon- GO:0046872|GO:0005829| drial protein, mRNA GO:0005739|GO:0005758| [NM_018947] GO:0045333|GO:0045155| GO:0006309|GO:0005759| GO:0006810|GO:0004722| GO:0022900|GO:0020037 A_33_P3244274 RNF208 Homo sapiens ring BC016958 727800 ring finger chr9:14011476 GO:0005515|GO:0008270| THC2473148 Hs.512767 finger protein 208, protein 208 0-140114701 GO:0046872 mRNA (cDNA clone MGC21544 IMAGE: 4151712), complete cds. [BC016958] A_23_P40192 CDH22 Homo sapiens NM_021248 ENST00000372262 64405 cadherin 22, chr20:4480279 GO:0005515|GO:0005886| NM_021248 THC2477489 Hs.472861 cadherin type 2 4-44802735 GO:0005509|GO:0016021| 22, type 2 (CDH22), GO:0007155|GO:0007156 mRNA [NM_021248] A_24_P131580 ALPPL2 Homo sapiens alka- NM_031313 ENST00000295453 251 alkaline chr2:23327534 GO:0016310|GO:0000287| NM_031313 THC2603490 Hs.333509 line phosphatase, phosphatase, 7-233275406 GO:0016787|GO:0005886| placental-like 2 placental- GO:0004035|GO:0008152| (ALPPL2), mRNA like 2 GO:0008270|GO:0031225 [NM_031313] A_23_P78092 EVI2A Homo sapiens eco- NM_001003927 ENST00000247270 2123 ecotropic viral chr17:2964546 GO:0016020|GO:0016021| NM_001003927 THC2462437 Hs.591198 tropic viral integration integration site 1-29645402 GO:0004888 site 2A (EVI2A), 2A transcript variant 1, mRNA [NM_001003927] A_33_P3367171 SLC22A8 solute carrier family AK123243 ENST00000451262 9376 solute carrier chr11:6276092 THC2602662 Hs.266223 22 (organic anion family 22 0-62760861 transporter), member (organic anion 8 [Source: HGNC transporter), Symbol; Acc: 10972] member 8 [ENST00000451262] A_33_P3264533 chr10:0927207 34-092720675 A_23_P200138 SLAMF8 Homo sapiens SLAM NM_020125 ENST00000289707 56833 SLAM chr1:15980698 GO:0016020|GO:0016021 NM_020125 THC2465098 Hs.438683 family member 8 family member 0-154807039 (SLAMF8), mRNA 8 [NM_020125] A_24_P148796 MST1 Homo sapiens macro- NM_020998 ENST00000493836 4485 macrophage chr3:49721610 GO:0008150|GO:0004252| NM_020998 NP299055 Hs.512587 phage stimulating 1 stimulating 1 49721551 GO:0007596|GO:0005509| (hepatocyte growth (hepatocyte GO:0006508|GO:0005576| factor-like) (MST1), growth GO:0003824 mRNA [NM_020998] factorlike) A_33_P3395876 PDE4A Homo sapiens phos- NM_001111307 ENST00000380702 5141 phospho- chr19:1057261 GO:0005515|GO:0048471| NM_001111307 THC2603099 Hs.89901 phodiesterase 4A, diesterase 4A, 5-10572674 GO:0004115|GO:0042493| cAMP-specific cAMP-specific GO:0005624|GO:0005625| (PDE4A), transcript GO:0005634|GO:0032587| variant 1, mRNA GO:0005829|GO:0007165| [NM_001111307] GO:0005737|GO:0016020| GO:0016787|GO:0019898 A_23_P200222 LRP8 Homo sapiens low NM_033300 ENST00000306052 7804 low density chr1:53711278- GO:0005515|GO:0006629| NM_033300 THC2470553 Hs.726256 density lipoprotein re- lipoprotein 53711219 GO:0005886|GO:0005509| ceptor-related protein receptor- GO:0019221|GO:0005576| 8, apolipoprotein e re- related protein GO:0021819|GO:0005615| ceptor (LRP8), 8, apolipopro- GO:0006897|GO:0021766| transcript variant 2, tein e receptor GO:0007165|GO:0030229| mRNA [NM_033300] GO:0005901|GO:0045860| GO:0006508|GO:0016021| GO:0034187|GO:0004888 A_33_P3303066 BTBD2 Homo sapiens BTB2 NM_017797 ENST00000255608 55643 BTB (POZ) chr19:1986041- GO:0005515|GO:0005737| NM_017797 THC2466054 Hs.465543 (POZ) domain domain 1985982 GO:0000932 containing (BTBD2), containing 2 mRNA [NM_017797] A_33_P3864861 LOC339505 Homo sapiens hypo- NR_033887 ENST00000426428 339505 hypothetical chr1:20687133- NR_033887 THC2606901 Hs.633269 thetical LOC339505 LOC339505 20687074 (LOC339505), non- coding RNA [NR_033887] A_32_P148122 immunoglobulin BC095489 ENST00000390265 chr2:89953072- NP093301 Hs.449621 kappa variable 1D-33 89953131 [Source: HGNC Symbol; Acc: 5753] [ENST00000390265] A_23_P142096 GPR32 Homo sapiens G NM_001506 ENST00000270590 2854 G protein- chr19:5127466 GO:0004982|GO:0007165| NM_001506 THC2480357 Hs.515555 protein-coupled coupled 4-51274723 GO:0007186|GO:0005886| receptor 32 (GPR32), receptor 32 GO:0005887|GO:0004930| mRNA [NM_001506] GO:0004872 A_33_P3365963 chr4:04136316 8-041363109 A_23_P143885 ARHGEF3 Homo sapiens Rho NM_019555 ENST00000413728 50650 Rho guanine chr3:56762170- GO:0005622|GO:0005085| NM_019555 THC2466586 Hs.476402 guanine nucleotide ex- nucleotide ex- 56762111 GO:0008624|GO:0007242| change factor (GEF) 3 change factor GO:0005737|GO:0035023| (ARHGEF3), (GEF) 3 GO:0006915|GO:0005089| transcript variant 3, GO:0005829 mRNA [NM_019555] A_33_P3316903 PREDICTED: XR_110873 ENST00000519753 chr8:30240735- XR 110873 THC2524368 Homo sapiens hypo- 30240676 thetical LOC100128750 (LOC100128750), partial miscRNA [XR_110873] A_24_P75680 SLC4A8 Homo sapiens solute NM_004858 ENST00000546663 9498 solute carrier chr12:5186520 GO:0006820|GO:0008509| NM_004858 THC2617779 Hs.370636 carrier family 4, family 4, 2-51865261 GO:0005215|GO:0015297| sodium bicarbonate sodium bicar- GO:0016020|GO:0005452| cotransporter, bonate cotrans- GO:0016021|GO:0031402| member 8 (SLC4A8), porter, member 8 GO:0006814 transcript variant 2, mRNA[NM_004858] A_23_P107735 CD79A Homo sapiens CD79a NM_001783 ENST00000221972 973 CD79a molecule, chr19:4238535 GO:0005515|GO:0050853| NM_001783 THC2467444 Hs.631567 molecule, immuno- immunoglo- 6-42385415 GO:0005886|GO:0005771| globulin-associated bulin-associated GO:0019815|GO:0006955| alpha (CD79A), alpha GO:0042100|GO:0030183| transcript variant 1, GO:0045121|GO:0016021| mRNA [NM_001783] GO:0007166|GO:0009897| GO:0004888 A_32_P32413 SETBP1 Homo sapiens SET NM_015559 ENST00000282030 26040 SET binding chr18:4264824 GO:0005515|GO:0005634| NM_015559 THC2755509 Hs.435458 binding protein 1 protein 1 7-42648306 GO:0003677 (SETBP1), transcript variant 1, mRNA [NM_015559] A_23_P202117 PCGF5 polycomb group ring BC007377 ENST00000490164 84333 polycomb chr10:9298745 GO:0005515|GO:0005813| THC2536515 Hs.500512 finger 5 [Source: group ring 8-92987517 GO:0008270|GO:0046872| HGNC Symbol; finger 5 GO:0045449 Acc: 28264] [ENST00000490164] A_23_P348911 LOC100129726 Homo sapiens hypo- NR_027251 100129726 hypothetical chr2:43455024- NR_027251 THC2481238 Hs.194480 thetical LOC100129726 43455083 LOC100129726 (LOC100129726), non-coding RNA [NR_027251] A_33_P3338491 LOC392196 Homo sapiens NR_003275 392196 ubiquitin chr8:720073 NR_003275 Hs.646768 ubiquitin specific pep- 3-7200792 specific peptidase tidase 17-like 17-like 2 pseudogene 2 pseudogene (LOC392196), non-coding RNA [NR_003275] A_24_P354715 NT5E Homo sapiens 5′ NM_002526 ENST00000257770 4907 5′-nucleotidase, chr6:86204891- GO:0005886|GO:0016788| NM_002526 THC2468393 Hs.153952 nucleotidase, ecto ecto (CD73) 86204950 GO:0005624|GO:0046086| (CD73) (NT5E), GO:0006259|GO:0031225| transcript variant 1, GO:0009166|GO:0046872| mRNA [NM_002526] GO:0008198|GO:0006196| GO:0005737|GO:0000166| GO:0050728|GO:0008253| GO:0008270|GO:0006164 A_33_P3381851 KRTAP10-10 Homo sapiens keratin NM_181688 ENST00000380095 353333 keratin associated chr21:4605813 GO:0045095 NM_181688 NP134181 Hs.474001 associated protein protein 10-10 4-46058193 10-10 (KRTAP10-10), mRNA [NM_181688] A_23_P139965 SERP2 Homo sapiens stress- NM_001010897 ENST00000493476 387923 stress-associated chr13:4497176 GO:0016020|GO:0005783| NM_001010897 THC2475127 Hs.377972 associated endoplasmic endoplasmic 0-44971820 GO:0016021|GO:0015031| reticulum protein reticulum GO:0055085 familymember 2 protein family (SERP2), mRNA member 2 [NM_001010897] A_24_P184445 MMP19 Homo sapiens matrix NM_002429 ENST00000394182 4327 matrix metal- chr12:5622948 GO:0030574|GO:0008152| NM_002429 THC2488331 Hs.591033 metallopeptidase 19 lopeptidase 19 1-56229422 GO:0005509|GO:0006508| (MMP19), transcript GO:0005578|GO:0008270| variant 1, mRNA GO:0008233|GO:0007275| [NM_002429] GO:0005576|GO:0001525| GO:0004222|GO:0030154 A_23_P88234 FAM158A Homo sapiens family NM_016049 ENST00000419198 51016 family with chr14:2460857 NM_016049 THC2502204 Hs.271614 with sequence sequence sim- 9-24608357 similarity 158, mem- ilarity 158, ber A (FAM158A), member A mRNA [NM_016049] A_33_P3329078 HBG1 Homo sapiens hemo- NM_000559 ENST00000380256 3047 hemoglobin, chr11:5269613- GO:0005515|GO:0019825| NM_000559 NP094052 Hs.712539 globin, gamma gamma A 5269554 GO:0005833|GO:0006810| A (HBG1), mRNA GO:0005344|GO:0046872| [NM_000559] GO:0020037|GO:0015671 A_33_P3257460 DPM3 Homo sapiens dolichyl- NM_018973 ENST00000368399 54344 dolichyl- chr1:15511242 GO:0005515|GO:0004582| NM_018973 THC2471966 Hs.110477 phosphate mannosyl- phosphate man- 8-155112369 GO:0033185|GO:0016020| transferase poly- nosyltransferase GO:0005975|GO:0005783| peptide 3 (DPM3), polypeptide 3 GO:0005789|GO:0018406| transcript variant 1, GO:0030176|GO:0016021| mRNA [NM_018973] GO:0035269|GO:0006506 A_33_P3368675 C6orf120 Homo sapiens chromo- NM_001029863 ENST00000332290 387263 chromosome chr6:17010614 GO:0005576 NM_001029863 Hs.591375 some 6 open reading 6 open reading 1-170106200 frame 120 (C6orf120), frame 120 mRNA [NM_001029863] A_23_P215461 LIMK1 Homo sapiens LIM NM_002314 ENST00000336180 3984 LIM domain chr7:73536663- GO:0005515|GO:0030036| NM_002314 THC2489637 Hs.647035 domain kinase 1 kinase 1 73536722 GO:0007266|GO:0005524| (LIMK1), transcript GO:0046872|GO:0007399| variant 1, mRNA GO:0007165|GO:0005737| [NM_002314] GO:0000166|GO:0004674| GO:0006468|GO:0008270| GO:0016740 A_33_P3287862 Homo sapiens cDNA AK301306 Chr2:91873675- NP511251 Hs.694621 FLJ59054 complete cds, 91873616 highly similar to D(1B) dopamine receptor. [AK301306] A_23_P206228 VPS13C Homo sapiens vacuolar NM_020821 ENST00000261517 54832 vacuolar chr15:6214489 GO:0008104 NM_020821 NP1403881 Hs.511668 protein sorting 13 protein sorting 1-62144832 homolog C (S. cerevisiae) 13 homologC (VPS13C), transcript (S. cerevisiae) variant 2A, mRNA [NM_020821] A_23_P167328 CD38 Homo sapiens CD38 NM_001775 ENST00000540195 952 CD38 molecule chr4:15850185- GO:0008624|GO:0005886| NM_001775 NP088570 Hs.479214 molecule (CD38), 15850244 GO:0030307|GO:0030890| mRNA [NM_001775] GO:0005634|GO:0060292| GO:0007204|GO:0045779| GO:0045907|GO:0016798| GO:0004872|GO:0032024| GO:0009725|GO:0032526| GO:0032355|GO:0033194| GO:0070555|GO:0005792| GO:0001666|GO:0007565| GO:0009986|GO:0016849| GO:0005624|GO:0007165| GO:0003953|GO:0005488| GO:0008152|GO:0032570| GO:0016021 A_33_P3372501 PPP1R13B Homo sapiens protein NM_015316 ENST00000380023 23368 protein phos- chr14:1042064 GO:0005515|GO:0005737| NM_015316 NP1151875 Hs.709297 phosphatase 1, regula- phatase 1, re- 83-104206424 GO:0006915|GO:0005634| tory (inhibitor) subunit gulatory (in- GO:0006917|GO:0045786 13B (PPP1R13B), hibitor) sub- mRNA [NM_015316] unit 13B A_33_P3349259 FAM115A Homo sapiens family NM_014719 ENST00000392900 9747 family with chr7:14355746 NM_014719 THC2787549 Hs.406492 with sequence simi- sequence 6-143557407 larity 115, member A similarity 115, (FAM115A), transcript member A variant 1, mRNA [NM_014719] A_23_P24784 TNNI2 Homo sapiens troponin NM_003282 ENST00000381906 7136 troponin 1 chr11:1862437- GO:0005515|GO:0031014| NM_003282 THC2467502 Hs.523403 1 type 2 (skeletal, fast) type 2 1862744 GO:0045941|GO:0005861| (TNNI2), transcript (skeletal, fast) GO:0003009|GO:0005634| variant 1, mRNA GO:0003779 [NM_003282] A_33_P3261433 LOC100131473 PREDICTED: XM_001720331 100131473 hypothetical chr2:74212866- XM_001720331 THC2660992 Homo sapiens hypo- protein 74212807 thetical protein LOC100131473 LOC100131473 (LOC100131473), mRNA[XM_001720331] A_23_P390744 FOPNL Homo sapiens NM_144600 ENST00000255759 123811 FGFRIOP chr16:1595968 NM_144600 THC2468681 Hs.514179 FGFRIOP N-terminal N-torminal 8-15959629 like (FOPNL), like mRNA [NM_14460C] A_23_P150609 IGF2 Homo sapiens insulin- NM_000612 ENST00000381319 3481 insulin-like chr11:2150453- GO:0005515|GO:0051897| NM_000612 THC2465311 Hs.272259 like growth factor 2 growth factor 2150394 GO:0008284|GO:0005159| (somatomedin A) 2 (somato- GO:0005975|GO:0005158| (IGF2), transcript medin A) GO:0046628|GO:0045840| variant 1, mRNA GO:0005576|GO:0007275| [NM_000612] GO:0005615|GO:0001649| GO:0001501|GO:0005179| GO:0032583|GO:0006349| GO:0009887|GO:0006006| GO:0051781|GO:0043410| GO:0008083 A_33_P3299487 AIM1L Homo sapiens absent NM_001039775 ENST00000374207 55057 absent in chr1:26671913- NM_001039775 THC2773713 Hs.128738 in melanoma 1-like melanoma 26671854 (AIM1L), mRNA 1-like [NM_001039775] A_24_P453544 Homo sapiens clone AY239294 ENST00000541658 chr9:13621792 THC2476915 FLB5634 PRO1477 3-136217864 mRNA, complete cds. [AF130059] A_33_P3256585 MUC8 Homo sapiens mucin U14383 4590 mucin 8 chr12:1330493 THC2488232 Hs.592357 (MUC8) mRNA, 93-133049334 partial cds. [U14383] A_33_P3292896 SFXN5 Homo sapiens sidero- NM_144579 ENST00000403277 94097 sideroflexin 5 chr2:73215461- GO:0005739|GO:0016020| NM_144579 THC2774255 Hs.368171 flexin 5 (SFXN5), 73215402 GO:0005506|GO:0008324| nucleargene encoding GO:0005743|GO:0006826| mitochondrial protein, GO:0016021|GO:0055085| mRNA [NM_144579] GO:0006812 A_23_P127721 P2RX3 Homo sapiens NM_002559 ENST00000534820 5024 purinergic chr11:5711615 GO:0030424|GO:0009408| NM_002559 THC2480784 Hs.146738 purinergic receptor receptor P2X, 8-57117269 GO:0010524|GO:0009409| P2X, ligand-gated ion ligand-gated GO:0042803|GO:0050850| channel, 3 (P2RX3), ion channel, 3 GO:0009743|GO:0050909| mRNA [NM_002559] GO:0048167|GO:0001614| GO:0033198|GO:0004872| GO:0014832|GO:0006812| GO:0001666|GO:0004931| GO:0046982|GO:0007274| GO:0005524|GO:0030432| GO:0007165|GO:0016020| GO:0005887|GO:0044424| GO:0005216|GO:0048266| GO:0050896 A_23_P53018 HRASLS5 Homo sapiens HRAS- NM_054108 ENST00000301790 117245 HRAS-like chr11:6323092 NM_054108 THC2485151 Hs.410316 like suppressor family, suppressor 0-63230861 member 5 (HRASLS5), family, transcript variant 1, member 5 mRNA [NM_054108] A_32_P103837 FAM60A Homo sapiens family NM_021238 ENST00000337682 58516 family with chr12:3143365 NM_021238 THC2472594 Hs.505154 with sequence similarity sequence 0-31433591 60, member A similarity 60, (FAM60A), member A transcript variant 2, mRNA [NM_021238] A_23_P74668 C1orf158 Homo sapiens chromo- NM_152290 ENST00000376210 93190 chromosome chr1:12821032- NM_152290 NP1155029 Hs.98095 some 1 open reading 1 open reading 12821091 frame 158 (C1orf158), frame 158 mRNA [NM_152290] A_33_P3305438 chr7:15568488 5-155684944 A_23_P396299 LOC100129827 Homo sapiens NR_034094 ENST00000529979 100129827 hypothetical chr11:1061567 NR_034094 THC2480303 Hs.246769 hypothetical LOC100129827 0-10615729 LOC100129827 (LOC100129827), non-coding RNA [NR_034094] A_33_P3239659 chr3:11395026 3-113950204 A_33_P3724155 DERL3 Homo sapiens Der1- NM_198440 ENST00000290730 91319 Der1-like chr22:2417677 GO:0005515|GO:0016020| NM_198440 THC2488725 Hs.593679 like domain family, domain family, 4-24176715 GO:0005783|GO:0030176| member 3 (DERL3), member 3 GO:0016021|GO:0030433| transcript variant 3, GO:0030968 mRNA [NM_198440] A_33_P3244843 PRKAG3 Homo sapiens protein NM_017431 ENST00000545803 53632 protein kinase, chr2:21968843 GO:0019901|GO:0015758| NM_017431 NP164557 Hs.591634 kinase, AMP- AMP- 6-219688377 GO:0004679|GO:0005978| activated, gamma 3 activated, GO:0006633|GO:0046320| non-catalytic subunit gamma 3 non- GO:0007243 (PRKAG3), mRNA catalytic [NM_017431] subunit A_33_P3251412 chr22:0230556 33-023055692 A_23_P81650 C5orf15 Homo sapiens chromo- NM_020199 ENST00000231512 56951 chromosome chr5:13329147 GO:0016020|GO:0016021 NM_020199 THC2469485 Hs.730670 some 5 open reading 5 open 6-133291417 frame 15 (C5orf15), reading frame mRNA[NM_020199] 15 A_33_P3359856 MZT2A mitotic spindle organ- ENST00000445782 653784 mitotic spindle chr2:13222781 THC2544251 izing protein 2A organizing 9-132227760 [Source: HGNC protein 2A Symbol; Acc: 33187] [ENST00000445782] A_33_P3370076 TFE3 Homo sapiens trans- NM_006521 ENST00000315869 7030 transcription chrX:4888778 GO:0005515|GO:0003700| NM_006521 THC2524136 Hs.730740 cription factor binding factor binding 8-48887729 GO:0006959|GO:0010843| to IGHM enhancer 3 to IGHM GO:0010552|GO:0005634| (TFE3), mRNA enhancer 3 GO:0045449 [NM_006521] A_33_P3419691 GATS Homo sapiens GATS, NR_028038 352954 GATS, chr7:9980662 NR_028038 THC2463982 Hs.556063 stromal antigen 3 stromal anti- 0-99806561 opposite strand (GATS), gen 3 opposite transcript variant 2, strand non-coding RNA [NR_028038] A_33_P3340649 KRTAP19-8 Homo sapiens keratin NM_001099219 ENST00000382822 728299 keratin chr21:3241053 GO:0005882 NM_001099219 NP1460239 Hs.580875 associated protein 19-8 associated 7-32410478 (KRTAP19-8), mRNA protein 19-8 [NM_001099219] A_33_P3291821 ANKRD26P1 Homo sapiens ankyrin NR_026556 ENST00000329373 124149 ankyrin repeat chr16:4650572 NR_026556 THC2621756 Hs.97414 repeat domain 26 domain 26 7-46505668 pseudogene 1 pseudogene 1 (ANKRD26P1), non- coding RNA [NR_026556] A_33_P3305102 GPR97 Homo sapiens G NM_170776 ENST00000327655 222487 G protein- chr16:5771961 GO:0005886|GO:0007218| NM_170776 NP587669 Hs.383403 protein-coupled coupled 4-57719673 GO:0004930|GO:0016021 receptor 97 (GPR97), receptor 97 mRNA [NM_170776] A_33_P3362048 SHMT1 serine hydroxy ENST00000395682 6470 serine hydro- chr17:1825689 methyltransferase 1 xymethyl- 0-18256831 (soluble) [Source: transferase HGNC Symbol; 1 (soluble) Acc: 10850] [ENST00000395682] A_24_P385190 SLC4A1 Homo sapiens solutem NM_000342 ENST00000471005 6521 solute carrier chr17:4233785 GO:0006820|GO:0005215| NM_000342 THC2474664 Hs.443948 carrier family 4, family 4, 8-42337799 GO:0008509|GO:0030018| anion exchanger, anion GO:0030506|GO:0006873| member 1 (erythro- exchanger, GO:0003779|GO:0008022| cyte membrane pro- member 1 GO:0042803|GO:0016323| tein band 3, Diego (erythrocyte GO:0005452|GO:0016020| blood group) membrane GO:0005887|GO:0030863| (SLC4A1), protein band 3, GO:0043495 RNA [NM_000342] Diego blood group) A_23_P49546 GRIN2C Homo sapiens gluta- NM_000835 ENST00000293190 2905 glutamate chr17:7283826 GO:0030054|GO:0005886| NM_000835 THC2476723 Hs.436980 mate receptor, iono- receptor, 3-72838204 GO:0005234|GO:0017146| tropic, N-methyl D- ionotropic, N- GO:0045202|GO:0008104| aspartate 2C methyl D- GO:0004972|GO:0048167| (GRIN2C), mRNA aspartate 2C GO:0045211|GO:0042391| [NM_000835] GO:0050885|GO:0004872| GO:0006811|GO:0005261| GO:0000287|GO:0033058| GO:0042177|GO:0005509| GO:0009611|GO:0060079| GO:0014069|GO:0007215| GO:0030165|GO:0047485| GO:0005887 A_33_P3324454 TPP1 Homo sapiens tri- NM_000391 ENST00000453338 1200 tripeptidyl chr11:6636189- GO:0005515|GO:0006629| NM_000391 THC2533577 Hs.523454 peptidyl peptidase I peptidase I 6636130 GO:0042470|GO:0008219| (TPP1), mRNA GO:0042277|GO:0004252| [NM_000391] GO:0045453|GO:0005625| GO:0005764|GO:0007399| GO:0005739|GO:0050885| GO:0006508|GO:0008240| GO:0008233|GO:0043171| GO:0007040 A_23_P309292 C12orf51 Homo sapiens chromo- NM_001109662 ENST00000311694 283450 chromosome chr12:1126889 GO:0005622|GO:0016881| NM_001109662 THC2560894 Hs.530943 some 12 open reading 12 open 11-112688852 GO:0016020|GO:0019941| frame 51 (C12orf51), reading GO:0016874|GO:0016021| mRNA [NM_001109662] frame 51 GO:0006464 A_33_P3293336 GFRA1 Homo sapiens GDNF NM_005264 2674 GDNF chr10:1178164 GO:0016167|GO:0005886| NM_005264 THC2537666 Hs.388347 family receptor alpha family 98-117816439 GO:0005102|GO:0004872| 1 (GFRA1), tran- receptor GO:0031225|GO:0007166| script variant 1, alpha 1 GO:0019898|GO:0007399 mRNA [NM_005264] A_33_P3246715 LOC441495 Homo sapiens NR_033773 441495 centromere chrX:51454417- NR_033773 THC2627621 Hs.730388 centromere protein protein V 51454476 V pseudogene pseudogene (LOC441495), non- coding RNA [NR_033773] A_33_P3424057 PEG3 Homo sapiens pater- NM_006210 ENST00000326441 5178 paternally chr19:5732576 GO:0005622|GO:0006355| NM_006210 THC2462814 Hs.201776 nally expressed 3 expressed 3 6-57325707 GO:0005737|GO:0003700| (PEG3), transcript GO:0006915|GO:0008270| variant 1, mRNA GO:0005634|GO:0003676| [NM_006210] GO:0046872 A_33_P3714341 Homo sapiens IGK A11363267 Hs.694269 mRNA for immuno- globulin kappa light chain, partial cds, clone: F010-014L [AB363267] A_33_P3252134 chr16:0303092 63-030309322 A_33_P3401138 chr17:0190430 02-019042943 A_23_P97990 HTRA1 Homo sapiens HtrA NM_002775 ENST00000435263 5654 HtrA serine chr10:1242743 GO:0030514|GO:0004252| NM_002775 NP710487 Hs.501280 serine peptidase 1 peptidase 1 38-124274397 GO:0006508|GO:0008233| (HTRA1), mRNA GO:0005576|GO:0005615| [NM_002775] GO:0001558|GO:0005520 A_23_P44768 TBK1 Homo sapiens NM_013254 ENST00000331710 29110 TANK- chr12:6489544 GO:0005515|GO:0005737| NM_013254 THC2467484 Hs.505874 TANK-binding binding 3-64895502 GO:0000166|GO:0004674| kinase 1 (TBK1), kinase 1 GO:0045087|GO:0044419| mRNA [NM_013254] GO:0006468|GO:0043123| GO:0009615|GO:0005524| GO:0016740|GO:0005829 A_23_P200936 MTU Homo sapiens 5- NM_000254 ENST00000470570 4548 5-methyl- chr1:23706352 GO:0005515|GO:0031419| NM_000254 THC2473394 Hs.498187 methyltetrahydrofolate- tetrahydrofolate- 3-237063582 GO:0008168|GO:0009086| homocysteine methyl- homocysteine GO:0008652|GO:0005625| transferase (MTR), methyl- GO:0008705|GO:0050667| mRNA [NM_000254] transferase GO:0046872|GO:0005829| GO:0007399|GO:0005622| GO:0005542|GO:0005737| GO:0046653|GO:0006479| GO:0008270|GO:0009396| GO:0004156|GO:0008898| GO:0044237|GO:0016740| GO:0050897 A_33_P3285092 LOC100129763 Homo sapiens cDNA AK126123 100129763 hypothetical chr4:8243806- THC2486333 Hs.636684 FLJ44135 fis, clone protein 8243865 THYMU2009134. LOC100129763 [AK126123] A_33_P3258546 PCDHA5 Homo sapiens proto- NM_031501 ENST00000378126 56143 protocadherin chr5:14020370 GO:0005515|GO:0005886| NM_031501 Hs.199343 cadherin alpha 5 alpha 5 0-140203759 GO:0005887|GO:0005509| (PCDHA5), transcript GO:0007155|GO:0007156| variant 2, mRNA GO:0007399 [NM_031501] A_24_P227211 KLC2 Homo sapiens kinesin NM_(122822 ENST00000394067 64837 kinesin light chr11:6603452 GO:0005515|GO:0043005| NM_022822 THC2462083 Hs.280792 light chain 2 (KLC2), chain 2 6-66034585 GO:0005871|GO:0005737| transcript variant 1, GO:0035253|GO:0005874| mRNA [NM_022822] GO:0008088|GO:0003777| GO:0005829 A_24_P416997 APOL3 Homo sapiens apoli- NM_145641 ENST00000397287 80833 apolipo- chr22:3653699 GO:0005737|GO:0006954| NM_145641 THC2494358 Hs.474737 poprotein L, 3 (APOL3), protein L, 3 5-36536936 GO:0006869|GO:0042157| transcript variant beta/a, GO:0005576|GO:0004871| mRNA [NM_145641] GO:0043123|GO:0005319| GO:0008289 A_32_P98298 DUSP8 Homo sapiens dual NM_004420 ENSTO0000528778 1850 dual specifi- chr11:1579394- GO:0000188|GO:0005737| NM_004420 THC2476346 Hs.41688 specificity phospha- city phos- 1579141 GO:0006470|GO:0016787| tase 8 (DUSP8), mRNA phatase 8 GO:0005634|GO:0017017| [NM_004420] GO:0004725 A_33_P3390637 SLC23A3 Homo sapiens solute NM_144712 ENST00000421779 151295 solute carrier chr2:22003411 GO:0005215|GO:0016020| NM_144712 THC2741672 Hs.124565 carrier family 23 (nu- family 23 7-220034058 GO:0016021|GO:0055085 cleobase transporters), (nucleobase member 3 (SLC23A3), transporters), transcript variant 1, member 3 mRNA [NM_144712] A_23_P85963 OR6Y1 Homo sapiens ol- NM_001005189 ENST00000302617 391112 olfactory chr1:15851737 GO:0007608|GO:0007165| NM_001005189 NP1461830 Hs.553780 factory receptor, family receptor, 0-158517311 GO:0004984|GO:0007186| 6, subfamily Y, member family 6, GO:0005886|GO:0004872| 1 (OR6Y1), mRNA subfamily Y, GO:0016021|GO:0050896 [NM_001005189] member 1 A_33_P3378514 PDE5A Homo sapiens phospho- NM_001083 ENST00000394439 8654 phospho- chr4:12041561 GO:0001666|GO:0000287| NM_001083 THC2501404 Hs.647971 diesterase 5A, cGMP- diesterase 5-120415556 GO:0009187|GO:0047555| specific (PDE5A), 5A, cGMP- GO:0046069|GO:0005575| transcript variant 1, specific GO:0007399|GO:0007165| mRNA [NM_001083] GO:0000166|GO:0016787| GO:0030553|GO:0042311| GO:0008270 A_23_P406227 MGC23284 Homo sapiens hypo- NR_024399 197187 hypothetical chr16:8875349 NR_024399 THC2480970 Hs.499548 thetical LOC197187 LOC197187 9-88753558 (MGC23284), tran- script variant 2, non- coding RNA [NR_024399] A_33_P3407062 Homo sapiens mRNA AB306126 ENST00000390468 chr14:2278902 NP1172335 Hs.74647 for T cell receptor alpha 4-22789083 variable 41, partial cds, clone: un 278. [AB306126] A_23_P130961 ELANE Homo sapiens elastase, NM_001972 ENST00000263621 1991 elastase, chr19:853356- GO:0006909|GO:0004252| NM_001972 THC2472602 Hs.99863 neutrophil expressed neutrophil 855575 GO:0009986|GO:0045415| (ELANE), mRNA expressed GO:0045416|GO:0006874| [NM_001972] GO:0005576|GO:0050900| GO:0048661|GO:0008367| GO:0050922|GO:0019955| GO:0043406|GO:0050728| GO:0045079|GO:0006508| GO:0008233|GO:0009411 A_33_P3401990 VPREB3 Homo sapiens pre- NM_013378 ENST00000248948 29802 pre-B chr22:2409514 GO:0005783 NM_013378 THC2476292 Hs.136713 B lymphocyte 3 lymphocyte 2-24095083 (VPREB3), mRNA 3 [NM_013378] A_23_P400147 CCDC61 Homo sapiens coiled- NM_001080402 ENST000002&3284 729440 coiled-coil chr19:4652054 NM_001080402 THC2619849 Hs.515479 coil domain containing domain 4-46521376 61 (CCDC61), mRNA containing [NM_001080402] 61 A_24_P400832 LOC100130950 Homo sapiens hypo- NR_034082 100130950 hypothetical chr17:5118521- NR_034082 THC2632507 Hs.668646 thetical LOC100130950 LOC100130950 5118580 (LOC100130950), non-coding RNA [NR_034082] A_33_P3332302 MTVR2 Homo sapiens mouse NR_027025 246754 mouse chr17:5496220 NR_027025 mammary tumor virus mammary 2-54962143 receptor homolog 2 tumor virus (MTVR2), non- receptor coding RNA homolog 2 [NR_027025] A_24_P131392 FAM82A1 Homo sapiens family NM_144713 ENST00000442857 151393 family with chr2:38231143- GO:0005737|GO:0016020| NM_144713 THC2480570 Hs.591566 with sequence similarity sequence 38231293 GO:0005488|GO:0005874| 82, member Al similarity GO:0005819|GO:0016021 (FAM82A1), transcript 82, variant 1, mRNA member A1 [NM_144713] A_33_P3341970 NEGR1 Homo sapiens neuro- NM_173808 ENST00000306821 257194 neuronal chr1:71868720- GO:0005515|GO:0005886| NM_173808 THC2606710 Hs.146542 nal growth regulator 1 growth 71868661 GO:0043025|GO:0031225| (NEGR1), mRNA regulator 1 GO:0007155|GO:0030425 [NM_173808] A_33_P3296024 SALL3 Homo sapiens sal- NM_171999 ENST00000537592 27164 sal-like 3 chr18:7675731 GO:0005622|GO:0021891| NM_171999 THC2601042 Hs.700557 like 3 (Drosophila) (Drosophila) 3-76757372 GO:0005737|GO:0008270| (SALL3), mRNA GO:0005634|GO:0003677| [NM_171999] GO:0046872|GO:0045449 A_32_P191860 SCGBL Homo sapiens secret- NM_001025591 ENST00000379204 284402 secretoglobin- chr19:3508440 GO:0005488|GO:0005576 NM_001025591 THC2615333 Hs.656990 oglobin-like (SCGBL), like 3-35084346 mRNA [NM_001025591] A_33_P3305725 LOC730102 Homo sapiens NR_037167 ENST00000512906 730102 quinone chr1:17800390 NR_037167 THC2644945 Hs.149540 oxidoreductase-like oxidoreduc- 2-178003843 protein 2 pseudo- tase-like quinonegene protein 2 (LOC730102), non- pseudogene coding RNA [NR_037167] A_23_P151506 PLEK2 Homo sapiens pleck- NM_016445 ENST00000216446 26499 pleckstrin 2 chr14:6785387 GO:0007242|GO:0005737| NM_016445 THC2462892 Hs.170473 strin 2 (PLEK2), 0-67853811 GO:0030036|GO:0005886| mRNA [NM_016445] GO:0042995|GO:0005856| GO:0019898 A_33_P3321682 chr2:23667334 2-236673283 A_33_P3275668 BAG6 Homo sapiens BCL2- NM_004639 ENST00000404765 7917 BCL2- chr6:31606925- GO:0005515|GO:0005634 NM_004639 THC2469828 Hs.440900 associated athanogene associated 31606866 6 (BAG6), transcript athanogene variant 1, mRNA 6 [NM_004639] A_33_P3269570 CD160 CD160 molecule EU016100 ENST00000369290 11126 CD160 chr1:14569884 THC2631630 Hs.488237 [Source: HGNC molecule 5-145698786 Symbol; Acc: 170131 [ENST00000369290] A_23_P108662 MOGS Homo sapiens man- NM_006302 ENST00000462189 7841 mannosyl- chr2:74688343- GO:0009311|GO:0016020| NM_006302 THC2681968 Hs.516119 nosyl-oligosaccharide oligosac- 74688284 GO:0005783|GO:0004573| glucosidase (MOGS), charide GO:0016798|GO:0008152| transcript variant 1, glucosidase GO:0005624|GO:0016021| mRNA [NM_006302] GO:0006487 A_33_P3346635 LOC100508554 PREDICTED: XR_112953 100508554 hypothetical chr7:197863- XR_112953 THC2477098 Hs.134742 Homo sapiens hypo- LOC100508554 197922 thetical LOC100508554 (LOC100508554), partial miscRNA [XR_112953] A_23_P111981 LYNX1 Homo sapiens Ly6/ NM_177457 ENST00000398906 66004 Ly6/neuro- chr8:14385279 GO:0005886|GO:0005576| NM_177457 THC2464267 Hs.158665 neurotoxin 1 (LYNX1), toxin 1 9-143852740 GO:0031225 transcript variant 3, mRNA [NM_177457] A_23_P95640 C1orf86 Homo sapiens chromo- NM_001007544 ENST00000331555 440712 chromosome chr1:20623907 GO:0016020|GO:0016021 NM_001007544 THC2475722 Hs.662248 some 1 open reading 1 open read- 3-206239014 frame 186 (C1orf186), ing frame mRNA 186 [NM_001007544] A_33_P3307490 SYNRG synergin, gamma AK126988 ENST00000378189 11276 synergin, chr17:3592703 THC2482261 Hs.594647 [Source: HGNC gamma 9-35926980 Symbol; Acc: 557] [ENST00000378189] A_33_P3245734 ZNF680 Homo sapiens zinc NM_001130022 ENST00000447137 340252 zinc finger chr7:63986836- GO:0005622|GO:0006355| NM_001130022 THC2478527 Hs.520886 finger protein 680 protein 680 63986777 GO:0005730|GO:0008270| (ZNF680), transcript GO:0005634|GO:0003677| variant 2, mRNA GO:0046872 [NM_001130022] A_23_P18246 XCR1 Homo sapiens chemo- NM_005283 ENST00000542109 2829 chemokine chr3:46062985- GO:0007165|GO:0051209| NM_005283 THC2481211 Hs.248116 kine (C motif) receptor (C motif) 46062926 GO:0006954|GO:0006935| 1 (XCR1), transcript receptor 1 GO:0005886|GO:0007187| variant 1, mRNA GO:0005887|GO:0004930| [NM_005283] GO:0004950|GO:0004872| GO:0034097|GO:0007204 A_23_P258381 SPSB4 Homo sapiens splA/ NM_080862 ENST00000508126 92369 splA/ryanodine chr3:14086737 GO:0007242|GO:0005737| NM_080862 THC2632742 Hs.655112 ryanodine receptor receptor 2-140867431 GO:0019941 domain and SOCS domain and box containing 4 SOCS box (SPSB4), mRNA containing 4 [NM_080862] A_23_P350451 PRDM1 Homo sapiens PR NM_001198 ENST00000456278 639 PR domain chr6:10655512 GO:0010628|GO:0005622| NM_001198 THC2470627 Hs.436023 domain containing 1, containing 1, 3-106555182 GO:0045165|GO:0003700| with ZNF domain with ZNF GO:0001893|GO:0001892| (PRDM1), transcript domain GO:0008270|GO:0005634| variant 1, mRNA GO:0000122|GO:0046872| [NM_001198] GO:0045449 A_33_P3370930 LAMB1 laminin, beta 1 ENST00000393559 3912 laminin, chr7:10764345 THC2637518 [Source: HGNC beta 1 7-107643398 Symbol; Acc: 6486] [ENST00000393559] A_23_P160438 MYOG Homo sapiens myo- NM_002479 ENST00000241651 4656 myogenin chr1:20305293 GO:0006355|GO:0007517| NM_002479 THC2479983 Hs.2830 genin (myogenic factor (myogenic 0-203052871 GO:0003700|GO:0045944| 4) (MYOG), mRNA factor 4) GO:0016563|GO:0048741| [NM_002479] GO:0007275|GO:0005634| GO:0030154 A_23_P57110 C20orf54 Homo sapiens chromo- NM_033409 ENST00000381944 113278 chromosome chr20:741069- GO:0034605|GO:0005515| NM_033409 THC2472248 Hs.283865 some 20 open reading 20 open 741010 GO:0016020|GO:0016021 frame 54 (C20orf54), reading mRNA [NM_033409] frame 54 A_33_P3209321 LOC729558 Homo sapiens cDNA AK096995 729558 hypothetical chr4:15150039 THC2616799 Hs.647978 FLJ39676 fis, clone protein 9-151500458 SMINT2009832. LOC729558 [AK096995] A_23_P202345 ADO Homo sapiens 2-amino- NM_032804 ENST00000373783 84890 2-amino- chr10:6456780 GO:0005506|GO:0016491| NM_032804 THC2493611 Hs.99821 ethanethiol (cyste- ethanethio 1 4-64567863 GO:0047800|GO:0046872| amine) dioxygenase (cysteamine) GO:0055114 (ADO), mRNA dioxygenase [NM_032804] A_23_P200298 AGL Homo sapiens amylo- NM_000028 ENST00000294724 178 amylo-alpha- chr1:10038922 GO:0005515|GO:0043033| NM_000028 THC2461565 Hs.904 alpha-1, 6-glucosidase, 1, 6-glucosidase, 9-100389288 GO:0043169|GO:0005975| 4-alpha-glucano- 4-alpha-glucano- GO:0016234|GO:0016757| transferase (AGL), transferase GO:0005978|GO:0005634| transcript variants GO:0005829|GO:0005737| mRNA [NM_000028] GO:0016798|GO:0008152| GO:0004134|GO:0004135| GO:0030247|GO:0031593 A_33_P3297545 T cell receptor beta ENST00000390376 chr7:14212431 THC2589734 variable 6-8 [Source: 0-142124251 HGNC Symbol; Acc: 12233] [ENST00000390376] A_33_P3410372 NUDT10 Homo sapiens nudix NM_153183 ENST00000376006 170685 nudix (nucleo- chrX:51076242- GO:0005737|GO:0030145| NM_153183 THC2476742 Hs.375178 (nucleoside diphosphate side diphos- 51076301 GO:0000287|GO:0016787| linked moiety X)- phate linked GO:0008486 type motif 10 moiety X)- (NUDT10), mRNA type motif [NM_153183] 10 A_24_P318990 immunoglobulin BC012876 ENST00000390291 chr22:2268208 NP1457207 Hs.449585 lambda variable 1-50 0-22682139 (non-functional) [Source: HGNC Symbol; Acc: 5881] [ENST00000390291] A_33_P3235721 C11orf87 Homo sapiens chromo- NM_207645 ENST00000327419 399947 chromosome chr11:1092962 GO:0016020|GO:0016021 NM_207645 THC2475112 Hs.172982 some 11 open 11 open 46-109296305 reading frame 87 reading (C11orf87), mRNA frame 87 [NM_207645] A_33_P3409249 LOC729424 PREDICTED: XM_001714320 729424 hypothetical chr4:12854467 XM_001714320 Homo sapiens hypo- protein 6-128544735 thetical protein LOC729424 LOC729424 (LOC729424), mRNA [XM_001714320] A_33_P3424489 immunoglobulin S73129 ENST00000390305 chr22:2302955 NP084490 Hs.449585 lambda variable 3-25 5-23029614 [Source: HGNC Symbol; Acc: 5908] [ENST00000390305] A_33_P3230259 NCAPH Homo sapiens non- NM_015341 23397 non-SMC chr2:97041160 GO:0000796|GO:0007076| NM_015341 THC2461132 Hs.308045 SMC condensin I condensin I 97041219 GO:0007067|GO:0005737| complex, subunit H complex, GO:0005634|GO:0000278| (NCAPH), mRNA subunit H GO:0051301 [NM_015341] A_33_P3380331 NKIRAS2 Homo sapiens NM_001144927 ENST00000316082 28511 NFKB chr17:4017589 GO:0005622|GO:0005737| NM_001144927 THC2623577 Hs.632252 NFKB inhibitor inhibitor 9-40175958 GO:0000166|GO:0007264| interacting Ras-like 2 interacting GO:0007249|GO:0003924| (NKIRAS2), transcript Ras-like 2 GO:0005575|GO:0005525 variant 3, mRNA [NM_001144927] A_33_P3298057 ABCC5 Homo sapiens ATP- NM_001023587 ENST00000438979 10057 ATP- chr3:18370564 GO:0032868|GO:0048471| NM_001023587 THC2525236 Hs.728765 binding cassette, sub- binding 5-183705586 GO:0016020|GO:0000166| family C (CFTR/ cassette, GO:0005887|GO:0032496| MRP), member 5 subfamily C GO:0042626|GO:0005624| (ABCC5), transcript (CFTR/MRP), GO:0008514|GO:0055085| variant 2, mRNA member 5 GO:0016887|GO:0005524 [NM_001023587] A_23_P30175 ERBB2IP Homo sapiens erbb2 NM_018695 ENST00000380943 55914 erbb2 inter- chr5:65375840- GO:0005515|GO:0030056| NM_018695 THC2670825 Hs.591774 interacting protein acting protein 65375899 GO:0030054|GO:0045104| (ERBB2IP), transcript GO:0005634|GO:0045175| variant 2, mRNA GO:0006605|GO:0045197| [NM_018695] GO:0005604|GO:0005176| GO:0007165|GO:0005737| GO:0007049|GO:0005178| GO:0007173|GO:0007229| GO:0005200|GO:0016049| GO:0007155 A_23_P204087 OAS2 Homo sapiens 2′-5′- NM_016817 ENST00000392583 4939 2′-5′-oligo- chr12:1134486 GO:0005792|GO:0005783| NM_016817 THC2461916 Hs.414332 oligoadenylate synthetase adenylate 01-113448660 GO:0001730|GO:0003723| 2, 69/71 kDa (OAS2), synthetase GO:0016779|GO:0005634| transcript variant 1, 2, 69/71 kDa GO:0005524|GO:0006401| mRNA [NM_016817] GO:0005739|GO:0006139| GO:0006955|GO:0000166| GO:0016020|GO:0016740 A_33_P3251283 CTAGE4 Homo sapiens NM_198495 ENST00000486333 100128553 CTAGE chr7:14388255 GO:0008150|GO:0016020| NM_198495 THC2477975 Hs.720693 CTAGE family, family, 9-143882618 GO:0016021|GO:0005575 member 4 (CTAGE4), member 4 mRNA [NM_198495] A_33_P3251932 BCL2L11 Homo sapiens BCL2- NM_207002 ENST00000337565 10018 BCL2-like chr2:11188635 GO:0005515|GO:0008017| NM_207002 THC2695067 Hs.469658 like 11 (apoptosis 11 (apoptosis 2-111886411 GO:0008624|GO:0001783| facilitator) (BCL2L11), facilitator) GO:0001782|GO:0005886| transcript variant 9, GO:0048538|GO:0005741| mRNA [NM_207002] GO:0030879|GO:0007283| GO:0048536|GO:0009791| GO:0005829|GO:0043583| GO:0005739|GO:0005737| GO:0042475|GO:0002262| GO:0043029|GO:0046620| GO:0008633|GO:0001822| GO:0035148|GO:0048563| GO:0001701|GO:0048070| GO:0007160|GO:0008584| GO:0000300|GO:0019898 A_33_P3308553 chr2:19414226 5-194142206 A_23_P6066 CPXM1 Homo sapiens car- NM_019609 ENST00000421947 56265 carboxy- chr20:2776406- GO:0006508|GO:0008270| NM_019609 THC2769779 Hs.659346 boxypeptidase X peptidase X 2776347 GO:0008233|GO:0005576| (M14 family), mem- (M14 family), GO:0007155|GO:0005615| ber 1 (CPXM1), member 1 GO:0046872|GO:0008237| transcript variant 1, GO:0004181 mRNA [NM_019609] A_33_P3250840 NIPA1 Homo sapiens non NM_144599 ENST00000437912 123606 non imprint- chr15:2304342 GO:0008219|GO:0016020| NM_144599 THC2492604 Hs.511797 imprinted in Prader- ed in Prader- 1-23043362 GO:0016021 Willi/Angelman syn- Willi/Angel- drome 1 (NIPA1), man syn- transcript variant 1, drome 1 mRNA[NM_144599] A_33_P3308434 MORN1 Homo sapiens NM_024848 ENST00000378525 79906 MORN chr1:2317328- NM_024848 THC2519762 Hs.642701 MORN repeat con- repeat 2317269 taining 1 (MORN1), containing 1 mRNA [NM_024848] A_23_P73150 TTC25 Homo sapiens tetra- NM_031421 ENST00000377540 83538 tetratrico- chr17:4011752 GO:0005515|GO:0005737 fV M 031421 NP1178351 Hs.201134 tricopeptide repeat peptide 4-40117583 domain 25 (TTC25), repeat mRNA [NM_031421] domain 25 A_23_P29067 TMPRSS2 Homo sapiens trans- NM_005656 ENST00000398585 7113 transmem- chr21:4283696 GO:0005737|GO:0005886| NM_005656 THC2485211 Hs.439309 membrane protease, brane pro- 3-42836904 GO:0004252|GO:0005887| serine 2 (TMPRSS2), tease, serine 2 GO:0006508|GO:0008233| transcript variant 2, GO:0005576|GO:0005044 mRNA [NM_005656] A_33_P3361891 TMPRSS7 Homo sapiens trans- NM_001042575 ENST00000419127 344805 transmem- chr3:11179988 GO:0005515|GO:0005886| NM_001042575 THC2487758 Hs.435490 membrane protease, brane pro- 5-111799944 GO:0004252|GO:0006508| serine 7 (TMPRSS7), tease, serine 7 GO:0008233|GO:0016021 transcript variant 1, mRNA [NM_001042575] A_33_P3369631 EIF3J Homo sapiens euka- NM_003758 ENST00000261868 8669 eukaryotic chr15:4485484 GO:0005515|GO:0005737| NM_003758 THC2473241 Hs.404056 ryotic translation translation 9-44854908 GO:0005852|GO:0003743| initiation factor 3, initiation GO:0006413|GO:0005829 subunit J (EIF3J), factor 3, mRNA [NM_003758] subunit J A_24_P141707 INHBE Homo sapiens inhibin, NM_031479 ENST00000266646 83729 inhibin, beta chr12:5785086 GO:0005179|GO:0005576| NM_031479 THC2472179 Hs.632713 beta E (INHBE), E 4-57850923 GO:0008083 mRNA [NM_031479] A_32_P140139 F13A1 Homo sapiens co- NM_000129 ENST00000264870 2162 coagulation chr6:6144484- GO:0005737|GO:0018149| NM_000129 THC2468237 Hs.335513 agulation factor XIII, factor XIII, 6144425 GO:0007596|GO:0003810| A1 polypeptide (F13A1), A1 polypeptide GO:0005509|GO:0031093| mRNA [NM_000129] GO:0005576|GO:0016740| GO:0008415 A_23_P143817 MYLK Homo sapiens myosin NM_053025 ENST00000475616 4638 myosin light chr3:12333313 GO:0005516|GO:0000287| NM_053025 THC2514570 Hs.477375 light chain kinase chain kinase 3-123333074 GO:0000166|GO:0005509| (MYLK), transcript GO:0004687|GO:0006468| variant 1, mRNA GO:0003779|GO:0005524| [NM_053025] GO:0016740 A_33_P3387170 LOC100129196 Homo sapiens hypo- NR_034182 ENST00000414532 100129196 hypothetical chr1:31192359- NR_034182 THC2624896 Hs.659751 thetical LOC100129196 LOC100129196 31194140 (LOC100129196), non- coding RNA [NR_034182] A_33_P3424217 major histocompatibility XM_003119092 ENST00000399670 XM_003119092 THC2560922 complex, class II, DQ beta 1 [Source: HGNC Symbol; Acc:4944] [ENST00000399670] A_33_P3218120 LOC402036 PREDICTED: XM_001719325 402036 hCG1646661- chr22:1901959 XM_001719325 Hs.646437 Homo sapiens like 3-19019534 hCG1646661-like (LOC402036), mRNA[XM_001719325] A_33_P3413394 ZACN zinc activated ligand- BC110596 ENST00000392503 353174 zinc activated chr17:7407692 THC2485792 gated ion channel ligand-gated 0-74076979 [Source: HGNC ion channel Symbol; Acc: 29504] [ENST00000392503] A_33_P3259705 SIGIRR single immunoglobulin AY358342 ENST00000382520 59307 single chr11:406142- THC2485349 Hs.501624 and toll-interleukin 1 immunoglobu- 406083 receptor (TIR) lin and toll- domain [Source: HGNC interleukin 1 Symbol; Acc: 30575] receptor [ENST00000382520] (TIR) domain A_23_P50508 PLA2G4C Homo sapiens phos- NM_003706 ENST00000354276 8605 phospho- chr19:4855130 GO:0019369|GO:0007242| NM_003706 Nl′1152204 Hs.631562 pholipase A2, group lipase A2, 7-48551248 GO:0007567|GO:0031225| IVC (cytosolic, calcium- group IVC GO:0005829|GO:0016042| independent) (PLA2G4C), (cytosolic, GO:0005543|GO:0006954| transcript variant 1, calcium- GO:0016020|GO:0016787| mRNA [NM_003706] independent) GO:0047499|GO:0008152| GO:0046475 A_23_P40453 CBR3 Homo sapiens car- NM_001236 ENST00000290354 874 carbonyl chr21:3751837 GO:0005737|GO:0004090| NM_001236 THC2472161 Hs.154510 bonyl reductase 3 reductase 3 9-37518438 GO:0005488|GO:0016491| (CBR3), mRNA GO:0070402|GO:0055114| [NM_001236] GO:0005829 A_23_P160460 UAP1 Homo sapiens UDP- NM_003115 ENST00000367926 6675 UDP-N- chr1:16256016 GO:0005737|GO:0003977| NM_003115 THC2602097 Hs.492859 N-acteylglucosamine acteylgluco- 2-162560221 GO:0008152|GO:0016779| pyrophosphorylase 1 samine pyro- GO:0005730|GO:0005634| (UAP1), mRNA phosphor- GO:0006048|GO:0016740 [NM_003115] ylase 1 A_33_P3294946 LOC100506173 PREDICTED: XM_003119122 100506173 putative killer chr19_gl00020 XM_003119122 Hs.730948 Homo sapiens puta- cell immuno- 9_random: tive killer cell immuno- globulin-like 51823-51882 globulin like receptor receptor like protein KIR3DP1- like protein like (LOC100506173), KIR3DP1- mRNA[XM_003119122] like A_23_P348063 SYNGR1 Homo sapiens synap- NM_004711 ENST00000328933 9145 synaptogyrin chr22:3978099 GO:0042470|GO:0030054| NM_004711 THC2618835 Hs.216226 togyrin 1 (SYNGR1), 1 5-39781054 GO:0016020|GO:0005887| transcript variant 1a, GO:0048169|GO:0045202| mRNA [NM_004711] GO:0030672|GO:0006605| GO:0048172 A_23_P7342 UGT2B10 Homo sapiens UDP NM_001075 ENST00000425704 7365 UDP glu- chr4:69696473- GO:0006629|GO:0005792| NM_001075 THC2703933 Hs.201634 glucuronosyltransferase curonosyl- 69696532 GO:0016020|GO:0005783| 2 family, polypeptide transferase 2 GO:0008152|GO:0015020| B10 (UGT2B10), family, poly- GO:0016021 transcript variant 1, peptide B10 mRNA[NM_001075] A_33_P3226135 Q13401_HUMAN chr7:07510390 THC2571723 (Q13401) HPMSR3, 7-075103848 partial (51%) [THC2571723] A_23_P76951 TMX1 Homo sapiens thio- NM_030755 ENST00000457354 81542 thioredoxin- chr14:5172255 GO:0005783|GO:0008283| NM_030755 THC2466402 Hs.125221 redoxin-related related 9-51722618 GO:0030612|GO:0006950| transmembrane protein transmem- GO:0005624|GO:0015036| 1 (TMX1), mRNA brane GO:0005634|GO:0006916| [NM_030755] protein 1 GO:0006260|GO:0006888| GO:0007165|GO:0045321| GO:0016020|GO:0005789| GO:0006810|GO:0045454| GO:0016021|GO:0045893| GO:0022900|GO:0045927 A_33_P3254191 OSBPL8 Homo sapiens oxy- NM_020841 ENST00000446075 114882 oxysterol chr12:7674839 GO:0006869|GO:0008202 NM_020841 THC2462486 Hs.430849 sterol binding protein- binding 9-76748340 like 8 (OSBPL8), protein- transcript variant 1, like 8 mRNA [NM_020841] A_23_P50508 PLA2G4C Homo sapiens phospho- NM_003706 ENST00000354276 8605 phospholipase chr19:4855130 GO:0019369|GO:0007242| NM_003706 NM_1152204 Hs.631562 lipase A2, group IVC A2, group 7-48551248 GO:0007567|GO:0031225| (cytosolic, calcium-inde- IVC GO:0005829|GO:0016042| pendent) (PLA2G4C), (cytosolic, GO:0005543|GO:0006954| transcript variant 1, calcium- GO:0016020|GO:0016787| mRNA [NM_003706] independent) GO:0047499|GO:0008152| GO:0046475 A_23_P40453 CBR3 Homo sapiens carbonyl NM_001236 ENST00000290354 874 carbonyl chr21:3751837 GO:0005737|GO:0004090| NM_001236 THC2472161 Hs.154510 reductase 3 (CBR3), reductase 3 9-37518438 GO:0005488|GO:0016491| mRNA [NM_001236] GO:0070402|GO:0055114| GO:0005829 A_23_P160460 UAP1 Homo sapiens UDP- NM_003115 ENST00000367926 6675 UDP-N- chr1:16256016 GO:0005737|GO:0003977| NM_003115 THC2602097 Hs.492859 N-acteylglucosamine acteylglu- 2-162560221 GO:0008152|GO:0016779| pyrophosphorylase 1 cosamine GO:0005730|GO:0005634| (UAP1), mRNA pyrophos- GO:0006048|GO:0016740 [NM_003115] phorylase 1 A_33_P3294946 LOC100506173 PREDICTED: XM_003119122 100506173 putative killer chr19_gl00020 XM_003119122 Hs.730948 Homo sapiens putative cell immuno- 9_random: killer cell immuno- globulin-like 51823-51882 globulin like receptor receptor like like protein KIR3DP1- protein like (LOC100506173), KIR3DP1- mRNA [XM_003119122] like A_23_P348063 SYNGR1 Homo sapiens synap- NM_004711 ENST00000328933 9145 synapto- chr22:3978099 GO:0042470|GO:0030054| NM_004711 THC2618835 Hs.216226 togyrin 1 (SYNGR1), gyrin 1 5-39781054 GO:0016020|GO:0005887| transcript variant 1a, GO:0048169|GO:0045202| mRNA [NM_004711] GO:0030672|GO:0006605| GO:0048172 A_23_P7342 UGT2B10 Homo sapiens UDP NM_001075 ENST00000425704 7365 UDP glucu- chr4:69696473- GO:0006629|GO:0005792| NM_001075 THC2703933 Hs.201634 glucuronosyltransferase ronosyltrans- 69696532 GO:0016020|GO:0005783| 2 family, polypeptide ferase 2 GO:0008152|GO:0015020| B10 (UGT2B10), family, GO:0016021 transcript variant 1, polypeptide mRNA [NM_001075] B10 A_33_P3226135 Q13401_HUMAN chr7:07510390 THC2571723 (Q13401) HPMSR3, 7-075103848 partial (51%) [THC2571723] A_23_P76951 TMX1 Homo sapiens thio- NM_030755 ENST00000457354 81542 thioredoxin- chr14:5172255 GO:0005783|GO:0008283| NM_030755 THC2466402 Hs.125221 redoxin-related related 9-51722618 GO:0030612|GO:0006950| transmembrane protein transmem- GO:0005624|GO:0015036| 1 (TMX1), mRNA brane protein GO:0005634|GO:0006916| [NM_030755] 1 GO:0006260|GO:0006888| GO:0007165|GO:0045321| GO:0016020|GO:0005789| GO:0006810|GO:0045454| GO:0016021|GO:0045893| GO:0022900|GO:0045927 A_33_P3254191 OSBPL8 Homo sapiens oxy- NM_020841 ENST00000446075 114882 oxysterol chr12:7674839 GO:0006869|GO:0008202 NM_020841 THC2462486 Hs.430849 sterol binding protein- binding 9-76748340 like 8 (OSBPL8), protein transcript variant 1, like 8 mRNA [NM_020841] A_23_P1206 RPS24 Homo sapiens riboso- NM_001026 ENST00000467106 6229 ribosomal chr10:7979537 GO:0005622|GO:0003735| NM_001026 THC2572247 Hs.280130 mal protein S24 (RPS24), protein S24 1-79795430 GO:0000166|GO:0022627| transcript variant c, GO:0006364|GO:0034101| mRNA [NM_001026] GO:0005840|GO:0031369| GO:0042274|GO:0006414| GO:0005829 A_33_P3320217 ADCY2 Homo sapiens adenylate NM_020546 ENST00000382532 108 adenylate chr5:7828412- GO:0009755|GO:0004016| NM_020546 THC2463084 Hs.481545 cyclase 2 (brain) cyclase 2 7828471 GO:0000287|GO:0005886| (ADCY2), mRNA (brain) GO:0000166|GO:0006171| [NM_020546] GO:0016021|GO:0007189| GO:0034199|GO:0007193| GO:0005524|GO:0030425 A_32_P133840 TMCC2 Homo sapiens trans- NM_014858 ENST00000358024 9911 transmem- chr1:20524211 GO:0016020|GO:0016021 NM_014858 THC2489531 Hs.6360 membrane and coiled- brane and 7-205242176 coil domain family 2 coiled-coil (TMCC2), transcript domain variant 1, mRNA family 2 [NM_014858] A_33_P3280531 CRAT Homo sapiens carni- NM_000755 ENST00000351352 1384 carnitine chr9:13185713 GO:0006629|GO:0004092| NM_000755 THC2467214 Hs.12068 tine O-acetyltransferase O-acetyltrans- 4-131857075 GO:0005783|GO:0005743| (CRAT), nuclear gene ferase GO:0005739|GO:0016020| encoding mitochondrial GO:0006631|GO:0006810| protein, transcript GO:0033540|GO:0015980| variant 1, mRNA GO:0016740|GO:0005777| [NM_000755] GO:0008415 A_33_P3228739 LRRC3C Homo sapiens leucine NM_001195545 ENST00000377924 100505591 leucine chr17:3810086 GO:0005515|GO:0016020| NM_001195545 Hs.145136 rich repeat containing rich repeat 9-38100928 GO:0016021 3C (LRRC3C), mRNA containing [NM_001195545] 3C A_33_P3250148 SP8 Homo sapiens Sp8 NM_198956 ENST00000297210 221833 Sp8 trans- chr7:20823968- GO:0005622|GO:0009954| NM_198956 THC2481338 Hs.195922 transcription factor (SP8), cription 20823909 GO:0008270|GO:0005634| transcript variant 2, factor GO:0030326|GO:0009953| mRNA [NM_198956] GO:0003677|GO:0046872 A_33_P3287661 LOC100130430 Homo sapiens cDNA AK126997 100130430 hypothetical chr16:1358800- THC2488009 FLJ45052 fis, Clone LOC100130430 1358741 BRAWH3022542. [AK126997] A_33_P3399438 C9orf29 Homo sapiens chromo- NR_034087 ENST00000536054 652972 chromosome 9 chr9:11436517 NR_034087 THC2609605 Hs.551134 some 9 open reading open reading 5-114365116 frame 29 (C9orf29), frame 29 non-coding RNA [NR_034087] A_33_P3343473 ATRNL1 Homo sapiens attractin- NM_207303 ENST00000303745 26033 attractin-like 1 chr10:1173089 GO:0005515|GO:0016020| NM_207303 THC2543996 Hs.501127 like 1 (ATRNL1), 76-117309035 GO:0007186|GO:0005529| mRNA [NM_207303] GO:0016021 A_33_P3353948 Q8NCT2_HUMAN chr7:04888627 THC2526367 (Q8NCT2) CDC14C 4-048886333 protein (Fragment), complete [THC2526367] A_33_P3851788 C19orf23 Homo sapiens chromo- NR_027271 148046 chromosome chr19:1267531- NR_027271 THC2485522 Hs.438829 some 19 open reading 19 open 1267472 frame 23 (C19orf23), reading frame 23 non-coding RNA [NR_027271] A_23_P16415 LRP3 Homo sapiens low NM_002333 ENST00000431491 4037 low density chr19:3369833 GO:0005905|GO:0016020| NM_002333 THC2461289 Hs.515340 density lipoprotein re- lipoprotein re- 6-33698395 GO:0004872|GO:0016021| ceptor-related protein ceptor-related GO:0006898 3 (LRP3), mRNA protein 3 [NM_002333] A_23_P21800 immunoglobulin DQ187531 ENST00000492167 chr2:89442284- NP511624 Hs.449621 kappa variable 3-20 89442225 [Source: HGNC Symbol; Acc: 5817) [ENST00000492167] A_23_P34382 CLCA3P Homo sapiens chloride NR_024604 ENST00000466454 9629 chloride chr1:87120974- GO:0005215|GO:0031404| NR_024604 channel accessory 3, channel 87121033 GO:0005262|GO:0005244| pseudogene (CLCA3P), accessory 3, GO:0005509|GO:0034707| non-coding RNA pseudogene GO:0006816|GO:0005576| [NR_024604] GO:0005615|GO:0005254| GO:0006811 A_33_P3373185 LOC399744 Homo sapiens hypo- NR_024497 ENST00000438516 399744 hypothetical chr10:3873784 NR_024497 THC2594684 Hs.730469 thetical LOC399744 LOC399744 0-38737899 (LOC399744), non- coding RNA [NR_024497] A_33_P3220994 chr6:02686997 9-026870038 A_24_P813550 immunoglobulin XM_003119589 ENST00000390629 chr14:1070833 XM_003119589 NP1077996 Hs.631647 heavy variable 4-59 60-107083301 [Source: HGNC Symbol; Acc: 5654] [ENST00000390629] A_33_P3273624 HYAL3 Homo sapiens hyaluro- NM_003549 ENST00000359051 8372 hyalurono- chr3:50330627- GO:0005975|GO:0016798| NM_003549 THC2486407 Hs.729310 noglucosaminidase 3 glucosa 50330568 GO:0008152|GO:0005576| (HYAL3), transcript minidase 3 GO:0004415|GO:0005764 variant 1, mRNA [NM_003549] A_33_P3310226 LOC100129115 Homo sapiens cDNA AK095213 100129115 hypothetical chr17:4320558 THC2484758 Hs.683858 FLJ37894 fis, clone protein 0-43205521 BRTHA2004639. LOC100129115 [AK095213] A_24_P182947 GCET2 Homo sapiens germinal NM_001190259 ENST00000308910 257144 germinal center chr3:11184002 GO:0005739|GO:0005737 NM_001190259 THC2517803 Hs.49614 center expressed tran- expressed 8-111839969 script 2 (GCET2), transcript 2 transcript variant 3, mRNA [NM_001190259] A_33_P3409580 LOC100129722 Homo sapiens hypo- NR_038389 100129722 hypothetical chr9:14014474 NR_038389 THC2619216 Hs.656347 thetical LOC100129722 LOC100129722 6-140144687 (LOC100129722), non-coding RNA [NR_038389] A_33_P3263666 ANKRD9 Homo sapiens ankyrin NM_152326 ENST00000286918 122416 ankyrin chr14:1029732 NM_152326 THC2480472 Hs.432945 repeat domain 9 repeat 57-102973198 (ANKRD9), mRNA domain 9 [NM_152326] A_33_P3343260 ALU1_HUMAN chr16:0031228 THC2541287 (P39188) Alu subfamily 24-003122765 J sequence contamin- ation warning entry, partial (16%) [THC2541287] A_33_P3266998 FAM106CP Homo sapiens family NR_026810 ENST00000379228 100129396 family with chr17:1669322 NR_026810 Hs.712114 with sequence similarity sequence simi- 4-16693282 106, member C, larity 106, pseudogene member C (FAM106CP), non- pseudogene coding RNA [NR_026810] A_33_P3374253 PREDICTED: Homo XM_001717762 chr18:7731928 XM_001717762 Hs.336526 sapiens similar to 4-77319225 hCG1645807 (LOC100127987), mRNA [XM_001717762] A_33_P3311830 OTOR Homo sapiens otora- NM_020157 ENST00000246081 56914 otoraplin chr20:1673267 GO:0001502|GO:0007605| NM_020157 THC2602987 Hs.41119 plin (OTOR), mRNA 4-16732733 GO:0005576 [NM_020157] A_23_P75800 RAB3IL1 Homo sapiens NM_013401 ENST00000394836 5866 RAB3A chr11:6166503 GO:0005515|GO:0005085 NM_013401 THC2472895 Hs.13759 RAB3A interacting interacting 8-61664979 protein (rabin3)-like protein 1 (RA83IL1), mRNA (rabin3)- [NM_013401] like 1 A_24_P38572 NOL6 Homo sapiens nucle- NM_022917 ENST00000325914 65083 nucleolar chr9:33464935- GO:0000794|GO:0003723| NM_022917 NP287178 H-,493709 olar protein family proteinated) 33464159 GO:0005730|GO:0005732| 6 (RNA-associated) family 6 GO:0005634 (NOL6), transcript (RNA-associ variant alpha, mRNA ated) [NM_022917] A_33_P3331882 CRTC1 Homo sapiens CREB NM_001098482 ENST00000262813 23373 CREB chr19:1888823 GO:0005515|GO:0008140| NM_001098482 THC2472431 Hs.371096 regulated transcription regulated 1-18888290 GO:0005737|GO:0045944| coactivator 1 (CRTC1), transcription GO:0044419|GO:0005634| transcript variant 3, coactivator 1 GO:0045449 mRNA [NM_001098482] A_33_P3261428 chr14:0750273 38-075027397 A_33_P3219870 PNPLA2 Homo sapiens patatin- NM_020376 ENST00000529255 57104 patatin-like chr11:824764- GO:0016042|GO:0004806| NM_020376 THC2466068 Hs.654697 like phospholipase domain phospholipase GO:0016787|GO:0005886| containing 2 (PNPLA2), domain con- 824823 GO:0010891|GO:0008152| mRNA [NM_020376] taining 2 GO:0010898|GO:0016021| GO:0012511|GO:0005829 A_33_P3262833 GOLGA8E Homo sapiens golgin NR_033350 ENST00000341390 390535 golgin A8 chr15:2344778 NR_033350 THC2493346 Hs.454647 A8 family, member E family, 9-23447848 (GOLGA8E), non- member E coding RNA [NR_033350] A_24_P401990 ERCC2 Homo sapiens excision NM_000400 ENST00000391940 2068 excision chr19:4586487 GO:0009650|GO:0006368| NM_000400 NP1457049 Hs.487294 repair cross-comple- repair cross- 4-45864815 GO:0006367|GO:0009791| menting rodent repair complementing GO:0016818|GO:0000166| deficiency, comple- rodent repair GO:0030198|GO:0044419| mentation group 2 deficiency, GO:0006979|GO:0045449| (ERCC2), transcript complemen- GO:0019907|GO:0000287| variant 1, tation group 2 GO:0005506|GO:0007568| mRNA[NM_000400] GO:0001701|GO:0006283| GO:0043388|GO:0000075| GO:0043139|GO:0005654| GO:0043588|GO:0035315| GO:0021510|GO:0008283| GO:0016563|GO:0005634| GO:0030282|GO:0004003| GO:0043249|GO:0035264| GO:0040016|GO:0045944| GO:0048820|GO:0043066| GO:0051536|GO:0004386| GO:0006917|GO:0060218| GO:0008022|GO:0032289| GO:0008353|GO:0003677| GO:0005524|GO:0006974| GO:0004672|GO:0047485| GO:0016787|GO:0000718| GO:0005675|GO:0033683 A_24_P323072 GNRH2 Homo sapiens gona- NM_178332 ENST00000359987 2797 go nadotro- chr20:3025110- GO:0007165|GO:0005179| NM_178332 THC2484054 Hs.129715 dotropin-releasing pin-releasing 3025169 GO:0007275|GO:0005625| hormone 2 (GNRH2), hormone 2 GO:0005576 transcript variant 2, mRNA [NM_178332] A_33_P3361991 OR9A2 Homo sapiens ol- NM_001001658 ENST00000350513 135924 olfactory chr7:14272337 GO:0007608|GO:0007165| NM_001001658 THC2603293 Hs.553594 factory receptor, family receptor, 1-142723312 GO:0004984|GO:0007186| 9, subfamily A, member family 9, GO:0005886|GO:0004872| 2 (OR9A2), mRNA subfamily A, GO:0016021|GO:0050896 [NM_001001658] member 7 A_24_P343095 DHFR Homo sapiens dihydro- NM_000791 ENST00000513048 1719 dihydrofolate chr5:79924927- GO:0050661|GO:0016491| NM_000791 NP098266 Hs.648635 folate reductase reductase 79924848 GO:0006545|GO:0005575| (DHFR), mRNA GO:0006730|GO:0009165| [NM_000791] GO:0055114|GO:0004146 A_24_P2361 CLCNKA Homo sapiens chloride NM_004070 ENST00000439316 1187 chloride chr1:16358986- GO:0007588|GO:0006821| NM_004070 THC2607488 Hs.591533 channel Ka (CLCNKA), channel Ka 16359688 GO:0031404|GO:0005244| transcript variant 1, GO:0016020|GO:0005887| mRNA[NM_004070] GO:0005247|GO:0034707| GO:0055085|GO:0006811 A_33_P3346937 MON2 Homo sapiens MON2 NM_015026 ENST00000393630 23041 MON2 chr12:6290215 GO:0005488|GO:0015031| NM_015026 NP796518 Hs.389378 homolog (S. cerevisiae) homolog 6-62902215 GO:0006895 (MON2), mRNA (S. cerevisiae) [NM_015026] A_33_P3716128 SMC4 Homo sapiens struct- NM_005496 ENST00000462787 10051 structural chr3:16015158 GO:0005515|GO:0000796| NM_005496 THC2478358 Hs.58992 ural maintenance of maintenance 1-160151640 GO:0007076|GO:0007049| chromosomes 4 of chromo- GO:0005737|GO:0046982| (SMC4), transcript somes 4 GO:0000166|GO:0005694| variant 1, mRNA GO:0005634|GO:0005524| [NM_005496] GO:0051301 A_23_P115519 LCE3D Homo sapiens late NM_032563 ENST00000368787 84648 late chr1:15255201 GO:0031424 NM_032563 THC2481277 Hs.244349 cornified envelope 3D cornified 7-152551958 (LCE3D), mRNA envelope 3D [NM_032563] A_33_P3681776 LOC255512 Homo sapiens hypo- NR_029409 ENST00000530897 255512 hypothetical chr11:1331801- NR_029409 THC2603843 Hs.588291 thetical LOC255512 LOC255512 1331860 (LOC255512), non- coding RNA [NR_029409] A_24_P388703 MGC42157 Homo sapiens cDNA BC030111 439933 hypothetical chr4:36258205- THC2485423 Hs.591071 clone IMAGE: 4799398. locus 36258264 [BC030111] MGC42157 A_32_P209230 CITED4 Homo sapiens Cbp/ NM_133467 ENST00000372638 163732 Cbp/p300- chr1:41326794- GO:0005737|GO:0045941| NM_133467 THC2473039 Hs.355820 p300-interacting trans- interacting 41326735 GO:0030528|GO:0003713| activator, with Glu/ transactivator, GO:0005634 Asp-rich carboxy- with Glu/Asp- terminal domain, 4 rich carboxy- (CITED4), mRNA terminal [NM_133467] domain, 4 A_23_P161968 SLC22A10 Homo sapiens solute NM_001039752 ENST00000332793 387775 solute carrier chr11:6307221 GO:0016020|GO:0016021| NM_001039752 THC2480380 Hs.188982 carrier family 22, family 22, 1-63072270 GO:0055085 member 10 (SLC22A10), member 10 mRNA [NM_001039752] A_33_P3325102 LOC644173 full-length cDNA CR604878 644173 hypothetical chr4:56814185 THC2739440 Hs.646314 clone CSODC007YI01 LOC644173 56814126 of Neuroblastoma Cot 25-normalized of Homo sapiens (human). [CR604878] A_33_P3304883 LOC100131372 PREDICTED: XR_113971 100131372 hypothetical chr7:469712- XR_113971 THC2632533 Hs.704272 Homo sapiens hypo- LOC100131372 469653 thetical LOC100131372 (LOC100131372), miscRNA [XR_113971] A_33_P3332135 PHOSPHO1 Homo sapiens phos- NM_001143804 ENST00000413580 162466 phosphatase, chr17:4730080 GO:0000287|GO:0016787| NM_001143804 THC2478263 Hs.405607 phatase, orphan 1 orphan 1 2-47300743 GO:0008152|GO:0033884 (PHOSPHO1), transcript variant 1, mRNA [NM_001143804] A_24_P286054 ZFYVE16 Homo sapiens zinc NM_001105251 ENST00000512907 9765 zinc finger, chr5:79774799 GO:0005515|GO:0030509| NM_001105251 THC2502523 HS.482660 finger, FYVE domain FYVE 79774858 GO:0046872|GO:0005545| containing 16 domain GO:0007165|GO:0016050| (ZFYVE16), transcript containing 16 GO:0005737|GO:0016020| variant 2, mRNA GO:0030100|GO:0031901| [NM_001105251] GO:0008565|GO:0016197| GO:0006622|GO:0008270| GO:0019898 A_23_P43412 HEMGN Homo sapiens hemo- NM_018437 ENST00000259456 55363 hemogen chr9:10069255 GO:0045667|GO:0007275| NM_018437 THC2464628 Hs.176626 gen (HEMGN), 0-100692491 GO:0005654|GO:0005634| transcript variant 1, GO:0030154 mRNA [NM_018437] A_33_P3347522 chr16:0298876 96-029887637 A_33_P3390539 GYLTL1B Homo sapiens glyco- NM_152312 ENST00000389968 120071 glycosyltrans- chr11:4594802 GO:0005794|GO:0016020| NM_152312 THC2742187 Hs.86543 syltransferase-like 1B ferase-like 1B 7-45948086 GO:0016757|GO:0016021| (GYLTL1B), mRNA GO:0046716 [NM_152312] A_23_P166848 LTF Homo sapiens lacto- NM_002343 ENST00000426532 4057 lactotransferrin chr3:46479489- GO:0006879|GO:0005515| NM_002343 THC2485813 Hs.529517 transferrin (LTF), 46477720 GO:0005737|GO:0004252| transcript variant 1, GO:0006959|GO:0006826| mRNA [NM_002343] GO:0008233|GO:0005576| GO:0046872|GO:0042742| GO:0008199|GO:0006811 A_33_P3306352 C20orf108 chromosome 20 ENST00000437418 116151 chromosome chr20:5493524 THC2691510 open reading frame 20 open 2-54935301 108 [Source: HGNC reading Symbol; Acc: 16102] frame 108 [ENST00000437418] A_23_P137689 OLFML2B Homo sapiens olfacto- NM_015441 ENST00000294794 25903 olfactomedin- chr1:16195327 GO:0016020|GO:0005576 NM_015441 THC2464089 Hs.507515 medin-like 2B like 2B 6-161953217 (OLFML2B), mRNA [NM_015441] A_32_P41604 F5 Homo sapiens co- NM_000130 2153 coagulation chr1:16948130 GO:0005886|GO:0007596| NM_000130 THC2654286 Hs.30054 agulation factor V factor V 2-169481243 GO:0005507|GO:0005509| (proaccelerin, labile (proaccelerin, GO:0016491|GO:0031093| factor) (F5), labile factor) GO:0005576|GO:0007155| mRNA [NM_000130] GO:0055114 A_33_P3386487 chr7:03140220 1-031402142 A_23_P409438 IL28A Homo sapiens inter- NM_172138 ENST00000331982 282616 interleukin 28A chr19:3976063 GO:0005576|GO:0009615| NM_172138 THC2481798 Hs.567792 leukin 28A (interferon, (interferon, 5-39760694 GO:0005615|GO:0005125 lambda 2) (IL28A), lambda 2) mRNA[NM_172138] A_33_P3253723 AQP1 Homo sapiens aqua- NM_198098 ENST00000265298 358 aquaporin 1 chr7:30963485- GO:0005515|GO:0043005| NM_198098 NP1203192 Hs.76152 porin 1 (Colton blood (Colton blood 30963544 GO:0005215|GO:0007588| group) (AQP1), group) GO:0043627|GO:0015696| transcript variant 1, GO:0015670|GO:0055085| mRNA [NM_198098] GO:0032809|GO:0016323| GO:0016324|GO:0016020| GO:0005887|GO:0015250| GO:0051739|GO:0043679| GO:0006833|GO:0009725 A_23_P352950 PNMA5 Homo sapiens para- NM_052926 ENST00000439251 114824 paraneoplastic chrX:15215775 NM_052926 Hs.573567 neoplastic antigen antigen like 5 5-152157696 like 5 (PNMA5), transcript variant 3, mRNA [NM_052926] A_33_P3240996 LOC100134240 PREDICTED: XM_001718062 100134240 hypothetical chr2:13311083 XM_001718062 THC2492745 Hs.98178 Homo sapiens hypo- protein 5-133110894 thetical protein LOC100134240 LOC100134240 (LOC100134240), mRNA[XM_001718062] A_24_P161144 ZNF843 Homo sapiens zinc NM_001136509 283933 zinc finger chr16:3144705 GO:0005622|GO:0008270| NM_001136509 THC2483860 Hs.722243 finger protein 843 protein 843 1-31446992 GO:0003676|GO:0046872 (ZNF843), mRNA [NM_001136509] A_33_P3361741 DNAJC15 Homo sapiens DnaJ NM_013238 29103 DnaJ (Hsp40) chr13:4368324 GO:0005737|GO:0005886| NM_013238 Hs.438830 (Hsp40) homolog, sub- homology 5-43683304 GO:0031072|GO:0005634| family C, member 15 subfamily C, GO:0016021|GO:0005925 (DNAJC15), mRNA member 15 [NM_013238] A_33_P3263387 TTLL4 Homo sapiens tubulin NM_014640 ENST00000392102 9654 tubulin tyrosine chr2:21962007 GO:0005929|GO:0004835| NM_014640 THC2661456 Hs.471405 tyrosine ligase like ligase like 7-219620136 GO:0016874|GO:0005932| family, member 4 family, GO:0006464 (TTLL4), mRNA member 4 [NM_014640] A_33_P3258593 PRB1 Homo sapiens proline- NM_005039 ENST00000240636 5542 proline-rich chr12:1150629 GO:0008150|GO:0003674| NM_005039 THC2476439 Hs.631726 rich protein BstNl protein BstNl 1-11506232 GO:0005576 subfamily 1(PRB1), subfamily 1 transcript variant 1, mRNA [NM_005039] A_23_P425073 RBMS2 Homo sapiens RNA NM_002898 ENST00000552916 5939 RNA binding chr12:5698276 GO:0006396|GO:0000166| NM_002898 THC2470737 Hs.505729 binding motif, single motif, single 5-56982945 GO:0003723|GO:0005634 stranded interacting stranded protein 2 (RBMS2), interacting mRNA [NM_002898] protein 2 A_33_P3290235 LOC149950 Homo sapiens hypo- NR_034152 ENST00000375673 149950 hypothetical chr20:3119644 NR_034152 THC2488463 Hs.516980 thetical LOC149950 LOC149950 7-31196506 (LOC149950), non- coding RNA [NR_034152] A_33_P3288924 PREDICTED: XM_003118609 chr9:130318386 XM_003118609 NP498580 Hs.683792 Homo sapiens hypo- 5-13031832 thetical protein LOC100506005 (LOC100506005), mRNA[XM_003118609] A_32_P204218 FAM180A Homo sapiens family NM_205855 ENST00000415751 389558 family with Chr7:13541888 GO:0005576 NM_205855 THC2478197 Hs.55200 with sequence similarity sequence 6-135418827 180, member A similarity 180, (FAM180A), mRNA member A [NM_205855] A_23_P92196 RETNLB Homo sapiens resistin NM_032579 ENST00000295755 84666 resistin like chr3:10847593 GO:0003674|GO:0005179| NM_032579 THC2479326 Hs.307047 like beta (RETNLB), beta 6-108475407 GO:0008283|GO:0005576 mRNA [NM_032579] A_33_P3216448 COL11A2 Homo sapiens collagen, NM_001163771 ENST00000383088 1302 collagen, chr6:33154291- GO:0005581|GO:0030020| NM_001163771 THC2481257 Hs.390171 type XI, alpha 2 type XI, 33154232 GO:0005592|GO:0001894| (COL11A2), transcript alpha 2 GO:0002062|GO:0030199| variant 4, mRNA GO:0007605|GO:0048705| [NM_001163771] GO:0005576|GO:0030674| GO:0007155|GO:0060023 A_33_P3308132 FLJ39632 PREDICTED: XR_110291 642477 hypothetical chr14:1988757 XR_110291 Hs.474095 Homo sapiens hypo- LOC642477 3-19887514 thetical LOC642477 (FLJ39632), miscRNA [XR_110291] A_33_P3396635 SSX3 Homo sapiens syno- NM_021014 ENST00000376895 10214 synovial chrX:48206180- GO:0005622|GO:0006355| NM_021014 THC2484853 Hs.558445 vial sarcoma, X break- sarcoma, 48206121 GO:0005634|GO:0003676 point 3 (SSX3), X breakpoint 3 transcript variant 1, mRNA [NM_021014] A_23_P103690 FAM189B Homo sapiens family NM_006589 ENST00000487649 10712 family with chr1:15521734 GO:0008150|GO:0003674| NM_006589 NP1167666 Hs.348308 with sequence similarity sequence 4-155217285 GO:0016020|GO:0050699| 189, member B similarity 189, GO:0016021 (FAM189B), transcript member B variant 1, mRNA [NM_006589] A_23_P80068 BTG3 Homo sapiens BTG NM_006806 ENST00000339775 10950 BTG family, chr21:1896611 GO:0005737|GO:0008285| NM_006806 THC2526595 Hs.473420 family, member 3 member 3 9-18966060 GO:0045930 (BTG3), transcript variant 2, mRNA [NM_006806] A_23_P65370 GLRX5 Homo sapiens gluta- NM_016417 ENST00000331334 51218 glutaredoxin 5 chr14:9601078 GO:0005739|GO:0015035| NM_016417 THC2463309 Hs.728210 redoxin 5 (GLRX5), 7-96010846 GO:0009055|GO:0045454 nuclear gene encoding mitochondrial protein, mRNA [NM_016417] A_33_P3282693 OR3A4 Homo sapiens ol- NR_024128 390756 olfactory chr17:3214592- NR_024128 THC2612119 Hs.632245 factory receptor, family receptor, 3214651 3, subfamily A, family 3, member 4 (OR3A4), subfamily A, non-coding RNA member A [NR_024128] A_33_P3362933 GYPA Homo sapiens glyco- NM_002099 ENST00000508337 2993 glycophorin chr4:14503590 GO:0005886|GO:0005624| NM_002099 NP082322 Hs.434973 phorin A (MNS blood A (MNS 2-145035843 GO:0016021|GO:0042802 group) (GYPA), mRNA blood group) [NM_002099] A_24_P339869 ZNF295 Homo sapiens zinc NM_020727 ENST00000310826 49854 zinc finger chr21:4340713 GO:0005622|GO:0005515| NM_020727 THC2755459 Hs.434947 finger protein 295 protein 295 9-43407080 GO:0008270|GO:0005634| (ZNF295), transcript GO:0003677|GO:0046872| variant 2, mRNA GO:0045449 [NM_020727] A_23_P431933 CAMKK1 Homo sapiens calcium/ NM_032294 ENST00000381771 84254 calcium/ chr17:3763939- GO:0005516|GO:0005737| NM_032294 THC2464408 Hs.8417 calmodulin dependent calmodulin- 3763880 GO:0000166|GO:0006468| protein kinase kinase dependent GO:0005634|GO:0004683| 1, alpha (CAMKK1), protein kinase GO:0005524|GO:0016740 transcript variant 1, kinase 1, alpha mRNA [NM_032294] A_33_P3284919 SEMA6C Homo sapiens sema NM_001178061 ENST00000341697 10500 sema domain, chr1:15110425 GO:0016020|GO:0007275| NM_001178061 THC2541643 Hs.516316 domain, transmembrane transmembrane 5-151104196 GO:0004872|GO:0016021| domain (TM), and cyto- domain (TM), GO:0030154|GO:0007399 plasmic domain, (sema- and cytoplas- phorin) 6C (SEMA6C), mic domain, transcript variant 1, (semaphorin) mRNA [NM_001178061] 6C A_33_P3327663 SUSD4 sushi domain containing ENST00000366877 55061 sushi domain chr1:22353360 THC2679732 4 [Source: HGNC containing 4 5-223533546 Symbol; Acc: 25470] [ENST00000366877] A_23_P24586 ACCS Homo sapiens 1- NM_032592 ENST00000263776 84680 1-amino- chr11:4410505 GO:0009058|GO:0016847| NM_032592 THC2470602 Hs.126706 aminocyclopropane-l- cyclopropane-l- 6-44105115 GO:0016769|GO:0030170| carboxylate synthase carboxylate syn- GO:0003824|GO:0042803 homolog (Arabidopsis) thase homolog (non-functional) (ACCS), (Arabidopsis) transcript variant 1, (no n-functional) mRNA [NM_032592] A_33_P3403733 UPF0627 protein XM_001721533 ENST00000434336 chr1:16999939- XM_001721533 ENSP00000341061/ 16999998 ENSP00000339743 [Source: UniProtKB/ Swiss-Prot; Acc: A6NEA5] [ENST00000434336] A_24_P913716 B3GNT7 Homo sapiens UDP- NM_145236 ENST00000287590 93010 UDP- chr2:23226545 GO:0005794|GO:0016020| NM_145236 THC2672480 Hs.299329 GlcNAc:betaGal beta-l,3- GlcNAc:betaGal 2-232265511 GO:0016757|GO:0006486| N-acetylglucosaminyl- beta-l,3-N- GO:0016021|GO:0008378 transferase 7 (B3GNT7), acetylgluco- mRNA [NM_145236] saminyltrans- ferase 7 A_33_P3351052 POU3F1 Homo sapiens POU NM_002699 (-NST00000373012 5453 POU class chr1:38509710- GO:0043565|GO:0010628| NM_002699 THC2498352 Hs.1837 class 3 homeobox 1 3 homeobox 1 38509651 GO:0005667|GO:0006355| (POU3F1), mRNA GO:0003700|GO:0008544| [NM_002699] GO:0030216|GO:0022011| GO:0016563|GO:0005634 A_23_P20804 C9orf25 Homo sapiens chromo- NM_147202 ENST00000297620 203259 chromosome chr9:34398447- NM_147202 THC2495188 Hs.493771 some 9 open reading 9 open reading 34398388 frame 25 (C9orf25), frame 25 transcript variant 4, mRNA [NM_147202] A_23_P114740 CFH Homo sapiens com- NM_000186 ENST00000466229 3075 complement chr1:19671655 GO:0006957|GO:0005576| NM_000186 THC2469545 Hs.363396 plement factor H (CFH), factor H 0-196716609 GO:0005615 transcript variant 1, mRNA [NM_000186] A_33_P3237874 TROAP Homo sapiens trophinin NM_001100620 ENST00000380327 10024 trophinin chr12:4971794 GO:0005515|GO:0005737| NM_001100620 THC2481969 Hs.524399 associated protein (tastin) associated 8-49718007 GO:0007155 (TROAP), transcript protein (tastin) variant 2, mRNA [NM_001100620] A_23_P202602 SEC23IP Homo sapiens SEC23 NM_007190 ENST00000369075 11196 SEC23 inter- chr10:1217007 GO:0005515|GO:0005793| NM_007190 THC2469270 Hs.435004 interacting protein acting protein 86-121700845 GO:0005737|GO:0016020| (SEC23IP), transcript GO:0005783|GO:0007030| variant 1, mRNA GO:0031410|GO:0006886| [NM_007190] GO:0046872 A_23_P210465 PI3 Homo sapiens pepti- NM_002638 ENST00000243924 5266 peptidase chr20:4380464 GO:0005515|GO:0004867| NM_002638 THC2461616 Hs.112341 dase inhibitor 3, skin- inhibitor 3, 5-43804704 GO:0005578|GO:0005576| derived (PI3), mRNA skin-derived GO:0007620 [NM_002638] A_33_P3279720 ARFRP1 ADP-ribosylation factor ENST00000217224 10139 ADP-ribo- chr20:6233260 THC2679434 related protein 1 sylation factor 2-62332543 [Source: HGNC related Symbol; Acc: 662] protein 1 [ENST00000217224] A_23_P57379 CDC45 Homo sapiens cell NM_003504 ENST00000493724 8318 cell division chr22:1950638 GO:0006260|GO:0005515| NM_003504 THC2492552 Hs.474217 division cycle 45 cycle 45 5-19508015 GO:0007049|GO:0005813| homolog (S. cerevisiae) homolog (S. GO:0005737|GO:0006270| (CDC45), transcript cerevisiae) GO:0000076|GO:0005654| variant 2, mRNA GO:0005634 [NM_003504] A_33_P3271711 Uncharacterized protein ENST00000449914 chr3:4856040- THC2706532 [Source: UniProtKB/ 4855981 TrEMBL; Acc: C 9JFK8] [ENST00000449914] A_24_P237389 EIF1AX Homo sapiens euka- NM_001412 ENST00000379607 1964 eukaryotic chrX:20143018- GO:0005737|GO:0003723| NM_001412 THC2559655 Hs.522590 ryotic translation initia- translation 20142959 GO:0003743|GO:0006413| tion factor 1A, X linked initiation GO:0005829 (EIF1AX), mRNA factor 1A, X- [NM_001412] linked A_33_P3399618 KLHL33 Homo sapiens kelch- NM_001109997 ENST00000344581 123103 kelch-like 33 chr14:2089720 GO:0005515 NM_001109997 Hs.556014 like 33 (Drosophila) (Drosophila) 5-20897146 (KLHL33), mRNA [NM_001109997] A_23_P142031 SBK2 Homo sapiens SH3- NM_001101401 ENST00000344158 646643 SH3-binding chr19:5604165 GO:0000166|GO:0004674| NM_001101401 THC2663623 Hs.532676 binding domain kinase domain kinase 3-56041594 GO:0006468|GO:0005524| family, member 2 family, GO:0016740 (SBK2), mRNA member 2 [NM_001101401] A_33_P3209706 ARGFX Homo sapiens arginine- NM_001012659 503582 arginine-fifty chr3:12130924 GO:0043565|GO:0006355| NM_001012659 Hs.224976 fifty homeobox homeobox 3-121309302 GO:0003700|GO:0005634 (ARGFX), mRNA [NM_001012659] A_32_P175349 cDNA FLJ46600 fis, AK128457 ENST00000374945 chr17:7625945 THC2485217 clone THYMU3047144 5-76259396 [Source: UniProtKB/ TrEMBL; Acc: Q6ZR66] [ENST00000374945] A_33_P3210363 LOC100128191 Homo sapiens hypo- NR_027157 100128191 hypothetical chr12:9890681 NR_027157 THC2492437 Hs.594042 thetical LOC100128191 LOC100128191 0-98906751 (LOC100128191), non-coding RNA [NR_027157] A_23_P170901 PACRG Homo sapiens NM_152410 ENST00000545186 135138 PARK2 chr6:16351037 NM_152410 THC2691532 Hs.25791 PARK2 co-regulated co-regulated 5-163510434 (PACRG), transcript variant 1, mRNA [NM_152410] A_33_P3570228 LOC644962 Homo sapiens cDNA AK127954 644962 trinucleotide chr4:14156241 THC2485964 Hs.676500 FLJ46065 fis, clone repeat 4-141562355 TBAES2007862. containing 18 [AK127954] pseudogene A_33_P3294377 DA880232 PROST2 DA880232 ENST00000550687 chr12:9428890 Hs.577495 Homo sapiens cDNA 1-94288842 clone PROST2019563 5′, mRNA sequence [DA880232] A_23_P69383 PARP9 Homo sapiens poly NM_031458 ENST00000452457 83666 poly (ADP- chr3:12224735 GO:0003674|GO:0016477| NM_031458 NP1159658 Hs.518200 (ADP-ribose) poly- ribose) poly- 6-122247297 GO:0005634|GO:0016740| merase family, mem- merase family, GO:0003950 ber 9 (PARP9), member 9 transcript variant 1, mRNA [NM_031458] A_33_P3406873 NFASC Homo sapiens neuro- NM_001005389 ENST00000403080 23114 neurofascin chr1:20494448 GO:0005515|GO:0030424| NM_001005389 NP1247431 Hs.13349 fascin (NFASC), 6-204944545 GO:0050808|GO:0005886| transcript variant 5, GO:0007411|GO:0016021| mRNA [NM_001005389] GO:0007155 A_33_P3742500 LOC642947 Homo sapiens hypo- BC132887 642947 hypothetical chr9:79809627- NP1472442 Hs.689418 thetical protein protein 79809686 LOC642947, mRNA LOC642947 (cDNA clone IMAGE: 40146909). [BC132887] A_23_P209954 GNLY Homo sapiens granu- NM_006433 ENST00000489980 10578 granulysin chr2:85924656- GO:0006968|GO:0050832| NM_006433 THC2641793 Hs.105806 lysin (GNLY), trans- 85924715 GO:0031640|GO:0005576| cript variant NKG5, GO:0005615|GO:0042742 mRNA [NM_006433] A_33_P3291484 ST8SIA4 Homo sapiens ST8 NM_005668 7903 ST8 alpha- chr5:10014301 GO:0003828|GO:0030173| NM_005668 THC2531659 Hs.308628 alpha-N-acetyl-neur- N-acetyl- 6-100142957 GO:0009311|GO:0005794| aminide alpha-2,8- neuraminide GO:0016020|GO:0006491| sialyltransferase 4 alpha-2,8- GO:0006486|GO:0016021| (ST8SIA4), transcript sialyltrans- GO:0007399 variant 1, mRNA ferase 4 [NM_005668] A_33_P3355208 CROT Homo sapiens carni- NR_026585 ENST00000412227 54677 carnitine O- chr7:86989366- GO:0006629|GO:0005782| NR_026585 Hs.125039 tine O-octanoyltrans- octanoyl- 86989425 GO:0006810|GO:0006631| ferase (CROT), trans- transferase GO:0008458|GO:0006091| cript variant 3, non- GO:0016740|GO:0008415| coding RNA GO:0005777 [NR_026585] A_32_P135517 LOC100506105 PREDICTED: XR_109318 100506105 hypothetical chr16:7149789 XR_109318 THC2568448 Hs.647355 Homo sapiens hypo- LOC100506105 6-71497955 thetical LOC100506105 (LOC100506105), partial miscRNA [XR_109318] A_33_P3403851 O52K2_HUMAN chr11:0044970 THC2647746 (Q8NGK3) Olfactory 21-004497080 receptor 52K2, partial (29%) [THC2647746] A_23_P343411 AGRN Homo sapiens agrin NM_198576 ENST00000461111 375790 agrin chr1:991186- GO:0007009|GO:0009986| NM_198576 NP1152870 Hs.273330 (AGRN), mRNA 991245 GO:0005605|GO:0045202| [NM_198576] GO:0005576|GO:0045213| GO:0007213|GO:0007416| GO:0007165|GO:0045162| GO:0007528|GO:0030548| GO:0045944|GO:0043236| GO:0005200|GO:0043113| GO:0008582 A_23_P61042 immunoglobulin heavy XR_111480 ENST00000390539 chr14:1060539 XR_111480 NP1154471 Hs.699841 constant alpha 2 30-106053649 (A2m marker) [Source: HGNC Symbol; Acc: 5479] [ENST00000390539] A_23_P127279 FAM35A Homo sapiens family with NM_019054 ENST00000298786 54537 family with chr10:8895074 NM_019054 THC2462523 Hs.500419 sequence similarity 35, sequence 1-88950800 member A (FAM35A), similarity 35, mRNA [NM_019054] member A A_23_P42768 SRRM3 Homo sapiens serine/ NM_001110199 ENST00000326382 222183 serine/arginine chr7:75890675- NM_001110199 THC2614609 Hs.511025 arginine repetitive repetitive 75890731 matrix 3 (SRRM3), matrix 3 mRNA [NM_001110199] A_33_P3260605 CTNNAL1 Homo sapiens catenin NM_003798 ENST00000374593 8727 catenin chr9:11175497 GO:0005737|GO:0045296| NM_003798 NP1195581 Hs.58488 (cadherin-associated (cadherin 3-111754914 GO:0005886|GO:0005198| protein), alpha-like 1 associated GO:0015629|GO:0007155| (CTNNAL1), protein), GO:0019898 mRNA [NM_003798] alphalike 1 A_33_P3316248 chrX:00051518 6-000515127 A_23_P132139 C21orf58 Homo sapiens chromo- NM_058180 ENST00000417060 54058 chromosome chr21:4773141 NM_058180 THC2482412 Hs.236572 some 21 open reading 21 open 7-47722479 frame 58 (C21orf58), reading mRNA [NM_058180] frame 58 A_33_P3305790 NOS3 Homo sapiens nitric NM_000603 ENST00000461406 4846 nitric oxide chr7:15071149 GO:0005516|GO:0014070| NM_000603 THC2520376 Hs.647092 oxide synthase 3 synthase 3 5-150711554 GO:0009408|GO:0010181| (endothelial cell) (endothelial GO:0034405|GO:0043267| (NOS3), transcript cell) GO:0006809|GO:0050880| variant 1, mRNA GO:0032496|GO:0051926| [NM_000603] GO:0005856|GO:0031663| GO:0032355|GO:0003100| GO:0010288|GO:0005794| GO:0051346|GO:0007568| GO:0005509|GO:0014806| GO:0001542|GO:0004517| GO:0043542|GO:0055094| GO:0055093|GO:0002028| GO:0016491|GO:0008270| GO:0031284|GO:0007005| GO:0055114|GO:0020037| GO:0050661|GO:0010544| GO:0005886|GO:0030324| GO:0045471|GO:0050660| GO:0043434|GO:0005634| GO:0046870|GO:0005829| GO:0005737|GO:0045909| GO:0006527|GO:0034097| GO:0043200|GO:0001666| GO:0042493|GO:0005730| GO:0045177|GO:0048662| GO:0006916|GO:0005625| GO:0045766|GO:0003785| GO:0007165|GO:0000139| GO:0014740|GO:0034618| GO:0001974|GO:0005901| GO:0034617|GO:0008217 A_23_P352291 SRSF10 Homo sapiens serine/ NM_054016 ENST00000374449 10772 serine/ chr1:24296306- GO:0000244|GO:0008380| NM_054016 THC2468077 Hs.3530 arginine-rich splicing arginine-rich 24296247 GO:0048025|GO:0003723| factor 10 (SRSF10), splicing GO:0006376|GO:0005634| transcript variant 2, factor 10 GO:0050733|GO:0005737| mRNA [NM_054016] GO:0006406|GO:0000166| GO:0016607|GO:0016482| GO:0005654|GO:0051082| GO:0045440 A_33_P3389342 ARID5A Homo sapiens AT NM_212481 ENST00000359765 10865 AT rich chr2:97216361- GO:0016564|GO:0005622| NM_212481 THC2627646 Hs.920 rich interactive domain interactive 97216420 GO:0005634|GO:0045892| 5A (MRFl-like) domain 5A GO:0003677|GO:0045449 (ARID5A), mRNA (MRFl-like) [NM_212481] A_33_P3285371 chr1:20446213 5-204462076 A_33_P3386132 C2orf49 chromosome 2 open AK304268 ENST00000437250 79074 chromosome chr2:10596199 THC2507880 Hs.549577 reading frame 49 2 open 2-105962051 [Source: HGNC reading frame Symbol; Acc: 28772] 49 [ENST00000437250] A_33_P3252181 cDNA FLJ40032 fis, AK097351 ENST00000358234 chr19:4983156 THC2482392 Hs.660609 clone STOMA2009256 3-49831504 [Source: UniProtKB/ TrEMBL; Acc: Q8N843] [ENST00000358234] A_23_P28334 IL18RAP Homo sapiens inter- NM_003853 ENST00000264260 8807 interleukin 18 chr2:10306888 GO:0006954|GO:0016020| NM_003853 THC2478417 Hs.158315 leukin 18 receptor receptor 5-103068944 GO:0045087|GO:0016021| accessory protein accessory GO:0007166|GO:0004888 (IL18RAP), mRNA protein [NM_003853] A_33_P3363100 chr6:02994291 1-029942852 A_33_P3261074 chr22:0186669 07-018666848 A_23_P129829 ORMDL3 Homo sapiens ORM1- NM_139280 ENST00000304046 94103 ORM1-like chr17:3807755 GO:0016020|GO:0005783| NM_139280 THC2461115 Hs.514151 like 3 (S. cerevisiae) 3 (S. cerevisiae) 8-38077499 GO:0016021 (ORMDL3), mRNA [NM_139280] A_32_P163533 ZNF322A Homo sapiens zinc NM_001242797 ENST00000375210 79692 zinc finger chr6:26637056- GO:0005622|GO:0008270| NM_001242797 THC2470822 Hs.126280 finger protein 322A protein 322A 26636997 GO:0005634|GO:0003677| (ZNF322A), GO:0046872|GO:0045449 transcript variant 1, mRNA [NM_001242797] A_33_P3423721 JPH3 junctophilin 3 AB593088 ENST00000301008 57338 junctophilin 3 chr16:8763792 THC2485118 Hs.592068 [Source: HGNC 2-87637981 Symbol; Acc: 14203] [ENST00000301008] A_23_P10194 SEZ6L2 Homo sapiens seizure NM_201575 ENST00000537485 26470 seizure related chr16:2988291 GO:0005886|GO:0005783| NM_201575 NP160855 Hs.6314 related 6 homolog 6 homolog 8-29882859 GO:0016021 (mouse)-like 2 (mouse)-like 2 (SEZ6L2), transcript variant 2, mRNA [NM_201575] A_33_P3363254 chr2:13144981 6-131449757 A_33_P3284888 DLEU7 Homo sapiens deleted NM_198989 ENST00000335465 220107 deleted in chr13:5141738 NM_198989 THC2485203 Hs.710878 in lymphocytic lymphocytic 4-51417325 leukemia, 7 (DLEU7), leukemia, 7 mRNA [NM_198989] A_33_P3263747 A_33_P3219303 CEL Homo sapiens car- NM_001807 ENST00000303626 1056 carboxyl ester chr9:13594709 GO:0006707|GO:0004806| NM_001807 THC2462969 Hs.533258 boxyl ester lipase lipase (bile 2-135947151 GO:0005576|GO:0030157| (bile salt-stimulated salt-stimulated GO:0018350|GO:0009062| lipase) (CEL), mRNA lipase) GO:0016042|GO:0030299| [NM_001807] GO:0005737|GO:0016787| GO:0047372|GO:0006641| GO:0046514|GO:0044258| GO:0008201|GO:0004771 A_33_P3289860 Homo sapiens BX648603 chr18:4808702 THC2652919 Hs.433728 mRNA; cDNA 4-48087083 DKFZp686G10213 (from clone DKFZp686G10213). [BX648603] A_23_P360804 CPNE5 Homo sapiens copine NM_020939 ENST00000244751 57699 copine V chr6:36708629- GO:0043005|GO:0043025 NM_020939 THC2464138 Hs.657869 V (CPNE5), mRNA 36708570 [NM_020939] A_33_P3301306 MLL3 Homo sapiens myeloid/ NM_170606 ENST00000355193 58508 myeloid/ chr7:15183208 GO:0005515|GO:0007242| NM_170606 THC2469247 Hs.647120 lymphoid or mixed- lymphoid or 9-151832030 GO:0006355|GO:0008168| lineage leukemia 3 mixed-lineage GO:0008270|GO:0005634| (MLL3), mRNA leukemia 3 GO:0003677|GO:0046872| [NM_170606] GO:0016740|GO:0018024| GO:0016568 A_33_P3333107 chr16:0856137 THC2764040 22-085613663 A_24_P191013 CYP4A11 Homo sapiens cyto- NM_000778 ENST00000371905 1579 cytochrome chr1:47398708- GO:0008393|GO:0005792| NM_000778 NP175000 Hs.1645 chrome P450, family P450, family 47398504 GO:0005783|GO:0018685| 4, subfamily A, 4, subfamily GO:0009055|GO:0046872| polypeptide 11 A, poly- GO:0016020|GO:0019825| (CYP4A11), mRNA peptide 11 GO:0005789|GO:0006631| [NM_000778] GO:0019898|GO:0020037| GO:0055114 A_23_P89780 LAMA3 Homo sapiens laminin, NM_198129 ENST00000416669 3909 laminin, chr18:2153473 GO:0045995|GO:0030334| NM_198129 THC2461199 Hs.436367 alpha 3 (LAMA3), alpha 3 5-21534794 GO:0008544|GO:0005198| transcript variant 1, GO:0005102|GO:0005606| mRNA [NM_198129] GO:0005576|GO:0030155| A_33_P3283400 LOC100507747 PREDICTED: XM_003119562 100507747 hypothetical GO:0005604 XM_003119562 THC2482547 Hs.704267 Homo sapiens hypo- protein thetical protein LOC100507747 LOC100507747 (LOC100507747), mRNA [XM_003119562] A_33_P3214012 HMGCLL1 Homo sapiens 3- NM_019036 ENST00000370852 54511 3-hydrox- chr6:55360319- GO:0008152|GO:0046872| NM_019036 THC2474902 Hs.147054 hydroxymethyl-3- methyl-3- 55360260 GO:0016829|GO:0004419 methylglutaryl-CoA methylglutaryl- lyase-like 1 CoA lyase-like 1 (HMGCLL1), transcript variant 1, mRNA [NM_019036] A_24_P104512 EVPL Homo sapiens envo- NM_001988 ENST00000301607 2125 envoplakin chr17:7400306 GO:0030057|GO:0005737| NM_001988 THC2471184 Hs.500635 plakin (EVPL), mRNA 7-74003008 GO:0030054|GO:0018149| [NM_001988] GO:0008544|GO:0005198| GO:0031424|GO:0030674| GO:0001533 A_23_P143713 APOBEC3G Homo sapiens apoli- NM_021822 ENST00000480000 60489 apolipoprotein chr22:3947748 GO:0030895|GO:0005515| NM_021822 THC2677649 Hs.660143 poprotein B mRNA B mRNA 1-39477540 GO:0003723|GO:0016553| editing enzyme, editing enzyme, GO:0045869|GO:0005730| catalytic polypep- catalytic poly- GO:0048525|GO:0005634| tide-like 3G peptide-like 3G GO:0006410|GO:0009615| (APOBEC3G), GO:0046872|GO:0042803| mRNA [NM_021822] GO:0005829|GO:0005739| GO:0005737|GO:0016787| GO:0045087|GO:0044419| GO:0002230|GO:0004126| GO:0008270 A_33_P3396891 AVPI1 Homo sapiens arginine NM_021732 ENST00000370626 60370 arginine chr10:9943752 GO:0007049 NM_021732 THC2602356 Hs.23918 vasopressin-induced 1 vasopressin- 1-99437462 (AVPI1), mRNA induced 1 [NM_021732] A_23_P202034 GUCY2GP Homo sapiens NR_028134 ENST00000490269 390003 guanylate chr10:1140740 NR_028134 THC2662526 guanylate cyclase 2G cyclase 2G 88-114074029 homolog (mouse), homolog pseudogene (GUCY2GP), (mouse), non-coding RNA pseudogene [NR_028134] A_33_P3589819 LOC100507637 Homo sapiens cDNA: AK026502 100507637 hypothetical chr22:2711755 THC2515177 Hs.730728 FLJ22849 fis, clone LOC100507637 5-27117614 KAIA987. [AK026502] A_33_P3495962 SNORA71A AGENCOURT BM918074 26777 small nucleolar chr20:3705497 Hs.681779 NIH_MGC_106 RNA, H/ACA 6-37054917 Homo sapiens cDNA box 71A clone IMAGE: 66113255485440 5′, mRNA sequence [BM918074] A_33_P3416622 NCRNA00322 PREDICTED: XR_109689 100126693 non-protein chr21:4474863 XR_109689 THC2482602 Hs.473952 Homo sapiens chromo- coding 7-44748578 some 21 open reading RNA 322 frame 136 (C21orf136), miscRNA[XR_109689] A_23_P88351 ATL1 Homo sapiens atlastin NM_181598 ENST00000441560 51062 atlastin chr14:5109505 GO:0030424|GO:0005792| NM_181598 THC2609154 Hs.584905 GTPase 1 (ATL1), GTPase 1 0-51095109 GO:0008219|GO:0005794| transcript variant 2, GO:0005783|GO:0003924| mRNA [NM_181598] GO:0007409|GO:0005525| GO:0042802|GO:0000137| GO:0000166|GO:0016020| GO:0005789|GO:0051260| GO:0016021|GO:0007029 A_23_P368484 C17orf76 Homo sapiens chromo NM_207387 ENST00000409887 388341 chromosome chr17:1634542 NM_207387 THC2473528 Hs.25425 some 17 open reading 17 open 8-16345369 frame 76 (C17orf76), reading transcript variant 2, frame 76 mRNA [NM_207387] A_24_P151032 MYL4 Homo sapiens myosin, NM_002476 ENST00000354968 4635 myosin, light chr17:4528675 GO:0005509|GO:0016459| NM_002476 NP093155 Hs.463300 light chain 4, alkali; chain 4, alkali; 8-45286817 GO:0032781|GO:0060048| atrial, embryonic atrial, GO:0003785|GO:0003774| (MYL4), transcript embryonic GO:0007517|GO:0051015| variant 2, mRNA GO:0002026|GO:0032038| [NM_002476] GO:0005859|GO:0008307| GO:0031672 A_33_P3241786 ADD2 Homo sapiens adducin NM_017482 ENST00000413157 119 adducin chr2:70902283- GO:0030097|GO:0005516| NM_017482 NP1475291 Hs.188528 2 (beta) (ADD2), 2 (beta) 70902224 GO:0030036|GO:0046982| transcript variant 2, GO:0005886|GO:0030507| mRNA [NM_017482] GO:0042803|GO:0046872| GO:0032092|GO:0051016| GO:0005737|GO:0051015| GO:0005198|GO:0008290| GO:0005856|GO:0051017| GO:0006811 A_33_P3342862 ZNF664- Homo sapiens NM_001204299 ENST00000324038 100533183 ZNF664- chr12:1247992 NM_001204299 THC2471258 Hs.432901 FAM101A ZNF664-FAM101A FAM101A 28-124799287 readthrough readthrough (ZNF664-FAM101A), mRNA [NM_001204299] A_33_P3380982 TMEM30A Homo sapiens trans- NM_018247 ENST00000545449 55754 transmembrane chr6:75962725 GO:0016020|GO:0016021 NM_018247 THC2654263 Hs.108530 membrane protein 30A protein 30A 75962666 (TMEM30A), transcript variant 1, mRNA [NM_018247] A_33_P3289246 immunoglobulin GQ232935 ENST00000390600 chr14:1065523 NP104532 Hs.720841 heavy variable 3-9 43-106552285 [Source: HGNC Symbol; Acc: 5628] [ENST00000390600] A_24_P393611 GNAO1 Homo sapiens guanine NM_138736 ENST00000262494 2775 guanine chr16:5637482 GO:0014070|GO:0042542| NM_138736 THC2495079 Hs.644524 nucleotide binding nucleotide 3-56374882 GO:0005886|GO:0031852| protein (G protein), binding GO:0003924|GO:0032403| alpha activating activity GO:0031175|GO:0006936| polypeptide 0 (GNAO1), GO:0000166|GO:0051926| transcript variant 2, GO:0004871|GO:0019717| mRNA [NM_138736] GO:0034097|GO:0042493| GO:0007568|GO:0010243| GO:0043278|GO:0005525| GO:0043547|GO:0007165| GO:0043234|GO:0019001| GO:0007186|GO:0031821| GO:0030900 A_33_P3391536 chr7:02647020 1-026470260 A_33_P3292164 KRTAP9-7 keratin associated XM_003120879 ENST00000391354 100505724 keratin chr17:3943226 GO:0045095 XM_003120879 protein 9-7 [Source: associated 4-39432323 HGNC Symbol; protein 9-7 Acc: 18915] [ENST00000391354] A_23_P72668 SDPR Homo sapiens serum NM_004657 ENST00000304141 8436 serum chr2:19270016 GO:0005515|GO:0005737| NM_004657 THC2461139 Hs.26530 deprivation response deprivation 1-192700102 GO:0016020|GO:0005901| (SDPR), mRNA response GO:0001786|GO:0005829 [NM_004657] A_33_P3362301 HSP90AA5P Homo sapiens heat AY956761 730211 heat shock pro- chr3:18383559 NP1455480 Hs.581644 shock protein 90Ae tein 90 kDa alpha 5-183835654 (HSP90Ae) mRNA, (cytosolic), class complete cds. A member [AY956761] 5, pseudogene A_33_P3323559 CRYAA Homo sapiens crystallin, NM_000394 ENST00000291554 1409 crystallin, chr21:4458928 GO:0005212|GO:0032387| NM_000394 THC2468650 Hs.184085 alpha A (CRYAA), alpha A 5-44589344 GO:0009408|GO:0006916| mRNA [NM_000394] GO:0042026|GO:0005737| GO:0070309|GO:0051260| GO:0007015|GO:0043010| GO:0007005|GO:0051082| GO:0000072|GO:0007601| GO:0050896 A_33_P3286929 chr15:0327813 87-032781328 A_33_P3292241 chr8:02784745 6-027847515 A_33_P1227467 BNIP2 Homo sapiens BCL2/ NM_004330 ENST00000267859 663 BCL2/ chr15:5995515 GO:0005515|GO:0048471| NM_004330 THC2496581 Hs.646490 adenovirus E1B 19 kDa adenovirus E1B 4-59955095 GO:0005737|GO:0005509| interacting protein 2 19 kDa GO:0006915|GO:0006916| (BNIP2), mRNA interacting GO:0005635|GO:0043231| [NM_004330] protein 2 GO:0005096 A_33_P3382489 ENST00000429878 chr2:12006351- THC2657735 12006410 A_33_P3224020 ARAF2P Homo sapiens v-raf BC033982 644000 v-raf murine chr7:62865027- THC2605425 murine sarcoma 3611 sarcoma 3611 62864968 viral oncogene homolog viral oncogene pseudogene, mRNA homolog 2, (cDNA clone IMAGE: pseudogene 5295529). [BC033982] A 23_P58482 MGAT1 Homo sapiens man- NM_002406 ENST00000446023 4245 mannosyl chr5:18021807 GO:0003827|GO:0005794| NM_002406 THC2470078 Hs.519818 nosyl (alpha-l,3-)- (alpha-1,3-)- 8-180218019 GO:0016020|GO:0000139| glycoprotein beta-l,2-N- glycoprotein GO:0016757|GO:0005975| acetylglucosaminyl- beta 1,2-N- GO:0016021|GO:0006487 transferase (MGAT1), acetylglucosa- transcript variant 2, minyltransferase mRNA [NM_002406] A_23_P214026 FBN2 Homo sapiens fibrillin NM_001999 ENST00000508053 2201 Fibrillin 2 chr5:12759423 GO:0005488|GO:0005509| NM_001999 THC2749486 Hs.519294 2 (FBN2), mRNA 2-127594173 GO:0005578|GO:0005576| [NM_001999] GO:0030326|GO:0009653| GO:0005201 A_33_P3387696 TMBIM4 Homo sapiens trans- NM_016056 ENST00000358230 51643 transmem- chr12:6653079 GO:0005515|GO:0016020| NM_016056 THC2544517 Hs.505934 membrane BAX brane BAX 2-66530733 GO:0016021 inhibitor motif con- inhibitor taining 4 (TMBIM4), motif con- mRNA [NM_016056] taining A A_24_P943472 NR1D2 Homo sapiens nuclear NM_005126 9975 nuclear chr3:24021460- GO:0043565|GO:0006355| NM_005126 THC2601359 Hs.37288 receptor subfamily 1, receptor 24021519 GO:0003700|GO:0003707| group D, member 2 subfamily 1, GO:0008270|GO:0005634| (NR1D2), transcript group D, GO:0046872 variant 1, mRNA member 2 [NM_005126] A_33_P3303463 LOC100128348 Homo sapiens cDNA AK128128 100128348 hypothetical chr16:3334756 Hs.637572 FLJ46249 fis, clone protein 6-33347507 TESTI4021377. LOC100128348 [AK128128] A_23_P145501 MED23 Homo sapiens mediator NM_004830 ENST00000545957 9439 mediator chr6:13190790 GO:0005515|GO:0005667| NM_004830 THC2620147 Hs.29679 complex subunit 23 complex 1-131907873 GO:0006367|GO:0006357| (MED23), transcript subunit 23 GO:0030528|GO:0003713| variant 1, mRNA GO:0005634 [NM_004830] A_33_P3325336 chrX:09764467 3-097644732 A_23_P13294 OR1S2 Homo sapiens ol- NM_001004459 ENST00000302592 219958 olfactory chr11:5797156 GO:0007608|GO:0007165| NM_001004459 THC2603194 Hs.553644 factory receptor, family receptor, 9-57971510 GO:0004984|GO:0007186| 1, subfamily S, family 1, GO:0005886|GO:0004872| member 2 (OR1S2), subfamily S, GO:0016021|GO:0050896 mRNA [NM_001004459] member 2 A_23_P163025 RNASE3 Homo sapiens ribo- NM_002935 ENST00000304639 6037 ribonuclease, chr14:2135959 GO:0004519|GO:0016787| NM_002935 THC2477182 Hs.73839 nuclease, RNase A RNase A 1-21359880 GO:0005625|GO:0005576| family, 3 (RNASE3), family, 3 GO:0004540|GO:0004522| mRNA [NM_002935] GO:0003676|GO:0042742| GO:0006401 A_24_P333993 OR2W3 Homo sapiens ol- NM_001001957 ENST00000360358 343171 olfactory chr1:24805952 GO:0007608|GO:0007165| NM_001001957 THC2480700 Hs.269151 factory receptor, family receptor, 0-248059579 GO:0004984|GO:0007186| 2, subfamily W, family 2, GO:0005886|GO:0004872| member 3 (OR2W3), subfamily W, GO:0016021|GO:0050896 mRNA [NM_001001957] member 3 A_23_P51679 MEF2D Homo sapiens myocyte NM_005920 ENST00000464356 4209 myocyte chr1:15643664 GO:0005515|GO:0006355| NM_005920 THC2462787 Hs.314327 enhancer factor 2D enhancer 4-156436585 GO:0003700|GO:0016563| (MEF2D), mRNA factor 2D GO:0005730|GO:0006915| [NM_005920] GO:0005634|GO:0007275| GO:0001649|GO:0007399| GO:0043565|GO:0001958| GO:0005737|GO:0007517| GO:0002062 A_24_P173566 immunoglobulin lambda X57818 ENST00000390319 chr22:2322330 NP1458222 Hs.449585 variable 3-1 [Source: 8-23223367 HGNC Symbol; Acc: 5896] [ENST00000390319] A_24_P11436 TTC22 Homo sapiens tetra- NM_017904 ENST00000488771 55001 tetratrico- chr1:55251801- GO:0005488 NM_017904 THC2655240 Hs.16230 tricopeptide repeat peptide 55251742 domain 22 (TTC22), repeat transcript variant 2, domain 22 mRNA [NM_017904] A_32_P66881 TLR4 Homo sapiens toll- NM_138554 7099 toll-like chr9:12047923 GO:0005515|GO:0032755| NM_138554 THC2629156 Hs.174312 like receptor 4 (TLR4), receptor 4 6-120479295 GO:0048471|GO:0005886| transcript variant 1, GO:0045471|GO:0046330| mRNA [NM_138554] GO:0001875|GO:0050731| GO:0032874|GO:0042088| GO:0002537|GO:0005737| GO:0051092|GO:0010572| GO:0032497|GO:0002282| GO:0070374|GO:0032609| GO:0043123|GO:0006979| GO:0046696|GO:0043065| GO:0032760|GO:0070434| GO:0045416|GO:0042535| GO:0045671|GO:0070430| GO:0002224|GO:0050829| GO:0007165|GO:0045084| GO:0042116|GO:0005887| GO:0052033|GO:0045087| GO:0050729|GO:0045121| GO:0016046|GO:0009897| GO:0004888|GO:0043548 A_33_P3253672 KCNH3 Homo sapiens potas- NM_012284 ENST00000257981 23416 potassium chr12:4995200 GO:0006355|GO:0000160| NM_012284 Hs.64064 sium voltage-gated voltage- 0-49952059 GO:0005244|GO:0016020| channel, subfamily H gated GO:0005249|GO:0030955| (eag-related), member channel, GO:0016021|GO:0055085| 3 (KCNH3), mRNA subfamily GO:0006813|GO:0000155| [NM_012284] H (eag- GO:0006811 related), member 3 A_23_P309701 PTPN2 Homo sapiens protein NM_002828 ENST00000309660 5771 protein chr18:1279403 GO:0008286|GO:0005515| NM_002828 THC2475995 Hs.654527 tyrosine phosphatase, tyrosine 9-12793980 GO:0005737|GO:0006470| non-receptor type 2 phosphatase, GO:0016787|GO:0004726 (PTPN2), transcript non-receptor variant 1, mRNA type 2 [NM_00282R] A_33_P3410206 C16orf7 Homo sapiens chromo- NM_004913 ENST00000261625 9605 chromosome chr16:8977724 GO:0005215|GO:0015986 NM_004913 THC2472575 Hs.164410 some 16 open reading 16 open 1-89777182 frame 7 (C16orf7), reading mRNA [NM_004913] frame 7 A_33_P3261953 chr19:0227911 81-022791240 A_23_P63379 CA14 Homo sapiens car- NM_012113 ENST000003691H 23632 carbonic chr1:15023736 GO:0016020|GO:0008270| NM_012113 THC2471240 Hs.528988 bonic anhydrase XIV anhydrase 9-150237428 GO:0016021|GO:0004089| (CA14), mRNA XIV GO:0046872|GO:0016829 [NM_012113] A_33_P3287348 CHN2 Homo sapiens chimerin NM_004067 ENST00000409041 1124 chimerin chr7:29553778- GO:0005622|GO:0005515| NM_004067 THC2463843 Hs.654611 (chimaerin) 2 (CHN2), (chimaerin) 2 29553837 GO:0007242|GO:0016020| transcript variant 2, GO:0005070|GO:0008270| mRNA [NM_004067] GO:0046872|GO:0019898| GO:0005096 A_33_P3364293 LOC389834 Homo sapiens ankyrin NR_027420 389834 ankyrin chr21:9921746- NR_027420 THC2474667 Hs.720653 repeat domain 57 repeat 9921687 pseudogene (LOC389834), domain 57 non-coding RNA pseudogene [NR_027420] A_23_P390734 FGFR1OP2 Homo sapiens FGFR1 NM_015633 ENST00000229395 26127 FGFR1 chr12:2711878 GO:0005737 NM_015633 THC2462507 Hs.591162 oncogene partner 2 oncogene 8-27118847 (FGFR1OP2), transcript partner 2 variant 1, mRNA [NM_015633] A_33_P3267640 HGFAC Homo sapiens HGF NM_001528 ENST00000382774 3083 HGF chr4:3451154- GO:0005515|GO:0004252| NM_001528 THC2478808 Hs.104 activator (HGFAC), activator 3451213 GO:0006508|GO:0008233| mRNA [NM_001528] GO:0005576|GO:0005615 A_33_P3362249 Homo sapiens cDNA AK128836 ENST00000434161 chr7:56877663- THC2481823 Hs.520384 FLJ46348 fis, clone 56877604 TESTI4047569. [AK128836] A_23_P158880 STARD5 Homo sapiens StAR- NM_181900 ENST00000325346 80765 StAR- chr15:8160526 GO:0006694|GO:0006869| NM_181900 THC2474209 Hs.513075 related lipid transfer related lipid 2-81605203 GO:0008289|GO:0005829 (START) domain transfer containing 5 (STARD5), (START) mRNA [NM_181900] domain containing 5 A_33_P3262156 SLC8A1 Homo sapiens solute NM_021097 ENST00000403092 6546 solute carrier chr2:40342452- GO:0060401|GO:0005516| NM_021097 THC2483436 Hs.468274 carrier family 8 family 8 40342393 GO:0042542|GO:0031402| (sodium/calcium ex- (sodium/ GO:0005432|GO:0007204| changer), member 1 calcium ex- GO:0007154|GO:0006936| (SLC8A1), transcript changer), GO:0015297|GO:0031072| variant A, mRNA member 1 GO:0051924|GO:0033198| [NM_021097] GO:0006811|GO:0001666| GO:0007584|GO:0042493| GO:0005509|GO:0006874| GO:0015085|GO:0005624| GO:0030315|GO:0015081| GO:0055085|GO:0009749| GO:0005887|GO:0002026| GO:0005901|GO:0002028 A_32_P44394 AIM2 Homo sapiens absent NM_004833 ENST00000368130 9447 absent in chr1:15903336 GO:0005515|GO:0006955| NM_004833 THC2474709 Hs.281898 in melanoma 2 melanoma 2 5-159033306 GO:0005634 (AIM2), mRNA [NM_004833] A_33_P3402257 LOCI00508241 PREDICTED: XM_003119499 ENST00000529108 100508241 membrane- chr11:6051140 XM_003119499 THC2717961 Hs.326275 Homo sapiens mem- spanning 4- 8-60511467 brane-spanning 4- domains domains subfamily A subfamily A member 18-like member 18 (LOC100508241), like mRNA [XM_003119499] A_33_P3344618 TFEB Homo sapiens trans- NM_007162 ENST00000373033 7942 transcription chr6:41651777 GO:0005667|GO:0005737| NM_007162 THC2463798 Hs.48536 cription factor EB factor EB 41651718 GO:0003700|GO:0006959| (TFEB), transcript GO:0010843|GO:0001892| variant 1, mRNA GO:0010552|GO:0005634| [NM_007162] GO:0045893 A_33_P3331237 G3BP1 GTPase activating pro- ENST00000394123 10146 GTPase chr5:15119228 GO:0005515|GO:0005886| THC2711864 tein (SH3 domain) activating 2-151192341 GO:0003723|GO:0004386| binding protein 1 protein GO:0007265|GO:0005634| [Source: HGNC (SH3 GO:0003677|GO:0005524| Symbol; Acc: 30292] domain) GO:0005829|GO:0004004| [ENST00000394123] binding GO:0005622|GO:0005737| protein 1 GO:0004003|GO:0004519| GO:0016787|GO:0000166| GO:0006810 A_33_P3370029 T cell receptor gamma S60780 ENST00000390340 chr7:38331276- THC2547979 Hs.534032 variable 11 (non-functional) 38331217 [Source: HGNC Symbol; Acc: 12286] [ENST00000390340] A_33_P3321678 RNF180 ring finger protein AK090756 ENST00000381081 285671 ring finger chr5:63513485 THC2478341 Hs.657843 180 [Source: HGNC protein 180 63513544 Symbol; Acc: 27752] [ENST00000381081] A_33_P3265504 EIF5AL1 Homo sapiens eukaryotic NM_001099692 ENST00000520547 143244 eukaryotic chr10:8200371 GO:0008612|GO:0005783| NM_001099692 THC2684242 Hs.104825 translation initiation translation 2-82003653 GO:0003723|GO:0005634| factor 5A-like 1 initiation GO:0003746|GO:0015031| (EIF5AL1), mRNA factor GO:0055085|GO:0006412| [NM_001099692] 5A-like 1 GO:0045905|GO:0005737| GO:0006452|GO:0016020| GO:0005643|GO:0043022| GO:0051028|GO:0045901 A_23_P74278 PDE4B Homo sapiens phos- NM_001037341 ENST00000329654 5142 phospho- chr1:66839789- GO:0007165|GO:0016787| NM_001037341 THC2477454 Hs.198072 phodiesterase 4B, diesterase 66839848 GO:0004115|GO:0005625| cAMP-specific 4B, cAMP- GO:0005626|GO:0005829 (PDE4B), transcript specific variant d, mRNA [NM_001037341] A_33_P3216532 EPHB4 Homo sapiens EPH NM_004444 ENST00000487222 2050 EPH chr7:10040059 GO:0005515|GO:0009986| NM_004444 NP1473086 Hs.437008 receptor B4 (EPHB4), receptor 0-100400531 GO:0008283|GO:0045765| mRNA [NM_004444] B4 GO:0005524|GO:0005003| GO:0000166|GO:0016020| GO:0005887|GO:0009887| GO:0004872|GO:0006468| GO:0007169|GO:0016740 A_33_P3422499 chr1:04690206 THC2704282 6-046902125 A_23_P20075 NPC1L1 Homo sapiens NPC1 NM_013389 ENST00000289547 29881 NPC1 chr7:44552449- GO:0042632|GO:0030299| NM_013389 THC2474926 Hs.567486 (Niemann-Pick disease, (Niemann- 44552390 GO:0006629|GO:0006695| type C1, gene) like Pick disease, GO:0005886|GO:0042157| 1 (NPC1L1), transcript type C1, GO:0008158|GO:0031410| variant 1, mRNA gene)-like 1 GO:0016021|GO:0008202 [NM_013389] A_23_P38952 ACER1 Homo sapiens alkaline NM_133492 ENST00000301452 125981 alkaline chr19:6312480- GO:0006665|GO:0017040| NM_133492 THC2490357 Hs.352609 ceramidase 1 (ACER1), ceramidase 6312421 GO:0016787|GO:0016020| mRNA [NM_133492] 1 GO:0000139|GO:0005783| GO:0005789|GO:0046514| GO:0016021|GO:0019216 A_33_P3241250 Homo sapiens cDNA AK128836 ENST00000434161 chr7:56876826- THC2481823 Hs.520384 FLJ46348 fis, clone 56876817 TESTI4047569. [AK128836] A_23_P394605 SEC24A Homo sapiens SEC24 NM_021982 ENST00000398844 10802 SEC24 chr5:13406322 GO:0005515|GO:0048471| NM_021982 THC2493017 Hs.595540 family, member A family, 3-134063282 GO:0030127|GO:0005794| (S. cerevisiae) (SEC24A), member A GO:0005783|GO:0006886| mRNA [NM_021982] (S. cerevisiae) GO:0006888|GO:0003674| GO:0005737|GO:0000139| GO:0016020|GO:0005789| GO:0008270|GO:0016192| GO:0016044 A_32_P112910 UBL4B Homo sapiens ubi- NM_203412 ENST00000334179 164153 ubiquitin- chr1:11065566 GO:0005737 NM_203412 THC2477239 Hs.374027 quitin-like 4B (UBL4B), like 4B 0-110655719 mRNA [NM_203412] A_23_P201951 ARID4B Homo sapiens AT NM_016374 ENST00000264183 51742 AT rich chr1:23533125 GO:0005622|GO:0008150| NM_016374 THC2490824 Hs.575782 rich interactive domain interactive 5-235331196 GO:0003674|GO:0005737| 4B (RBPl-like) domain 4B GO:0003682|GO:0005634| (ARID4B), transcript (RBP1-tike) GO:0005575|GO:0003677| variant 1, mRNA GO:0000785|GO:0045449| [NM_016374] GO:0006333 A_33_P3306287 METTL16 Homo sapiens methyl- NM_024086 ENST00000399834 79066 methyl- chr17:2371115 GO:0008168|GO:0016740 NM_024086 THC2487575 Hs.632237 transferase like 16 transferase 2371056 (METTL16), mRNA like 16 [NM_024086] A_32_P40547 MEG3 Homo sapiens mater- NR_002766 ENST00000452514 55384 maternally chr14:1012959 NR_002766 THC2722032 Hs.728839 nally expressed 3 expressed 3 74-101296033 (non-protein coding) (nonprotein (MEG3), transcript coding) variant 1, non-coding RNA [NR_002766] A_33_P3291772 chr18:0611640 87-061164146 A_33_P3356816 LCE1B Homo sapiens late NM_178349 ENST00000360090 353132 late cornified chr1:15278528 GO:0031424 NM_178349 Hs.375103 cornified envelope IB envelope 1B 0-152785339 (LCE1B), mRNA [NM_178349] A_23_P167599 FAM134B Homo sapiens family NM_001034850 ENST00000306320 54463 family with chr5:16473404 GO:0016020|GO:0016021 NM_001034850 THC2461507 Hs.662367 with sequence similarity sequence 16473345 134, member B similarity 134, (FAM134B), transcript member B variant 1, mRNA [NM_001034850] A_23_P122439 BTN2A2 Homo sapiens butyro- NM_181531 ENST00000416795 10385 butyrophilin, chr6:26394026- GO:0016020|GO:0016021 NM_181531 THC2612342 Hs.373938 philin, subfamily 2, subfamily 2, 26394085 member A2 (BTN2A2), member A2 transcript variant 2, mRNA [NM_181531] A_33_P3306802 LOC100130916 Homo sapiens clone AY358791 100130916 HSAL5836 chr9:99840523- THC2486676 Hs.655523 DNA131652 HSAL5836 99840464 (UNQ5836) mRNA, complete cds. [AY358791] A_33_P3340868 LOC643719 Homo sapiens hypo- NR_027620 643719 hypothetical chr19:3506786 NR_027620 THC2622807 Hs.686754 thetical LOC643719 LOC643719 9-35067810 (LOC643719), non-coding RNA [NR_027620] A_23_P169934 RILPL1 Homo sapiens Rab NM_178314 ENST00000376874 353116 Rab interacting chr12:1239569 GO:0005737|GO:0005829 NM_178314 THC2488648 Hs.530315 interacting lysosomal lysosomal 85-123956926 protein-like 1 protein- (RILPL1), mRNA like 1 [NM_178314] A_33_P3272663 PREDICTED: XM_003118587 chr7:95778898- XM_003118587 THC2486345 Hs.665212 Homo sapiens hypo- 95778839 thetical protein LOC100506093 (LOC100506093), mRNA [XM_003118587] A_23_P9485 ORM2 Homo sapiens oroso- NM_000608 ENST00000412657 5005 orosomucoid 2 chr9:11709390 GO:0005488|GO:0002682| NM_000608 THC2562815 Hs.719954 mucoid 2 (ORM2), 5-117094115 GO:0005576|GO:0006953| mRNA [NM_000608] GO:0005615 A_33_P3350892 LOC651337 PREDICTED: XM_003118884 651337 hypothetical chr9:14067970 XM_003118884 THC2482301 Hs.603195 Homo sapiens hypo- protein 1-140679642 thetical protein LOC651337 LOC100506062 (LOC100506062), mRNA [XM_003118884] A_23_P129413 DPEP3 Homo sapiens dipepti- NM_022357 ENST00000268793 64180 dipeptidase 3 chr16:6800964 GO:0016020|GO:0008235| NM_022357 THC2472083 Hs.302028 dase 3 (DPEP3), 0-68009581 GO:0006508|GO:0005624| transcript variant 1, GO:0008270|GO:0008233| mRNA [NM_022357] GO:0031225|GO:0008239| GO:0016805|GO:0046872 A_33_P3414202 MBNL3 Homo sapiens muscle- NM_001170704 ENST00000465964 55796 musclcblind chrX:13151629 GO:0005737|GO:0005794| NM_001170704 THC2608812 Hs.105134 blind-like 3 (Drosophila) like 3 5-131516236 GO:0005730|GO:0008270| (MBNL3), transcript (Drosophila) GO:0007275|GO:0005634| variant 6, mRNA GO:0003676|GO:0046872| [NM_001170704] GO:0045662 A_33_P3356792 GGT7 Homo sapiens gamma- NM_178026 ENST00000470952 2686 gamma- chr20:3343917 GO:0016020|GO:0003840| NM_178026 NP325734 Hs.433738 glutamyltransferase 7 glutamyl- 0-33439111 GO:0006750|GO:0016021| (GGT7), mRNA transferase 7 GO:0016740|GO:0008415 [NM_178026] A_33_P3223243 ST7L suppression of tumor- AK301869 ENST00000369664 54879 suppression chr1:11316068 THC2508274 Hs.201921 igenicity 7 like of tumorig- 9-113160630 [Source: HGNC enicity 7 like Symbol; Acc: 18441] [ENST00000369664] A_32_P72341 TRIM59 Homo sapiens tripartite NM_173084 ENST00000309784 286827 tripartite chr3:16015358 GO:0005622|GO:0005515| NM_173084 THC2525484 Hs.212957 motif containing 59 motif 5-160153526 GO:0016020|GO:0008270| (TRIM59), mRNA containing GO:0016021|GO:0046872 [NM_173084] 59 A_23_P168916 CA1 Homo sapiens carbonic NM_001738 ENST00000523022 759 carbonic chr8:86240793- GO:0005737|GO:0008270| NM_001738 THC2667429 Hs.23118 anhydrase 1 (CA1), antiydrase 1 86240734 GO:0004089|GO:0006730| transcript variant 2, GO:0046872|GO:0016829 mRNA [NM_001738] A_24_P189739 DUSP16 Homo sapiens dual NM_030640 ENST00000228862 80824 dual chr12:1262942 GO:0045209|GO:0005515| NM_030640 THC2463749 Hs.536535 specificity phosphatase 16 specificity 9-12629370 GO:0000188|GO:0005737| (DUSP16), mRNA phosphatase GO:0006470|GO:0016787| [NM_030640] 16 GO:0005634|GO:0045204| GO:0017017|GO:0004725 A_33_P3301075 immunoglobulin heavy XM_003120441 ENST00000390615 chr14:1068158 XM_003120441 NP240776 Hs.703889 variable 3-33 [Source: 14-106815755 HGNC Symbol; Acc: 5596] [ENST00000390615] A_32_P41553 C1orf182 Homo sapiens chromo- NM_144627 ENST00000466306 128229 chromosome chr1:15631671 NM_144627 NP397546 Hs.534539 some 1 open reading 1 open 1-156316770 frame 182 (C1orf182), reading mRNA [NM_144627] frame 182 A_24_P119685 OBSCN Homo sapiens obscurin, NM_052843 ENST00000284548 84033 obscurin, chr1:22854857 GO:0005515|GO:0008624| NM_052843 NP1165096 Hs.656999 cytoskeletal calmodulin cytoskeletal 6-228548635 GO:0030018|GO:0005886| and titin-interacting calmodulin GO:0035023|GO:0005634| RhoGEF (OBSCN), and titin- GO:0030016|GO:0030154| transcript variant 1, interacting GO:0005829|GO:0005622| mRNA [NM_052843] RhoGEF GO:0005085|GO:0005737| GO:0000166|GO:0005089| GO:0008307|GO:0000287| GO:0006915|GO:0007275| GO:0005524|GO:0031430| GO:0031432|GO:0004674| GO:0006468|GO:0004713| GO:0016740 A_23_P90997 OTOS Homo sapiens otospiralin NM_148961 ENST00000391989 150677 otospiralin chr2:24107867 GO:0007605|GO:0005576 NM_148961 THC2481051 Hs.148586 (OTOS), mRNA 3-241078614 [NM_148961] A_33_P3417281 MUC4 Homo sapiens mucin NM_018406 ENST00000479406 4585 mucin 4, chr3:19550636 GO:0005515|GO:0008150| NM_018406 THC2584230 Hs.369646 4, cell surface associated cell surface 9-195506310 GO:0005176|GO:0030197| (MUC4), transcript associated GO:0016020|GO:0007160| variant 1, mRNA GO:0005887|GO:0005578| [NM_018406] GO:0005576|GO:0007155 A_23_P18692 ADH5 Homo sapiens alcohol de- NM_000671 ENST00000296412 128 alcohol chr4:99992455- GO:0051409|GO:0045777| NM_000671 THC2465499 Hs.78989 hydrogenase 5 (class III), dehydrogenase 99992396 GO:0042803|GO:0046872| chi polypeptide (ADH5), 5 (class III), GO:0005739|GO:0004022| mRNA [NM_000671] chi polypeptide GO:0005737|GO:0003016| GO:0051287|GO:0051903| GO:0032496|GO:0005504| GO:0006069|GO:0009055| GO:0005625|GO:0018119| GO:0001523|GO:0035276| GO:0046294|GO:0005488| GO:0016491|GO:0051775| GO:0008270|GO:0018467| GO:0055114 A_33_P3274691 LOC619207 Homo sapiens scavenger NR_002934 ENST00000356567 619207 scavenger chr10:1352781 GO:0016020|GO:0005576| NR_002934 NP1076594 Hs.659384 receptor protein family receptor 88-135278247 GO:0005044 member (LOC619207), protein non-coding RNA family [NR_002934] member A_33_P3259423 WDR55 Homo sapiens WD NM_017706 ENST00000358337 54853 WD repeat chr5:14005049 GO:0008150|GO:0003674| NM_017706 THC2464522 Hs.286261 repeat domain 55 domain 55 4-140050553 GO:0005737|GO:0006364| (WDR55), mRNA GO:0005730|GO:0005634| [NM_017706] GO:0005575 A_33_P3380567 SHARPIN Homo sapiens NM_030974 ENST00000532536 81858 SHANK- chr8:14515359 GO:0005622|GO:0005737| NM_030974 THC2488562 Hs.529755 SHANK-associated RH associated 5-145153536 GO:0030262|GO:0008544| domain interactor RH domain GO:0031424|GO:0008270| (SHARPIN), transcript interactor GO:0007005|GO:0046872| variant 1, mRNA GO:0042802 [NM_030974] A_33_P3406281 SAMHD1 Homo sapiens SAM NM_015474 ENST00000262878 25939 SAM chr20:3552081 GO:0005622|GO:0051607| NM_015474 Hs.580681 domain and HD domain 8-35520759 GO:0016787|GO:0045088| domain 1 (SAMHD1), and HD GO:0005634 mRNA [NM_015474] domain 1 A_23_P87279 TRPM5 Homo sapiens transient NM_014555 ENST00000452833 29850 transient chr11:2427270- GO:0005244|GO:0005886| NM_014555 NP166373 Hs.272287 receptor potential cation receptor 2426786 GO:0004872|GO:0016021| channel, subfamily M, potential GO:0055085|GO:0006811 member 5 (TRPM5), cation channel, mRNA [NM_014555] subfamily M, member 5 A_24_P52921 BCAT1 Homo sapiens branched NM_005504 ENST00000544418 586 branched chr12:2499504 GO:0005737|GO:0000082| NM_005504 THC2739017 Hs.438993 chain amino-acid chain amino- 0-24989496 GO:0009082|GO:0008283| transaminase 1, acid trans GO:0004084|GO:0008152| cytosolic (BCAT1), aminase GO:0009083|GO:0016740| transcript variant 1, 1, cytosolic GO:0042802|GO:0005829 mRNA [NM_005504] A_33_P3441583 SRGAP2P1 AGENCOURT_6387596 BM453041 653464 SLIT-ROBO Hs.698027 NIH_MGC_71 Rho GTPase Homo sapiens cDNA activating clone IMAGE: 5529651 protein 2 5′, mRNA sequence pseudogene 1 [BM453041] A_23_P380240 CEACAM8 Homo sapiens carcino- NM_001816 ENST00000244336 1088 carcinoembry- chr19:4308456 GO:0006955|GO:0005886| NM_001816 THC2475392 Hs.41 embryonic antigen- onic antigen- 5-43084506 GO:0005887|GO:0031225| related cell adhesion related cell GO:0005615 molecule 8 (CEACAM8), adhesion mRNA [NM_001816] molecule 8 A_33_P3265941 chr5:01279430 1-012794242 A_33_P3291329 LOC100510004 PREDICTED: XM_003119032 100510004 hypothetical chr7:47093109- XM_003119032 Homo sapiens hypo- protein 47093168 thetical protein LOC100510004 LOC100510004 (LOC100510004), mRNA [XM_003119032] A_33_P3347772 2-Sep septin 2 [Source: HGNC AK025163 ENST00000473479 septin 2 chr2:24227551 THC2514366 Hs.335057 Symbol; Acc: 7729] 6-242275575 [ENST00000473479] A_23_P16110 OR7E24 Homo sapiens olfactory NM_001079935 ENST00000456448 26648 olfactory chr19:9362278- GO:0007608|GO:0007165| NM_001079935 THC2533847 Hs.129832 receptor, family 7, receptor, 9362337 GO:0004984|GO:0007186| subfamily E, family 7, GO:0005886|GO:0004872| member 24 (OR7E24), subfamily E, GO:0016021|GO:0050896 mRNA [NM_001079935] member 24 A_33_P3378383 DNM1P46 Homo sapiens DNM1 NR_003260 ENST00000455423 196968 DNM1 chr15:1003403 NR_003260 THC2485999 Hs.585319 pseudogene 46 (DNM1P46), pseudogene 50-100340291 non-coding RNA 46 [NR_003260] A_24_P944458 INSIG2 Homo sapiens insulin NM_016133 ENST00000471186 51141 insulin chr2:11886696 GO:0006629|GO:0005515| NM_016133 THC2461710 Hs.7089 induced gene 2 induced 4-118867023 GO:0016020|GO:0005783| (INSIG2), mRNA gene 2 GO:0032937|GO:0030967| [NM_016133] GO:0016021|GO:0008202| GO:0008203 A_33_P3326892 cDNA FLJ26718 fis, AK130228 ENST00000398957 chr3:47645495- NP852683 clone PNC03325 47645436 [Source: UniProtKB/ TrEMBL; Acc: Q6ZP17] [ENST00000398957] A_33_P3651948 NEO1 Homo sapiens neogenin NM_002499 ENST00000261908 4756 neogenin 1 chr15:7359601 GO:0005515|GO:0045296| NM_002499 THC2492572 Hs.388613 1 (NEO1), transcript 5-73596074 GO:0005886|GO:0005887| variant 1, mRNA GO:0030528|GO:0007520| [NM_002499] GO:0004872|GO:0007155| GO:0045449 A_33_P3302312 IER5L Homo sapiens imme- NM_203434 ENST00000372491 389792 immediate chr9:13193983 NM_203434 THC2464402 Hs.529857 diate early response 5- early response 2-131939773 like (IER5L), mRNA 5-like [NM_203434] A_33_P3334828 INSL3 Homo sapiens insulin- NM_005543 ENST00000379695 3640 insulin-like 3 chr19:1792738 GO:0005179|GO:0005158| NM_005543 NP881609 Hs.37062 like 3 (Leydig cell) (Leydig cell) 3-17927324 GO:0007267|GO:0005625| (INSL3), mRNA GO:0005576|GO:0007283| [NM_005543] GO:0004871 A_33_P3399788 SERPINA3 Homo sapiens serpin NM_001085 ENST00000380354 12 serpin peptidase chr14:9509033 GO:0005622|GO:0005515| NM_001085 THC2509353 Hs.534293 peptidase inhibitor, clade inhibitor, clade 0-95090389 GO:0006954|GO:0030277| A (alpha-1 antiproteinase, A (alpha-1 GO:0004867|GO:0005634| antitrypsin), member 3 antiproteinase, GO:0005576|GO:0006953| (SERPINA3), mRNA antitrypsin), GO:0030414|GO:0003677| [NM_001085] member 3 GO:0019216 A_24_P132633 C9orf71 Homo sapiens chromo- NM_153237 ENST00000377311 169693 chromosome chr9:71152330- GO:0016020|GO:0016021 NM_153237 THC2484013 Hs.663056 some 9 open reading 9 open 71152271 frame 71 (C9orf71), reading frame mRNA [NM_153237] 71 A_33_P3396010 AGER Homo sapiens advanced NM_001206966 ENST00000438221 177 advanced chr6:32149366- NM_001206966 NP868672 Hs.534342 glycosylation end product- glycosylation 32149307 specific receptor (AGER), end product- transcript variant 9, specific mRNA [NM_001206966] receptor A_24_P21831 ZNF26 Homo sapiens zinc NM_019591 ENST00000391574 7S74 zinc finger chr12:1335880 GO:0005622|GO:0006355| NM_019591 THC2477768 Hs.489608 finger protein 26 protein 26 1-133588060 GO:0008270|GO:0005634| (ZNF26), mRNA GO:0003677|GO:0046872 [NM_019591] A_33_P3247540 LOC389834 Homo sapiens ankyrin NR_027420 389834 ankyrin repeat chr21:9921687- NR_027420 THC2499620 Hs.720653 repeat domain 57 domain 57 9921628 pseudogene (LOC389834), pseudogene non-coding RNA [NR_027420] A_33_P3294252 ATF1 Homo sapiens activating NM_005171 ENST00000262053 466 activating chr12:5121484 GO:0043565|GO:0005667| NM_005171 THC2552669 Hs.648565 transcription factor 1 transcription 6-51214905 GO:0006355|GO:0003700| (ATF1), mRNA factor 1 GO:0046983|GO:0005634 [NM_005171] A_32_P86150 CTRB2 Homo sapiens chymo- NM_001025200 ENST00000303037 440387 chvmotryp- chr16:7523805 GO:0004252|GO:0007586| NM_001025200 THC2562346 Hs.632211 trypsinogen B2 sinogen B2 9-75238000 GO:0006508|GO:0008233| (CTRB2), mRNA GO:0005576|GO:0005615 [NM_001025200] A_33_P3314401 CLDN16 Homo sapiens claudin NM_006580 ENST00000264734 10686 claudin 16 chr3:19012821 GO:0007588|GO:0030054| NM_006580 THC2475714 Hs.251391 16 (CLDN16), mRNA 6-190128275 GO:0016338|GO:0000287| [NM_006580] GO:0005886|GO:0005198| GO:0015095|GO:0016021| GO:0006875|GO:0005923| GO:0042802|GO:0006811 A_33_P3220415 GALT galactose-l-phos- AK096026 ENST00000487381 2592 galactose-l- chr9:34648451- THC2504909 phate uridylyltransferase phosphate 34648510 [Source: HGNC uridylyl- Symbol; Acc: 4135] transferase [ENST00000487381] A_33_P3401571 MUC2 Homo sapiens mucin NM_002457 ENST00000359061 4583 mucin 2, chr11:1092337- GO:0005515|GO:0070703| NM_002457 THC2461569 Hs.315 2, oligomeric mucus/ oligomeric 1092396 GO:0070702|GO:0005576 gel-forming (MUC2), mucus/gel- mRNA [NM_002457] forming A_24_P322353 PSTPIP2 Homo sapiens proline- NM_024430 ENST00000495213 9050 proline-serine- chr18:4356441 GO:0005737|GO:0016020| NM_024430 THC2472686 Hs.567384 serine-threonine phos- threonine 7-43564358 GO:0005624|GO:0005856| phatase interacting phosphatase GO:0019898|GO:0005829 protein 2 (PSTPIP2), interacting mRNA [NM_024430] protein 2 A_33_P3270346 KIR2DL5A Homo sapiens killer NM_020535 ENST00000391731 57292 killer cell chr19_gl00020 GO:0005886|GO:0004872| NM_020535 THC2489091 Hs.676464 cell immunoglobulin-like immunoglobulin 9_random:897 GO:0016021 receptor, two domains, like receptor, 04-89763 long cytoplasmic tail, two domains, 5A (KIR2DL5A), long cytoplas- mRNA [NM_020535] mic tail, 5A A_23_P395911 FBXO17 Homo sapiens cDNA AK021860 115290 F-box protein chr19:3943663 THC2483169 Hs.531770 FLJ11798 fis, clone 17 6-39436577 HEMBA1006198. [AK021860] A_24_P38702 NKX2-3 Homo sapiens NK2 NM_145285 ENST00000344586 159296 NK2 homeo- chr10:1012929 GO:0003700|GO:0016563| NM_145285 NP1246719 Hs.243272 homeobox 3 (NKX2-3), box 3 09-101292968 GO:0005634|GO:0009791| mRNA [NM_145285] GO:0048536|GO:0050900| GO:0048535|GO:0006955| GO:0048541|GO:0042127| GO:0045944|GO:0030183| GO:0030225|GO:0022612| GO:0001776|GO:0048621| GO:0006355|GO:0043367| GO:0048565|GO:0005575| GO:0043565|GO:0008150| GO:0016333|GO:0002317| GO:0006641 A_33_P3416503 NUDT8 Homo sapiens nudix NM_181843 ENST00000534054 254552 nudix (nucleo- chr11:6739576 GO:0005739|GO:0030145| NM_181843 THC2604113 Hs.433329 (nucleoside diphosphate side diphos- 4-67395705 GO:0000287|GO:0016787 linked moiety X)- phate linked type motif 8 (NUDT8), moiety X)- mRNA [NM_181843] type motif 8 A_23_P58606 CCNG1 Homo sapiens cyclin NM_004060 ENST00000393929 900 cyclin G1 chr5:16287100 GO:0007067|GO:0007049| NM_004060 THC2516963 Hs.79101 G1 (CCNG1), 9-162871068 GO:0016049|GO:0005634| transcript variant 1, GO:0000079|GO:0051301 mRNA [NM_004060] A_33_P3222769 PRR25 Homo sapiens proline NM_001013638 ENST00000301698 388199 proline rich 25 chr16:863802- NM_001013638 NP366233 Hs.528461 rich 25 (PRR25), 863861 mRNA [NM_001013638] A_33_P3405004 NFXL1 Homo sapiens nuclear NM_152995 ENST00000464756 152518 nuclear chr4:47849447- GO:0005515|GO:0006355| NM_152995 THC2471778 Hs.646325 transcription factor, transcription 47849388 GO:0003700|GO:0016020| X-box bindinglike 1 factor, X- GO:0008270|GO:0005634| (NFXL1), mRNA box binding- GO:0016021|GO:0046872 [NM_152995] like 1 A_23_P346302 ZMAT2 Homo sapiens zinc NM_144723 ENST00000274712 153527 zinc finger, chr5:14008600 GO:0005622|GO:0008270| NM_144723 THC2468624 Hs.350194 finger, matrin-type 2 matrin-type 2 2-140086061 GO:0005634|GO:0003677| (ZMAT2), mRNA GO:0046872 [NM_144723] A_33_P3221111 PGA3 Homo sapiens mRNA; AL832946 ENST00000538258 643834 pepsinogen chr11:6097847 THC2558400 Hs.601055 cDNA DKFZp666J2410 3, group 1 1-60978530 (from clone (pepsinogen A) DKFZp666J2410). [AL832946] A_33_P3351062 chr17:0391147 04-039114645 A_24_P167642 GCH1 Homo sapiens GTP cy- NM_000161 ENST00000491895 2643 GTP cyclo- chr14:5530944 GO:0050662|GO:0014916| NM_000161 THC2463290 Hs.86724 clohydrolase 1 (GCH1), hydrolase 1 7-55309388 GO:0051066|GO:0006729| transcript variant 1, GO:0005634|GO:0045776| mRNA [NM_000161] GO:0051291|GO:0042803| GO:0006809|GO:0005829| GO:0042416|GO:0005737| GO:0000166|GO:0042311| GO:0050884|GO:0032496| GO:0046654|GO:0051260| GO:0034341|GO:0005509| GO:0003934|GO:0005625| GO:0006917|GO:0031410| GO:0005525|GO:0006184| GO:0043234|GO:0030742| GO:0006461|GO:0016787| GO:0051000|GO:0048265| GO:0008270|GO:0034612 A_23_P124760 MED24 Homo sapiens mediator NM_014815 ENST00000422942 9862 mediator chr17:3817829 GO:0046966|GO:0003712| NM_014815 THC2578251 Hs.462983 complex subunit 24 complex 6-38178237 GO:0006355|GO:0030374| (MED24), transcript subunit 24 GO:0006367|GO:0042809| variant 1, mRNA GO:0016592|GO:0016563| [NM_014815] GO:0005634|GO:0004872| GO:0016455|GO:0030521 A_33_P3395743 VWA1 Homo sapiens von NM_022834 ENST00000476993 64856 von Willebrand chr1:1376086- GO:0030198|GO:0005576| NM_022834 THC2469429 Hs.449009 Willebrand factor A factor A 1376145 GO:0005614|GO:0005604 domain containing 1 domain (VWA1), transcript containing 1 variant 1, mRNA [NM_022834] A_33_P3275722 LY6G6D Homo sapiens lym- NM_021246 ENST00000383415 58530 lymphocyte chr6:31685522- GO:0005886|GO:0031225 NM_021246 NP510943 Hs.591792 phocyte antigen 6 com- antigen 6 31685581 plex, locus G6D complex, (LY6G6D), mRNA locus G6D [NM_021246] A_24_P40417 FMR1 Homo sapiens fragile NM_002024 ENST00000370477 2332 fragile X chrX:14703175 GO:0005515|GO:0005737| NM_002024 THC2661856 Hs.103183 X mental retardation 1 mental re- 2-147031811 GO:0042788|GO:0006810| (FMR1), transcript tardation 1 GO:0005730|GO:0005654| variant ISO1, mRNA GO:0005634|GO:0005625| [NM_002024] GO:0051028|GO:0003729 A_33_P3358228 VWA2 Homo sapiens von NM_198496 ENST00000298715 340706 von Willebrand chr10:1160496 GO:0005576|GO:0042802 NM_198496 THC2480326 Hs.197741 Willebrand factor A factor A 14-116049673 domain containing 2 domain (VWA2), mRNA containing 2 [NM_198496] A U P3263359 DGKA diacylglycerol kinase, BC008292 ENST00000546995 1606 diacylglycerol chr12:5632204 THC2510364 Hs.524488 alpha 80 kDa [Source: kinase, alpha 1-56322100 HGNC Symbol; 80 kDa Acc: 2849] [ENST00000546995] A_24_P148907 MAB21L2 Homo sapiens mab- NM_006439 ENST00000317605 10586 mab-21-like chr4:15150499 GO:0010172|GO:0008284| NM_006439 THC2472779 Hs.584852 21-like 2 (C. elegans) 2 (C. elegans) 1-151505050 GO:0043010|GO:0007275| (MAB21L2), mRNA GO:0005634|GO:0007399 [NM_006439] A_33_P3401711 USH1G Homo sapiens Usher NM_173477 ENST00000319642 124590 Usher chr17:7291223 GO:0005515|GO:0005737| NM_173477 Hs.376688 syndrome 1G syndrome 1G 5-72912176 GO:0060113|GO:0042472| (autosomal recessive) (autosomal GO:0007605|GO:0050957| (USH1G), mRNA recessive) GO:0045494|GO:0015629| [NM_173477] GO:0050896|GO:0042803 A_33_P3401169 T cell receptor beta ENST00000331828 chr9:33629473- THC2565247 variable 21/OR9-2 33629532 (non-functional) [Source: HGNC Symbol; Acc: 12199] [ENST00000331828] A_33_P3260969 PRAP1 Homo sapiens proline- NM_145202 ENST00000463201 118471 proline- chr10:1351659 GO:0005576 NM_145202 NP587643 Hs.15951 rich acidic protein 1 rich acidic 87-135166046 (PRAP1), transcript protein 1 variant 1, mRNA [NM_145202] A_32_P202859 H1FNT Homo sapiens H1 NM_181788 ENST00000335017 341567 HI histone chr12:4872398 GO:0000790|GO:0000166| NM_181788 THC2475276 Hs.155833 histone family, member family, 3-48724042 GO:0030261|GO:0005694| N, testis-specific member N, GO:0007290|GO:0007275| (H1FNT), mRNA testis specific GO:0005634|GO:0007283| [NM_181788] GO:0035092|GO:0005524| GO:0003677|GO:0030154 A_33_P3260373 ISY1-RAB43 Homo sapiens ISY1- NM_001204890 ENST00000315150 100534599 ISY1-RAB43 chr3:12881012 GO:0005886|GO:0000166| NM_001204890 THC2604277 Hs.512661 RAB43 readthrough readthrough 3-128810064 GO:0007264|GO:0015031| (ISY1-RAB43), mRNA GO:0005525 [NM_001204890] A_33_P3378291 IL17REL Homo sapiens inter- NM_001001694 ENST00000341280 400935 interleukin chr22:5043306 NM_001001694 THC2486439 Hs.526712 leukin 17 receptor E-like 17 receptor 1-50433002 (IL17REL), mRNA E-like [NM_001001694] A_23_P50646 LOC390940 Homo sapiens hypo- NM_001193621 390940 hypothetical chr19:4408613 GO:0004859|GO:0005576 NM_001193621 THC2515604 Hs.22049 thetical protein protein 9-44086198 LOC390940 LOC390940 (LOC390940), trans- cript variant 1, mRNA [NM_001193621] A_33_P3235282 LOC401561 PREDICTED: XR_110095 401561 FP7915 protein chr9:13951120 XR_110095 NP924771 Hs.609301 Homo sapiens FP7915 3-139511144 protein (LOC401561), miscRNA [XR_110095] A_23_P387552 RARG Homo sapiens retinoic NM_000966 ENST00000425354 5916 retinoic acid chr12:5360462 GO:0005515|GO:0005667| NM_000966 THC2465083 Hs.1497 acid receptor, gamma receptor, 4-53604565 GO:0008361|GO:0006355| (RARG), transcript gamma GO:0043065|GO:0003700| variant 1, mRNA GO:0008285|GO:0003707| [NM_000966] GO:0005634|GO:0000122| GO:0003708|GO:0046872| GO:0048384|GO:0043565| GO:0046965|GO:0045944| GO:0035116|GO:0008270| GO:0016021|GO:0032526| GO:0060070|GO:0048048 A_23_P168229 TXNDC5 Homo sapiens thiore- NM_030810 ENST00000439343 81567 thioredoxin chr6:7882079- GO:0005783|GO:0006892| NM_030810 THC2483613 Hs.150837 doxin domain containing domain 7882020 GO:0005788|GO:0045454| 5 (endoplasmic reticu- containing 5 GO:0006916|GO:0016853| lum) (TXNDC5), (endoplasmic GO:0016044 transcript variant 1, reticulum) mRNA [NM_030810] A_33_P3382887 chr18:0584620 67-058462008 A_23_P377882 KCNH2 Homo sapiens potas- NM_172056 ENST00000430723 3757 potassium chr7:15064704 GO:0005251|GO:0005242| NM_172056 THC2730451 Hs.647099 sium voltage-gated voltage- 3-150646984 GO:0006355|GO:0005244| channel, subfamily H gated channel, GO:0005886|GO:0008015| (cog related), member 2 subfamily H GO:0008016|GO:0030955| (KCNH2), transcript (eag-related), GO:0005635|GO:0055085| variant 2, mRNA member 2 GO:0000155|GO:0000160| [NM_172056] GO:0005737|GO:0006936| GO:0008076|GO:0042391| GO:0006813|GO:0006811 A_33_P3383856 TREX2 Homo sapiens three NM_080701 ENST00000330912 11219 three prime chrX:15271055 GO:0005622|GO:0008296| NM_080701 NP1214668 Hs.644635 prime repair exonuclease repair exo- 4-152710495 GO:0004527|GO:0006281| 2 (TREX2), mRNA nuclease 2 GO:0000287|GO:0016787| [NM_080701] GO:0008853|GO:0005634| GO:0003676|GO:0006974 A_23_P148015 AXIN2 Homo sapiens axin NM_004655 ENST00000307078 8313 axin 2 chr17:6352544 GO:0008219|GO:0008285| NM_004655 THC2461858 Hs.156527 2 (AXIN2), mRNA 8-63525389 GO:0008013|GO:0019901| [NM_004655] GO:0001756|GO:0030178| GO:0005634|GO:0007275| GO:0005622|GO:0007165| GO:0005737|GO:0045668| GO:0001957|GO:0004871 A_33_P3374258 NHLH2 nescient helix loop AK056621 ENST00000369506 4808 nescient chr1:11638108 GO:0007617|GO:0030528| THC2601021 helix 2 [Source: HGNC helix loop 0-116381021 GO:0042698|GO:0007275| Symbol; Acc: 7818] helix 2 GO:0005634|GO:0007417| [ENST00000369506] GO:0003677|GO:0045449| GO:0030154 A_24_P341019 C20orf30 Homo sapiens chromo- NM_001009924 ENST00000379276 29058 chromosome chr20:5089998- GO:0016020|GO:0016021 NM_001009924 THC2529296 Hs.472024 some 20 open reading 20 open 5086918 frame 30 (C20orf30), reading frame transcript variant 2, 30 mRNA [NM_001009924] A_23_P154849 OLIG1 Homo sapiens oligo- NM_138983 ENST00000426947 116448 oligoden- chr21:3444453 GO:0005515|GO:0030528| NM_138983 THC2464968 Hs.56663 dendrocyte transcription drocyte 7-34444596 GO:0007275|GO:0005634| factor 1 (OLIG1), mRNA transcription GO:0048663|GO:0003677| [NM_138983] factor 1 GO:0045449 A_23_P207842 RARA Homo sapiens retinoic NM_001024809 ENST00000394089 5914 retinoic chr17:3851317 GO:0005515|GO:0032753| NM_001024809 THC2473007 Hs.654583 acid receptor, alpha acid 4-38513233 GO:0006355|GO:0032754| (RARA), transcript receptor, GO:0003700|GO:0009986| variant 2, mRNA alpha GO:0003713|GO:0003707| [NM_001024809] GO:0032720|GO:0005634| GO:0032736|GO:0003708| GO:0046872|GO:0048384| GO:0043565|GO:0007165| GO:0001972|GO:0008270| GO:0032526|GO:0045630| GO:0032689|GO:0032355| GO:0030520 A_33_P3399468 Homo sapiens cDNA, AK311115 chr16:9023543 Hs.661255 FLJ18157. [AK311115] 5-90235494 A_23_P46039 FCRLA Homo sapiens Fc NM_032738 ENST00000236938 84824 Fc receptor- chr1:16168379 GO:0005737|GO:0005576| NM_032738 THC2463353 Hs.266331 receptor-like A like A 2-161683851 GO:0030154 (FCRLA), transcript variant 2, mRNA [NM_032738] A_33_P3301025 CPOX Homo sapiens copro- NM_000097 ENST00000264193 1371 copropor- chr3:98298372 GO:0005739|GO:0005758| NM_000097 THC2463467 Hs.476982 porphyrinogen oxidase phyrinogen 98298313 GO:0046685|GO:0005737| (CPOX), mRNA oxidase GO:0042493|GO:0016491| [NM_000097] GO:0046689|GO:0004109| GO:0055114|GO:0042802| GO:0006783 A_33_P3363637 BLNK Homo sapiens B cell NM_013314 ENST00000393898 29760 B-cell linker chr10:9795169 GO:0005622|GO:0005515| NM_013314 THC2479443 Hs.665244 linker (BLNK), trans- 7-97951638 GO:0007242|GO:0005737| cript variant 1, mRNA GO:0006954|GO:0005886| [NM_013314] GO:0006959|GO:0005070| GO:0030183|GO:0005068 A_33_P3214072 LOC729175 PREDICTED: XM_001129558 729175 hypothetical chr4:24474070- XM_001129558 Hs.627177 Homo sapiens hypo- protein 24474011 thetical protein LOC729175 LOC729175 (LOC729175), mRNA [XM_001129558] A_24_P22079 FOXO1 Homo sapiens fork- NM_002015 ENST00000379561 2308 forkhead chr13:4113076 GO:0005515|GO:0008286| NM_002015 THC2606078 Hs.370666 head box O1 (FOXO1), box O1 8-41130709 GO:0006355|GO:0001568| mRNA [NM_002015] GO:0003700|GO:0016563| GO:0005634|GO:0006916| GO:0005829|GO:0043565| GO:0005737|GO:0045941| GO:0045944|GO:0042127| GO:0005654 A_33_P3245674 ZNF329 zinc finger protein AK090893 ENST00000500161 79673 zinc finger chr19:5866616 THC2550377 Hs.458377 329 [Source: HGNC protein 329 2-58666103 Symbol; Acc: 14209] [ENST00000500161] A_33_P3562537 RET Homo sapiens ret NM_020630 ENST00000340058 5979 ret proto- chr10:4362221 GO:0005515|GO:0001657| NM_020630 NP838836 Hs.350321 proto-oncogene (RET), oncogene 3-43622272 GO:0042551|GO:0001755| transcript variant 4, GO:0005509|GO:0001838| mRNA [NM_020630] GO:0005524|GO:0048484| GO:0007399|GO:0007165| GO:0016020|GO:0000166| GO:0000165|GO:0007497| GO:0004872|GO:0006468| GO:0016021|GO:0004714| GO:0007169|GO:0007156| GO:0016740 A_33_P3334398 CA6 Homo sapiens car- NM_001215 ENST00000475703 765 carbonic chr1:9030977- GO:0008270|GO:0005576| NM_001215 NP1400569 Hs.100322 bonic anhydrase VI anhydrase 9031036 GO:0004089|GO:0006730| (CA6), mRNA VI GO:0046872|GO:0016829 [NM_001215] A_23_P81441 C5orf20 Homo sapiens chromo- NM_130848 ENST00000537858 140947 chromosome chr5:13478003 GO:0005634 NM_130848 THC2480949 Hs.152477 some 5 open reading 5 open 3-134779974 frame 20 (C5orf20), reading mRNA [NM_130848] frame 20 A_24_P227450 ACAD10 Homo sapiens acyl- NM_025247 ENST00000547491 80724 acyl-CoA chr12:1121934 GO:0016787|GO:0050660| NM_025247 NP1163233 Hs.331141 CoA dehydrogenase dehydro 89-112193548 GO:0003995|GO:0055114 family, member 10 genase family, (ACAD10), transcript member 10 variant 2, mRNA [NM_025247] A_32_P86180 chromosome 6 open BF223582 ENST00000369123 chr6:10538838 Hs.649249 reading frame 220 7-105388328 [Source: HGNC Symbol; Acc: 21553] [ENST00000369123] A_33_P3268954 FBLL1 Homo sapiens fibril- NR_024356 345630 fibrillarin- chr5:16795739 GO:0030529|GO:0006364| NR_024356 THC2623630 larin-like 1 (FBLL1), like 1 5-167957454 GO:0003723|GO:0008168| non-coding RNA GO:0005730|GO:0005634| [NR_024356] GO:0016740|GO:0008033 A_33_P3225378 OR10G3 Homo sapiens olfactory NM_001005465 ENST00000303532 26533 olfactory chr14:2203799 GO:0007608|GO:0007165| NM_001005465 THC2612456 Hs.554581 receptor, family 10, receptor, 3-22037934 GO:0004984|GO:0007186| subfamily G, member 3 family 10, GO:0005886|GO:0004872| (OR10G3), mRNA subfamily G, GO:0016021|GO:0050896 [NM_001005465] member 3 A_33_P3417123 LOC652119 PREDICTED: XM_001720798 652119 double chrUn_gl00023 XM_001720798 Homo sapiens double homeobox 5:000001907- homeobox protein 4- protein 4-like 000001848 like (LOC652119), mRNA [XM_001720798) A_23_P211326 CECR2 Homo sapiens cat eye NM_031413 ENST00000355219 27443 cat eye syn- chr22:1803338 GO:0000910|GO:0006309| NM_031413 NP500153 Hs.658723 syndrome chromosome drome chro- 7-18033446 GO:0007010|GO:0006915| region, candidate 2 mosome GO:0005634|GO:0016192| (CECR2), mRNA region, GO:0016568 [NM_031413] candidate 2 A_24_P170726 LOC645427 Homo sapiens cDNA AK094407 645427 hypothetical chr17:2131732 THC2487445 Hs.683873 FLJ37088 fis, clone LOC645427 7-21317386 BRACE2017124. [AK094407] A_33_P3382111 chr1:22716354 2-227163483 A_23_P201181 PTPN22 Homo sapiens protein NM_012411 ENST00000354605 26191 protein chr1:11437699 GO:0005515|GO:0050852| NM_012411 NP079320 Hs.535276 tyrosine phosphatase, tyrosine 0-114376931 GO:0007165|GO:0005737| non-receptor type 22 phosphatase, GO:0006470|GO:0030217| (lymphoid) (PTPN22), non-receptor GO:0016787|GO:0004725 transcript variant 2, type 22 mRNA [NM_012411] (lymphoid) A_23_P218126 immunoglobulin heavy BC024289 ENST00000390549 chr14:1062083 NP852618 Hs.510635 constant gamma 1 (G1m 10-106208251 marker) [Source: HGNC Symbol; Acc: 5525] [ENST00000390549] A_23_P150053 ACTA2 Homo sapiens actin, NM_001613 ENST00000458208 59 actin, alpha chr10:9069795 GO:0005515|GO:0005737| NM_001613 THC2573035 Hs.500483 alpha 2, smooth muscle, 2, smooth 8-90697899 GO:0000166|GO:0008217| aorta (ACTA2), muscle, aorta GO:0015629|GO:0005524| transcript variant 2, GO:0030485|GO:0014829 mRNA [NM_001613] A_23_P38190 ORMDL3 Homo sapiens ORM1- NM_139280 HNST00000394169 94103 ORMl-like 3 chr17:3807939 GO:0016020|GO:0005783| NM_139280 NP842990 Hs.514151 like 3 (S. cerevisiae) (S. cerevisiae) 7-38078912 GO:0016021 (ORMDL3), mRNA [NM_139280] A_33_P3789056 C1orf200 Homo sapiens chromo- NR_027045 ENST00000377320 644997 chromosome chr1:9712762- NR_027045 THC2482521 Hs.568595 some 1 open reading 1 open 9712703 frame 200 (C1orf200), reading non-coding RNA frame 200 [NR_027045] A_33_P3271925 ARFGEF2 Homo sapiens ADP- NM_006420 ENST00000371917 10564 ADP-ribo- chr20:4765281 GO:0005802|GO:0007242| NM_006420 THC2533999 Hs.62578 ribosylation factor sylation 7-47652876 GO:0050811|GO:0006887| guanine nucleotide factor GO:0005829|GO:0005622| exchange factor 2 guanine GO:0005086|GO:0005737| (brefeldin A-in- nucleotide GO:0000139|GO:0016020| hibited) (ARFGEF2), exchange GO:0005488|GO:0032012| mRNA [NM_006420] factor 2 GO:0017022 (brefeldin A-inhibited) A_23_P1602 CDC42EP2 Homo sapiens CDC42 NM_006779 ENST00000544348 10435 CDC42 chr11:6508974 GO:0005515|GO:0005886| NM_006779 THC2461993 Hs.343380 effector protein (Rho effector 6-65089805 GO:0008360|GO:0005100| GTPase binding) 2 protein (Rho GO:0005737|GO:0031334| (CDC42EP2), mRNA GTPase GO:0030838|GO:0001515| [NM_006779] binding) 2 GO:0031274|GO:0007015| GO:0017049|GO:0005856| GO:0019898 A_33_P3289491 LOC100129069 Homo sapiens cDNA AK127359 100129069 hypothetical chr11:1246301 THC2482533 Hs.675422 FLJ45433 fis, clone protein 28-124630069 BRHIP3040878. LOC100129069 [AK127359] A_33_P3367701 TMEM164 Homo sapiens trans- NM_032227 ENST00000288381 84187 transmembrane chrX:10941671 GO:0016020|GO:0016021 NM_032227 THC2483947 Hs.496572 membrane protein 164 protein 164 1-109416770 (TMEM164), transcript variant 2, mRNA [NM_032227] A_33_P3377294 TCF7L2 transcription factor 7- ENST00000349937 6934 transcription chr10:1149058 THC2504286 like 2 (T-cell specific, factor 7-like 2 03-114905862 HMG-box) [Source: (T-cell specific, HGNC Symbol; HMG-box) Acc: 11641] [ENST00000349937] A_32_P353072 TMEM106B Homo sapiens trans- NM_018374 ENST00000396667 54664 transmembrane chr7:12276527- GO:0008150|GO:0003674| NM_018374 THC2714339 Hs.396358 membrane protein 106B protein 106B 12276586 GO:0016020|GO:0016021| (TMEM106B), transcript GO:0005575 variant 1, mRNA [NM_018374] A_33_P3237574 HLA-A Homo sapiens major NM_001242758 ENST00000355767 3105 major histo- chr6:29910343- GO:0005515|GO:0002474| NM_001242758 NP1275975 Hs.181244 histocompatibility compatibility 29910402 GO:0006955|GO:0016020| complex, class I, A complex, GO:0000139|GO:0019882| (HLA-A), transcript class I, A GO:0005887|GO:0044419| variant 2, mRNA GO:0042612|GO:0031901| [NM_001242758] GO:0016021|GO:0032393 A_33_P3250857 axin interactor, dorsal- BC043142 ENST00000474863 chr1:22288599 GO:0043496|GO:0005515| THC2507656 Hs.534965 ization associated 7-222885938 GO:0046329|GO:0007275| [Source: HGNC GO:0009953|GO:0005575 Symbol; Acc: 25761] [ENST00000474863] A_33_P3399598 ABCD4 Homo sapiens cDNA AK125109 5826 ATP-binding chr14:7476628 THC2523786 Hs.94395 FLJ43119 fis, clone cassette, sub- 5-74766344 CTONG3003179. family D (ALD), [AK125109] member 4 A_33_P3381292 chr11:0699243 28-069924387 A_32_P385587 ALAS2 Homo sapiens amino- NM_000032 ENST00000330807 212 amino chrX:55035564- GO:0042541|GO:0005515| NM_000032 THC2470945 Hs.522666 levulinate, delta-, levulinate, 55035505 GO:0050662|GO:0001666| synthase 2 (ALAS2), delta-, GO:0009058|GO:0016769| nuclear gene encoding synthase 2 GO:0005743|GO:0033014| mitochondrial protein, GO:0006783|GO:0005739| transcript variant 1, GO:0006879|GO:0006778| mRNA [NM_000032] GO:0005759|GO:0030218| GO:0030170|GO:0016594| GO:0032364|GO:0003870| GO:0008415 A_33_P3322553 MED25 Homo sapiens mediator NM_030973 ENST00000377077 81857 mediator chr19:5033830 GO:0005634|GO:0045449 NM_030973 NP1193880 Hs.656639 complex subunit 25 complex 3-50338362 (MED25), mRNA subunit 25 [NM_030973] A_32_P49668 LOC100510697 PREDICTED: XM_003118465 100510697 putative chr5:69826390- XM_003118465 Hs.634013 Homo sapiens putative POM121-like 69826449 POM 121-like protein protein 1-like 1-like (LOC100510697), mRNA [XM_003118465] A_33_P3321070 WNT4 wingless-type MMTV ENST00000374655 54361 wingless- chr1:22453872- THC2680884 integration site family, type MMTV 22453813 member 4 [Source: integration HGNC Symbol; site family, Acc: 12783] [ENST00000374655] member 4 A_33_P3342653 ADAM33 Homo sapiens ADAM NM_153202 ENST00000358035 80332 ADAM chr20:3657774- GO:0016020|GO:0006508| NM_153202 NP805663 Hs.173716 metallopeptidase do- metallopeptidase 3657715 GO:0008270|GO:0008233| main 33 (ADAM33), domain 33 GO:0016021|GO:0004222| transcript variant 2, GO:0046872 mRNA [NM_153202] A_33_P3322103 A_33_P3375398 TBL3 Homo sapiens trans- NM_006453 ENST00000332704 10607 transducin chr16:2028684- GO:0006364|GO:0032040| NM_006453 THC2468480 Hs.513267 ducin (beta)-like 3 (beta)-like 3 2028743 GO:0007199|GO:0005730| (TBL3), mRNA GO:0005634|GO:0005057 [NM_006453] A_33_P3358799 SLC35C2 Homo sapiens solute NM_173179 ENST00000372223 51006 solute carrier chr20:4497843 GO:0016020|GO:0006810| NM_173179 THC2481513 Hs.593344 carrier family 35, family 35, 7-44978378 GO:0016021 member C2 (SLC35C2), member C2 transcript variant 1, mRNA [NM_173179] A_33_P3364637 PREDICTED: XR_109540 ENST00000378108 chr19:4274735 XR 109540 THC2484875 Hs.711405 Homo sapiens hypo- 7-42747416 thetical LOC100132272 (LOC100132272), miscRNA [XR_109540] A_24_P95723 KIAA0125 Homo sapiens NR_026800 9834 KIAA0125 chr14:1063983 NR_026800 THC2657912 Hs.649259 KIAA0125 (KIAA0125), 26-106398385 non-coding RNA [NR_026800] A_23_P27571 MCOLN1 Homo sapiens muco- NM_020533 ENST00000394321 57192 mucolipin 1 chr19:7593764 GO:0005261|GO:0005886| NM_020533 THC2467038 Hs.631858 lipin 1 (MCOLN1), 7593823 GO:0005887|GO:0005509| mRNA [NM_020533] GO:0006816|GO:0055085| GO:0005764|GO:0006812| GO:0005768 A_23_P405282 MGC45922 Homo sapiens hypo- NR_038359 ENST00000326989 284365 hypothetical chr19:5132167 NR_038359 THC2485442 Hs.161397 thetical LOC284365 LOC284365 4-51321733 (MGC45922), non- coding RNA [NR_038359] A_33_P3313532 ANKRD20A1 Homo sapiens ankyrin NM_032250 ENST00000485255 84210 ankyrin re- chr9:67927016- GO:0005886 NM_032250 Hs.632671 repeat domain 20 peat domain 67927074 family, member A1 20 family, (ANKRD20A1), member Al mRNA [NM_032250] A_23_P500130 KANK1 Homo sapiens KN NM_153186 ENST00000382289 23189 KN motif chr9:746006- GO:0005737 NM_153186 NP1165352 Hs.306764 motif and ankyrin and ankyrin 746065 repeat domains 1 repeat do- (KANK1), transcript mains 1 variant 2, mRNA [NM_153186] A_33_P3360886 GRP33_ARTSA chr13:0443602 THC2642603 (P13230) Glycine-rich 75-044360216 protein GRP33, partial (8%) [THC2642603] A_33_P3270593 chr1:02852779 2-028527851 A_33_P3228732 LOC100131551 Homo sapiens hypo- NR_024480 ENST00000397644 100131551 hypothetical chr3:19402362 NR_024480 THC2519857 Hs.128066 thetical LOC100131551 LOC100131551 1-194023562 (LOC100131551), non- coding RNA [NR_024480] A_23_P139600 RASAL1 Homo sapiens RAS NM_004658 ENST00000446861 8437 RAS protein chr12:1135376 GO:0005622|GO:0005099| NM_004658 THC2483187 Hs.528693 protein activator like 1 activator 35-113537576 GO:0051056|GO:0007242| (GAP1 like) (RASAL1), like 1 GO:0005543|GO:0008270| transcript variant 2, (GAP1 like) GO:0046872 mRNA [NM_004658] A_23_P144627 PCDHB13 Homo sapiens proto- NM_018933 ENST00000419217 56123 protocadherin chr5:14059597 GO:0016339|GO:0005515| NM_018933 NP285722 Hs.283803 cadherin beta 13 beta 13 8-140596037 GO:0005886|GO:0005509| (PCDHB13), mRNA GO:0007268|GO:0016021| [NM_018933] GO:0007155|GO:0007416| GO:0007156 A_33_P3390546 PREDICTED:thetical), XM_003118499 chr1:20147485 XM_003118499 NP852558 Hs.689295 Homo sapiens hypo- 2-201474793 protein LOC100506590 (LOC100506590 mRNA [XM_003118499] A_33_P3382924 SPARC Homo sapiens secreted NM_003118 ENST00000231061 6678 secreted pro- chr5:15104109 GO:0007165|GO:0001503| NM_003118 THC2465583 Hs.111779 protein, acidic, cysteine- tein, acidic, 9-151041040 GO:0005507|GO:0042127| rich (osteonectin) (SPARC), cysteine-rich GO:0005518|GO:0005509| mRNA [NM_003118] (osteonectin) GO:0050840|GO:0031093| GO:0005576|GO:0005604 A_33_P3323136 ENKUR Homo sapiens enkurin, NM_145010 ENST00000376363 219670 enkurin, chr10:2530486 GO:0019861|GO:0005929| NM_145010 NP841402 Hs.534486 TRPC channel interacting TRPC 5-25304806 GO:0005516|GO:0017124 protein (ENKUR), channel inter- mRNA [NM_145010] acting protein A_33_P3349495 TTTY16 Homo sapiens testis- NR_001552 ENST00000437686 252948 testis-specific chrY:7569288- NR_001552 NP1161733 Hs.522848 specific transcript, Y- transcript, Y- 7569229 linked 16 (nonprotein linked 16 coding) (TTTY16), (nonprotein non-coding RNA coding) [NR_001552] A_23_P215931 LEPROTL1 Homo sapiens leptin NM_015344 ENST00000321250 23484 leptin receptor chr8:29965452- GO:0016020|GO:0016021 NM_015344 THC2469608 Hs.146585 receptor overlapping overlapping 29965511 transcript-like 1 transcript- (LEPROTL1), like 1 transcript variant 1, mRNA [NM_015344] A_33_P3382648 RBMY1B Homo sapiens RNA NM_001006121 ENST00000382658 378948 RNA binding chrY:23681093- GO:0008380|GO:0006397| NM_001006121 THC2487576 Hs.725744 binding motif protein, motif protein, 23681152 GO:0005515|GO:0000166| Y-linked, family 1, Y-linked, GO:0003723|GO:0005634| member B (RBMY1B), family 1, GO:0007283|GO:0008584 mRNA [NM_001006121] member B A_33_P3291891 LOC100130825 PREDICTED: XM_001720026 100130825 hypothetical chr12:1321483 XM_001720026 Hs.538511 Homo sapiens hypo- protein 78-132148319 thetical protein LOC100130825 LOC100130825 (LOC100130825), mRNA [XM_001720026] A_23_P104413 DUX4 Homo sapiens double NM_033178 ENST00000507734 22947 double chrUn_gl00022 GO:0043565|GO:0006355| NM_033178 THC2493180 Hs.553518 homeobox 4 (DUX4), homeobox 8:77218-77276 GO:0003700|GO:0005634 mRNA[NM_033178] 4 A_33_P3268313 PGAM2 Homo sapiens phos- NM_000290 ENST00000297283 5224 phospho- chr7:44102471- GO:0048037|GO:0004082| NM_000290 THC2472046 Hs.632642 phoglycerate mutase 2 glycerate 44102412 GO:0004083|GO:0046538| (muscle) (PGAM2), mutase 2 GO:0006094|GO:0006941| mRNA (muscle) GO:0005625|GO:0005634| [NM_000290] GO:0005575|GO:0007283| GO:0006096|GO:0005829| GO:0010035|GO:0016787| GO:0008152|GO:0016853| GO:0046689 A_23_P67367 DHDH Homo sapiens dihydro- NM_014475 ENST00000520557 27294 dihydrodiol chr19:4944811 GO:0005975|GO:0005488| NM_014475 THC2478626 Hs.631555 diol dehydrogenase dehydrogenase 2-49448171 GO:0047837|GO:0047115| (dimeric) (DHDH), (dimeric) GO:0016491|GO:0008746| mRNA [NM_014475] GO:0009055|GO:0055114 A_23_P150428 OR6M1 Homo sapiens olfactory NM_001005325 ENST00000309154 390261 olfactory chr11:1236765 GO:0007608|GO:0007165| NM_001005325 THC2612208 Hs.557924 receptor, family 6, receptor, 31-123676472 GO:0004984|GO:0007186| subfamily M, member 1 family 6, GO:0005886|GO:0004872| (OR6M1), mRNA subfamily M, GO:0016021|GO:0050896 [NM_001005325] member 1 A_33_P3375576 MAP7 Homo sapiens micro- NM_003980 ENST00000345567 9053 microtubule- chr6:13666709 GO:0016323|GO:0048471| NM_003980 NP208771 Hs.486548 tubule-associated pro- associated 5-136667036 GO:0005737|GO:0007163| tein 7 (MAP7), trans- protein 7 GO:0005886|GO:0005198| cript variant 4, GO:0005875|GO:0005874| mRNA [NM_003980] GO:0000226 A_23_P25626 C13orf34 Homo sapiens chromo- NM_024808 ENST00000377815 79866 chromosome chr13:7332935 GO:0007067|GO:0007049| NM_024808 THC2464290 Hs.643464 some 13 open reading 13 open 6-73329415 GO:0051301 frame 34 (C13orf34), reading mRNA [NM_024808] frame 34 A_24_P382579 OXT Homo sapiens oxytocin, NM_000915 ENST00000217386 5020 oxytocin, chr20:3053096- GO:0005515|GO:0014070| NM_000915 THC2480057 Hs.113216 prepropeptide (OXT), prepropeptide 3053155 GO:0060406|GO:0042220| mRNA [NM_000915] GO:0001696|GO:0005615| GO:0051591|GO:0007507| GO:0051789|GO:0070474| GO:0034695|GO:0009744| GO:0051602|GO:0007613| GO:0005185|GO:0032355| GO:0045925|GO:0051965| GO:0007565|GO:0044058| GO:0006950|GO:0030431| GO:0042538|GO:0051384| GO:0010701|GO:0002125| GO:0002027|GO:0005179| GO:0050806|GO:0035176| GO:0032570|GO:0003079| GO:0060179|GO:0003077| GO:0051930|GO:0045472| GO:0031855|GO:0043434| GO:0045776|GO:0045777| GO:0007204|GO:0045778| GO:0005737|GO:0043195| GO:0007625|GO:0032526| GO:0030141|GO:0014823| GO:0042711|GO:0005576| GO:0042713|GO:0007165| GO:0001975|GO:0042756| GO:0032308|GO:0042755 A_33_P3348884 CCDC141 Homo sapiens coiled- NM_173648 ENST00000480419 285025 coiled-coil chr2:17969895 NM_173648 THC2485672 Hs.324341 coil domain containing domain con 9-179698900 141 (CCDC141), taining 141 mRNA [NM_173648] A_33_P3214042 chr1 1:0646458 THC2598321 81-064645940 A_33_P3263512 chr12:1222068 35-122206776 A_33_P3347452 RPS6KA2 Homo sapiens ribo- NM_021135 ENST00000510118 6196 ribosomal chr6:16682296 GO:0000287|GO:0000166| NM_021135 THC2635208 Hs.655277 somal protein S6 protein S6 1-166822902 GO:0004674|GO:0006468| kinase, 90 kDa, poly- kinase, 90 GO:0005654|GO:0005634| peptide 2 (RPS6KA2), kDa, poly- GO:0005524|GO:0016740| transcript variant 1, peptide 2 GO:0007243 mRNA [NM_021135] A_23_P3963 CDR2L Homo sapiens cerebellar NM_014603 ENST00000337231 30850 cerebellar chr17:7300155 NM_014603 THC2784175 Hs.78358 degeneration-related degeneration- 7-73001616 protein 2-like related (CDR2L), mRNA protein 2- [NM_014603] like A_33_PWW18 TUBBP5 Homo sapiens tubulin, NR_027156 643224 tubulin, chr9:14107182 GO:0051258|GO:0000166| NR_027156 THC2493332 beta pseudogene 5 beta 0-141071879 GO:0005198|GO:0005874| (TUBBP5), non- pseudogene 5 GO:0003924|GO:0005525| coding RNA GO:0007018 [NR_027156] A_24_P50972 GOLGA6L6 Homo sapiens golgin NM_001145004 ENST00000454724 727832 golgin A6 chr15:2073877 GO:0016020|GO:0016021 NM_001145004 THC2481492 Hs.125917 A6 family-like 6 family-like 6 1-20738712 (GOLGA6L6), mRNA [NM_001145004] A_33_P3274009 LOC100132966 Homo sapiens cDNA AK124556 100132966 hypothetical chr1:14391452 THC2585044 Hs.730332 FLJ42565 fis, clone LOC100132966 3-143914582 BRACE3007472. [AK124556] A_33_P3222932 SHISA8 Homo sapiens shisa NM_001207020 440829 shisa homolog chr22:4230588 NM_001207020 THC2683228 Hs.526704 homolog 8 (Xenopus 8 (Xenopus 4-42305825 laevis) (SHISA8), laevis) mRNA [NM_001207020] A_23_P85703 SOX13 Homo sapiens SRY NM_005686 ENST00000367204 9580 SRY (sex chr1:20409655 GO:0043565|GO:0003700| NM_005686 THC2462481 Hs.201671 (sex determining region determining 1-20406610 GO:0005634|GO:0009653| Y)-box 13 (SOX13), region Y)- GO:0045449 mRNA [NM_005686] box 13 A_33_P3303469 chr16:0860076 78-086007737 A_23_P428129 CDKN1C Homo sapiens cyclin- NM_000076 ENST00000313407 1028 cyclin-depend- chr11:2904962- GO:0033673|GO:0005515| NM_000076 THC2646038 Hs.106070 dependent kinase ent kinase 2904903 GO:0016564|GO:0042551| inhibitor 1C (p57, Kip2) inhibitor GO:0045735|GO:0016563| (CDKN1C), 1C (p57, Kip2) GO:0050680|GO:0005730| transcript variant 1, GO:0005634|GO:0000079| mRNA [NM_000076] GO:0000122|GO:0042326| GO:0005737|GO:0007049| GO:0032582|GO:0004861| GO:0004860|GO:0007050| GO:0000080|GO:0030511 A_23_P434518 LFNG Homo sapiens LFNG NM_001040168 ENST00000359574 3955 LFNG O-fuco- chr7:2568740- GO:0007389|GO:0033829| NM_001040168 THC2486300 Hs.159142 O-fucosylpeptide 3-beta- sylpeptide 3- 2568799 GO:0007386|GO:0005794| N-acetylglucosaminyl- beta-N-acetyl GO:0016757|GO:0005576| transferase (LFNG), glucosaminyl- GO:0003674|GO:0001541| transcript variant 2, transferase GO:0030173|GO:0016020| mRNA [NM_001040168] GO:0009887|GO:0016021| GO:0007143 A_33_P3290567 WEE1 Homo sapiens WEE1 NM_003390 ENST00000299613 7465 WEE1 chr11:9611073- GO:0005515|GO:0000287| NM_003390 THC2616575 Hs.249441 homolog (S. pombe) homolog 9611132 GO:0005634|GO:0005524| (WEE1), transcript (S. pombe) GO:0007049|GO:0007067| variant 1, mRNA GO:0000166|GO:0004674| [NM_003390] GO:0005654|GO:0006468| GO:0004715|GO:0016740| GO:0051301 A_23_P431981 HMGXB4 Homo sapiens HMG box NM_001003681 ENST00000216106 10042 HMG box chr22:3569138 GO:0008333|GO:0030178| NM_001003681 THC2461089 Hs.588815 domain containing 4 domain 4-35691443 GO:0005634|GO:0003677 (HMGXB4), trans- containing 4 cript variant 1, mRNA [NM_001003681] A_32_P168349 C6orf25 Homo sapiens chromo- NM_138277 ENST00000466799 80739 chromosome chr6:31694319- GO:0005794|GO:0005886| NM_138277 THC2534407 Hs.247879 some 6 open reading 6 open 31694378 GO:0005783|GO:0004872| frame 25 (C6orf25), reading frame GO:0016021|GO:0008201 transcript variant 7, 25 mRNA [NM_138277] A_33_P3273732 chr9:13700036 8-137000309 A_24_P323084 C17orf55 Homo sapiens chromo- NR_038080 ENST00000332012 284185 chromosome chr17:7927669 NR_038080 THC2478525 Hs.631762 some 17 open reading 17 open 6-79276637 frame 55 (C17orf55), reading non-coding RNA frame 55 [NR_038080] A_23_P379630 SLC38A10 Homo sapiens solute NM_138570 ENST00000288439 124565 solute carrier chr17:7922512 GO:0016020|GO:0006865| NM_138570 THC2464913 Hs.352240 carrier family 38, family 38, 4-79225065 GO:0016021|GO:0031402| member 10 (SLC38A10), member 10 GO:0006814|GO:0006811 transcript variant 2, mRNA [NM_138570] A_24_P128727 Homo sapiens olfactory AF359419 chr2:71282963- THC2529021 Hs.382969 receptor-like (PJCG9) 71283022 pseudogene mRNA, partial sequence. [AF359419] A_33_P3701139 LOC440525 602939790F1 BI224516 440525 proline rich Hs.631599 NIH_MGC_12 Homo 13 pseudogene sapiens cDNA clone IMAGE: 5102926 5′, mRNA sequence [BI224516] A_33_P3222761 T cell receptor ENST00000390431 chr14:2227988 alpha variable 9-1 3-22279942 [Source: HGNC Symbol; Acc: 12153] [ENST00000390431] A_23_P302018 TXK Homo sapiens TXK NM_003328 ENST00000514937 7294 TXK chr4:48069318- GO:0005515|GO:0005737| NM_003328 THC2476508 Hs.479669 tyrosine kinase (TXK), tyrosine kinase 48069259 GO:0000166|GO:0006468| mRNA [NM_003328] GO:0005524|GO:0004715| GO:0016740|GO:0007243 A_33_P3219596 LOC254559 Homo sapiens hypo- NR_015411 254559 hypothetical chr15:8994165 NR_015411 THC2601829 Hs.136313 thetical LOC254559 LOC254559 8-89941717 (LOC254559), non- coding RNA [NR_015411] A_32_P76060 CTDSPL2 Homo sapiens CTD 2 NM_016396 ENST00000396780 51496 CTD chr15:4481936 GO:0016787|GO:0004721 NM_016396 THC2532072 Hs.497967 (carboxy-terminal do- (carboxy- 6-44819425 main, RNA polymerase terminal II, polypeptide A) domain, RNA small phosphatase like polymerase II, (CTDSPL2), polypeptide mRNA [NM_016396] A) small A_33_P3217619 ENST00000552290 phosphatase chr12:7608336 like 2 6-76083307 A_23_P69826 DHX15 Homo sapiens DEAH NM_001358 ENST00000535946 1665 DEAH chr4:24531344- GO:0008380|GO:0008026| NM_001358 THC2549682 Hs.696074 (Asp-Glu-Ala-His) box (Asp-Glu-Ala 24531285 GO:0006397|GO:0003724| polypeptide 15 His) box GO:0016787|GO:0000166| (DHX15), mRNA polypeptide 15 GO:0005634|GO:0003676| [NM_001358] GO:0005524|GO:0005689 A_24_P51683 CDK5R2 Homo sapiens cyclin- NM_003936 ENST00000302625 8941 cyclin- chr2:21982608 GO:0016534|GO:0016533| NM_003936 THC2472201 Hs.158460 dependent kinase 5, dependent 3-219826142 GO:0000079 regulatory subunit 2 kinase 5, (p39) (CDK5R2), regulatory mRNA [NM_003936] subunit 2 (p39) A_23_P258164 CORT Homo sapiens corti- NM_001302 ENST00000320498 1325 cortistatin chr1:10511688- GO:0001664|GO:0007268| NM_001302 THC2479856 Hs.412311 statin (CORT), mRNA 10511747 GO:0005625|GO:0005576| [NM_001302] GO:0005184|GO:0007193 A_33_P3345354 RRNAD1 Homo sapiens riboso- NM_015997 ENST00000368216 51093 ribosomal chr1:15670665 GO:0008649|GO:0016020| NM_015997 THC2463346 Hs.512597 mal RNA adenine di- RNA adenine 5-156706714 GO:0016021|GO:0000154| methylase domain con- dimethylase GO:0000179 taining 1 (RRNAD1), domain transcript variant 1, containing 1 mRNA [NM_015997] A_33_P3247858 MPP1 Homo sapiens mem- NM_001166461 ENST00000488694 4354 membrane chrX:15401931 GO:0005622|GO:0005515| NM_001166461 NP1465354 Hs.496984 brane protein, palmi- protein, 8-154019259 GO:0007165|GO:0016020| toylated 1, 55 kDa (MPP1), palmitoylated GO:0005887|GO:0032420| transcript variant 3, 1, 55 kDa GO:0005624|GO:0004385| mRNA [NM_001166461] GO:0030863|GO:0042995| GO:0019898 A_32_P219148 LOC497257 Homo sapiens cDNA BC030211 497257 hypothetical chr8:7917445- THC2499286 Hs.322761 clone IMAGE: 5199989. LOC497257 7917504 [BC030211] A_33_P3253239 chr1:18092278 THC2497493 4-180922843 A_24_P295999 CD4 Homo sapiens CD4 NM_000616 ENST00000011653 920 CD4 chr12:6929910- GO:0042289|GO:0005886| NM_000616 THC2470142 Hs.631659 molecule (CD4), molecule 6929969 GO:0050731|GO:0019059| transcript variant 1, GO:0001816|GO:0042803| mRNA [NM_000616] GO:0050850|GO:0051789| GO:0006955|GO:0001948| GO:0042101|GO:0044419| GO:0045860|GO:0007155| GO:0019901|GO:0015026| GO:0045058|GO:0006948| GO:0045086|GO:0050870| GO:0005789|GO:0005788| GO:0045121|GO:0008270| GO:0006487|GO:0016021| GO:0007169|GO:0005769| GO:0009897|GO:0005201| GO:0004888GO:0005769| A_33_P3369245 LOC100129826 PREDICTED: XR_114456 100129826 hypothetical chr11:1997823- XR_114456 THC2479538 Hs.3254 Homo sapiens hypo- LOC100129826 1997882 thetical LOC100129826 (LOC100129826), misc RNA [XR_114456] A_24_P816384 UBE2Q2P1 Homo sapiens ubiquitin- NR_003661 ENST00000339094 388165 ubiquitin- chr15:8509827 NR_003661 THC2783302 Hs.498348 conjugating enzyme E2Q conjugating 3-85098214 family member 2 enzyme E2Q pseudogene 1 family (UBE2Q2P1), non- member 2 coding RNA pseudogene 1 [NR_003661] A_33_P3331992 Uncharacterized protein ENST00000401694 chr7:15540401 THC2558637 [Source: UniProtKB/ 4-155403955 TrEMBL; Acc: B5MCR4] [ENST00000401694] A_23_P203475 PRKCDBP Homo sapiens protein NM_145040 ENST00000303927 112464 protein kinase chr11:6340269- GO:0005080 NM_145040 THC2467530 Hs.434044 kinase C, delta binding C, delta 6340210 protein (PRKCDBP), binding mRNA [NM_145040] protein A_33_P3268612 IL28RA Homo sapiens inter- NM_170743 ENST00000374421 163702 interleukin 28 chr1:24483896- GO:0005515|GO:0008285| NM_170743 NP610669 Hs.221375 leukin 28 receptor, receptor, alpha 24483837 GO:0004896|GO:0016020| alpha (interferon, lambda (interferon, GO:0032002|GO:0004872| receptor) (IL28RA), lambda GO:0016021|GO:0050691 transcript variant 1, receptor) mRNA [NM_170743] A_33_P3240340 chr17:0008624 93-000862552 A_33_P3261720 LOC151009 Homo sapiens hypo-9 NR_027244 151009 hypothetical chr2:11113460 NR_027244 THC2497499 Hs.516403 thetical LOC151009 LOC151009 3-111134544 (LOC151009), non- coding RNA [NR_027244] A_32_P32739 NAGS Homo sapiens N- NM_153006 ENST00000293404 162417 N-acetyl- chr17:4208630 GO:0005739|GO:0006536| NM_153006 THC2661443 Hs.8876 acetylglutamate synthase glutamate 2-42086361 GO:0003991|GO:0005759| (NAGS), mRNA synthase GO:0008152|GO:0006526| [NM_153006] GO:0000050|GO:0008652| GO:0016740|GO:0008415| GO:0004042 A_33_P3287815 DDX21 Homo sapiens DEAD NM_004728 ENST00000354185 9188 DEAD (Asp- chr10:7074418 GO:0005515|GO:0004004| NM_004728 THC2469678 Hs.223141 (Asp-Glu-Ala-Asp) box Glu-Ala-Asp) 6-70744245 GO:0016787|GO:0000166| polypeptide 21 (DDX21), box poly- GO:0003723|GO:0005730| mRNA [NM_004728] peptide 21 GO:0004386|GO:0005634| GO:0005524 A_33_P3249872 FBLN1 Homo sapiens fibulin NM_001996 ENST00000262722 2192 fibulin 1 chr22:4595917 GO:0005515|GO:0044419| NM_001996 THC2513019 Hs.24601 1 (FBLN1), transcript 3-45959232 GO:0005509|GO:0005578| variant C, mRNA GO:0005625|GO:0005576| [NM_001996] GO:0005615|GO:0005201 A_33_P3235132 LOC400968 Homo sapiens AK127783 ENST00000412149 400968 hypothetical chr15:2135658 THC2481983 Hs.592022 cDNA FLJ45884 LOC400968 9-21356648 fis, clone OCBBF3021166. [AK127783] A_24_P308029 HSPB6 Homo sapiens heat NM_144617 ENST00000416180 126393 heat shock chr19:3624607 GO:0005515|GO:0009408 NM_144617 THC2661563 Hs.534538 shock protein, alpha- protein, 9-36246020 crystallin-related, B6 alpha- (HSPB6), mRNA crystallin- [NM_144617] related, B6 A_23_P139198 LGALS12 Homo sapiens lectin, NM_033101 ENST00000394618 85329 lectin, chr11:6328393 GO:0005529|GO:0006915| NM_033101 NP374307 Hs.502774 galactoside-binding, galactoside- 7-63283996 GO:0005634|GO:0030395| soluble, 12 (LGALS12), binding, GO:0008629 transcript variant 2, soluble, 12 mRNA [NM_033101] A_33_P3375859 CXCR2P1 Homo sapiens chemo- NR_002712 ENST00000439871 3580 chemokine chr2:21892395 NR_002712 THC2605732 Hs.647858 kine (C-X-C motif) (C-X-C 9-218923900 receptor 2 pseudogene motif) 1 (CXCR2P1), non- receptor 2 coding RNA pseudogene 1 [NR_002712] A_33_P3303507 HSPA6 full-length cDNA CR623806 3310 heat shock chr1:16149384 THC2683968 Hs.654614 clone CS0DI029YJ23 70 kDa 9-161493908 of Placenta Cot 25- protein 6 normalized of Homo (HSP70B1) sapiens (human). [CR623806] A_33_P3220160 RAC2 Homo sapiens cDNA AK096924 ENST00000401529 5880 ras-related chr22:3763690 THC2510406 Hs.517601 FLJ39605 fis, clone C3 botuli- 7-37636848 SKNSH2005981, num toxin weakly similar to substrate 2 RAS-RELATED C3 (rho family, BOTULINUM small GTP TOXIN SUB. binding STRATE 2. [AK09G924] protein Rac2) A_33_P3424882 CSPG4P6Y PREDICTED: XM_002344203 100287758 chondroitin chrY:27626260- XM_002344203 Homo sapiens chondro- sulfate pro- 27626319 itin sulfate proteoglycan 4 teoglycan 4 pseudogene 6, Y linked pseudogene (CSPG4P6Y), mRNA 6, Y-linked [XM_002344203] A_33_P3224250 CLCC1 Homo sapiens chloride NM_001048210 ENST00000369971 23155 chloride chr1:10947221 GO:0006821|GO:0005792| NM_001048210 Hs.658489 channel CLIC-like 1 channel 5-109472156 GO:0005737|GO:0005794| (CLCC1), transcript CLIC-like 1 GO:0016020|GO:0005783| variant 1, mRNA GO:0005634|GO:0016021| [NM_001048210] GO:0005254 A_33_P3333603 SMOC1 Homo sapiens SPARC NM_022137 ENST00000381280 64093 SPARC chr14:7049010 GO:0005509|GO:0005576| NM_022137 THC2461766 Hs.497349 related modular calcium related 4-70490163 GO:0005604 binding 1 (SMOC1), modular transcript variant 2, calcium mRNA [NM_022137] binding 1 A_23_P76386 SLC6A12 Homo sapiens solute NM_003044 ENST00000424061 6539 solute carrier chr12:299799- GO:0016020|GO:0005887| NM_003044 THC2479328 Hs.437174 carrier family 6 (neuro- family 6 299740 GO:0005328|GO:0006865| transmitter transporter, (neurotransmitter GO:0006836|GO:0005332| betaine/GABA), member transporter, GO:0015293 12 (SLC6A12), betaine/GABA), transcript variant 1, member 12 mRNA [NM_003044] A_24_P233078 PYY2 Homo sapiens peptide NR_003064 ENST00000441253 23615 peptide YY, chr17:2655490 GO:0005179|GO:0005576 NR_003064 THC2480408 Hs.157195 YY, 2 (seminalplasmin) 2 (semi- 8-26554967 (PYY2), non-coding nalplasmin) RNA [NR_003064] A_33_P3313476 ZAR1L Homo sapiens zygote NM_001136571 ENST00000345108 646799 zygote arrest chr13:3287797 NM_001136571 THC2759804 Hs.569254 arrest 1-like (ZAR1L), 1-like 3-32877914 mRNA [NM_001136571] A_33_P3303394 chr17:0552088 95-055208836 A_33_P3376958 LOC96610 Homo sapiens BMS1 NR_027293 ENST00000390290 BMS1 homo- chr22:2267717 NR_027293 NP162580 Hs.449601 homolog, ribosome ass- log, ribosome 4-22677233 embly protein (yeast) assembly pro- pseudogene (LOC96610), tein (yeast) non-coding RNA pseudogene [NR_027293] A_32_P142700 C22orf15 Homo sapiens chromo- NM_182520 ENST00000336186 150248 chromosome chr22:2410683 NM_182520 NP1077442 Hs.116254 some 22 open reading 22 open 5-24106894 frame 15 (C22orf15), reading frame mRNA [NM_182520] 15 A_33_P3210622 ASB13 Homo sapiens ankyrin NM_024701 ENST00000482921 79754 ankyrin repeat chr10:5693260- GO:0005515|GO:0007242| NM_024701 THC2490517 Hs.445899 repeat and SOCS box and SOCS 5693201 GO:0019941 containing 13 (ASB13), box containing transcript variant 1, 13 mRNA [NM_024701] A_33_P3240318 PITX3 Homo sapiens paired- NM_005029 ENST00000370002 5309 paired like chr10:1039900 GO:0043565|GO:0006355| NM_005029 NP083974 Hs.137568 like homeodomain 3 homeo- 06-103989947 GO:0003700|GO:0048666| (PITX3), mRNA domain 3 GO:0009887|GO:0030901| [NM_005029] GO:0007626|GO:0007275| GO:0005634 A_23_P73747 ARMCX2 Homo sapiens arma- NM_014782 ENST00000328766 9823 armadillo chrX:10091039 GO:0016020|GO:0005488| NM_014782 THC2467696 Hs.48924 dillo repeat containing, repeat con- 4-100910335 GO:0016021 X-linked 2 (ARMCX2), taining, mRNA [NM_014782] X-linked 2 A_23_P325726 ACOT11 Homo sapiens acyl- NM_015547 ENST00000481208 26027 acyl-CoA chr1:55070090- GO:0004091|GO:0007242| NM_015547 THC2707621 Hs.729424 CoA thioesterase 11 thioesterase 11 55070795 GO:0005737|GO:0016787| (ACOT11), trans- GO:0016291|GO:0009409| cript variant 1, mRNA GO:0006631 [NM_015547] A_33_P3638471 TRGV7 Homo sapiens T cell BC027954 6981 T cell receptor chr7:38373063- THC2480213 Hs.534032 receptor gamma variable gamma 38373004 7 pseudogene, mRNA variable 7 (cDNA clone (pseudogene) IMAGE: 5210958). [BC027954] A_24_P64167 PTGS1 Homo sapiens prosta- NM_000962 ENST00000362012 5742 prostaglandin- chr9:12515753 GO:0005886|GO:0032811| NM_000962 THC2601958 Hs.201978 glandin-endoperoxide syn- endoperoxide 6-125157595 GO:0005783|GO:0005634| thase 1 (prostaglandin synthase 1 GO:0005635|GO:0046872| G/H synthase and cyclo- (prostaglandin GO:0008289|GO:0005737| oxygenase) (PTGS1), G/H synthase GO:0004601|GO:0001516| transcript variant 1, and cyclo- GO:0045907|GO:0045987| mRNA [NM_000962] oxygenase) GO:0042127|GO:0006633| GO:0006979|GO:0051412| GO:0005792|GO:0005794| GO:0007568|GO:0004666| GO:0010243|GO:0010700| GO:0008217|GO:0016491| GO:0016702|GO:0055114| GO:0019898|GO:0020037 A_23_P118095 RPL3L Homo sapiens ribosomal NM_005061 ENST00000268661 6123 ribosomal chr16:1995873- GO:0005622|GO:0003735| NM_005061 THC2472677 Hs.657266 protein L3-like (RPL3L), protein L3- 1995598 GO:0003723|GO:0005840| mRNA [NM_005061] like GO:0006414|GO:0005829 A_33_P3281283 S1PR3 Homo sapiens sphingo- NM_005226 ENST00000375846 1903 sphingosine-1- chr9:91619814- GO:0008284|GO:0005886| NM_005226 THC2494541 Hs.585118 sine-1-phosphate receptor phosphate 91619873 GO:0004930|GO:0001816| 3 (S1PR3), mRNA receptor 3 GO:0009653|GO:0007193| [NM_005226] GO:0007204|GO:0008289| GO:0007165|GO:0006954| GO:0001619|GO:0007186| GO:0005887|GO:0004872| GO:0032651 A_33_P3621701 Novel protein [Source: BC048428 ENST00000463107 chr22:4893919 THC2609712 Hs.159057 UniProtKB/TrEMBL; 3-48939134 Acc: A6ZJ83] [ENST00000463107] A_33_P3220445 SMAD5 Homo sapiens SMAD NM_001001419 ENST00000514641 4090 SMAD chr5:13551310 GO:0030618|GO:0005515| NM_001001419 THC2462440 Hs.167700 family member 5 family 9-135513168 GO:0005667|GO:0006355| (SMAD5), transcript member 5 GO:0003700|GO:0016563| variant 2, mRNA GO:0002051|GO:0005634| [NM_001001419] GO:0030509|GO:0060048| GO:0007281|GO:0005829| GO:0045669|GO:0009880| GO:0005622|GO:0007165| GO:0005737|GO:0045944| GO:0030218|GO:0001880| GO:0007179|GO:0005654| GO:0016021|GO:0005057 A_33_P3399634 RASSF10 Homo sapiens Ras NM_001080521 644943 Ras asso- chr11:1303258 GO:0007165 NM_001080521 Hs.134650 association (RalGDS/ ciation 8-13032647 AF-6) domain (RalGDS/AF-6) family (N-terminal) domain family member 10 (RASSF10), (N terminal) mRNA [NM_001080521] member 10 A_33_P3363355 ICAM4 Homo sapiens intercellular NM_022377 ENST00000393717 3386 intercellular chr19:1039913 GO:0005515|GO:0016337| NM_022377 THC2490784 Hs.706750 adhesion molecule 4 adhesion 9-10399198 GO:0005178|GO:0005886| (Landsteiner-Wiener molecule 4 GO:0005576|GO:0016021 blood group) (ICAM4), (Landsteiner- transcript variant 2, Wiener blood mRNA [NM_022377] group) A_33_P3223397 DHH_HUMAN (O43323) ENST00000553174 chr12:4948675 THC2641433 Desert hedgehog protein 2-49486811 precursor (DHH) (HHG-3) [Contains: Desert hedgehog protein N-product; Desert hedgehog protein C- product], partial (19%) [THC2641433] A_33_P3411985 RABGAP1 RAB GTPase activating ENST00000402311 23637 RAB chr9:12570765 THC2679929 protein 1 [Source: HGNC GTPase 1-125707710 Symbol; Acc: 17155] activating [ENST00000402311] protein 1 A_33_P3351180 immunoglobulin heavy XR_114797 ENST00000390547 chr14:1061735 XR_114797 NP852642 Hs.699841 constant alpha 1 [Source: 64-106173505 HGNC Symbol; Acc: 5478] [ENST00000390547] A_33_P3298567 ZNF692 zinc finger protein 692 AK309421 ENST00000391820 55657 zinc finger chr1:24915224 THC2523720 Hs.377705 [Source: HGNC Symbol; protein 692 7-249152188 Acc: 26049] [ENST00000391820] A_23_P209129 LAIR 2 Homo sapiens leukocyte- NM_002288 ENST00000301202 3904 leukocyte- chr19:5502180 GO:0005576|GO:0004872 NM_002288 THC2480754 Hs.43803 associated immunoglobulin- associated 9-55021868 like receptor 2 (LAIR2), immunoglo- transcript variant 1, bulin-like mRNA [NM_002288] receptor 2 A_33_P3405038 LOC100130264 Homo sapiens hypo- NR_024564 ENST00000319682 100130264 hypothetical chr20:1922300 NR_024564 THC2487513 Hs.683814 thetical LOC100130264 LOC100130264 5-19222946 (LOC100130264), non- coding RNA [NR_024564] A_23_P255257 DCAF12 Homo sapiens DDB1 NM_015397 ENST00000361264 25853 DDB1 and chr9:34086957- GO:0005813|GO:0005737 NM_015397 THC2468846 Hs.493750 and CUL4 associated CUL4 ass- 34086898 factor 12 (DCAF12), ociated factor mRNA [NM_015397] 12 A_33_P3329128 Q96DD6_HUMAN chr1:08975500 THC2715547 (Q96DD6) LOC119710 0-089754941 protein (HEPIS), partial (10%) [THC2715547] A_33_P3430391 LOC389273 Homo sapiens cDNA AK130861 ENST00000506021 389273 hypothetical chr5:10505167- NP1157119 Hs.519206 FLJ27351 fis, clone LOC389273 10505108 TST05050. [AK130861] A_33_P3214849 KDELC2 Homo sapiens KDEL NM_153705 ENST00000434945 143888 KDEL (Lys- chr11:1083431 GO:0005783|GO:0005788 NM_153705 THC2499983 Hs.83286 (Lys-Asp-Glu-Leu) con- Asp-Glu-Leu) 24-108343065 taining 2 (KDELC2), containing 2 mRNA [NM_153705] A_23_P342709 FBXO15 Homo sapiens F-box NM_152676 ENST00000269500 201456 F-box protein chr18:7174079 GO:0005515|GO:0019941| NM_152676 THC2472376 Hs.664011 protein 15 (FBXO15), 15 7-71740738 GO:0019005 transcript variant 1, mRNA [NM_152676] A_33_P3414228 chr15:0227486 70-022748611 A_33_P3356220 STARD3 Homo sapiens StAR- NM_001165937 ENST00000471896 10948 StAR-related chr17:3781966 GO:0006629|GO:0006694| NM_001165937 THC2526791 Hs.728838 related lipid transfer lipid transfer 3-37819722 GO:0005737|GO:0016020| (START) domain con- (START) GO:0015485|GO:0017127| taining 3 (STARD3), domain GO:0006869|GO:0016021| transcript variant 2, containing 3 GO:0006839|GO:0008289| mRNA [NM_001165937] GO:0008203|GO:0005768 A_24_P44462 TPM1 Homo sapiens tropo- NM_000366 ENST00000317516 7168 tropomyosin chr15:6335344 GO:0005862|GO:0055010| NM_000366 NP1470921 Hs.133892 myosin 1 (alpha) (TPM1), 1 (alpha) 1-63354441 GO:0008016|GO:0006928| transcript variant 5, GO:0060048|GO:0030017| mRNA [NM_000366] GO:0031529|GO:0006937| GO:0005737|GO:0003065| GO:0007010|GO:0008307| GO:0005856|GO:0001725| GO:0030336|GO:0030049| GO:0045214|GO:0003779| GO:0032587|GO:0032781| GO:0045785|GO:0032059| GO:0042060|GO:0051496| GO:0005200|GO:0034614 A_24_P813147 TUBB8 Homo sapiens tubulin, NM_177987 ENST00000328974 347688 tubulin, beta 8 chr10:93404- GO:0051258|GO:0000166| NM_177987 NP1178315 Hs.532659 beta 8 (TUBB8), trans- 93345 GO:0005198|GO:0005874| cript variant 1, GO:0003924|GO:0005525| mRNA[NM_177987] GO:0007018 A_33_P3259522 CDCP2 Homo sapiens CUB NM_201546 ENST00000371330 200008 CUB domain chr1:54605389- GO:0005576 NM_201546 THC2486749 Hs.568555 domain containing protein containing 54605330 2 (CDCP2), mRNA protein 2 [NM_201546] A_33_P3290124 ASB10 Homo sapiens ankyrin NM_001142459 ENST00000420175 136371 ankyrin repeat chr7:15087284 GO:0007242|GO:0019941 NM_001142459 NP1150152 Hs.647081 repeat and SOCS box and SOCS 8-150872789 containing 10 (ASB10), box containing transcript variant 1, 10 mRNA [NM_001142459] A_33_P3414017 chr7:00229924 2-002299301 A_23_P138717 RGS10 Homo sapiens regulator NM_001005339 ENST00000369103 6001 regulator of chr10:1212595 GO:0005515|GO:0009968| NM_001005339 THC2783455 Hs.501200 of G-protein signaling 10 G-protein 82-121259523 GO:0004871 (RGS10), transcript variant signaling 10 1, mRNA [NM_001005339] A_33_P3248586 DUX4 Homo sapiens double NM_033178 ENST00000507734 22947 double home- chrUn_gl00022 GO:0043565|GO:0006355| NM_033178 THC2493180 Hs.553518 homeobox 4 (DUX4), obox 4 8:77296-77355 GO:0003700|GO:0005634 mRNA [NM_033178] A_24_P56317 MBNL2 Homo sapiens muscle- NM_144778 ENST00000343600 10150 muscleblind- chr13:9804622 GO:0005737|GO:0003723| NM_144778 THC2468304 Hs.657347 blind-like 2 (Drosophila) like 2 6-98046285 GO:0008270|GO:0005634| (MBNL2), transcript (Drosophila) GO:0046872 variant 1, mRNA [NM_144778] A_23_P142389 LSR Homo sapiens lipolysis NM_205834 ENST00000361790 51599 lipolysis chr19:3575843 GO:0005794|GO:0005886| NM_205834 THC2519817 Hs.466507 stimulated lipoprotein stimulated 4-35758493 GO:0005730|GO:0042627| receptor (LSR), lipoprotein GO:0005634|GO:0009790| transcript variant 2, receptor GO:0019216|GO:0001889| mRNA [NM_205834] GO:0034361|GO:0005737| GO:0034362|GO:0004872| GO:0016021 A_33_P3354990 SYNJ2 synaptojanin 2[Source: AK296242 ENST00000449320 8871 synapto- chr6:15843876 THC2549364 Hs.434494 HGNC Symbol; janin 2 7-158438826 Acc: 11504] [ENST00000449320] A_33_P3295803 RAB2B Homo sapiens RAB2B, NM_032846 ENST00000304034 84932 RAB2B, chr14:2192838 GO:0005794|GO:0005886| NM_032846 THC2771975 Hs.22399 member RAS oncogene member 5-21928326 GO:0000166|GO:0000139| family (RAB2B), RAS onco- GO:0007264|GO:0005783| transcript variant 1, gene family GO:0005789|GO:0016192| mRNA [NM_032846] GO:0015031|GO:0005525 A_33_P3276329 Homo sapiens cDNA AK123110 chr7:74803807- THC2509132 Hs.594823 FLJ41115 fis, clone 74803748 BRACE1000533. [AK123110] A_33_P3303031 FLJ40606 Homo sapiens hypo- BC133006 643549 hypothetical chr20:4456322 Hs.472856 thetical protein LOC643549, protein 9-44563170 mRNA (cDNA Clone LOC643549 IMAGE: 40147028). [BC133006] A_23_P51487 GBP3 Homo sapiens guanylate NM_018284 ENST00000370481 2635 guanylate chr1:89472608- GO:0016020|GO:0000166| NM_018284 THC2491572 Hs.720167 binding protein 3 binding 89472549 GO:0003924|GO:0016021| (GBP3), mRNA protein 3 GO:0005525 [NM_018284] A_33_P3219811 PTGDS prostaglandin D2 syn- CR610092 ENST00000371623 5730 prostaglandin chr9:13987379 THC2644569 Hs.446429 thase 21 kDa (brain) D2 synthase [Source: HGNC Symbol; 21 kDa (brdin) 4-139873853 Acc: 9592] [ENST00000371623] A_23_P14302 C14orf139 Homo sapiens chromo- NR_026779 ENST00000464767 79686 chromosome chr14:9587374 NR_026779 THC2472996 Hs.41502 some 14 open reading 14 open 8-95873689 frame 139 (C14orf139), reading non-coding RNA frame 139 [NR_026779] A_33_P3373775 BCL2L15 Homo sapiens BCL2- NM_001010922 440603 BCL2-like chr1:11441952 GO:0006915|GO:0005634| NM_001010922 THC2651058 Hs.123106 like 15 (BCL2L15), 15 4-114419465 GO:0005829 mRNA [NM_001010922] A_33_P3357658 HMGA2 Homo sapiens high NM_003484 ENST00000354636 8091 high mobility chr12:6630924 GO:0005515|GO:0006355| NM_003484 THC2477434 Hs.505924 mobility group AT- group AT- 0-66309299 GO:0005694|GO:0006325| hook 2 (HMGA2), hook 2 GO:0005634|GO:0007275| transcript variant 2, GO:0003677|GO:0007049| mRNA [NM_003484] GO:0007067|GO:0003680| GO:0000785|GO:0040008| GO:0051301 A_32_P206735 L22858 AcOrf-91 chr3:11439201 THC2483664 peptide {Autographa- 2-114391953 californica nucleopolyhedro- virus}(exp = −1; wgp = 0; cg = 1), partial (8%) [THC2483664] A_33_P3239744 PREDICTED: XR_109661 ENST00000433071 chr21:3293257 XR_109661 THC2610508 Hs.708976 Homo sapiens hypo- 2-32932631 thetical LOC150051 (LOC150051), misc RNA [XR_109661] A_33_P3376925 chrX:09357475 7-093574816 A_23_P64070 SLC25A45 Homo sapiens solute NM_182556 ENST00000417511 283130 solute carrier chr11:6514381 GO:0005739|GO:0016020| NM_182556 NP1076259 Hs.661604 carrier family 25, family 25, 0-65143751 GO:0005488|GO:0005743| member 45 (SLC25A45), member 45 GO:0016021|GO:0055085 transcript variant 1, mRNA [NM_182556] A_33_P3273906 OR10G4 Homo sapiens olfactory NM_001004462 ENST00000320891 390264 olfactory re- chr11:1238870 GO:0007608|GO:0007165| NM_001004462 Hs.553760 receptor, family 10, ceptor, family 13-123887072 GO:0004984|GO:0007186| subfamily G, member 4 10, subfamily GO:0005886|GO:0004872| (OR10G4), mRNA G, member 4 GO:0016021|GO:0050896 [NM_1004462] A_33_P3333455 EMILIN1 Homo sapiens elastin NM_007046 ENST00000544143 11117 elastin chr2:27309204- GO:0030198|GO:0010811| NM_007046 THC2601131 Hs.63348 microfibril interfacer 1 microfibril 27309263 GO:0005578|GO:0030023| (EMILIN1), mRNA interfacer 1 GO:0005576|GO:0007155| [NM_007046] GO:0042802 A_33_P3279009 HMX1 Homo sapiens H6 NM_018942 ENST00000400677 3166 H6 family chr4:8869424- GO:0043565|GO:0016564| NM_018942 THC2476064 Hs.104134 family homeobox 1 homeobox 1 8869365 GO:0003700|GO:0007275| (HMX1), mRNA GO:0005634|GO:0045892 [NM_018042] A_33_P3257607 PPP1R12B Homo sapiens protein NM_001197131 4660 protein chr1:20250928 NM_001197131 Hs.444403 phosphatase 1, regu- phosphatase 1, 8-202509347 latory (inhibitor) subunit regulatory 12B (PPP1R12B), (inhibitor) transcript variant 7, subunit 12B mRNA [NM_001197131] A_33_P3289204 AAK1 Homo sapiens AP2 NM_014911 ENST00000409085 22848 AP2 chr2:69736579- GO:0005905|GO:0005886| NM_014911 THC2517701 Hs.468878 associated kinase 1 associated 69736520 GO:0000166|GO:0004674| (AAK1), kinase 1 GO:0006468|GO:0005524| mRNA [NM_014911] GO:0016740|GO:0019898 A_23_P63390 FCGR1B Homo sapiens Fc NM_001017986 ENST00000444948 2210 Fc fragment chr1:12092735 GO:0006955|GO:0005886| NM_001017986 THC2717837 Hs.534956 fragment of IgG, high of IgG, 3-120927294 GO:0019864|GO:0004872| affinity Ib, receptor high affinity GO:0016021|GO:0019763 (CD64) (FCGR1B), Ib, receptor transcript variant 1, (CD64) mRNA [NM_001017986] A_23_P5221 ZNF333 Homo sapiens zinc NM_032433 ENST00000292530 84449 zinc finger chr19:1483116 GO:0005622|GO:0006355| NM_032433 THC2515092 Hs.515215 finger protein 333 protein 333 7-14831226 GO:0008270|GO:0005634| (ZNF333), mRNA GO:0003677|GO:0046872 [NM_032433] A_33_P3274501 KLRF1 Homo sapiens killer NM_016523 ENST00000545196 51348 killer cell chr12:9984950- GO:0016020|GO:0005887| NM_016523 Hs.183125 cell lectin-like receptor lectin-like 9985009 GO:0005488|GO:0005529| subfamily F, member 1 receptor sub- GO:0007166|GO:0032393 (KLRF1), mRNA family F, [NM_016523] member 1 A_33_P3219591 RNF213 Homo sapiens ring NM_020954 ENST00000319921 57674 ring finger chr17:7829519 GO:0005515|GO:0017111| NM_020954 THC2470667 Hs.195642 finger protein 213 protein 213 9-78295258 GO:0000166|GO:0008270| (RNF213), transcript GO:0046872 variant 2, mRNA [NM_020954] A_33_P3376154 LOC100130825 PREDICTED: XM_001720026 100130825 hypothetical chr12:1321485 XM_001720026 Homo sapiens hypo- protein 97-132148538 thetical protein LOC100130825 LOC100130825 (LOC100130825), mRNA [XM_001720026] A_24_P943106 U2SURP Homo sapiens U2 NM_001080415 ENST00000473835 23350 U2 snRNP- chr3:14277866 GO:0006396|GO:0000166| NM_001080415 THC2556970 Hs.596572 snRNP-associated SURP associated 0-142778719 GO:0003723 domain containing SURP (U2SURP), domain mRNA [NM_001080415] containing A_24_P37409 DUSP2 Homo sapiens dual NM_004418 ENST00000488952 1844 dual specificity chr2:96809962- GO:0000188|GO:0006470| NM_004418 THC2687427 Hs.1183 specificity phosphatase 2 phosphatase 2 96809903 GO:0016787|GO:0008330| (DUSP2), mRNA GO:0005634|GO:0017017| [NM_004418] GO:0004725|GO:0051019 A_23_P164927 SYNGR4 Homo sapiens synap- NM_012451 ENST00000344846 23546 synaptogyrin 4 chr19:4887953 GO:0016020|GO:0016021 NM_012451 THC2478295 Hs.408333 togyrin 4 (SYNGR4), 8-48879597 mRNA [NM_012451] A_33_P3344291 CDNA FLJ46261 fis, XR_111092 ENST00000356374 chr10:8201292 XR_111092 THC2484630 Hs.447456 clone TESTI4025062 6-82012985 [Source: UniProtKB/ TrEMBL; Acc: Q6ZRL6] [ENST00000356374] A_23_P59772 CLCN1 Homo sapiens chloride NM_000083 ENST00000343257 1180 chloride chr7:14304368 GO:0042383|GO:0006821| NM_000083 THC2482326 Hs.121483 channel 1, skeletal channel 1, 3-143043742 GO:0031404|GO:0006036| muscle (CLCN1), skeletal GO:0005244|GO:0016020| mRNA [NM_000083] muscle GO:0005887|GO:0005247| GO:0034707|GO:0055085| GO:0019227|GO:0006811 A_33_P3340065 chr9:11741663 9-117416580 A_33_P3329549 FBRS Homo sapiens fibrosin NM_001105079 ENST00000395073 64319 fibrosin chr16:3068144 NM_001105079 THC2467136 Hs.247186 (FBRS), mRNA 4-30681503 [NM_001105079] A_32_P159445 IQSEC2 Homo sapiens IQ 2 NM_015075 ENST00000375365 23096 IQ motif chrX:53263787- GO:0005622|GO:0005086| NM_015075 THC2715714 Hs.496138 motif and Sec7 domain and Sec7 53263728 GO:0005737|GO:0032012 (IQSEC2), transcript domain 2 variant 2, mRNA [NM_015075] A_23_P25069 XM_003119523 ENST00000542925 chr12:3126780 XM_003119523 THC2503104 Hs.434604 0-31267369 A_33_P3262089 OR8G2 Homo sapiens olfactory NM_001007249 26492 olfactory chr11:1240960 GO:0007608|GO:0007165| NM_001007249 THC2605277 Hs.381319 receptor, family 8, receptor, 44-124096103 GO:0004984|GO:0007186| subfamily G, member family 8, GO:0005886|GO:0004872| 2 (OR8G2), mRNA subfamily G, GO:0016021|GO:0050896 [NM_001007249] member 2 A_32_P167471 CLMN Homo sapiens calmin NM_024734 ENST00000298912 79789 calmin chr14:9564867 GO:0005737|GO:0016020| NM_024734 THC2496792 Hs.301478 (calponin-like, trans- (calponin- 6-95648617 GO:0003779|GO:0016021 membrane) (CLMN), like, trans- mRNA [NM_024734] membrane) A_33_P3402010 LOC100508141 PREDICTED: XM_003119578 100508141 hypothetical chr14:7168309 XM_003119578 THC2750828 Hs.551210 Homo sapiens hypo- protein 5-71683036 thetical protein LOC100508141 LOC100508141 (LOC100508141), mRNA [XM_003119578] A_24_P272845 DOCK3 Homo sapiens dedi- NM_004947 ENST00000266037 1795 dedicator of chr3:51399313- GO:0005515|GO:0005085| NM_004947 THC2472118 Hs.476284 cator of cytokinesis 3 cytokinesis 3 51399372 GO:0017124|GO:0005737| (DOCK3), mRNA GO:0051020|GO:0005625| [NM_004947] GO:0005525 A_23_P140675 EPB42 Homo sapiens erythro- NM_000119 ENST00000397027 2038 erythrocyte chr15:4348956 GO:0005515|GO:0005737| NM_000119 NP1465858 Hs.368642 cyte membrane protein membrane 5-43489506 GO:0043249|GO:0018149| band 4.2 (EPB42), protein GO:0005886|GO:0008360| transcript variant 1, band 4.2 GO:0003810|GO:0005200| mRNA [NM_000119] GO:0005856|GO:0005524 A_33_P3389773 EFCB_PAPAN chr7:06429575 THC2739063 (P61552) ERV-BabFcenv 9-064295700 provirus ancestral Env polyprotein precursor (En- velope polyprotein) (BabFcenv) [Includes: Surface protein (SU); Transmembrane protein (TM)], partial (28%) [THC2739063] A_33_P3245623 TSPY17P PREDICTED: XM_003118834 100132124 testis specific chrY:6388944- XM_003118834 Homo sapiens testis protein, Y- 6389003 specific protein, Y- linked 17, linked 17 (pseudogene) pseudogene (TSPY17P), mRNA [XM_003118834] A_33_P3882264 GRASPOS Homo sapiens cDNA BC028005 692159 GRP1-asso- chr12:5240008 Hs.621295 clone IMAGE: 5212507. ciated scaffold 7-52400028 [BC028005] protein op- posite strand A_33_P3419621 LOC100289580 Homo sapiens cDNA AK127064 100289580 hypothetical chr16:8880774 THC2664787 FLJ45121 fis, clone LOC100289580 8-88807807 BRAWH3036077. [AK127064] A_33_P3285354 C11orf95 Homo sapiens chromo- NM_001144936 ENST00000445014 65998 chromosome chr11:6353333 NM_001144936 THC2632379 Hs.101073 some 11 open reading 11 open reading 9-63533280 frame 95 (C11orf95), frame 95 mRNA [NM_001144936] A_33_P3220149 MAML1 mastermind-like 1 AB209135 ENST00000503050 9794 mastermind- chr5:17922321 THC2776662 Hs.631951 (Drosophila) [Source: like 1 3-179223272 HGNC Symbol; (Drosophila) Acc: 13632] [FNST00000503050] A_23_P16252 KLK1 Homo sapiens kallikrein NM_002257 ENST00000448701 3816 kallikrein 1 chr19:5132250 GO:0004252|GO:0006508| NM_002257 NP113453 Hs.123107 1 (KLK1), mRNA 6-51322447 GO:0008233 [NM_002257] A_23_P354894 ZNF567 Homo sapiens zinc NM_152603 ENST00000360729 163081 zinc finger chr19:3721195 GO:0005622|GO:0006355| NM_152603 THC2628196 Hs.412517 finger protein 567 protein 567 4-37212013 GO:0008270|GO:0005634| (ZNF567), mRNA GO:0003677|GO:0046872 [NM_52603] A_23_P366812 AQP5 Homo sapiens aqua- NM_001651 ENST00000553132 362 aquaporin 5 chr12:5035882 GO:0005515|GO:0005215| NM_001651 THC2616592 Hs.298023 porin 5 (AQP5), mRNA 1-50358880 GO:0007588|GO:0005783| [NM_001651] GO:0015670|GO:0055085| GO:0005902|GO:0016324| GO:0009925|GO:0016020| GO:0005887|GO:0015250| GO:0006833 A_24_P363548 HIP1 Homo sapiens hunting- NM_005338 ENST00000336926 3092 huntingtin chr7:75164311- GO:0008219|GO:0005794| NM_005338 THC2501285 Hs.329266 tin interacting protein interacting 75164252 GO:0006919|GO:0005624| 1 (HIP1), mRNA protein 1 GO:0042981|GO:0003779| [NM_005338] GO:0005634|GO:0031410| GO:0006917|GO:0030154| GO:0006897|GO:0012505| GO:0030665|GO:0005737| GO:0016020|GO:0030276| GO:0048260|GO:0005200| GO:0035091|GO:0005856| GO:0045449|GO:0048268 A_33_P3383029 MXI1 Homo sapiens MAX NM_130439 ENST00000369613 4601 MAX chr10:1120447 GO:0008285|GO:0003714| NM_130439 THC2522010 Hs.501023 interactor 1 (MXI1), interactor 1 47-112044806 GO:0030528|GO:0042994| transcript variant 2, GO:0005634|GO:0003677| mRNA [NM_130439] GO:0045449 A_33_P3302210 LOC100129129 PREDICTED: XR_113108 ENST00000525867 100129129 hypothetical chr8:11203536- XR_113108 THC2610893 Hs.662094 Homo sapiens hypo- LOC100129129 11203477 thetical LOC100129129 (LOC100129129), partial miscRNA [XR_113108] A_24_P346762 KIAA1539 Homo sapiens NM_025182 ENST00000479357 80256 KIAA1539 chr9:35105138- GO:0005634 NM_025182 THC2653744 Hs.301696 KIAA1539 (KIAA1539), 35105079 mRNA [NM_025182] A_24_P134392 HSPA13 Homo sapiens heat NM_006948 ENST00000285667 6782 heat shock chr21:1574363 GO:0005792|GO:0000166| NM_006948 THC2469197 Hs.352341 shock protein 70 kDa protein 70 kDa 5-15743576 GO:0005783|GO:0005524 family, member 13 family, (HSPA13), mRNA member 13 [NM_006948] A_33_P3374388 LOC100131702 Homo sapiens cDNA AK126983 100131702 hypothetical chr22:2424712 Hs.656723 FU45037 fis, clone protein 1-24247062 BRAWH3019820. LOC100131702 [AK126983] A_33_P3344339 KCNH5 Homo sapiens potas- NM_139318 ENST00000420622 27133 potassium chr14:6317408 GO:0005516|GO:0006355| NM_139318 THC2490856 Hs.27043 sium voltage-gated voltage- 4-63174025 GO:0000160|GO:0005244| channel, subfamily H gated channel, GO:0016020|GO:0005249| (eag-related), member 5 subfamily H GO:0030955|GO:0016021| (KCNH5), transcript (eag-related), GO:0055085|GO:0006813| variant 1, mRNA member 5 GO:0000155|GO:0006811 [NM_139318] A_24_P312519 PBLD Homo sapiens phenazine NM_001033083 ENST00000468798 64081 phenazine chr10:7004871 GO:0008150|GO:0009058| NM_001033083 THC2576209 Hs.198158 biosynthesis-like pro- biosynthesis- 9-70048391 GO:0005575|GO:0016853 tein domain containing like protein (PBLD), transcript domain variant 2, mRNA containing [NM_001033083] A_23_P96285 REEP1 Homo sapiens receptor NM_022912 ENST00000535845 65055 receptor chr2:86441557- GO:0005739|GO:0008219| NM_022912 THC2468332 Hs.368884 accessory protein 1 accessory 86441498 GO:0005737|GO:0016020| (REEP1), nuclear gene protein 1 GO:0051205|GO:0016021| encoding mitochondrial GO:0031849 protein, transcript variant 2, mRNA [NM_022912] A_33_P3413795 XM_001721393 ENST00000427872 chr1:12090512 XM_001721393 THC2698492 Hs.568526 8-120905069 A_33_P3326447 LOC100510506 PREDICTED: XM_003120741 100510506 hypothetical chr12:1293281 XM_003120741 THC2479151 Hs.449723 Homo sapiens hypo- protein 17-129328058 thetical protein LOC100510506 LOC100510506 (LOC100510506), mRNA [XM_003120741] A_33 P3213747 ZNHIT2 Homo sapiens zinc NM_014205 ENST00000310597 741 zinc finger, chr11:6488413 GO:0008270|GO:0046872 NM_014205 THC2467573 Hs.121025 finger, HIT-type con- HIT-type 1-64884072 taining 2 (ZNHIT2), containing 2 mRNA [NM_014205] A_33_P3271885 chrY:01967126 1-019671202 A_33_P3413759 ACER2 Homo sapiens alkaline NM_001010887 ENST00000380376 340485 alkaline chr9:19424730- GO:0006629|GO:0017040| NM_001010887 NP1212864 Hs.41379 ceramidase 2 (ACER2), ceramidase 2 19424789 GO:0005794|GO:0016787| mRNA [NM_001010887] GO:0016020|GO:0000139| GO:0006672|GO:0005789| GO:0016021 A_32_P224850 chr2:12048089 THC2715283 2-120480833 A_33_P3410925 KLF1 Homo sapiens Kruppel- NM_006563 ENST00000264834 10661 Kruppel-like chr19:1299529 GO:0005622|GO:0001889| NM_006563 THC2478746 Hs.37860 like factor 1 (erythroid) factor 1 5-12995236 GO:0043249|GO:0003700| (KLF1), mRNA (erythroid) GO:0008270|GO:0006338| [NM_006563] GO:0005634|GO:0035162| GO:0001701|GO:0046872| GO:0045449 A_23_P1682 TMEM45B Homo sapiens trans- NM_138788 ENST00000281441 120224 transmem chr11:1297289 GO:0016020|GO:0016021 NM_138788 THC2463597 Hs.504301 membrane protein 45B brane protein 46-129729005 (TMEM45B), mRNA 45B [NM_138788] A_23_P430161 EXOC8 Homo sapiens exocyst NM_175876 ENST00000366645 149371 exocyst com- chr1:23146914 GO:0005515|GO:0005737| NM_175876 THC2474277 Hs.356198 complex component 8 plex compo- 5-231469086 GO:0000145|GO:0042995| (EXOC8), mRNA nents GO:0015031|GO:0006887| [NM_175876] GO:0030426 A_33_P3276784 ENST00000454671 chr16:2312284- 2312343 A_33_P3268234 KRT39 Homo sapiens keratin NM_213656 ENST00000355612 390792 keratin 39 chr17:3911474 GO:0005882|GO:0005198 NM_213656 THC2487370 Hs.28467 39 (KRT39), mRNA 0-39114681 [NM_213656] A_23_P134814 THAP1 Homo sapiens THAP NM_018105 ENST00000345117 55145 THAP chr8:42692056- GO:0043565|GO:0007346| NM_018105 THC2605203 Hs.7432 domain containing, apop- domain con- 42691997 GO:0007049|GO:0006355| tosis associated protein 1 taining, apop- GO:0030528|GO:0001935| (THAP1), transcript tosis asso- GO:0008270|GO:0005654| variant 1, mRNA ciated protein GO:0005634|GO:0046872 [NM_018105] 1 A_33_P3355418 AGBLl Homo sapiens ATP/ NM_152336 ENST00000389298 123624 ATP/GTP chr15:8721754 GO:0005737|GO:0005488| NM_152336 Hs.679833 GTP binding protein-like binding 6-87217605 GO:0006508|GO:0008270| 1 (AGBL1), mRNA protein-like 1 GO:0008233|GO:0046872| [NM_152336] GO:0008237|GO:0004181 A_24_P212024 immunoglobulin kappa AY867113 ENST00000498435 chr2:89513053- NP1400333 Hs.720289 variable 1-27 [Source: 89512994 HGNC Symbol; Acc: 5735] [ENST00000498435] A_33_P3775281 LOC644050 Homo sapiens cDNA AK055260 644050 hypothetical chr19:3627983 THC2637220 Hs.651888 FLJ30698 fis, clone LOC644050 7-36279778 FCBBF2000825. [AK055260] A_33_P3305320 LOC100289383 PREDICTED: XM_002344123 100289383 capicua chr16:9023891 XM_002344123 THC2481163 Homo sapiens protein homolog 6-90238857 capicua homolog pseudogene (LOC100289383), mRNA [XM_002344123] A_24_P605563 immunoglobulin AY172962 ENST00000390323 chr22:2324328 NP493030 Hs.625768 lambda constant 2 (Kern- 6-23243345 Oz- marker) [Source: HGNC Symbol; Acc: 5856] [ENST00000390323] A 33_P3346098 TAOK2 Homo sapiens TAO NM_016151 ENST00000308893 9344 TAO chr16:2999951 GO:0030036|GO:0000287| NM_016151 NP797374 Hs.291623 kinase 2 (TAOK2), kinase 2 5-29999574 GO:0008360|GO:0046330| transcript variant 2, GO:0006950|GO:0006915| mRNA [NM_016151] GO:0001558|GO:0005524| GO:0000186|GO:0016477| GO:0000166|GO:0016020| GO:0004674|GO:0048041| GO:0006612|GO:0016023| GO:0016021|GO:0016740 A_33_P3408711 FLNA Homo sapiens filamin NM_001456 ENST00000369852 2316 filamin A, chrX:15358990 GO:0005802|GO:0005886| NM_001456 THC2728266 Hs.195464 A, alpha (FLNA), trans- alpha 3-153589844 GO:0031267|GO:0005634| cript variant 1, mRNA GO:0007195|GO:0015629| [NM_001456] GO:0045022|GO:0042993| GO:0042803|GO:0043433| GO:0045184|GO:0005829| GO:0005737|GO:0051015| GO:0001948|GO:0005080| GO:0051764|GO:0004871| GO:0043123|GO:0005938| GO:0034989|GO:0034988| GO:0031532|GO:0042177| GO:0051220|GO:0050821| GO:0005576|GO:0048365| GO:0034394|GO:0043113| GO:0008134 A_33_P3316093 ENST00000415226 chr2:23720349 3-237203552 A_23_P128919 LGALS3 Homo sapiens lectin, NM_002306 ENST00000254301 3958 lectin, galac chr14:5560945 GO:0005515|GO:0019863| NM_002306 THC2745323 Hs.531081 galactoside-binding, soluble, toside-binding, 4-55611879 GO:0005737|GO:0001501| 3 (LGALS3), soluble, 3 GO:0005886|GO:0030198| transcript variant 1, GO:0005578|GO:0005529| mRNA [NM_002306] GO:0005634|GO:0030154 A_24_P64918 ZBTB1 Homo sapiens zinc NM_014950 ENST00000394712 22890 zinc finger chr14:6499000 GO:0005622|GO:0005515| NM_014950 THC2471109 Hs.605143 finger and BTB domain and BTB 3-64990062 GO:0008270|GO:0005634| containing 1 (ZBTB1), domain GO:0003677|GO:0046872| transcript variant 2, containing 1 GO:0045449 mRNA [NM_014950] A_33_P3294217 UTF1 Homo sapiens undif- NM_003577 ENST00000304477 8433 undifferentiated chr10:1350450 GO:0005515|GO:0003702| NM_003577 THC2486743 Hs.458406 ferentiated embryonic cell embryonic cell 03-135045062 GO:0045944|GO:0003713| transcription factor 1 transcription GO:0005634|GO:0045449| (UTF1), mRNA factor 1 GO:0008584 [NM_003577] A_33_P3799692 LOC338620 Homo sapiens hypothe- BC043009 338620 hypothetical chr10:3317636 THC2707863 Hs.660499 tical protein LOC338620, protein 5-33176306 mRNA (cDNA clone LOC338620 IMAGE:6023208), partial cds. [BC043009] A_33_P3228757 ZNF814 Homo sapiens zinc NM_001144989 ENST00000376205 730051 zinc finger chr19:5838424 GO:0005622|GO:0006355| NM_001144989 Hs.634143 finger protein 814 protein 814 9-58384190 GO:0008270|GO:0005634| (ZNF814), mRNA GO:0003677|GO:0046872 [NM_001144989] A_33_P3226070 chr4:00154889 6-001548955 A_33_P3216487 chr11:1113290 97-111329156 A_23_PI24988 KCNH4 Homo sapiens potas- NM_012285 ENST00000264661 23415 potassium chr17:4031177 GO:0006355|GO:0000160| NM_012285 THC2488133 Hs.304081 sium voltage-gated chan- voltage-gated 6-40309105 GO:0005244|GO:0016020| nel, subfamily H (eag- channel, sub- GO:0008076|GO:0005249| related), member 4 family H GO:0030955|GO:0016021| (KCNH4), mRNA (eag-related), GO:0055085|GO:0006813| [NM_012285] member 4 GO:0000155|GO:0006811 A_33_P3366903 CHST6 Homo sapiens carbo- NM_021615 ENST00000390664 4166 carbohydrate chr16:7551246 GO:0006790|GO:0005794| NM_021615 THC2483430 Hs.655622 hydrate (N-acetyl- (N-acetylglu- 3-75512404 GO:0018146|GO:0016020| glucosamine cosamine 6-O) GO:0000139|GO:0005975| 6-O) sulfotransferase 6 sulfotransferase 6 GO:0006044|GO:0016021| (CHST6), mRNA GO:0001517|GO:0016740 [NM_021615] A_24_P374244 GATA1 Homo sapiens GATA NM_002049 ENST00000376665 2623 GATA binding chrX:48650853- GO:0043565|GO:0005515| NM_002049 NP370725 Hs.765 binding protein 1 protein 1 48651615 GO:0003700|GO:0006357| (globin transcription (globin trans- GO:0005730|GO:0008270| factor 1) (GATA1), cription factor GO:0007275|GO:0005634| mRNA 1) GO:0046872 [NM_002049] A_24_P686965 SH2D5 Homo sapiens SH2 NM_001103161 ENST00000375031 400745 SH2 domain chr1:21046321- GO:0005515 NM_001103161 THC2473200 Hs.591522 domain containing 5 containing 5 21046262 (SH2D5), transcript variant 1, mRNA [NM_001103161] A_33_P3210671 GPAT2 Homo sapiens glycerol- NM_207328 ENST00000458519 150763 glycerol-3- chr2:96690381- GO:0005739|GO:0016020| NM_207328 THC2483887 Hs.348629 3-phosphate acyltrans- phosphate 96690322 GO:0008152|GO:0005741| ferase 2, mitochondrial acyltransferase GO:0004366|GO:0016021| (GPAT2), nuclear gene 2, mitochondrial GO:0008654|GO:0016740| encoding mitochondrial GO:0008415 protein, mRNA [NM_207328] A_33_P3281465 SLC5A6 Homo sapiens solute NM_021095 ENST00000408041 8884 solute carrier chr2:27423946- GO:0012506|GO:0015887| NM_021095 THC2507513 Hs.435735 carrier family 5 (sodium- family 5 27423887 GO:0005215|GO:0005624| dependent vitamin trans- (sodium- GO:0031526|GO:0031402| porter), member 6 dependent GO:0055085|GO:0016020| (SLC5A6), transcript vitamin GO:0005887|GO:0008523| variant 1, mRNA transporter), GO:0015878|GO:0006814| [NM_021095] member 6 GO:0006811|GO:0015293 A_23_P8142 CLPS Homo sapiens colipase, NM_001832 ENST00000541088 1208 colipase, chr6:35762842- GO:0016042|GO:0007586| NM_001832 THC2601801 Hs.1340 pancreatic (CLPS), pancreatic 35762783 GO:0005576|GO:0043085| mRNA [NM_001832] GO:0009791|GO:0008047| GO:0032094 A_33_P3236327 Homo sapiens cDNA AK128005 ENST00000371169 chr20:5653224 THC2484382 FLJ46124 fis, clone 1-56532182 TESTI2040372. [AK128005] A_23_P64792 KCNMB4 Homo sapiens potas- NM_014505 ENST00000258111 27345 potassium chr12:7082462 GO:0005515|GO:0005513| NM_014505 THC2470841 Hs.525529 sium large conductance large con- 3-70824682 GO:0016020|GO:0008076| calcium-activated ductance cal- GO:0046928|GO:0007268| channel, subfamily M, cium-activated GO:0015269|GO:0006813| beta member 4 channel, sub- GO:0005216|GO:0019228| (KCNMB4), family M, GO:0019229|GO:0006811 mRNA [NM_014505] beta member 4 A_33_P3379039 IGLL5 Homo sapiens immuno- NM_001178126 ENST00000390321 100423062 immunoglo- chr22:2323763 NM_001178126 NP492959 Hs.449585 globulin lambda-like bulin lambda- 0-23237689 polypeptide 5 (IGLL5), like poly- transcript variant 1, peptide 5 mRNA [NM_001178126] A_32_P516342 ANKRD33 Homo sapiens ankyrin NM_182608 ENST00000548383 341405 ankyrin chr12:5228498 NM_182608 NP1159358 Hs.433492 repeat domain 33 repeat 5-52285044 (ANKRD33), transcript domain 33 variant 2, mRNA [NM_182608] A_33_P3337161 ADCY4 Homo sapiens adenylate NM_001198568 ENST00000396747 196883 adenylate chr14:2479333 GO:0000287|GO:0005886| NM_001198568 THC2471883 Hs.443428 cyclase 4 (ADCY4), cyclase 4 1-24793272 GO:0005524|GO:0007193| transcript variant 3, GO:0030425|GO:0005622| mRNA [NM_001198568] GO:0004016|GO:0009755| GO:0000166|GO:0006171| GO:0007189|GO:0016021| GO:0034199 A_33_P3321611 PHACTR4 Homo sapiens phos- NM_001048183 ENST00000463428 65979 phosphatase chr1:28792957- GO:0004864|GO:0003779 NM_001048183 THC2478475 Hs.225641 phatase and actin regu- and actin 28793016 lator 4 (PHACTR4), regulator 4 transcript variant 1, mRNA [NM_001048183] A_24_P402898 OTUD4 Homo sapiens OTU NM_001102653 ENST00000454497 54726 OTU chr4:14605562 GO:0005515|GO:0008150| NM_001102653 THC2603393 Hs.270851 domain containing 4 domain 3-146055564 GO:0003674|GO:0005575 (OTUD4), transcript containing 4 variant 3, mRNA [NM_001102653] A_24_P18917 LMF1 Homo sapiens lipase NM_022773 ENST00000543238 64788 lipase chr16:904229- GO:0009306|GO:0016020| NM_022773 THC2628156 Hs.71912 maturation factor 1 maturation 904170 GO:0005783|GO:0016021 (LMF1), transcript factor 1 variant 1, mRNA [NM_022773] A_33_P3226008 GCET2 Homo sapiens germinal NM_001190259 ENST00000495418 257144 germinal chr3:11184240 GO:0005739|GO:0005737 NM_001190259 THC2607167 Hs.49614 center expressed trans- center ex- 6-111842347 cript 2 (GCET2), pressed transcript variant 3, transcript 2 mRNA [NM_001190259] A_24_P288836 HLA-DPB2 Homo sapiens major NR_001435 3116 major histo- chr6:33096422- NR_001435 histocompatibility complex, compatibility 33096481 class II, DP beta 2 complex, (pseudogene) (HLA- class II, DPB2), non-coding RNA DP beta 2 [NR_001435] (pseudogene) A_32_P158966 KLRF1 Homo sapiens killer NM_016523 ENST00000535631 51348 killer cell chr12:9997324- GO:0016020|GO:0005887| NM_016523 NP183062 Hs.183125 cell lectin-like receptor lectin-like 9997383 GO:0005488|GO:0005529| subfamily F, member 1 receptor GO:0007166|GO:0032393 (KLRF1), mRNA subfamily F, [NM_016523] member 1 A_33_P3360392 NCRNA00092 Homo sapiens non- NR_024129 100188953 non-protein chr9:98782134- NR_024129 THC2497538 Hs.434310 protein coding RNA coding 98782075 92 (NCRNA00092), non- RNA92 coding RNA [NR_024129] A_32_P205110 FOXC1 Homo sapiens fork- NM_001453 ENST00000380874 2296 forkhead chr6:1613858- GO:0001657|GO:0055010| NM_001453 THC2495614 Hs.348883 head box C1 (FOXC1), box C1 1613917 GO:0003705|GO:0016563| mRNA [NM_001453] GO:0048844|GO:0005634| GO:0001541|GO:0050880| GO:0007219|GO:0014032| GO:0045944|GO:0030199| GO:0042475|GO:0043010| GO:0030203|GO:0001945| GO:0048010|GO:0046620| GO:0008354|GO:0001568| GO:0035050|GO:0001822| GO:0008301|GO:0048762| GO:0006916|GO:0001701| GO:0060038|GO:0043565| GO:0032808|GO:0005720| GO:0003007|GO:0001501| GO:0001503|GO:0045930| GO:0001974|GO:0007420| GO:0048341|GO:0008134 A_23_P95594 NAT1 Homo sapiens N-acetyl- NM_000662 ENST00000520546 9 N-acetyl- chr8:18080376- GO:0005737|GO:0008152| NM_000662 THC2490997 Hs.591847 transferase 1 (arylamine transferase 18080435 GO:0004060|GO:0016407| N-acetyltransferase) 1 (arylamine GO:0016740|GO:0005829 (NAT1), transcript N-acetyl- variant 5, mRNA transferase ) [NM_000662] A_33_P3344451 C16orf13 Homo sapiens chromo- NM_032366 ENST00000301686 84326 chromosome chr16:684643- NM_032366 THC2653959 Hs.239500 some 16 open reading 16 open 684584 frame 13 (C16orf13), reading transcript variant 1, frame 13 mRNA[NM_032366] A_32_P172864 FAM102B Homo sapiens family NM_001010883 ENST00000483371 284611 family with chr1:10918162 NM_001010883 THC2601428 Hs.200230 with sequence similarity sequence 2-109181681 102, member B similarity (FAM102B), mRNA 102, member [NM_001010883] B A_23_P144126 FETUB Homo sapiens fetuin NM_014375 ENST00000420570 26998 fetuin B chr3:18637051 GO:0008150|GO:0003674| NM_014375 THC2470628 Hs.81073 B (FETUB), mRNA 8-186370577 GO:0004869|GO:0005576 [NM_014375] A_32_PI33090 RST35951 Athersys BG216262 chr3:12551663 THC2580853 Hs.637431 RAGE Library Homo 4-125516693 sapiens cDNA, mRNA sequence [BG216262] A_33_P3419808 immunoglobulin lambda AF060129 ENST00000390304 chr22:2301121 THC2523002 Hs.729081 variable 3-27[Source: 9-23011276 HGNC Symbol; Acc: 5910] [ENST00000390304] A_24_P331150 CYP4F22 Homo sapiens cyto- NM_173483 ENST00000269703 126410 cytochrome chr19:1566272 GO:0005792|GO:0004497| NM_173483 THC2479532 Hs.156452 chrome P450, family 4, P450, family 0-15662779 GO:0016020|GO:0005783| subfamily F, polypeptide 4, subfamily GO:0009055|GO:0046872| 22 (CYP4F22), mRNA F, polypep- GO:0055114|GO:0020037| [NM_173483] tide 22 GO:0019898 A_23_P141173 MPO Homo sapiens myelo- NM_000250 ENST00000340482 4353 myelo- chr17:5634792 GO:0005509|GO:0005634| NM_000250 THC2776236 Hs.458272 peroxidase (MPO), nuclear peroxidase 7-56347868 GO:0006916|GO:0006952| gene encoding mito- GO:0005615|GO:0005764| chondrial protein, mRNA GO:0004601|GO:0034374| [NM_000250] GO:0003682|GO:0016491| GO:0042744|GO:0006979| GO:0055114|GO:0020037 A_33_P3320748 FDX1L Homo sapiens ferre- NM_001031734 ENST00000343376 112812 ferredoxin chr19:1042158 GO:0005739|GO:0005506| NM_001031734 THC2668248 Hs.654865 doxin 1-like (FDX1L), 1-like 9-10421530 GO:0051537|GO:0005759| nuclear gene encoding GO:0006810|GO:0009055| mitochondrial protein, GO:0022900|GO:0046872 mRNA [NM_001031734] A_33_P3301620 RNF32 Homo sapiens ring NM_001184997 ENST00000392740 140545 ring finger chr7:15643739 GO:0005515|GO:0005737| NM_001184997 THC2771893 Hs.446194 finger protein 32 (RNF32), protein 32 1-156437450 GO:0016235|GO:0008270| transcript variant 2, GO:0046872|GO:0005768 mRNA[NM_001184997] A_33_P3295738 CNGB1 Homo sapiens cyclic NM_001135639 ENST00000311183 1258 cyclic nu- chr16:5799480 GO:0007608|GO:0005222| NM_001135639 NP087010 Hs.147062 nucleotide gated channel cleotide 4-57994745 GO:0005624|GO:0045494| beta 1 (CNGB1), gated chan- GO:0055085|GO:0030552| transcript variant 2, nel beta 1 GO:0000166|GO:0016020| mRNA [NM_001135639] GO:0016021|GO:0007602| GO:0050896|GO:0006811| GO:0015276|GO:0017071 A_23_P21485 PID1 Homo sapiens phos- NM_017933 ENST00000392055 55022 phospho- chr2:22988903 GO:0005737 NM_017933 THC2606128 Hs.409352 photyrosine interaction tyrosine in- 0-229888971 domain containing 1 teraction (PID1), transcript domain variant 1, mRNA containing 1 [NM_017933] A_33_P3355306 LYG2 Homo sapiens LYGH AF323919 ENST00000409679 254773 lysozyme chr2:99860310- THC2487325 Hs.436468 mRNA, complete cds. G-like 2 99860251 [AF323919] A_33_P3320953 CTXN1 Homo sapiens cortexin NM_206833 ENST00000318978 404217 cortexin 1 fhrl9:7989441- GO:0016020|GO:0016021 NM_206833 THC2471562 Hs.657978 1 (CTXN1), mRNA 7989382 [NM_206833] A_33_P3247890 T cell receptor alpha X58744 ENST00000390423 chr14:2211173 NP096670 Hs.455887 variable 1-2 [Source: 2-22111791 HGNC Symbol; Acc: 12102] [ENST00000390423] A_23_P49559 GPR142 Homo sapiens G NM_181790 ENST00000335666 350383 G protein- chr17:7236829 GO:0007165|GO:0007186| NM_181790 THC2603174 Hs.574368 protein-coupled receptor coupled re- 8-72368357 GO:0005886|GO:0004930| 142 (GPR142), mRNA ceptor 142 GO:0004872|GO:0016021 [NM_181790] A_33_P3316273 CCL3 Homo sapiens chemo- NM_002983 ENST00000470334 6348 chemokine chr17:3441566 GO:0008009|GO:0007267| NM_002983 THC2601998 Hs.514107 kine (C-C motif) ligand (C-C motif) 4-34415605 GO:0006874|GO:0045069| 3 (CCL3), mRNA ligand 3 GO:0006928|GO:0005576| [NM_002983] GO:0005625|GO:0006887| GO:0042056|GO:0005615| GO:0007165|GO:0006955| GO:0006954|GO:0006935| GO:0007186|GO:0007010| GO:0004871 A_23_P78543 AP1M2 Homo sapiens adaptor- NM_005498 ENST00000250244 10053 adaptor-related chr19:1068562 GO:0005515|GO:0030131| NM_005498 THC2780514 Hs.18894 related protein complex protein 1-10685159 GO:0005794|GO:0016020| 1, mu 2 subunit (AP1M2), complex 1, GO:0006892|GO:0031410| mRNA[NM_005498] mu 2 subunit GO:0006605|GO:0016044| GO:0006903|GO:0005829 A_33_P3321372 CNTNAP3 contactin associated AK024257 ENST00000377653 79937 contactin chr9:39174527- THC2481668 Hs.604441 protein-like 3 [Source: associated 39174468 HGNC Symbol; protein- Acc: 13834] like 3 [ENST00000377653] A_33_P3353979 SYT15 Homo sapiens synap- NM_181519 ENST00000374330 83849 synaptotag- chr10:4696752 GO:0005886|GO:0016021 NM_181519 THC2665044 Hs.696346 totagmin XV (SYT15), min XV 3-46967464 transcript variant b, mRNA [NM_181519] A_33_P3346680 GB chr16:0287115 NP105946 89-028711530 A_33_P3312682 REXO1 Homo sapiens REX1, NM_020695 ENST00000170168 57455 REX1, chr19:1815304- GO:0005622|GO:0004527| NM_020695 THC2612197 Hs.192477 RNA exonuclease 1 RNA exo- 1815245 GO:0016787|GO:0005634| homolog (S. cerevisiae) nuclease 1 GO:0003676 (REXO1), mRNA homolog (S. [NM_020695] cerevisiae) A_33_P3419594 PDE9A Homo sapiens cDNA AK074662 5152 phospho- chr21:4419011 THC2686196 FLJ90181 fis. Clone diesterase 9A 9-44190178 MAMMA1000706. [AK074662] A_23_P46238 CELA2A Homo sapiens chymo- NM_033440 ENST00000375924 63036 chymotryp- chr1:15793981- GO:0004252|GO:0006508| NM_033440 THC2472773 Hs.631866 trypsin-like elastase sin-like elas- 15798491 GO:0008233|GO:0005576 family, member 2A tase family, (CELA2A), mRNA member 2A [NM_033440] A_23_P51936 TNFRSF9 Homo sapiens tumor NM_001561 ENST00000377507 3604 tumor necrosis chr1:7980782- GO:0005515|GO:0008285| NM_001561 THC2479062 Hs.86447 necrosis factor receptor factor receptor 7980723 GO:0016020|GO:0005887| superfamily, member 9 superfamily, GO:0004872|GO:0006917 (TNFRSF9), mRNA member 9 [NM_001561] A_33_P3367073 chr17:0026274 68-002627409 A_33_P3261620 GHSR Homo sapiens growth NM_004122 ENST00000427970 2693 growth chr3:17216554 GO:0008343|GO:0005515| NM_004122 THC2603925 Hs.130212 hormone secretagogue hormone 3-172165484 GO:0043005|GO:0005886| receptor (GHSR), secret- GO:0032691|GO:0032100| transcript variant 1b, agogue GO:0045409|GO:0016520| mRNA [NM_004122] receptor GO:0032094|GO:0046697| GO:0045923|GO:0001616| GO:0004872|GO:0030252| GO:0009725|GO:0040018| GO:0046676|GO:0051963| GO:0032869|GO:0009986| GO:0042536|GO:0007165| GO:0009755|GO:0007186| GO:0008154|GO:0043568| GO:0050728|GO:0045121| GO:0016021|GO:0017046| GO:0043134 A_33_P3396473 PPP6R2 Homo sapiens protein NM_001242898 ENST00000395741 9701 protein chr22:5088269 GO:0005515|GO:0005737 NM_001242898 THC2466888 Hs.449098 phosphatase 6, regulatory phosphatase 9-50882758 subunit 2 (PPP6R2), 6, regulatory transcript variant 1, subunit 2 mRNA [NM_001242898] A_33_P3418597 GAS2L1 Homo sapiens growth NM_152237 ENST00000360113 10634 growth chr22:2970842 GO:0005737|GO:0007050| NM_152237 THC2743842 Hs.322852 arrest-specific 2 like 1 arrest- 7-29708486 GO:0005856 (GAS2L1), transcript specific 2 variant 3, mRNA like 1 [NM_152237] A_24_P347880 ALOXE3 Homo sapiens arachi- NM_021628 ENST00000318227 59344 arachidonate chr17:8006732- GO:0019370|GO:0005506| NM_021628 THC2477386 Hs.232770 donate lipoxygenase 3 lipoxygenase 8006673 GO:0016165|GO:0016491| (ALOXE3), transcript 3 GO:0046872|GO:0055114 variant 2, mRNA [NM_021628] A_33_P3353921 GNLY granulysin [Source: AK310057 ENST00000489214 10578 granulysin chr2:85923450- THC2674183 Hs.105806 HGNC Symbol; 85923509 Acc: 4414] [ENST00000489214] A_33_P3272527 MAVS Homo sapiens mito- NM_001206491 ENST00000356687 57506 mitochondrial chr20:3835323- GO:0005515|GO:0032728| NM_001206491 THC2488008 Hs.570362 chondrial antiviral antiviral 3835382 GO:0032727|GO:0005741| signaling protein (MAVS), signaling GO:0009615|GO:0005739| nuclear gene encoding protein GO:0016020|GO:0045087| mitochondrial protein, GO:0002230|GO:0044419| transcript variant 3, GO:0004871|GO:0016021| mRNA [NM_001206491] GO:0043123|GO:0042742 A_33_P3864411 ARP3 actin-related AY026352 ENST00000541147 chr22:1696902 THC2487688 protein 3 homolog B 1-16969080 (yeast) pseudogene 5 [Source: HGNC Symbol; Acc:38682] [ENST00000541147] A_33_P3350748 KRT7 Homo sapiens keratin NM_005556 ENST00000422319 3855 keratin 7 chr12:5264259 GO:0006260|GO:0005515| NM_005556 THC2465320 Hs.411501 7 (KRT7), mRNA 0-52642649 GO:0005737|GO:0005198| [NM_005556] GO:0044419|GO:0007010| GO:0045095|GO:0051325| GO:0006417 A_33_P3373810 Q5K675_HUMAN chr5:14848921 THC2668752 (Q5K675) Osteoligament 9-148489278 factor, partial (23%) [THC2668752] A_23_P315286 C19orf22 Homo sapiens chromo- NM_138774 ENST00000361574 91300 chromosome chr19:897179- GO:0005634|GO:0003676 NM_138774 THC2560561 Hs.557655 some 19 open reading 19 open 897120 frame 22 (C19orf22), reading mRNA [NM_138774] frame 22 A_24_P259922 LANCL1 Homo sapiens LanC NM_006055 ENST00000443314 10314 LanC chr2:21129674 GO:0005737|GO:0016020| NM_006055 THC2734611 Hs.13351 lantibiotic synthetase lantibiotic 4-211296685 GO:0007186|GO:0005887| component C-like 1 synthetase GO:0004930|GO:0003824| (bacterial) (LANCL1), component GO:0050750|GO:0019898 transcript variant 1, C-like 1 mRNA [NM_006055] (bacterial) A_33_P3223678 LHX3 Homo sapiens LIM NM_014564 ENST00000325195 8022 LIM chr9:13908923 GO:0043565|GO:0006355| NM_014564 NP183253 Hs.148427 homeobox 3 (LHX3), homeobox 3 0-139089171 GO:0003700|GO:0003702| transcript variant 2, GO:0009887|GO:0008270| mRNA [NM_014564] GO:0005634|GO:0046872 A_33_P3381762 chr19:0047918 16-004791757 A_33_P3274245 ENDOV Homo sapiens endonu- NM_173627 ENST00000521565 284131 endonuclease chr17:7839570 GO:0006281|GO:0004519| NM_173627 THC2526422 Hs.728933 clease V (ENDOV), V 2-78395761 GO:0016787|GO:0006974 transcript variant 1, mRNA [NM_173627] A_33_P3256105 DUX4 Homo sapiens double NM_033178 ENST00000507734 22947 double chrUn_gl00022 GO:0043565|GO:0006355| NM_033178 THC2493180 Hs.553518 homeobox 4 (DUX4), homeobox 4 8:77296-77355 GO:0003700|GO:0005634 mRNA [NM_033178] A_23_P117363 SERPINA6 Homo sapiens serpin NM_001756 ENST00000341584 866 serpin peptidase chr14:9477068 GO:0004867|GO:0006810| NM_001756 NP705151 Hs.532635 peptidase inhibitor, clade inhibitor, clade 9-94770630 GO:0005576|GO:0005615| A (alpha-1 antiproteinase, A (alpha-1 GO:0005496|GO:0008211 antitrypsin), member 6 antiproteinase, (SERPINA6), mRNA antitrypsin), [NM_001756] member 6 A_33_P3364959 Homo sapiens isolate DQ098707 chr22:2304084 THC2524123 Hs.449585 N1408L immunoglobulin 7-23040906 lambda light chain variable region (IGLV2) mRNA, IGLV2-23*02 allele, partial Cds. [DQ098707] A_33_P3400217 SLC4A1 Homo sapiens solute NM_000342 ENST00000262418 6521 solute carrier chr17:4233062 GO:0006820|GO:0005215| NM_000342 THC2474664 Hs.443948 carrier family 4, family 4, 8-42330569 GO:0008509|GO:0030018| anion exchanger, anion ex- GO:0030506|GO:0006873| member 1 (erythrocyte changer, GO:0003779|GO:0008022| membrane protein member 1 GO:0042803|GO:0016323| band 3, Diego blood (erythrocyte GO:0005452|GO:0016020| group) (SLC4A1), membrane GO:0005887|GO:0030863| mRNA [NM_000342] protein band GO:0043495 3, Diego blood group) A_23_P142187 HIF3A Homo sapiens hypoxia NM_022462 ENST000OO33%13 64344 hypoxia chr19:4684638 GO:0007165|GO:0001666| NM_022462 THC2470601 Hs.420830 inducible factor 3, inducible 1-46846440 GO:0006355|GO:0005737| alpha subunit (HIF3A), factor 3, GO:0003700|GO:0006366| transcript variant 2, alpha subunit GO:0005634|GO:0004871 mRNA [NM_022462] A_23_P1056 GPR89B Homo sapiens G NM_016334 ENST00000493684 51463 G protein- chr1:14746517 NM_016334 NP1454439 Hs.645432 protein-coupled receptor coupled 3-147465232 89B (GPR89B), receptor 89B mRNA [NM_016334] A_33_P3262024 ATMIN Homo sapiens cDNA AK302556 23300 ATM chr3:19567236 THC2500773 Hs.589959 FLJ61620 complete cds. interactor 8-195672427 [AK302556] A_33_P3378354 guanylate cyclase 1, CR615161 ENST00000389600 chr13:5158961 THC2603577 Hs.411573 soluble, beta 2 4-51589554 [Source:HGNC Symbol; Acc: 4686] [ENST00000389600] A_33_P3230037 Homo sapiens AF336885 chr11:6446943 NP316843 FKSG58 (FKSG58) 4-64469375 mRNA, complete cds. [AF336885] A_33_P3259293 SLC37A3 solute carrier family AK131347 ENST00000493423 84255 solute carrier chr7:14010239 THC2487539 Hs.446021 37 (glycerol-3 phosphate family 37 2-140102333 transporter), member (glycerol-3- 3[Source: HGNC phosphate Symbol; Acc: 20651] transporter), [ENST00000493423] member 3 A_23_P160159 SLC2A5 Homo sapiens solute NM_003039 ENST00000377424 6518 solute carrier chr1:9097229- GO:0015755|GO:0005215| NM_003039 THC2467315 Hs.530003 carrier family 2 family 2 9097170 GO:0015758|GO:0005886| (facilitated glucose/ (facilitated GO:0005975|GO:0022891| fructose transporter), glucose/ GO:0005353|GO:0008643| member 5 (SLC2A5), fructose GO:0016021|GO:0055085| transcript variant 1, transporter), GO:0005355 mRNA [NM_003039] member 5 A_33_P3242458 SLC41A3 Homo sapiens solute NM_017836 ENST00000506102 54946 solute carrier chr3:12572588 GO:0005515|GO:0005886| NM_017836 THC2707275 Hs.573007 carrier family 41, family 41, 8-125725829 GO:0008324|GO:0016021| member 3 (SLC41A3), member 3 GO:0006812 transcript variant 2, mRNA [NM_017836] A_33_P3235400 HDGF Homo sapiens hepatoma- NM_004494 ENST00000406805 3068 hepatoma- chr1:15671361 GO:0007165|GO:0005737| NM_004494 NP417915 Hs.506748 derived growth factor derived 0-156713551 GO:0000166|GO:0008483| (HDGF), transcript growth factor GO:0005634|GO:0008201| variant 1, mRNA GO:0008083|GO:0005615| [NM_004494] GO:0003677|GO:0045449 A_33_P3354137 MAP4 Homo sapiens micro- NM_030885 ENST00000360240 4134 microtubule- chr3:48130383- GO:0005515|GO:0005198| NM_030885 THC2519872 Hs.517949 tubule-associated protein associated 48130324 GO:0005875|GO:0005874| 4 (MAP4), transcript protein 4 GO:0007026 variant 3, mRNA [NM_030885] A_24_P239176 MUC4 Homo sapiens mucin NM_018406 ENST00000479406 4585 mucin 4, cell chr3:19551481 GO:0005515|GO:0008150| NM_018406 THC2575387 Hs.369646 4, cell surface asso- surface 9-195514760 GO:0005176|GO:0030197| ciated (MUC4), associated GO:0016020|GO:0007160| transcript variant 1, GO:0005887|GO:0005578| mRNA [NM_018406] GO:0005576|GO:0007155 A_33_P3267865 GB chr6:02997524 NP111779 3-029975302 A_33_P3351554 ETNK2 Homo sapiens ethanol- NM_018208 ENST00000367199 55224 ethanolamine chr1:20410026 GO:0004305|GO:0008150| NM_018208 THC2466750 Hs.497469 amine kinase 2 (ETNK2), kinase 2 3-204100204 GO:0006646|GO:0035264| mRNA [NM_018208] GO:0000166|GO:0004103| GO:0005575|GO:0001890| GO:0009791|GO:0005524| GO:0001701|GO:0016740 A_33_P3247210 chr2:01793526 8-017935209 A_33_P3333683 AF039690 antigen NY- chr1:24364619 THC2493232 CO-8 {Homo sapiens} 1-243646132 (exp = −1; wgp = 0; cg = 0), partial (10%) [THC2493232] A_24_P336853 PNO1 Homo sapiens partner NM_020143 ENST00000263657 56902 partner of chr2:68402335- GO:0003723|GO:0005730| NM_020143 THC2462538 Hs.262858 of NOB1 homolog (S. NOB1 68402394 GO:0005634 cerevisiae) (PNO1), homolog mRNA [NM_020143] (S. cerevisiae) A_33_P3291176 VMAC Homo sapiens vimentin- NM_001017921 ENST00000339485 400673 vimentin-type chr19:5910197- GO:0005737 NM_001017921 NP1158993 Hs.020821 type intermediate fila- intermediate 5910256 ment associated coiled- filament coil protein (VMAC), associated mRNA [NM_001017921] coiled-coil protein A_23_P53176 FOLR1 Homo sapiens folate NM_016725 ENST00000393679 2 348 folate receptor chr11:7190726 GO:0005903|GO:0005542| NM_016725 NP226704 Hs.73769 receptor 1 (adult) 1 (adult) 8-71907327 GO:0005886|GO:0005887| (FOLR1), transcript GO:0015884|GO:0005624| variant 1, mRNA GO:0046655|GO:0005576| [NM_016725] GO:0004872|GO:0046658| GO:0006898 A_33_P3325429 Homo sapiens mRNA AB306153 NP404580 Hs.382212 for T cell receptor beta variable 5, partial cds, clone: un 66. [AB306153] A_24_P277657 GMPR Homo sapiens guano- NM_006877 ENST00000540478 2766 guanosine chr6:16290766- GO:0009409|GO:0016491| NM_006877 THC2640768 Hs.484741 sine monophosphate monophos- 16290825 GO:0030955|GO:0003920| reductase (GMPR). phate reductase GO:0046872|GO:0009117| mRNA [NM_006877] GO:0055114 A_33_P3280346 LOC100130857 Homo sapiens cDNA AK097050 100130857 hypothetical chr15:3226864 THC2488237 Hs.636752 FLJ39731 fis, clone protein 1-32268700 SMINT2015745. LOC100130857 [AK097050] A_23_P254271 TUBB6 Homo sapiens tubulin, NM_032525 ENST00000417736 84617 tubulin, beta 6 chr18:1232647 GO:0051258|GO:0000166| NM_032525 THC2493956 Hs.193491 beta 6 (TUBB6), mRNA 6-12326535 GO:0005198|GO:0005874| [NM_032525] GO:0003924|GO:0005525| GO:0007018 A_33_P3383551 SEC14L3 SEC14-like 3 (S. AK131358 ENST00000415957 266629 SEC14-like 3 chr22:3084400 THC2508076 Hs.505601 cerevisiae) [Source: (S. cerevisiae) 5-30843946 HGNC Symbol; Acc: 18655] [ENST00000415957] A_33_P3256257 KRTAP4-7 Homo sapiens keratin NM_033061 ENST00000391417 100132476 keratin chr17:3924083 GO:0045095 NM_033061 THC2488799 Hs.632746 associated protein 4-7 associated 1-39240890 (KRTAP4-7), mRNA protein 4-7 [NM_033061] A_24_P417007 POLR2F Homo sapiens poly- NM_021974 FNST00000442738 5435 polymerase chr22:3836519 GO:0030880|GO:0006368| NM_021974 THC2612620 Hs.436578 merase (RNA) II (DNA (RNA) II 4-38365253 GO:0006367|GO:0004672| directed) polypeptide F (DNA GO:0003899|GO:0000398| (POLR2F), mRNA directed) poly- GO:0005730|GO:0005665| [NM_021974] peptide F GO:0005654|GO:0005634| GO:0003677 A_33_P3485976 Homo sapiens CDNA AK095081 ENST00000528482 chr11:1343577 THC2629979 Hs.504390 FLJ37762 lis, clone 50-134357809 BRHIP2024347, weakly similar to GALECTIN-3. [AK095081] A_33_P3374957 KLF16 Homo sapiens Kruppel- NM_031918 ENST00000250916 83855 Kruppel- chr19:1852458- GO:0005622|GO:0003700| NM_031918 THC2631959 Hs.136280 like factor 16 (KLF16), like factor 1852399 GO:0006357|GO:0008270| mRNA [NM_031918] 16 GO:0005634|GO:0007212| GO:0046872|GO:0045449 A_33_P3312799 Q9UMX8_HUMAN chr2:09545477 THC2774746 (Q9UMX8) Melanoma 6-095454835 antigen, complete [THC2774746] A_33_P3331220 immunoglobulin heavy Z46771 ENST00000390617 chr14:1068454 NP1166158 Hs.510635 variable 3-35 (non- 16-106845357 functional) [Source: HGNC Symbol ; Acc: 5598] [ENST00000390617] A_23_P406785 C9orf50 Homo sapiens chromo- NM_199350 ENST00000372478 375759 chromosome chr9:13237459 NM_199350 THC2478134 Hs.124223 some 9 open reading 9 open 9-132374540 frame 50 (C9orf50), reading frame 50 mRNA[NM_199350] A_32_P107002 RUNDC2A Homo sapiens RUN NM_032167 ENST00000502626 84127 RUN chr16:1214597 NM_032167 THC2476984 Hs.458401 domain containing 2A domain 8-12146037 (RUNDC2A), mRNA containing 2A [NM_032167] A_33_P3279640 HCN2 Homo sapiens hyper- NM_001194 ENST00000251287 610 hyperpolarization chr19:617098- GO:0005515|GO:0005244| NM_001194 THC2473872 Hs.124161 polarization activated activated cyclic 617157 GO:0005272|GO:0007267| cyclic nucleotide-gated nucleotide- GO:0030955|GO:0031402| potassium channel 2 gated potassium GO:0055085|GO:0030552| (HCN2), mRNA channel 2 GO:0006936|GO:0000166| [NM_001194] GO:0016020|GO:0005249| GO:0008076|GO:0042391| GO:0016021|GO:0006814| GO:0006813|GO:0006812 A_23_P67952 MYCNOS Homo sapiens v-myc NR_026766 10408 v-myc myelo- chr2:16080141- GO:0007275 NR_026766 THC2481543 Hs.651453 myelocytomatosis viral cytomatosis viral 16080082 related oncogene, neuro- related oncogene, blastoma derived (avian) neuroblastoma opposite strand derived (avian) (MYCNOS), non- opposite coding RNA strand [NR_026766] A_33_P3371553 FLJ32756 Homo sapiens cDNA AK057318 642757 hypothetical chr22:4731005 THC2484067 Hs.632786 FLJ32756 fis, clone LOC642757 6-47309997 TESTI2001758. [AK057318] A_33_P33U267 KRTAP19-2 Homo sapiens keratin NM_181608 ENST00000334055 337969 keratin chr21:3185956 GO:0005882 NM_181608 THC2488580 Hs.553692 associated protein 19-2 associated 8-31859509 (KRTAP19-2), mRNA protein 19-2 [NM_181608] A_24_P41939 chr9:08165199 6-081651936 A_23_P74799 SLC25A24 Homo sapiens solute NM_213651 ENST00000370041 29957 solute carrier chr1:10867755 GO:0005739|GO:0016020| NM_213651 THC2477421 Hs.656870 carrier family 25 family 25 1-108677492 GO:0005488|GO:0005509| (mitochondrial carrier; (mitochondrial GO:0005743|GO:0016021| phosphate carrier), carrier; phos- GO:0055085 member 24 (SLC25A24), phate carrier), nuclear gene encoding member 24 mitochondrial protein, transcript variant 2, mRNA [NM_213651] A_23_P109133 AVP Homo sapiens arginine NM_000490 ENST00000380293 551 arginine chr20:3063624- GO:0008284|GO:0030307| NM_000490 THC2480295 Hs.89648 vasopressin vasopressin 3063391 GO:0045471|GO:0030819| (AVP), mRNA GO:0007267|GO:0031894| [NM_000490] GO:0006091|GO:0051970| GO:0031895|GO:0007204| GO:0005615|GO:0030425| GO:0014049|GO:0003084| GO:0045907|GO:0007626| GO:0006833|GO:0007625| GO:0030141|GO:0005185| GO:0042711|GO:0030146| GO:0031394|GO:0006950| GO:0032849|GO:0042538| GO:0005625|GO:0005576| GO:0043084|GO:0002125| GO:0007165|GO:0007186| GO:0050891|GO:0035176| GO:0003078|GO:0007621| GO:0035094 A_33_P3368950 LOC389333 Homo sapiens hypo- NM_001161546 ENST00000434752 389333 hypothetical chr5:13872872 NM_001161546 THC2603790 Hs.729482 thetical protein protein 5-138728666 LOC389333 LOC389333 (LOC389333), mRNA [NM_001161546] A_33_P3322373 GBGT1 Homo sapiens globoside NM_021996 ENST00000372038 26301 globoside chr9:13603691 GO:0009247|GO:0030145| NM_02199h THC2630024 Hs.495419 alpha-1,3-N-acetylgalacto- alpha-1,3-N- 4-136036855 GO:0005794|GO:0016758| saminyltransferase 1 acetylgalac- GO:0016020|GO:0005975| (GBGT1), mRNA tosaminyl- GO:0047277|GO:0016021| [NM_021996] transferase 1 GO:0046872 A_23_P214950 PERP Homo sapiens PERP, NM_022121 ENST00000265603 64065 PERP, TP53 chr6:13841211 GO:0030057|GO:0005739| NM_022121 THC2545695 Hs.201446 TP53 apoptosis effector apoptosis effector 5-138412056 GO:0005515|GO:0030054| (PERP), mRNA GO:0005794|GO:0005886| [NM_022121] GO:0005887|GO:0006915| GO:0006917|GO:0007155 A_33_P3250055 MAPK12 Homo sapiens cDNA, AK308768 ENST00000395778 6300 mitogen- chr22:5069617 THC2621046 Hs.432642 FLJ98809. [AK308768] activated 7-50696118 protein kinase 12 A_33_P3215797 AHDC1 Homo sapiens AT NM_001029882 ENST00000482400 27245 AT hook, chr1:27877922- GO:0003677 NM_001029882 THC2470530 Hs.469280 hook, DNA binding motif, DNA binding 27877863 containing 1 (AHDC1), motif, mRNA[NM_001029882] containing 1 A_33_P3333648 OR51I2 Homo sapiens olfactory NM_001004754 ENST00000341449 390064 olfactory receptor, chr11:5475338- GO:0007608|GO:0007165| NM_001004754 NP1461849 Hs.553733 receptor, family 51, family 51, 5475397 GO:0004984|GO:0007186| subfamily 1, member 2 subfamily 1, GO:0005886|GO:0004872| (OR51I2), mRNA member 2 GO:0016021|GO:0050896 [NM_001004754] A_33_P3345708 CREB3L4 Homo sapiens cAMP NM_130898 ENST00000368600 148327 cAMP respon- chr1:15394548 GO:0043565|GO:0006986| NM_130898 THC2775729 Hs.372924 responsive element binding sive element 4-153945543 GO:0006355|GO:0005794| protein 3-like 4 binding protein GO:0003700|GO:0016020| (CREB3L4), 3-like 4 GO:0005783|GO:0045944| mRNA [NM_130898] GO:0046983|GO:0005634| GO:0016021|GO:0007283 A_33_P3869455 ATXN8 Homo sapiens ataxin DQ641254 724066 ataxin 8 chr13:7071208 Hs.645205 8 (ATXN8) mRNA, 9-70712030 partial cds. [DQ641254] A_33_P3281444 immunoglobulin kappa DQ100647 ENST00000468879 chr2:90249232- THC2561290 Hs.558199 variable 10-43 [Source: 90249291 HGNC Symbol; Acc: 5758] [ENST00000468879] A_33_P3835524 POU2F2 Homo sapiens POU class NM_001207026 ENST00000534559 5452 POU class chr19:4260000 GO:0043565|GO:0006355| NM_001207026 THC2604353 Hs.654420 2 homeobox 2 (POU2F2), 2 homeobox 2 0-42599941 GO:0005737|GO:0003700| transcript variant 3, GO:0006366|GO:0006959| mRNA [NM_001207026] GO:0005634 A_33_P3424507 OR51F1 Homo sapiens olfactory NM_001004752 ENST00000380383 256892 olfactory receptor, chr11:4790483- GO:0007608|GO:0007165| NM_001004752 NP1461808 Hs.553659 receptor, family 51, sub- family 51, 4790424 GO:0004984|GO:0007186| family F, member 1 subfamily F, GO:0005886|GO:0004872| (OR51F1), mRNA member 1 GO:0016021|GO:0050896 [NM_001004752] A_23_P16225 BEST2 Homo sapiens bestro- NM_017682 ENST00000549706 54831 bestrophin 2 chr19:1286898 GO:0007608|GO:0031404| NM_017682 THC2481764 Hs.435611 phin 2 (BEST2), mRNA 1-12869040 GO:0051899|GO:0005886| [NM_017682] GO:0005509|GO:0034707| GO:0005254|GO:0003674| GO:0005929|GO:0008150| GO:0016021|GO:0005216| GO:0006811 A_33_P3310976 chr20:0605200 44-060520103 A_23_P411113 CNTNAP1 Homo sapiens contactin NM_003632 ENST00000264638 8506 contactin chr17:4085161 GO:0007165|GO:0017124| NM_003632 THC2470788 Hs.408730 associated protein 1 associated 1-40851671 GO:0016020|GO:0005887| (CNTNAP1), mRNA protein 1 GO:0005070|GO:0005102| [NM_003632] GO:0033270|GO:0004872| GO:0007155 A_33_P3398005 chr3:01160600 THC2708197 0-011605941 A_33_P3316696 A_24_P353289 C22orf13 Homo sapiens chromo- NM_031444 ENST00000490922 83606 chromosome 22 chr22:2493668 NM_031444 THC2520972 Hs.9850 some 22 open reading open reading 6-24936627 frame 13 (C22orf13), frame 13 mRNA [NM_031444] A_23_P47102 ACY3 Homo sapiens asparto- NM_080658 ENST00000255082 91703 aspartoacylase chr11:6741255 GO:0016324|GO:0005737| NM_080658 THC2491201 Hs.126265 acylase (aminocyclase) 3 (aminocyclase) 5-67412321 GO:0019807|GO:0008152| (ACY3), mRNA 3 GO:0016788|GO:0005624| [NM_080658] GO:0008270|GO:0004046| GO:0046872|GO:0042802 A_24_P373885 C19orf25 Homo sapiens chromo- NM_152482 ENST00000335104 148223 chromosome 19 chr19:1474952- GO:0005515 NM_152482 THC2617463 Hs.532840 some 19 open reading open reading 1474893 frame 25 (C19orf25), frame 25 mRNA [NM_152482] A_23_P135239 TLE1 Homo sapiens transducin- NM_005077 ENST00000355002 7088 transducin-like chr9:84199177- GO:0007165|GO:0005667| NM_005077 THC2776653 Hs.197320 like enhancer of split 1 enhancer of 84199118 GO:0003714|GO:0003682| (E(spl) homolog, split 1 (E(spl) GO:0030178|GO:0016481| Drosophila) (TLE1), homolog, GO:0009887|GO:0007275| mRNA [NM_005077] Drosophila) GO:0005634|GO:0000122| GO:0008134 A_33_P3258316 LOC100507269 PREDICTED: XM_003118986 100507269 hypothetical chr7:55812467- XM_003118986 THC2558116 Hs.730469 Homo sapiens hypothetical protein 55812408 protein LOC100507269 LOC100507269 (LOC100507269), mRNA [XM_003118986] A_23_P259506 C5orf32 Homo sapiens chromo- NM_032412 ENST00000261811 84418 chromosome 5 chr5:13962312 NM_032412 THC2580943 Hs.529798 some 5 open reading open reading 6-139623185 frame 32 (C5orf32), frame 32 mRNA [NM_032412] A_33_P3270435 HIGD2B Homo sapiens HIG1 NR_002780 ENST00000311755 123346 HIG1 hypoxia chr15:7296827 GO:0016020|GO:0016021 NR_002780 THC2609380 Hs.434111 hypoxia inducible domain inducible do- 3-72968214 family, member 2B (pseudo- main family, gene) (HIGD2B), non- member 2B coding RNA [NR_002780] (pseudogene) A_23_P106258 SLC25A47 Homo sapiens solute NM_207117 ENST00000361529 283600 solute carrier chr14:1007962 GO:0005739|GO:0005215| NM_207117 THC2624616 Hs.108268 carrier family 25, member family 25, 35-100796294 GO:0016020|GO:0005488| 47 (SLC25A47), member 47 GO:0005743|GO:0016021| mRNA [NM_207117] GO:0055085 A_33_P3408237 Q71V99_HUMAN chr11:0434889 THC2560329 (Q71V99) Cyclophilin, 22-043488981 partial (12%) [THC2560329] A_33_P3297345 TTC24 Homo sapiens tetra- NM_001105669 ENST00000368236 164118 tetratricopeptide chr1:15655650 GO:0005488 NM_001105669 THC2645990 Hs.447851 tricopeptide repeat domain repeat domain 3-156556562 24 (TTC24), mRNA 24 [NM_001105669] A_23_P85441 IGSF9 Homo sapiens immuno- NM_020789 ENST00000198587 57549 immunoglobulin chr1:15989699 GO:0030054|GO:0005886| NM_020789 THC2473023 Hs.591472 globulin superfamily, superfamily, 5-159896936 GO:0045202|GO:0007275| member 9 (IGSF9), trans- member 9 GO:0016021|GO:0030425| cript variant 2, mRNA GO:0030154|GO:0016358| [NM_020789] GO:0007399 A_23_P502350 RFX2 Homo sapiens regulatory NM_000635 ENST00000303657 5990 regulatory factor chr19:5993250- GO:0006355|GO:0030528| NM_000635 THC2466761 Hs.465709 factor X, 2 (influences HLA X, 2 (influences 5993191 GO:0005634|GO:0003677 class II expression) (RFX2), HLA class II transcript variant 1, expression) mRNA [NM_000635] A_33_P3353816 ITGA4 Homo sapiens integrin, NM_000885 3676 integrin, alpha 4 chr2:18240227 GO:0008305|GO:0005886| NM_000885 THC2465069 Hs.440955 alpha 4 (antigen CD49D, (antigen CD49D, 5-182402334 GO:0005509|GO:0042802| alpha 4 subunit of VLA- alpha 4 subunit GO:0007507|GO:0016477| 4 receptor) (ITGA4), of VLA-4 GO:0001974|GO:0007229| mRNA [NM_000885] receptor) GO:0030183|GO:0007159| GO:0004872|GO:0016021| GO:0001968|GO:0007155| GO:0007157|GO:0009897 A_33_P3363645 MGAT1 Homo sapiens mannosyl NM_001114618 ENST00000504385 4245 mannosyl chr5:18023594 GO:0003827|GO:0005794| NM_001114618 THC2513235 Hs.519818 (alpha-1,3-)-glycoprotein (alpha-1,3-)- 8-180235889 GO:0016020|GO:0000139| beta-1,2-N-acetylglucos- glycoprotein beta GO:0016757|GO:0005975| aminyltransferase (MGAT1), 1,2-N-acetylglu- GO:0016021|GO:0006487 transcript variant 1, cosaminyl- mRNA [NM_001114618] transferase A_23_P93562 SESN1 Homo sapiens sestrin NM_014454 ENST00000302071 27244 sestrin 1 chr6:10930853 GO:0008285|GO:0007050| NM_014454 THC2467659 Hs.591336 1 (SESN1), transcript 6-109308477 GO:0005634|GO:0006974 variant 1, mRNA [NM_014454] A_33_P3420852 KIRREL2 Homo sapiens kin of NM_199180 ENST00000360202 84063 kin of chr19:3635733 GO:0005886|GO:0016021| NM_199180 THC2603242 Hs.145729 IRRE like 2 (Drosophila) IRRE like 2 5-36357394 GO:0007155 (KIRREL2), transcript (Drosophila) variant 3, mRNA [NM_199180] A_33_P3227010 chr2:07311423 4-073114175 A_23_P162596 ACTR6 Homo sapiens ARP6 NM_022496 ENST00000188312 64431 ARP6 actin- chr12:1006180 GO:0005515|GO:0005737| NM_022496 THC2519245 Hs.115088 actin-related protein 6 related protein 04-100618063 GO:0005856 homolog (yeast) (ACTR6), 6 homolog mRNA [NM_022496] (yeast) A_24_P923251 TGM2 Homo sapiens trans- NM_198951 ENST00000468262 7052 transglutaminase chr20:3676650 GO:0005886|GO:0005509| NM_198951 THC2659478 Hs.517033 glutaminase 2 (C poly- 2 (C polypep- 5-36766446 GO:0019904|GO:0006917| peptide, protein-glutamine- tide, protein- GO:0005525|GO:0048661| gamma-glutamyltransferase) glutamine- GO:0045785|GO:0005739| (TGM2), transcript gamma- GO:0018149|GO:0001974| variant 2, mRNA glutamyl- GO:0051482|GO:0003810| [NM_198951] transferase) GO:0050729|GO:0051260| GO:0018153|GO:0043123| GO:0016740|GO:0008415 A_23_P211345 TBX1 Homo sapiens T-box 1 NM_080647 ENST00000332710 6899 T-box 1 chr22:1975478 GO:0003700|GO:0006357| NM_080647 THC2477322 Hs.173984 (TBX1), transcript variant 8-19754847 GO:0003702|GO:0005634| C, mRNA [NM_080647] GO:0048538|GO:0048703| GO:0009653|GO:0042803| GO:0060037|GO:0007507| GO:0043565|GO:0060017| GO:0060023 A_23_P344853 WDR43 Homo sapiens WD NM_015131 ENST00000407426 23160 WD repeat chr2:29170870- GO:0005730|GO:0005634 NM_015131 THC2553340 Hs.709228 repeat domain 43 domain 43 29170929 (WDR43), mRNA [NM_015131] A_33_P3303086 HNRPLL Homo sapiens hetero- NM_138394 ENST00000272249 92906 heterogeneous chr2:38790718- GO:0006397|GO:0005515| NM_138394 NP1156896 Hs.445497 geneous nuclear ribonucleo- nuclear ribo- 38790659 GO:0000166|GO:0030529| protein L-like (HNRPLL), nucleoprotein GO:0005634|GO:0003729| transcript variant 1, L-like GO:0033120 mRNA [NM_138394] A_23_P201211 FCRL5 Homo sapiens Fc NM_031281 ENST00000461387 83416 Fc receptor- chr1:15748329 GO:0005886|GO:0004872| NM_031281 THC2617135 Hs.415950 receptor-like 5 (FCRL5), like 5 7-157483238 GO:0016021 transcript variant 1, mRNA[NM_031281] A_33_P3395823 KCNQ2 Homo sapiens potas- NM_172109 ENST00000344425 3785 potassium chr20:6206515 GO:0005244|GO:0016020| NM_172109 THC2474136 Hs.161851 sium voltage-gated channel, voltage-gated 7-62065098 GO:0008076|GO:0005249| KQT-like subfamily, channel, GO:0007268|GO:0030955| member 2 (KCNQ2), KQT-like GO:0016021|GO:0055085| transcript variant 5, subfamily, GO:0006813|GO:0007399| mRNA [NM_172109] member 2 GO:0006811 A_33_P3314481 Homo sapiens mRNA AB305728 ENST00000390447 chr14:2247631 NP1074392 Hs.495021 for T cell receptor alpha 1-22476370 variable 19, partial cds, clone: SEB 274. [AB305728] A_33_P3300142 ANKFY1 Homo sapiens ankyrin NM_016376 ENST00000341657 51479 ankyrin repeat chr17:4066776- GO:0005515|GO:0005737| NM_016376 THC2638444 Hs.696087 repeat and FYVE domain and FYVE 4066717 GO:0016020|GO:0008270| containing 1 (ANKFY1), domain GO:0046872|GO:0010008| transcript variant 1, containing 1 GO:0019898|GO:0005768 mRNA [NM_016376] A_33_P3375646 GTP binding protein 6 XM_003120165 ENST00000485332 chrY:179213- XM_003120165 THC2551411 Hs.437145 (putative) [Source: HGNC 179154 Symbol; Acc: 30189] [ENST00000485332] A_23_P347632 MTSS1 Homo sapiens metastasis NM_014751 ENST00000520771 9788 metastasis chr8:12556331 GO:0017124|GO:0030036| NM_014751 THC2487877 Hs.336994 suppressor 1 (MTSS1), suppressor 1 4-125563255 GO:0005102|GO:0006928| mRNA [NM_014751] GO:0030139|GO:0015629| GO:0001726|GO:0003785| GO:0007165|GO:0005737| GO:0046847|GO:0007155| GO:0007169|GO:0008093 A_24_P368544 SLC25A26 Homo sapiens solute NM_173471 ENST00000336733 L15286 solute carrier chr3:66428767- NM_173471 THC2463927 Hs.379386 carrier family 25, member family 25, 66428826 26 (SLC25A26), nuclear member 26 gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_173471] A_33_P3546161 C8orf67 RC2-BT0841-021000- BF742660 619338 chromosome chr8:675800- THC2707252 Hs.678836 012-C08 BT0841 Homo 8 open reading 675859 sapiens cDNA, mRNA frame 67 sequence [BF742660] A_24_P174341 CCNT2 Homo sapiens cyclin NM_058241 ENST00000419781 905 cyclin T2 chr2:13571365 GO:0005515|GO:0007049| NM_058241 THC2631629 Hs.591241 12 (CCNT2), transcript 2-135713711 GO:0005737|GO:0006366| variant b, mRNA GO:0044419|GO:0005730| [NM_058241] GO:0005654|GO:0005634| GO:0000079|GO:0045449| GO:0051301 A_24_P33461 LOC100507496 chromosome 5 open AK093197 ENST00000425471 100507496 putative un- chr5:17907890 THC2510113 Hs.631949 reading frame 60 [Source: characterized 2-179078961 HGNC Symbol; Acc: 27753] protein [ENST00000511063] FLJ35723-like A_33_P3291414 PREDICTED: Homo XM_003118886 chr12:1331296 XM_003118886 THC2626595 Hs.678863 sapiens hypothetical protein 93-133129752 LOC100507023 (LOC100507023), mRNA [XM_003118886] A_23_P316381 ACOX3 Homo sapiens acyl- NM_003501 ENST00000356406 8310 acyl-CoA chr4:8368669- GO:0006629|GO:0006635| NM_003501 THC2463761 Hs.479122 CoA oxidase 3, pristanoyl oxidase 3, 8368610 GO:0050660|GO:0006631| (ACOX3), transcript pristanoyl GO:0003997|GO:0008206| variant 1, mRNA GO:0003995|GO:0055114| [NM_003501] GO:0005777 A_33_P3228564 DOK3 Homo sapiens docking NM_001144875 ENST00000312943 79930 docking chr5:17693022 GO:0005515|GO:0005737| NM_001144875 THC2482593 Hs.720849 protein 3 (DOK3), trans- protein 3 3-176930164 GO:0005886|GO:0005158| cript variant 2, mRNA GO:0007265 [NM_001144875] A_33_P3388283 HMGCL 3-hydroxymethyl-3- ENST00000496907 3155 3-hydroxymethyl- chr1:24133704- THC2522126 methylglutaryl CoA lyase 3-methylglutaryl- 24133645 [Source: HGNC Symbol; CoA lyase Acc: 5005] [ENST00000496907] A_33_P3376273 GK glycerol kinase ENST00000378941 2710 glycerol kinase chrX:30696155- [Source: HGNC Symbol; 30696214 Acc: 4289] [ENST00000378941]

APPENDIX D Name Accession Comment ACTB|0 NM_001101.2 Normalizer B2M|0 NM_004048.2 Normalizer ebv-miR-BART16|0.008 MIMAT0003714 ebv-miR-BART6-5p|0 MIMAT0003414 GAPDH|0 NM_002046.3 Normalizer hcmv-miR-UL112|0 MIMAT0001577 hcmv-miR-US5-2|0 MIMAT0001580 hiv1-miR-TAR-3p|0 MIMAT0006017 hsa-let-7b|0 MIMAT0000063 hsa-let-7c|0 MIMAT0000064 hsa-let-7d|0 MIMAT0000065 hsa-let-7e|0.009 MIMAT0000066 hsa-let-79|0 MIMAT0000414 hsa-let-7i|0 MIMAT0000415 hsa-miR-101|0 MIMAT0000099 hsa-miR-103|0 MIMAT0000101 hsa-miR-106b|0 MIMAT0000680 hsa-miR-107|0 MIMAT0000104 hsa-miR-10a|0 MIMAT0000253 hsa-miR-10b|0 MIMAT0000254 hsa-miR-1180|0 MIMAT0005825 hsa-miR-1205|0 MIMAT0005869 hsa-miR-1206|0 MIMAT0005870 hsa-miR-122|0 MIMAT0000421 hsa-miR-1244|0 MIMAT0005896 hsa-miR-126|0 MIMAT0000445 hsa-miR-1266|0 MIMAT0005920 hsa-miR-1283|0 MIMAT0005799 hsa-miR-1297|0 MIMAT0005886 hsa-miR-1302|0 MIMAT0005890 hsa-miR-1307|0 MIMAT0005951 hsa-miR-130b|0 MIMAT0000691 hsa-miR-132|0.009 MIMAT0000426 hsa-miR-136|0 MIMAT0000448 hsa-miR-137|0 MIMAT0000429 hsa-miR-140-3p|0 MIMAT0004597 hsa-miR-142-3p|0 MIMAT0000434 hsa-miR-144|0 MIMAT0000436 hsa-miR-145|0 MIMAT0000437 hsa-miR-148a|0 MIMAT0000243 hsa-miR-151-3p|0 MIMAT0000757 hsa-miR-1537|0 MIMAT0007399 hsa-miR-154|0 MIMAT0000452 hsa-miR-15a|0 MIMAT0000068 hsa-miR-181b+ MIMAT0000257 hsa-miR-181d|0 hsa-miR-183|0 MIMAT0000261 hsa-miR-185|0 MIMAT0000455 hsa-miR-186|0 MIMAT0000456 hsa-miR-18a|0 MIMAT0000072 hsa-miR-1914|0 MIMAT0007889 hsa-miR-193a-3p|0.02 MIMAT0000459 hsa-miR-196a|0.009 MIMAT0000226 hsa-miR-199a-3p + hsa- MIMAT0000232 miR-199b-3p|0 hsa-miR-19a|0 MIMAT0000073 hsa-miR-19b|0 MIMAT0000074 hsa-miR-200b|0 MIMAT0000318 hsa-miR-206|0 MIMAT0000462 hsa-miR-208a|0 MIMAT0000241 hsa-miR-21|0 MIMAT0000076 hsa-miR-2114|0 MIMAT0011156 hsa-miR-215|0 MIMAT0000272 hsa-miR-221|0 MIMAT0000278 hsa-miR-222|0 MIMAT0000279 hsa-miR-223|0 MIMAT0000280 hsa-miR-23a|0 MIMAT0000078 hsa-miR-25|0 MIMAT0000081 hsa-miR-28-5p|0 MIMAT0000085 hsa-miR-29b|0 MIMAT0000100 hsa-miR-29c|0 MIMAT0000681 hsa-miR-300|0 MIMAT0004903 hsa-miR-30a|0 MIMAT0000087 hsa-miR-30b|0 MIMAT0000420 hsa-miR-30c|0 MIMAT0000244 hsa-miR-30d|0 MIMAT0000245 hsa-miR-30e|0 MIMAT0000692 hsa-miR-32|0 MIMAT0000090 hsa-miR-320a|0 MIMAT0000510 hsa-miR-320b|0 MIMAT0005792 hsa-miR-320c|0.028 MIMAT0005793 hsa-miR-320d|0 MIMAT0006764 hsa-miR-324-3p|0 MIMAT0000762 hsa-miR-324-5p|0 MIMAT0000761 hsa-miR-326|0 MIMAT0000756 hsa-miR-330-5p|0 MIMAT0004693 hsa-miR-331-3p|0 MIMAT0000760 hsa-miR-335|0 MIMAT0000765 hsa-miR-342-3p|0 MIMAT0000753 hsa-miR-34b|0 MIMAT0004676 hsa-miR-34c-5p|0 MIMAT0000686 hsa-miR-361-5p|0 MIMAT0000703 hsa-miR-362-3p|0 MIMAT0004683 hsa-miR-363|0 MIMAT0000707 hsa-miR-372|0 MIMAT0000724 hsa-miR-374a|0 MIMAT0000727 hsa-miR-377|0 MIMAT0000730 hsa-miR-378|0 MIMAT0000732 hsa-miR-379|0 MIMAT0000733 hsa-miR-381|0 MIMAT0000736 hsa-miR-383|0 MIMAT0000738 hsa-miR-409-3p|0 MIMAT0001639 hsa-miR-410|0 MIMAT0002171 hsa-miR-423-3p|0 MIMAT0001340 hsa-miR-425|0 MIMAT0003393 hsa-miR-431|0 MIMAT0001625 hsa-miR-450b-5p|0 MIMAT0004909 hsa-miR-453|0 MIMAT0001630 hsa-miR-455-3p|0 MIMAT0004784 hsa-miR-485-3p|0.01 MIMAT0002176 hsa-miR-486-3p|0 MIMAT0004762 hsa-miR-494|0.025 MIMAT0002816 hsa-miR-495|0 MIMAT0002817 hsa-miR-517c+hsa- MIMAT0002866 miR-519a|0 hsa-miR-518f|0 MIMAT0002842 hsa-miR-520d-5p + hsa- MIMAT0002855 miR-527+hsa-miR-518a-5p|0 hsa-miR-526a + hsa-miR- MIMAT0002845 518d-5p+hsa-miR-520c-5p|0 hsa-miR-532-5p|0 MIMAT0002888 hsa-miR-539|0 MIMAT0003163 hsa-miR-542-3p|0 MIMAT0003389 hsa-miR-542-5p|0 MIMAT0003340 hsa-miR-544|0.049 MIMAT0003164 hsa-miR-548a-3p|0 MIMAT0003251 hsa-miR-548a-5p|0 MIMAT0004803 hsa-miR-548b-3p|0 MIMAT0003254 hsa-miR-548f|0 MIMAT0005895 hsa-miR-548g|0 MIMAT0005912 hsa-miR-548h|0 MIMAT0005928 hsa-miR-551b|0 MIMAT0003233 hsa-miR-553|0 MIMAT0003216 hsa-miR-555|0 MIMAT0003219 hsa-miR-563|0 MIMAT0003227 hsa-miR-566|0 MIMAT0003230 hsa-miR-570|0 MIMAT0003235 hsa-miR-576-5p|0 MIMAT0003241 hsa-miR-589|0 MIMAT0004799 hsa-miR-590-5p|0.029 MIMAT0003258 hsa-miR-591|0 MIMAT0003259 hsa-miR-595|0 MIMAT0003263 hsa-miR-600|0 MIMAT0003268 hsa-miR-601|0 MIMAT0003269 hsa-miR-603|0.016 MIMAT0003271 hsa-miR-613|0 MIMAT0003281 hsa-miR-615-5p|0 MIMAT0004804 hsa-miR-619|0 MIMAT0003288 hsa-miR-648|0 MIMAT0003318 hsa-miR-651|0 MIMAT0003321 hsa-miR-655|0 MIMAT0003331 hsa-miR-656|0 MIMAT0003332 hsa-miR-659|0 MIMAT0003337 hsa-miR-660|0 MIMAT0003338 hsa-miR-664|0.018 MIMAT0005949 hsa-miR-759|0 MIMAT0010497 hsa-miR-764|0 MIMAT0010367 hsa-miR-767-5p|0 MIMAT0003882 hsa-miR-769-5p|0 MIMAT0003886 hsa-miR-875-5p|0 MIMAT0004922 hsa-miR-877|0 MIMAT0004949 hsa-miR-892b|0 MIMAT0004918 hsa-miR-92a|0 MIMAT0000092 hsa-miR-92b|0 MIMAT0003218 hsa-miR-934|0 MIMAT0004977 hsa-miR-96|0 MIMAT0000095 hsa-miR-99a|0 MIMAT0000097 hsv1-miR-H1|0 MIMAT0003744 kshv-miR-K12-4-5p|0 MIMAT0002191 kshv-miR-K12-7|0 MIMAT0002187 kshv-miR-K12-9|0 MIMAT0002185 RPL19|0 NM_000981.3 Normalizer

APPENDIX E Sequence Description hsa-miR-142-3p hsa-miR-150 hsa-miR-144 hsa-miR-720 hsa-miR-145 hsa-miR-23a hsa-miR-191 hsa-miR-192 hsa-miR-30c hsa-miR-223 hsa-miR-151-3p hsa-miR-30b hsa-miR-19b hsa-miR-342-3p hsa-miR-296-5p hsa-miR-423-3p hsa-miR-425 hsa-miR-19a hsa-miR-186 hsa-miR-146a hsa-miR-26a hsa-miR-151-5p hsa-miR-194 hsa-miR-374b hsa-miR-25 hsa-miR-320d hsa-miR-142-5p hsa-miR-532-3p hsa-miR-328 hsa-miR-1307 hsa-miR-30a hsa-miR-574-3p hsa-miR-484 ebv-miR-BART9 hsa-miR-21 hsa-miR-26b hsa-miR-103 hsa-miR-93 hsa-let-7d hsa-let-7f hsa-let-7g hsa-miR-20a + hsa-miR-20b hsa-miR-15a hsa-miR-222 hsa-miR-30e hsa-miR-106b hsa-miR-148a hsa-miR-490-3p hsa-let-7i hsa-let-7b hsa-miR-126 hsa-miR425b

APPENDIX F BULLET POINTS By using a Support Vector Machine classification algorithm, patients and controls were stratified with an average success rate of roughly 90% using an N-Fold validation, Subjects were segragated into gender before classification attempts. Females Males Total successful prediction rate 91.0% 89.9% Successful control prediction rate 93.5% 93.8% Successful patient prediction rate 89.4% 85.4% Average confidence of false predictions 78.0% 79.0% Average confidence of true predictions 89.0% 94.0% range range average age control 48.90 29-67 48.30 31-67 average age patient 45.70 22-58 47.10 29-65 SVM parameters Kernel; Linear Iterations; 1,000,000 Cost; 200 Repeats; 100 Ratio; 1.0 Kernel parameter 1; 0.1 Kernel parameter 2; 1 Exponent; 2 Sigma; 1 N-Fold; 3 Subject Identifier Subject Value Predicted Value Confidence Prediction Result Age C55 f50 1835_2 [control female] [control, female] 1 T 50 C55-3 f50 4157_4 [control, female] [control female] 1 T 50 CFP P3 f47 2536_1 [patient, female] [patient, female] 1 T 47 Shm EC f32 2528_2 [patient, female] [patient, female] 1 T 32 Shm127 f44 2521_3 [patient, female] [patient, female] 1 T 44 Shm163 f47 2520_1 [patient, female] [patient, female] 1 T 47 Shm212-2 f35 2521_4 [patient, female] [patient, female] 1 T 35 Shm233 f53 2533_4 [patient, female] [patient, female] 1 T 53 Shm234 f56 2534_1 [patient, female] [patient, female] 1 T 56 Shm250 f44 2535_1 [patient, female] [patient, female] 1 T 44 Shm262 f50 4908_4 [patient, female] [patient, female] 1 T 50 Shm269 f45 4392_4 [patient, female] [patient, female] 1 T 45 Shm270 f54 4909_2 [patient, female] [patient, female] 1 T 54 Shm283 f42 2519_2 [patient, female] [patient, female] 1 T 42 Shm284 f30 4909_4 [patient, female] [patient, female] 1 T 30 Shm290 f52 4910_4 [patient, female] [patient, female] 1 T 52 Shm293 f53 4158_3 [patient, female] [patient, female] 1 T 53 Shm295 f33 2519_4 [patient, female] [patient, female] 1 T 33 Shm306 f58 2518_4 [patient, female] [patient, female] 1 T 58 Shm309 f52 4158_1 [patient, female] [patient, female] 1 T 52 Shm309 f52 4160_2 [patient, female] [patient, female] 1 T 52 Shm337 f50 4390_2 [patient, female] [patient, female] 1 T 50 Shm78 f42 2521_2 [patient, female] [patient, female] 1 T 42 Shm9 f40 2522_4 [patient, female] [patient, female] 1 T 40 ShmA17 f53 2525_2 [patient, female] [patient, female] 1 T 53 C46-1 f55 2542_3 [control, female] [control, female] 0.99 T 55 C62 f31 1839_4 [control, female] [control, female] 0.99 T 31 Shm319 f53 2520_2 [patient, female] [patient, female] 0.99 T 53 Shm319 f53 4157_3 [patient, female] [patient, female] 0.99 T 53 C46-3 f55 2534_2 [control, female] [control, female] 0.98 T 55 C62 f31 2541_3 [control, female] [control, female] 0.98 T 31 CCC799 f56 2523_4 [control, female] [control, female] 0.98 T 56 Shm258 f50 4393_2 [patient, female] [control, female] 0.98 F 50 PCC405 f55 2535_4 [patient, female] [patient, female] 0.98 T 55 C73-1 f38 4156_4 [control, female] [control, female] 0.97 T 38 CCC799 f56 2536_2 [control, female] [control, female] 0.97 T 56 ShmA10 f38 2522_1 [patient, female] [control, female] 0.97 F 38 Shm246-1 f52 1839_2 [patient, female] [patient, female] 0.97 T 52 C46-2 f55 2530_1 [control, female] [control, female] 0.96 T 55 Shm276 f35 4391_4 [patient, female] [patient, female] 0.96 T 35 C93-1 f67 4909_1 [control, female] [control, female] 0.95 T 67 Shm325-3 f52 4160_4 [patient, female] [patient, female] 0.94 T 52 Shm144 f56 2528_4 [patient, female] [control, female] 0.92 F 56 C47 f34 2528_1 [control, female] [control, female] 0.90 T 34 Shm349 f50 4389_2 [patient, female] [patient, female] 0.90 T 50 C93-2 f67 4389_3 [control, female] [control, female] 0.88 T 67 Shm212 f35 2542_2 [patient, female] [patient, female] 0.88 T 35 Shm246-2 f52 2542_4 [patient, female] [patient, female] 0.88 T 52 C73-2 f38 43923 [control, female] [control, female] 0.87 T 38 C45-2 f43 2531_3 [control, female] [control, female] 0.86 T 43 C105 f59 4909_3 [control, female] [control, female] 0.85 T 59 Shm151 f22 1836_3 [patient, female] [patient, female] 0.85 T 22 PCC405 f55 2524_4 [patient, female] [patient, female] 0.84 T 55 Shm271 f46 4392_2 [patient, female] [patient, female] 0.84 T 46 TW-1 f45 2531_4 [patient, female] [patient, female] 0.82 T 45 TW-2 f45 2533_2 [patient, female] [patient, female] 0.82 T 45 C51 f32 1837_4 [control, female] [patient, female] 0.81 F 32 C45-1 f43 2542_1 [control, female] [control, female] 0.81 T 43 CCC765 f52 2523_1 [control, female] [control, female] 0.80 T 52 C108 f64 4910_1 [control, female] [control, female] 0.79 T 64 C71-1 f53 2518_2 [control, female] [control, female] 0.78 T 53 Shm260 f45 4393_4 [patient, female] [patient, female] 0.77 T 45 CCC765 f52 2537_4 [control, female] [control, female] 0.76 T 52 C57 f45 2541_2 [control, female] [control, female] 0.74 T 45 C68-1 f29 2519_1 [control, female] [patient, female] 0.73 F 29 C57 f45 1838_4 [control, female] [control, female] 0.72 T 45 C71-2 f53 4159_4 [control, female] [control, female] 0.70 T 53 Shm187 f50 2541_1 [patient, female] [patient, female] 0.70 T 50 Shm286 f47 4391_2 [patient, female] [patient, female] 0.69 T 47 C36-1 f49 2528_3 [control, female] [control, female] 0.67 T 49 C36-2 149 2533_3 [control, female] [control, female] 0.67 T 49 Shm352-2 f32 4160_1 [patient, female] [patient, female] 0.65 T 32 Shm3524 f32 4156_3 [patient, female] [patient, female] 0.64 T 32 C105-2 f59 4389_1 [control, female] [control, female] 0.63 T 59 C37-2 f61 4390_1 [control, female] [control, female] 0.61 T 61 C52 f30 1836_2 [control, female] [control, female] 0.60 T 30 Shm245 f52 2532_3 [patient, female] [control, female] 0.56 F 52 Shm204 f30 2541_4 [patient, female] [control, female] 0.52 F 30 total successful prediction rate 0.91 successful control prediction rate 0.94 successful patient prediction rate 0.89 average confidence of false predictions 0.78 average confidence of true predictions 0.89 range average age control 48.90 29-67 average age patient 45.70 22-58 Subject identifier Subject Value Predicted Value Confidence Prediction Result Age C111 m41 4910_3 [control, male] [control, male] 1 T 41 C41-2 m36 4392_1 [control, male] [control, male] 1 T 36 C44-2 m31 4157_2 [control, male] [control, male] 1 T 31 C54 m48 2526_2 [control, male] [control, male] 1 T 48 C54-2 m48 2532_4 [control, male] [control, male] 1 T 48 C54-3 m48 2520_3 [control, male] [control, male] 1 T 48 C56-2 m40 4158_2 [control, male] [control, male] 1 T 40 C59-2 m61 4391_3 [control, male] [control, male] 1 T 61 C65-1 m40 2540_1 [control, male] [control, male] 1 T 40 C65-2 m40 2534_4 [control, male] [control, male] 1 T 40 C66-2 m59 2537_2 [control, male] [control, male] 1 T 59 C67-1 m35 2520_4 [control, male] [control, male] 1 T 35 C70-1 m51 2518_1 [control, male] [control, male] 1 T 51 CC211 m59 2524_1 [control, male] [control, male] 1 T 59 CC211 m59 2535_3 [control, male] [control, male] 1 T 59 CFP C4-2 m49 2526_4 [control, male] [control, male] 1 T 49 CFP P1-1 m60 2527_4 [patient, male] [patient, male] 1 T 60 CFP P1-2 m60 2539_2 [patient, male] [patient, male] 1 T 60 CFP P8-1 m46 2526_3 [patient, male] [patient, male] 1 T 46 CFP P8-1 m46 2532_1 [patient, male] [patient, male] 1 T 46 CFP P8-2 m46 2525_4 [patient, male] [patient, male] 1 T 46 PCC991 m65 2523_3 [patient, male] [patient, male] 1 T 65 Shm153 m29 1836_1 [patient, male] [patient, male] 1 T 29 Shm239 m49 2540_2 [patient, male] [patient, male] 1 T 49 Shm239-2 m49 2538_3 [patient, male] [patient, male] 1 T 49 5hrn298 m43 4159_1 [patient, male] [patient, male] 1 T 43 Shm308 m55 4159_3 [patient, male] [patient, male] 1 T 55 Shm71-1 m33 1835_1 [patient, male] [patient, male] 1 T 33 Shm73 m41 1835_3 [patient, male] [patient, male] 1 T 41 C32-2 m46 2538_4 [control, male] [control, male] 0.99 T 46 C42-2 m36 2522_3 [control, male] [control, male] 0.99 T 36 C44-1 m31 2529_1 [control, male] [control, male] 0.39 T 31 C60-2 m64 4158_4 [control, male] [control, male] 0.99 T 64 C61-2 m29 4391_1 [control, male] [control, male] 0.99 T 29 C66-1 m59 2540_4 [control, male] [control, male] 0.99 T 59 C70-2 m51 4159_2 [control, male] [control, male] 0.99 T 51 PCC991 m65 2536_3 [patient, male] [patient, male] 0.39 T 65 Shm175-2 m29 2530_4 [patient, male] [patient, male] 0.99 T 29 Shm261 m54 4908_2 [patient, male] [patient, male] 0.99 T 54 Shm287 m49 4910_2 [patient, male] [patient, male] 0.99 T 49 Shm353 m44spc 4156_1 [patient, male] [control, male] 0.98 F 44 C32 m48 1837_2 [control, male] [control, male] 0.98 T 48 C59-1 m61 1839_3 [control, male] [control, male] 0.98 T 61 C72-2 m32 4390_3 [control, male] [control, male] 0.98 T 32 CCC505 m45 2536_4 [control, male] [control, male] 0.98 T 45 CCC505 m45 4160_3 [control, male] [control, male] 0.98 1 45 Shm186-2 m46 2540_3 [patient, male] [patient, male] 0.98 T 46 C81 m55 4393_1 [control, male] [control, male] 0.97 T 55 Shm132 m57 1837_8 [patient, male] [patient, male] 0.97 T 57 Shm186 m46 2538_1 [patient, male] [patie.nt, male] 0.97 T 46 Shm1864 m46 1838_2 [patient, male] [patient, male) 0.97 T 46 Shm175 m29 1838_1 [patient, male] [patient, male] 0.96 T 29 Shm241 m35 2534_3 [patient, male] [control, male] 0.95 F 35 C27 m33 1835_4 [control, male] [control, male] 0.95 T 33 C31-2 m52 2538_2 [control.. male] [control, male] 0.95 T 52 CFP C4-1 m49 2527_1 [control, male] [control, male] 0.95 T 49 PCC27 m34 2524_2 [patient, male] [patient, male] 0.94 T 34 Shm158 m34 2529_2 [patient, male] [patient, male] 0.94 T 34 CFP P7-1 m58 2526_1 [patient, male] [patient, male] 0.93 T 58 C35 m55 2532_2 [control, male] [control, male] 0.92 T 55 C56 m40 1836_4 [control, male] [control, male] 0.92 T 40 CFP C1-2 m60 2527_3 [control, male] [control, male] 0.92 T 60 PCC569 m47 2523_2 [patient, male] [patient, male] 0.91 T 47 ShmGW-1 m47 1837_1 [patient, male] [patient, male] 0.91 T 47 ShmGW-3 m47 2537_3 [patient, male] [patient, male] 0.91 T 47 PCC27 m34 2537_1 [patient, male] [patient, male] 0.9 T 34 Shm191 m59 1839_1 [patient, male] [control, male] 0.88 F 59 Shm201 m53 2531_2 [patient, male] [control, male] 0.88 F 53 PCC569 m47 2535_2 [patient, male] [patient, male] 0.88 T 47 ShmGW m47 2539_3 [patient, male] [patient, male] 0.88 T 47 CFP P7-2 m58 2527_2 [patient, male] [patient, male] 0.87 T 58 C49-2 m49 2525_1 [control, male] [patient, male] 0.85 F 49 C92 m67 4908_3 [control, male] [control, male] 0.85 T 67 CFP C1-1 m60 2539_1 [control, male] [control, male] 0.81 T 60 C34-2 m55 2531_1 [control, male] [control, male] 0.79 T 55 C34-1 m55 1838_3 [control, male] [control, male] 0.78 T 55 C72-1 m32 4156_2 [control, male] (control, male] 0.78 T 32 C31-1 m52 2529_3 [control, male] [control, male] 0.77 T 52 ShmA14 m53 2525_3 [patient, male] [patient, male] 0.74 T 53 C43-2 m42 2533_1 [control, male] [patient, male] 0.73 F 42 C33 m49 2539_4 [control, male] [control, male] 0.73 T 49 C33-2 m49 2530_3 [control, male] [control, male] 0.73 T 49 Shm344 m45 4389_4 [patient, male] [patient, male] 0.72 T 45 C69-2 m63 2519_3 [control, male] [control, male] 0.7 T 63 Shm236 m47 2529_4 [patient, male] [patient, male] 0.7 T 47 ShmA18 m41 2522_2 [patient, male] [control, male] 0.68 F 41 Shm136 m59 2530_2 [patient, male] [control, male] 0.6 F 59 C88 m58 4908_1 [control, male] [control, male] 0.57 T 58 C82 m50 4393_3 [control, male] [patient, male] 0.55 F 50 total successful prediction rate 0.90 successful control prediction rate 0.94 successful patient prediction rate 0.85 average confidence of false predictions 0.79 average confidence of true predictions 0.94 range average age control 48.30 31-67 average age patient 47.10 29-65 

The invention claimed is:
 1. A method of treating chronic inflammatory response syndrome (CIRS) in a subject, comprising administering a therapeutically effective amount of vasoactive intestinal peptide (VIP) to the subject.
 2. The method of claim 1, wherein the therapeutically effective amount of VIP is 10 to 100 micrograms.
 3. The method of claim 1, wherein the therapeutically effective amount of VIP is 25 to 75 micrograms.
 4. The method of claim 1, wherein the therapeutically effective amount of VIP is 50 micrograms.
 5. The method of claim 1, wherein the therapeutically effective amount is administered 1 to 4 times per day.
 6. The method of claim 1, wherein the therapeutically effective amount is administered nasally or injected.
 7. The method of claim 1, wherein the therapeutically effective amount is 10 to 100 micrograms, is administered 1 to 4 times per day, and is administered nasally.
 8. The method of claim 1, wherein the therapeutically effective amount is 50 micrograms, is administered 1 to 4 times per day, and is administered nasally.
 9. The method of claim 1, wherein the subject additionally exhibits an increase in forebrain parenchyma, an increase in cortical gray area, an increase in the volume of the hippocampus, a decrease in the volume of caudate, and/or an increase in the volume of palladium compared to a subject not having CIRS.
 10. The method of claim 1, further comprising administering a therapeutically effective amount of cholestyramine to the subject; treating the subject to eliminate MARCoNS infection if the subject has MARCoNS infection; and correcting or restoring levels of antigliadin, androgens, ADH/osmolality, MMP9, VEGF, C3a, C4a, and TGF-β1 in the subject before administering said therapeutically effective amount of VIP.
 11. The method of claim 7, further comprising administering a therapeutically effective amount of cholestyramine to the subject; treating the subject to eliminate MARCoNS infection if the subject has MARCoNS infection; and correcting or restoring levels of antigliadin, androgens, ADH/osmolality, MMP9, VEGF, C3a, C4a, and TGF-β1 in the subject before administering said therapeutically effective amount of VIP.
 12. The method of claim 8, further comprising administering a therapeutically effective amount of cholestyramine to the subject; treating the subject to eliminate MARCoNS infection if the subject has MARCoNS infection; and correcting or restoring levels of antigliadin, androgens, ADH/osmolality, MMP9, VEGF, C3a, C4a, and TGF-β1 in the subject before administering said therapeutically effective amount of VIP. 